Unique Drugs,Unique Targets,Drug Names,Target Name
O=C(O)CCC(=O)C(=O)O,Q9GZT9,2-ketoglutaric acid,Egl nine homolog 1;
CC(=O)OCC[N+](C)(C)C,P58154,acetylcholine,Acetylcholine-binding protein;
CCCC(=O)O,Q9Z429,butyric acid,Methyl-accepting chemotaxis protein NahY;
O=C(O)CC(O)(CC(=O)O)C(=O)O,P15474,citric acid,3-dehydroquinate dehydratase;
O=C(O)CC(O)C(=O)O,P9WNS1,malic acid,1-deoxy-D-xylulose 5-phosphate reductoisomerase {ECO:0000255|HAMAP-Rule:MF_00183};
O=CN(O)CCCP(=O)(O)O,P07550,fosmidomycin,Beta-2 adrenergic receptor;
NCCc1ccc(O)c(O)c1,P21728,dopamine,D(1A) dopamine receptor;
NCCc1cnc[nH]1,P25102,histamine,Histamine H2 receptor;
c1ccc2[nH]ccc2c1,P31390,indole,Histamine H1 receptor;
O=C([O-])Cc1c[nH]c2ccccc12,P47747,indole-3-acetate,Histamine H2 receptor;
CNCC(O)c1ccc(O)c(O)c1,P0A881,DL-Adrenaline,Trp operon repressor;
O=C(O)CC(=O)C(=O)O,P55263,oxalacetic acid,Beta-adrenergic receptor kinase 1;
CCCCCCCCCCCCCCCC(=O)O,P25098,palmitic acid,"Fatty acid-binding protein, adipocyte;"
c1ccncc1,P15090,PYRIDINE,Fatty acid-binding protein 5 {ECO:0000305};
O=C(O)c1cccnc1C(=O)O,Q01469,quinolinic acid,Advanced glycosylation end product-specific receptor;
O=C(O)CCC(=O)O,P08684,succinic acid,Thiamine-binding periplasmic protein;
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,Q15109,thiamine,1-deoxy-D-xylulose-5-phosphate synthase;
Cc1ncc(C[n+]2csc(CCOP(=O)(O)O)c2C)c(N)n1,P31550,thiamine monophosphate,5-hydroxytryptamine receptor 2B;
Cc1ncc(C[n+]2csc(CCOP(=O)(O)OP(=O)(O)O)c2C)c(N)n1,Q9RUB5,thiamine diphosphate,Translocator protein;
NCCc1c[nH]c2ccccc12,P30994,tryptamine,Carbonic anhydrase 2;
O=C(O)CC(C(=O)O)C(O)C(=O)O,P16257,isocitric acid,Sex hormone-binding globulin {ECO:0000305};
CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1,P00918,PK 11195,5-hydroxytryptamine receptor 2C {ECO:0000305};
O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12,P04278,8-Anilino-1-naphthalenesulfonic acid,5-hydroxytryptamine receptor 1D;
COc1cccc(N2CCc3cc(S(N)(=O)=O)sc3S2(=O)=O)c1,P08909,AL7182,BDNF/NT-3 growth factors receptor;
COc1ccc(N2CC(O)c3cc(S(N)(=O)=O)sc3S2(=O)=O)cc1,P28221,N-Pyridoxyl-Glycine-5-Monophosphate,Acetylcholinesterase;
CCCCCCCCCc1ccc(O)cc1,Q16620,4-nonylphenol,Beta-1 adrenergic receptor {ECO:0000305};
NCCc1c[nH]c2ccc(C(N)=O)cc12,P21836,5-Carboxamidotryptamine,Beta-3 adrenergic receptor;
O=c1cc(-c2ccccc2)oc2c(O)c(O)ccc12,P08588,"7,8-dihydroxyflavone",Cytochrome P450 1A1 {ECO:0000303|PubMed:11555828};
Nc1c2c(nc3ccccc13)CCCC2,P13945,Tacrine,Carbonic anhydrase 12 {ECO:0000305};
CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,P04798,acebutolol,Carbonic anhydrase 1;
CC(=O)Nc1ccc(O)cc1,O43570,acetaminophen,Carbonic anhydrase 4;
CC(=O)Nc1nnc(S(N)(=O)=O)s1,P00915,acetazolamide,Carbonic anhydrase 6;
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,P22748,Salbutamol,"Carbonic anhydrase 5A, mitochondrial {ECO:0000305|PubMed:8356065};"
O=c1[nH]cnc2n[nH]cc12,P23280,allopurinol,Carbonic anhydrase 7;
O=P(O)(O)Oc1cccc2ccccc12,P35218,1-Naphthyl phosphate,Carbonic anhydrase 9;
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,P43166,alprazolam,Carbonic anhydrase 13;
C=CCc1ccccc1OCC(O)CNC(C)C,Q16790,alprenolol,Beta-2 adrenergic receptor;
CC1(C)CCC(C)(C)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21,Q8N1Q1,AM580,Purine nucleoside phosphorylase;
CN(C)CCC=C1c2ccccc2CCc2ccccc21,Q28044,amitriptyline,Tyrosine-protein kinase Lck;
CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,P9WP01,amodiaquine,Bromodomain-containing protein 4;
COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,P06239,astemizole,Retinoic acid receptor alpha;
CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,O60885,atenolol,Retinoic acid receptor gamma;
CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,P10276,azelastine,Heparanase;
COC(=[OH+])C1=C(C)[N-]C(C)=C([N+](=O)[O-])C1c1ccccc1C(F)(F)F,P13631,71145-03-4,Beta-2 adrenergic receptor;
CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,P04629,bepridil,Histamine H1 receptor;
COc1c2ccoc2cc2oc(=O)ccc12,Q9Y251,Bergapten,Voltage-dependent L-type calcium channel subunit alpha-1C;
CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,Q8K4Z4,betaxolol,Envelope glycoprotein;
CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,P35367,BISOPROLOL,Potassium voltage-gated channel subfamily A member 3;
COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,Q13936,Bmy-7378,Potassium voltage-gated channel subfamily A member 6;
CCCCOc1ccc(CC(=O)NO)cc1,Q05320,bufexamac,Potassium voltage-gated channel subfamily A member 5;
Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1,P16390,BUPRANOLOL,Potassium voltage-gated channel subfamily C member 1;
CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,P17658,candesartan,Alpha-1A adrenergic receptor;
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,P22460,carvedilol,Histone deacetylase 3;
CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc4cc(C(=O)O)ccc4c3)ccc21,P48547,cd564,Type-1 angiotensin II receptor A {ECO:0000303|PubMed:2041570};
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,P43140,celecoxib,Retinoic acid receptor beta;
Cn1cc(C(F)(F)F)nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(C(N)=O)c2)cc1,O15379,CGP-20712,Prostaglandin G/H synthase 2 {ECO:0000305};
CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12,P25095,Cgp 12177,Bcl-2-like protein 1;
CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,P10826,chlorcyclizine,Riboflavin-binding protein;
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,P35354,chloroquine,Albumin;
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,Q07817,chlorpromazine,Calmodulin;
CNC(=NC#N)NCCSCc1[nH]cnc1C,P02752,cimetidine,Histamine H3 receptor;
CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,P02768,clenbuterol,Cytochrome P450 144;
NC(=NCc1ccc(Cl)cc1)SCCCc1cnc[nH]1,P62157,clobenpropit,Steroid C26-monooxygenase {ECO:0000250|UniProtKB:P9WPL5};
Clc1cccc(Cl)c1N=C1NCCN1,Q9JI35,clonidine,Cytochrome P450 130;
Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,P9WPL0,clotrimazole,Mycocyclosin synthase;
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,P9WPL4,clozapine,5-hydroxytryptamine receptor 2A;
CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,P9WPN4,CYPROHEPTADINE,Histamine H1 receptor;
N=C(N)c1ccc(-c2cc3ccc(C(=N)N)cc3[nH]2)cc1,P9WPP7,dapi,Cell division protein FtsZ {ECO:0000255|HAMAP-Rule:MF_00909};
Cc1cc(=[NH2+])c2ccccc2n1CCCCCCCCCCn1c(C)cc(=[NH2+])c2ccccc21,P14842,dequalinium,Small conductance calcium-activated potassium channel protein 3;
CNCCCN1c2ccccc2CCc2ccccc21,P31389,desipramine,Gamma-aminobutyric acid receptor subunit alpha-1;
CC(N)Cc1ccccc1,P0A9A6,AMPHETAMINE,Nicotinamide phosphoribosyltransferase;
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,P70605,diazepam,Retinoic acid receptor RXR-alpha;
CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1,P14867,diazoxide,Gamma-butyrobetaine dioxygenase;
O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,P43490,diflunisal,Cytochrome P450 130;
CN(C)CCCSC(=N)N,P19793,Dimaprit,Steroid C26-monooxygenase {ECO:0000303|PubMed:20545858};
O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,O75936,domperidone,Aurora kinase B {ECO:0000303|PubMed:33542149};
O=c1c2ccccc2[se]n1-c1ccccc1,P9WPN5,ebselen,Lanosterol 14-alpha demethylase {ECO:0000305};
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,P9WPP0,econazole,"Sterol 14-alpha demethylase {ECO:0000303|PubMed:16321980, ECO:0000312|EMBL:AAW47718.1};"
CCOc1ccc2nc(S(N)(=O)=O)sc2c1,Q96GD4,ethoxzolamide,Sodium-dependent noradrenaline transporter;
CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,Q16850,felodipine,Sodium-dependent serotonin transporter;
Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,Q7Z1V1,fenoldopam,3-phosphoshikimate 1-carboxyvinyltransferase {ECO:0000255|HAMAP-Rule:MF_00210};
OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,P23975,fluconazole,Mitogen-activated protein kinase 1 {ECO:0000305};
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,P31645,fluoxetine,Rho-associated protein kinase 2;
Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,P0A6D3,ganciclovir,Muscarinic acetylcholine receptor M3;
O=C(O)CNCP(=O)(O)O,P28482,glyphosate,Muscarinic acetylcholine receptor M2;
Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,O75116,gossypol,Adenosine receptor A1;
NC(N)=NCCNS(=O)(=O)c1cccc2cnccc12,P08483,ha-1004,Alpha-2B adrenergic receptor;
O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,P10980,Fasudil,Retinoic acid receptor RXR-beta;
CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,P30542,Butylscopolamine BR,Sodium-dependent dopamine transporter;
Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2,P18089,"ICI-118,551",Muscarinic acetylcholine receptor M2;
CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,P28704,indapamide,Muscarinic acetylcholine receptor M1;
COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,P23977,indomethacin,Beta-1 adrenergic receptor;
CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21,P08172,3-Isobutyl-1-methylxanthine,Fibroblast growth factor 1;
CC(C)NCC(O)c1ccc(O)c(O)c1,P08482,isoproterenol,Fibroblast growth factor 2;
CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,P18090,labetalol,Sodium-dependent dopamine transporter;
Cc1cc2c(cc1C1(c3ccc(C(=O)O)cn3)CC1)C(C)(C)CCC2(C)C,P05230,153559-76-3,5-hydroxytryptamine receptor 3A {ECO:0000305|PubMed:9463477};
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,P09038,losartan,Tyrosine-protein phosphatase non-receptor type 1;
OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21,Q01959,mazindol,Carbon monoxide dehydrogenase small chain;
CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21,O70212,medazepam,"Poly [ADP-ribose] polymerase 1 {ECO:0000303|PubMed:2824474, ECO:0000303|PubMed:3120710};"
CC(C)NCC(O)c1cc(O)cc(O)c1,P18031,metaproterenol,Beta-2 adrenergic receptor;
COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC,P19921,Methoctramine,Sodium-dependent serotonin transporter;
C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,P09874,Pamine Bromide,5-hydroxytryptamine receptor 1A;
COCCc1ccc(OCC(O)CNC(C)C)cc1,P54833,metoprolol,ATP-dependent translocase ABCB1 {ECO:0000250|UniProtKB:P08183};
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,Q2NNR5,miconazole,D(2) dopamine receptor;
CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,P31652,Moxisylyte,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform;"
NS(=O)(=O)c1ccc(S(=O)(=O)NCc2cccs2)s1,P08908,"n-(2-thienylmethyl)-2,5-thiophenedisulfonamide",Serine/threonine-protein kinase PLK4 {ECO:0000305};
COc1ccc2c(c1)c(CC(=O)NCCc1cccnc1)c(C)n2C(=O)c1ccc(Cl)cc1,P21447,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",Dual specificity mitogen-activated protein kinase kinase 7;
COc1ccc(CNS(=O)(=O)c2ccc(S(N)(=O)=O)s2)cc1,P14416,AL5927,Aurora kinase A {ECO:0000312|HGNC:HGNC:11393};
O=S(=O)([O-])c1ccc2c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])cc2c1,O00329,naphthalene trisulfonate,Cyclin-G-associated kinase {ECO:0000305};
CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,O00444,nefazodone,Serine/threonine-protein kinase DCLK1;
CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,O14733,ofloxacin,Ephrin type-B receptor 6;
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,O14965,olanzapine,Mitogen-activated protein kinase 13;
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,O14976,ondansetron,Mitogen-activated protein kinase kinase kinase 13;
O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,O15075,oxazepam,Death-associated protein kinase 3;
O=c1[nH]c(=O)c2c[nH]nc2[nH]1,O15197,Oxypurinol,Mitogen-activated protein kinase kinase kinase 7;
Nc1ccc(C(=O)O)c(O)c1,O15264,4-Aminosalicylic acid,NUAK family SNF1-like kinase 1;
O=C1C=CC(=O)C=C1,O43283,p-benzoquinone,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma {ECO:0000305|PubMed:12422219};
CC(C)NCC(O)COc1cccc2[nH]ccc12,O43293,pindolol,Serine/threonine-protein kinase ULK1 {ECO:0000305};
CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,O43318,PJ34,Ribosomal protein S6 kinase alpha-5;
CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,O60285,practolol,Serine/threonine-protein kinase 16;
O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1,O60331,Pranlukast,Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma {ECO:0000305};
CC(C)NCC(O)c1ccc2ccccc2c1,O75385,pronethalol,Serine/threonine-protein kinase PAK 3;
CC(C)NCC(O)COc1cccc2ccccc12,O75582,propranolol,Cyclin-dependent kinase 14;
O=[N+]([O-])c1ccc2nc(N3CCNCC3)ccc2c1,O75716,6-nitroquipazine,Mitogen-activated protein kinase kinase kinase 6;
CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1,O75747,ROXATIDINE ACETATE,Serine/threonine-protein kinase OSR1;
OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,O75914,Salmeterol,Mitogen-activated protein kinase kinase kinase kinase 4;
Cn1ccc2cc3c(cc21)CCN3C(=O)Nc1cccnc1,O94921,158942-04-2,Serine/threonine-protein kinase LATS1;
NCCc1c[nH]c2ccc(O)cc12,O95382,serotonin,Serine/threonine-protein kinase PAK 4;
COc1cc(C2Oc3cc(C4Oc5cc(O)cc(O)c5C(=O)C4O)ccc3OC2CO)ccc1O,O95747,SILYMARIN,Serine/threonine-protein kinase Chk2;
CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,O95819,sotalol,Tyrosine-protein kinase ABL1;
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,O95835,spiperone,Epidermal growth factor receptor {ECO:0000305};
CCCCCCCCCCCCCCCCCC(=O)O,O96013,stearic acid,High affinity nerve growth factor receptor;
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,O96017,Imatinib,Insulin receptor;
O=C(CCCCCCC(=O)Nc1ccccc1)NO,P00519,Vorinostat,Tyrosine-protein kinase Fyn;
Nc1ccc(S(N)(=O)=O)cc1,P00533,sulfanilamide,Tyrosine-protein kinase Fes/Fps;
CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,P06213,sumatriptan,Tyrosine-protein kinase Yes;
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,P06241,terazosin,Tyrosine-protein kinase Lyn;
CC(C)(C)NCC(O)c1cc(O)cc(O)c1,P07332,terbutaline,Proto-oncogene tyrosine-protein kinase receptor Ret {ECO:0000305};
CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,P07947,terfenadine,Insulin-like growth factor 1 receptor;
CCCCNc1ccc(C(=O)OCCN(C)C)cc1,P07948,tetracaine,Hepatocyte growth factor receptor;
CN(C)C(=S)SSC(=S)N(C)C,P07949,thiram,Tyrosine-protein kinase HCK;
CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,P08069,racemic-Timolol,Uncharacterized serine/threonine-protein kinase SBK3;
CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,P08581,tolbutamide,Mast/stem cell growth factor receptor Kit;
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,P08631,triazolam,Serine/threonine-protein kinase pim-1;
Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,P0C264,triclosan,"Myosin light chain kinase, smooth muscle;"
CN1C(=O)OC(C)(C)C1=O,P10721,trimethadione,Serine/threonine-protein kinase B-raf {ECO:0000305};
NCCc1ccc(O)cc1,P11309,tyramine,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform;"
COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,P11799,venlafaxine,Platelet-derived growth factor receptor alpha;
CCOc1ccccc1OCC1CNCCO1,P15056,viloxazine,Tyrosine-protein kinase Fer;
COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,P15735,WB-4101,cAMP-dependent protein kinase catalytic subunit alpha;
Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C,P16234,Pirinixic acid,Vascular endothelial growth factor receptor 1;
NS(=O)(=O)Cc1noc2ccccc12,P16591,zonisamide,Casein kinase II subunit alpha';
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,P17612,CORTICOSTERONE,Serine/threonine-protein kinase MAK;
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,P17948,estradiol,Ephrin type-A receptor 1;
Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,P19784,phentolamine,Receptor tyrosine-protein kinase erbB-3;
CNC[C@H](O)c1ccc(O)c(O)c1,P20794,epinephrine,Fibroblast growth factor receptor 4;
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12,P21709,ALDOSTERONE,cAMP-dependent protein kinase catalytic subunit beta;
C[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,P21860,"3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane",Ribosomal protein S6 kinase beta-1;
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,P22455,estrone,Tyrosine-protein kinase JAK1;
C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O,P22694,androsterone,Cyclin-dependent kinase 2;
C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O,P23443,etiocholanolone,Ephrin type-A receptor 2;
C[C@@]12CCC[C@H]1[C@@H]1CCc3cc(O)ccc3[C@H]1CC2,P23458,17-Deoxyestradiol,Ephrin type-A receptor 3;
CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C,P24941,pilocarpine,Ephrin type-A receptor 8;
N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,P29317,liothyronine,Leukocyte tyrosine kinase receptor {ECO:0000303|PubMed:1655406};
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[P@@](=O)(O)O[P@](=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,P29320,Adenosine triphosphate,Non-receptor tyrosine-protein kinase TYK2;
C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,P29322,ethinyl estradiol,Wee1-like protein kinase;
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,P29376,cholesterol,Tyrosine-protein kinase receptor UFO;
COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C,P29597,tubocurarine,RAC-alpha serine/threonine-protein kinase;
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,P30291,apomorphine,RAC-beta serine/threonine-protein kinase;
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,P30530,methyltestosterone,G protein-coupled receptor kinase 4;
COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2,P31749,TETRABENAZINE,Dual specificity protein kinase TTK;
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,P31751,Adenosine 5'-diphosphate,Vascular endothelial growth factor receptor 3;
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[P@](=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,P32298,Adenosine 5'-diphosphate,Activin receptor type-1B;
c1ccc2c(c1)OCC(CN1CCCCC1)O2,P33981,Piperoxan,Serine/threonine-protein kinase receptor R3;
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O,P35916,5'-adenylic acid,Tyrosine-protein kinase CSK;
CNCCc1c[nH]c2ccccc12,P36896,N-Methyltryptamine,Protein kinase C iota type;
CN(C)CCc1c[nH]c2ccccc12,P37023,"N,N-DIMETHYLTRYPTAMINE","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;"
O=C(O)CCCC[C@@H]1CCSS1,P41240,1200-22-2,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform;"
Nc1ccccc1,P41743,ANILINE,Serine/threonine-protein kinase mTOR {ECO:0000305};
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CCC2=O,P42336,androstenedione,Tyrosine-protein kinase ABL2;
Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1,P42338,Cytidine 5'-diphosphate,Tyrosine-protein kinase FRK;
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,P42345,(+)-Lactose,Tyrosine-protein kinase SYK;
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,P42684,norethindrone,Mitogen-activated protein kinase 8;
CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1,P42685,BENZIODARONE,Mitogen-activated protein kinase 9;
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,P43405,hydroxyprogesterone,Casein kinase I isoform alpha;
Nc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,P45983,tubercidin,Casein kinase I isoform delta;
Cc1ccc(S(N)(=O)=O)cc1,P45984,P-TOLUENESULFONAMIDE,MAP kinase-activated protein kinase 2;
CC(C)NCC(O)c1ccc([N+](=O)[O-])cc1,P48729,Nifenalol,Casein kinase I isoform epsilon;
O=C(O)CCS,P48730,3-MERCAPTOPROPIONIC ACID,Dual specificity protein kinase CLK2;
CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,P49137,Bisphenol A,Dual specificity protein kinase CLK3;
CN1[C@@H]2CC[C@@H]1CC(OC(c1ccccc1)c1ccccc1)C2,P49674,Mipsagargin,Glycogen synthase kinase-3 beta {ECO:0000305};
Oc1c(Cl)cccc1Cl,P49760,"2,6-DICHLOROPHENOL",Cyclin-dependent kinase 7;
Oc1c(Cl)cc(Cl)cc1Cl,P49761,"2,4,6-TRICHLOROPHENOL",Cyclin-dependent kinase 9;
Cc1ccc(O)c(C(=O)O)c1,P49841,5-Methylsalicylic acid,Tyrosine-protein kinase Blk;
Oc1cccc2ccccc12,P50613,1-NAPHTHOL,Interleukin-1 receptor-associated kinase 1 {ECO:0000303|PubMed:16024789};
CCN(CC)c1ccc2c(C)cc(=O)oc2c1,P50750,7-DIETHYLAMINO-4-METHYLCOUMARIN,Ribosomal protein S6 kinase alpha-3;
Oc1ccc(-c2ccccc2)cc1,P51451,4-Phenylphenol,Cytoplasmic tyrosine-protein kinase BMX;
Oc1ccc(-c2ccc(O)cc2)cc1,P51617,"4,4'-Dihydroxybiphenyl",cAMP-dependent protein kinase catalytic subunit PRKX;
Oc1ccccc1Cl,P51812,2-CHLOROPHENOL,Serine/threonine-protein kinase Nek2;
CC(OP(C)(=O)F)C(C)(C)C,P51813,SOMAN,Serine/threonine-protein kinase Nek4;
Cc1ccccc1N=C(N)Nc1ccccc1C,P51817,"1,3-Di-o-tolylguanidine",Tyrosine-protein kinase JAK3 {ECO:0000305};
NS(=O)(=O)c1ccccc1,P51955,BENZENESULFONAMIDE,Serine/threonine-protein kinase PLK1;
Nc1cccc(C(=O)O)c1,P51957,3-AMINOBENZOIC ACID,Death-associated protein kinase 1;
NCc1ccccc1,P52333,BENZYLAMINE,LIM domain kinase 1;
CC(C)OP(C)(=O)F,P53350,SARIN,LIM domain kinase 2;
COc1ccc(CC(C)N)cc1OC,P53355,"3,4-Dimethoxyamphetamine",Mitogen-activated protein kinase 10;
CC(C)NCC(=O)c1ccc(O)c(O)c1,P53667,121-28-8,Ephrin type-B receptor 3;
Oc1c2ccccc2c2c3c(cccc13)N=N2,P53671,129-56-6,Ephrin type-A receptor 4;
O=C(O)c1cc(-c2ccccc2)nc2ccccc12,P53779,Cinchophen,Hormonally up-regulated neu tumor-associated kinase;
Oc1ccc2ccccc2c1,P54753,2-NAPHTHOL,Serine/threonine-protein kinase SIK1;
Nc1nc2ccccc2s1,P54764,2-AMINOBENZOTHIAZOLE,Tubulin alpha-1A chain;
NS(=O)(=O)c1ccc(C(=O)O)cc1,P57058,4-Sulfamoylbenzoic acid,Casein kinase II subunit alpha;
CC(C)(C)CC(C)(C)c1ccc(O)cc1,P57059,4-tert-Octylphenol,Serine/threonine-protein kinase PknB;
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,P68370,pregnenolone,Cyclin-dependent kinase 3;
Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1,P68400,Guanosine 5'-diphosphate,Cyclin-dependent kinase 5 {ECO:0000312|HGNC:HGNC:1774};
Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,P9WI81,Cianidanol,Cyclin-dependent kinase 16;
c1ccc2[nH]ncc2c1,Q00526,1H-Indazole,Cyclin-dependent kinase 17;
Cc1cc(C(=O)O)n[nH]1,Q00535,5-Methyl-1H-pyrazole-3-carboxylic acid,Angiopoietin-1 receptor;
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,Q00536,LITHOCHOLIC ACID,Protein kinase C theta type;
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)C(=O)C[C@@]21C,Q00537,9-Fluoro-17-methyl-11-oxotestosterone,Activin receptor type-1;
CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,Q02763,enoxolone,Macrophage-stimulating protein receptor;
C=C(C)[C@H]1CN[C@H](C(=O)O)[C@H]1CC(=O)O,Q04759,kainic acid,Protein kinase C delta type {ECO:0000305};
O=c1[nH]ccc2ccccc12,Q04771,1-Hydroxyisoquinoline,Epithelial discoidin domain-containing receptor 1;
O=C(NO)c1ccccc1,Q04912,N-Hydroxybenzamide,Myotonin-protein kinase;
O=C(O)c1ccnc(C(=O)O)c1,Q05655,"Pyridine-2,4-dicarboxylic acid",Mitogen-activated protein kinase kinase kinase kinase 2;
Nc1ccccn1,Q08345,2-AMINOPYRIDINE,Mitogen-activated protein kinase kinase kinase 12;
COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,Q09013,podophyllotoxin,Serine/threonine-protein kinase 4;
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,Q12851,mestanolone,5'-AMP-activated protein kinase catalytic subunit alpha-1;
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,Q12852,Androstenediol,Serine/threonine-protein kinase PAK 1 {ECO:0000303|PubMed:8805275};
C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,Q13043,STANOLONE,Mitogen-activated protein kinase 7;
O=c1cc(-c2ccccc2)oc2ccccc12,Q13131,FLAVONE,Serine/threonine-protein kinase PAK 2;
OCCc1c[nH]c2ccccc12,Q13153,Tryptophol,cGMP-dependent protein kinase 2;
O=c1c(O)c(-c2ccccc2)oc2ccccc12,Q13164,3-Hydroxyflavone,Rho-associated protein kinase 1;
Nc1ccc2ccccc2n1,Q13177,2-AMINOQUINOLINE,Non-receptor tyrosine-protein kinase TNK1;
Oc1cc(Cl)cc(Cl)c1,Q13237,"3,5-DICHLOROPHENOL",Calcium/calmodulin-dependent protein kinase type II subunit beta;
N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12,Q13464,TOYOCAMYCIN,Calcium/calmodulin-dependent protein kinase type II subunit delta;
Oc1cc(Cl)c(Cl)c(Cl)c1,Q13470,"3,4,5-TRICHLOROPHENOL",Dual specificity tyrosine-phosphorylation-regulated kinase 1A;
Cc1ccc2[nH]ccc2c1,Q13554,5-METHYLINDOLE,Activin receptor type-2B;
O=C(O)c1ccc[nH]1,Q13557,PYRROLE-2-CARBOXYLIC ACID,Bone morphogenetic protein receptor type-2;
c1ccc(-n2cccc2)cc1,Q13627,1-Phenylpyrrole,cGMP-dependent protein kinase 1;
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Q13705,erythromycin,Cyclin-dependent kinase 13;
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,Q13873,Levonorgestrel,Calcium/calmodulin-dependent protein kinase type 1;
Oc1c(Cl)c(Cl)cc(Cl)c1Cl,Q13976,"2,3,5,6-TETRACHLOROPHENOL",Inhibitor of nuclear factor kappa-B kinase subunit epsilon;
O=c1oc2ccccc2cc1O,Q14004,3-Hydroxycoumarin,Protein-tyrosine kinase 2-beta;
c1ccc(-c2ccncc2)cc1,Q14012,4-PHENYLPYRIDINE,Maternal embryonic leucine zipper kinase;
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,Q14164,VANCOMYCIN,Serine/threonine-protein kinase 38;
CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,Q14289,Glycyrrhizic acid,Ribosomal protein S6 kinase alpha-1;
CN1C[C@H](CO)C=C2c3cccc4[nH]cc(c34)C[C@H]21,Q14680,lysergol,Mitogen-activated protein kinase 11;
C[C@H]1CC(=O)C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]12C,Q15208,Mesterolone,Rhodopsin kinase GRK1;
c1ccc([Se][Se]c2ccccc2)cc1,Q15418,Diphenyl diselenide,Serine/threonine-protein kinase N1;
Cc1ccc2[nH]cc(CCN)c2c1,Q15759,5-Methyltryptamine,Serine/threonine-protein kinase N2;
C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,Q15835,Hombreol,Calcium/calmodulin-dependent protein kinase type IV;
Cc1cccc(N)c1N,Q16512,"2,3-DIAMINOTOLUENE",Mitogen-activated protein kinase kinase kinase 11;
COc1ccc(OC)c(C(O)C(C)NC(C)(C)C)c1,Q16513,Butaxamine,Mitogen-activated protein kinase 6;
c1ccc(-c2nnc[nH]2)cc1,Q16566,"3-Phenyl-1H-1,2,4-triazole","Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform;"
CC(C)NCC(O)c1cccc(O)c1,Q16584,Metaterol,Discoidin domain-containing receptor 2;
N[C@@H]1C[C@H]1c1ccccc1,Q16659,tranylcypromine,AP2-associated protein kinase 1;
Nc1ncncn1,Q16816,"1,3,5-Triazin-2-amine",Serine/threonine-protein kinase SBK1;
CC(C)NC[C@@H](O)COc1cccc2ccccc12,Q16832,DEXPROPRANOLOL,Mitogen-activated protein kinase kinase kinase 19;
Cl[Se]c1ccccc1,Q2M2I8,5707-04-0,Serine/threonine-protein kinase TNNI3K;
O=[Se](O)c1ccccc1,Q52WX2,Benzeneseleninic acid,Leucine-rich repeat serine/threonine-protein kinase 2;
CC(C)NCC(O)c1ccc(O)cc1,Q56UN5,Deterenol,Serine/threonine-protein kinase MRCK gamma;
CC(C)(C)NCC(O)c1ccc(O)cc1,Q59H18,t-Butylnorsynephrine,Serine/threonine-protein kinase Nek5;
CC(C)(C)NCC(O)c1ccc(O)c(O)c1,Q5S007,Colterol,Serine/threonine-protein kinase ULK3;
CN(C)CCCc1ccccc1,Q6DT37,"N,N-dimethyl-3-phenylpropan-1-amine",Dual serine/threonine and tyrosine protein kinase;
NC(=O)Nc1cccc(C(F)(F)F)c1,Q6P3R8,13114-87-9,Mitogen-activated protein kinase kinase kinase 15;
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC,Q6PHR2,Gestrinone,Serine/threonine-protein kinase MARK2;
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,Q6XUX3,danazol,Serine/threonine-protein kinase TAO1;
CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,Q6ZN16,LISURIDE,Serine/threonine-protein kinase tousled-like 2;
Oc1cccc2cnccc12,Q7KZI7,5-Hydroxyisoquinoline,Serine/threonine-protein kinase pim-3;
COc1ccc(CC(C)N)c(OC)c1OC,Q7L7X3,"1-(2,3,4-trimethoxyphenyl)propan-2-amine",Myosin light chain kinase family member 4;
COc1cc(OC)c(OC)cc1CC(C)N,Q86UE8,"2,4,5-Trimethoxyamphetamine",Homeodomain-interacting protein kinase 1;
CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,Q86V86,timolol,Calcium/calmodulin-dependent protein kinase type 1D;
NC1CCc2ccccc2C1,Q86YV6,2954-50-9,Mitogen-activated protein kinase kinase kinase kinase 3;
C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,Q86Z02,S-adenosyl-L-methionine,Cyclin-dependent kinase-like 3 {ECO:0000305};
CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC,Q8IU85,"Phorbol 12,13-dibutyrate",MAP kinase-activated protein kinase 5;
CC(C)NCC(O)COc1ccccc1C#N,Q8IVH8,38555-07-6,Serine/threonine-protein kinase NIM1;
Cc1cccc2sc3nncn3c12,Q8IVW4,TRICYCLAZOLE,Serine/threonine-protein kinase ULK2;
CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2,Q8IW41,nadolol,Misshapen-like kinase 1;
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC,Q8IY84,DESOGESTREL,Homeodomain-interacting protein kinase 4;
Cc1nc[nH]c1CSCCN=C(N)NCCCc1cnc[nH]1,Q8IYT8,IMPROMIDINE,Myosin-IIIa;
CC(C)NC[C@H](O)COc1ccc(O)cc1,Q8N4C8,Prenalterol,Ankyrin repeat and protein kinase domain-containing protein 1;
Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,Q8NE63,paroxetine,Serine/threonine-protein kinase Nek11;
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,Q8NEV4,captopril,Serine/threonine-protein kinase Nek9 {ECO:0000305};
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Q8NFD2,staurosporine,Serine/threonine-protein kinase BRSK1;
CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Q8NG66,ketoconazole,Serine/threonine-protein kinase 35;
N=C(N)c1ccc(Oc2ccc(-c3cc4ccc(C(=N)N)cc4[nH]3)cc2)cc1,Q8TD19,2-[4-(4-carbamimidoylphenoxy)phenyl]-1H-indole-6-carboximidamide,Serine/threonine-protein kinase Nek7 {ECO:0000305|PubMed:31409757};
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,Q8TDC3,forskolin,Rhodopsin kinase GRK7;
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,Q8TDR2,lovastatin,Serine/threonine-protein kinase 32A;
CNCC[C@@H](Oc1ccccc1C)c1ccccc1,Q8TDX7,Atomoxetine,Myosin-IIIb;
O=c1[nH]c(=O)n(COCCO)cc1Cc1ccccc1,Q8WTQ7,5-Benzylacyclouridine,Cyclin-dependent kinase-like 2 {ECO:0000305};
CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Q8WU08,itraconazole,Mitogen-activated protein kinase kinase kinase kinase 1;
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,Q8WXR4,ESMOLOL,"Atypical kinase COQ8B, mitochondrial {ECO:0000305};"
CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1,Q92772,Levobetaxolol,MAP/microtubule affinity-regulating kinase 4 {ECO:0000305};
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,Q92918,topotecan,Calcium/calmodulin-dependent protein kinase type 1G;
CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,Q96D53,zolmitriptan,Serine/threonine-protein kinase Nek1;
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,Q96L34,adenosine,Cyclin-dependent kinase 15;
c1ccc(CNc2ncnc3nc[nH]c23)cc1,Q96NX5,6-Benzylaminopurine,Calcium/calmodulin-dependent protein kinase kinase 2;
COc1ccc(OC)c(CC(C)N)c1,Q96PY6,"2,5-Dimethoxyamphetamine",SRSF protein kinase 1;
O=c1[nH]cnc2ccccc12,Q96Q40,4-Hydroxyquinazoline,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase;
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,Q96RR4,beta-D-glucose,Mitogen-activated protein kinase kinase kinase 5;
O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,Q96SB4,(-)-Epigallocatechin gallate,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha {ECO:0000305|PubMed:19158393};
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,Q99640,25-Hydroxycholesterol,Serine/threonine-protein kinase RIO1;
NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1N,Q99683,AICA ribonucleotide,Serine/threonine-protein kinase RIO2;
COc1ccc(CCN(C)CCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,Q99755,Dexverapamil,Transient receptor potential cation channel subfamily M member 6;
COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,Q9BRS2,2-Methoxyestradiol,Testis-specific serine/threonine-protein kinase 1;
Oc1c(Cl)c(Cl)c(O)c(Cl)c1Cl,Q9BVS4,Tetrachlorohydroquinone,Serine/threonine-protein kinase 33;
O=C(O)c1ccc(-c2ccc([N+](=O)[O-])cc2)cc1,Q9BX84,92-89-7,Serine/threonine-protein kinase D2;
O=C(O)c1ccc(-c2ccccc2)cc1,Q9BXA7,4-Biphenylcarboxylic acid,Serine/threonine-protein kinase DCLK3;
COc1c(C(C)=O)c(O)c(OC)c2occc12,Q9BYT3,Khellinone,Serine/threonine-protein kinase SIK2;
Oc1cccc2c1CCCC2,Q9BZL6,"5,6,7,8-Tetrahydro-1-naphthol","Myosin light chain kinase 2, skeletal/cardiac muscle;"
CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,Q9C098,sertraline,Serine/threonine-protein kinase TAO3;
c1ccc(-c2c[nH]cn2)cc1,Q9H0K1,4-Phenylimidazole,Homeodomain-interacting protein kinase 2;
c1ccc(-c2ncc[nH]2)cc1,Q9H1R3,2-Phenylimidazole,Dual specificity protein kinase CLK4;
Cc1cccc2cc[nH]c12,Q9H2K8,7-Methylindole,Serine/threonine-protein kinase Nek6 {ECO:0000305|PubMed:11516946};
c1ccc(-n2cccn2)cc1,Q9H2X6,1-Phenylpyrazole,Casein kinase I isoform gamma-1;
C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21,Q9HAZ1,methscopolamine,SNF-related serine/threonine-protein kinase;
CC(C)NCC(O)COc1ccccc1C1CC1,Q9HC98,Procinolol,Serine/threonine-protein kinase LATS2;
CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O,Q9HCP0,Bestatin,Serine/threonine-protein kinase 36;
O=C1COc2ccccc2N1,Q9NRH2,"2H-1,4-Benzoxazin-3(4H)-one",BMP-2-inducible protein kinase {ECO:0000250|UniProtKB:Q91Z96};
O=C(c1ccc(O)cc1)c1ccc(O)cc1O,Q9NRM7,"2,4,4'-Trihydroxybenzophenone",Interleukin-1 receptor-associated kinase 4;
O=S(=O)(Nc1ccccc1)c1ccccc1,Q9NRP7,Benzenesulfonanilide,Mitogen-activated protein kinase kinase kinase 20 {ECO:0000305};
O=C(O)c1ccc(Oc2ccccc2)cc1,Q9NSY1,4-Phenoxybenzoic acid,Serine/threonine-protein kinase PLK2;
Cc1cc(=O)oc2ccc(O)cc12,Q9NWZ3,6-Hydroxy-4-methylcoumarin,Serine/threonine-protein kinase PAK 5 {ECO:0000305};
CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,Q9NYL2,3396-99-4,eIF-2-alpha kinase GCN2 {ECO:0000250|UniProtKB:Q9QZ05};
CN(C)CCC(=O)c1ccccc1,Q9NYY3,3-(dimethylamino)-1-phenylpropan-1-one,Serine/threonine-protein kinase NLK;
COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,Q9P286,Methyl L-tryptophanate,Phosphatidylinositol 4-kinase beta {ECO:0000305};
CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,Q9P2K8,rosiglitazone,Death-associated protein kinase 2;
NS(=O)(=O)C(F)(F)F,Q9UBE8,Trifluoromethanesulfonamide,Serine/threonine-protein kinase tousled-like 1;
CCOC(=O)C1CCC(=O)C=C1C,Q9UBF8,487-51-4,SRSF protein kinase 3;
Cc1cc(O)[nH]c(=O)c1C#N,Q9UIK4,5444-02-0,Cyclin-dependent kinase 11A;
CN(C)CCNc1ccccc1,Q9UKI8,"N,N-Dimethyl-N'-phenylethylenediamine",Aurora kinase C;
O=P(O)(O)Cc1ccccc1,Q9UPE1,Benzylphosphonic acid,Calcium/calmodulin-dependent protein kinase type II subunit alpha;
c1ccc(-n2ccnc2)cc1,Q9UQ88,1-Phenylimidazole,RAC-gamma serine/threonine-protein kinase;
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,Q9UQB9,Bexarotene,Serine/threonine-protein kinase 38-like;
O=C(c1ccccc1)c1cccc(O)c1,Q9UQM7,3-Hydroxybenzophenone,Microtubule-associated serine/threonine-protein kinase 1;
O=C1NC(=O)C(c2ccccc2)O1,Q9Y243,"5-PHENYLOXAZOLIDINE-2,4-DIONE",Mitogen-activated protein kinase kinase kinase 2;
c1ccc(-c2nnn[nH]2)cc1,Q9Y2H1,5-Phenyl-1H-tetrazole,Dual specificity tyrosine-phosphorylation-regulated kinase 1B;
CN1CCC[C@H]1c1cccnc1,Q9Y2H9,nicotine,Serine/threonine-protein kinase MRCK beta;
CCCCCCOC(=O)c1cccnc1,Q9Y2U5,Hexyl nicotinate,Interleukin-1 receptor-associated kinase 3;
CC(C)(C)NCC(O)CO,Q9Y463,"3-(tert-Butylamino)propane-1,2-diol",Serine/threonine-protein kinase 24;
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,Q9Y5S2,17alpha-Hydroxypregnenolone,Casein kinase I isoform gamma-3;
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,Q9Y616,4-Cholesten-3-one,Mitogen-activated protein kinase kinase kinase 4;
CC(C)NCC(O)COc1ccc(O)c2ccccc12,Q9Y6E0,4-Hydroxypropranolol,Histone deacetylase 7;
O=C(O[C@@H]1[C@@H]2O[C@]2(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C[C@@H]12)c1ccc(O)cc1,Q9Y6M4,Catalposide,Histone deacetylase 2 {ECO:0000305};
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,Q9Y6R4,1824-94-8,"Histone deacetylase 8 {ECO:0000303|PubMed:10748112, ECO:0000303|PubMed:10926844};"
O=C1C(=O)c2cc([N+](=O)[O-])ccc2-c2ccccc21,Q8WUI4,"2-nitrophenanthrene-9,10-dione",Histone deacetylase 6;
O=C(O)c1cc2ccccc2s1,Q92769,Benzo[b]thiophene-2-carboxylic acid,5-hydroxytryptamine receptor 2C {ECO:0000305};
CCCCCCCCOC(=O)c1cccnc1,Q9BY41,Octyl nicotinate,5-hydroxytryptamine receptor 1D;
O=P(O)(O)Cc1cccc2ccccc12,Q9UBN7,4730-77-2,cGMP-gated cation channel alpha-1;
N#Cc1ccc(O)[nH]c1=O,P28335,"2,6-Dihydroxy-3-cyanopyridine",Transthyretin;
CC1(C)SSC(C)(C)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H]1C(=O)O,P79400,DPDPE,Peroxisome proliferator-activated receptor gamma;
Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,Q00194,Rimonabant,Peroxisome proliferator-activated receptor alpha;
CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CC[C@H]2CCCO)c(O)c1,P02766,CP55940,Mineralocorticoid receptor;
COc1ccccc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1,P37231,132746-60-2,Estrogen receptor;
CCCc1c(OCC(O)COc2ccc3c(=O)cc(C(=O)O)oc3c2CCC)ccc(C(C)=O)c1O,Q07869,Fpl 55712,Estrogen receptor beta;
CN(C(=O)Cc1ccccc1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1,P08235,U-69593,Muscarinic acetylcholine receptor M1;
CC(C)CNCC(O)COc1cccc2ccccc12,P03372,"PROPRANOLOL, dl",Thyroid hormone receptor alpha;
COC(=O)c1cc2c(cn1)[nH]c1ccccc12,Q92731,beta-CCM,Thyroid hormone receptor beta;
Cc1cc(C[C@H](N)C(=O)O)cc(C)c1Oc1ccc(O)c(C(C)C)c1,P11229,26384-44-1,Oxysterol-binding protein 2;
COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2,P10827,Zacopride,Synaptic vesicular amine transporter;
COC(=O)[C@H]1[C@@H](c2ccc(I)cc2)C[C@@H]2CC[C@H]1N2C,P10828,Iometopane,Heat shock cognate 71 kDa protein {ECO:0000250|UniProtKB:P11142};
CCCCCCCOC1OC(CO)C(O)C(O)C1O,Q969R2,Heptyl D-glucoside,2-dehydropantoate 2-reductase {ECO:0000305};
COc1cc(C(=O)NS(=O)(=O)c2ccccc2)ccc1Cn1ncc2ccc(NC(=O)OC3CCCC3)cc21,Q01827,Ici 198615,Heat shock cognate 71 kDa protein {ECO:0000305};
CC[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@H]1C(=O)CO,P19120,Org 2058,Alpha-1D adrenergic receptor;
OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,P0A9J4,Thiodigalactoside,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase {ECO:0000255|HAMAP-Rule:MF_00107};"
COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccnc2cc(Cl)ccc12,P11142,Meclinertant,Galectin-8 {ECO:0000303|Ref.2};
CN1CC[C@@]2(C)c3cc(O)ccc3N(C)[C@@H]12,P23944,Eseroline,Galectin-1;
COc1cc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O,Q63T71,Matairesinol,Galectin-7;
Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc21,O00214,GR 113808,Progesterone receptor;
CCCCCCCC(=O)[O-],P09382,octanoate,Baculoviral IAP repeat-containing protein 5;
CCCN[C@H]1CCc2nc(N)sc2C1,P47929,pramipexole,Pentachlorophenol 4-monooxygenase;
O=C(O)c1ccc(-c2ccccc2)nc1,P06401,6-Phenylnicotinic acid,DNA repair and recombination protein RadA;
O=C(O)c1cnn(-c2ccccc2)c1,O15392,1-Phenyl-1H-pyrazole-4-carboxylic acid,Stromelysin-1;
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,P08254,methyl lactoside,Acetylcholinesterase;
O=C(O)C1=C[C@@H](OP(=O)(O)O)[C@@H](O)[C@H](O)C1,Q15382,shikimate-3-phosphate,Sigma non-opioid intracellular receptor 1;
COC(=O)C(N)Cc1c[nH]c2ccccc12,P42535,Methyl 2-amino-3-(1H-indol-3-yl)propanoate,Mitogen-activated protein kinase 12;
Br[Se]c1ccccc1,O74036,Phenylselenyl bromide,Serine/threonine-protein kinase ULK3;
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,P15692,Gefitinib,MAP kinase-interacting serine/threonine-protein kinase 2;
N#Cc1ccccc1OCC(O)CNCCNC(=O)Nc1ccccc1,O42275,ICI 89406,Serine/threonine-protein kinase 3;
NC1Cc2cc3c(cc2C1)OCO3,Q99720,132741-81-2,Serine/threonine-protein kinase 17A;
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Q13093,66556-73-8,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A;"
O=C(O)CCCCCCCn1ccnc1,P53778,1-(7-Carboxyheptyl)imidazole,Prothrombin;
C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,Q3U3Q1,Lestaurtinib,D-amino-acid oxidase;
Cc1nc(N)sc1CCN,Q9HBH9,Amthamine,Vitamin D3 receptor;
Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc21,Q9JI10,143797-63-1,Protein kinase C eta type;
CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1,Q9UEE5,101565-18-8,"Glutamate receptor ionotropic, kainate 2;"
Oc1cc2oc(-c3ccc(O)c(O)c3)c(O)cc-2c(=[OH+])c1,Q9Y233,Cyanidin,Peregrin {ECO:0000305};
CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,P00734,TAMSULOSIN,Regulatory protein E2 {ECO:0000255|HAMAP-Rule:MF_04001};
CCNC(=O)NCCCOc1cccc(CN2CCCCC2)c1,P07900,Dalcotidine,Regulatory protein E2 {ECO:0000255|HAMAP-Rule:MF_04001};
CCCCc1nn(CCCC)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,P14920,133690-62-7,ATP-dependent translocase ABCB1 {ECO:0000305};
Cc1ccnc2c1nc(C1CC1)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,P11473,135070-05-2,Beta-secretase 1 {ECO:0000305};
COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,P24723,Cyclazosin,D-amino-acid oxidase;
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncccc1C(=O)O,P42260,141887-34-5,High mobility group protein B1;
CCc1cc(OCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2ccccc2n1,P55201,Ici-D8731,Lysine-specific histone demethylase 1A {ECO:0000305};
Ic1ccc(COCCCc2cnc[nH]2)cc1,Q8CFK4,Iodoproxyfan,Steroid Delta-isomerase;
CCc1nc2c(C)cc(C)nc2n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)c2ccccc2)cc1,P03118,MK-996,Phenylethanolamine N-methyltransferase;
CNC=Nc1ccc(-c2c[nH]cn2)cc1,P03120,83184-12-7,Proto-oncogene vav;
CC(C)(C)NC=Nc1ccc(-c2c[nH]cn2)cc1,P08183,DA 4626,Protein kinase C alpha type;
COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC,P56817,Dipyrocetyl,Protein kinase C delta type {ECO:0000305};
C[C@]12CC[C@H]3[C@@H](CCC4=C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,P00371,4-Androstenediol,Protein kinase C epsilon type;
c1ccc(-c2ccno2)cc1,P09429,5-phenylisoxazole,Leukotriene A-4 hydrolase;
N#Cc1ccc(-c2ccc(O)cc2)cc1,P15379,19812-93-2,Serine/threonine-protein kinase 25;
COc1ccc(CC(C)N)c(OC)c1,P16070,"2,4-Dimethoxyamphetamine",Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta;
COc1cccc(OC)c1CC(C)N,O60341,"2,6-Dimethoxyamphetamine",Citron Rho-interacting kinase;
COc1cc(Br)c(CC(C)N)cc1OC,P07445,32156-25-5,Serine/threonine-protein kinase RIO3;
O=C(O)Cc1cccc(Oc2ccccc2)c1,P11086,3-Phenoxyphenylacetic acid,Inhibitor of nuclear factor kappa-B kinase subunit beta;
COc1cc(OC)c(SC)cc1CC(C)N,P15498,79440-52-1,"Muscle, skeletal receptor tyrosine-protein kinase;"
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,P17252,docetaxel,3-phosphoinositide-dependent protein kinase 1;
Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,P28867,Vatalanib,Receptor-interacting serine/threonine-protein kinase 2;
CNCCN(Cc1ccc(OC)cc1)c1ccccn1,Q02156,104499-47-0,Tyrosine-protein kinase JAK2 {ECO:0000305};
CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,P09960,Ruboxistaurin,Serine/threonine-protein kinase/endoribonuclease IRE1 {ECO:0000305};
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,O00506,Canertinib,Cyclin-dependent kinase-like 5 {ECO:0000305};
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,O00750,Doramapimod,Serine/threonine-protein kinase 17B;
C[C@@H](N)Cc1cnc[nH]1,O14578,(R)-alpha-Methylhistamine,Serine/threonine-protein kinase 10;
CCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,O14730,81147-95-7,Receptor tyrosine-protein kinase erbB-2;
COc1ccccc1CC(C)N,O14920,1-(2-methoxyphenyl)propan-2-amine,Tyrosine-protein kinase Fgr;
NCC(O)COc1cccc2ccccc12,O15146,N-Desisopropylpropranolol,Fibroblast growth factor receptor 1;
NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)c2cc(F)ccc2O1,O15530,Fidarestat,Insulin receptor-related protein;
CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,O43353,roscovitine,"Interferon-induced, double-stranded RNA-activated protein kinase;"
CN(C)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OCc2ccccc2)c(O)c1,O60674,6-hydroxy-FAD,Fibroblast growth factor receptor 2;
O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c2ncn2ccnc32)[C@H](O)[C@@H]1O,O75460,Etheno-amp,Activin receptor type-2A {ECO:0000305|PubMed:1314589};
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,O76039,N-Propylnorapomorphine,Mitogen-activated protein kinase 3;
NCCCc1cnc[nH]1,O94768,40546-33-6,Mitogen-activated protein kinase 4;
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O,O94804,ANGIOTENSIN II,Tyrosine-protein kinase receptor Tie-1;
CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2,P04626,ATROPINE,Vascular endothelial growth factor receptor 2 {ECO:0000305};
CS(=O)c1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1,P09769,152121-47-6,Dual specificity mitogen-activated protein kinase kinase 2;
Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,P11362,Enzastaurin,Bone morphogenetic protein receptor type-1A;
Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12,P14616,139180-30-6,Tyrosine-protein kinase Tec;
Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12,P19525,Sch 58261,Tyrosine-protein kinase ZAP-70;
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,P21802,Erlotinib,Dual specificity mitogen-activated protein kinase kinase 4;
Cc1ccc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)O)cc4)cc32)cc1,P27037,AGN 193109,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;"
CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12,P27361,(-)-Iodocyanopindolol,Dual specificity protein kinase CLK1 {ECO:0000305|PubMed:10480872};
O=C1CC2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1ccc(F)cc12,P31152,Minalrestat,Serine/threonine-protein kinase Nek3;
CCCCCCCN(CC)CCCCc1ccc(Cl)cc1,P35590,72456-59-8,5'-AMP-activated protein kinase catalytic subunit alpha-2;
COc1cc(CC(C)N)ccc1O,P35968,4-(2-Aminopropyl)-2-methoxyphenol,Ephrin type-A receptor 5;
CC1(c2cccc(O)c2)CCCN(CCc2ccccc2)C1,P36507,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",Ephrin type-B receptor 4;
N=C(N)N1CCN(c2ccc(Cl)cc2)CC1,P36894,4-(4-chlorophenyl)piperazine-1-carboximidamide,Receptor-interacting serine/threonine-protein kinase 4;
Cc1ncsc1CCN,P42680,58981-35-4,SRSF protein kinase 2;
NC1=NC2=C(CCCC2)C2(CCCCC2)S1,P43403,5778-24-5,Casein kinase I isoform gamma-2;
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,P45985,Lapatinib,Mitogen-activated protein kinase kinase kinase 9;
Oc1noc2ccccc12,P48736,benzo[d]isoxazol-3-ol,Mitogen-activated protein kinase kinase kinase 10;
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,P49759,Sorafenib,Tyrosine-protein kinase receptor TYRO3;
CC(=O)N(C)C1(c2ccccc2)CCN(CCC[C@]2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)c3ccccc3)C2)CC1,P51956,Osanetant,Activated CDC42 kinase 1;
O=C(O)c1nc(-c2ccccc2)[nH]c1C(=O)O,P54646,"2-phenyl-1H-imidazole-4,5-dicarboxylic acid",Tyrosine-protein kinase Mer;
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O,P54756,cholic acid,Serine/threonine-protein kinase 3;
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C,P54760,DEOXYCHOLIC ACID,Serine/threonine-protein kinase PRP4 homolog;
CC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC=C1[C@@]3(C)CC[C@H](O)C[C@]34C=C[C@@]12C(C(=O)O)C4C(=O)O,P57078,NSC9746,Receptor-interacting serine/threonine-protein kinase 1;
Cc1ccc(NS(=O)(=O)N2CCCCC2)cc1,P78362,N-(4-methylphenyl)piperidine-1-sulfonamide,Protein-tyrosine kinase 6;
O=C(O)CS(=O)c1ccc2c3c(cccc13)C(=O)c1ccccc1-2,P78368,NSC16211,Serine/threonine-protein kinase D1;
Cc1cc(N)nc2ccccc12,P80192,4-methylquinolin-2-amine,Receptor tyrosine-protein kinase erbB-4;
CC(C)CNCC(O)COc1ccccc1,Q02779,39631-75-9,Dual specificity testis-specific protein kinase 1;
Oc1cc(-c2ccc(Cl)cc2)nc2ccccc12,Q06418,6337-51-5,"Myosin light chain kinase, smooth muscle {ECO:0000305};"
CC1=C2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CCC1=O,Q07912,4-Methyltestosterone,Serine/threonine-protein kinase STK11 {ECO:0000305};
CCCC(=O)c1cc(O)c(O)c(O)c1,Q12866,3329-02-0,NT-3 growth factor receptor;
O=C1c2ccccc2-c2c1cc([N+](=O)[O-])cc2[N+](=O)[O-],Q13188,"2,4-dinitro-9H-fluoren-9-one",Myosin light chain kinase 3;
Nc1nc(CCc2ccccc2)cc(=O)[nH]1,Q13523,2-amino-6-(2-phenylethyl)pyrimidin-4(3h)-one,Serine/threonine-protein kinase MRCK alpha;
C[C@]12CC[C@@H]3c4ccc(O)cc4C=C[C@H]3[C@@H]1CC[C@@H]2O,Q13546,7291-41-0,Serine/threonine-protein kinase 32C;
O=C1c2cc(F)ccc2-c2cc(F)c([N+](=O)[O-])cc21,Q13882,"3,7-difluoro-2-nitro-9H-fluoren-9-one",Serine/threonine-protein kinase DCLK2;
c1cncc(-c2nc3ccccc3[nH]2)c1,Q15139,1137-67-3,Calcium/calmodulin-dependent protein kinase kinase 1;
C[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21,Q15303,7alpha-Methyltestosterone,Casein kinase I isoform alpha-like;
Nc1c(-c2ccccc2)oc2ccccc2c1=O,Q15569,3-Amino-2-phenyl-4H-chromen-4-one,"Atypical kinase COQ8A, mitochondrial {ECO:0000305};"
O=C(O)CCCc1ccc(Oc2ccccc2)cc1,Q15746,4-(4-phenoxyphenyl)butanoic acid,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma {ECO:0000305};
Nc1nc(N)c2cc([N+](=O)[O-])ccc2n1,Q15831,"2,4-Diamino-6-nitroquinazoline",Dual specificity tyrosine-phosphorylation-regulated kinase 2;
Cc1nnc2ccc3ccccc3n12,Q16288,"1-methyl-[1,2,4]triazolo[4,3-a]quinoline",Serine/threonine-protein kinase Sgk3;
C[C@@H]1CC2=CC(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21,Q32MK0,"17beta-Hydroxy-7alpha,17-dimethylandrosta-1,4-dien-3-one",Mitogen-activated protein kinase kinase kinase 3;
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,Q5VT25,Methyltrienolone,STE20-like serine/threonine-protein kinase;
COc1ccc(C(c2ccccc2)C(CC#N)CC#N)cc1,Q86UX6,94377-98-7,Tyrosine-protein kinase Srms;
O=C1c2ccccc2-c2cc([N+](=O)[O-])c([N+](=O)[O-])cc21,Q8N568,NSC133896,Homeodomain-interacting protein kinase 3;
N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2,Q8N5S9,23903-48-2,Serine/threonine-protein kinase PLK3;
c1ccc(CCc2nc3ccccc3[nH]2)cc1,Q8N752,2-(2-phenylethyl)-1H-benzimidazole,Serine/threonine-protein kinase 32B;
Nc1ccc2nc(N)nc(N)c2c1,Q8NI60,"quinazoline-2,4,6-triamine",Serine/threonine-protein kinase 26 {ECO:0000305};
Cc1nc2ccccc2c(C(=O)O)c1C,Q8TBX8,"2,3-dimethylquinoline-4-carboxylic acid",Ephrin type-A receptor 6;
O=C(O)c1ccc(-c2ccc(O)cc2)cc1,Q92630,58574-03-1,TRAF2 and NCK-interacting protein kinase;
CC1Oc2ccccc2NC1=O,Q96BR1,21744-83-2,Serine/threonine-protein kinase TAO2;
Cc1cc(C)nc(NC(=O)c2cc(C(=O)O)c(C(=O)Nc3cc(C)cc(C)n3)cc2C(=O)O)c1,Q99759,Propiomazine,ALK tyrosine kinase receptor {ECO:0000305};
Nc1ccc(-c2ccc(C(=O)O)cc2)cc1,Q9H2G2,5730-78-9,Serine/threonine-protein kinase ICK;
CC(=O)Nc1ccc(NC(=O)C2CC2)cc1,Q9H3Y6,N-[4-(acetylamino)phenyl]cyclopropanecarboxamide,Gonadotropin-releasing hormone receptor;
O=[N+]([O-])c1ccc(Sc2cccc[n+]2[O-])c2nonc12,Q9H422,113104-25-9,Botulinum neurotoxin type A;
CCOC(=O)Cn1cnc2sc3c(c2c1=O)CCCC3,Q9H4B4,40277-49-4,"Solute carrier family 2, facilitated glucose transporter member 1 {ECO:0000305};"
O=P(O)(O)c1cccc2ccccc12,Q9NY57,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,Adenylate cyclase type 1;
c1ccc2c(N3CCOCC3)ncnc2c1,Q9P289,7471-81-0,Integrin alpha-L {ECO:0000305};
CCCCCOC(=O)c1cccnc1,Q9UF33,AMYL NICOTINATE,Uridine phosphorylase 1 {ECO:0000303|PubMed:19291308};
NCc1nc2ccccc2s1,Q9UKE5,"1,3-benzothiazol-2-ylmethylamine",DNA topoisomerase 1;
CC(C)NCC(O)COC(=O)c1cccs1,Q9UL54,NSC624534,D(1A) dopamine receptor;
COc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1C,Q9UM73,5-Hydroxy-7-methoxy-6-methylflavone,5-hydroxytryptamine receptor 1B;
O=C(NP(=O)(N1CCOCC1)N1CCOCC1)c1ccccc1,Q9UPZ9,NSC715371,Signal transducer and activator of transcription 1-alpha/beta;
CCC(C(=O)Nc1ccncc1)c1ccccc1,P30969,2-phenyl-N-(pyridin-4-yl)butanamide,Potassium voltage-gated channel subfamily A member 3;
C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,P0DPI0,5'-deoxyadenosine,Muscarinic acetylcholine receptor M4;
O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,P11166,naringenin,Heat shock protein HSP 90-beta;
NC[C@H](O)c1ccc(O)c(O)c1,P19754,norepinephrine,PA-I galactophilic lectin;
CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O,P20701,N-acetyllactosamine,DNA repair protein RAD51 homolog 1 {ECO:0000305};
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,Q16831,OXYTOCIN,Cytochrome P450 2E1 {ECO:0000303|PubMed:8031147};
C=C(O[C@@H]1CC(C(=O)O)=C[C@@H](OP(=O)(O)O)[C@H]1O)C(=O)O,P11387,5-O-(1-carboxyvinyl)-3-phosphoshikimic acid,Heat shock protein HSP 90-alpha {ECO:0000305};
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1OP(=O)(O)O,P18901,adenosine-2'-5'-diphosphate,Adenosine 5'-phosphosulfate reductase {ECO:0000255|HAMAP-Rule:MF_00063};
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,P28222,mometasone furoate,Delta-type opioid receptor;
C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,P07306,naringin,Cannabinoid receptor 1;
CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,P42224,N-Formyl-Met-Leu-Phe,Cannabinoid receptor 2;
CO[C@]12CC[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,P62959,Diprenorphine,Neuromedin-K receptor;
OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,P22001,beta-CYCLODEXTRIN,Substance-P receptor;
O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12,Q92934,Forodesine,Cysteinyl leukotriene receptor 1;
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(CC(=O)O)cc1)NC(C)=O)C(=O)O,O43175,Entrectinib,Kappa-type opioid receptor;
Cc1ccc(CNS(=O)(=O)c2ccc(S(N)(=O)=O)s2)cc1,P08173,AL5917,5-hydroxytryptamine receptor 3A {ECO:0000305};
CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1,P08238,trichostatin A,Type 1 fimbrin D-mannose specific adhesin;
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,O00182,Retinoic acid,Galectin-9;
C[C@]12CCc3c(ccc4cc(O)ccc34)[C@@H]1CCC2=O,P17931,EQUILENIN,Galectin-3;
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,Q05097,arachidonic acid,Neurotensin receptor type 1;
O=C(O)/C=C/C(=O)O,Q06609,fumaric acid,5-hydroxytryptamine receptor 4;
Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,P05181,resveratrol,UDP-3-O-acyl-N-acetylglucosamine deacetylase {ECO:0000255|HAMAP-Rule:MF_00388};
CC1(C)O[C@H]2[C@@H]3OS(=O)(=O)O[C@@H]3CO[C@@]2(COS(N)(=O)=O)O1,P9WIK2,RWJ-37947,D(2) dopamine receptor;
CC1(C)CCC(C)(C)c2cc([C@@H](O)c3ccc4cc(C(=O)O)ccc4c3)ccc21,P41143,BMS184394,Hematopoietic prostaglandin D synthase {ECO:0000305};
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,P21554,tacrolimus,Inhibitor of nuclear factor kappa-B kinase subunit alpha;
O=C(O)[C@]1(O)C=C[C@@H](O)[C@H](O)C1,P34972,"2,3-anhydroquinic acid",Serine/threonine-protein kinase D3;
CC(C)n1c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,P16177,fluvastatin,Macrophage colony-stimulating factor 1 receptor;
NS(=O)(=O)c1ccc(C(=O)NCc2ccc(F)c(F)c2F)cc1,P25103,"4-(AMINOSULFONYL)-N-[(2,3,4-TRIFLUOROPHENYL)METHYL]-BENZAMIDE",Proto-oncogene tyrosine-protein kinase ROS;
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,P41144,Eicosapentaenoic acid,Platelet-derived growth factor receptor beta;
COc1ccc(S(=O)(=O)N(Cc2cccnc2)[C@@H](C(=O)NO)C(C)C)cc1,P35563,CGS-27023A,Wee1-like protein kinase 2;
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,P08191,mycophenolic acid,Cyclin-dependent kinase 4;
CCO[C@@H](Cc1ccc(OCCn2c3ccccc3c3ccccc32)cc1)C(=O)O,P30989,(S)-3-(4-(2-CARBAZOL-9-YL-ETHOXY)-PHENYL)-2-ETHOXY-PROPIONIC ACID,Fibroblast growth factor receptor 3;
O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12,Q13639,130798-51-5,Ephrin type-B receptor 2;
CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,O67648,260415-63-2,Receptor-type tyrosine-protein kinase FLT3;
O=C(O)C(=O)N(c1ccccc1C(=O)O)c1cccc2ccccc12,P20288,Benzilone,TGF-beta receptor type-2;
O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,P00338,293754-55-9,Megakaryocyte-associated tyrosine-protein kinase;
Cc1nc(C)c(-c2ccnc(N)n2)s1,O60760,364334-94-1,Tyrosine-protein kinase TXK;
c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,O15111,396129-53-6,Ephrin type-B receptor 1;
CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,O94806,NECA,Cyclin-dependent kinase 2 homolog {ECO:0000305};
CSCC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,P07333,MEEVD,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta {ECO:0000305};
Cc1ccc(C[n+]2csc(CCOP(=O)(O)OP(=O)(O)O)c2C)c(N)n1,P08922,Cefmenoxime,Dual specificity mitogen-activated protein kinase kinase 1 {ECO:0000305};
CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1,P09619,9-CIS-RETINOIC ACID,Tyrosine-protein kinase BTK;
O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,P0C1S8,h-89,Tyrosine-protein kinase ITK/TSK;
CN[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,P11802,staurosporine,Ribosomal protein S6 kinase alpha-2;
CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@]3(O)C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(=O)CCC,P22607,"4Alpha-Phorbol 12,13-Dibutyrate",Serine/threonine-protein kinase VRK2;
Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O,P29323,Apogossypol,Serine/threonine-protein kinase BRSK2;
CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,P36888,ketoconazole,MAP kinase-interacting serine/threonine-protein kinase 1;
O=C(O)c1ccc(O)c2ncccc12,P37173,5852-78-8,NUAK family SNF1-like kinase 2;
CC(=O)c1cnc(N)nc1C,P42679,5-Acetyl-2-amino-4-methylpyrimidine,Serine/threonine-protein kinase PAK 6;
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O,P42681,Leu-enkephalin,Serine/threonine-protein kinase MARK1;
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(N(CC)CC)cc1,P54762,Clofedanol,Serine/threonine-protein kinase TBK1 {ECO:0000305};
Cc1cc2c(C(C)C)c(O)c(O)c(C(=O)O)c2cc1-c1cc2c(C(=O)O)c(O)c(O)c(C(C)C)c2cc1C,P61075,Cyclacillin,fMet-Leu-Phe receptor;
Cc1ccc2c(C=O)c(O)c(O)c(C(C)C)c2c1,P78356,LTX-315,Bone morphogenetic protein receptor type-1B;
CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NS(=O)(=O)c1cccc2c(N(C)C)cccc12)C(C)C)C(=O)NCc1ccccn1,Q02750,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,Serine/threonine-protein kinase Chk1;
O=C1c2cc(F)ccc2-n2c1nc1ccccc1c2=O,Q06187,"8-Fluoroindolo[2,1-b]quinazoline-6,12-dione",Peripheral plasma membrane protein CASK {ECO:0000305};
O=C(NCCCN1CCCC1)c1ccc(/C=C2\CCn3c2nc2cc(NCCN4CCCC4)c(F)cc2c3=O)cc1,Q08881,Acetarsol,U4/U6 small nuclear ribonucleoprotein Prp4;
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OC)cc1,Q15349,Ergocalciferol,Dual specificity mitogen-activated protein kinase kinase 3;
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O[C@@H]2[C@H](O)[C@@H](COP(=O)(O)O[C@@H]3[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]3n3cnc4c(N)ncnc43)O[C@H]2n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O,Q86Y07,Reserpine,Dual specificity mitogen-activated protein kinase kinase 6;
O=C([O-])C(Cl)Cl.[Na+],Q8IWQ3,Sodium dichloroacetate,Protein delta homolog 1;
Nc1ncc2ccccc2n1,Q9BUB5,2-Aminoquinazoline,Focal adhesion kinase 1 {ECO:0000305};
O=C(CCc1ccccc1)N1CCOCC1,Q9H093,1-(morpholin-4-yl)-3-phenylpropan-1-one,Dual specificity mitogen-activated protein kinase kinase 5;
CC(C)(C)NCC(O)c1ccccc1,Q9NQU5,2-(tert-Butylamino)-1-phenylethanol,Eukaryotic translation initiation factor 2-alpha kinase 1 {ECO:0000305};
CC(C)(C)c1ccc(-c2ccc(C(=O)O)cc2)cc1,Q9P0L2,5748-42-5,STE20/SPS1-related proline-alanine-rich protein kinase;
CC(C)NCC(O)COCc1ccccc1,Q9UHD2,19343-24-9,Ribosomal protein S6 kinase alpha-6;
O=C(NC1CCCCC1)C(F)(F)F,P21462,"N-Cyclohexyl-2,2,2-trifluoroacetamide",Oxysterols receptor LXR-beta;
COC(=O)c1ccc(OCC(O)CNC(C)(C)C)cc1,O00238,Vipadenant,Alpha-1A adrenergic receptor;
c1ccc(CNc2nc3ccccc3[nH]2)cc1,O14757,27185-21-3,Type-1 angiotensin II receptor;
COP(C)(=O)SCCN(C(C)C)C(C)C,O14936,2-Amino-3-Ketobutyric Acid,Proto-oncogene tyrosine-protein kinase Src {ECO:0000305};
O=C(O)CCC(=O)Nc1ccc(O)cc1,O43172,62558-67-2,Glycogen synthase kinase-3 alpha;
CC1(C)CNC(=O)c2sc(N)nc2C1,P46734,123973-48-8,Aldo-keto reductase family 1 member B1;
Oc1nc2ccccc2nc1C(F)(F)F,P52564,58457-64-0,Nucleoside diphosphate kinase B;
O=C(O)c1ccc(-c2ccc(Cl)cc2)cc1,P80370,5748-41-4,Carbamoyl phosphate synthase small chain {ECO:0000255|HAMAP-Rule:MF_01209};
O/N=C1/c2ccccc2-c2nc3ccccc3nc21,Q05397,23146-22-7,Type-1 angiotensin II receptor;
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]2O,Q13163,11-A-Hydroxy canrenone methyl ester,Type-1 angiotensin II receptor {ECO:0000303|PubMed:1550596};
CCCCCCCC/C=C/CCCCCCCC(=O)O,Q9BQI3,Elaidic acid,Adenosine receptor A2a;
COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1,Q9UEW8,Xanthohumol,Adenosine receptor A2a;
COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21,Q9UK32,Rauwolscine,Potassium voltage-gated channel subfamily H member 2;
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C,P55055,flavin mononucleotide,Mu-type opioid receptor;
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,P35348,ARGIPRESSIN,Acidic mammalian chitinase;
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,P34976,Nilotinib,ATPase family AAA domain-containing protein 2;
Cn1nccc1C(=O)Nc1cccnc1,P12931,1-methyl-N-(pyridin-3-yl)-1H-pyrazole-5-carboxamide,Poly [ADP-ribose] polymerase tankyrase-2 {ECO:0000305};
CCOc1c2ccoc2c(OCC)c2oc(=O)ccc12,P49840,"5,8-Diethoxypsoralen",Neuromedin-K receptor;
c1cc2cc(c1)Cn1cc[c+](c3ccccc31)NCc1ccc(cc1)CN[c+]1ccn(c3ccccc31)C2,P15121,UCL1684,Neuromedin-K receptor;
O=C(Nc1nnc[nH]1)c1c(Cl)ccc(Cl)c1Cl,P22392,"2,3,6-trichloro-N-(1H-1,2,4-triazol-5-yl)benzamide",Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1;
S=c1[nH]cnc2nc[nH]c12,P0A6F1,6-Mercaptopurine,Phospholipase A2;
CN(C)CCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OCc2ccccc2)cc1O,P25104,"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",Peptidyl-prolyl cis-trans isomerase FKBP1A;
C[C@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,P30556,"(S,R)-(+)-fenoterol",Endothiapepsin;
O=C(COc1ccc(Cl)cc1Cl)N1CCOCC1,P29274,Tropinone,Pteridine reductase 1;
Cn1c(=S)n(CCSc2nc3ccccc3[nH]2)c2ccccc21,P30543,BIC1,Protein polybromo-1;
Cc1c(-c2ccccc2)nc2ccccc2c1C(=O)O,Q12809,3-methyl-2-phenylquinoline-4-carboxylic acid,Androgen receptor;
Nc1nc2[nH]c(SCc3ccccc3)nc2c(=O)[nH]1,P33535,"2-amino-8-benzylsulfanyl-3,7-dihydropurin-6-one",Bifunctional dihydrofolate reductase-thymidylate synthase;
O=C(Nc1ccccc1)O[C@H]1CN2CCC1CC2,Q9BZP6,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,Phosducin-like protein 3;
C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,Q6PL18,"(R,S)-(-)-fenoterol",Oxytocin receptor;
O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1,Q9H2K2,2-({2-[(4-carboxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid,Formyl peptide receptor-related sequence 1;
COc1ccc2c(C)nc(Nc3nc(C)cc(=O)[nH]3)nc2c1,P29371,332074-13-2,N-formyl peptide receptor 2;
COc1ccc2c(C)nc(Nc3nc(C)cc(O)n3)nc2c1,P30098,332074-13-2,Kappa-type opioid receptor;
O=c1[nH]c(-c2cccc(O)c2)nc2sc3c(c12)CCCC3,Q13526,357618-26-9,Purine nucleoside phosphorylase;
O=C(COc1cccc(Cl)c1)N1CCOCC1,P04054,2-(3-chlorophenoxy)-1-morpholinoethanone,Histone deacetylase 1 {ECO:0000305};
COc1cccc2c(C(=O)O)cc(-c3ccccc3)nc12,P62942,489-75-8,Retinoic acid receptor alpha;
CC(C)COC(=O)Cn1cnc2sc3c(c2c1=O)CCCC3,P11838,Oprea1_107684,Retinoic acid receptor gamma;
CCOc1ccc(C(C)=O)cc1Cc1c(O)nc(N)[nH]c1=O,Q01782,CS55,Cellular retinoic acid-binding protein 2;
N[C@H]1CN2CCC1CC2,Q86U86,(R)-quinuclidin-3-amine,Retinoic acid receptor RXR-alpha;
Cc1ccc(-c2ccc(OCC(=O)N3CCOCC3)cc2)cc1,P10275,Forasartan,Retinoic acid receptor RXR-beta;
Cc1cccc(OCCn2c(SCC(=O)O)nc3ccccc32)c1,P07382,"4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME",Retinoic acid receptor RXR-gamma;
CCc1nc2sc(C)c(C)c2c(=O)n1N,Q9H2J4,"3-amino-2-ethyl-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",Protein phosphatase 3 catalytic subunit alpha {ECO:0000312|HGNC:HGNC:9314};
O=S(=O)(Nc1ccc(F)cc1)N1CCCCC1,Q9NPD8,N-(4-fluorophenyl)piperidine-1-sulfonamide,3-dehydroquinate dehydratase;
CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(C#N)cc2)cc1,P22303,8-Bromo-Adenosine-5'-Monophosphate,3-dehydroquinate dehydratase;
Fc1cccc(Cl)c1CN1CCNCC1,P30559,1-(2-Chloro-6-fluorobenzyl)piperazine,Uracil nucleotide/cysteinyl leukotriene receptor;
c1cc(-c2cnco2)ccn1,O08790,"5-(4-pyridyl)-1,3-oxazole",Oxysterols receptor LXR-alpha;
Fc1ccc(Cn2c(-c3cscn3)nc3ccccc32)c(Cl)c1,P25090,Nicofetamide,Serine/threonine-protein phosphatase 5;
Nc1nc(N)nc(-c2ccc(Oc3ccccc3N)cc2)n1,P41145,Hypoxanthine,Transketolase;
Cc1cc(O)cc(C)c1NS(=O)(=O)c1ccccc1,P00491,"N-(4-hydroxy-2,6-dimethylphenyl)benzenesulfonamide",Retinoic acid receptor beta;
Cc1c(-c2ccc(C(C)C)cc2)nc2ccccc2c1C(=O)O,Q13547,2-(4-isopropylphenyl)-3-methylquinoline-4-carboxylic acid,Cellular retinoic acid-binding protein 1;
CCc1cc(C(=O)Cc2ccc(OC)cc2)c(O)cc1O,P11416,96644-03-0,Protein kinase C beta type;
CCCc1cc(C(=O)Cc2ccc(C(=O)OCC)o2)c(O)cc1O,P18911,SMR000059974,Proenkephalin-B;
O=C(Cc1ccc2c(c1)OCCCO2)c1ccc(O)c(O)c1O,P22935,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",Renin {ECO:0000303|PubMed:6324167};
Cc1cc(Cl)ccc1OCC(=O)N1CCOCC1,P28700,2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol,"Indoleamine 2,3-dioxygenase 1 {ECO:0000303|PubMed:2109605};"
Clc1ccc(-n2ccc3ccccc32)cc1,P28702,1-(4-chlorophenyl)-1H-indole,2-5A-dependent ribonuclease;
COc1ccc(/C=C2\NC(=S)NC2=O)c(OC)c1,P48443,Tiropramide,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial;"
CCOC(=O)Cn1cnc2sc3c(c2c1=O)CCC3,Q08209,433702-79-5,Tyrosine-protein kinase {ECO:0000256|RuleBase:RU362096};
Cc1cc(N)cc(C)c1OCC(=O)N1CCOCC1,P9WPX7,345991-01-7,Cytochrome P450 2B1;
COC(=O)COc1ccc(/C=C2\Sc3ccccc3C2=O)cc1,Q48255,Mitemcinal,Ketohexokinase {ECO:0000312|HGNC:HGNC:6315};
CCc1ccc(OCC(=O)N2CCOCC2)cc1,Q13304,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",Uncharacterized PhzA/B-like protein PA3332;
COc1ccc(OCC(=O)N2CCOCC2)cc1,Q13133,"Morpholine, 4-((4-methoxyphenoxy)acetyl)-",Lymphocyte antigen 96;
O=C(O)Cn1c(SCc2ccccc2)nc2ccccc21,P53041,[2-(Benzylthio)-1H-benzimidazol-1-yl]acetic acid,Adenosine receptor A2b;
Oc1ccc(-c2cc3ccc(O)cc3o2)cc1,P29401,2-(4-hydroxyphenyl)benzofuran-6-ol,Chorismate synthase {ECO:0000255|HAMAP-Rule:MF_00300};
COc1ccc(C(=O)Nc2ccccn2)cc1,P22605,4-methoxy-N-pyridin-2-ylbenzamide,Vasopressin V1a receptor;
O=C(Nc1ccccc1)c1cnc2ccccc2n1,P62965,N-phenyl-2-quinoxalinecarboxamide,Vasopressin V2 receptor;
Cn1c(COc2cccc3cccnc23)nnc1SCC(N)=O,P05771,612525-79-8,Bromodomain-containing protein 2 {ECO:0000305};
COc1ccc(NC(=O)c2ccco2)cc1NC(=O)c1cccnc1,P01213,N-[5-(2-furoylamino)-2-methoxyphenyl]nicotinamide,Dihydropteroate synthase {ECO:0000303|PubMed:1522070};
Cc1nccn1C(=O)c1ccccc1C(=O)O,P00797,247088-99-9,Cytohesin-2;
CC(C)Cn1c(-c2ccco2)n[nH]c1=S,P14902,"5-(2-furyl)-4-isobutyl-4H-1,2,4-triazole-3-thiol",Segment polarity protein dishevelled homolog DVL-1;
NC(=O)[C@@H]1CCCN1C(=O)CCC(=O)O,Q05823,Quinagolide,Apoptosis regulator Bcl-2;
CN(C)CCCC(O)(c1ccccc1)c1ccccc1,Q15118,"4-(dimethylamino)-1,1-diphenylbutan-1-ol",2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;
COc1ccc2nc(NC(=O)C(C)C)sc2c1,P00176,Rofecoxib,Replication protein A 70 kDa DNA-binding subunit;
COc1ccc(NC(=O)CSc2nnnn2C)cc1,P50053,N-(4-methoxyphenyl)-2-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]acetamide,WD repeat-containing protein 5;
Clc1ccc([C@H]2C[C@@H]3CC[C@H]2N3)cn1,Q9HYR3,Epibatidine,C-C chemokine receptor type 5 {ECO:0000305};
NCCc1c[nH]c2cc(F)ccc12,Q9Y6Y9,6-Fluorotryptamine,Transforming protein RhoA {ECO:0000305};
NCCc1cccnc1,P29276,20173-24-4,Heme ligase;
COc1ccc(-n2c(SCC(N)=O)nnc2-c2cccs2)cc1,P0A2Y6,"2-{[4-(4-methoxyphenyl)-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide",Kelch-like ECH-associated protein 1 {ECO:0000303|PubMed:14585973};
Nc1nc2nc(SCC(=O)c3ccccc3)[nH]c2c(=O)[nH]1,P30560,Mibenratide,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta;"
CCN(CC)C(=O)CSc1nc2c(=O)[nH]c(N)nc2[nH]1,P48044,Iodipamide,Protein S100-B;
Nc1nc2[nH]c(SCc3ccccc3F)nc2c(=O)[nH]1,P25440,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,Cell division protein FtsZ {ECO:0000255|HAMAP-Rule:MF_00909};
Nc1nc2nc(SCc3ccc(Cl)cc3)[nH]c2c(=O)[nH]1,P0AC13,Ziresovir,UDP-galactopyranose mutase {ECO:0000303|PubMed:9692181};
N#Cc1ccc(CSc2nc3nc(N)[nH]c(=O)c3[nH]2)cc1,Q99418,Cositecan,Substance-K receptor;
Cc1cccc(-n2nc(C(=O)O)cc2-c2ccccc2)c1,O14640,62160-79-6,Cyclic GMP-AMP synthase {ECO:0000303|PubMed:23258413};
Cc1nnc2ccc(N3CCCC3)nn12,P10415,Raxatrigine,Prostaglandin E2 receptor EP1 subtype;
O=C(Nc1cc([N+](=O)[O-])ccc1F)c1ccccc1Cl,P26281,2-chloro-N-(2-fluoro-5-nitrophenyl)benzamide,CREB-binding protein;
NC(=O)/C=C/c1cccc(C(F)(F)F)c1,P27694,"2-Propenamide, 3-(3-(trifluoromethyl)phenyl)-, (E)-",7-dehydrocholesterol reductase {ECO:0000303|PubMed:9683613};
Cc1ccc(SCC(=O)N2CCOCC2)cc1,P61964,392313-31-4,Histone acetyltransferase KAT2B;
Cc1ccc(OCC(=O)N2CCOCC2)c(C)c1,P24593,148183-90-8,Bcl2-associated agonist of cell death;
Cc1c(O)ccc(C(=O)Cc2ccccc2Cl)c1O,P51681,Sonedenoson,Catechol O-methyltransferase {ECO:0000305};
Cc1cc(C)c(OCC(=O)N2CCOCC2)c(C)c1,P61586,Antrafenine,Mitogen-activated protein kinase 1 {ECO:0000305};
Cc1cc(C)c(C)c(OCC(=O)N2CCOCC2)c1,Q8IL04,Roxithromycin,Myc proto-oncogene protein;
COc1ccccc1NC(=O)CSc1nncn1C,Q14145,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",Endothelial PAS domain-containing protein 1;
O=C(COc1ccc(F)cc1)N1CCOCC1,Q9Y4K3,Ciluprevir,L-lactate dehydrogenase A chain {ECO:0000305};
CC(C)NS(=O)(=O)c1ccc(OCC(=O)N2CCOCC2)cc1,O43924,SC-74020,P2X purinoceptor 7;
Cn1nc([N+](=O)[O-])nc1Oc1ccccc1C(=O)N1CCOCC1,P04271,"4-{2-[(1-methyl-3-nitro-1H-1,2,4-triazol-5-yl)oxy]benzoyl}morpholine",Retinoic acid receptor RXR-gamma;
O=C(O)c1cc(-c2ccc(F)cc2)n[nH]1,P17865,870704-22-6,Histamine H3 receptor;
Cc1c(C(=O)O)[nH]c2c1C(=O)CCC2,P9WIQ1,6577-89-5,Neuropeptide Y receptor type 1;
O=C(O)c1cccc(CSc2nnc(-c3ccncc3)o2)c1,Q64077,"3-({[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}methyl)benzoic acid","Glutamate receptor ionotropic, kainate 1;"
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,Q8N884,curcumin,DNA (cytosine-5)-methyltransferase 1;
O=C(N[C@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21,P34995,Fmoc-D-phenylalanine,B-cell lymphoma 6 protein;
COc1ccc(-c2nnc(SCC(=O)O)n2-c2ccc(Cl)cc2)cc1,Q92793,Tenoxicam,P2X purinoceptor 1;
CCc1nnc(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)cc2)s1,Q9UBM7,299952-42-4,P2Y purinoceptor 1;
COC(=O)c1ccc(NC(=O)CSc2nnnn2-c2ccccc2OC)cc1,Q92831,methyl 4-[({[1-(2-methoxyphenyl)-1H-tetrazol-5-yl]sulfanyl}acetyl)amino]benzoate,Eukaryotic initiation factor 4A-III;
Brc1ccc(OCc2ccccc2)c(CNCc2ccccn2)c1,P21964,P-Cresol,Orexin/Hypocretin receptor type 1 {ECO:0000305|PubMed:11723285};
O=C(O)c1cccc(Nc2nc(Nc3ccccc3)nc(Nc3ccccc3)n2)c1,P63085,"3-[(4,6-dianilino-1,3,5-triazin-2-yl)amino]benzoic acid",Tumor susceptibility gene 101 protein;
FC(F)(F)c1cccc(N2CCN(C3=Cc4ccccc4CC3)CC2)c1,P01106,Calanolide A,D-3-phosphoglycerate dehydrogenase;
CCn1c(SCC(=O)Nc2cccc(OC)c2)nnc1-c1ccncc1,Q99814,575467-06-0,Histamine H4 receptor;
COc1ccc(S(=O)(=O)Nc2ccc(NS(=O)(=O)c3ccc(OC)cc3)c3ccccc23)cc1,Q99572,"N,N'-Naphthalene-1,4-Diylbis(4-Methoxybenzenesulfonamide)",HTH-type transcriptional regulator EthR;
O=C(Cn1cnc2sc3c(c2c1=O)CCCC3)OCc1ccccc1,P28705,Oprea1_178926,5-hydroxytryptamine receptor 2A;
COc1ccc2c(c1)c(CC(=O)Nc1ccccn1)c(C)n2C(=O)c1ccc(Cl)cc1,Q9Y5N1,2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-(pyridin-2-yl)acetamide,Cystic fibrosis transmembrane conductance regulator;
O=C(Cn1c(=O)sc2ccccc21)Nc1ccc(C(=O)O)cc1,P25929,Platelet Activating Factor,"Vascular endothelial growth factor A, long form;"
CCn1c(SCC(=O)Nc2ccccc2OC)nnc1-c1ccco1,P22756,CBKinase1_003458,Placenta growth factor;
Cc1cc(C)c(S(=O)(=O)N(C)CC(=O)N2CCC(C(N)=O)CC2)c(C)c1,P13864,"1-{N-methyl-N-[(2,4,6-trimethylphenyl)sulfonyl]glycyl}piperidine-4-carboxamide",Cell cycle checkpoint protein RAD1;
COc1ccc(OCC(=O)Nc2cc(-c3nn4c(C)nnc4s3)ccc2C)cc1,P41182,SMR000092753,Fatty acid-binding protein 5 {ECO:0000305};
CC(=O)Nc1ccc(S(=O)(=O)Nc2c(C)nn(-c3ccccc3)c2C)cc1,P47824,"N-{4-[(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)sulfamoyl]phenyl}acetamide",Peptidyl-prolyl cis-trans isomerase A;
Cc1ccc(NS(=O)(=O)c2ccc(OCC(=O)N3CCOCC3)cc2)cc1,P47900,MLS000124061,5-hydroxytryptamine receptor 3A {ECO:0000305|PubMed:7565620};
CCn1c(SCC(=O)Nc2cccc(C(C)=O)c2)nnc1-c1ccncc1,P38919,"N-(3-acetylphenyl)-2-{[4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide",Delta-type opioid receptor;
Nc1ccc(Oc2ccc3nc(-c4ccccn4)c(-c4ccccn4)nc3c2)cc1,O43613,Arylamine compound 5,C-C chemokine receptor type 5;
CCOc1cc(/C=C2\Sc3ccccc3C2=O)cc(Br)c1OCC(=O)O,Q99816,Ipamorelin,Cathepsin S;
CCN1C(=O)c2cccc3c(S(=O)(=O)NC4CCCCC4)ccc1c23,Q9H3N8,"N-cyclohexyl-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide",Sialic acid-binding Ig-like lectin 7;
Nc1ccc(Sc2ccc(N3C(=O)c4ccc(N)cc4C3=O)cc2)cc1,P9WMC1,"5-amino-2-{4-[(4-aminophenyl)sulfanyl]phenyl}-1H-isoindole-1,3(2H)-dione",Acetylcholinesterase {ECO:0000305};
COc1ccccc1NC(=O)CSc1nnc(-c2ccc([N+](=O)[O-])cc2)n1-c1ccccc1,P50129,"N-(2-methoxyphenyl)-2-{[5-(4-nitrophenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide",P2Y purinoceptor 12;
c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1,P34158,1-Benzyl-2-phenyl-1H-benzoimidazole,Neuronal acetylcholine receptor subunit alpha-7;
CN1CCN(C(=O)c2ccccc2N(Cc2ccccc2)S(C)(=O)=O)CC1,P49763,N-benzyl-N-{2-[(4-methylpiperazin-1-yl)carbonyl]phenyl}methanesulfonamide,Oxytocin receptor;
N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O,O60671,TCS PIM-1 1,Substance-P receptor;
O=S(=O)(NCc1ccccn1)c1cc(Cl)c(Cl)cc1Cl,Q05816,"2,4,5-trichloro-N-(pyridin-2-ylmethyl)benzenesulfonamide",Gastrin/cholecystokinin type B receptor;
Cc1c(NS(=O)(=O)c2cccc3nonc23)c(=O)n(-c2ccccc2)n1C,P62937,CBKinase1_002868,Somatostatin receptor type 1;
CC(C)(C)c1csc(NC(=O)C2CCC2)n1,P46098,Rotigaptide,Somatostatin receptor type 2;
COc1ccccc1NC(=O)CSc1nnc(-c2ccccc2Cl)n1-c1ccccc1,P32300,"2-{[5-(2-chlorophenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(2-methoxyphenyl)acetamide",Somatostatin receptor type 1;
O=C(O)c1ccccc1SCC(=O)N1CCOCC1,P51682,MLS000862372,Somatostatin receptor type 2;
Cc1ccc(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3C(=O)N3CCOCC3)ccc2Cl)c(C)c1,P25774,CBKinase1_011006,Somatostatin receptor type 4;
CCOc1ccc(/C=C2\SC(=O)N(CCN)C2=O)cc1,Q9Y286,Undecyl-Beta-D-Maltopyranoside,B2 bradykinin receptor;
Cn1c(Cc2ccccc2)nnc1Sc1ccc([N+](=O)[O-])cc1C(=O)N1CCOCC1,Q9H244,CBKinase1_011647,B1 bradykinin receptor;
O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(N2CCOCC2)c(Cl)c1,P36544,CBKinase1_011222,Tumor necrosis factor;
Cc1cc(C)c(N2C(=O)c3ccc(C(=O)Nc4cc(C(=O)O)cc(C(=O)O)c4)cc3C2=O)c(C)c1,P70536,Pramipexole,Thromboxane A2 receptor;
O=C(Cn1ccc([N+](=O)[O-])n1)N1CCCc2ccccc21,P30547,MLS000582718,E3 ubiquitin-protein ligase XIAP;
CC(=O)c1cccc(NS(=O)(=O)N2CCCCC2)c1,P30553,N-(3-acetylphenyl)piperidine-1-sulfonamide,"Fatty acid-binding protein, heart;"
O=C(Cn1c(-c2cscn2)nc2ccccc21)Nc1ccccc1F,P28646,Malacidin B,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;
CSc1ccc(S(=O)(=O)NCc2ccccn2)cc1,P30680,CBKinase1_010459,Peptidyl-prolyl cis-trans isomerase FKBP4;
Cc1cccc(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3C(=O)N3CCOCC3)ccc2Cl)c1,P30872,CBKinase1_010342,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial;"
Brc1ccccc1Cn1c(-c2cscn2)nc2ccccc21,P30874,Cibinetide,D(3) dopamine receptor;
c1ccc2c(c1)nc(-c1cscn1)n2Cc1ccc(-c2nnn[nH]2)cc1,P31391,Mitoglitazone,Polyunsaturated fatty acid lipoxygenase ALOX15 {ECO:0000305};
O=C1NC(=S)S/C1=C/c1ccc(-c2cccc(C(F)(F)F)c2)o1,O70526,ccr-11,Plasminogen activator inhibitor 1;
COc1ccc(-c2nnc(SCC(=O)Nc3c(F)cc(F)cc3Br)n2C)cc1,P97583,"N-(2-bromo-4,6-difluorophenyl)-2-{[5-(4-methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide",Peptidyl-prolyl cis-trans isomerase B;
O=C(COc1ccccc1[N+](=O)[O-])Nc1ccccc1N1CCOCC1,P01375,CBKinase1_002629,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial;"
O=C1c2ccccc2C(=O)N1CCCc1nc(-c2cccc([N+](=O)[O-])c2)[n-][o+]1,P21731,"2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",Protein Tat {ECO:0000255|HAMAP-Rule:MF_04079};
O=C1c2ccccc2C(=O)N1CCCc1nc(-c2cccc([N+](=O)[O-])c2)no1,P98170,CS148,"Glutamate receptor ionotropic, NMDA 2B;"
COc1cc(OC)c(NC(=O)CSc2nnc(-c3ccncc3)n2-c2ccccc2)cc1Cl,P05413,"N-(5-chloro-2,4-dimethoxyphenyl)-2-{[4-phenyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide",B2 bradykinin receptor;
O=C(Nc1cccc(Cl)c1Cl)c1ccccc1OCC(=O)N1CCOCC1,P04191,Ribavirin monophosphate,B2 bradykinin receptor;
CCc1ccccc1NC(=O)CSc1nnc(-c2cccc(OC)c2)n1C,Q02790,"N-(2-ethylphenyl)-2-{[5-(3-methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide",Tubulin beta-1 chain;
O=C(Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1)c1c(Cl)cccc1Cl,Q15119,"2,6-dichloro-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]benzamide",Bromodomain-containing protein 9;
CCOc1cc(/C=C2\SC(=S)N(Cc3ccccc3)C2=O)ccc1OCC(=O)O,P19020,Regrelor,Hepatocyte growth factor;
CC1CCN(S(=O)(=O)c2ccc(Cl)c(C(=O)Nc3ccc(C(=O)O)cc3)c2)CC1,P16050,Cambridge id 7101959,Glycogen synthase kinase-3 beta;
COc1cc(/C=C2/NC(=O)NC2=O)ccc1OCc1ccc(Br)cc1,P20961,Sulfaperin,Corticotropin-releasing factor receptor 1;
Clc1cccc(Cl)c1Cn1c(-c2cscn2)nc2ccccc21,P23284,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",Substance-K receptor;
O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1ccc(Cl)c([N+](=O)[O-])c1,P30405,CBMicro_009209,Proteinase-activated receptor 1;
CC(C)(C)NC(=O)c1cccc(N2C(=O)c3ccc(C(=O)O)cc3C2=O)c1,P04608,Troriluzole,Cholecystokinin receptor type A;
COc1ccc(/C=C2\SC(=O)NC2=O)c(OC)c1,Q13224,Pacritinib,Gastrin/cholecystokinin type B receptor {ECO:0000303|PubMed:8415658};
COc1ccc(/C=C2\SC(=S)NC2=O)c(OC)c1,P06730,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine","Glutamate receptor ionotropic, NMDA 1;"
Cc1ccc(CNC(=O)c2c(N)n(-c3cccc(O)c3)c3nc4ccccc4nc23)cc1,P25023,FET F-18,Prostaglandin D2 receptor;
Clc1ccc(CNc2nc3ccccc3[nH]2)cc1Cl,P30411,Quisqualic acid,Adenosine receptor A3;
O=C(O)c1cc(-c2ccc(Cl)cc2)n(-c2ccc(Cl)cc2)n1,Q9H4B7,"1,5-bis(4-chlorophenyl)-1H-pyrazole-3-carboxylic acid",Cathepsin D;
O=C(O)c1cc(-c2ccc(Cl)cc2)n(-c2ccc(Cl)cc2Cl)n1,Q9H8M2,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-1H-pyrazole-3-carboxylic acid",Adenylate cyclase type 5;
Cc1cc2ccccc2nc1-c1ccccc1,P48061,3-methyl-2-phenylquinoline,Somatostatin receptor type 3;
O=c1c2cnn(-c3ccccc3)c2nc2scc(-c3ccccc3)n12,P05162,174535-76-3,Muscarinic acetylcholine receptor M3;
Cc1cccc(-n2cnc3cc(N)ccc32)c1,P14210,1-(3-methylphenyl)-1H-benzimidazol-5-amine,Substance-K receptor;
FC(F)(F)c1cccc(Cn2c(-c3cscn3)nc3ccccc32)c1,Q9WV60,Daprodustat,Peroxisome proliferator-activated receptor delta;
CSc1ccccc1NC(=O)Cn1c(-c2cscn2)nc2ccccc21,P34998,Telavancin,Kinesin-like protein KIF11;
CCN1C(=O)c2cccc3c(S(=O)(=O)Nc4ccc(F)cc4)ccc1c23,P21452,"1-ethyl-N-(4-fluorophenyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide",Histamine H3 receptor;
O=C(O)CSc1nnc(-c2sc3ccccc3c2Cl)n1-c1ccccc1,P25116,Tulathromycin A,UDP-3-O-acyl-N-acetylglucosamine deacetylase {ECO:0000255|HAMAP-Rule:MF_00388};
CC(C)C[C@@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O,P32238,Fmoc-D-Leu-OH,Glutamate receptor 2 {ECO:0000305};
CCN1C(=O)c2cccc3c(S(=O)(=O)Nc4ccccc4C(=O)O)ccc1c23,P32239,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",Type-2 angiotensin II receptor {ECO:0000303|PubMed:8227010};
O=c1/c(=C/c2cc([N+](=O)[O-])c(O)cc2Cl)sc2nc3ccccc3n12,Q05586,"2-{2-chloro-4-hydroxy-5-nitrobenzylidene}[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one",Melanocortin receptor 3;
N=C1S/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N1c1ccc(F)cc1,Q13258,N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,Glutamate carboxypeptidase 2 {ECO:0000305};
Cc1ccc(S(=O)(=O)Nc2ccccc2CNc2cnc3ccccc3c2)cc1,P0DMS8,4-methyl-N-{2-[(3-quinolinylamino)methyl]phenyl}benzenesulfonamide,Plasminogen activator inhibitor 1;
CCN1C(=CC(C)=O)Sc2ccc(OC)cc21,P07339,300801-52-9,Mu-type opioid receptor;
COc1ccc2[nH]cc(CCNC(=O)Nc3ccc(Cl)c(Cl)c3)c2c1,O95622,"1-(3,4-dichlorophenyl)-3-[2-(5-methoxy-1H-indol-3-yl)ethyl]urea",Urokinase-type plasminogen activator;
O=S(=O)(NCCSc1ccccn1)c1ccc(Br)cc1,P32745,CBKinase1_001954,Serine protease 1 {ECO:0000250|UniProtKB:P07477};
Cc1ccc(-c2ccc(C(=O)O)cc2)cc1,P20309,720-73-0,Cyclin-A2 {ECO:0000312|HGNC:HGNC:1578};
NS(=O)(=O)c1c(F)c(F)c(F)c(F)c1F,P79218,Pentafluorobenzenesulfonamide,Substance-K receptor;
Oc1cc(-c2ccccc2)nc2nnnn12,Q03181,Daidzein,Neuronal acetylcholine receptor subunit alpha-9;
CN(C)CCOCCOc1ccccc1-c1ccccc1,P52732,Ravuconazole,Muscarinic acetylcholine receptor M4;
COC(=O)c1ccc(NC(=O)CSc2nnc(-c3ccc(NC(C)=O)cc3)n2C)cc1,Q9QYN8,CBKinase1_002647,5-hydroxytryptamine receptor 4;
CC(=O)Nc1cccc(-c2nnc(SCC(=O)Nc3ccc(C(C)=O)cc3)n2C)c1,P47205,"2-({5-[3-(acetylamino)phenyl]-4-methyl-4H-1,2,4-triazol-3-yl}sulfanyl)-N-(4-acetylphenyl)acetamide",Potassium voltage-gated channel subfamily A member 2;
O=C(CSc1ccc2ccccc2c1)N1CCOCC1,P42262,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,"Inositol 1,4,5-trisphosphate receptor type 3;"
CS(=O)(=O)N(CC(=O)Nc1ccccc1C(=O)N1CCOCC1)c1ccc(Cl)cc1,P35351,CBKinase1_006589,Substance-K receptor;
O=C(Cc1ccccc1[N+](=O)[O-])Nc1ccccc1C(=O)N1CCOCC1,P33033,CBKinase1_007200,Thromboxane A2 receptor;
COc1cc(OC)c(NC(=O)CSc2nnc(-c3ccncc3)n2C)cc1Cl,Q04609,"N-(5-chloro-2,4-dimethoxyphenyl)-2-{[4-methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide",Neutrophil elastase;
COc1ccc(NC(=O)CCSc2nnc3scc(-c4ccc(C)cc4)n23)cc1,P05121,CBKinase1_007697,Nuclear receptor subfamily 4immunitygroup A member 1;
CCOc1ccc2nc(SCC(=O)Nc3c(C)n(C)n(-c4ccccc4)c3=O)sc2c1,P97266,"N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]acetamide",Melanocortin receptor 4;
Cc1c(Cl)cccc1NC(=O)CNC(=O)c1ccccc1F,P00749,Leucine Phosphonic Acid,Histone acetyltransferase p300 {ECO:0000305};
Cc1cc(S(=O)(=O)N2CCCC2)ccc1OCC(=O)N1CCOCC1,P00760,R-1487,Alpha-1B adrenergic receptor;
Cc1[nH]c2ncnn2c(=O)c1NS(=O)(=O)c1ccc(Br)cc1,P20248,CS237,C-C chemokine receptor type 2;
Cc1ccc2cccc(SCC(=O)N3CCOCC3)c2n1,P16610,2-(2-methylquinolin-8-yl)sulfanyl-1-morpholin-4-ylethanone,Growth factor receptor-bound protein 2;
COC(=O)c1ccccc1Oc1nc(NC(C)C)nc(NC(C)C)n1,P43144,CBKinase1_001488,Voltage-dependent anion-selective channel protein 2;
O=S(=O)(NCc1ccccn1)c1ccc(Cl)c(Cl)c1Cl,P08485,"(2-pyridylmethyl)[(2,3,4-trichlorophenyl)sulfonyl]amine",Induced myeloid leukemia cell differentiation protein Mcl-1 homolog;
CCc1ccccc1N(CC(=O)NCCc1ccc(OC)c(OC)c1)S(=O)(=O)c1ccc(C)cc1,Q62758,"N-(3,4-dimethoxyphenethyl)-2-(N-(2-ethylphenyl)-4-methylphenylsulfonamido)acetamide",Bcl-2-related protein A1;
C=CCNCCOc1ccccc1-c1ccccc1,P16389,Hexocyclium,Cytochrome P450 165B3;
Oc1[nH]c(S)nc2nc(S)nc1-2,Q14573,15986-32-0,Leukocyte surface antigen CD47;
Nc1nc2[nH]c(=S)[nH]c2c(=O)[nH]1,P51144,2-Amino-6-hydroxy-8-mercaptopurine,Arginase-1;
Nc1nc2[nH]c(S)nc2c(=O)[nH]1,P30987,2-Amino-6-hydroxy-8-mercaptopurine,C-X-C chemokine receptor type 2;
Nc1ccc2nnc(-c3ccccc3)n2n1,P08246,Leptazoline A,Prostaglandin E2 receptor EP1 subtype;
CC(=O)N1CCC(c2c[nH]c3ccccc23)CC1,P22736,30030-83-2,Adenosine receptor A2b;
O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1,P39900,133961-81-6,Programmed cell death 1 ligand 1 {ECO:0000303|PubMed:28813417};
N=C(N)N=C(N)Nc1ccc(Cl)cc1C(=O)c1ccccc1,Q15369,2-(2-benzoyl-4-chlorophenyl)-1-(diaminomethylidene)guanidine,Prostaglandin D2 receptor 2;
CC(=O)Nc1ccc(-c2cc(C(=O)O)c3ccc(C)cc3n2)cc1,P56450,beta-D-glucuronic acid,Asialoglycoprotein receptor 1;
N=C(N)SCc1c(F)cccc1Cl,Q09472,Acetazolamide,Galanin receptor type 2;
CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,P35368,tamoxifen,Secreted frizzled-related protein 1;
NC(=O)c1ccc(F)c(Cl)c1,P41597,3-Chloro-4-fluorobenzamide,Macrophage metalloelastase;
Nc1cccc(-c2cnco2)c1,P62993,"3-(1,3-oxazol-5-yl)aniline",Sigma non-opioid intracellular receptor 1;
O=C(O)c1ccc(-c2cccc([N+](=O)[O-])c2)cc1,P45880,4-(3-nitrophenyl)benzoic Acid,Urotensin-2 receptor;
Nc1cccc(-c2ccc(C(=O)O)cc2)c1,P97287,124221-69-8,Insulin-like growth factor-binding protein 5;
O=C(O)c1ccc(-c2cc(Cl)cc(Cl)c2)cc1,Q16548,190911-79-6,Vasopressin V2 receptor;
O=C(O)c1ccc(-c2ccc(Cl)c(Cl)c2)cc1,Q8RN04,7111-64-0,Thromboxane A2 receptor;
COc1ccccc1-c1ccc(C(=O)O)cc1,Q08722,5728-32-5,Neuropeptide Y receptor type 2;
COc1ccc(-c2ccc(C(=O)O)cc2)cc1,P05089,725-14-4,Glutamate racemase {ECO:0000255|HAMAP-Rule:MF_00258};
c1ccc(-c2ncc(-c3cc[nH]n3)s2)cc1,P25025,"2-phenyl-5-(1H-pyrazol-3-yl)-1,3-thiazole",B1 bradykinin receptor;
Cc1ccc(S(=O)(=O)c2cc(C)nc(N)n2)cc1,P35375,860648-93-7,Gonadotropin-releasing hormone receptor;
CNC(=O)c1cc(Br)c[nH]1,P29275,4-bromo-N-methyl-1H-pyrrole-2-carboxamide,Galanin receptor type 3;
O=C(O)c1cc(-c2ccc(Br)cc2)on1,Q9NZQ7,5-(4-Bromophenyl)isoxazole-3-carboxylic acid,Galanin receptor type 1;
O=C(O)Cn1c(SCCOc2ccccc2)nc2ccccc21,Q9Y5Y4,{2-[(2-phenoxyethyl)thio]-1H-benzimidazol-1-yl}acetic acid,Glucagon-like peptide 1 receptor;
O=C(O)Cn1c(SCCOc2ccccc2F)nc2ccccc21,O43603,2-(2-((2-(2-Fluorophenoxy)ethyl)thio)-1H-benzo[d]imidazol-1-yl)acetic acid,14-3-3 protein theta;
COc1ccccc1OCCSc1nc2ccccc2n1CC(=O)O,Q8N474,H3B-6527,14-3-3 protein beta/alpha;
Cc1ccccc1OCCSc1nc2ccccc2n1CC(=O)O,Q60492,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,Acyl-protein thioesterase 2;
Cc1nn(-c2ccccc2)nc1C(N)=O,Q9UKP6,"5-methyl-2-phenyl-2H-1,2,3-triazole-4-carboxamide",Prostate-specific antigen;
O=c1[nH]oc2cc(Cl)ccc12,Q00788,6-chlorobenzo[d]isoxazol-3-ol,Beta-lactamase;
CSc1nc(N)nc(-c2ccncc2)n1,P34978,175204-63-4,Adiponectin receptor protein 2 {ECO:0000303|PubMed:25969726};
O=C(O)c1ccc(-c2ccc(F)cc2)cc1,P49146,4-(4-Fluorophenyl)benzoic acid,Adiponectin receptor protein 1 {ECO:0000303|PubMed:12802337};
O=C(O)c1ccc(-c2cccc(C(F)(F)F)c2)cc1,P56068,195457-70-6,Vesicular acetylcholine transporter;
O=C(O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1,P46663,195457-71-7,T-cell surface glycoprotein CD4;
CCOC(=O)C(CC)n1cnc2sc3c(c2c1=O)CCCC3,P30968,BAS 03542826,Transient receptor potential cation channel subfamily V member 1;
CCOC(=O)C(C)n1cnc2sc3c(c2c1=O)CCCC3,O60755,BAS 04801367,P2X purinoceptor 7;
Cc1cc(N)c(N)cc1Cl,P47211,"4-chloro-5-methylbenzene-1,2-diamine",Chymotrypsin-C;
Cc1nc(C)c(-c2cc[nH]n2)s1,P43220,"2,4-Dimethyl-5-(1H-Pyrazol-3-Yl)-1,3-Thiazole",Poly [ADP-ribose] polymerase 2 {ECO:0000305};
NC(=O)C1CCN(c2ccc(C(F)(F)F)cn2)CC1,P27348,1-[5-(trifluoromethyl)pyridin-2-yl]piperidine-4-carboxamide,Lysosomal alpha-glucosidase;
O=S1(=O)C=CC(OS(=O)(=O)c2ccccc2)C1,P31946,39582-95-1,5-hydroxymethyl-dUMP N-hydrolase {ECO:0000250|UniProtKB:O43598};
O=[N+]([O-])c1ccc(Nc2ccccc2-c2ccccc2)c2nonc12,O95372,413611-93-5,Inositol-pentakisphosphate 2-kinase;
O=[N+]([O-])c1cc(Nc2ccc3nonc3c2[N+](=O)[O-])ccc1Cl,P07288,HIF-2alpha-IN-3,Dipeptidyl peptidase 8 {ECO:0000303|PubMed:11012666};
O=[N+]([O-])c1c(Nc2cccc(C(F)(F)F)c2)ccc2nonc12,P05364,Pefcalcitol,NAD-dependent protein deacetylase sirtuin-1 {ECO:0000305};
Cc1cc(C)cc(OCC(O)CNC(C)C)c1,Q86V24,Fosbretabulin,Coagulation factor X;
Cc1cccc(C)c1OCCSc1nc2ccccc2n1CC(=O)O,Q96A54,CRTh2 antagonist 3,N-lysine methyltransferase SMYD2;
CSC1=NC(c2cccc([N+](=O)[O-])c2)C(C(=O)OC(C)C)=C(C)N1,Q62666,"propan-2-yl 6-methyl-2-methylsulfanyl-4-(3-nitrophenyl)-1,4-dihydropyrimidine-5-carboxylate",Hemagglutinin {ECO:0000255|HAMAP-Rule:MF_04072};
O=C(Cn1c(NCCO)nc2ccccc21)c1cccc([N+](=O)[O-])c1,P01730,CBMicro_042615,IgG receptor FcRn large subunit p51;
CC1CC(OCC(O)CNC(C)(C)C)CC(C)(C)C1,Q8NER1,Tesevatinib,Small conductance calcium-activated potassium channel protein 1;
N#Cc1c(-c2ccccc2)nc(SCC(=O)Nc2ccc(S(N)(=O)=O)cc2)[nH]c1=O,Q64663,13-deoxydoxorubicin,Small conductance calcium-activated potassium channel protein 2;
NC(=O)c1ccc(NCCCN2CCOCC2)c([N+](=O)[O-])c1,Q99895,CBKinase1_001439,Sonic hedgehog protein {ECO:0000305};
O=C(NCC12CC3CC(CC(C3)C1)C2)c1ccccc1Cl,Q9UGN5,2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID,cAMP-dependent protein kinase catalytic subunit alpha;
Cc1[n-][o+]nc1OCCNc1cc(N2CCOCC2)ccc1[N+](=O)[O-],P10253,Lorecivivint,Histone-lysine N-methyltransferase EHMT2;
Cc1nonc1OCCNc1cc(N2CCOCC2)ccc1[N+](=O)[O-],O35820,CS204,Phosphatidylinositol 3-kinase catalytic subunit type 3;
CN1CCN(C(=O)CN(c2cc(C(F)(F)F)ccc2Cl)S(=O)(=O)c2ccccc2)CC1,Q93YN9,N-[2-chloro-5-(trifluoromethyl)phenyl]-N-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]benzenesulfonamide,SHC-transforming protein 1;
COc1ccc(C(=O)C(C)Oc2cccc(NC(=O)c3cccc([N+](=O)O)c3)c2)cc1,Q6V1X1,N-(3-{[1-(4-methoxyphenyl)-1-oxopropan-2-yl]oxy}phenyl)-3-nitrobenzamide,C-X-C chemokine receptor type 3;
O=C(Cn1nc(-c2cccc([N+](=O)[O-])c2)c2ccccc2c1=O)NCC1CCCO1,Q96EB6,2-[4-(3-nitrophenyl)-1-oxophthalazin-2(1H)-yl]-N-(tetrahydrofuran-2-ylmethyl)acetamide,Polycomb protein EED {ECO:0000305};
CCOC(=O)c1cnc(Nc2nc3ccccc3o2)nc1CN1CCN(c2ccccc2)CC1,P00742,"ethyl 2-(1,3-benzoxazol-2-ylamino)-4-[(4-phenylpiperazin-1-yl)methyl]pyrimidine-5-carboxylate",ADP-ribosylation factor 1;
O=C(CC1OCCN(Cc2ccccc2)C1=O)Nc1ccc2c(c1)OCCO2,Q9NRG4,"2-(4-benzyl-3-oxomorpholin-2-yl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide",Stromal cell-derived factor 1;
Cc1ccc(OCC(=O)N2CC(C)OC(C)C2)cc1C,P03452,Carteolol,Tubulin--tyrosine ligase;
CC1CN(C(=O)COc2ccccc2Cl)CC(C)O1,P55899,Methyl undecenoyl leucinate,"Glutamate receptor ionotropic, NMDA 1;"
Brc1ccc(OCc2ccccc2)c(CNCC2CCCO2)c1,Q92952,NRX-1074,Serine protease 1 {ECO:0000312|HGNC:HGNC:9475};
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccco2)CC1,Q9H2S1,Levosimendan,Somatostatin receptor type 5;
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)Cc2ccccc2)CC1,Q15465,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,Thromboxane-A synthase;
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)CC1,P05132,WDR5-0102,B2 bradykinin receptor;
COc1cccc(C(=O)Nc2cc([N+](=O)[O-])ccc2N2CCN(C)CC2)c1,Q96KQ7,Quinalizarin,Cholecystokinin receptor type A;
O=C(Nc1cc([N+](=O)[O-])ccc1N1CCCCC1)c1ccccc1Cl,Q8NEB9,Erythritol,Glucagon receptor;
CC(=O)Nc1cc([N+](=O)[O-])ccc1N1CCN(C)CC1,P29353,Phenylethyl alcohol,Caspase-6 {ECO:0000303|PubMed:11953316};
OC(Cn1ccc2ccccc21)Cn1cnc2ccccc21,P49682,Nialamide,Alpha-ketoglutarate-dependent dioxygenase FTO {ECO:0000305};
O=C(c1ccccc1)N1CCN(CCc2ccccc2)CC1,O75530,Methylnaltrexone,Mu-type opioid receptor;
O=S(=O)(Nc1ccc2c(c1)oc1ccccc12)N1CCCCC1,P84077,N-Acetylmethionine,Probable global transcription activator SNF2L2;
COc1ccc(NC(=O)CN2CCOCC2)c([N+](=O)[O-])c1,Q8NG68,CBKinase1_011551,Transcription initiation factor TFIID subunit 1-like;
COc1cc([N+](=O)[O-])ccc1NC(=O)CN1CCOCC1,P35439,CBKinase1_011911,Bromodomain adjacent to zinc finger domain protein 2B;
CC1=NN(c2nc3ccccc3[nH]2)C(=O)C1CCC(C)C,P07477,"2-(1H-benzimidazol-2-yl)-5-methyl-4-(3-methylbutyl)-2,4-dihydro-3H-pyrazol-3-one",Bromodomain adjacent to zinc finger domain protein 2A;
Cc1ccc(NS(=O)(=O)N2CCCCC2)c(C)c1,P35346,"N-(2,4-dimethylphenyl)piperidine-1-sulfonamide",Melanocortin receptor 4;
Cc1cc(C)cc(NS(=O)(=O)N2CCCCC2)c1,P24557,"N-(3,5-dimethylphenyl)piperidine-1-sulfonamide",Melanocortin receptor 3;
CCCCNS(=O)(=O)c1ccc(OCC(=O)N2CCOCC2)cc1,Q28642,20-hydroxycholesterol,Melanocyte-stimulating hormone receptor;
CCOc1ccc(NS(=O)(=O)N2CCCCC2)cc1,Q63931,N-(4-ethoxyphenyl)piperidine-1-sulfonamide,Bromodomain-containing protein 1 {ECO:0000303|PubMed:16387653};
COc1cc(NC(C)=O)c(Cl)cc1C(=O)Nc1nccs1,P30082,3-Acetylpyridine Adenine Dinucleotide,Bromodomain and PHD finger-containing protein 3 {ECO:0000303|PubMed:26620551};
Cc1ccc(NS(=O)(=O)N2CCCCC2)cc1Cl,P55212,N-(3-chloro-4-methylphenyl)piperidine-1-sulfonamide,Bromodomain-containing protein 3;
O=C(O)c1ccc(-c2ccc(F)c(Cl)c2)o1,Q9C0B1,5-(3-chloro-4-fluorophenyl)furan-2-carboxylic acid,Endothelin-1 receptor {ECO:0000305};
Cc1cc(OCC(=O)N2CCOCC2)ccc1NC(=O)OCc1ccccc1,P35372,PAC-1,Multidrug resistance-associated protein 1 {ECO:0000305};
Cc1cc(OCC(=O)N2CCOCC2)ccc1C(C)C,P51531,4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,Dihydrofolate reductase;
CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,Q8IZX4,lincomycin,Dihydrofolate reductase;
CN/C([CH-][N+](=O)[O-])=[NH+]\CCSCc1ccc(CN(C)C)o1,Q9UIF8,Gastrosedol,Potassium voltage-gated channel subfamily A member 1 {ECO:0000305};
Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,Q9UIF9,Maraviroc,Prostaglandin E2 receptor EP2 subtype;
CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1,P32245,toremifene,Protein Tat {ECO:0000255|HAMAP-Rule:MF_04079};
CN[C@H]1CN(c2cccc(OC)c2)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,P41968,AL7089A,Galectin-3;
COc1c(C(C)=O)c(O)cc2occc12,Q01726,Visnaginone,Cell division protein ZipA {ECO:0000255|HAMAP-Rule:MF_00509};
CC1(C)CCC(C)(C)c2cc(Sc3ccc(C(=O)O)cc3)ccc21,O95696,Dihydrocapsiate,Metabotropic glutamate receptor 8;
Cc1cc2c(cc1Sc1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,Q9ULD4,173156-91-7,ATP-binding cassette sub-family C member 8;
Cc1cc2c(cc1Sc1ccc(C(=O)O)cn1)C(C)(C)CCC2(C)C,Q15059,"3-Pyridinecarboxylic acid, 6-((5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)thio)-",Calcitonin gene-related peptide type 1 receptor {ECO:0000305};
Cc1cc2c(cc1S(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,P26684,179762-65-3,Urotensin-2 receptor;
Cc1cc2c(cc1S(=O)(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,P33527,"4-((5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)sulfonyl)benzoic acid",Sterol carrier protein 2;
Cc1cc2c(cc1Sc1ncc(C(=O)O)s1)C(C)(C)CCC2(C)C,P00374,"2-((5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)thio)-5-thiazolecarboxylic acid",Nucleosome-remodeling factor subunit BPTF;
CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,P00378,345627-80-7,Glycophorin-A {ECO:0000305};
CNC(=S)NCCCCc1cnc[nH]1,P00747,BURIMAMIDE,Menin;
C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,Q09470,Quinine,Bcl2-associated agonist of cell death;
S=C(NC1CCCCC1)N1CCC(c2cnc[nH]2)CC1,P43116,Thioperamide,Parathyroid hormone/parathyroid hormone-related peptide receptor;
COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,P04326,Tandutinib,Beta-lactoglobulin;
O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,P34971,209410-46-8,Complement factor D;
CC(C)NCC(O)COc1ccc(COCC2CC2)cc1,P16110,63659-22-3,Cysteine synthase;
COc1ccc(CC2SC(=O)NC2=O)c(OC)c1,P77173,79525-07-8,Histone-lysine N-methyltransferase EHMT1;
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,O00222,Dasatinib,Dipeptidyl peptidase 4 {ECO:0000305};
O=C(O)CNC(=O)C(=O)O,Q09428,N-Oxalylglycine,Granulocyte colony-stimulating factor receptor;
N=C(NCCCc1cnc[nH]1)NCCC(c1ccc(F)c(F)c1)c1ccccn1,Q16602,114667-74-2,Metabotropic glutamate receptor 5;
N=C(NCCCc1cnc[nH]1)NCCC(c1cc(F)cc(F)c1)c1ccccn1,P49684,BU-E-76,"cGMP-specific 3',5'-cyclic phosphodiesterase {ECO:0000305};"
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,P22307,Vandetanib,Bcl-2-like protein 2;
CNC(=S)NCCCc1cnc[nH]1,Q12830,34970-65-5,Signal transducer and activator of transcription 3 {ECO:0000312|MGI:MGI:103038};
CN(C)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(O)c(O)c1,P02724,Dinoprost tromethamine,Trifunctional purine biosynthetic protein adenosine-3 {ECO:0000250|UniProtKB:P22102};
CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc32)[C@H](O)[C@@H]1O,O00255,Cgs 21680,"3',5'-cyclic-AMP phosphodiesterase 4D {ECO:0000305};"
COc1ccccc1CN(C[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CN1CCC(N2CCCCC2)CC1)C(C)=O,Q61337,LANEPITANT,Bromodomain testis-specific protein;
CC(C)NCC(O)COc1ccccc1,Q03431,7695-63-8,Cell division protein FtsZ {ECO:0000255|HAMAP-Rule:MF_00909};
CCc1c(O)nc2[nH]c3ccccc3n2c1=O,P02754,"3-ethylpyrimido[1,2-a]benzimidazole-2,4-diol",Poly [ADP-ribose] polymerase 1;
c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1,P00746,ML106,"Dihydroorotate dehydrogenase (quinone), mitochondrial;"
CCCN1Cc2cccc(C(N)=O)c2C1=O,P45040,Phosphocreatine,Probable UDP-galactopyranose mutase;
Nc1nc(Sc2ccc([N+](=O)[O-])c3nonc23)c2[nH]cnc2n1,Q9H9B1,NSC348401,Ras-related protein Rap-1A;
NS(=O)(=O)c1cccc2c1c([N+](=O)[O-])cc1[nH]c(=O)c(=O)[nH]c12,P27487,nbqx,Baculoviral IAP repeat-containing protein 2;
Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1,Q99062,SB 204741,ATP-dependent Clp protease ATP-binding subunit ClpC1;
NC(N)=Nc1nc(C2COc3ccccc3O2)cs1,P31424,Marbofloxacin,Orexin receptor type 2;
COc1ccc(Br)cc1CN1CCCC(C(=O)N2CCCCC2)C1,O76074,Misoprostol,Placenta growth factor;
CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(=O)O,Q92843,GW7647,Cell division protein FtsZ {ECO:0000255|HAMAP-Rule:MF_00909};
COc1ccc(CCC(=O)N2CCOCC2)cc1,P42227,Biliverdine IX Alpha,Elongation factor 1-alpha 1;
O=C(NC1CCCC1)c1cnc2ccccc2n1,Q64737,N-cyclopentylquinoxaline-2-carboxamide,Histone-arginine methyltransferase CARM1;
CC(=O)Nc1cc2c(cc1[N+](=O)[O-])-c1ccccc1C2=O,Q08499,2-Acetamido-3-nitro-9-fluorenone,Protein arginine N-methyltransferase 6;
O=C([O-])CCCc1c[nH]c2ccccc12,P20273,Indole-3-butanoate,Glyceraldehyde-3-phosphate dehydrogenase {ECO:0000303|PubMed:6096136};
O=[N+]([O-])c1cccc(Nc2ccc3nonc3c2[N+](=O)[O-])c1,Q58F21,Moclobemide,Acetylcholinesterase;
CC(C)NCC(O)COC(Cn1c2ccccc2c2ccccc21)Cn1c2ccccc2c2ccccc21,P0A031,DC_517,DNA gyrase subunit B {ECO:0000255|HAMAP-Rule:MF_01898};
Cc1[nH]nc2c1C(c1cccs1)C1=C(CC(C)(C)CC1=O)N2,P11103,865658-72-6,ELAV-like protein 1;
Nc1nc(-c2ccc(Cc3ccccc3)cc2)cs1,Q63707,"4-(4-benzylphenyl)-1,3-thiazol-2-amine",Amyloid-beta precursor protein {ECO:0000312|HGNC:HGNC:620};
O=C(O)CC(C(=O)O)N1C(=O)/C(=C2/C(=O)Nc3ccc(Br)cc32)SC1=S,Q48481,CID5721353,von Hippel-Lindau disease tumor suppressor;
CN1Cc2ccccc2NC1=O,P62834,24365-65-9,Oxidized purine nucleoside triphosphate hydrolase {ECO:0000305|PubMed:10373420};
Cc1cc(C)c(Nc2cc(S(=O)(=O)[O-])c(N)c3c2C(=O)c2ccccc2C3=O)c(C)c1,Q13490,S-(4-BROMOBENZYL)CYSTEINE,Glucokinase regulatory protein {ECO:0000303|PubMed:8589523};
CC(C)c1ccc2cc(C(=O)O)[nH]c2c1,P9WPC9,6-isopropyl-1H-indole-2-carboxylic acid,IGF-like family receptor 1;
[NH3+]CCc1c[nH]c2ccccc12,O43614,tryptaminium,Carbonic anhydrase 1;
CNC(=O)c1ccc(S(N)(=O)=O)cc1,P49764,N-methyl-4-sulfamoylbenzamide,Microtubule-associated protein tau {ECO:0000305};
[NH3+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],O66809,2-azaniumyl-3-(1H-indol-3-yl)propanoate,Histone deacetylase-like amidohydrolase;
CCCCc1nc2ccccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,P68104,Orlistat,"Histone-lysine N-methyltransferase, H3 lysine-79 specific {ECO:0000305};"
Cc1[nH]nc2c1C(c1ccsc1)C1=C(CC(C)(C)CC1=O)N2,Q86X55,GSK3-IN-2,DNA ligase {ECO:0000255|HAMAP-Rule:MF_01588};
Nc1nccc(-c2nccs2)n1,Q96LA8,"4-(1,3-thiazol-2-yl)pyrimidin-2-amine",Lethal(3)malignant brain tumor-like protein 3 {ECO:0000305};
CCc1cc(C(=O)Cc2ccccc2C)c(O)cc1O,P04406,"1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-methylphenyl)ethanone","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A;"
O=C1C=C(Nc2cccc3cc(S(=O)(=O)O)ccc23)c2ccccc2C1=O,P37136,3-(Mercaptomethylene)Pyridine,Nuclear receptor subfamily 1 group D member 1;
O=[N+]([O-])c1c(NCCCO)cc(Nc2ccc(F)cc2)c2nonc12,P0AES6,Purvalanol A,Endoplasmin;
NS(=O)(=O)c1ccc(SCCO)cc1,Q15717,4-[(2-hydroxyethyl)sulfanyl]benzenesulfonamide,"Heat shock protein 75 kDa, mitochondrial;"
O=C(O)c1ccc(Nc2ncnc3nc[nH]c23)cc1,P05067,TAS-108,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305};"
[NH3+]C(Cc1ccc(O)cc1)C(=O)[O-],P40337,"L-Tyrosine, 24","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 {ECO:0000305};"
Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,P36639,288150-92-5,Cytohesin-3;
S=C(NCCc1cnc[nH]1)Nc1ccccc1,Q14397,Calcifediol,Cytochrome P450 3A4 {ECO:0000303|PubMed:15373842};
O=C(CC12CC3CC(CC(C3)C1)C2)Nc1ccccc1,Q9H665,Oprea1_263122,Platelet-derived growth factor subunit B;
CN[C@@H]1CN(c2cccc(OC)c2)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,P00916,AL7099A,Polymerase basic protein 2 {ECO:0000255|HAMAP-Rule:MF_04062};
CCN[C@H]1CN(CCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,P10636,AL4623,Carbonic anhydrase 1;
C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O,Q70I53,Tirasemtiv,Endoplasmin;
O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1,Q8TEK3,"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",GTPase HRas;
O=C(O)CSC1=C(SCC(=O)O)C(=O)C(SCC(=O)O)=C(SCC(=O)O)C1=O,Q9AIU7,"({2,4,5-tris[(carboxymethyl)sulfanyl]-3,6-dioxo-1,4-cyclohexadien-1-yl}sulfanyl)acetic acid",Aryl hydrocarbon receptor;
CC1CN(C(=O)CSc2ccccc2)CC(C)O1,Q96JM7,Zinc glycinate,"Carbonic anhydrase 5B, mitochondrial;"
CN(C)CCc1cccnc1,Q9QYJ6,D-Asparagine,Signal transducer and activator of transcription 6;
COc1ccc(NC(=O)c2cnc3ccccc3n2)cc1,P20393,5-HT3 antagonist 5,Vasopressin V2 receptor;
O=C(NCC12CC3CC(C1)CC(CNC(=O)c1ccc(Cl)cc1Cl)(C3)C2)c1ccc(Cl)cc1Cl,P41148,2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine,Gag-Pol polyprotein;
O=C(Nc1ccncc1)C1CC1,Q12931,186253-90-7,3-oxoacyl-[acyl-carrier-protein] synthase 1;
CC1(C)CCC(C)(C)c2cc(C(O)c3ccc4cc(C(=O)O)ccc4c3)ccc21,P10688,"4-(N,N-Dimethylamino)cinnamoyl-CoA",GRB10-interacting GYF protein 2 {ECO:0000303|PubMed:12771153};
NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,P51178,301836-41-9,Tyrosyl-DNA phosphodiesterase 1;
NC(Cc1ccc(OP(=O)(O)O)cc1)C(=O)O,P97696,41863-47-2,Ubiquitin-conjugating enzyme E2 D3;
CCCCCCCCCC(=O)[O-],P01127,decanoate,Ribonucleoside-diphosphate reductase subunit alpha;
O=C(NP(=O)(Cl)Cl)c1ccccc1,P03428,"Phosphoramidic dichloride, benzoyl-",Transcription activator BRG1;
CN1CCN(C(=O)c2cc3cc(Cl)ccc3[nH]2)CC1,P00917,459168-41-3,Histone acetyltransferase KAT2A;
O=C(O)c1cc2sccc2[nH]1,P14625,"4H-thieno[3,2-b]pyrrole-5-carboxylic acid",Chromatin remodeling regulator CECR2 {ECO:0000305};
OCc1cn2ccsc2n1,P01112,"imidazo[2,1-b]thiazol-6-ylmethanol",Bromodomain-containing protein 8;
COc1ccc2c(c1)c(CC(=O)NCc1ccncc1)c(C)n2C(=O)c1ccc(Cl)cc1,P30561,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,Bromodomain-containing protein 7;
COc1ccc([N+](=O)[O-])cc1CSc1nnc(N)s1,Q9Y2D0,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,Bromodomain and WD repeat-containing protein 1;
Cc1cc(=O)n2[nH]c(C)c(C#N)c2n1,P42226,"2,5-dimethyl-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile",E3 ubiquitin-protein ligase TRIM33;
O=C(CCC1CCCC1)N1CCCC1,P32307,3-cyclopentyl-1-pyrrolidin-1-yl-propan-1-one,Coagulation factor XI;
COc1ccc(C2OC(=O)NC2=O)c(OC)c1,P12497,MGL-3196,Antithrombin-III;
S=C(NCCc1cnc[nH]1)NC1CCCCC1,P9WQD9,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",Peptidyl-prolyl cis-trans isomerase FKBP5;
Cc1nc(C(F)(F)F)c(-c2nc[nH]n2)s1,Q6Y7W6,338978-10-2,Mu-type opioid receptor;
NC(=O)c1ccc(Cl)s1,Q9NUW8,5-chlorothiophene-2-carboxamide,G-protein coupled receptor 35;
CCC(Sc1nc(-c2cccc(OC)c2)c(C#N)c(=O)[nH]1)C(=O)Nc1ccc(S(N)(=O)=O)cc1,P61077,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,Signal transducer and activator of transcription 5A;
O=C(NCC12CC3CC(CC(C3)C1)C2)c1ccc(Cl)cc1Cl,P9WH75,Ruzasvir,Mitotic checkpoint serine/threonine-protein kinase BUB1;
CN1CCc2ccccc2Cc2ccccc2CC1,P51532,"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",Choline kinase alpha;
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,Q92830,quercetin,Choline/ethanolamine kinase;
O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,Q9BXF3,apigenin,Integrin-linked protein kinase {ECO:0000303|PubMed:8538749};
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O,Q9H0E9,calcitriol,Beta sliding clamp {ECO:0000303|PubMed:2040637};
CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,Q9NPI1,Bryostatin 1,Pantothenate synthetase;
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Q9NSI6,genistein,Integrin alpha-3;
O=c1cc(O)cc2oc(-c3ccc(O)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)cc(O)c1-2,Q9UPN9,"2-(3-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl)-4-hydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one",Chromobox protein homolog 7;
O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,P03951,Galangin,Chromobox protein homolog 8;
COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1,P01008,Kaempferide,CD44 antigen;
COc1c(-c2ccccc2)oc2cc(O)cc(O)c2c1=O,Q13451,Galangin 3-methyl ether,Carbonic anhydrase 14;
C=CC(C)(C)c1c(O)cc(O)c2c(=O)c(O)c(-c3ccc(OC)cc3)oc12,P79350,"8-(1,1-DMA)kaempferide",Nuclear receptor ROR-gamma;
C=CC(C)(C)c1c(O)cc(O)c2c(=O)c(O)c(-c3ccccc3)oc12,Q9HC97,"8-(1,1-Dimethylallyl)galangin",Endothelin-1 receptor {ECO:0000305};
O=S(=O)(O)c1cc(N=C=S)ccc1/C=C/c1ccc(N=C=S)cc1S(=O)(=O)O,P42229,dids,Complement C3;
COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,O43683,Tectochrysin,Transcription intermediary factor 1-alpha;
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,P35790,Anandamide,Transcription initiation factor TFIID subunit 1 {ECO:0000305};
CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,Q9Y259,4759-48-2,Histone-lysine N-methyltransferase 2A;
Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1,Q13418,triprolidine,ATPase family AAA domain-containing protein 2B;
CCCCC/C=C\C=C\C(O)CCCCCCCC(=O)O,P0A988,9-Hode,Gag-Pol polyprotein;
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,P9WIL5,cyclosporin A,PH domain leucine-rich repeat-containing protein phosphatase 1;
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O,P26006,NATAMYCIN,Interferon gamma;
CN1[C@H]2CCC[C@@H]1C[C@H](NC(=O)c1nn(C)c3ccccc13)C2,O95931,granisetron,Platelet factor 4;
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,Q9HC52,naloxone,Bone morphogenetic protein 2;
CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,Q9ULX7,topiramate,Bone morphogenetic protein 6;
NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3,P51449,Irosustat,Eotaxin;
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1ccccc1,Q29010,MORPHOLINE-4-CARBOXYLIC ACID [1S-(2-BENZYLOXY-1R-CYANO-ETHYLCARBAMOYL)-3-METHYL-BUTYL]AMIDE,Tryptophan 5-hydroxylase 1;
CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,P01024,Flavopiridol,CD44 antigen;
COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,O15164,geldanamycin,Chromobox protein homolog 1;
CC(=O)N[C@@H]1[C@@H](O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO,P21675,GM3 carbohydrate moiety,Ezrin;
N=C(N)NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1,Q03164,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",Proto-oncogene tyrosine-protein kinase Src;
C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O,Q9ULI0,Calcipotriol,Poly [ADP-ribose] polymerase 2;
C/C(=C\c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C,P04585,TTNPB,Lysine-specific demethylase 5A;
Nc1ccc2c3ccc(=[NH2+])cc-3n(CCCCCCc3cnnn3CCNc3c4c(nc5ccccc35)CCCC4)c(-c3ccccc3)c2c1,O60346,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",Pituitary adenylate cyclase-activating polypeptide type I receptor;
CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]3O)c2n1,P01579,AR-C67085,Lysine-specific demethylase 2A;
NCCc1cnc(-c2cccc(C(F)(F)F)c2)[nH]1,P02776,2-(3-trifluoromethylphenyl)histamine,Catenin beta-1 {ECO:0000312|HGNC:HGNC:2514};
COc1ccc(/C=C2\CCCN=C2c2cccnc2)c(OC)c1,P12643,Gts-21,Type-1 angiotensin II receptor;
CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,P22004,Atosiban,Nociceptin receptor;
COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC,P51671,cisapride,Nociceptin receptor;
COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1,P17752,136982-36-0,Nociceptin receptor;
N#Cc1cc(OCCOCC2CC2)ccc1OCC(O)CNCCNC(=O)Nc1ccc(O)cc1,P83916,LK 204-545,Nociceptin receptor;
CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1ccc(C(=O)O)c(F)c1)c(O)c2Br,P15311,Atrasentan,Pirin;
Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1,P00523,118101-09-0,Bifunctional purine biosynthesis protein ATIC;
CCCCC/C=C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O,O88554,87893-55-8,Myelin-associated glycoprotein;
CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,P29375,101204-49-3,Transcription factor Jun {ECO:0000305};
CN[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cccc2cc[nH]c12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)(C)C,P41586,Geraniol,Sodium channel protein type 9 subunit alpha {ECO:0000250|UniProtKB:Q15858};
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,Q9Y2K7,Obelin,Sodium channel protein type 1 subunit alpha;
CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1,P35222,PD0166285,Sodium channel protein type 2 subunit alpha {ECO:0000305};
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O,Q9WV26,185052-09-9,Sodium channel protein type 3 subunit alpha;
CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1,P35370,Talnetant,Sodium channel protein type 4 subunit alpha;
O=C1CNc2ccc(C(F)(F)F)cc2N1,P35377,716-81-4,Kelch-like ECH-associated protein 1 {ECO:0000303|PubMed:9887101};
Cc1noc(C)c1-c1ccccc1,P47748,"3,5-dimethyl-4-phenyl-1,2-oxazole",Mitogen-activated protein kinase 14 {ECO:0000305};
Cc1cc2occ(CN(C)CCN(C)Cc3cn(-c4cccc(C(F)(F)F)c4)c4ccccc34)c(=O)c2cc1C,P41146,869998-49-2,E3 SUMO-protein ligase CBX4;
Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1,O00625,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",Chromobox protein homolog 6;
COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,P31939,Bosutinib,Chromobox protein homolog 5;
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,P20916,Sunitinib,Chromobox protein homolog 3;
Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,P05412,JNJ-7706621,Chromobox protein homolog 2;
CCCC(=O)Nc1cc(C2CC2)[nH]n1,O08562,N-(5-cyclopropyl-1H-pyrazol-3-yl)butanamide,Chromodomain Y-like protein 2;
NC(=O)c1ccc(C(=O)Nc2cc(C3CC3)n[nH]2)cc1,P04774,Darolutamide,Testis-specific chromodomain protein Y 1;
O=C(Nc1cc(C2CCCCC2)[nH]n1)c1ccc(Br)cc1,P04775,AZD-6280,Tyrosine-protein phosphatase non-receptor type 6;
Cc1cc(NC(=O)c2ccc(Br)cc2)[nH]n1,P08104,4-bromo-N-(5-methyl-1H-pyrazol-3-yl)benzamide,Signal transducer and activator of transcription 3 {ECO:0000305};
O=C(Cc1ccc(OC(F)(F)F)cc1)Nc1cc(C2CC2)n[nH]1,P15390,N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-[4-(trifluoromethoxy)phenyl]acetamide,ATP-dependent Clp protease proteolytic subunit {ECO:0000255|HAMAP-Rule:MF_00444};
O=C(Cc1ccc(-c2cccs2)cc1)Nc1cc(C2CC2)[nH]n1,Q9Z2X8,N-(3-Cyclopropyl-1h-Pyrazol-5-Yl)-2-[4-(Thiophen-2-Yl)phenyl]acetamide,Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase {ECO:0000255|HAMAP-Rule:MF_00387};
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C/c2cccc(Br)c2)SC1=S,P47811,"2-[(5Z)-5-[(3-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid",Alpha-2A adrenergic receptor {ECO:0000305};
COc1c(C(=O)/C=C/c2ccccc2)c(O)c(OC)c2occc12,O00257,Levodropropizine,Coagulation factor XIII A chain;
N#Cc1cc2c(cc1[N+](=O)[O-])=NC(=O)C(=O)N=2,O95503,"7-Nitro-2,3-Dioxo-2,3-Dihydroquinoxaline-6-Carbonitrile",Growth/differentiation factor 8;
N=C(CCSCc1csc(N=C(N)N)n1)NS(N)(=O)=O,P45973,famotidine,Vasopressin V1a receptor;
Oc1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1,Q13185,152121-30-7,Vasopressin V2 receptor;
O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,Q14781,sulfasalazine,Vasopressin V1b receptor {ECO:0000305};
C/C(=C/c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C,Q8N8U2,110917-84-5,"Peptidyl-prolyl cis-trans isomerase D {ECO:0000305|PubMed:11350175, ECO:0000305|PubMed:20676357};"
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5,Q9Y6F8,Dihydromorphine,Platelet-activating factor acetylhydrolase;
O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,P29350,sulfasalazine,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha;
O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1,P40763,5-[[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid,TNF receptor-associated factor 6;
c1cnc2[nH]ccc2n1,P0A6G7,"5H-Pyrrolo[2,3-b]pyrazine",Isocitrate dehydrogenase [NADP] cytoplasmic;
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,P0A722,Rifampicin,Growth factor receptor-bound protein 7;
CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](Oc2ccccc2)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C,P08913,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",Growth factor receptor-bound protein 10;
CCc1cc(=O)oc2c(C)c(O)c(CN(C)C)cc12,P00488,MLS000042532,Tyrosine-protein kinase BAZ1B;
O=C1N/C(=N\c2ccc(O)cc2)S/C1=C\c1c[nH]c2ccccc12,O14793,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,Glycine receptor subunit alpha-3;
COc1ccc(C(=O)O/N=C2/c3ccccc3-c3nc4ccccc4nc32)cc1OC,P37288,Salicylamide,Myeloperoxidase;
CCNC(=S)N/N=C\c1ccc(-c2ccc(C(=O)O)c(Cl)c2)o1,P30518,PKUMDL-WQ-2201,RNA polymerase sigma factor SigB;
COC(=O)CN1C(=O)S/C(=C/c2ccc(-c3cccc(C(=O)O)c3C)o2)C1=O,P47901,2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid,Telomeric repeat-binding factor 2-interacting protein 1;
CCCCCCCC/C=C\CCCCCCCC(=O)[O-],Q08752,oleate,Caveolin-1;
CCCCC/C=C\C/C=C\CCCCCCCC(=O)[O-],O00443,Linoleate,Free fatty acid receptor 1;
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)[O-],O75874,alpha-Linolenate,Nitric oxide synthase 3 {ECO:0000305};
CCCCCCCCCCC/C=C\CCCCC(=O)[O-],Q14451,petroselinate,UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase;
CCCCCCCC/C=C/CCCCCCCC(=O)[O-],Q13322,Elaidate,Lysine-specific demethylase 6A;
C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCO,Q9UIG0,DAMGO,Shiga toxin subunit A;
C/C(=N/OCC(O)CNC(C)(C)C)C1CC1,O75311,Falintololum,Nicotinamide N-methyltransferase {ECO:0000303|PubMed:21823666};
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@@H](O)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,P05164,debutanoylthapsigargin,Ribonucleoside-diphosphate reductase large subunit;
C[n+]1c(/C=C/c2ccccc2Cl)sc2ccccc21,P9WGI5,"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",Eukaryotic translation initiation factor 4E {ECO:0000303|PubMed:1993647};
NC(N)=Nc1nc(CSCCNC2=NS(=O)N=C2N)cs1,Q9NYB0,78441-84-6,Bile acid receptor;
CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,Q03135,cefotaxime,14-3-3 protein zeta/delta;
COc1cc(/C=C2\CCn3c2nc2cc(NCCCN4CCOCC4)c(F)cc2c3=O)cc(OC)c1OC,O14842,Alovudine F-18,Transient receptor potential cation channel subfamily V member 1;
O=Cc1ccc(/C=C2\CCn3c2nc2cc(NCCCN4CCOCC4)c(F)cc2c3=O)cc1,P29473,Thymectacin,Plasminogen {ECO:0000303|PubMed:2318848};
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(F)cc1,P21645,Chlorophyll B,"NAD-dependent protein deacylase sirtuin-5, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03160};"
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccccc1OC,O15550,Indacaterol,GTPase KRas;
COc1cc(/C=C2\CCn3c2nc2cc(NCCCN(C)C)c(F)cc2c3=O)cc(OC)c1OC,Q9FBI2,Clioquinol,"Glutaminase kidney isoform, mitochondrial;"
Cc1ccc(OC[C@H](O)[C@H](C)NC(C)C)c2c1CCC2,P40261,"(2R,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol",Elongation factor 1-alpha 2;
O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1,P23921,MLS006011723,Tubulin beta chain;
C[C@H](Cc1ccc2c(c1)OC(C(=O)O)(C(=O)O)O2)NC[C@H](O)c1cccc(Cl)c1,Q96RI1,Cl-316243 Free diacid,Bifunctional cytochrome P450/NADPH--P450 reductase {ECO:0000305};
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)[nH]n1,P63104,Tozasertib,Interferon alpha/beta receptor 1;
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,O35433,Tozasertib,Signal transducer and activator of transcription 5B;
C[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,Q9NXA8,N-Succinyl-Ala-Ala-Pro-Phe-pNA,
CCn1c(SCC(=O)Nc2ccccc2OC)nnc1-c1c[nH]c2ccccc12,P01116,832680-82-7,Acetylcholinesterase;
Brc1cccc([C@@H]2C[C@H](c3ccccc3)n3nnnc3N2)c1,O94925,Leucovorin,Alcohol dehydrogenase 1A;
Brc1cccc([C@H]2C[C@@H](c3ccccc3)n3nnnc3N2)c1,Q05639,Uridine triacetate,"cGMP-dependent 3',5'-cyclic phosphodiesterase {ECO:0000250|UniProtKB:O00408};"
COc1cc(/C=N/CCc2ccccc2)ccc1O,P02554,Thymidine-5'-diphospho-beta-D-xylose,Histo-blood group ABO system transferase;
Oc1ccc(-c2n[nH]c(=S)n2-c2cccc3ccccc23)c(O)c1,P14779,Metrifonate,Interleukin-1 receptor-associated kinase-like 2;
O=C(O[C@@H]1[C@@H]2O[C@]2(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OCC[C@@H]12)c1ccc(O)cc1,P17181,"3,4-Dihydrocatalposide",Gamma-aminobutyric acid receptor subunit rho-1;
O=C1NC(=O)/C(=C/c2ccccc2)N1,P51692,5-Benzylidenehydantoin,5-hydroxytryptamine receptor 7;
Oc1ccccc1-c1nnc(S)o1,"P0DP25,P0DP24,P0DP23","2-(5-mercapto-1,3,4-oxadiazol-2-yl)phenol",N-lysine methyltransferase KMT5A {ECO:0000305};
O=c1c2ccccc2nc(/C=C/c2cccnc2)n1Cc1ccccc1,P04058,RAD51 inhibitor B02,Heterogeneous nuclear ribonucleoprotein A1;
O=C(CSc1nnc(-c2ccccc2O)n1-c1ccccc1)Nc1cccc(C(=O)O)c1,P07327,CBKinase1_011500,Histone-lysine N-methyltransferase EHMT2;
Brc1cccc(C2CC(c3ccccc3)n3nnnc3N2)c1,Q01062,MLS000042986,Baculoviral IAP repeat-containing protein 3;
COc1ccc(OC)c(/C=C2\SC(=S)N(C(C(=O)O)c3ccccc3)C2=O)c1,P16442,MLS001043289,Advanced glycosylation end product-specific receptor;
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C\c2cccc(Br)c2)SC1=S,O43187,"Thiazolidinone core, 6",Gamma-aminobutyric acid receptor subunit rho-2;
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C\c2cccc([N+](=O)[O-])c2)SC1=S,P24046,"Thiazolidinone core, 26",Glutamate receptor 2 {ECO:0000305};
O=C1Nc2ccccc2/C1=C/c1ccc[nH]1,P34969,oxindole i,Envelope glycoprotein gp160 {ECO:0000255|HAMAP-Rule:MF_04083};
CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12,Q9NQR1,N-[(Aminooxy)Carbonyl]Aniline,E-selectin;
CCOC(=O)c1ccc(-c2c(-c3cc(CC)c(O)cc3O)n[nH]c2C)o1,P09651,Ularitide,Protein Wnt-3a;
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C\c2ccccc2)SC1=S,Q9Z148,"Thiazolidinone core, 29",Albumin;
CC(=O)c1cccc(NC(=O)CSc2nnc(-c3cc4ccccc4cc3O)n2C)c1,Q13489,CBKinase1_008021,Lymphotoxin-alpha;
O=c1c2ccccc2oc2ccc(S(=O)(=O)Nc3nnn[nH]3)cc12,Q63495,"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",Dipeptidyl peptidase 1;
CC(C(=O)O)N1C(=O)/C(=C\c2cccc(Br)c2)SC1=S,P28476,"2-[(5E)-5-[(3-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid",Regulatory protein E2 {ECO:0000255|HAMAP-Rule:MF_04001};
Cc1cc(O)cc(O)c1/N=N/c1nccs1,P19491,5-Methyl-4-(2-thiazolylazo)resorcinol,Thymidylate synthase {ECO:0000305};
O=c1c2cc(F)c(NCCCN3CCOCC3)cc2nc2n1CC/C2=C\c1ccc(OCc2ccccc2)cc1O,P04578,"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE",Sigma non-opioid intracellular receptor 1;
CCCN(C/C=C/I)C1CCc2ccc(O)cc2C1,P16581,7-hydroxy-PIPAT,Endothelin-1 receptor {ECO:0000305};
C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,P56704,radicicol,Major pollen allergen Bet v 1-A;
O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2,P02769,Palonosetron,14-3-3 protein eta;
CC/C=C/CCOC(=O)c1cccnc1,P01374,"Auxiliary substrate, 16a",Adenosine 5'-monophosphoramidase HINT1 {ECO:0000250|UniProtKB:P49773};
Cc1[nH]nc2cn[nH]c12,P53634,Ceftazidime,C-C motif chemokine 2;
c1cc2c3c(cccc3c1)-c1n[n+]3cc4ccccn4c3cc1-2,P04015,Diacerein,Enoyl-[acyl-carrier-protein] reductase [NADH] {ECO:0000303|PubMed:7599116};
C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12,P04818,Himbacine,Histone-lysine N-methyltransferase EZH2 {ECO:0000305};
CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1,Q9R0C9,104693-32-5,Hypoxia-inducible factor 1-alpha {ECO:0000305};
CC1=C(/C=C/C#Cc2ccc(C(=O)O)cc2)C(C)(C)CCC1,P25101,132032-67-8,Protein kinase C gamma type;
C/C(=C\c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,P15494,3-Methyl TTNPB,C-terminal-binding protein 1;
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,Q04917,Pelitinib,Translocator protein;
CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,P13500,Axitinib,Bifunctional protein GlmU {ECO:0000255|HAMAP-Rule:MF_01631};
O=C(O)C(=O)c1cn(Cc2ccccc2)c2ccc(-c3ccc(OC(F)(F)F)cc3)cc12,P9WGR1,Tiplaxtinin,Gamma-aminobutyric acid receptor subunit gamma-1;
COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2ccccc2Cl)c1,Q15910,Ibodutant,Cell division protein FtsZ {ECO:0000255|HAMAP-Rule:MF_00909};
O=C(COc1ccc2c(c1)OCO2)N1CCOCC1,Q16665,Coproporphyrin I,Thermolysin;
O=S(=O)(Nc1cc(Cl)cc(Cl)c1)N1CCCCC1,P05129,"N-(3,5-dichlorophenyl)piperidine-1-sulfonamide",5-hydroxytryptamine receptor 4;
Nc1ccccc1-c1nnc(-c2ccncc2)o1,Q13363,54754-58-4,Segment polarity protein dishevelled homolog DVL-1;
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,P30536,NIM811,14-3-3 protein sigma {ECO:0000303|PubMed:9659898};
COc1cc(/C=C2\CCn3c2nc2cc(NCCCN(C)C)c(F)cc2c3=O)cc(OC)c1O,Q5HIH6,"5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol",Adenosine receptor A1;
NCCCC[C@H](COC(N)=O)NC(=O)CN(CCCCN)C(=O)OC[C@@H](N)CCCN=C(N)N[N+](=O)[O-],P23574,Aurotioprol,Vitamin D3 receptor;
NCCCC[C@H](COC(N)=O)NC(=O)CN(CCCCN)C(=O)OC[C@@H](N)CCCNc1c(N)c(=O)c1=O,P9WN95,Pomalidomide,Serine/threonine-protein kinase haspin;
N=C(N)NCCC[C@H](N)COC(=O)N(CCCCN)CC(=O)N[C@H](CCCCN)COC(N)=O,P00800,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,Cytosolic phospholipase A2;
Cc1cc2c(cc1N)n(C)c(=O)n2C,O70528,73778-94-6,Lysine-specific demethylase 6B;
Cc1ccc(NC(=O)CN2C(=O)S/C(=C\c3ccc(-c4cc(C(=O)O)ccc4C)o3)C2=O)cc1,P51141,Oseltamivir,Neuronal acetylcholine receptor subunit alpha-7;
COc1ccc(C2C3=C(N=c4s/c(=C\c5ccc(OCc6cccc(C(=O)O)c6)c(OC)c5)c(=O)n42)c2ccccc2CC3)cc1,P31947,6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid,Chromodomain Y-like protein {ECO:0000303|PubMed:10192397};
COc1ccccc1C1C2=C(N=c3s/c(=C\c4cccc(OCC(=O)O)c4)c(=O)n31)c1ccccc1CC2,P25099,Isosorbide,"Serine hydroxymethyltransferase, cytosolic;"
NC(=O)c1cc[n+](COC[n+]2ccccc2/C=N/O)cc1,A3RGC1,(Z)-1-(((4-Carbamoylpyridin-1-ium-1-yl)methoxy)methyl)-2-((hydroxyimino)methyl)pyridin-1-ium,Ribosyldihydronicotinamide dehydrogenase [quinone];
NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1,Q8TF76,GW300660X,Transient receptor potential cation channel subfamily M member 8;
COc1cccc(OC)c1CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,P47712,CS247,Melatonin receptor type 1B;
COc1cccc(OC)c1CNC(=O)c1ccc2c(c1)C(=NNc1ccc(S(N)(=O)=O)cc1)C(=O)N2,O15054,CS247,Genome polyprotein;
NS(=O)(=O)c1ccc(N=Nc2c(=O)[nH]c3ccc4[nH][nH]nc4c23)cc1,Q05941,CS242,Substance-P receptor;
O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc2c(c1)CS(=O)(=O)C2,Q9Y232,Rilematovir,Neurotensin receptor type 2;
Cc1nc(C)c(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)s1,P34896,"4-(2,4-dimethyl-1,3-thiazol-5-yl)-N-(3-nitrophenyl)pyrimidin-2-amine","72 kDa type IV collagenase {ECO:0000303|PubMed:2162831, ECO:0000303|PubMed:2834383};"
C=CCNc1nc(C)c(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)s1,P16083,2-Anilino-4-(thiazol-5-yl)pyrimidine deriv. 31,1-deoxy-D-xylulose-5-phosphate synthase {ECO:0000255|HAMAP-Rule:MF_00315};
Cc1nc(C)c(-c2ccnc(Nc3cccc(C#N)c3)n2)s1,Q7Z2W7,2-Anilino-4-(thiazol-5-yl)pyrimidine deriv. 36,"Leucine--tRNA ligase, cytoplasmic;"
Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)c([N+](=O)[O-])c3)n2)s1,P49286,"N~4~-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)pyrimidin-2-Yl]-N~1~,N~1~-Dimethyl-2-Nitrobenzene-1,4-Diamine",Transient receptor potential cation channel subfamily M member 8;
Cc1nc(N)sc1-c1ccnc(Nc2ccc(N(C)C)cc2)n1,P03300,"N'-[4-(2-Amino-4-Methyl-1,3-Thiazol-5-Yl)pyrimidin-2-Yl]-N,N-Dimethylbenzene-1,4-Diamine",
O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1,P14600,Beta-Hydroxytryptophane,
COc1ccc(S(=O)(=O)N[C@@H](C(=O)NO)C(C)C)cc1,P14174,Clebopride,
C[C@H](NC(=O)CCC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,O95665,Suc-Ala-Gly-Pro-Phe-pNA,
CC(C)(C)c1ccc([C@@H](O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,P08253,"Terfenadine, (S)-",
O=C(NCCNC[C@@H](O)COc1ccc(O)cc1)N1CCOCC1,P9WNS3,1229516-19-1,
C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,P26637,"Ifenprodil, erythro-",
O=C(O)COc1ccc(OCCNC[C@@H](O)COc2ccccc2)cc1,Q8R4D5,2-[4-[2-[[(2R)-2-hydroxy-3-phenoxypropyl]amino]ethoxy]phenoxy]acetic acid,
N[C@@H](Cn1ccc(=O)n(Cc2ccc(C(=O)O)cc2)c1=O)C(=O)O,,UBP 282,
N[C@@H](Cn1cc(I)c(=O)n(Cc2ccc(C(=O)O)cc2)c1=O)C(=O)O,,569371-10-4,
CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,Threonine,
CC(=O)Nc1sccc1C(N)=O,,2-acetamidothiophene-3-carboxamide,
Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2,,62751-59-1,
O=C(O/N=C1/c2ccccc2-c2nc3ccccc3nc21)c1ccco1,,312538-03-7,
O=C(O)/C(Cc1ccccc1[N+](=O)[O-])=N\Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1,,4egi-1,
O=C(O)CNC(=O)c1nc(Cl)c2ccccc2c1O,,223387-75-5,
C/C(=N\OCC(O)CNC(C)(C)C)C1CC1,,"Falintolol, (Z)-",
NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C(=O)O,,Icatibant,
CCCCc1nc2ccc(C(C)(C)OC)cc2c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,CL-329167,
O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,,212631-79-3,
CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](/C=C(\C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1,,Taltobulin,
COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,,741713-40-6,
CC(=O)Nc1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1,,849234-64-6,
O=C([O-])/C=C/c1c[nH]c2ccccc12,,(2E)-3-(1H-indol-3-yl)prop-2-enoate,
CN(C)c1nc2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,Phthalocyanine,
CC(=O)n1cc(-c2c(C)[nH][nH]c2=O)c2ccccc21,,Fomepizole,
N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,H-Trp-Glu-OH,
COc1ccc(/C=C2\NC(=O)NC2=O)c(OC)c1,,[4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid,
C[C@@H]1Nc2ccccc2NC1=O,,"(S)-3-Methyl-3,4-dihydroquinoxalin-2(1H)-one",
Cc1ccc(NC(=O)c2cnc3ccccc3n2)cc1,,N-(4-methylphenyl)quinoxaline-2-carboxamide,
O=C(O)CNS(=O)(=O)c1ccc2c(c1)C(=O)c1ccccc1C2=O,,MLS001195924,
O=C(O)CCc1nc2cc(Cl)ccc2s1,,"3-(5-chloro-1,3-benzothiazol-2-yl)propanoic acid",
O=C(O)c1cc2occc2[nH]1,,"4H-Furo[3,2-b]pyrrole-5-carboxylic acid",
Cc1nn(C)cc1-c1cc[nH]n1,,"1',3'-dimethyl-1H,1'H-3,4'-bipyrazole",
C=CS(=O)(=O)c1cccc(Nc2cc(S(=O)(=O)[O-])c(N)c3c2C(=O)c2ccccc2C3=O)c1,,Uniblue A,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1,,28244-98-6,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@@H]1O,,methyl beta-D-talopyranoside,
O=C(NC1CCCCC1)c1cnc2ccccc2n1,,N-cyclohexylquinoxaline-2-carboxamide,
O=C(Nc1cccc(Cl)c1)c1cnc2ccccc2n1,,N-(3-chlorophenyl)quinoxaline-2-carboxamide,
CC(=O)c1cccc(NC(=O)c2cnc3ccccc3n2)c1,,N-(3-acetylphenyl)quinoxaline-2-carboxamide,
CCC(=O)N1CCc2[nH]nc(-c3ccccc3)c2C1,,Beta-D-Glucose,
Cc1cc(O)c(C[NH+](C)C)c2c1C(=O)/C(=C/c1ccccc1)O2,,Metrizoic acid,
COc1cccc(/C=C2\Oc3c(CN4CCN(C)CC4)c(O)cc(C)c3C2=O)c1,,903867-92-5,
COc1cccc(/C=C2\Oc3c(C[NH+]4CCCC4)c(O)cc(C)c3C2=O)c1,,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",
Cc1c(Cl)cccc1NC(=O)c1cnc2ccccc2n1,,930478-88-9,
O=C(Nc1nc2ccccc2s1)c1cnc2ccccc2n1,,Isoglutamine,
COc1ccccc1CNC(=O)CSc1nnnn1-c1c(C)cccc1C,,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cccc(Cl)c1Cl,,Lifibrol,
O=C(O)Cc1coc2cc(OS(=O)(=O)c3ccc(Cl)cc3F)ccc12,,Emricasan,
Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(-c3ccc(Nc4cc(S(=O)(=O)[O-])c(N)c5c4C(=O)c4ccccc4C5=O)cc3)cc2)c2c1C(=O)c1ccccc1C2=O,,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,
O=C([O-])C(O)Cc1c[nH]c2ccccc12,,3-(indol-3-yl)lactate,
C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C,,"3alpha,12alpha-Dihydroxy-5beta-cholanate",
Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,,TWS119,
CC(C)Oc1ccc(/C=C2\CCn3c2nc2cc(NCCCN(C)C)c(F)cc2c3=O)cc1,,BMS-791826,
O=C1/C(=N/Nc2ccc(Cl)c([N+](=O)[O-])c2)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,,332420-90-3,
CO/N=C1/C[C@@H](C(=O)NC[C@@H](O)c2ccccc2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1,,OT-R antagonist 2,
NCCCCCc1cnc[nH]1,,Impentamine,
CC(C)(C)CCOCCCN1CCCCC1,,Sulfamazone,
O=C(CCCc1ccccc1)N1CCC(Cc2cnc[nH]2)CC1,,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",
CC(/C=C/C1CC1(C)c1cc2c(cc1C)C(C)(C)CCC2(C)C)=C\C(=O)O,,Letosteine,
C=CCC(c1ccc(O)c(C(C)C)c1)c1c(C)cc(OCC(=O)O)cc1C,,Pasireotide,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1Cl)C(C)(C)CCC2(C)C,,Galicaftor,
Cc1ccc(C2=C(/C=C/C#Cc3ccc(C(=O)O)cc3)C(C)(C)CCC2)cc1,,4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C(C)C)C(C)(C)CCC2(C)C,,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",
COc1cc(N)c(Cl)cc1C(=O)OCCN1CCN(c2ncccn2)CC1,,Vactosertib,
CCc1nc2c(CC)cn(Cc3ccc(-c4ccccc4-c4nnn[nH]4)cc3)n2n1,,YM-358,
CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc(C(=O)O)cc3)c(Br)cc21,,Threonine-Aspartic Ester,
CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nnn[nH]3)cc1)C(=O)CCCC2,,Pratosartan,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(OC2CCNCC2)ccc1Cl,,CRA_10433,
CCOC(=O)/C=C1\CC2(CCCC2)CC(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",
COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,,Nintedanib,
Cc1cc2c(cc1C(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,153559-46-7,
NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,,252003-65-9,
Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,,445430-58-0,
CNCC(O)c1ccc(O)c2[nH]c(=O)sc12,,220752-37-4,
CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc(C(=O)O)cc3)c(O)cc21,,Squalamine,
Cc1cc2c(cc1C1(c3ccc(C(=O)O)cc3)CC1)C(C)(C)CCC2(C)C,,Brensocatib,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1CC)C(C)(C)CCC2(C)C,,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",
CN(CCCOc1ccc(Cc2ccccc2)cc1)CCC(=O)O,,179022-08-3,
CC(/C=C/CC1(c2cc3c(cc2C)C(C)(C)CCC3(C)C)CC1)=C\C(=O)O,,N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid,
CC(/C=C/CC1(c2cc(C(C)(C)C)cc3c2CCC3(C)C)CC1)=C\C(=O)O,,"[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid",
CCCN(CCC)c1cc(C)nc2c(-c3cnc(N(C)C)cc3C)c(C)nn12,,195055-03-9,
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,,Lenvatinib,
O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,,391210-10-9,
CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,Midostaurin,
C[C@H](NC(=O)c1c(CN2CCC(N3CCCCC3)CC2)c(-c2ccccc2)nc2ccccc12)C1CCCCC1,,Zeranol,
NCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)Nc1ccc2c(CN3CCCC3)nn(Cc3c(Cl)cccc3Cl)c2c1)C(=O)NCc1ccccc1,,RWJ-58259,
Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,Vestipitant,
O=C(O)c1cccc(NC(=O)c2[nH]c(C3CCCCC3)nc2COC23CC4CC(CC(C4)C2)C3)c1,,Carbazochrome,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Sincalide,
Cc1cccc(N(C(=O)C(=O)O)c2ccccc2C(=O)O)c1C,,1618-52-6,
CCCCN(C)Cc1ccc(OC2CCN(C(C)C)CC2)cc1,,"1,3-Thiazole-4-Carboxylic Acid",
CC(C)N1CCC(Oc2ccc(CNc3ccccc3)cc2)CC1,,"4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID",
NC(C(=O)O)c1ccc(CP(=O)(O)O)cc1,,AR-9281,
C#Cc1ccc2c(c1)C(c1ccccc1)=NCC(=O)N2C,,QH-II-66,
Cc1cc2c(cc1C1(c3ccc(C(=O)O)cc3)CO1)C(C)(C)CCC2(C)C,,1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,
CC1(C)CC=C(c2cccs2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,Vardenafil,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)CCc1ccccc1,,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",
CCCCNc1ccc(C(=O)OCC[N+](C)(C)CCCC)cc1,,"2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",
Cc1ccc(C2=CC(C)(C)Oc3cc4ccc(-c5ccc(C(=O)O)cc5)cc4cc32)s1,,Oleoyl-estrone,
C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,,Tauroursodeoxycholic acid,
CN1C[C@H](C(=O)N2CCN(c3cccc(=O)n3C)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,Homogentisic acid,
O=C1NCC2(CN3CCC2CC3)O1,,178419-45-9,
COc1ccc(C[C@H](NC(=O)Nc2ccc3c(CN4CCCC4)cn(Cc4ccc(F)cc4)c3c2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCc2ccccc2)cc1,,Dotatate,
CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)N2C(=O)OC[C@@H]2C)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)CC3CC3)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCc3ccc(Cl)c(Cl)c3)C(=O)O[C@]12C,,Tryptamine,
Cc1ccc2nc(N)ccc2c1,,6-methylquinolin-2-amine,
CC(C)N1CCC(Oc2ccc(CN3CCOCC3)cc2)CC1,,4-(4-((1-Isopropylpiperidin-4-yl)oxy)benzyl)morpholine,
O=C(CCOc1ccccc1)N1CCC(Cc2cnc[nH]2)CC1,,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",
Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1,,Sobetirome,
O=C(CCN1CCC(Cc2cnc[nH]2)CC1)Nc1cccc(F)c1,,Reactive Red 6 hapten,
CC(/C=C/[C@@H]1C[C@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\C(=O)O,,220619-73-8,
CC(/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\C(=O)O,,BW-A 58C,
CC(C)=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,,Floctafenine,
CCc1ccc(C2=C(/C=C/C#Cc3ccc(C(=O)O)cc3)C(C)(C)CCC2)cc1,,Banoxantrone,
CC1(C)CCC(C)(C)c2cc(C(=O)Nc3cc(F)c(C(=O)O)c(F)c3)c(O)cc21,,AGN 194078,
CC(=O)c1ccc(OCc2ccc(CN3CCCC3)cc2)cc1,,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2[nH]c3ccccc3c21,,qf2004b,
CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3,,Laropiprant,
CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl,,367273-07-2,
COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,,Ki20227,
Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CC[C@H](C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1,,148927-60-0,
Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C4,,Proanthocyanidin A1,
COc1ccccc1CNCCNC(=O)N1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1,,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,
COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,,CP-724714,
CC(C)N1CCC(Oc2ccc(CNC3CC3)cc2)CC1,,Silibinin,
c1cc(OCCCN2CCCCC2)ccc1CN1CCOCC1,,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,
CC(C)N1CCC(Oc2ccc(CNc3ccccn3)cc2)CC1,,2'-Deoxymaltose,
c1cc(OCCCN2CCCCC2)ccc1CNC1CCCCC1,,Acetylleucine,
CC(C)N1CCC(Oc2ccc(CN3CCC(O)CC3)cc2)CC1,,"6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid",
CC[C@@H]1Cn2c(c3nc(-c4ccccc4)nc-3n(C)c2=O)N1,,Deacetylbisacodyl,
CC1=C(/C=C/c2ccccc2/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",
Cc1cc(=O)c2c(O)cc3c(c2o1)C(=O)c1c(O)cc(O)cc1C3=O,,TOPOPYRONE C,
O=C(CCN1CCC(Cc2cnc[nH]2)CC1)Nc1cccc(Cl)c1,,Etamicastat,
Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,,PI-103,
CCC(CC)Nc1cc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12,,DMP-904,
CC(/C=C/CC1(c2cc(C(C)(C)C)cc(C(C)(C)C)c2)CC1)=C\C(=O)O,,Dihydroxyphenylglycine,
CC(=C/C(=O)O)/C=C/C1CC1(C)c1cc2c(cc1C)C(C)(C)CCC2(C)C,,"(2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide",
CC(C)c1cc2c(cc1C(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,AZD-1981,
O=C(c1ccc(F)cc1)C1CCN(CCC2CCc3ccccc3C2=O)CC1,,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,
CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,,Dovitinib,
CC1(C)CC=C(c2cccs2)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21,,"(3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol",
CCc1cc(OCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2c(n1)CCCC2,,ZD-6888,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1Br)C(C)(C)CCC2(C)C,,Etoricoxib,
Cc1ccc(C2=CC(C)(C)Oc3cc4ccc(-c5ccc(C(=O)O)cc5)cc4cc32)cc1,,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,
O=C(O)c1cc(Cl)cc2c(=O)cc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)oc12,,Telbivudine,
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@H]1c2ccccc2C[C@H]1O,,KNI-10006,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(C)=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Rostafuroxin,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)C[C@@H](N)CCC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,D-Glutamine,
C[C@]12CC[C@@H]3[C@H]4CC[C@H](O)CC4=CC[C@H]3[C@@H]1CC[C@@H]2O,,19-Nor-5-androstenediol,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCc2ccccc21,,Retinoid 9CUAB30,
COC(=O)CCc1ccccc1OCC(O)CNC(C)C,,Phosphorylated Dihydropteroate,
C=C(c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C,,PRI-724,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1O)C(C)(C)CCC2(C)C,,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",
Cc1cc2c(cc1C(C)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",
CC(/C=C/CC1(c2ccc3c(c2)C(C)(C)CCC3(C)C)CC1)=C\C(=O)O,,3'-THIO-THYMIDINE-5'-PHOSPHATE,
CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc(C(=O)O)cc3)c(Cl)cc21,,"3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole",
CC(/C=C/CC1(c2ccc3c(c2)C(C)(C)CCC3(C)C)CCCC1)=C\C(=O)O,,Regadenoson,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(N2CCNCC2)ccc1Cl,,CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2nc[nH]c12,,Dehydrocholic acid,
CCOCC1(COCC)N[C@@H](c2nc(-c3ccccc3)c[nH]2)Cc2c1[nH]c1ccccc21,,Tannic acid,
CC1(C)CC=C(c2ccc(C(F)(F)F)cc2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,Benzoylformic Acid,
CCOC(=O)/C=C1\CC(C)(CC)CC(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,RWJ-46458,
COc1nsnc1OCCOCCOCCOCCOc1nsnc1C1=CCCN(C)C1,,UNII-9JE7TAT31D,
NS(=O)(=O)N1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,UK-224671,
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,,Neratinib,
COc1ccc(Cn2ccc(C)c(NC(=O)[C@H](Cc3ccc(C(C)(C)C(=O)O)cc3)NC(=O)C(C)(C)c3ccc4ccccc4c3)c2=O)cc1,,Colistin,
CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C,,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,
c1cc(OCCN2CCCCC2)ccc1CN1CCCCC1,,"9r,13r-Opda",
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,,Tofacitinib,
COc1ccc(C)c(NC(=O)CC23CC4CC(CC(C4)C2)C3)c1,,Ribose-5-phosphate,
COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,,783348-36-7,
O=C(c1ccc(F)cc1)C1CCN(CCC2CCCc3ccccc3C2=O)CC1,,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,
CSC1=NC(C)=C2C(=[OH+])OCCCCCSc3c(cccc3[N+](=O)[O-])C2[N-]1,,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,
CC1(C)CC=C(c2ccc(Cl)cc2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,"9,10-Deepithio-9,10-Didehydroacanthifolicin",
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,,Cediranib,
O=C(CCSCc1ccco1)NCC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,Nifurpirinol,
O=C(CCSCc1ccco1)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,SC-51322,
Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)c(F)c3)nc2C)ccc1OCC(=O)O,,GW0742,
Cc1ccc(C(=O)N(CCCN)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1,,SB-743921,
CCCCN(C)C(=O)CCCCCCCCCCC(c1ccc(O)c(C(C)C)c1)c1c(C)cc(OCC(=O)O)cc1C,,Sodium feredetate,
CCCCCc1nc(SCc2ccc(-c3ccccc3C(=O)O)cc2)nn1Cc1ccc(-c2ccccc2C(=O)O)cc1,,"1,2-Dipalmitoyl-Phosphatidyl-Glycerole",
CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1,,UNII-G9BL4978MZ,
C(#Cc1cccc(CN2CCOCC2)c1)CCN1CCCCC1,,JNJ-10181457,
Clc1ccc(CCCOCCCN2CCCCC2)cc1,,Pitolisant,
c1ccc(OCCCN2CCC(Cc3cnc[nH]3)CC2)cc1,,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",
CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc(C(=O)O)cc3)ccc21,,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,
Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)ccc1Cl,,303727-31-3,
CCc1cc2c(cc1C(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,
O=C(c1ccc(F)cc1)C1CCN(CCC2Cc3ccccc3C2=O)CC1,,Sapacitabine,
O=C(c1ccc(F)cc1)C1CCN(CCC2Cc3cc(F)ccc3C2=O)CC1,,M-2698,
O=C(NCC(c1ccccc1)n1ccnc1)c1ccc(-c2ccc(Cl)cc2)cc1,,174262-13-6,
CC1(C)CC=C(c2cccs2)c2cc(C(=O)Oc3ccc(C(=O)O)cc3)ccc21,,Camostat,
CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Br,,Sulfamerazine,
O=c1cc(-c2nnn[nH]2)oc2cc(OCCCN3CCC(=C(c4ccccc4)c4ccccc4)CC3)ccc12,,Ribavirin,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1,,"1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine",
O=C1CC[C@](CCN2CC(N3CCC(F)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CCC(F)(F)CC1,,Alrestatin,
C[C@@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12,,"(3S,4R)-Tofacitinib",
O=C(NO)[C@H]1COC(c2ccc(F)c(C(F)(F)F)c2)=N1,,"(r)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-N-hydroxy-4,5-dihydrooxazole-4-carboxamide",
NS(=O)(=O)c1ccc(C(=O)NCC2CCCCC2)cc1,,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,
CCn1ccc2cc3c(cc21)CCN3C(=O)Nc1cccnc1,,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",
CCC1=C(C(C)C)/C(=C/C(C)=C\C=C\C(C)=C\C(=O)O)CCC1,,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2,,Sofalcone,
S=C(NCCCCCc1cnc[nH]1)NCc1ccc(Cl)cc1,,2-OXOHEPTYLPHOSPHONIC ACID,
C/C(=C\c1cc(C(=O)O)no1)c1ccc2c(c1)C(C)(C)CCC2(C)C,,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",
COc1cc(C[C@H]2COC[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O,,Anhydrosecoisolariciresinol,
Cc1nc[nH]c1CSCCNC(=N)NCCSCc1[nH]cnc1C,,Kojic acid,
c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1,,"(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL",
CC1(C)CCC(C)(C)c2cc(C(=O)Nc3cc(F)c(C(=O)O)c(F)c3)ccc21,,191469-29-1,
O=C(CCCN1CCN(CCC2CCc3ccccc3C2=O)CC1)c1ccc(F)cc1,,Bucetin,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCCCN(C)C)CC5)CCCC4)c3Cl)c2n1,,Olomoucine,
CCOCCCc1cnc[nH]1,,FUB 465,
c1ccc(CCCCc2cnc[nH]2)cc1,,FUB 349,
CNCCc1cnc(-c2cccc(C(F)(F)F)c2)[nH]1,,Usistapide,
Cc1ccccc1CNC(=O)c1ccc(S(N)(=O)=O)cc1,,Dapagliflozin,
C[C@]12CC[C@H]3[C@@H](C[C@H](F)[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,,Phenothiazine,
Cn1c2c([n+](C)c1CCl)C(=O)c1ccccc1C2=O,,GNF-Pf-5569,
Cc1nc[nH]c1CSCCNC(=NC#N)NCCCc1cnc[nH]1,,Setrobuvir,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1OC)C(C)(C)CCC2(C)C,,2-deoxy-2-fluoro-alpha-D-mannosyl fluoride,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1CCC)C(C)(C)CCC2(C)C,,Pritelivir,
CCCCCCCCc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1,,Fluciclovine,
CCc1c(C)[nH]c2c1C(=O)C(CCN1CCN(c3ccccc3OC)CC1)CC2,,QF-0402B,
S=C(NCc1ccc(I)cc1)N1CCC(c2cnc[nH]2)CC1,,GLPG-0187,
N#C[C@H](CCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)N1CCOCC1,,Fesoterodine,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=N)N)CC4)c3Cl)c2n1,,Rizatriptan,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)[C@@H](N)CCCCN(C)C)CC4)c3Cl)c2n1,,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)[C@@H](N)CCCCN(C)C)CC4)c3Cl)c2n1,,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,
CCN1CNS(=O)(=O)c2ncccc21,,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",
C=CCN1CC[C@H]2c3cccc(O)c3CC[C@H]21,,Atevirdine,
CNC(=S)NCCCCCCc1cnc[nH]1,,Cambendazole,
Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)on1,,GSK-2018682,
CC(C)(C)NCC(O)c1cc(Cl)c(O)c(Cl)c1,,Chlorphenesin,
S=C(NCCCCc1cnc[nH]1)NCc1ccccc1,,4-Hydroxytestosterone,
S=C(NCCCCCc1cnc[nH]1)NCc1ccccc1,,Viomycin,
S=C(NCCCCc1cnc[nH]1)NCCc1ccccc1,,Norfloxacin,
Cc1cc2c(cc1C(=O)c1ccccc1C(=O)O)C(C)(C)CCC2(C)C,,Ixabepilone,
Cc1cc2c(cc1C(C)(C)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,AMY-101,
O=C(c1ccc(F)cc1)C1CCN(CCC2Cc3sccc3C2=O)CC1,,Moxestrol,
N=C(NCCCc1cnc[nH]1)NCCCC(c1ccccc1)c1ccccn1,,(R)-2-Hydroxy-3-Sulfopropanoic Acid,
CCCc1cc2c(cc1C(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,Tisopurine,
CCc1c(C)[nH]c2c1C(=O)CC(CN1CCN(c3ccccc3OC)CC1)C2,,Acetophenone,
O=C1c2ccoc2CCC1CCN1CCC(c2noc3cc(F)ccc23)CC1,,Biotinyl P-Nitroaniline,
COC(=O)[C@]12CCCN1C(=O)[C@](Cc1ccc3ccccc3c1)(NC(C)=O)CC2,,Sulfadiazine,
O=C(CCCN1CCN(CCC2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1,,Migalastat,
CCCn1c(=O)c2[nH]c(CNC(=O)c3cccc(S(=O)(=O)F)c3)nc2n(CCC)c1=O,,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",
CCCn1c(=O)c2[nH]c(CCNC(=O)c3ccc(S(=O)(=O)F)cc3)nc2n(CCC)c1=O,,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(CCCC(F)(F)F)c5cc(F)ccc54)CC3)CC2)ccn1,,Ingavirin,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)[C@@H](N)CCCCN=C(N)N)CC4)c3Cl)c2n1,,Iopentol,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,,155-30-6,
Cc1c([N+](=O)[O-])ccc2nc(N3CCNCC3)ccc12,,IDD594,
S=C(NCCCCc1cnc[nH]1)NC1CCCCC1,,"N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide",
N#Cc1ccc(-c2ccc(OCCC(=O)NO)cc2)cc1,,3-[(4'-Cyanobiphenyl-4-Yl)oxy]-N-Hydroxypropanamide,
S=C(NCCCCCc1cnc[nH]1)Nc1ccccc1,,Sulfamethazine,
C=C(/C=C/C=C/C(=O)O)c1cc(C(C)(C)C)cc2c1CCC2(C)C,,ME-344,
CN(C)CCc1cnc(CCC(c2ccccc2)c2ccccc2)[nH]1,,dimethylhistaprodifen,
COc1ccccc1N1CCN(CCC2CCc3ccccc3C2=O)CC1,,QF0301B,
CC1(C)CCC(C)(C)c2cc(C(=O)Nc3ccc(C(=O)O)c(F)c3)ccc21,,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",
O=c1cc(-c2ccc(I)cc2)oc2cc(O)cc(O)c12,,Apstatin,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CN2CCNCC2)ccc1Cl,,"beta-D-fructofuranose 1,6-bisphosphate",
CCCn1c(=O)c2[nH]c(NC(=O)c3ccc(S(=O)(=O)F)cc3)nc2n(CCC)c1=O,,Budesonide,
COC(=O)[C@]12CCCN1C(=O)[C@](Cc1ccc3ccccc3c1)(NC(=O)OCc1ccccc1)CC2,,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(NC(=O)C(=O)O)cc2)NC(C)=O)cc1,,"(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium",
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)cc1,,Toloxatone,
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1)C(=O)O,,Octisalate,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)C[C@@H](N)CCCCN=C(N)N)CC4)c3Cl)c2n1,,"1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxy-2(1H)-quinolinone",
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(CCCCCCN)CC4)c3Cl)c2n1,,CMX-2043,
CC(C)NCC(O)COc1ccccc1CO,,"(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one",
CC(C)NC(=S)NCCCCc1cnc[nH]1,,alpha-L-fucose,
O=C(Nc1ccccc1)OCCCc1cccnc1,,"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",
NS(=O)(=O)c1ccc(C(=O)NCc2cccnc2)cc1,,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,
c1ccc2c(Nc3ccc(OCCCN4CCCCC4)cc3)ccnc2c1,,BMS-955176,
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2[nH]c3ccccc3c21,,Etilefrine,
CCc1nc2c(C)cc(C)nc2n1Cc1ccc([C@H](c2ccccc2)[C@H](C)C(=O)O)cc1,,Flunoxaprofen,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3)nc(N)c2cc1OC,,Esketamine,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCN)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,CHROMOPHORE (LYS-TYR-GLY),
NS(=O)(=O)c1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)NCC(=O)O)cc1,,"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE",
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,,Masitinib,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)C[C@@H](N)CCCN)CC5)CCCC4)c3Cl)c2n1,,Pilsicainide,
O=C(NCCCc1cnc[nH]1)NC1CCCCC1,,"Adenosine-5'-diphosphate-2',3'-vanadate",
CC(C)(C)[C@H](O)[C@@H](CN)c1ccc2ccccc2c1,,Dexfosfoserine,
S=C(NCCCc1cnc[nH]1)NCc1ccccc1,,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1S,,2'-Thioadenosine,
S=C(NCCCCCc1cnc[nH]1)NC1CCCCC1,,2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,
CC1=C(C(C)C)/C(=C/C(C)=C/C=C/C(C)=C/C(=O)O)CCC1,,Dexmedetomidine,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)CCCC2(C)C,,Phenformin,
COc1cccc(/C=C/C(=O)c2c(O)c(OC)c3occc3c2OC)c1,,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2occc21,,"4-(3-ethylthiophen-2-yl)benzene-1,2-diol",
O=C(c1ccc(F)cc1)C1CCN(CCC2CCc3occc3C2=O)CC1,,Trimegestone,
O=C(CCCN1CCN(CCC2Cc3sccc3C2=O)CC1)c1ccc(F)cc1,,S-Adenosyl-L-Homoselenocysteine,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccc(Cl)c(Cl)c1)c1ccccn1,,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,
CCCCc1nc2cc(NC(C)=O)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,KRN-7000,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC,,Formononetin,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)c1ccc(C(C)C)cc1,,"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",
CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(=O)CNC(=O)CCCCCCCCCCCCC)C(=O)OCc1ccccc1,,Chloramphenicol palmitate,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)[C@@H](N)CCCN(C)C)CC4)c3Cl)c2n1,,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,
CC(=O)Nc1cc2ccccc2cc1C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,,Metronidazole,
COC(=O)/C=C1/C[C@H]2C[C@]3(O)O[C@@H](C[C@H](OC(C)=O)C3(C)C)C[C@@H](O)CC(=O)O[C@@H]([C@@H](C)O)C[C@@H]3C/C(=C\C(=O)OC)[C@H](OC(C)=O)[C@@](O)(O3)C(C)(C)/C=C/[C@@H](C1)O2,,Bryostatin 7,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)C[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)C[C@@H](N)CCCN(C)C)CC4)c3Cl)c2n1,,MK-7145,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@H](CCCCN)[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",
C[N+](C)(C)CC#CCOC1=NOCC1,,iperoxo,
CNc1cc(C(O)CNC(C)(C)C)ccc1O,,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",
S=C(NCCCc1cnc[nH]1)NC1CCCCC1,,"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",
NC[C@@H](c1ccc2ccccc2c1)[C@@H](O)c1ccccc1,,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",
O=C(NCCC1CCCCC1)OCCCc1cnc[nH]1,,Morphine,
Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,,Pazopanib,
Cc1ccc(C2=CCC(C)(C)c3cc4ccc(-c5ccc(C(=O)O)cc5)cc4cc32)cc1,,Eluxadoline,
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,,Selumetinib,
O=C(O)CCC(CP(=O)(O)O)C(=O)O,,2-(phosphonomethyl)pentanedioic acid,
CC(C)N1CCC(Oc2ccc(CN3CCN(C)CC3)cc2)CC1,,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,
OC1CCN(Cc2ccc(OCCCN3CCCCC3)cc2)CC1,,PF-00356231,
CC(C)N1CCC(Oc2ccc(CN(C)CCN(C)C)cc2)CC1,,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",
O=C(OCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE,
CC(C)N1CCC(COc2ncc(C(=O)c3ccc(Cl)cc3)n2C)CC1,,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,
CC1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CCC1(C)c1cccc(O)c1,,Erythromycin,
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,,452105-23-6,
c1ncc(CCC2CCNCC2)[nH]1,,4-[2-(1H-Imidazol-4-yl)ethyl]piperidine,
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,,Afatinib,
C(#Cc1ccc(CN2CCCCC2)cc1)CCN1CCCCC1,,TAK-593,
C(#Cc1ccc(CN2CCOCC2)cc1)CCN1CCCCC1,,"(2s,4s)-Alpha-Campholinic Acid",
Cc1ccc(C2=CCC(C)(C)c3cc4ccc(-c5ccc(C(=O)O)cc5)cc4cc32)s1,,Benzhydroxamic Acid,
COc1c(C(C)=O)c(OCCCCCOc2c(C(C)=O)c(OC)c3ccoc3c2OC)c(OC)c2occc12,,"(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine",
CC(C)N1CCC(Oc2ccc(CN3CCN(c4ccccc4)CC3)cc2)CC1,,Indalpine,
Cc1nc2c(c(=O)[nH]1)CSCC2,,284028-90-6,
S=C(NCCCCc1cnc[nH]1)Nc1ccccc1,,Flortaucipir,
CN(C)CCCNC(=O)c1nc(-c2ccncc2)c(-c2ccc(Cl)c(O)c2)[nH]1,,"1,4-dithio-alpha-D-glucopyranose",
CC(C)N1CCC(Oc2ccc(CN3CCC(Cc4ccccc4)CC3)cc2)CC1,,KW-7158,
CN(CCc1c[nH]c2ccccc12)C(=O)c1ccccc1C(=O)N(CCCN1CCSCC1)CCc1c[nH]c2ccccc12,,Hydrolyzed Cephalothin,
O=C(O)c1cccc(C2=C(c3cc(Cl)ccc3OCc3ccc(F)cc3F)CCC2)n1,,612831-24-0,
CC(C)NC(=S)NCCCc1cnc[nH]1,,CM-4307,
C=C1CC(c2ccc(N=C(N)N)cc2)CC(=O)O1,,Epacadostat,
Cc1cc(OCC(=O)O)cc(C)c1Oc1ccc(O)c(C(C)C)c1,,Aminolevulinic acid,
C=C(c1ccc2c(c1)C(C)(C)CCC2(C)C)c1ccc2cc(C(=O)O)ccc2c1,,N-Pyridoxyl-2-Methylalanine-5-Phosphate,
O=C(c1ccc(F)cc1)C1CCN(CCC2CCc3sccc3C2=O)CC1,,Dydrogesterone,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)OCc2ccccc2)cc1,,2(S)-Amino-6-Boronohexanoic Acid,
CC1(C)CCCC(c2ccc(C(C)(C)C)cc2)=C1/C=C/C#Cc1ccc(C(=O)O)cc1,,Dimethylcurcumin,
O=C(O[C@H]1CCCC[C@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,Loprazolam,
COc1c(I)cc(Cl)cc1C(=O)N[C@@H]1CN2CCC1CC2,,(S)-3-phenyllactic acid,
N#C[C@H](COCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)N1CCOCC1,,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(CCCCCCN=C(N)N)CC4)c3Cl)c2n1,,Magnesium ascorbate,
C=C1CCC(c2ccc(CNC(=N)N)cc2)C(=O)O1,,S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine,
NS(=O)(=O)c1ccc(C(=O)NCc2ccncc2)cc1,,SCH-486757,
Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12,,PIK-75,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Iopydol,
COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1,,Gitoformate,
COc1c(C(C)=O)c(OCCCCCCOc2c(C(C)=O)c(OC)c3ccoc3c2OC)c(OC)c2occc12,,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,
Cc1ccccc1N1CCN(C(=O)[C@H](Cc2ccc(OS(=O)(=O)c3cccc4cnccc34)cc2)N(C)S(=O)(=O)c2cccc3cnccc23)CC1,,PF-03654746,
CC(C)N1CCC(Oc2ccc(CN3CCCN(C)CC3)cc2)CC1,,Ramelteon,
CC(C)N1CCC(Oc2ccc(CN3CCN(Cc4ccccc4)CC3)cc2)CC1,,P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate,
CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,,497839-62-0,
CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,,Saracatinib,
CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1,,AZD-4818,
NS(=O)(=O)c1ccc(C(=O)NCc2ccc([N+](=O)[O-])cc2)cc1,,Ascorbic acid,
O=C1ON=C(c2ccccc2F)/C1=C/c1ccc(N2CCCC2)cc1,,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",
CC(C)N1CCC(C)(C)c2ccc(C#Cc3ccc(C(=O)O)cc3)cc21,,Idarubicin,
NS(=O)(=O)c1ccc(C(=O)NCC23CC4CC(CC(C4)C2)C3)cc1,,4-Iodo-D-phenylalanine,
CCCOc1ccc(/C=C2\CCn3c2nc2cc(NCCCN(C)C)c(F)cc2c3=O)cc1,,AZD-1386,
COc1cc2c(cc1C(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,"7,8-dihydroinosine",
CC(=O)O[C@H]1O[C@@H](C)[C@@H]2[C@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@H]3CCCC[C@@H]3C[C@H]12,,Chloroxine,
COc1cc(N)c(I)cc1C(=O)NC1CN2CCC1CC2,,TD-8954,
CCc1ccc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)O)cc4)cc32)cc1,,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,
CCCn1c(=O)c2[nH]c(NC(=O)c3cccc(S(=O)(=O)F)c3)nc2n(CCC)c1=O,,Florasulam,
Cc1cc(OCC(=O)O)cc(C)c1Cc1cc(-c2ccc([N+](=O)[O-])cc2)c(O)c(C(C)C)c1,,GC 14,
CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](/C=C(\C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccc(OC)cc1,,Tadalafil,
NS(=O)(=O)c1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)NCC(=O)OCc2ccccc2)cc1,,Givinostat,
COc1ccccc1CN(C[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN1CCC(N2CCCCC2)CC1)C(C)=O,,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,
CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CNC(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2,,MEN-10627,
c1ncc(CCCC2CCNCC2)[nH]1,,4-[3-(1h-imidazol-4-yl)propyl]piperidine,
CN1C2CCC1C(c1ccc(Cl)cc1)C2,,Motixafortide,
NS(=O)(=O)c1ccc(C(=O)NCc2ccccn2)cc1,,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",
Cn1ccc2c3c(ccc21)N(C(=O)Nc1cccnc1)CCC3,,"5,6-Diaminouracil",
Cn1ccc2cc3c(cc21)CCCN3C(=O)Nc1cccnc1,,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,
CCCC#CCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,AUY922,
CSC1=NC2=C(C(=[OH+])OC2)C(c2cccc([N+](=O)[O-])c2SC)[N-]1,,"L-erythro-7,8-dihydrobiopterin",
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2occc21,,Netivudine,
N=C(N)Nc1ccc(C2CC(=O)O/C(=C/I)C2)cc1,,"1,2-diacyl-sn-glycero-3-phosphoinositol",
CC1(C)CC=C(c2ccccc2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,AGN 192870,
O=[N+]([O-])c1cc(Br)c(O)c(/C=C/c2ccc3cccc(O)c3n2)c1,,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",
CC1(C)C=C(/C=C/C#Cc2ccc(C(=O)O)cc2)C(c2ccc(C(C)(C)C)cc2)=CC1,,"4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL",
CCCN1CCN(c2nc3ccccc3s2)CC1,,769907-98-4,
COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC,,cystazosin,
CCCCc1ccc(COC(=O)CNC(=O)CNC(=O)CNC(=O)c2ccc(S(N)(=O)=O)cc2)cc1,,Haloxazolam,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(-c5ccc(F)c(F)c5)c5cc(F)ccc54)CC3)CC2)ccn1,,Eribulin,
Cc1cc(NC(=O)Nc2ccc3sccc3c2)sn1,,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",
CC1=C(C(C)C)/C(=C/C(C)=C\C=C\C(C)=C\C(=O)O)CCC1,,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,
C=C(c1ccc(C(=O)O)cn1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",
N=C(N)NCc1ccc(C2CC/C(=C\I)OC2=O)cc1,,2-Deoxy-2-Amino Glucitol-6-Phosphate,
N[C@@H](Cn1cc(I)c(=O)n(CCC(=O)O)c1=O)C(=O)O,,12-Hydroxydodecanoic Acid,
COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1,,"N,N-[2,5-O-di-2-fluoro-benzyl-glucaryl]-di-[1-amino-indan-2-ol]",
c1ccc(C(CCc2ncc(CCNCCc3ccccn3)[nH]2)c2ccccc2)cc1,,SLx-4090,
O=C(O[C@H]1CN2CCC1CC2)[C@@](O)(C/C=C/I)c1ccccc1,,Fedovapagon,
CCCn1c(=O)c2[nH]c(CCNC(=O)c3cccc(S(=O)(=O)F)c3)nc2n(CCC)c1=O,,Nitrosoethane,
O=C1c2ccsc2CCC1CCN1CCC(c2noc3cc(F)ccc23)CC1,,QF-0610B,
CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,Clocortolone caproate,
O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,Modified Acarbose Pentasaccharide,
Cc1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccc(C)o2)o1,,Tobramycin,
N=C(N)NCCCN1C(=O)C(CCNC(=N)N)N=C(c2ccccc2)c2cc(N(Cc3ccccc3)Cc3ccccc3)ccc21,,3-Tyrosine,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCCCN=C(N)N)CC5)CCCC4)c3Cl)c2n1,,Diacetyldeuteroheme,
CCCCCOCCCc1cnc[nH]1,,Zidebactam,
C#CCOc1ccccc1OCC(O)CNC(C)C,,Sulopenem,
NS(=O)(=O)c1ccc(C(=O)NCc2cccc3ccccc23)cc1,,Acetyldigoxin,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1F)C(C)(C)CCC2(C)C,,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",
Cc1ccc(C2=CCC(C)(C)C=C2/C=C/C#Cc2ccc(C(=O)O)cc2)cc1,,PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE,
O=C(CCCN1CCN(CC2CC(=O)c3ccccc3C2)CC1)c1ccc(F)cc1,,Heptulose-2-Phosphate,
O=C(O[C@H]1CN2CCC1CC2)[C@@](O)(C/C=C\I)c1ccccc1,,Pipradrol,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)O)cc1,,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N/c1ccccc1C,,"2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID",
CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](CN[C@@H](Cc1ccccc1)C(N)=O)Cc1ccccc1,,U-73777E,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)Cc2cccc3ccccc23)cc1,,VP-14637,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)CCC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,PF-06751979,
CNC(=S)NCCc1cnc[nH]1,,1-[2-(1h-imidazol-4-yl)ethyl]-3-methylthiourea,
CCCNC(=S)NCCCc1cnc[nH]1,,Lasofoxifene,
S=C(NCCc1cnc[nH]1)NCc1ccccc1,,Vadimezan,
COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,,ME bromodomain inhibitor,
CCN(CC)CCCCCCNCc1ccccc1OC,,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",
Clc1ccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)cc1,,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,
CNCCc1cnc(CCC(c2ccccc2)c2ccccc2)[nH]1,,methylhistaprodifen,
CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O,,I-BRD9,
CCCn1c(=O)c2[nH]c(CN3C(=O)C=CC3=O)nc2n(CCC)c1=O,,3-AMINO-AZACYCLOTRIDECAN-2-ONE,
CN(C)CCc1cnc(-c2cccc(C(F)(F)F)c2)[nH]1,,OT-551,
S=C(NCc1ccccc1I)N1CCC(c2cnc[nH]2)CC1,,Selamectin,
c1ccc(C(CCc2ncc(CCNCCCCc3ccccn3)[nH]2)c2ccccc2)cc1,,"(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid",
CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CC(C)OC(=O)CBr)c1=O,,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",
N#C[NH+]=C([N-]CCCCCCCCNc1ccc([N+](=O)[O-])c2n[o+][n-]c12)NCCCOc1cccc(CN2CCCCC2)c1,,ONO-8539,
CN(CCCCCCN)CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,Dipitramine,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=N)NCCCN)CC4)c3Cl)c2n1,,3-(5-methoxy-1H-indol-3-yl)propanoic acid,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=N)NCCCN)CC4)c3Cl)c2n1,,Elamipretide,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)C[C@@H](N)CCCN=C(N)N)CC5)CCCC4)c3Cl)c2n1,,Glyceraldehyde-3-Phosphate,
CC(C)NC(=S)NCCc1cnc[nH]1,,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,
COCc1cc(=O)oc2cc3occ(C)c3cc12,,Robenacoxib,
CC(C)NC(=S)NCCCCCc1cnc[nH]1,,OLOMOUCINE II,
Cc1cccc2nc(N3CCN(C)CC3)c3cccn3c12,,CRA_16847,
S=C(NCCCc1cnc[nH]1)NCCc1ccccc1,,Hydroxychloroquine,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OCc2ccccc2)cc1O,,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",
Cc1cc2c(cc1Cc1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,Fluprednisolone,
COc1c(C(=O)/C=C/c2cccc(O)c2)c(O)c(OC)c2occc12,,Pevonedistat,
Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,,TG100-115,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)OCc2ccccc2)cc1,,Leuprolide,
CCCn1c(=O)c2[nH]c(CCCNC(=O)c3cccc(S(=O)(=O)F)c3)nc2n(CCC)c1=O,,2-Phenylamino-Ethanesulfonic Acid,
O=C(O)c1cc(=O)c2cc(OCCCN3CCC(=C(c4ccccc4)c4ccccc4)CC3)ccc2o1,,Radicicol,
NS(=O)(=O)c1ccc(C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)OCc2ccccc2)c2ccccc2)cc1,,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)C[C@@H](N)CCCN(C)C)CC4)c3Cl)c2n1,,"(4S)-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone",
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=N)NCCC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,Etafedrine,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@H](CCCC[N+](C)(C)C)[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,Protokylol,
CC(C)NCC(O)c1ccc(O)c(CO)c1,,Trimethyllysine,
c1ccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)cc1,,3-Fluoro-L-tyrosine,
NCCc1cnc(CCC(c2ccccc2)c2ccccc2)[nH]1,,Histaprodifen,
CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc(C(=O)O)cc3)c(F)cc21,,GDC-0084,
CC(C)n1cc2c3c(cccc31)C1=C[C@@H](COC(=O)C3CC3)CN(C)[C@@H]1C2,,Bupropion,
CCCn1c(=O)c2[nH]c(NC(=O)CBr)nc2n(CCC)c1=O,,"7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane",
C=CCN1CCc2c(cc(O)c(O)c2Br)[C@@H](c2ccccc2)C1,,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",
O=c1c(O)c(-c2ccc(I)cc2)oc2cc(O)cc(O)c12,,328548-28-3,
CC1(C)CC=C(c2ccc(F)cc2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",
CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H](CN1CCCC1)c1cccc(N)c1,,Vesnarinone,
CCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CO)C(=O)OCc1ccccc1,,Irdabisant,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)OCc2ccccc2)cc1,,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,
C=C/C(C)=C/C[C@@]1(C)[C@@H]2C[C@@H](OC(=O)c3ccc(O)cc3)C=C3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32[C@@H](O)C[C@H]1C,,Casearborin D,
CCN(Cc1cccnc1)C(=O)c1ccc(Cl)c([C@]2(C)C(=O)N(Cc3ccc(OC)cc3OC)c3ccc(Cl)cc32)c1,,SSR126768A,
CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C,,Volasertib,
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,,PHA-665752,
O=C(NCCCOP(=O)(O)O[C@H]1[C@H](O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]1O)Oc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21,,Disaccharide tripeptide glycerol dipalmitoyl,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)[C@@H](N)CCCN(C)C)CC4)c3Cl)c2n1,,Allopurinol,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)C[C@@H](N)CCCCN(C)C)CC4)c3Cl)c2n1,,Sulprostone,
CCCNC(=S)NCCc1cnc[nH]1,,Kebuzone,
CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1,,Cisapride,
COCc1c2occc2c(OC)c2ccc(=O)oc12,,Mannitol busulfan,
O=C(O)CCCCc1ccc(Oc2ccccc2)cc1,,3'-deoxy-3'-aminothymidine monophosphate,
N=C(NCc1ccccc1)SCCCc1cnc[nH]1,,Nebivolol,
Cc1cc2c(cc1C(=O)c1cccc(C(=O)O)c1)C(C)(C)CCC2(C)C,,Mannosulfan,
COc1ccccc1N1CCN(CC2CC(=O)c3ccsc3C2)CC1,,Concanamycin A,
CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Geneticin,
OCCc1cc(-c2ccccc2OCc2ccc(Br)cc2)no1,,beta-D-Galactosamine,
O=C(Nc1ccc(Br)cc1)N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1,,Becatecarin,
Cc1ccc(C2=CC(C)(C)Sc3cc4ccc(-c5ccc(C(=O)O)cc5)cc4cc32)cc1,,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",
NCCCN1C(=O)C(CN)N=C(c2ccccc2)c2cc(N(Cc3ccccc3)Cc3ccccc3)ccc21,,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",
NS(=O)(=O)c1ccc(C(=O)N[C@H](Cc2ccccc2)C(=O)NCC(=O)NCC(=O)OCc2ccccc2)cc1,,CDC-801,
NS(=O)(=O)c1ccc(C(=O)NCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc1,,SR11254,
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)O,,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",
CC(/C=C1\C=CCCC1)=C\C=C\C(C)=C\C(=O)O,,3-nitro-L-tyrosine,
O=C(O)c1ccc(-c2ccc([N+](=O)[O-])c(Cl)c2)cc1,,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",
Fc1cccc(CNC(=S)N2CCC(c3cnc[nH]3)CC2)c1,,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",
Fc1ccc(CNC(=S)N2CCC(c3cnc[nH]3)CC2)cc1,,"2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",
CCCn1ccc2cc3c(cc21)CCN3C(=O)Nc1cccnc1,,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",
CN1CC(COC(=O)C2CCCCC2)=C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,Semagacestat,
O=C(O)c1cccc2c(=O)cc(-c3ccc(/C=C/c4ccc5ccccc5n4)cc3)oc12,,4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1ccccc1,,6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1ccc(C(C)C)cc1,,Fulvestrant,
COc1ccccc1CN(C[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN1CCN(c2ccccc2)CC1)C(C)=O,,Verdinexor,
COc1ccc(CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)cc1OC,,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",
N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)Nc1ccc2c(CN3CCCC3)cn(Cc3ccc(F)cc3)c2c1)C(=O)NCc1ccccc1,,Quinestrol,
C=CCN1CCN(c2nc3ccccc3s2)CC1,,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",
CC(C)c1c(O)cc2oc(-c3ccccc3)cc(=O)c2c1O,,4SC-203,
CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](COC(=O)C3CCC3)CN(C)[C@@H]1C2,,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",
CC(C)n1cc2c3c(cccc31)[C@H]1C=C(COC(=O)C3CCCCC3)CN(C)[C@@H]1C2,,5-Fluorolevulinic Acid,
O=C(O)c1cccc2c(=O)cc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)oc12,,Amdoxovir,
COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21,,A-131701,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1ccc(C)cc1,,beta-Mannobiose,
COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC,,SP-876,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N(C)Cc1ccc(C)cc1,,Clorsulon,
CC(OCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1)C1CCCCC1,,Prilocaine,
CNCCCCCCN(C)Cc1cccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)c1,,Ferrous ascorbate,
Cc1ncc(Cc2csc(CCO)c2C)c(N)n1,,3-Deazathiamine,
CN1CCN(c2nc3cccc(F)c3n3cccc23)CC1,,PASBN,
Cc1cc2c(cc1-c1cc(C(=O)O)no1)C(C)(C)CCC2(C)C,,Formoterol,
CN1CC(COC(=O)C2CCC2)=C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,Ethylmorphine,
COc1ccccc1N1CCN(CC2CC(=O)c3ccccc32)CC1,,Aminorex,
CC(C)(C)c1ccccc1CNC(=S)N1CCC(c2cnc[nH]2)CC1,,Allysine,
O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1,,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",
CC(C)n1cc2c3c(cccc31)[C@H]1C=C(COC(=O)C3CCCC3)CN(C)[C@@H]1C2,,Pemigatinib,
COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1,,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",
COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C#N)CC3)nc(N)c2cc1OC,,Racecadotril,
O=C(CCN1CCCCC1)Nc1cncc(-c2cccc3[nH]ccc23)c1,,Phthalofyne,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC,,Bis(5-Amidino-2-Benzimidazolyl)Methanone,
O=C(O)c1cc(Br)cc2c(=O)cc(-c3cccc(OCc4ccc5ccccc5n4)c3)oc12,,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,
O=C(O)c1cc(Br)cc2c(=O)cc(-c3cccc(OCc4nc5ccccc5s4)c3)oc12,,Mitoxantrone,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CN(C)C)nc(N)c2cc1OC,,4-Deoxyglucarate,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCC3)co2)cc1)c1cccnc1,,"5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID",
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCOC3CCCCC3)co2)cc1)c1cccnc1,,NAP-226-90,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)c1ccc(C)cc1,,DTP-348,
COc1ccc(CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)cc1,,Pyruvamide,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1ccc(C(C)(C)C)cc1,,"(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid",
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C,,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,
CC1(C)CCC(C)(C)c2cc(C(=C(F)F)c3ccc4cc(C(=O)O)ccc4c3)ccc21,,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",
O=C(O)c1cccc2c(=O)cc(-c3cccc(OCc4ccc5ccccc5n4)c3)oc12,,Higenamine,
CO[C@H]1CC[C@H](C(=O)OCC2=C[C@@H]3c4cccc5c4c(cn5C(C)C)C[C@H]3N(C)C2)CC1,,Benzoylecgonine,
Cn1c(COc2cccc(-c3cc(=O)c4cc(Br)cc(C(=O)O)c4o3)c2)nc2ccccc21,,Dinalbuphine sebacate,
COC(=O)[C@]12CCCN1C(=O)[C@@H](NC(=O)OC(C)(C)C)CC2,,Oxymetazoline,
CN[C@H](Cc1c(C)cc(O)cc1C)C(=O)N1Cc2ccccc2CC1C(=O)O,,Nesbuvir,
O=C(CCCN1CCN(CC2CC(=O)c3ccoc3C2)CC1)c1ccc(F)cc1,,Indantadol,
CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](COC(=O)C3CCCCC3)CN(C)[C@@H]1C2,,m-Hydroxyhippuric acid,
CCS(=O)(=O)CCC(=O)CNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,Cilengitide,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCO3)co2)cc1)c1cccnc1,,3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN4CCSC4)cc3)nc(N)c2cc1OC,,Emtricitabine,
CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,,Deoxyamidinoproclavaminic acid,
CC1(C)Oc2ccccc2NC1=O,,10514-70-2,
CC(C)(C)[C@H](O)[C@@H](CN)c1ccccc1,,"4-Methyl-1,2-Benzenediol",
CN(C)c1cccc(-c2ccc(C(=O)O)cc2)c1,,Iproniazid,
CC(C)N1CCN(c2nc3ccccc3s2)CC1,,Prednylidene,
O=c1cc(-c2ccccc2)oc2cc(O)c(Cc3ccccc3)c(O)c12,,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,
O=c1cc(-c2ccccc2)oc2c(Cc3ccccc3)c(O)cc(O)c12,,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",
CN1CC(COC(=O)C2CCCCCC2)=C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,Diiodohydroxypropane,
COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1,,Phenprocoumon,
O=C(CCCN1CCN(CCC2Cc3cc(F)ccc3C2=O)CC1)c1ccc(F)cc1,,Ethyl hydroxybenzoate,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(N)=O,,Obeticholic acid,
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C,,3-amino-5-phenylpentane,
O=C(O)c1ccc(-c2ccc(F)c(Cl)c2)cc1,,195457-73-9,
NNC(=O)c1ccc(OCCCc2cnc[nH]2)cc1,,16-Bromoepiandrosterone,
N=C(NO)c1ccc(OCCCc2cnc[nH]2)cc1,,Ombrabulin,
CCN(CC)c1nc2sc(C(N)=O)c(C)c2c(=O)o1,,Perphenazine,
O=C(O)c1ccc(-c2ccc(Oc3ccccc3)cc2)cc1,,Vemurafenib,
CN1CCc2cc3c(cc21)CCN3C(=O)Nc1cccnc1,,"2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",
Oc1cccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)c1,,(S)-acetoin,
Cn1cncc1CC(=O)Nc1cncc(-c2cccc3[nH]ccc23)c1,,Sitravatinib,
O=C(CCCN1CCN(CC2CC(=O)c3ccsc3C2)CC1)c1ccc(F)cc1,,Levamlodipine,
O=C(O)c1cc(Br)cc2c(=O)cc(-c3cccc(OCc4ccc5ccccc5c4)c3)oc12,,2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID,
O=C(O)c1cc(Br)cc2c(=O)cc(-c3ccc(OCc4ccc5ccccc5n4)cc3)oc12,,alpha-Conotoxin VC 1.1,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(CC(=O)O)cc2)NC(C)=O)cc1,,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCN3CCOCC3)co2)cc1)c1cccnc1,,Glyceryl stearate SE,
CNCCCCCCN(C)Cc1ccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)cc1,,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",
O=C(NS(=O)(=O)c1ccccc1)c1cc(Br)cc2c(=O)cc(-c3ccc(OCc4ccc5ccccc5n4)cc3)oc12,,N-acetyl-N'-beta-D-glucopyranosyl urea,
CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,
CO/N=C(\C)c1ccc(OCCCc2cnc[nH]2)cc1,,Emodin,
S=C(NCc1cccc(Br)c1)N1CCC(c2cnc[nH]2)CC1,,Ebastine,
COc1ccc(CCCn2ncc3c2nc(N)n2nc(-c4ccco4)nc32)cc1,,316173-57-6,
CC(C)n1cc2c3c(cccc31)C1=C[C@@H](COC(=O)C3CCCCCC3)CN(C)[C@@H]1C2,,"3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",
O=C(CCc1ccncc1)NCC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,Etofamide,
CC1(C)CCC(C)(C)c2cc(/C(=N/NS(C)(=O)=O)c3ccc4cc(C(=O)O)ccc4c3)ccc21,,TRIAZOLOPYRIMIDINE,
COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC,,"2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE",
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1ccc(N(C)C)cc1,,Florantyrone,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(CS(=O)(=O)O)cc2)NC(C)=O)cc1,,N-[(2S)-3-Phenyl-2-sulfanylpropanoyl]-L-phenylalanyl-L-tyrosine,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(NC(=O)C(=O)O)cc2)NC(=O)CCc2ccccc2)cc1,,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,
CCCCCCCCCCCCCCCC(=O)Oc1ccc(C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)O)C(C)C)cc1,,Renzapride,
CC(=C\C=C\C(C)=C\C(=O)O)/C=C1/C=CCCC1,,Etorphine,
O=C(Nc1cccnc1)N1CCc2cc3[nH]ccc3cc21,,Thymidine,
S=C(NCc1ccccc1)N1CCC(c2cnc[nH]2)CC1,,Cinoxacin,
CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC,,CYTOSPORONE B,
Cc1cc2c(cc1-c1cc(C(=O)O)no1)C(C)(C)C(C)CC2(C)C,,Deoxyepinephrine,
CCNCCc1cnc(CCC(c2ccccc2)c2ccccc2)[nH]1,,Guanadrel,
O=C(Nc1cccnc1)N1CCc2cc3c(ccn3Cc3ccccc3)cc21,,Cefsulodin,
CC(C)n1cc2c3c(cccc31)C1=C[C@@H](COC(=O)C3CCC3)CN(C)[C@@H]1C2,,"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID",
O=C(CCCN1CCN(CCC2CCc3sccc3C2=O)CC1)c1ccc(F)cc1,,AT-001,
COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C(N)=O)CC3)nc(N)c2cc1OC,,(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,
COCCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1,,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(NC(=O)C(=O)O)cc2)NC(=O)Cc2cccc3ccccc23)cc1,,L-2-aminopimelic acid,
CCCCCCCCCCCCCCCC(=O)OCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,,Englitazone,
CO/N=C/c1ccc(OCCCc2cnc[nH]2)cc1,,Tivozanib,
CC1=C(C)/C(=C/C(C)=C/C=C/C(C)=C/C(=O)O)CCC1,,Guanidinoethylmercaptosuccinic acid,
O=C(O)[C@@H]1O[C@H]2CN(Cc3ccccc3)C[C@@H]1O2,,Tosedostat,
CC1(C)CCC(C)(C)c2cc(-c3cc(C(=O)O)no3)ccc21,,Vesatolimod,
O=C1CC(CN2CCN(c3ncccn3)CC2)Cc2occc21,,D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,
S=C(NCc1ccccc1Cl)N1CCC(c2cnc[nH]2)CC1,,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,
S=C(NCc1ccc(Br)cc1)N1CCC(c2cnc[nH]2)CC1,,"3,5-diiodothyropropionic acid",
COc1ccccc1N1CCN(CC2CC(=O)c3c([nH]c4ccccc34)C2)CC1,,Coumermycin A1,
COC(c1ccc2c(c1)C(C)(C)CCC2(C)C)c1ccc2cc(C(=O)O)ccc2c1,,Ajulemic acid,
CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](COC(=O)C3CCCCCC3)CN(C)[C@@H]1C2,,Vazegepant,
O=C(O)c1cc(F)cc2c(=O)cc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)oc12,,Filociclovir,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN)c3)nc(N)c2cc1OC,,R-82913,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCc3ccccc3)co2)cc1)c1cccnc1,,"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(NC(=O)C(=O)O)cc2)NC(=O)c2ccccc2)cc1,,DiaPep 277,
COc1ccc([C@H](CN)[C@@H](O)C2CCCCC2)cc1,,S-Phosphocysteine,
CN1C[C@H](COC(=O)C2CCCC2)C=C2c3cccc4[nH]cc(c34)C[C@H]21,,Zorubicin,
CC(C)n1cc2c3c(cccc31)[C@H]1C=C(COC(=O)C3CCCCCC3)CN(C)[C@@H]1C2,,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",
COC(=O)[C@H]1[C@@H](c2ccc(C)cc2)C[C@@H]2CC[C@H]1N2C/C=C/I,,188680-71-9,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)cc3)nc(N)c2cc1OC,,Frovatriptan,
O=C(N[C@H](CN1CCC(OC2c3ccccc3CCc3ccccc32)CC1)C(=O)O)OCc1ccccc1,,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(C(F)(F)C(=O)O)cc2)NC(C)=O)cc1,,D-Glutamic Acid,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCN)nc(N)c2cc1OC,,CP-195543,
COc1ccc(C[C@H](NC(=O)Nc2ccc3c(CNC4CCCC4)cn(Cc4ccc(F)cc4)c3c2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCc2ccccc2)cc1,,Elesclomol,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)O)C(C)C)C(C)C,,Pemafibrate,
O=C(O)c1ccc(-c2ccc(Cl)cc2Cl)cc1,,195457-72-8,
CC1=C(C)/C(=C/C(C)=C\C=C\C(C)=C\C(=O)O)CCC1,,"(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid",
Cc1cc2cc3c(cc2n1C)CCN3C(=O)Nc1cccnc1,,"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",
Oc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1,,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",
CN1C[C@H](COC(=O)C2CCC2)C=C2c3cccc4[nH]cc(c34)C[C@H]21,,Octyldodecanol,
CC(C)n1cc2c3c(cccc31)C1=C[C@@H](COC(=O)C3CCCC3)CN(C)[C@@H]1C2,,BI-671800,
O=C(O)c1ccc2c(=O)cc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)oc2c1,,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",
O=C(O)c1cccc2c(=O)cc(-c3ccc(OCc4ncc5ccccc5n4)cc3)oc12,,Heparin Disaccharide I-S,
C=CCn1cc2c(nc(NC(=O)Nc3ccc(OC)cc3)n3nc(-c4ccco4)nc23)n1,,Lemborexant,
Cc1cc(C(=O)O)c2oc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)cc(=O)c2c1,,Ergometrine,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CCl)nc(N)c2cc1OC,,Tacalcitol,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)cc3)nc(N)c2cc1OC,,"Thymidine-3',5'-Diphosphate",
COc1cccc(CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(C)=O)c1,,Cimicoxib,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOC3CCCCC3)co2)cc1)c1cccnc1,,N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide,
O=Cc1ccc2c(c1)NC(=O)CO2,,200195-15-9,
CC(NO)c1ccc(OCCCc2cnc[nH]2)cc1,,gamma-Tocopherol,
O=C(O)/C=C/C=C/c1ccc(Oc2ccccc2)cc1,,JNJ-27548547,
CC(=NNC(N)=O)c1ccc(OCCCc2cnc[nH]2)cc1,,GYWPLFKAZIVXBG-UHFFFAOYSA-N,
CN1C[C@H](COC(=O)C2CCCCC2)C=C2c3cccc4[nH]cc(c34)C[C@H]21,,O-(cyclohexanecarbonyl)lysergol,
CN1C[C@H](COC(=O)C2CCCCCC2)C=C2c3cccc4[nH]cc(c34)C[C@H]21,,Thiamylal,
N#Cc1ccc2oc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)cc(=O)c2c1,,Apratastat,
O=C(Cn1cnnn1)Nc1cncc(-c2cccc3[nH]ccc23)c1,,Uridylyl-2'-5'-phospho-adenosine,
CNC(=O)[C@@H]1C[C@@H](O)CN1C(C)=O,,(4r)-1-Acetyl-4-Hydroxy-N-Methyl-L-Prolinamide,
O=C1CC(CN2CCN(c3ccccc3)CC2)Cc2occc21,,FK-614,
O=C1CC(CN2CCN(c3ccccn3)CC2)Cc2occc21,,Isoetharine,
S=C(NCc1cccc(Cl)c1)N1CCC(c2cnc[nH]2)CC1,,Cisatracurium,
S=C(NCc1ccc(Cl)cc1)N1CCC(c2cnc[nH]2)CC1,,Silodosin,
COc1ccccc1N1CCN(CCC2CCc3sccc3C2=O)CC1,,Cytidine-5'-diphospho-beta-D-xylose,
O=C(CCCN1CCN(CC2CC(=O)c3ccccc32)CC1)c1ccc(F)cc1,,(S)-carazolol,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC,,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CCl)c3)nc(N)c2cc1OC,,Atopaxar,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1ccccn1,,Ribostamycin,
COC(=O)c1ccc(OCCCc2cnc[nH]2)cc1,,Biliverdin Ix Gamma Chromophore,
Cc1cc(C)c([C@H](O)[C@@H](CN)c2ccccc2)c(C)c1,,Ertugliflozin,
O=C(c1ccc(OCCCc2cnc[nH]2)cc1)N1CCCC1,,E-6201,
Cc1ccccc1CNC(=S)N1CCC(c2cnc[nH]2)CC1,,Beta-3-Cysteine,
C[C@@H]1O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,,CEP-9722,
CN1CC(COC(=O)C2CCCC2)=C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,Palmitoyl tetrapeptide-7,
CC1(C)CCC(C)(C)c2cc([C@H](O)c3ccc4cc(C(=O)O)ccc4c3)ccc21,,5'-S-[2-(decylamino)ethyl]-5'-thioadenosine,
COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1,,Tezacitabine,
O=C(O)c1cc(Br)cc2c(=O)cc(-c3cccc(OCc4ncc5ccccc5n4)c3)oc12,,Linsidomine,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(CCC(=O)O)cc2)NC(C)=O)cc1,,Dihydroetorphine,
NC(=O)c1ccc(OCCCc2cnc[nH]2)cc1,,Acetyl hexapeptide-3,
O=C(Nc1cccnc1)N1CCc2cc3sccc3cc21,,Amrubicin,
O=C1CCC(CCN2CC(N3CCNCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,Hydrocortisone succinate,
CN1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(Cc4ccccc4)C3)C2)CC1,,Narlaprevir,
O=C1CCC(CCN2CC(N3CCSCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,Ropidoxuridine,
Clc1ccc2c(NCCc3ccc(OCCCN4CCCCC4)cc3)ccnc2c1,,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",
O=C1c2ccoc2CCC1CCN1CCN(c2ccccn2)CC1,,Puerarin,
O=C(CN1CCOCC1)Nc1cc(CO)cc(Nc2ccnc3cc(Cl)ccc23)c1,,N-acetylhistamine,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1cccc(Cl)c1,,"N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE",
COC(=O)[C@]12CCCN1C[C@@H](NC(=O)OC(C)(C)C)CC2,,Astaxanthin,
CC(C)(C#N)NC(=O)[C@H](CC1CCCCC1)NC(=O)N1CCOCC1,,"(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine",
N#C[C@H](COCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)c1cnccn1,,Lifirafenib,
O=C(CN1CCCCC1)Nc1cc(CN2CCC(O)CC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,
Oc1cc(-c2ccc3c(c2)OCO3)nc2ccccc12,,5-fluorouridine,
CC(C)(C)C(NC(=O)OCCCc1cnc[nH]1)C(C)(C)C,,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",
O=C1CCC(CCN2CC(N3CCC(O)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,(R)-1-phenylethanol,
Clc1ccc2c(Nc3ccc(OCCCN4CCCCC4)cc3)ccnc2c1,,3-Dehydroquinic Acid,
CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C5=CC(=O)OC5)CC[C@]4(O)[C@@H]3CC[C@@H]2C1,,Digitoxigenin acetate,
O=C1CCC(CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,Thenoyltrifluoroacetone,
COc1ccccc1N1CCN(CCC2Cc3ccccc3C2=O)CC1,,CF-102,
CC(/C=C/[C@H]1C[C@@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\C(=O)O,,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,
N#C[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1,,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,
O=C1CC[C@](CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CCCCC1,,Bevenopran,
CC(NC(=O)OCCCc1cnc[nH]1)C1CC1,,Galactose-uridine-5'-diphosphate,
CC(=O)c1ccc(OCc2ccc(CN3CCCCC3)cc2)cc1,,Tetulomab tetraxetan Lu-177,
Cc1cc(CCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1,,Tepoxalin,
Cc1cc(C[C@H](N)C(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1,,BMS-986104,
N#C[C@H](COCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccco1,,Biopterin,
CN(C)S(=O)(=O)N1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Adenosine-5-Diphosphoribose,
c1ccc2c(NCCCc3ccc(OCCCN4CCCCC4)cc3)ccnc2c1,,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",
CC(C)C(C)NC(=O)OCCCc1cnc[nH]1,,SD-0006,
C[C@@H](NC(=O)OCCCc1cnc[nH]1)C1CCCCC1,,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,
CCCC[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)CCc1ccccc1,,Pregnenolone acetate,
NCCc1csc(N)n1,,124458-10-2,
O=C1CC[C@](CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CC1,,7-ethyl-10-hydroxycamptothecin,
CC(C)(C)CCCOCCCc1cnc[nH]1,,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",
CC(NC(=O)OCCCc1cnc[nH]1)C1(C)CC1,,GDC-0349,
O=C(NC(C1CC1)C1CC1)OCCCc1cnc[nH]1,,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",
N#C[C@H](CCc1ccccc1)NC(=O)[C@@H](NC(=O)N1CCOCC1)C1CCCCC1,,Nifuroxazide,
CC(=O)N1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(Cc4ccccc4)C3)C2)CC1,,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,CHEBI:62124,
COC(=O)[C@]12CCCN1C(=O)[C@](Cc1ccccc1)(NC(=O)OC(C)(C)C)CC2,,Phenylacetaldehyde,
O=C(NO)[C@H]1COC(c2ccc(F)cc2)=N1,,Para-Bromobenzyl Alcohol,
O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,,TAFAMIDIS,
c1ccc2c(NCCc3ccc(OCCCN4CCCCC4)cc3)ccnc2c1,,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",
c1ccc2c(NCCc3ccc(OCCCN4CCCCC4)cc3)c3c(nc2c1)CCCC3,,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",
Cc1ccccc1CN1CC(CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CCC1=O,,Oxybuprocaine,
COc1ccc(Cn2ccc(C)c(NC(=O)C(Cc3ccc(C(C)(C)C(=O)O)cc3)NC(=O)Cc3cccc4ccccc34)c2=O)cc1,,Tromethamine,
CCCc1ccc(-c2ccc(C3=N[C@@H](C(=O)NO)CO3)cc2)cc1,,Naquotinib,
O=C1CC(CN2CCN(c3ccccn3)CC2)Cc2sccc21,,Tomivosertib,
O=C1CCC(CCN2CC(N3CCS(=O)(=O)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE,
COc1ccc(Cn2ccc(C)c(NC(=O)C(Cc3ccc(C(C)(C)C(=O)O)cc3)NC(=O)Cc3ccc4ccccc4c3)c2=O)cc1,,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",
NS(=O)(=O)Oc1ccccc1,,phenyl sulfamate,
O=C(NO)[C@H]1COC(c2ccc([N+](=O)[O-])cc2)=N1,,Laninamivir octanoate,
CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,,Noxytiolin,
COC(=O)[C@]12CCCN1C(=O)[C@H](NC(=O)OCc1ccccc1)CC2,,Ferric maltol,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)c1ccccc1,,"1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine",
c1ccc2c(NCCCCc3ccc(OCCCN4CCCCC4)cc3)c3c(nc2c1)CCCC3,,Gedocarnil,
CC(C)(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1ccccc1,,Platensimycin,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)Cc1ccc(Cl)c(Cl)c1,,DCFBC F-18,
Cc1ccccc1COC[C@@H](C#N)NC(=O)[C@H](CC1CCCCC1)NC(=O)N1CCOCC1,,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",
CN(CCO)C1CN(CCC2(c3ccc(Cl)c(Cl)c3)CCC(=O)N(Cc3ccccc3)C2)C1,,MK-3207,
O=C1CCC(CCN2CC(N3CCCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,Bevirimat,
CS(=O)(=O)N1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(Cc4ccccc4)C3)C2)CC1,,Lamivudine,
N[C@@H](Cn1ccc(=O)n(CCC(=O)O)c1=O)C(=O)O,,"3-[3-(2-Carboxyethyl)-2,4-Dioxo-3,4-Dihydropyrimidin-1(2h)-Yl]-L-Alanine",
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OC)c(OC)c1,,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",
c1ccc2c(NCCCCc3ccc(OCCCN4CCCCC4)cc3)ccnc2c1,,Aviptadil,
O=C(CN1CCCCC1)Nc1cc(COC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,,1-Hexadecanosulfonyl-O-L-Serine,
O=C(NC(c1ccccc1)C1CCCCC1)OCCCc1cnc[nH]1,,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,
CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,,5-methylcytidine 5'-monophosphate,
O=C1CC[C@@](CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CCCCC1,,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",
CC(CC(C)(C)C)OCCCc1cnc[nH]1,,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,
CC(=O)N(CCOc1ccc([N+](=O)[O-])cc1)CCc1ccc([N+](=O)[O-])cc1,,Guvacine,
O=C(NO)[C@H]1COC(c2ccc(OCc3cccc(F)c3)c(OC(F)(F)F)c2)=N1,,"(r)-2-(4-(3-fluorobenzyloxy)-3-(trifluoromethoxy)phenyl)-N-hydroxy-4,5-di-hydrooxazole-4-carboxamide",
CCOC(=O)/C(C)=C/[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)(C)c1ccccc1)C(C)(C)C,,Ilorasertib,
O=C1c2ccsc2CCC1CCN1CCN(c2ccccn2)CC1,,Clarithromycin,
O=C1CCC(CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccncc1,,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",
CN(C)c1ccc(C2=N[C@@H](C(=O)NO)CO2)cc1,,"LpxC Inhibitor, L8",
CC(=O)c1ccc(OCc2ccc(CN3CCCCCC3)cc2)cc1,,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",
COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1,,Gabapentin enacarbil,
COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1,,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",
O=C1CCC(CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccc(F)cc1,,Fiboflapon,
COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1,,2-Deoxy-Glucose-6-Phosphate,
CC(C)=CC[C@H]1C[C@@]23C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(C(=O)c4ccc(O)c(O)c4)=C2OC1(C)C)C3=O,,Isogarcinol,
O=C1CC(CN2CCN(c3ccccn3)CC2)c2ccccc21,,"N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",
CC(C)(C)OCCCc1cnc[nH]1,,XR5944,
CCCN1CCN(c2nc3cnccc3o2)CC1,,2-Hydroxyquinoline,
Cc1c(CCO)sc[n+]1Cc1ccc(N)nc1,,Famitinib,
CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,Menthyl salicylate,
C[C@@H](O)[C@H](NC(=O)c1ccc(C#CC#Cc2ccccc2)cc1)C(=O)NO,,"N-[(1s,2r)-2-Hydroxy-1-(Hydroxycarbamoyl)propyl]-4-(4-Phenylbuta-1,3-Diyn-1-Yl)benzamide",
COc1c(C(C)=O)c(OCc2ccc(COc3c(C(C)=O)c(OC)c4ccoc4c3OC)c(C(=O)O)c2)c(OC)c2occc12,,Calcium saccharate,
CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O,,Omadacycline,
C=CCOCCCc1cnc[nH]1,,Paratoulene phosphate,
O=c1[nH]oc2cc(Cl)c(Cl)cc12,,"5,6-dichloro-1,2-benzoxazol-3-ol",
CCCCc1nc(-c2ccc(OCCCN(CC)CC)cc2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1,,Azeliragon,
CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1,,MK-0812,
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc(CP(C)(=O)O)cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",
C#CCCCOCCCc1cnc[nH]1,,Soblidotin,
Nc1ccc2cc(Br)ccc2n1,,6-bromoquinolin-2-amine,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cc4ccccc4cn3)cc2)no1,,852668-48-5,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ncccc3O)cc2)no1,,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",
COc1c(C(=O)/C=C/c2cc(Br)cs2)c(O)c(OC)c2occc12,,Batefenterol,
CCCN1CCN(c2nc3cnccc3s2)CC1,,Sinefungin,
COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,,841290-80-0,
CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,,ERASTIN,
Nc1ccc2cc(C(F)(F)F)ccc2n1,,6-(trifluoromethyl)quinolin-2-amine,
CCCCCCCOCCCc1cnc[nH]1,,Lutetium Lu 177 dotatate,
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-],,ABT-737,
NS(=O)(=O)NCC1CCc2ccccc2O1,,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",
CC(=O)N[C@H](C(=O)N1CSC[C@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,AZD-8330,
Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,,Brivanib,
c1ccc(C(CCc2ncc(CCNCCCCc3cnc[nH]3)[nH]2)c2ccccc2)cc1,,Apararenone,
CN[C@H](CC(C)C)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1ccc(O)cc1)c1ccc(O)cc1,,alpha-D-glucose-1-phosphate,
C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(C#N)c4)ccc3F)c2)CCN1,,Imidurea,
COc1c(C(=O)/C=C/c2ccc(C)cc2)c(O)c(OC)c2occc12,,"3-(4-hydroxy-3-imino-6-oxo-cyclohexa-1,4-dienyl)-alanine",
c1ncc(COCC2CCCCC2)[nH]1,,Inarigivir soproxil,
C[C@@H]1C[C@@H]2O[C@@H]2C=CC=CC(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,,"(2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid",
c1ccc(C(CCc2ncc(CCNCCc3cccnc3)[nH]2)c2ccccc2)cc1,,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,
CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O,,Oxogluric acid,
c1ncc(CCCOCCC2CCCCC2)[nH]1,,Cloranolol,
NC(=O)[C@@H]1CCCN1C(=O)CCP(=O)(O)O,,Methionine,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)no1,,AZD-7295,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)CCc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O,,Naloxone,
Nc1ccc2cc(C3OCCO3)ccc2n1,,2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin,
CC(=O)N[C@H](C(=O)N1CCC[C@@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,Sorivudine,
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCCNCC1,,KU-0058948,
NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNc1c(O)c(=O)c1=O)NC(=O)OCC1c2ccccc2-c2ccccc21,,3-Hydroxyimino Quinic Acid,
CC(=O)N[C@H](C(=O)N1CC=C[C@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,Beta-D-Fructopyranose,
COCCCc1cnc[nH]1,,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,
c1ccc(-n2ncc3cncnc32)cc1,,"1-Phenyl-1H-pyrazolo[3,4-d]pyrimidine",
Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,A-674563,
NC(=O)[C@@H]1CCCN1C(=O)CCNS(=O)(=O)C(F)(F)F,,"1D-myo-inositol 1,3,4-trisphosphate",
Cc1ccc(C[n+]2c(C)sc(CCO)c2C)c(N)n1,,Plinabulin,
O=C(NC1CCNCC1)c1[nH]ncc1NC(=O)c1c(Cl)cccc1Cl,,AT7519,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ccc4ccccc4c3)cc2)no1,,Eritoran,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)CCCCc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O,,Tocotrienol,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N1CCC[C@H]1C(N)=O,,Benzthiazide,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O,,149234-04-8,
c1ncc(CCCOCCCC2CCCCC2)[nH]1,,Copanlisib,
c1ncc(COCCCC2CCCCC2)[nH]1,,LY-2623091,
NS(=O)(=O)OCC1CCc2ccccc2O1,,Sulfamic acid chroman-2-ylmethyl ester,
CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,,BI 2536,
CCC(=O)c1cccc(C(=O)NCc2ccc(F)c(-c3cccc(CN4CCN[C@@H](C)C4)c3)c2)c1,,"4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide",
COc1cc2c(cc1OC)[C@H](c1ccccc1)N(CCCCCCc1cnnn1CCNc1c3c(nc4ccccc14)CCCC3)CC2,,TOP-1288,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)CCCc1ccccc1)C(=O)N1CC=C[C@H]1C(N)=O,,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",
COc1c(C(C)O)c(OCc2ccc(COc3c(C(C)O)c(OC)c4occc4c3OC)cc2)c(OC)c2occc12,,"6-Aminohexyl-uridine-C1,5'-diphosphate",
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc(C(C(=O)O)C(=O)O)cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,JPC-3210,
C#CCOCCCc1cnc[nH]1,,GW-3965,
CC(=O)N[C@H](C(=O)N1CC[C@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE",
NC(=O)[C@@H]1CCCN1C(=O)CCCC(=O)O,,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,
Nc1ccc2cc(F)ccc2n1,,6-fluoroquinolin-2-amine,
COc1c(C(=O)/C=C/c2ccccc2)c(O)cc2occc12,,NOP-1A,
Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21,,449811-92-1,
CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,,630124-46-8,
CCCCCCOCCCc1cnc[nH]1,,N(2)-succinyl-L-arginine,
COc1c(C(C)=NN=C(C)c2c(O)c(OC)c3occc3c2OC)c(O)c(OC)c2occc12,,Palmitoyl-Linoleoyl Phosphatidylcholine,
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc(CP(=O)(O)Cc4ccccc4)cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,Methyl aminolevulinate,
N[C@@H](CCCCC=O)C(=O)O,,Calusterone,
COc1c(O)c(C(=O)CCc2ccccc2)c(OC)c2c1OCC2,,Phenacetin,
O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,,KW-2449,
C[C@H](N)C(=O)Nc1nc(-c2ccc(Br)cc2)c(-c2ccccc2)s1,,SMAC mimetic compound 20g,
COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC,,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",
COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC,,Cloprostenol,
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc(CC(=O)O)cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,Delanzomib,
c1ncc(CCCOCCCC2CCCC2)[nH]1,,Glyburide,
Cc1ccc([C@@H](OCCN(C)C)c2ccccc2)cc1,,(S)-Neobenodine,
CC(=O)N[C@H](C(=O)N1C[C@@H](F)C[C@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,Darexaban,
C[C@H](CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12,,Sulfatide,
CC(=O)N[C@H](C(=O)N1CCCC[C@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,Emodepside,
CCCS(=O)(=O)N1CCC(c2c[nH]c3c(C(N)=O)cc(-c4ccccc4)cc23)CC1,,Triapine,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N1CCC[C@H]1C(N)=O,,Geldanamycin,
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc(O)cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,Technetium Tc-99m mebrofenin,
CCCCCCCCOCCCc1cnc[nH]1,,Pirlimycin,
CC1(C)O[C@H]2[C@@H]3OS(=O)(=O)O[C@@H]3CO[C@@]2(CNS(N)(=O)=O)O1,,alpha-D-Fucopyranose,
COc1c(C(C)=O)c(OCCCCCCCOc2c(C(C)=O)c(OC)c3ccoc3c2OC)c(OC)c2occc12,,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,
CC(=O)N[C@H](C(=O)N1C[C@H](F)C[C@H]1C(N)=O)[C@@H](C)OP(=O)(O)O,,Suxibuzone,
c1ccc(C(CCc2ncc(CCNCCCc3ccccn3)[nH]2)c2ccccc2)cc1,,AC-(D)Phe-pro-borolys-OH,
CCOc1ccc(C(C)=O)cc1NC(=O)c1cc(COC2CCCCO2)cc(C(=O)O)c1,,Genistein,
CCCOCCCc1cnc[nH]1,,Seletracetam,
Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,,Linifanib,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)Cc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O,,Dichlororibofuranosylbenzimidazole,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)CCCc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O,,"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",
Cc1cc(F)ccc1-c1cc(N2CCN(S(C)(=O)=O)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,Onapristone,
Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,,"5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine",
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(-c3ccccc3)nn2)[C@H]1O,,Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,
O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,GSK-269984B,
Cc1ccccc1-c1nc(CCC2CCCCC2)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,Treosulfan,
Cc1cc(C)c(-c2nc(CCC34CC5CC(CC(C5)C3)C4)c(C(=O)Nc3ccc(C)c(C(=O)O)c3)[nH]2)c(C)c1,,BIO-11006,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCOCC4)c3Cl)c2n1,,Fasitibant,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(S(=O)(=O)c3ccc(C)cc3)nn2)[C@H]1O,,Adefovir dipivoxil,
C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CC5CCNCC5)c4)ccc3F)c2)CCN1,,4-Thio-beta-D-glucopyranose,
Cc1ccccc1-c1nc(CCc2ccccc2)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",
CN1CC2(CN3CCC2CC3)OC1=O,,Penfluridol,
Cc1ccccc1-c1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2ccc(F)c(C(=O)O)c2)[nH]1,,"N,N-Dimethyl-L-Alanine",
CNc1cccc(NC(=O)CN2N=C(c3ccccn3)c3ccccc3N(CC(=O)c3ccccc3C)C2=O)c1,,Monoisopropylphosphorylserine,
O=C(O)c1cccc(NC(=O)c2[nH]c(C34CCC(CC3)CC4)nc2CCC23CC4CC(CC(C4)C2)C3)c1,,Modufolin,
CC(=O)N[C@@H](CCCCN(C)C)C(=O)N1CCN(C(=O)C(C)(C)NS(=O)(=O)c2ccc(Cl)c(COc3cccc4ccc(C)nc34)c2Cl)CC1,,Tanespimycin,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Alisporivir,
CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2ccc(O)cc2)C(=O)O1)C(C)C,,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(C(=O)NCCN3CCOCC3)nn2)[C@H]1O,,BMS-777607,
O=C(NC(Cn1ccnc1)c1ccc(Cl)cn1)c1ccc(-c2ccc(Cl)cc2)cc1,,"Azole, 20",
O=C(O)c1cccc(NC(=O)c2[nH]c(C3CCCC3)nc2CCC23CC4CC(CC(C4)C2)C3)c1,,"3,20-Pregnanedione",
CC1(C)OCC(CNS(N)(=O)=O)O1,,CoA-S-acetyl 5-bromotryptamine,
CCCc1cn([C@@H]2[C@@H](O)[C@H](SC)O[C@H](CO)[C@@H]2O)nn1,,Bambermycins,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(C(=O)O)c2)N=C(C2CCCCC2)c2ccccc21,,ZD-6126,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(CCN=C(N)N)CC4)c3Cl)c2n1,,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",
COc1cccc(C(=O)N[C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](NC(=O)c4cccc(OC)c4)[C@H]3O)O[C@H](CO)[C@@H]2O)c1,,cis-tetracosenoyl sulfatide,
Cc1c(O)cc2oc(-c3ccccc3)cc(=O)c2c1O,,Strobochrysin,
O=C(NC(Cn1ccnc1)c1ccccc1)c1ccc(-c2ccc(Cl)cc2)cc1,,SDZ-285604,
CNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NC)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,Citicoline,
O=C(O)c1cccc(NC(=O)c2[nH]c(C3CC3)nc2CCC23CC4CC(CC(C4)C2)C3)c1,,Ioforminol,
Cc1ccccc1-c1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,Brostallicin,
COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1,,Diaminopropanol tetraacetic acid,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(-c3ccccc3F)nn2)[C@H]1O,,PF-06651600,
O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F,,874101-00-5,
CNc1cccc(NC(=O)C[C@H]2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Copper gluconate,
Cc1ccc(NC(=O)c2[nH]c(C3(C)CCCCC3)nc2CCC23CC4CC(CC(C4)C2)C3)cc1C(=O)O,,Deserpidine,
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-],,A-385358,
C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CC[N+](C)(C)CC5)c4)ccc3F)c2)CCN1,,Duvelisib,
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,,Flurithromycin,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCC(C2CC2)=C1CCC(C)C,,N(6)-(pyridoxal phosphate)-L-lysine,
Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21,,396091-16-0,
Cn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(F)cc4)cc3)cc2n(C)c1=O,,Zingerone,
CC1(c2nc(CCC34CC5CC(CC(C5)C3)C4)c(C(=O)Nc3cccc(C(=O)O)c3)[nH]2)CCCCC1,,Fe-Mesopone,
Cc1cccc(C)c1-c1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,PTI-428,
CCCCNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](SC)O[C@H](CO)[C@@H]2O)nn1,,Evacetrapib,
CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2ccccc2O)C(=O)O1)C(C)C,,"Cyclic 3',5'-thymidine monophosphate",
CNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](CO)O[C@@H](OC)[C@H](NC(C)=O)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,Modafinil,
CNCCN(C)c1cccc(NC(=O)CN2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Embutramide,
CCC[N+]1(C)CCN(Cc2cccc(C(=O)NCc3ccc(F)c(-c4cccc(CN5CCN[C@@H](C)C5)c4)c3)c2)CC1,,beta-D-galactose 6-phosphate,
Nc1ccc(/C=C2\CCCN=C2c2cccnc2)cc1,,Technetium Tc-99m sestamibi,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(C3(O)CCCCC3)nn2)[C@H]1O,,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(C(=O)NCCCO)nn2)[C@H]1O,,Isopenicillin N,
CCOCCNc1cccc(NC(=O)CN2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Urea C-14,
O=C(N[C@@H]1[C@@H](O)[C@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=O)c3ccccc3)[C@H]2O)O[C@H](CO)[C@@H]1O)c1ccccc1,,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,
C=CCN(CC=C)C(=O)c1cc(OCC(=O)NCCCCCN)cc(C(=O)N[C@H](C)c2ccccc2)c1,,oxyacetamide 1,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)C[C@@H](N)CCCCN(C)C)CC4)c3Cl)c2n1,,Brodimoprim,
CC1CCc2ccccc2C1Nc1nc2ccccc2[nH]1,,Gadoxetic acid,
Cc1c(COc2cc(F)c(CNC[C@@H](O)CC(=O)O)cc2F)cccc1-c1ccc2c(c1)OCCO2,,Lanosterol,
Cc1ccc(NC(=O)c2[nH]c(-c3ccccc3C)nc2CCC23CC4CC(CC(C4)C2)C3)cc1C(=O)O,,Ziprasidone,
CNc1cccc(NC(=O)CN2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,D-Tyrosine,
C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CC[N+]6(CCCCC6)CC5)c4)ccc3F)c2)CCN1,,PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2ccnn2)[C@H]1O,,Balicatib,
O=C(O)c1cccc(NC(=O)c2[nH]c(-c3ccccc3)nc2CCC23CC4CC(CC(C4)C2)C3)c1,,Chymostatin,
Cc1cc(C)c(-c2nc(CCC34CC5CC(CC(C5)C3)C4)c(C(=O)Nc3cccc(C(=O)O)c3)[nH]2)c(C)c1,,2'-Deoxyguanosine-5'-Triphosphate,
Cc1cc(C)c(-c2nc(COC34CC5CC(CC(C5)C3)C4)c(C(=O)Nc3cccc(C(=O)O)c3)[nH]2)c(C)c1,,Coprogen,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(N3CCCC3)c2)N=C(C2CCCCC2)c2ccccc21,,LFA703,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCC(c2ccccc2)=C1C(C)C,,2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL,
COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,,870483-87-7,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(-c3cccc4ccccc34)nn2)[C@H]1O,,Tiletamine,
O=C(Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1)c1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1,,"CypA Inhibitor, 4f",
Cc1cc(C)c2c(c1)C(Nc1nc3ccccc3[nH]1)CCC2,,Norgestomet,
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,,Crizotinib,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(-c3cccnc3)nn2)[C@H]1O,,Equilin,
Cn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccccc4)cc3)cc2n(C)c1=O,,Ibuproxam,
COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1,,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",
Cn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(C#N)cc4)cc3)cc2n(C)c1=O,,Bafilomycin A1,
COc1cc(OCC(=O)Nc2ccc(Br)cc2)ccc1-c1cc2c([nH]1)c(=O)n(C)c(=O)n2C,,Palomid 529,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(-n3ccnc3)c2)N=C(C2CCCCC2)c2ccccc21,,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",
Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)c3ccc4nc(-c5ccco5)c(-c5ccco5)nc4c3)cc2)n1,,"CypA Inhibitor, 4d",
Cc1ccccc1-c1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2cccc(CCC(=O)O)c2)[nH]1,,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",
CCN(CC)C(=O)CNCc1cc(-c2ccc3ccccc3c2)nc2ccccc12,,"CypA Inhibitor, 1e",
COc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCN(C)CC2)c1,,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,
CC(C)(C)NC(=O)[C@@H]1Cc2ccccc2CN1Cc1cc(-c2cccc(Cl)c2)nc2ccccc12,,"CypA Inhibitor, 1a",
CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(-c5ccccc5)cc4)cc3)cc2n(C)c1=O,,Lidoflazine,
COC(=O)c1cn([C@@H]2[C@@H](O)[C@H](SC)O[C@H](CO)[C@@H]2O)nn1,,Tioguanine,
CC(C)(C)NC(=O)[C@@H]1Cc2ccccc2CN1Cc1cc(-c2ccc3ccccc3c2)nc2ccccc12,,"CypA Inhibitor, 1b",
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(CO)c2)N=C(C2CCCCC2)c2ccccc21,,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",
Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,,RAF265,
c1ccc2c(c1)CC(Nc1nc3ccccc3[nH]1)C2,,(1H-Benzoimidazol-2-yl)indan-2-ylamine,
N[C@@H](Cn1cc(I)c(=O)n(Cc2ccccc2C(=O)O)c1=O)C(=O)O,,5-methyl-2'-fluoroarauracil F-18,
CNc1cccc(NC(=O)CN2N=C(c3ccccc3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Trabodenoson,
Cc1ccnc(NS(=O)(=O)c2ccc(NC(=O)c3ccc4nc(-c5ccco5)c(-c5ccco5)nc4c3)cc2)n1,,"CypA Inhibitor, 4c",
CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,,Motesanib,
N[C@@H](Cn1ccc(=O)n(Cc2cccc(C(=O)O)c2)c1=O)C(=O)O,,MK-5108,
NC(Cn1ccc(=O)n(Cc2ccccc2C(=O)O)c1=O)C(=O)O,,UBP 296,
COc1ccc(-c2cn([C@@H]3[C@@H](O)[C@H](SC)O[C@H](CO)[C@@H]3O)nn2)cc1,,8-anilinonaphthalene-1-sulfonic acid,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(C(=O)NCc3ccccc3)nn2)[C@H]1O,,Nabilone,
CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3ncc(C#N)[nH]3)c(C3=CCCCC3)c2)CC1,,885692-52-4,
C[C@H](OC(=O)N[C@@H]1CN2CCC1CC2)c1ccccc1F,,Acetophenazine,
Cn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(Br)cc4)cc3)cc2n(C)c1=O,,IRX-5183,
COC(=O)c1cc(NC(=O)c2ccc3nc(-c4ccco4)c(-c4ccco4)nc3c2)ccc1NCc1ccccc1,,"CypA Inhibitor, 4a",
Cc1ccccc1-c1nc(CCC(C)C)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,GLPG-0974,
C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CC[N+](C)(Cc6ccccc6)CC5)c4)ccc3F)c2)CCN1,,Dianhydrogalactitol,
COc1cccc(-c2cn([C@@H]3[C@@H](O)[C@H](SC)O[C@H](CO)[C@@H]3O)nn2)c1,,Bromopride,
CCCc1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,Romidepsin,
CNc1cccc(NC(=O)CN2N=C(c3ccccn3)c3ccccc3N(CC(=O)N3CCCC3)C2=O)c1,,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",
CCS(=O)(=O)c1ccc(Cn2c(C)c(CC(=O)O)c3cccnc32)c(Cl)c1,,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,
COc1cccc(Sc2ccc(C(=O)NCC(c3ccccc3)n3ccnc3)cc2)c1,,"Azole, 9",
COC(=O)c1cc(C(=O)Nc2cc(-c3cccc(Cl)c3)nc3ccccc23)ccc1NCc1ccccc1,,"CypA Inhibitor, 3a",
c1ccc2cc(-c3cc(CN4CCCCC4)c4ccccc4n3)ccc2c1,,"CypA Inhibitor, 1c",
CC(=O)N[C@H]1C(OC(C)=O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,,76375-60-5,
O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,,MLN8054,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(O)c2)N=C(C2CCCCC2)c2ccccc21,,"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",
CNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](SC)O[C@H](CO)[C@@H]2O)nn1,,Methyl red,
Cc1c(CCO)sc[n+]1Cc1ccc(C(F)(F)F)nc1,,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,
Cc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccc4nc(-c5ccco5)c(-c5ccco5)nc4c3)cc2)no1,,"CypA Inhibitor, 4e",
C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(C[N+]5(C)CCNCC5)c4)ccc3F)c2)CCN1,,Lapyrium,
COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1,,5'-Fluoro-5'-Deoxyadenosine,
NC(=O)c1cccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)c1,,Baricitinib,
S=C(NCCCCCc1cnc[nH]1)NCCc1ccccc1,,Cefpiramide,
CC1=C(/C=C/c2occc2/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,,Moexipril,
C/C(=C/c1cc(C(=O)O)no1)c1ccc2c(c1)C(C)(C)CCC2(C)C,,Tilarginine,
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)C(C)C2(C)C,,Vinblastine,
CO/N=C(\C)c1ccc(OCc2ccc(CN3CCCCC3)cc2)cc1,,Procaine merethoxylline,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccc1)c1ccccn1,,Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide,
NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)O)cc32)cc1,,CS260,
NS(=O)(=O)c1ccc(NN=C2C(=O)Nc3ccc(C(=O)O)cc32)cc1,,CS260,
COC(=O)[C@]12CCCN1C(=O)[C@](Cc1ccc3ccccc3c1)(NC(=O)OC(C)(C)C)CC2,,Midodrine,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1ccccc1Cl,,Glutaral,
CCCCN(CCCC)c1ccc(/C=C2\C(=O)ON=C2c2ccccc2)cc1,,ALK-4290,
c1ccc(C(CCc2ncc(CCNCCc3cnc[nH]3)[nH]2)c2ccccc2)cc1,,Levovirin,
COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1,,Ethyl salicylate,
O=C(NC(c1ccccc1)C1CC1)OCCCc1cnc[nH]1,,Doxorubicin,
COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC,,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",
CC(=O)c1cccc(C(=O)NCc2ccc(F)c(-c3cccc(CN4CCN[C@@H](C)C4)c3)c2)c1,,Dexpanthenol,
COc1ccccc1N1CCN(CCC2CCc3occc3C2=O)CC1,,Benziodarone,
COCC(O)CNC(C)(C)C,,7-beta-Hydroxyepiandrosterone,
c1ccc(C(CCc2ncc(CCNCCCCCc3cccnc3)[nH]2)c2ccccc2)cc1,,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",
S=C(NCCCc1cnc[nH]1)Nc1ccccc1,,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,
O=C(NCCCC1CCCCC1)OCCCc1cnc[nH]1,,(1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate,
S=C(NCCCCCCc1cnc[nH]1)Nc1ccccc1,,Articaine,
c1ccc(C(CCc2ncc(CCNC3CC3)[nH]2)c2ccccc2)cc1,,Cabotegravir,
CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](COC(=O)C3CCCC3)CN(C)[C@@H]1C2,,Hydrocortisone,
O=C(O)c1cccc2c(=O)cc(-c3ccc(OCc4ccc5ccccc5n4)cc3)oc12,,(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1ccncc1,,Guaiacol,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCc1ccccc1,,Fluclorolone,
COc1ccc2c(c1)C(CCN(C)C)CN2,,Cladribine,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](CC#N)CCc1ccccc1,,Samidorphan,
O=C1CCC(CCN2CC(N3CCC(O)C3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,"L-Alfa-Lysophosphatidylcholine, Lauroyl",
Cc1ccc(CN2CC(CCN3CC(N4CCOCC4)C3)(c3ccc(Cl)c(Cl)c3)CCC2=O)cc1,,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,
c1ccc2c(NCCCc3ccc(OCCCN4CCCCC4)cc3)c3c(nc2c1)CCCC3,,Succinylsulfathiazole,
COC(=O)[C@]12CCCN1C[C@H](NC(=O)OC(C)(C)C)CC2,,Acetylcysteine zinc,
Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3F)nncc2c1,,"3,7,11,15-tetramethyl-hexadecan-1-ol",
O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C2C=CO[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C2[C@]2(CO)O[C@H]12,,verminoside,
O=C(/C=C/c1ccc(O)cc1)O[C@@H]1[C@@H]2O[C@]2(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C[C@@H]12,,Specioside,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)NCc3cccnc3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,"(2S,2'S)-2,2'-(1,2-Hydrazinediylbis{methylene[(2S)-1-oxo-2,1-hexanediyl]imino})bis(6-amino-N-phenylhexanamide)",
CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)O,,PF-00489791,
CN(C)CCNC(=O)COc1c2cccc1Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)C2,,OTX008,
C[C@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CC[C@@H]2O,,17beta-Dihydroequilin,
C[C@@H]1CC2=CC(=O)C=C[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21,,1-Dehydro-7alpha-methyltestosterone,
O=C(c1ccc(O)cc1O)N1Cc2ccccc2C1,,"4-(1,3-Dihydro-2h-Isoindol-2-Ylcarbonyl)benzene-1,3-Diol",
CC(CC(=O)NC(N)=NCCCc1cnc[nH]1)C1CCCCC1,,UR-AK57,
C[C@]1(c2nc3cccc(C(N)=O)c3[nH]2)CCCN1,,Veliparib,
CCc1nc(N)nc(NCCNS(=O)(=O)c2ccc3ccccc3c2)c1-c1ccc2c(c1)N(CCCOC)C(=O)C(C)(C)O2,,"N-[2-({2-Amino-6-Ethyl-5-[4-(3-Methoxypropyl)-2,2-Dimethyl-3-Oxo-3,4-Dihydro-2h-1,4-Benzoxazin-6-Yl]pyrimidin-4-Yl}amino)ethyl]naphthalene-2-Sulfonamide",
CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@@H]1O[C@H]12,,scopolamine,
Cc1ccc(S(=O)(=O)c2ccccc2)cc1S(=O)(=O)NCCc1ccccc1,,Calcium ascorbate,
C=C1CC/C=C/CC[C@@H]2[C@@H]1CC2(C)C,,Tioxidazole,
O=C(NCc1ccc(-c2ccccc2)cc1)[C@@H]1O[C@H]2CN(C(=O)NO)C[C@@H]1O2,,"(1s,5s,7r)-N~7~-(Biphenyl-4-Ylmethyl)-N~3~-Hydroxy-6,8-Dioxa-3-Azabicyclo[3.2.1]octane-3,7-Dicarboxamide",
O=c1n(Cc2ccc(C(F)(F)F)nc2)nc2c(-c3ccncc3)c(-c3ccc(Cl)cc3)cnn12,,Oxaceprol,
Cc1ccccc1C1=CCC(C)(C)c2ccc(C#Cc3ccc(C(=O)O)cc3)cc21,,Diethylpropion,
Cc1cccc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)O)cc4)cc32)c1,,Pregnenolone,
Cc1cc(C)cc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)O)cc4)cc32)c1,,Benzquinamide,
CC(C)c1ccc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)O)cc4)cc32)cc1,,Neridronic Acid,
CC1(C)CC=C(c2cccc(O)c2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,alpha-L-iduronic acid,
CC1(C)CC=C(c2ccc(O)cc2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,Ceftiofur,
CC1(C)CC=C(c2ccc(C#N)cc2)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,Diltiazem,
COc1ccc(NS(N)(=O)=O)cc1,,4-methoxyphenylsulfamide,
CN(c1ncnc2[nH]ccc12)C1CCCCC1,,"1H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-cyclohexyl-N-methyl-",
Nc1nc2[nH]c(SCC(O)CO)nc2c(=O)[nH]1,,L-778123,
Cc1cccc(OC[C@@H](O)CNC(C)C)c1,,Telotristat ethyl,
Brc1c[nH]c2nccnc12,,"3-BROMO-4,7-DIAZAINDOLE",
CCCOc1ccc(CN)cc1Cl.Cl,,"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile",
CC(C)Oc1ccc(CN)cc1Cl.Cl,,Lefradafiban,
c1ccc(CNc2ccc3ccccc3n2)cc1,,N-benzylquinolin-2-amine,
COC(=O)c1ccc(OCC(O)CNC(C)C)cc1,,33947-97-6,
CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1,,4-nitrophenyl-beta-D-galactoside,
CC(C)=CCN1CC[C@]2(C)c3cc(O)ccc3C[C@H]1[C@H]2C,,(+)-Pentazocine,
CSc1nc(N)nc(-c2ccccc2)n1,,14945-93-8,
Nc1nccc(-c2cccnc2)n1,,66521-66-2,
CC(C)(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1,,Phosphatidyl serine,
Cc1c[nH]c(-c2ccc(OCC(O)CNC(C)(C)C)cc2)n1,,Ziritaxestat,
CNc1ccc2ccccc2n1,,N-methylquinolin-2-amine,
CC[C@@H](C1CCC(O)CC1)[C@H](CC)C1CCC(O)CC1,,Semaxanib,
COC(=O)c1ccc2[nH]c(=O)oc2c1,,72752-80-8,
CSc1nc(N)nc(-c2ccccc2Cl)n1,,ATB-346,
CC(C)COCC(O)CNC(C)(C)C,,Potassium lactate,
CC(C)COCC(O)CNC(C)C,,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",
CC(C)NCC(O)COC(C)C,,Formebolone,
CC(C)NCC(O)CON=C1CCCCC1,,Retaspimycin,
CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)C,,"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",
CC(C)=NOCC(O)CNC(C)C,,(S)-4-hydroxymandelonitrile,
CC(C)=NOCC(O)CNC(C)(C)C,,Temsavir,
CC(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C,,2-deoxy-2-fluoro-β-D-mannose,
CC(C)(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C,,Aldosterone,
CC(C)NOCC(O)CNC(C)(C)C,,PROPYL-1-PHOSPHATE,
COc1cc(CC(C)N)c(O)cc1C,,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,
COc1ccc(O)c(CC(C)N)c1,,2-(2-aminopropyl)-4-methoxyphenol,
COc1ccc(CC(C)N)cc1O,,5-(2-Aminopropyl)-2-methoxyphenol,
COc1ccc(O)c(CC(C)N(C)C)c1,,Fluticasone,
COc1ccc(OCc2ccccc2)c(CCN(C)C)c1,,Scopolamine,
COc1ccc(O)c(CCN(C)C)c1,,Namn,
CCOC(=O)[C@]1(c2cccc(O)c2)CCCN(C)C1,,2-Decenoyl N-Acetyl Cysteamine,
CCOC(=O)[C@]1(c2cccc(O)c2)CCCN(CC2CC2)C1,,Meglutol,
c1ccc(CNc2nccc3[nH]c4ccccc4c23)cc1,,1-Deoxy-1-Thio-Heptaethylene Glycol,
OC(CN1CCCCC1)C1=COc2ccccc2O1,,Etohexadiol,
OC(CN1CCCCCC1)C1=COc2ccccc2O1,,alpha-Arbutin,
CCc1[nH]nc2oc(=O)c3ccccc3c12,,5'-Deoxy-5'-(Methylthio)-Tubercidin,
CCCc1[nH]nc2oc(=O)c3ccccc3c12,,DONU,
CC(C)NCC(O)COCCCc1ccccc1,,80617-74-9,
O=C(O)CCCCCCCCCCCn1ccnc1,,12-(1H-imidazol-1-yl)dodecanoic acid,
CC(C)(C)NC[C@H](O)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1,,Clometocillin,
COC[C@H]1O[C@@H](OC)[C@H](OC)[C@@H](OC)[C@H]1OC,,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,
COC[C@H]1O[C@H](OC)[C@H](OC)[C@@H](OC)[C@H]1OC,,PD-168393,
CC(C)(C)Oc1ccc(C[C@@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)cc1,,Fmoc-D-Tyr(tBu)-OH,
CSP(C)(=O)OC(C)C,,Efloxate,
CCOC(=O)c1ccccc1OCC(O)CNC(C)(C)C,,IC261,
COC(=O)c1ccccc1OCC(O)CNC(C)(C)CO,,19-norandrostenedione,
C=COC(=O)c1cccc(OCC(O)CNC(C)C)c1,,Lasmiditan,
C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1,,Estradiol valerate,
COC(=O)CCCc1ccc(OCC(O)CNC(C)C)cc1,,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,
COC(=O)/C=C/c1ccc(OCC(O)CNC(C)C)cc1,,KKW5E9UE22,
CCCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,,4-Deoxy-4-Amino-Beta-D-Glucose,
COC(=O)CCc1ccc(OCC(O)CNCc2ccccc2)cc1,,RAD-140,
COC(=O)CCc1ccc(OCC(O)CNCCCc2ccccc2)cc1,,Propiopromazine,
CCOC(=O)CCNCC(O)COc1ccc(CCC(=O)OC)cc1,,LY-3023414,
CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC,,Daxalipram,
Cc1c(CN(C)C)c(O)[nH]c(=O)c1C#N,,Cariporide,
COc1ccc(CCNCC(O)COc2ccc(-c3ncc(C(F)(F)F)[nH]3)cc2)cc1OC,,Testosterone undecanoate,
COc1ccc(CC(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC,,Diazolidinylurea,
COc1ccc(CC(C)(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC,,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,
COc1ccc(CCNC[C@@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC,,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,
COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC,,L-643717 free base,
O[C@@H](CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1,,CHF-6001,
CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1,,Ethyl loflazepate,
OC(CNCCc1ccccc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1,,Tiapride,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2)cc1OC,,Methcathinone,
CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1,,Teniposide,
O[C@H](COc1cccc2ccccc12)[C@H]1CCCCN1,,Edotecarin,
COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1,,ITI-214,
Nc1nc(N)nc(-c2cc3ccccc3cc2Br)n1,,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",
Cc1nc[nH]c1CSCCNC(=N)NCCCCc1cnc[nH]1,,"8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One",
Cc1nc[nH]c1CSCCNC(=N)NCCCc1nccs1,,D-Methionine,
Cc1nc[nH]c1CSCCNC(=N)NCCSCc1nccs1,,CGP 4832,
CNC(=N)NCCCCc1cnc[nH]1,,AC-430,
CNC(=N)NCCSCc1nccs1,,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",
Cc1nc[nH]c1CSCCNC(=S)NCCCc1cnc[nH]1,,3-phospho-D-glyceric acid,
Cc1nc[nH]c1CSCCNC(=N)NCCCc1cn(C)cn1,,"4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid",
O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1,,Pirprofen,
C[n+]1cn(/N=C/c2ccccc2)c2ccccc21.[I-],,Nalfurafine,
CN1CCCC(C)(c2cccc(O)c2)C1,,2-Bromohypoxanthine,
CC1(c2cccc(O)c2)CCCN(CC2CC2)C1,,5-Amino 6-Nitro Uracil,
CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2c(ccn2C)c1,,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,
COc1ccc(CCNCC(O)COc2ccc(-c3ncc(Br)[nH]3)cc2Cl)cc1OC,,3-Amino-3-Oxopropanoic Acid,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2Cl)cc1OC,,2'-C-methylcytidine,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2C)cc1OC,,Gluco-Phenylimidazole,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(C)[nH]3)cc2)cc1OC,,Mericitabine,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(Cl)[nH]3)cc2)cc1OC,,Zosuquidar,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(Br)[nH]3)cc2)cc1OC,,"(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid",
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(C(C)=O)[nH]3)cc2)cc1OC,,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",
COCc1cnc(-c2ccc(OC[C@@H](O)CNCCc3ccc(OC)c(OC)c3)cc2)[nH]1,,102281-28-7,
CCOCc1cnc(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)[nH]1,,3'-Fluoro-3'-deoxythymidine 5'-monophosphate,
COCCc1cnc(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)[nH]1,,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,
COc1ccc(CCNCC(O)COc2ccc(-c3ncc(CN4CCOCC4)[nH]3)cc2)cc1OC,,JNJ-41443532,
COc1ccc(CCNCC(O)COc2ccc(-c3ncc(Br)[nH]3)cc2)cc1OC,,Serabelisib,
COc1ccc(CCNCC(O)COc2ccc(-c3ncc(Cl)[nH]3)cc2)cc1OC,,Eliglustat,
CC(C)NCC(O)COc1ccc(-c2nc(C(C)C)c[nH]2)cc1,,Pyridoxine phosphate,
CCOCCNC[C@H](O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1,,Amineptine,
CCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1,,102151-07-5,
OC(CNCCc1ccncc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1,,1-Deoxy-D-xylulose 5-phosphate,
CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1,,123744-02-5,
O=C(NCCNCC(O)COc1ccc(-c2ncc[nH]2)cc1)Nc1ccccc1,,8-Methyl-9-Oxoguanine,
COc1ccc(CCNCC(O)COc2ccc(Cc3ncc(C)[nH]3)cc2)cc1OC,,2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,
COc1ccc(CCNC[C@H](O)COc2ccc(Cc3nc(C(C)=O)c[nH]3)cc2)cc1OC,,Amdinocillin,
COc1ccc(CCNCC(O)COc2ccc(CCc3nc(-c4cccs4)c[nH]3)cc2)cc1OC,,Undecanal,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cn2)cc1OC,,Epicillin,
NCCc1cnc(N)s1,,5-(2-aminoethyl)thiazol-2-amine,
CC1(C)OCC(COS(N)(=O)=O)O1,,"(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate",
C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,,Ulimorelin,
O=C(NNc1ccccc1)c1cnc2ccccc2n1,,Ambroxol,
CCOC(=O)C1=C(C)N=C(OC)NC1c1cccc([N+](=O)[O-])c1,,(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE,
CNc1nc2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,8-methylaminoadenosine,
CC(=O)Oc1ccc([N+](=O)[O-])c2ccccc12,,hsp90_165,
Nc1nc(Nc2cccc(Cl)c2)c2[nH]cnc2n1,,Bromperidol,
Nc1nc(Nc2ccc(Cl)c(Cl)c2)c2[nH]cnc2n1,,Carba-nicotinamide-adenine-dinucleotide,
CCOC(=O)C1=C(C)NC(SC)=NC1c1ccccc1C(F)(F)F,,O-Trifluoromethylphenyl Anthranilic Acid,
N=C(NCCCc1cnc[nH]1)NCCSC(c1ccccc1)c1ccccn1,,Gadoteric acid,
O[C@H](COc1ccc2ccccc2c1)[C@H]1CCCCN1,,Chiniofon,
Cc1cccc(OC[C@@H](O)[C@H]2CCCCN2)c1,,Uridine 5'-triphosphate,
CN1CCCC[C@@H]1[C@H](O)COc1ccccc1,,Meclofenamic acid,
C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(N=C2NCCN2)c(Cl)c1,,L002301,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccccc2CO)cc1,,Raltitrexed,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC,,IOWH-032,
CCNC=Nc1ccc(-c2c[nH]cn2)cc1,,"3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline",
COc1nc2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,8-Methoxyadenosine,
COc1ccc(NC(=O)NCCCOc2cccc(CN3CCCCC3)c2)cc1,,Betazole,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1cccc(C(F)(F)F)c1,,Prasterone sulfate,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1cccc(Cl)c1,,Prexasertib,
COc1ccccc1NC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,Clevudine,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1ccc([N+](=O)[O-])cc1,,Tapinarof,
CCOc1ccc(NC(=O)NCCCOc2cccc(CN3CCCCC3)c2)cc1,,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,
COc1ccc(NC(=S)NCCCOc2cccc(CN3CCCCC3)c2)cc1,,Dexelvucitabine,
CCCNC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,2'-Deoxy-Thymidine-Beta-L-Rhamnose,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)NCc1ccccc1,,Solithromycin,
CCCCNC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,AZD-6482,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)NC1CCCCC1,,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",
CNC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,6-hydroxy-D-norleucine,
CC(C)(C)NC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,Telaglenastat,
CCC(C)NC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,PBT-1033,
CC(C)CNC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,Choline salicylate,
O=C(c1ccc(O)cc1)c1cc(Cl)ccc1O,,(5-Chloro-2-Hydroxyphenyl)(4-Hydroxyphenyl)methanone,
CN(CCOc1ccc([N+](=O)[O-])cc1)CCc1ccc([N+](=O)[O-])cc1,,115287-37-1,
CN(CCCCOc1ccc([N+](=O)[O-])cc1)CCc1ccc([N+](=O)[O-])cc1,,Citiolone,
N=C(NCCCc1cnc[nH]1)NCCCC(c1ccc(F)cc1)c1ccccn1,,N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine,
Cc1ccc(C(CCNC(=N)NCCCc2cnc[nH]2)c2ccccn2)cc1,,"(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",
COc1ccc(C(CCNC(=N)NCCCc2cnc[nH]2)c2ccccn2)cc1,,"1,N6-Ethenoadenine",
N=C(NCCCc1cnc[nH]1)NCCC(c1ccc(Cl)cc1)c1ccccn1,,BU-E 47,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccc(C(F)(F)F)cc1)c1ccccn1,,N-(Chlorophenyl)-N'-hydroxyguanidine,
N=C(NCCCc1cnc[nH]1)NCCC(c1cccc(F)c1)c1ccccn1,,Dexketoprofen,
NC(=NCCC(c1cccc(Cl)c1)c1ccccn1)NCCCc1cnc[nH]1,,"1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-propoxy-ethoxy-ethoxy]-propyl-]amino-carbonyloxy)-2-amino-propane",
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccn1)c1ccccc1F,,Levodopa,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccn1)c1ccccc1Cl,,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,
N=C(NCCCc1cnc[nH]1)NCCC(c1cc(Cl)cc(Cl)c1)c1ccccn1,,Fosfomycin,
CN(CCC(c1ccc(F)cc1)c1ccccn1)C(=N)NCCCc1cnc[nH]1,,(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccn1)c1ccccn1,,Litronesib,
NC(=NCC(c1ccccc1)c1ccccn1)NCCCc1cnc[nH]1,,Huperzine A,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccc(F)cc1)c1cccnc1,,Aetiocholanolone,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccc1)c1ccc(F)cc1,,Bis(Adenosine)-5'-Pentaphosphate,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccc1)c1ccc(Cl)cc1,,Brecanavir,
N=C(NCCCc1cnc[nH]1)NCCC(O)(c1ccc(F)cc1)c1ccccn1,,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccn1)c1cccs1,,Minaprine,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccc(O)cc1)c1ccccn1,,Eliprodil,
[NH2+]=C([N-]CCC(c1cccc([N+](=O)[O-])c1)c1ccccn1)NCCCc1cnc[nH]1,,Lanifibranor,
COc1c(C(=O)/C=C/c2cccs2)c(O)c(OC)c2occc12,,(2Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-2-propen-1-one,
CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)cc1,,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",
N=C(N)N1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,,Trestolone acetate,
N=C(N)N1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,,Benorilate,
N=CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,,"6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid",
CC(=N)N1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,,Afabicin,
CC(=N)N1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,,Vindesine,
CC(C)C(=O)OCC(O)CNC(C)(C)C,,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1ccc2c(c1)OCO2,,"2-amino-3-[4-hydroxy-6-oxo-3-(2-phenyl-cyclopropylimino)-cyclohexa-1,4-dienyl]-propionic acid",
Nc1cccc(NC(=O)NCCCOc2cccc(CN3CCCCC3)c2)c1,,Epothilone D,
C#C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,17-ethinyl-dihydrotestosterone,
CN(CCCCCCN)CCCCCCCCN(C)CCCCCCN,,Torasemide,
CN(CCCCCCN)CCCCCCCCN(C)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",
COc1ccccc1CNCCCCCCN(C)CCCCCCCCN(C)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,LY-2452473,
COc1ccccc1CNCCCCCCN(C)CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",
COc1ccccc1CN(CCCCCCN(C)CCCCCCCCN(C)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,t-Butylhydroquinone,
CNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Adenosine-5'-Pentaphosphate,
CCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Bromochlorosalicylanilide,
CCCCCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Pirbuterol,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NC2CCCCC2)co1,,4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(Cl)cc2)co1,,Enalaprilat,
O=C(NNC(=O)C(F)(F)C(O)c1ccccn1)N1Cc2ccccc2Oc2ccc(Cl)cc21,,"8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-[2,2-difluoro-3-hydroxy-1-oxo-3-(2-pyridinyl)propyl]hydrazide",
Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1,,8-azaguanine,
O=C(NCCF)NCCCOc1cccc(CN2CCCCC2)c1,,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",
NCCC1CCc2ccccc21,,"2-(2,3-dihydro-1H-inden-1-yl)ethan-1-amine",
COc1ccccc1N1CCN(CC2CC(=O)c3ccccc3C2)CC1,,Ponazuril,
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2ccccc21,,Pteric acid,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1,,Dethiobiotin,
CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,ABT-384,
CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,"alpha,beta-Dehydroaminobutyric acid",
CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",
CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Thalidomide,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1,,Allosamidin,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1,,Rifapentine,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1,,Celgosivir,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1,,Ipragliflozin,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1,,Talazoparib,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1,,Phenibut,
Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Ulixertinib,
CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Nedocromil,
CCCCc1nc2cc(NC(=O)CCC)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,NS-3728,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCc1ccc(O)cc1)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,D-glucose,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](OC(=O)NCCN)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,Bis(Adenosine)-5'-Triphosphate,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCNC(=O)CCc1ccc(O)cc1)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,"(6S)-N-[(2S,3R,6R,7R)-3-(Acetyloxymethyl)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-7-yl]-6-[(2-aminoacetyl)amino]-7-hydroxy-7-oxoheptanimidate",
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCCCNC(=O)CCc1ccc(O)cc1)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,Managlinat dialanetil,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCCCCCNC(=O)CCc1ccc(O)cc1)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,Imrecoxib,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCCCCCCNC(=O)CCc1ccc(O)cc1)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,Tucaresol,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](O)[C@@H](OC(=O)NCCNC(=O)CCc1ccc(O)cc1)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,Tinostamustine,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](O)[C@@H](OC(=O)NCCCCNC(=O)CCc1ccc(O)cc1)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,"5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione",
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](O)[C@@H](OC(=O)NCCCCCCNC(=O)CCc1ccc(O)cc1)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](OC(=O)NCCNC(=O)CCc1ccc(O)cc1)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](OC(=O)NCCNC(=O)CBr)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,Muraglitazar,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCN=C=S)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,4-O-methyl-alpha-D-glucuronic acid,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](OC(=O)NCCN=C=S)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acid,
C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1,,L002304,
O=C(O[C@@H]1C[C@@](O)(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C[C@H]21)c1ccc(O)cc1,,Naluzotan,
N#CN=C(NCCN)NCCCOc1cccc(CN2CCCCC2)c1,,Selenazole-4-carboxyamide-adenine dinucleotide,
CCCCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1,,TU-100,
C=CC(C)(C)c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,
COC(=O)[C@]12CCCN1C(=O)[C@H](NC(=O)OC(C)(C)C)CC2,,Pipemidic acid,
CCc1nc(NCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2ccccc2n1,,Everolimus,
O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1,,AZD-9056,
O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1,,Dalcetrapib,
CN(C)C[C@@H](c1ccc2ccccc2c1)[C@@H](O)C(C)(C)C,,Adenosine-5'-ditungstate,
CN(C)C[C@@H](c1ccc2ccccc2c1)[C@@H](O)c1ccccc1,,Sphingosine,
O=C(O)CCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1,,(6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine,
O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCC3CC3)CO2)cc1)c1cccnc1,,Zardaverine,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1,,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",
O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCc3ccccc3)CO2)cc1)c1cccnc1,,3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1,,Zanubrutinib,
CCOC(=O)CC(C)(C)NCC(O)COc1ccccc1C,,Formestane,
CCOC(=O)CCCNCC(O)COc1ccccc1,,Caspofungin,
COC(=O)CCNCC(O)COc1cccc2ccccc12,,Lobeline,
CCOC(=O)CCNCC(O)COc1ccccc1Cl,,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",
CCOC(=O)CCNCC(O)COc1cccc(Cl)c1,,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",
CCOC(=O)CCNCC(O)COc1ccccc1C,,Molidustat,
CCOC(=O)CCNCC(O)COc1cccc(C)c1,,Maduramicin,
CCOC(=O)CCNCC(O)COc1cccc(OC)c1,,Gadoversetamide,
CCOC(=O)CCNCC(O)COc1ccc(OC)cc1,,Acridine Carboxamide,
CCOC(=O)CNCC(O)COc1ccccc1C,,Cambinol,
CCOC(=O)CCCNCC(O)COc1ccccc1C,,Human blood group H type 1 trisaccharide,
O=C1NC(=S)SC1Cc1ccccc1,,GW-590735,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncncc1C(=O)O,,acetylleucyl-leucyl-norleucinal,
Cc1nc(C)c(CCN)s1,,142437-68-1,
COC(=O)C1=C(C)N=C(SC)NC1c1cccc([N+](=O)[O-])c1,,LG-100268,
O=C(O)CC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1,,Omeprazole,
O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1,,Deoxyuridine monophosphate,
O=C(O)CCCC/C=C(/c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1,,Anatibant,
CSc1nc(N)nc(SCc2ccc(Cl)cc2)n1,,Methicillin Acyl-Serine,
CC(C)(C)c1ccc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)O)cc4)cc32)cc1,,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,
COc1ccc(C2=CCC(C)(C)c3ccc(C#Cc4ccc(C(=O)O)cc4)cc32)cc1,,5-(2-CHLOROBENZYL)-2-FUROIC ACID,
Cc1ccc(C2=CC(C)(C)Sc3cc4ccc(-c5ccc(C(=O)O)cc5)cc4cc32)s1,,GLUTATHIONE SULFINATE,
CCCNS(=O)(=O)c1ccc2c3c(cccc13)C(=O)N2CC,,Deoxycholic acid,
O=CN(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,Norethindrone enanthate,
C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,,GSK461364,
O=S(=O)(Nc1cc(Cl)ccc1Cn1ccnn1)c1ccc(Cl)c(Cl)c1,,Limaprost,
O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCC3)cc2)C(=O)C1,,(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide,
CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1,,722544-51-6,
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,,761439-42-3,
CC(C)OC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]2CCC[N+]3(CCCCCC3)C2)cc1,,Equol,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1,,Olumacostat glasaretil,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid,
CCCCCCc1ccc2nc(C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)OC)cc(C(=O)O)c2c1,,Radafaxine,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1,,alpha-Pyrrolidinononanophenone,
CCCCCCCN(CCc1ccc(O[C@](C)(CC)C(=O)O)cc1)c1nc2ccccc2o1,,"(2r)-2-(4-{2-[1,3-Benzoxazol-2-Yl(Heptyl)amino]ethyl}phenoxy)-2-Methylbutanoic Acid",
O=C(O)COc1cc(Cl)ccc1C(=O)NCc1cccc([N+](=O)[O-])c1,,(5-Chloro-2-{[(3-Nitrobenzyl)amino]carbonyl}phenoxy)acetic Acid,
CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Nc3c(C)noc3C)cc2F)CC1,,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",
CC(C)Cn1c(=O)n(C)c(=O)c2c(-c3ccncc3)n(Cc3cccc4ccccc34)nc21,,"5-methyl-7-(2-methylpropyl)-2-(naphthalen-1-ylmethyl)-3-pyridin-4-yl-2H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione",
C[C@]1(Cc2ccc(Br)cc2)NC(=O)N(c2cc(Cl)cc(Cl)c2)C1=O,,(2S)-2-(3-Carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid,
CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1,,Methadone,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)CCCC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,Methyclothiazide,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@H](CCCN)[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,Fluciclovine (18F),
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCN(C)CC4)c3Cl)c2n1,,Cannabidiol,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCCCN)CC5)CCCC4)c3Cl)c2n1,,"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@H](CCCCN=C(N)N)[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,Carbidopa,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCSCC4)c3Cl)c2n1,,Fozivudine Tidoxil,
O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21,,chroman 28,
NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,"d[Cha4,Lys8]VP",
NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,"d[Cha4,Orn8]VP",
NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,"d[Cha4,Dab8]VP",
C[N+]1(C)CCC[C@H]1[C@H]1CS[C@](c2ccccc2)(C2CCCCC2)O1,,Phloretin,
C[N+]1(C)CCC[C@H]1[C@H]1CS[C@@](c2ccccc2)(C2CCCCC2)O1,,SP4160,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Abarelix,
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(N)=O,,Galantide,
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)O,,Galanin (1-16),
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,,Insulinotropin,
CC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@H](Cc2ccc(NC(C)=O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Acyline,
CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O,,R18 peptide,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)O,,U-62168E,
CC(=O)Nc1ccc(C[C@@H](NC(=O)[C@H](Cc2ccc(NC(=O)[C@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Alpha-L-Arabinose,
CC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@H](Cc2ccc(NC(N)=O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Sotirimod,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Nz-(1-Carboxyethyl)-Lysine,
CC(=O)Nc1ccc(C[C@@H](NC(=O)[C@H](Cc2ccc(NC(=O)[C@@H]3CC(=O)NC(=O)N3)cc2)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(CNC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Sulpiride,
CC(=O)NCc1ccc(C[C@@H](NC(=O)[C@H](Cc2ccc(NC(=O)[C@@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Pyronaridine,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C,,Esaxerenone,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(N)=O)C(C)C,,"Guanosine-2',3'-cyclophosphorothioate",
CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)O,,"9-Amino-2-deoxy-2,3-dehydro-n-acetyl-neuraminic acid",
CSCC[C@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(N)=O)C(C)C,,Fosfructose,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)CN)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C,,Fenbendazole,
CN(CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,Candoxatril,
Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,,SGX-523,
COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3S(=O)(=O)C4)CC2)cc1,,ML349,
CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",
O=C([O-])[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21,,clavulanic acid anion,
Nc1cccc2c1CCNC2,,115955-90-3,
Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21,,Pamapimod,
O=C(COc1ccc(C(=O)c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1,,AdipoRon,
O[C@@H]1CCCCC1N1CCC(c2ccccc2)CC1,,1214630-12-2,
Cc1cc(O)c(CN2CCCC2)c2c1C(=O)/C(=C/c1cc3ccccc3o1)O2,,929837-79-6,
c1nc2nc(Nc3ccc4c(c3)OCCO4)nc(Nc3ccc4c(c3)OCCO4)c2[nH]1,,4-(2-aminoethyl)-2-ethylphenol,
COc1cc(Nc2nc(N)nc3nc[nH]c23)cc(OC)c1,,Dexpramipexole,
CCOC(=O)c1cccc(Nc2nc(N)nc3nc[nH]c23)c1,,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",
Nc1nc(Nc2ccc(F)c(Cl)c2)c2[nH]cnc2n1,,"(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one",
COc1ccc(OC)c(Nc2nc(N)nc3nc[nH]c23)c1,,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",
Nc1nc(Nc2cccc(C(F)(F)F)c2)c2[nH]cnc2n1,,RPR131247,
CCCCN(C)Cc1c(O)cc(C)c2c1O/C(=C\c1cc3cc(Br)ccc3o1)C2=O,,Paricalcitol,
CSc1ccc(-c2nc3cnccn3c2NC2CCCCC2)cc1,,methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,
Nc1ccc2c(c1)N(C(=O)C1CC1)CCC2,,927996-40-5,
Cc1cccc2c(-c3ccccc3)c(C(=O)O)[nH]c12,,7-methyl-3-phenyl-1H-indole-2-carboxylic acid,
Clc1ccc(CNc2nc3ccccc3[nH]2)cc1,,BNC105,
Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,,Buparlisib,
CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3c(C)noc3C)cc2F)CC1,,GW-813893,
CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,,Milciclib,
COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,,Cobiprostone,
COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,,Guanosine-5'-Diphosphate,
Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,,Fedratinib,
COC(=O)[C@@H]1CCCCN1C(=O)C(=O)c1cc(OC)c(OC)c(OC)c1,,"[(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate",
CC(C)c1ccc(SCC(=O)O)cc1,,2-{[4-(propan-2-yl)phenyl]sulfanyl}acetic acid,
CC(C)c1ccc(SCC(=O)N2CCOCC2C(=O)O)cc1,,2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose,
COC(=O)C1COCCN1C(=O)C(F)(F)Sc1ccc(C(C)C)cc1,,"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",
CC(C)c1ccc(CCC(=O)N2CCOCC2)cc1,,Rhamnose,
CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,937174-76-0,
CCN1CNS(=O)(=O)c2cc(F)ccc21,,Fluoroestradiol F-18,
CNC(=O)c1cnn2c(O)cc(-c3ccccc3)nc12,,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE",
C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,,H3B-8800,
CCCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1,,GI-181771X,
CCCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1,,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",
C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1,,Reactive Red 1 Dye,
C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,,Uridine-5'-diphosphate-mannose,
COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,,Flunisolide,
C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1,,Imidapril,
C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1,,2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol,
CCc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,Prephenic acid,
Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1,,L-Histidine Beta Naphthylamide,
CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,"[Mpa1, D-Tic2, Aib7]OT",
C[C@@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1,,Celiprolol,
C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1,,Cytidine-5'-Diphosphate,
CCCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1,,"N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",
Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1,,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,"[Mpa1, L-Tic7]OT",
CCCC(=O)N1CCC(C(=O)N(C)Cc2cc(Cl)cc(-c3cc(-c4cc(C(F)(F)F)ccc4Cl)c(C#N)c(=O)[nH]3)c2O)CC1,,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1COC(=S)NC1CC1)[C@@H](C)O,,Ethenzamide,
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)COC(=O)NC(C)(C)C)[C@@H](C)O,,Umbralisib,
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)COC(=O)NC12CC3CC(CC(C3)C1)C2)[C@@H](C)O,,(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate,
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1cccc2cccnc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)COC(=O)NC(C)(C)C)[C@@H](C)O,,CHROMOPHORE (ASP-TYR-GLY),
CCCN(CCC)C(=O)c1ccccc1C(=O)O,,"N,N-Dipropyl-phthalamic acid",
NC(=O)c1cccnc1N1CCNCC1,,87394-64-7,
Cc1cccc(OCCSc2nc3ccccc3n2CC(=O)O)c1C,,3'-deoxyguanosine,
Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)O)c(C)c1,,Pravastatin,
COc1cc(/C=C2\Sc3ccccc3C2=O)ccc1OCC(=O)O,,4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid,
Cc1ccc(/C=C/c2nc(N)nc(-c3ccccc3O)n2)o1,,Anecortave,
O=C(O)c1sc2cc(-n3c(-c4ccccc4)n[nH]c3=S)ccc2c1Cl,,Vaniprevir,
Cc1ccc(-c2n[nH]c(=S)n2-c2ccc3c(Cl)c(C(=O)O)sc3c2)cc1,,6-bromoindirubin-3'-oxime,
O=C(O)C1CCN(C(=O)c2cc(-c3ccc(Cl)s3)nc3ccccc23)CC1,,Clocortolone,
Cc1c(C(=O)Nc2cccnc2)cnn1-c1ccccc1,,Oxypertine,
CCCCc1nc2cccc(C(=O)OC)c2n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1,,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,
NS(=O)(=O)c1ccc2nc3n(c2c1)N=S=C3N1CCOCC1,,FG-9041,
CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,,957054-30-7,
CN1CCCc2ccccc2Cc2ccc(O)cc2CC1,,L-threonic acid,
CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2cnccc12,,A778317,
COc1cc(CCc2ccccc2)c(C(=O)O)c(O)c1CC=C(C)C,,80489-90-3,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(Cl)ccc1Cl,,Ethanolamine,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CC2CCCNC2)ccc1Cl,,Succinobucol,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CC2CCNCC2)ccc1Cl,,Bazedoxifene,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CN2CC3CNCC(C2)O3)ccc1Cl,,"(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide",
COc1cc(C=O)ccc1Oc1ccccc1,,3-methoxy-4-phenoxybenzaldehyde,
C[C@]12CC[C@@H]3[C@H]4CCC(=O)CC4CC[C@H]3[C@@H]1CC[C@@H]2O,,19-nor-dihydrotestosterone,
O=C(O)Cc1cccc(CC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,alpha-Fluoro-carboxymethyldethia coenzyme A complex,
CCCCCCCN(CCc1ccc(OC(C)(C)C(=O)O)cc1)c1nc2ccccc2o1,,Benzylparaben,
Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1,,Piritrexim,
O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1,,S-Methyl Thiocysteine Group,
CN(CC(CCN1CCC(O)(c2ccccc2)CC1)c1ccc(Cl)c(Cl)c1)C(=O)c1ccccc1,,Synephrine,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=S)NCCCCC2CCCCC2)co1,,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",
O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)C(Cl)Cl,,Fenobam,
CCCCCCC(C(=O)O)n1cnc(NC(=O)c2cccc(O)c2C(=O)O)c1,,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,
Nc1cccc(-c2nnc(-c3cccs3)o2)c1,,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,
Cn1nccc1-c1cc[nH]n1,,"2'-methyl-1H,2'H-3,3'-bipyrazole",
COc1ccc(CN(CCN(C)CCN)c2ccccn2)cc1,,Dexniguldipine,
O=C(NCCCCC1CCCCC1)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCCO)n1,,Orantinib,
O=C(O)Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,Medetomidine,
O=C(O)COc1ccccc1CC1C2CCC(O2)C1C=NNC(=O)Nc1ccccc1,,Acebilustat,
O=C(O)Cc1cccc(CCC2C3CCC(O3)C2C=NNC(=O)Nc2ccccc2)c1,,Sumatriptan,
CSC(=N)NCCCc1cnc[nH]1,,Serdemetan,
COc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1,,"3,4-Dihydro-5-Methyl-Isoquinolinone",
O=C(O)c1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,Lauryl alcohol diphosphonic acid,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCC2CCCCC2)co1,,2-heptyl-4-hydroxyquinoline N-oxide,
CC(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Lynestrenol,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccccc2)co1,,Felypressin,
O=C(O)Cc1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,Spironolactone,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(F)cc2)co1,,Fiacitabine,
CCC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Cidofovir,
CS(=O)(=O)NC(=O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,PCS-499,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccccc2)co1,,Pyroxamide,
CCCCCN(C)C(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Capreomycin,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(O)cc2)co1,,Afimoxifene,
CC(C)(C)CCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Alanyl glutamine,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)CCCCCC2CCCCC2)co1,,CP1-1189,
Brc1cccc(-c2cnc3ccccc3c2)c1,,3-(3-bromophenyl)quinoline,
C[C@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12,,"(3S,4S)-Tofacitinib",
O=c1[nH]c2ncccc2cc1O,,"3-hydroxy-1,2-dihydro-1,8-naphthyridin-2-one",
CCCCNC=Nc1ccc(-c2c[nH]cn2)cc1,,D-Galctopyranosyl-1-On,
CCC(C)NC=Nc1ccc(-c2c[nH]cn2)cc1,,Aminopterin,
CC(C)CNC=Nc1ccc(-c2c[nH]cn2)cc1,,TG-100801,
CC(C)NCC(O)COc1ccc(CCSCC2CCC2)cc1,,BMS-599626,
CC(=O)NCCNCC(O)COc1ccc(CCOCC2CCC2)cc1,,Nateglinide,
CCn1c2ccccc2c2cc(/C=C/c3ccc4ccccc4[n+]3CCCCS(=O)(=O)[O-])ccc21,,Sul-33,
NC(=O)c1ccc(-c2cccc(F)c2)nc1,,6-(3-Fluorophenyl)pyridine-3-carboxamide,
COc1cccc(NC(=O)CC23CC4CC(CC(C4)C2)C3)c1C,,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",
COc1ccc(Cn2ccc(C)c(NC(=O)C(Cc3ccc(CC(=O)O)cc3)NC(=O)Cc3cccc4ccccc34)c2=O)cc1,,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",
CCc1cccc(-c2ccc(C(=O)O)cc2)c1,,PF-477736,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1C=NNC(=O)Nc1ccccc1,,Morinidazole,
COCCCN1Cc2cccc(C(N)=O)c2C1=O,,compound 10b [PMID: 26222319],
Cc1ccc(-n2nc3c(=O)n(CCCC(=O)NCC(C)c4ccccc4)nc(C)c3c2C)cc1,,Deltazinone,
CC(=O)c1ccc(N2CCN(S(=O)(=O)c3ccc4c(c3)CC(=O)N4)CC2)cc1,,(S)-alpha-methyl-4-carboxyphenylglycine,
CN(C)CCOc1ccc2ccccc2c1C=O,,Chlormadinone,
COc1ccccc1NC(=O)CSc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1,,1-hydroxy-2-isopropylguanidine,
N#Cc1c(-c2ccc(Cl)cc2)nc(SCC(=O)Nc2ccc(Cl)cc2)[nH]c1=O,,LSZ-102,
Cc1ccccc1NC(=O)CSc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1,,L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,
Cc1ccc(NC(=O)CSc2nc(-c3ccc(Cl)cc3)c(C#N)c(=O)[nH]2)cc1C,,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",
CC(C)c1ccc(NC(=O)CSc2nc(-c3ccc(Cl)cc3)c(C#N)c(=O)[nH]2)cc1,,Marizomib,
CC(C)(CNS(C)(=O)=O)c1nc(-c2ccncc2)c(-c2ccc(Cl)c(O)c2)[nH]1,,Cefaloridine,
C/C(CCN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCCN1CCOCC1,,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",
CC(C)(C)NCC(O)COC(C1CC1)C1CC1,,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,
CN1C(=O)CNc2ccccc21,,20934-50-3,
O[C@H](COc1ccccc1)[C@@H]1CCCCN1,,Fluoroazomycin arabinoside F-18,
O[C@H](COc1cccc2ccccc12)[C@@H]1CCCCN1,,Cerulenin,
O[C@H](COc1ccc2ccccc2c1)[C@@H]1CCCCN1,,N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide,
Cc1ccc(OC[C@@H](O)[C@@H]2CCCCN2)cc1,,Fluspirilene,
Cc1cccc(OC[C@@H](O)[C@@H]2CCCCN2)c1,,Paromomycin,
O[C@H](COCc1ccccc1)[C@@H]1CCCCN1,,Meropenem,
O[C@H](COCCCc1ccccc1)[C@@H]1CCCCN1,,Arabinouridine 3'-phosphate,
O=C1CCC(CCN2CCC(O)(c3ccccc3)CC2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,Bronopol,
NC(=O)N1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,"5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide",
NS(=O)(=O)N1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Tachykinin angatonist 1,
O=C(O)C1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Domoic Acid,
NC1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,K-00546,
CS(=O)(=O)NC1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Streptomycin,
Cc1cc(-c2ccc3c4c(cccc24)COC3)nc(N)n1,,2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate),
CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Isopropyl alcohol,
Nc1nc2c(ncn2C2CC(O)C(COP(=O)([O-])[O-])O2)c(=O)[nH]1,,Oxaloacetate Ion,
CCCCCCCCc1cccc(CCCCCCCC)n1,,Licogliflozin,
CCN(CC)CCOc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2c(Cl)cccc2Cl)C3)cc1,,D-Eritadenine,
CCCCCCCOc1ccc(C(=O)[O-])cc1,,4-(heptyloxy)benzoate,
NCc1ccc(-c2nc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)[nH]2)cc1,,(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE,
CC(C)(CN)c1nc(-c2ccncc2)c(-c2ccc(Cl)c(O)c2)[nH]1,,MMV030084,
CC(C)(CNC(=O)Nc1ccc(Cl)cc1)c1nc(-c2ccncc2)c(-c2ccc(Cl)c(O)c2)[nH]1,,"N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",
CC(=C/C(=O)O)/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C,,N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,
Oc1cc(-c2[nH]cnc2-c2ccncc2)ccc1Cl,,Triamterene,
O=C(c1cccc(O)c1)c1ccc(O)cc1O,,"(2,4-Dihydroxyphenyl)(3-Hydroxyphenyl)methanone",
Fc1ccccc1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Dihydrotachysterol,
O=C(O)c1cc(Br)cc(-c2ccccc2)c1O,,99514-99-5,
COc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2,,Nitrocefin,
Nc1ccc2c(Br)cccc2n1,,5-BROMOQUINOLIN-2-AMINE,
Cn1cc(CC(N)C(=O)[O-])c2ccccc21,,"1-Methyl-L-tryptophan, 8",
CC(C)N1CCC(C)(C)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",
CCOc1ccc(C(C)=O)cc1NC(=O)c1cc(COC)cc(C(=O)O)c1,,Icaridin,
CC(C)c1csc(CCc2ccn3c(=O)c(-c4nnn[nH]4)cnc3c2)n1,,"(2S)-2-amino-6-[[(3R,4R)-1-[(1S)-1-carboxy-2-[(S)-methylsulfinyl]ethyl]-2-oxo-4-sulfanylazetidin-3-yl]amino]-6-oxohexanoic acid",
CC(C)c1csc(COc2ccn3c(=O)c(-c4nnn[nH]4)cnc3c2)n1,,Silver sulfadiazine,
Brc1cccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)c1,,4-(4-Chlorophenyl)Imidazole,
O=[N+]([O-])c1ccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)cc1,,TAS-117,
O=[N+]([O-])c1cccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)c1,,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,
O=S(=O)(Oc1ccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)cc1)c1ccccc1,,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",
O=C(O)CCCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1,,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,
O=c1[nH]c2ccc(F)cc2cc1O,,6-Fluoro-3-hydroxyquinolin-2(1H)-one,
Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(NC3CCOCC3)nc21,,Bb-3497,
Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1C(F)(F)F,,Fevipiprant,
CC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)C(C)C)C(C)C,,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",
COc1ccc(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,Danoprevir,
O=P([O-])([O-])O[C@H]1[C@@H](O)[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@@H]1OP(=O)([O-])[O-],,"1L-myo-inositol 1,2,3,4,6-pentakisphosphate(10-)",
C[C@@H]1C[C@H]2C[C@@H](O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21,,7642-54-8,
O=C(O)[C@@H]1O[C@H]2CN(Cc3ccccc3)C(=O)[C@@H]1O2,,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,
CCc1nc(N)nc(NCCc2ccccc2NC(=O)c2ccc(N)c(OC)c2)c1-c1ccc2c(c1)N(CCCOC)C(=O)C(C)(C)O2,,THIO-ATPA,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1,,2-propenyl-N-acetyl-neuramic acid,
CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2c3ccccc3CN2C(=O)[C@@H](N)CCCCN)cc1,,"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN[C@@H]1C2,,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,
O=C(O)c1ccc(Oc2ccc(Cl)cc2Cl)c(O)c1,,Ipratropium,
O=Cc1ccc(Oc2ccc(Cl)cc2Cl)c(O)c1,,"4-(2,4-dichlorophenoxy)-3-hydroxybenzaldehyde",
OCc1ccc(Oc2ccc(Cl)cc2Cl)c(O)c1,,"2-(2,4-dichlorophenoxy)-5-(hydroxymethyl)phenol",
COc1cc(C(=O)O)ccc1Oc1ccc(Cl)cc1Cl,,Beta-(2-Naphthyl)-Alanine,
CC[C@@H](C)[C@H](N)C(=O)N1Cc2ccccc2C1P(=O)(Oc1ccc(NC(C)=O)cc1)Oc1ccc(NC(C)=O)cc1,,Rebamipide,
O=C(O)Cn1cc(CCN(Cc2ccccc2)S(=O)(=O)c2ccc(F)cc2)c2ccccc21,,MK-6325,
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,Olaparib,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(C2CCNCC2)ccc1Cl,,"2,6-Diaminopimelic Acid",
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(NC2CCNCC2)ccc1Cl,,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CN2C[C@@H]3C[C@H]2CN3)ccc1Cl,,Cabazitaxel,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1c(Cl)cccc1OC1CCNCC1,,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",
Cc1oc(CN2CCNCC2)cc1C(=O)NCC12CC3CC(CC(C3)C1)C2,,Phenacemide,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1nc(OC2CCCNC2)ncc1Cl,,IPI-493,
NCCNC(=O)CCCCC[n+]1c(/C=C/c2c(-c3ccccc3)[nH]c3ccccc23)ccc2ccccc21,,ATP,
N#Cc1c(-c2ccccc2)cc(-c2ccccc2O)[nH]c1=O,,Aloxiprin,
NCCc1cnc(-c2cccc(Br)c2)[nH]1,,2-(3-Bromophenyl)histamine,
COc1ccc(-c2cc(C(=O)O)nn2-c2ccc(C)cc2)cc1,,5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid,
CCCCCc1cc(OC)c(CC=C(C)C)c(O)c1C(=O)O,,Amorfrutin 2,
COc1cc(C(=O)Nc2ccccc2-c2cn3c(CN4CCNCC4)csc3n2)cc(OC)c1OC,,925432-73-1,
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,,918505-84-7,
CO[C@H]1[C@@H](N(C)C(=O)c2ccccc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,Benzoylstaurosporine,
CNC(=O)c1ccccc1OC1CCOCC1,,N-Methyl-2-(Tetrahydro-2h-Pyran-4-Yloxy)benzamide,
O=C(O)c1cc(-c2ccccc2)n(-c2ccc(Cl)c(Cl)c2)n1,,3-(4-nitrophenyl)-1H-pyrazole,
Cc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,Uproleselan,
COc1ccc(-c2cc(C(=O)O)nn2-c2cccc(Cl)c2)cc1,,MAX-40279,
COc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)cc2)cc1,,p-Aminophenol,
COc1cc(CCc2ccccc2)c(C(=O)O)c(O)c1C/C=C(\C)CCC=C(C)C,,Amorfrutin B,
O=P([O-])([O-])O[C@H]1[C@@H](O)[C@@H](OP(=O)([O-])[O-])[C@H](O)[C@@H](OP(=O)([O-])[O-])[C@@H]1OP(=O)([O-])[O-],,"1D-myo-inositol 1,3,4,5-tetrakisphosphate(8-)",
C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2=O)cc1,,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",
CC(C)c1ccc(S(=O)(=O)CC(=O)N2CCOCC2C(=O)OCCCc2ccc[n+]([O-])c2)cc1,,Tribenuron Methyl,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(N)=S)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",
CNC(=S)N[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CO)O[C@@H](OC)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H]1O,,Glycochenodeoxycholic Acid,
C=CCNC(=S)N[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CO)O[C@@H](OC)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H]1O,,"1,2-Dihydroxynaphthalene",
CCCCNC(=S)N[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CO)O[C@@H](OC)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H]1O,,Leukotriene C4,
CCN(CC)C(=S)N[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CO)O[C@@H](OC)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H]1O,,Selonsertib,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)NCCO)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,Pyridoxal phosphate,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)NCCCO)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,Ceftaroline fosamil,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)Nc3ccccc3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,Amoxicillin,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)NC3CCCCC3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,4-hydroxybenzoyl-CoA,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)N3CCOCC3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,"UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE",
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)N[C@@H]3[C@@H](O)[C@H](O[C@@H]4[C@@H](CO)O[C@@H](OC)[C@H](NC(C)=O)[C@H]4O)O[C@H](CO)[C@@H]3O)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](NC(=O)c2ccc(C)cc2)[C@H]1O[PH](=O)O,,Galactose-Derived Compound 13,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](NC(=O)c2ccc(C)cc2)[C@H]1OP(=O)(O)O,,Galactose-Derived Compound 14,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](NC(=O)c2ccc(C)cc2)[C@H]1OP(=O)(O)OCc1ccccc1,,Methyl 2-O-[(S)-(Benzyloxy)(Hydroxy)phosphoryl]-3-Deoxy-3-{[(4-Methylphenyl)carbonyl]amino}-1-Thio-Beta-D-Galactopyranoside,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](NC(=O)c2ccc(C)cc2)[C@H]1OC(C)=O,,Galactose-Derived Compound 16,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](NC(=O)c2ccc(C)cc2)[C@H]1OCc1ccccc1,,Galactose-Derived Compound 17,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](NC(=O)c2ccc(C)cc2)[C@H]1O,,Galactose-Derived Compound 18,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1OS(=O)(=O)O,,Galactose-Derived Compound 20,
Cc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(-c3cccc(Nc4c(NC5CC5)c(=O)c4=O)c3)cc2)C(=O)O)c(C)c1,,Imidazole,
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3cc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc23)cc1[N+](=O)[O-],,"2,6-Diamino-Hexanoic Acid Amide",
COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1,,Rigosertib,
CCC1(CC)C(=O)N(c2ccc(Cl)cc2)C1=O,,Phloretic acid,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O,,Phloxine B,
CCCCn1c(=O)c2cccnc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,2-Hydroxy-Tryptophan,
CCCCn1c2ncccc2c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,BA-2664,
N#Cc1c(NCc2ccccc2)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12,,3-Mercuri-4-Aminobenzenesulfonamide,
O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,,Pitavastatin calcium,
O=C(Nc1ccc(Cl)cn1)[C@H]1CN(CC(F)F)C[C@@H]1C(=O)Nc1ccc(-n2ccccc2=O)cc1F,,H5XZ7LKC6C,
CC1(C)O[C@H]2[C@@H]3OC4(CCCC4)O[C@@H]3CO[C@@]2(CNS(N)(=O)=O)O1,,Oxitriptan,
CC1(C)O[C@H]2[C@@H]3OCO[C@@H]3CO[C@@]2(CNS(N)(=O)=O)O1,,Atabecestat,
CC1(C)O[C@H]2[C@@H]3OC4(CCCCC4)O[C@@H]3CO[C@@]2(CNS(N)(=O)=O)O1,,Lamotrigine,
C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,,MK-1775,
CCCCCCCOc1ccc(CC(=O)[O-])cc1,,2-[4-(heptyloxy)phenyl]acetate,
CCCCCCCOc1ccc(C(=O)[O-])cc1OC,,"benzoic acid derivative, 11",
CCCCCCCOc1ccc(C(=O)[O-])cc1[N+](=O)[O-],,"benzoic acid derivative, 12",
CCCCCCCOc1cccc(C(=O)[O-])c1,,3-(heptyloxy)benzoate,
CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,,SB-649868,
CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C,,4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol,
CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(CCCCN)C(=O)CN(Cc1ccco1)C(=O)CN(CCCCN)C(=O)CNCCc1c[nH]c2ccccc12,,N-(carboxycarbonyl)-D-phenylalanine,
CC1(CNC(=O)c2ccc(C#Cc3ccccc3)cc2)NC(=O)NC1=O,,CS22,
CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,,Quizartinib,
COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O,,"(3R)-3-[3,5-Bis(trifluoromethyl)anilino]-2-cyano-3-sulfanylpropanamide",
CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,,PP242,
Cc1cc(C)c2cc1C(=O)NCCCCCNC(=O)CCSc1cc-2nc(N)n1,,Bismuth subcitrate potassium,
O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNCc1ccc(I)cc1)C(=O)O)C(=O)O,,Iofolastat,
O=C1COc2c(CCNCCN(C(=O)CCNCCc3ccc(Cl)c(Cl)c3)C3CCCCC3)ccc(O)c2N1,,AZ505,
CCN[C@H]1CN(CCCO[N+](=O)[O-])S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,Sorbitan,
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc(CP(=O)(O)O)cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,
O=C(Nc1ccccc1)N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1,,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",
COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O,,Pilaralisib,
Cc1c(CCO)sc[n+]1Cc1ccc(C(F)(F)F)nc1N,,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cc(Cl)cc(Cl)c3)ccc2n1,,Tropicamide,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1,,Hydrocortamate,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccc(Cl)cc3)ccc2n1,,"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide",
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3)ccc2n1,,Colchicine,
CC(C)OC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]2CCC[N+](C)(Cc3cccc(O)c3)C2)cc1,,Carnosine,
Cc1cn2cc(CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)Nc3ccc(C(=O)OC(C)C)cc3)[n+](Cc3ccc4ccccc4c3)c2s1,,Dronabinol,
Cc1cn2cc(CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)Nc3ccc(C(=O)OC4CCCCC4)s3)[n+](Cc3ccc4ccccc4c3)c2s1,,"4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid",
Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O,,3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,
O=C(Cc1csc2ccc(Cl)cc12)N1CCC[C@H](c2ccccc2)[C@@H]1CN1CCCC1,,3'-phospho-5'-adenylyl sulfate,
CCCCNc1nccc2[nH]c3ccccc3c12,,"(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID",
CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,,L-Glycero-D-Manno-Heptopyranose,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Cetrorelix,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O,,NEUROTENSIN,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,SYN-1327,
O=C(Nc1ccccc1N1CCNCC1)c1csc(-c2ccc3c(c2)CCO3)n1,,"1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE",
Clc1cc2c(cc1Cl)C(Nc1nc3ccccc3[nH]1)CCC2,,NS11757,
COC(=O)c1c(Cc2ccc(C(=O)NCCO)cc2)c(=O)c2ccc(Cl)cc2n1-c1ccccc1,,Oxametacin,
O=C(C[C@@H]1C/C=C/CCC(=O)O[C@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,Robotnikinin,
CCCCc1nc2cc(NC(=O)CC)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Fosphenytoin,
CCCCc1nc2cc(NC(=O)c3ccccc3Cl)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Rebeccamycin,
CCCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Adenylosuccinic acid,
CC[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1,,1-[(2r)-2-Aminobutanoyl]-N-(4-Carbamimidoylbenzyl)-L-Prolinamide,
Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccc(F)cc3F)c2n(C)c1=O,,Balsalazide,
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,,Ruxolitinib,
Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1,,Lck inhibitor 2,
NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,ARC-1034,
CN(C)CCCNC(=O)c1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,,Grazoprevir,
COc1cccc(C(=O)O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](OC(=O)c4cccc(OC)c4)[C@H]3O)[C@@H]2O)c1,,Sobrerol,
O=C(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](OC(=O)c3cccc4ccccc34)[C@H]2O)[C@@H]1O)c1cccc2ccccc12,,H TYPE II TRISACCHARIDE,
NC(=NCCCc1cnc[nH]1)NC(=O)CC(c1ccc(F)cc1)c1ccccn1,,Oxo-arpromidine,
NC(=NCCCc1cnc[nH]1)NC(=O)CC(c1ccc(F)c(F)c1)c1nccs1,,"N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",
CC(CC(=O)NC(N)=NCCCc1cnc[nH]1)c1ccccc1,,AC-(D)PHE-PRO-BOROHOMOLYS-OH,
CC(C(=O)NC(N)=NCCCc1cnc[nH]1)C1CCCCC1,,UR-AK59,
NC(=NCCCc1cnc[nH]1)NC(=O)C1CCCCC1,,UR-AK46,
NC(=NCCCc1cnc[nH]1)NC(=O)CCCC1CCCCC1,,UR-AK64,
Cc1nc[nH]c1CSCC(=O)NC(N)=NCCCc1cnc[nH]1,,UR-PG146,
NC(=NCCCc1cnc[nH]1)NC(=O)CC(c1ccccc1)c1ccccc1,,Beta-Amino Isobutyrate,
NC(=NCCCc1cnc[nH]1)NC(=O)CC(c1ccccc1)c1ccccn1,,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,
NC(=NCCCc1cnc[nH]1)NC(=O)CC(c1ccccc1)c1nccs1,,Methylestrenolone,
CC(C(=O)NC(N)=NCCCc1cnc[nH]1)c1ccccc1,,UR-AK68,
NC(=NCCCc1cnc[nH]1)NC(=O)CCc1ccccc1,,Penbutolol,
NC(=NCCCc1cnc[nH]1)NC(=O)CC1CCCCC1,,UR-AK62,
COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC,,BIX-01294,
Cc1cc(CN2CCN(c3c(Br)cnc4nc(-c5ccc(N6CCN(C)CC6)cc5)[nH]c34)CC2)no1,,1095382-05-0,
c1ccc(C2CCCN2c2nc3ccccc3[nH]2)cc1,,"(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one",
c1ccc2c(c1)CCN(c1nc3ccccc3[nH]1)C2,,"(2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",
Clc1cccc2c1C(Nc1nc3ccccc3[nH]1)CCC2,,Mosapride,
Clc1ccc2c(c1)C(Nc1nc3ccccc3[nH]1)CCC2,,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",
Clc1cccc2c1CCCC2Nc1nc2ccccc2[nH]1,,Fradafiban,
Brc1ccc2c(c1)C(Nc1nc3ccccc3[nH]1)CCC2,,Lincomycin,
COc1ccc2c(c1)C(Nc1nc3ccccc3[nH]1)CCC2,,S-2-(Boronoethyl)-L-Cysteine,
c1ccc2c(c1)OCCC2Nc1nc2ccccc2[nH]1,,(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid,
c1ccc2c3c(ccc2c1)CCCC3Nc1nc2ccccc2[nH]1,,Reidispongiolide C,
c1ccc(C2CCCCN2c2nc3ccccc3[nH]2)cc1,,7-methyl-guanosine-5'-triphosphate-5'-guanosine,
c1ccc2c(c1)CCC(Nc1nc3ccccc3[nH]1)C2,,L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,
Clc1ccc2c(c1)CCCC2Nc1nc2ccccc2[nH]1,,Elenbecestat,
Fc1ccc2c(c1)C(Nc1nc3ccccc3[nH]1)CCC2,,"N-(3,5-dibromo-4-hydroxyphenyl)benzamide",
c1ccc2c(c1)SCCC2Nc1nc2ccccc2[nH]1,,Tirapazamine,
c1ccc(-c2ccc3c(c2)C(Nc2nc4ccccc4[nH]2)CCC3)cc1,,PF-04447943,
COc1ccc(Nc2nc3cc(C(=O)O)ccc3n2Cc2ccccc2OC)cc1,,"KSP Inhibitor, 4d",
COc1ccc(Nc2nc3cc(C(=O)O)ccc3n2Cc2ccccc2C(F)(F)F)cc1,,Labetalol,
NC(=O)c1ccc2c(c1)nc(Nc1ccc(S(N)(=O)=O)cc1)n2Cc1ccccc1C(F)(F)F,,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",
COc1ccc(Nc2nc3cc(C(=O)O)ccc3n2Cc2ccccc2OC(F)(F)F)cc1,,"KSP Inhibitor, 4g",
O=C(O)c1ccc2c(c1)nc(Nc1ccc(OCc3ccccc3)cc1)n2Cc1ccccc1C(F)(F)F,,"KSP Inhibitor, 4c",
CS(=O)(=O)c1ccc(Nc2nc3cc(C(N)=O)ccc3n2Cc2ccccc2C(F)(F)F)cc1,,Mephenytoin,
CC1(C)OC(=O)NC1=O,,dimethadione,
CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1,,1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea,
CCN[C@H]1C[C@H](CCO[N+](=O)[O-])S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,Mesobiliverdin IV alpha,
Cc1cc(C)c2cc1C(=O)NCCNC(=O)CCCSc1cc-2nc(N)n1,,Aspartic acid,
Cc1cc(C)c2cc1C(=O)NCCCCNC(=O)CCSc1cc-2nc(N)n1,,Moexiprilat,
Nc1nc2cc(n1)-c1cc(c(Cl)cc1Cl)OCCCCOc1cccc(c1)S2,,Zolmitriptan,
CCOc1cc(C)c2cc1C(=O)NCCCOc1cccc(c1)Sc1cc-2nc(N)n1,,Mannose,
COc1cc(C)c2cc1C(=O)NCCCOc1cccc(c1)Sc1cc-2nc(N)n1,,Benzodiazepine,
Cc1cc(C)c2cc1C(=O)NCCNC(=O)OCCSc1cc-2nc(N)n1,,Vintafolide,
Cc1cc(C)c2cc1C(=O)NCCCCOc1cccc(c1)Sc1cc-2nc(N)n1,,Amylmetacresol,
Cc1ccc(C(=O)O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](OC(=O)c4ccc(C)cc4)[C@H]3O)[C@@H]2O)cc1,,Baloxavir,
O=C(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](OC(=O)c3ccc4ccccc4c3)[C@H]2O)[C@@H]1O)c1ccc2ccccc2c1,,DL-dimyristoylphosphatidylcholine,
O=C(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](OC(=O)c3ccccc3)[C@H]2O)[C@@H]1O)c1ccccc1,,Davunetide,
C[C@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,,"(3R,4S)-Tofacitinib",
CCC(=O)NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1,,Eszopiclone,
CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,,GSK1838705A,
NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Teriflunomide,
NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",
NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,ARC-1012,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,Ferrous aspartate,
C[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,ARC-1039,
C[C@@H](NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,Voxilaprevir,
Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NCCCCCC(=O)O)[C@@H](O)[C@H]1O,,5-(2-chlorophenyl)furan-2-carbohydrazide,
NC(=O)CCCNC(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Tridolgosir,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O,,Ecgonine,
NCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Metildigoxin,
NCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",
NCCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Methyl alpha-galactoside,
NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Apomine,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,"3,4-Dihydro-2'-deoxyuridine-5'-monophosphate",
NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,Briciclib,
NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Bucladesine,
NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Eldecalcitol,
NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCCCNC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,6-hydroxymethylpterin diphosphate,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O,,Declopramide,
NCCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,"2,3-Didehydroalanine",
NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,N-[4-(benzyloxy)phenyl]glycinamide,
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(OC)cc32)c1C,,"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",
CC(C)(C)OC(=O)NC12CC3(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(C3)C1)C2,,Rupintrivir,
CC(C)(C)OC(=O)NCCCCCC(=O)NC12CC3(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(C3)C1)C2,,Boc-AdamGPI Trimer,
O=P([O-])([O-])O[C@H]1[C@@H](O)[C@@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@@H]1OP(=O)([O-])[O-],,"1D-myo-inositol 3,4,5,6-tetrakisphosphate(8-)",
O=P([O-])([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@@H](O)[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H]1O,,"myo-inositol 1,3,4,6-tetrakisphosphate(8-)",
Cc1ccc2[nH]cc(CC([NH3+])C(=O)[O-])c2c1,,"5-Methyl-L-tryptophan, 2",
CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1,,Danazol,
CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc([N+](=O)[O-])c2)n1,,Minocycline,
CN(Cc1ccc(F)c(C(F)(F)F)c1)C(=O)C(C)(CCN1CCC(N2CCCC2=O)CC1)c1ccc(Cl)c(Cl)c1,,"N-[3-[4-(3-aminopropyl)piperazin-1-yl]propyl]-3-[(2-thiophen-2-ylacetyl)amino]-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzamide",
CC(=O)N(C)C1CCN(CCC(C)(C(=O)N(C)Cc2ccc(F)c(C(F)(F)F)c2)c2ccc(Cl)c(Cl)c2)CC1,,OXI-4503,
Cc1cc2c(C(=O)Cc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)Cc3ccccc3)c(O)c(O)cc2c1O,,CRA_23653,
[NH3+]C(Cc1c[nH]c2ccc(O)cc12)C(=O)[O-],,2-ammonio-3-(5-hydroxy-1H-indol-3-yl)propanoate,
Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,,Apitolisib,
CC(=O)NCCCCC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(N)=O,,MK-3118,
Nc1ncnc2c1nc(NCc1ccc3ncccc3c1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,"(2r,3r,4s,5r)-2-(6-Amino-8-((Quinolin-7-Ylmethyl)amino)-9h-Purin-9-Yl)-5-(Hydroxymethyl)tetrahydrofuran-3,4-Diol",
O=C(O)[C@@H]1O[C@H]2CN(Cc3ccc(-c4ccccc4)cc3)C(=O)[C@@H]1O2,,Ethylaminobenzylmethylcarbonyl Group,
CCOC(=O)C1CCN(C(=O)NO)CC1,,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",
CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1ccc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)cc12,,Minodronic acid,
C[C@H]1CN(S(=O)(=O)C[C@]23CC[C@H](C[C@@H]2O)C3(C)C)CCN1c1ncc(C(F)(F)F)cc1F,,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",
Cc1ccc(CC(=O)c2c(O)c(O)cc3c(O)c(-c4c(C)cc5c(C(=O)Cc6ccc(C)cc6)c(O)c(O)cc5c4O)c(C)cc23)cc1,,D-Xylulose,
CCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C(c1ccccc1)c1ccccc1,,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,
COc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,,"9-Cyclopentyl-2-(4-(4-hydroxypiperidin-1-yl)-2-methoxyphenylamino)-5-methyl-8,9-dihydro-5H-pyrimido[5,4-b][1,4]diazepin-6(7H)-one",
CC(C)(C)NC[C@@H](O)COc1ccccc1-c1ccccc1,,"Berlafenone, (R)-",
CCOc1ccccc1NC(=O)c1ccoc1,,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,
Cc1nc(-c2ccc3c(c2)CCN3S(=O)(=O)c2ccc(CCC(=O)O)cc2)cs1,,Cloxazolam,
O=C(c1cnc2ccccc2n1)N1CCCC1,,Pazufloxacin,
C[C@@H](CN[C@H](c1ccc(F)c(F)c1)P(=O)(O)O)c1ccccc1,,Fosinoprilat,
C[C@H](CN[C@H](c1ccc(F)cc1)P(=O)(O)O)c1ccccc1,,PF-04217903,
Cc1ccnc(NC(=O)C2CCNCC2)c1,,N-(4-methylpyridin-2-yl)piperidine-4-carboxamide,
Fc1ccccc1CNc1ccc2ccccc2n1,,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,
O=C(O)c1cc(-c2ccco2)n(-c2ccc(Cl)c(Cl)c2)n1,,3-Hydroxybutyryl-Coenzyme A,
CC(=O)c1c[nH]c2c(C)cccc12,,278180-95-3,
Cc1cc2ncccc2nc1O,,"3-methyl-1,5-naphthyridin-2-ol",
Cc1nc[nH]c1CN1CCc2ccccc2C1,,Docosanol,
COc1ccccc1N1CCN(C(=O)c2ccccc2S(C)(=O)=O)CC1,,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",
Nc1ccc2cccc(Br)c2n1,,8-Bromoquinolin-2-amine,
Nc1cccc(-c2n[nH]c(-c3ccccc3)n2)c1,,1092305-74-2,
CCCCNC(=O)c1cnc2ccccc2n1,,N-butylquinoxaline-2-carboxamide,
CN1CCN(c2ccc(C(F)(F)F)cc2NC(=O)c2ccccc2Cl)CC1,,Hygromycin B,
N#Cc1c(-c2ccc(Cl)cc2)nc(SCC(=O)Nc2ccc(S(N)(=O)=O)cc2)[nH]c1=O,,Vamorolone,
CC(=O)Nc1ccc(Nc2ncnc3nc[nH]c23)cc1,,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,
Nc1nc(Nc2ccccc2O)c2[nH]cnc2n1,,Iopanoic acid,
Nc1nc(Nc2cccc(O)c2)c2[nH]cnc2n1,,Clorazepic acid,
Cc1ccc(NS(=O)(=O)c2ccc(OCC(=O)O)c(C)c2)cc1C,,LY-2584702,
Fc1ccccc1Nc1ncnc2n[nH]cc12,,"N-(2-Fluorophenyl)-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine",
COCCCNC(=O)c1nc(-c2cccc3[nH]ccc23)no1,,"3-(1H-indol-4-yl)-N-(3-methoxypropyl)-1,2,4-oxadiazole-5-carboxamide",
CCCN1CCN(c2ncc(CCNC=O)s2)CC1,,Fotemustine,
CCCN1CCN(c2ncc(CCN)s2)CC1,,Magnesium levulinate,
CCCN1CCN(c2ncc(CCNC)s2)CC1,,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,
CCCN1CCN(c2ncc(CCN(C)C)s2)CC1,,Terguride,
CCCCCN(C)CCc1cnc(N2CCN(CCC)CC2)s1,,Cefroxadine,
CCCN1CCN(c2ncc(CCN(C)CCCc3ccccc3)s2)CC1,,Oxazolam,
CCCN(C)CCc1cnc(N2CCN(CCC)CC2)s1,,Nadolol,
CCCN1CCN(c2ncc(CCN(C)Cc3ccccc3)s2)CC1,,4-Deoxylactose,
CCCN1CCN(c2ncc(CCN(C)CCCCCc3ccccc3)s2)CC1,,Levomenthol,
COc1ccc2c(c1)c(CC(=O)Nc1cccnc1C)c(C)n2C(=O)c1ccc(Cl)cc1,,Picric acid,
COc1ccc2c(c1)c(CC(=O)NC(C)c1ccncc1)c(C)n2C(=O)c1ccc(Cl)cc1,,Pentostatin,
COc1ccc2c(c1)c(CC(=O)NCc1ccc(C(F)(F)F)nc1)c(C)n2C(=O)c1ccc(Cl)cc1,,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",
COc1ccc2c(c1)c(CC(=O)NCc1ccc(Cl)nc1)c(C)n2C(=O)c1ccc(Cl)cc1,,PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER,
COc1ccc2c(c1)c(CC(=O)NCC(C)c1ccccc1)c(C)n2C(=O)c1ccc(Cl)cc1,,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,
CNC(=O)[C@@H]1CCCN1C(=O)CCc1ccc(Cl)cc1,,"proline scaffold, 1",
CCCNC(=O)[C@@H]1CCCN1C(=O)CCc1ccc(Cl)cc1,,"proline scaffold, 2",
COCCNC(=O)[C@@H]1CCCN1C(=O)CCc1ccc(Cl)cc1,,"proline scaffold, 3",
O=C(NCc1cccs1)[C@@H]1CCCN1C(=O)CCc1ccc(Cl)cc1,,"proline scaffold, 4",
CNC(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)c1ccccc1,,"proline scaffold, 5",
CCCNC(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)c1ccccc1,,"proline scaffold, 6",
COCCNC(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)c1ccccc1,,"proline scaffold, 7",
O=C(NCc1cccs1)[C@@H]1CCCN1C(=O)CC(c1ccccc1)c1ccccc1,,"proline scaffold, 8",
CNC(=O)[C@@H]1CCCN1C(=O)CC1CCCCC1,,"proline scaffold, 9",
CCCNC(=O)[C@@H]1CCCN1C(=O)CC1CCCCC1,,"proline scaffold, 10",
CNC(=O)[C@@H]1CCCN1C(=O)CC1(O)c2ccccc2-c2ccccc21,,"proline scaffold, 13",
CCCNC(=O)[C@@H]1CCCN1C(=O)CC1(O)c2ccccc2-c2ccccc21,,"proline scaffold, 14",
O=C(NCc1cccs1)[C@@H]1CCCN1C(=O)CC1(O)c2ccccc2-c2ccccc21,,"proline scaffold, 16",
CNC(=O)[C@@H]1CCCN1C(=O)Cc1ccc2c(c1)OCO2,,"proline scaffold, 17",
CCCNC(=O)[C@@H]1CCCN1C(=O)Cc1ccc2c(c1)OCO2,,"proline scaffold, 18",
COCCNC(=O)[C@@H]1CCCN1C(=O)Cc1ccc2c(c1)OCO2,,"proline scaffold, 19",
O=C(NCc1cccs1)[C@@H]1CCCN1C(=O)Cc1ccc2c(c1)OCO2,,"proline scaffold, 20",
CNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccc(Cl)cc1,,"proline scaffold, 21",
CCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccc(Cl)cc1,,"proline scaffold, 22",
COCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccc(Cl)cc1,,"proline scaffold, 23",
N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCC[C@H]1C(=O)NCc1cccs1,,"proline scaffold, 24",
COCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C(c1ccccc1)c1ccccc1,,"proline scaffold, 27",
N[C@@H](C(=O)N1CCC[C@H]1C(=O)NCc1cccs1)C(c1ccccc1)c1ccccc1,,"proline scaffold, 28",
CCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C1CCCCC1,,"proline scaffold, 30",
COCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C1CCCCC1,,"proline scaffold, 31",
N[C@@H](C(=O)N1CCC[C@H]1C(=O)NCc1cccs1)C1CCCCC1,,"proline scaffold, 32",
CNC(=O)[C@@H]1CCCN1C(=O)[C@H](NS(=O)(=O)Cc1ccccc1)C1CCCCC1,,"proline scaffold, 35",
COCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](O)C1CCCCC1,,"proline scaffold, 36",
OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,,QS11,
COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,,Foretinib,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,beta-cellotriose,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Carfilzomib,
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Plevitrexed,
CC(C)O.CCCOc1ccc(C(Nc2ccc(F)cc2)P(=O)(O)O)cc1,,LCL-161,
NS(=O)(=O)c1c(F)c(F)cc(F)c1F,,"2,3,5,6-Tetrafluorobenzenesulfonamide",
CCN1C(=O)CCc2cc(N)ccc21,,"6-amino-1-ethyl-1,2,3,4-tetrahydroquinolin-2-one",
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C/c2cccc(Cl)c2)SC1=S,,"Thiazolidinone core, 21",
O=C(NP(=O)(N1CCOCC1)N1CCOCC1)c1ccc(Br)cc1,,"Carbacylamidophosphate, 2b",
CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,,MK-2461,
O=c1[nH]c2cccc(Cl)c2cc1O,,5-Chloro-3-hydroxyquinolin-2(1H)-one,
CCc1cccc2[nH]c(=O)c(O)cc12,,1159706-34-9,
O=c1[nH]c2cc(F)ccc2cc1O,,7-Fluoro-3-hydroxyquinolin-2(1H)-one,
O=c1[nH]c2cccc(F)c2cc1O,,5-Fluoro-3-hydroxyquinolin-2(1H)-one,
O=c1[nH]c2ccc(F)c(Cl)c2cc1O,,5-Chloro-6-fluoro-3-hydroxyquinolin-2(1H)-one,
CCO[C@H]1O[C@H]2C[C@@](C)(O)[C@H](CC/C(C)=C/[C@H](O)[C@H]3OC(=O)C=C3C)[C@@]3(C)CCC[C@]1(C)[C@H]23,,"(S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid",
CC1=CC(=O)O[C@@H]1C/C=C(\C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(CO)[C@@H]2[C@@H](O)C[C@@]1(C)O,,2'-fluoro-2'-deoxyuridine 3'-monophosphate,
CC1=CC(=O)O[C@@H]1C/C=C(\C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(C=O)[C@@H]2[C@@H](O)C[C@@]1(C)O,,Imipenem,
CC1=CC(=O)O/C1=C\C=C(/C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(CO)[C@@H]2[C@@H](O)C[C@@]1(C)O,,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",
C=C1C[C@@H]2OC[C@]3(C)CCC[C@](C)([C@H]1CC/C(C)=C/C[C@H]1OC(=O)C=C1C)[C@@H]23,,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,
CC1=CC(=O)O[C@@H]1[C@@H](O)/C=C(\C)CC[C@@H]1[C@@]2(C)CCC[C@@]3(C)[C@@H](O)O[C@@H](C[C@@]1(C)O)[C@H]23,,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",
CCO[C@H]1O[C@H]2C[C@@](C)(O)[C@H](CC/C(C)=C/C[C@H]3OC(=O)C=C3C)[C@@]3(C)CCC[C@]1(C)[C@H]23,,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,
CC1=CC(=O)O[C@@H]1[C@@H](O)/C=C(\C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(C(=O)O)[C@@H]2[C@@H](O)C[C@@]1(C)O,,N-Acetyl-L-Citrulline,
COC(=O)[C@]1(C)CCC[C@]2(C)[C@@H](CC/C(C)=C/[C@H](O)[C@H]3OC(=O)C=C3C)[C@](C)(O)C[C@H](O)[C@H]21,,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",
CC1=CC(=O)O[C@@H]1[C@@H](O)/C=C(\C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(C=O)[C@@H]2[C@@H](O)C[C@@]1(C)O,,Ritobegron,
C=C1C[C@H](O)[C@H]2[C@](C)(CO)CCC[C@]2(C)[C@H]1CC/C(C)=C/[C@H](O)[C@H]1OC(=O)C=C1C,,5-fluoro-2'-deoxycytidine,
CC1=CC(=O)O/C1=C\C=C(/C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(C(=O)O)[C@@H]2[C@@H](O)C[C@@]1(C)O,,Lomefloxacin,
CC1=CC(=O)O/C1=C\C=C(/C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(C=O)[C@@H]2[C@@H](O)C[C@@]1(C)O,,"2,6-anhydro-3-deoxy-3-fluoronononic acid",
CC1=CC(=O)O/C1=C\C=C(/C)CC[C@@H]1[C@@]2(C)CCC[C@@]3(C)C(=O)O[C@@H](C[C@@]1(C)O)[C@H]23,,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,
CCc1ccc(CCNC(=O)c2c(O)c(O)cc3c(O)c(-c4c(C)cc5c(C(=O)NCCc6ccc(CC)cc6)c(O)c(O)cc5c4O)c(C)cc23)cc1,,"Apogossypol derivative, 8q",
Cc1cc2c(C(=O)NC(C)c3ccc(Cl)cc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC(C)c3ccc(Cl)cc3)c(O)c(O)cc2c1O,,"Apogossypol derivative, 8k",
Cc1cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c1O,,"Apogossypol derivative, 8m",
O=C(O)Cc1cccc(CC2C3CCC(O3)C2C=NNC(=O)Nc2ccccc2)c1,,Fexofenadine,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2nc(C)[nH]c12,,Pictilisib,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2nc[nH]c12,,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2ccc(C(=O)O)nc12,,Larazotide,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCS(C)(=O)=O,,Lucitanib,
Cc1cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c1O,,1228108-65-3,
O=C(O)CCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,Resveratrol Hexanoic Acid,
Cc1cc(F)ccc1-c1cc(N2CCN(S(C)(=O)=O)[C@@H](C)C2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,P-Aminophenyl-Alpha-D-Galactopyranoside,
CCOC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Oc2ncnc3cc(OC)c(OC)cc23)c1,,"(5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine",
CCOC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)n(-c2ccccc2)n1,,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(CN5CCOCC5)cc(C(F)(F)F)c4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(3-(morpholinomethyl)-5-(trifluoromethyl)phenyl)urea",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(C(F)(F)F)c(OC)c4)c3)c2cc1OC,,"US9730937, Example 190",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)c2cc1OC,,4-Hydroxybutan-1-Aminium,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"1-[3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl]-3-[1-phenyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(=O)N5CCOCC5)cc(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 205",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)C)on4)c3)c2cc1OC,,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)n(C)n4)c3)c2cc1OC,,1-{3-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy]phenyl}-3-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]urea,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(C(F)(F)F)c(OC)c4)c3)c2cc1OC,,1-(3-methoxy-4-(trifluoromethyl)phenyl)-3-(3-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy)phenyl)urea,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccc(F)cc4)c3)c2cc1OC,,1-[1-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]-3-{3-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy]phenyl}urea,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4C)c3)c2cc1OC,,1-{3-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-ylthio]phenyl}-3-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea,
CCOC(C)(C)c1cc(NC(=O)Nc2cccc(Sc3ncnc4cc(OCCOC)c(OC)cc34)c2)n(-c2ccccc2)n1,,"(2R)-3-[(tetrahydroxyphosphoranyl)oxy]-1,2-propanediyl dibutanoate",
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccc(C)cc4)c3)c2cc1OC,,1-{3-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-ylthio]phenyl}-3-[1-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)n(-c5ccccc5)n4)c3)c2cc1OC,,"US9730937, Example 244",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCS(=O)(=O)CC1,,"2-Amino-3-[5-(Amino-Carboxy-Methyl)-2,3-Dihydro-Isoxazol-3-Ylsulfanyl]-Propionic Acid",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)no4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(3-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-5-yl)urea",
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)F)no4)c(F)cc3F)c2cc1OC,,Gilteritinib,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5(C(F)(F)F)CC5)nn4-c4ccc(C)cc4)c3)c2cc1OC,,"US9730937, Example 347",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5CC5)nn4-c4ccccc4)c3)c2cc1OC,,Phosphonoacetohydroxamic Acid,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4Cc4ccccc4)c3)c2cc1OC,,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Tetrahydrodeoxyuridine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C(F)(F)F)cc4)c3)c2cc1OC,,"US9730937, Example 373",
CCOc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)ncnc2cc1OC,,S-sulphocysteine,
CCOc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)ncnc2cc1OC,,Faropenem,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCCCC1,,Bemotrizinol,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCN(CCO)CC1,,Turofexorate isopropyl,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C#N)cc4)c3)c2cc1OC,,"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3C)c2cc1OC,,"Hexane-1,6-Diol",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c3C)c2cc1OC,,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",
COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)cc1,,Teclozan,
CCOc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)ncnc2cc1OC,,Sotagliflozin,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCN(S(C)(=O)=O)CC1,,N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CC[C@H](O)C1,,Phenytoin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccnc4)c3)c2cc1OC,,"N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(F)F)nn4-c4cccnc4)c3)c2cc1OC,,"1-(3-(1,1-difluoroethyl)-1-(pyridin-3-yl)-1H-pyrazol-5-yl)-3-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)urea",
CCn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Sc2ncnc3cc(OC)c(OC)cc23)c1,,5-PENTYL-2-PHENOXYPHENOL,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3F)c2cc1OC,,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CC[C@@H](O)C1,,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCN(C)CC1,,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)nc4)c3)c2cc1OC,,"N,O-Didansyl-L-Tyrosine",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCN(CCO)CC1,,Parachlorophenol,
CCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Cephalexin,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCC(CO)CC1,,Chromium picolinate,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCS(=O)(=O)CC1,,Clindamycin,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCOCC1,,Delorazepam,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCC(CO)CC1,,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCN(CCO)CC1,,Bupivacaine,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCCCC1,,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,
COc1cc2nc(Cl)nc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1O[C@H]1CCN(C(=O)OC(C)(C)C)C1,,9-aminocamptothecin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1O[C@H]1CCN(CC(F)F)C1,,"(S)-1-(5-tert-butylisoxazol-3-yl)-3-(3-(6-(1-(2,2-difluoroethyl)pyrrolidin-3-yloxy)-7-methoxyquinazolin-4-yloxy)phenyl)urea",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)C)no4)c3)c2cc1OC,,Pyrithiamine Pyrophosphate,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CC5)no4)c3)c2cc1OC,,Veledimex,
CCOc1ccccc1N1CCN(CC(O)CN2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1,,Tezosentan,
NC[C@@H]1NC(=O)CNC1=O,,"(S)-3-(aminomethyl)piperazine-2,5-dione",
CC(C)NCC(O)COc1ccc(COCC2CCC2)cc1,,Verteporfin,
CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCO2)cc1,,Leriglitazone,
CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCCC2)cc1,,Phenylephrine,
CC(C)NCC(O)COc1ccc(CS(=O)CC2CC2)cc1,,Ginsenosides,
CC(CC#N)NCC(O)COc1ccc(CCOCC2CCC2)cc1,,Metocurine,
OC(CNC1CC1)COc1ccc(CCOCC2CCC2)cc1,,Nylidrin,
CC(C)NCC(O)COc1ccc(CCCOCC2CCC2)cc1,,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC1=O,,ginkgolide-B,
CSCC[C@@H]1NC(=O)[C@@H](CC(C)C)N2C=CC(NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H](CCC(N)=O)NC(=O)CNC1=O)C2=O,,Umeclidinium,
CSCC[C@@H]1NC(=O)[C@@H](CC(C)C)N2C=CC(NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](CCC(N)=O)NC(=O)CNC1=O)C2=O,,CI-1040,
CC(C)C[C@H]1C(=O)N[C@H](CCSCCSCC[C@H]2NC(=O)[C@H](CC(C)C)N3C=CC(NC(=O)[C@H](Cc4ccccc4)N(C)C(=O)C(Cc4c[nH]c5ccccc45)NC(=O)C(CCC(N)=O)NC2=O)C3=O)C(=O)NC(CCC(N)=O)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NC2C=CN1C2=O,,Histidinol,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)N2C=CC(NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C(CCC(N)=O)NC1=O)C2=O,,Moroxydine,
CSCC[C@@H]1NC(=O)[C@@H](CC(C)C)N2C=CC(NC(=O)[C@@H](Cc3ccccc3)NC(=O)C(Cc3c[nH]c4ccccc34)NC(=O)[C@@H](CCC(N)=O)NC(=O)CNC1=O)C2=O,,"2,3-Dideoxyfucose",
CSCC[C@H]1NC(=O)[C@H](CC(C)C)N2C=CC(NC(=O)[C@H](Cc3ccccc3)NC(=O)C(C)(c3cccc4ccccc34)NC(=O)CNC1=O)C2=O,,Sitafloxacin,
CSCC[C@@H]1NC(=O)[C@@H](CC(C)C)N2C=CC(NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](CCC(N)=O)NC(=O)CNC1=O)C2=O,,Lysine Nz-Carboxylic Acid,
CSCC[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCC(N)=O)NC1=O,,3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)N2C=CC(NC(=O)[C@H](Cc3ccccc3)NC(=O)C(C)(c3cccc4ccccc34)NC(=O)C(CCC(N)=O)NC1=O)C2=O,,BMS-214662,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)N2C=CC(NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CCC(N)=O)NC1=O)C2=O,,Vitamin K7,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)N2C=CC(NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)C(CCC(N)=O)NC1=O)C2=O,,Diatrizoate,
NC(CCN[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)Nc1ccc2c(CN3CCCC3)cn(Cc3c(Cl)cccc3Cl)c2c1)C(=O)NCc1ccccc1)C(=O)O,,Macimorelin,
N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)Nc1ccc2c(CN3CCCC3)cn(Cc3c(Cl)cccc3Cl)c2c1)C(=O)NCc1ccncc1,,L-1-naphthyl-2-acetamido-ethane boronic acid,
COc1ccc(CN(CCN(C)CCCCCCCCN)c2ccccn2)cc1,,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",
COc1ccc(CN(CCN(C)CCNc2ccc([N+](=O)[O-])c3n[o+][n-]c23)c2ccccn2)cc1,,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",
COc1ccc(CN(CCN(C)CCCCCCNC(=O)c2ccc(-c3c4ccc(=N)cc-4oc4cc(N)ccc34)c(C(=O)O)c2)c2ccccn2)cc1,,N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine,
COc1ccc(CN(CCN(C)CCCCCCNC(=O)c2ccc(-c3c4ccc(=[N+](C)C)cc-4oc4cc(N(C)C)ccc34)c(C(=O)[O-])c2)c2ccccn2)cc1,,Buprenorphine,
COc1ccc(CN(CCN(C)CCCCNC(=O)c2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)c2ccccn2)cc1,,Isatoribine,
COc1ccc(CN(CCN(C)CCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)c2ccccn2)cc1,,Alclofenac,
COc1ccc(CN(CCN(C)CCCCCCCCNC(=O)c2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)c2ccccn2)cc1,,2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-alpha-D-glucopyranose,
CC(OCC(O)CNC(C)(C)C)C1CC1,,"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",
CC(C)(C)NCC(O)COCC1CC1,,Trestolone,
C=C1C[C@H](c2ccc(NC(=N)N)cc2)[C@@H](NC(=O)c2ccccc2)C(=C)O1,,DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID,
CCOC(=O)CCNCC(O)COC1=CC=CCC1(C)C,,Tiracizine,
C=C1O/C(=C/I)C[C@H](c2ccc(NC(=N)N)cc2)[C@H]1NC(=O)c1ccccc1,,Mosapramine,
Cc1ccccc1OCC(O)CNCC(C)C,,"S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE",
C#CCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Farnesol,
C=C1CC(c2ccc(NC(=N)N)cc2)C/C(=C\I)O1,,Bindarit,
C=C1CC(c2ccc(NC(=N)N)cc2)CC(=C)O1,,Levothyroxine,
CC(C)(C)CCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Telotristat,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)OCCCCC2CCCCC2)co1,,"2,3,-Dihydroxybenzoylserine",
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(F)(F)F)co1,,Ceftazidime BATSI,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCCO)co1,,Enalapril,
CC(C)(Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1)C(=O)O,,Maltotetraose,
CN[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC1=O,,Paramethasone acetate,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N(C)[C@H](C(N)=O)[C@@H](C)O)NC1=O,,"2,4-Dihydroxy-Trans Cinnamic Acid",
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,Argininosuccinate,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,Droperidol,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N(C)[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,"6-Hydroxymethyl-7,8-Dihydropterin",
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N(C)[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,Choline alfoscerate,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](N)Cc2ccc(O)cc2)CSSC[C@@H](C(=O)N(C)[C@H](C(N)=O)[C@@H](C)O)NC1=O,,Pentamycin,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](N(C)C(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,Pentazocine,
CN[C@H](Cc1ccccc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC1=O,,PF-04691502,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1C)C(N)=O,,Phosphatidylethanolamine,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N(C)[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,N-Dimethyl-Lysine,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccc(O)cc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,Cimetidine,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1C)C(N)=O,,Clobetasol,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N(C)[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,Paclitaxel,
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@@H](N(C)C(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O,,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",
COc1cccc(OC)c1OCCNCC1CO[C@](C)(c2ccccc2)O1,,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",
O=C(O)CCC/C=C\C[C@H]1[C@@H]2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1,,SQ-29548,
CC(C)NCC(O)CON=C(C(C)C)C(C)C,,TAK-733,
CCCC(CCC)=NOCC(O)CNC(C)(C)C,,19-Nor-5-androstenedione,
CCC(CC)=NOCC(O)CNC(C)(C)C,,Tribromometacresol,
CC(C)NCC(O)CON=C1CCCC1,,Telmisartan,
CCCC(CCC)=NOCC(O)CNC(C)C,,"6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione",
CC(C)(C)NCC(O)CON=C1CCCC1,,D-Alanine,
CC(C)C(=NOCC(O)CNC(C)(C)C)C(C)C,,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",
CSCC[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(N)=O,,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",
COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1,,4-Methylpiperazin-1-Yl Carbonyl Group,
COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1,,9GA78MV6TU,
COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O,,Tretoquinol,
Clc1ccc(Cc2noc(CCCc3cnc[nH]3)n2)cc1,,Decitabine,
O=S(=O)([O-])CC1OC(OC2(COS(=O)(=O)[O-])OC(COS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C2OS(=O)(=O)[O-])C(CS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],,3-Isopropylmalic Acid,
O=S(=O)([O-])OC[C@H]1OCC[C@@H](OCc2ccccc2)C1OS(=O)(=O)[O-],,D-threo-neopterin,
C=CCOC1C(C)OC(OC)C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",
COC1OC(C)C(OCc2ccccc2)C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],,Kaempherol,
COC1C(OCc2ccccc2)C2COC(O2)C1OS(=O)(=O)[O-],,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,
[N-]=[N+]=NCC1OC(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],,Omapatrilat,
O=C(CN(Cc1ccccc1)C(=O)C1OC(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-])NC1CCCCC1,,Glucosamine 1-Phosphate,
NCCCOP(=O)(O)O[C@H]1[C@H](O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]1O,,Elvitegravir,
N#CN=C(NCCCOc1cccc(CN2CCCCC2)c1)NCCNC(=O)c1c2ccccc2nc2ccccc12,,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",
CC(=O)c1ccc2n(c1=O)[C@H](COC(=O)CCC(=O)NCCCOc1cccc(CN3CCCCC3)c1)Cc1c-2[nH]c2ccccc12,,N-2-Thiophen-2-Yl-Acetamide Boronic Acid,
N#CN=C(NCCCCNC(=O)c1ccc(C2c3ccc(O)cc3OC3=CC(=O)C=CC32)c(C(=O)O)c1)NCCCOc1cccc(CN2CCCCC2)c1,,Glutamine t-butyl ester,
N#CN=C(NCCCOc1cccc(CN2CCCCC2)c1)NCCNC(=O)c1ccc(C2c3ccc(O)cc3OC3=CC(=O)C=CC32)c(C(=O)O)c1,,CAP-1,
N#C[NH+]=C([N-]CCCCCCNc1ccc([N+](=O)[O-])c2n[o+][n-]c12)NCCCOc1cccc(CN2CCCCC2)c1,,Luseogliflozin,
N#C[NH+]=C([N-]CCCNc1ccc([N+](=O)[O-])c2n[o+][n-]c12)NCCCOc1cccc(CN2CCCCC2)c1,,Tazobactam,
N#C[NH+]=C([N-]CCNC(=O)CCCCCNc1ccc([N+](=O)[O-])c2n[o+][n-]c12)NCCCOc1cccc(CN2CCCCC2)c1,,3-Amino-1-Chloro-4-Phenyl-Butanol-2-Yl,
C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O,,KB-141,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,o-Bromophenol,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2ncn(C)c12,,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",
CCc1nc(NCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2c[nH]nc2n1,,Ajmaline,
CCc1nc(NCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2ncn(C)c2n1,,"N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamide",
CCc1nc(NCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2cc(C(=O)O)ccc2n1,,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,
CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O,,Gavestinel,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2cc(C(=O)O)ccc12,,Clidinium,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2ncn(CC(=O)O)c12,,Phosphoglycolohydroxamic Acid,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2n[nH]cc12,,Amelubant,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nc(S(C)(=O)=O)n2C,,N-Methylleucine,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nnn2C,,Reversine,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2oc(C)nc12,,Bisoxatin,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1[nH]c(=O)n2C,,Entecavir,
CCCC1(CC)CC(=O)N(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)/C(=C/C(=O)OCC)C1,,INHIBITOR Q8467 OF DUPONT MERCK,
CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1,,Hydroxyethyl cellulose,
CCN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1,,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,
CCN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1,,Aldoxorubicin,
CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1,,Testosterone,
N=C(N)NCCC[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,Rifaximin,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2cccnc12,,S-40503,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2ccc(OC)cc12,,Pyruvaldehyde,
CCc1nc(NCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2c(OC)cccc2n1,,Magnesium glycinate,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2ccc(O)cc12,,Myristyl glyceryl ether,
CCc1nc(N(C)Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2cc(OC)ccc2n1,,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nc(C#N)n2C,,Dotatate gallium Ga-68,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2nccnc12,,Phenylethyl resorcinol,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2cccc(C(=O)OC)c12,,Remikiren,
CN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1,,Prostaglandin B2,
CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1,,Ospemifene,
CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O,,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,
CCC(CC)NC=Nc1ccc(-c2c[nH]cn2)cc1,,Furosemide,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,Pheneturide,
CCC(C)(C)NC=Nc1ccc(-c2c[nH]cn2)cc1,,Elbasvir,
CCOC(=O)/C=C1\CC2(CCCCC2)CC(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Doravirine,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nc(CC)n2C,,1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,
CCOC(=O)/C=C1\CC(C)(C)CC(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,EM-1745,
NS(=O)(=O)c1ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc1,,Enalkiren,
NS(=O)(=O)c1ccc(C(=O)N[C@@H](CO)C(=O)O)cc1,,"(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL",
CC[C@@H](C)[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Violaxanthin,
NC(=O)CC[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,
CC(C)[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,N-Methylmesoporphyrin Containing Copper,
C[C@@H](O)[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",
CSCC[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,2-Aminobenzyl alcohol,
NS(=O)(=O)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,,"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE",
NS(=O)(=O)c1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc1,,"1-(2-{[(6-amino-2-methylpyridin-3-yl)methyl]amino}ethyl)-6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-1,4-dihydropyrazin-2-ol",
CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,,BMS-582949,
CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,,Nicotinyl alcohol,
CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,,Isoflupredone,
CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,staurosporine,
C[NH+](C)C1CCc2cc(O)c(O)cc2C1,,TL99,
NCc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,Choline C 11,
NCc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)c(C(=O)O)c1,,Virginiamycin M1,
N=C(N)NCCC[C@H](N)C(=O)NCc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,Cevipabulin,
CCCC[N+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,Zonisamide,
CCNC(=NCc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1)NCC,,Finasteride,
N=C(N)NCc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",
N=C(N)NCc1ccc(NC(=O)[C@@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,Ethchlorvynol,
CCCC[N+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,2-Allylphenol,
O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1,,(4S)-5-[[(1S)-1-Carboxy-2-cyclohexylethyl]amino]-4-[[(2S)-2-[[(3R)-4-cyclohexyl-2-oxo-3-(phenylmethoxycarbonylamino)butanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-oxopentanoic acid,
O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)c1,,"1,6-DI-O-PHOSPHONO-D-MANNITOL",
O=C(O)CCCC/C=C(/c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1,,5-methylbenzimidazole,
O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1,,Curcumin sulfate,
CCOC(=O)[C@]1(c2cccc(O)c2)CCCN(CC2CC2)[C@H]1C,,Zuclopenthixol,
C=CCN1CCC[C@](C(=O)OCC)(c2cccc(O)c2)[C@@H]1C,,ORE-1001,
CCOC(=O)[C@]1(c2cccc(O)c2)CCCN(C)[C@H]1C,,Bicisate,
N=C(N)NCCCCC(=O)NC(Cc1cccs1)C(=O)N1Cc2ccccc2CC1C(=O)N1C(C(=O)NC(CCCNC(=N)N)C(=O)O)CC2CCCCC21,,"4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One",
N=C(N)NCCCCCC(=O)NC(Cc1cccs1)C(=O)N1Cc2ccccc2CC1C(=O)N1C(C(=O)NC(CCCNC(=N)N)C(=O)O)CC2CCCCC21,,Dextromethadone,
CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccc(NC(=O)Nc2ccccc2C)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc1ccc(C)cc1)C(N)=O,,Brovanexine,
N=C(N)NCCCC(NC(=O)C1CC2CCCCC2N1C(=O)C1Cc2ccccc2CN1C(=O)C(Cc1ccccc1)NC(=O)CCCN)C(=O)O,,Sulfachlorpyridazine,
N=C(N)NCCCC(NC(=O)C1CC2CCCCC2N1C(=O)C1Cc2ccccc2CN1C(=O)C(Cc1cccs1)NC(=O)CCCN)C(=O)O,,(S)-famoxadone,
NS(=O)(=O)c1ccc(C(=O)NC(=O)c2ccco2)cc1,,"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",
CC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)NC(Cc1cccc(NC(=O)Nc2ccccc2C)c1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(C)cc1)C(N)=O,,"3h-Indole-5,6-Diol",
CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC(Cc1cccc(NC(=O)Nc2ccccc2C)c1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc1ccc(C)cc1)C(N)=O,,Tribenoside,
CN1CCCC[C@H]1[C@H](O)COc1ccccc1,,Gepefrine,
CC(C)N(C)CC(O)COc1ccccc1,,1-[Methyl(propan-2-yl)amino]-3-phenoxypropan-2-ol,
NCC(=O)[C@@H]([NH3+])C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1,,4-Nitrophenyl-Ara,
NCCCCC(N)C(=O)[C@@H]([NH3+])C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1,,Minoxidil,
NC(CCC(=O)O)C(=O)[C@@H]([NH3+])C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1,,4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE,
C/C=C(\C)CC(=C/C(=O)O)/C=C(C)/C=C1\CCCC(CC)=C1C(C)C,,RU79073,
CCC(C)/C=C/CC(=C/C(=O)O)/C=C/C1=C(C)CCCC1(C)C,,Oxyphencyclimine,
COc1c(C(C)=O)c(OCc2ccccc2)c(OC)c2occc12,,N-sulfo-flavin mononucleotide,
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@@H](O)[C@@H](OC)C[C@@H](C)c2ncoc2C(=O)N2CCCC[C@H]2C(=O)O[C@H](/C(C)=C/[C@@H]2CC[C@@H](O)[C@H](OC)C2)[C@H](C)C(O)CC1=O,,"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",
CCCC1C(=O)CC[C@@H](C)[C@@H](CCc2cccnc2)OC(=O)[C@@H]2CCCN(C2)C(=O)C(O)CCS(=O)CC[C@@H](OC)C[C@@H](C)CC(=O)N1C,,"(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid",
CCC(C)C1C(=O)CC[C@@H](C)[C@@H](CCc2cccnc2)OC(=O)[C@@H]2CCCN(C2)C(=O)C(=O)CCSCC[C@@H](OC)C[C@@H](C)CC(=O)N1C,,2-(Thiomethylene)-4-Methylpentanoic Acid,
COc1c(C(C)=O)c(Oc2ccc(Oc3c(C(C)=O)c(OC)c4ccoc4c3OC)c(C)c2C)c(OC)c2occc12,,GSI-136,
CCCC1C(=O)CC[C@@H](C)[C@@H](CCc2cccnc2)OC(=O)[C@@H]2CCCN(C2)C(=O)C(=O)CSCC[C@@H](OC)C[C@@H](C)CC(=O)N1C,,Zilucoplan,
COc1c(C(C)=O)c(Oc2cc(C)c(Oc3c(C(C)=O)c(OC)c4ccoc4c3OC)cc2C)c(OC)c2occc12,,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,
COc1c(C(C)=O)c(Oc2cc(C)c(Oc3c(C(C)=O)c(OC)c4ccoc4c3OC)c(C)c2)c(OC)c2occc12,,Almorexant,
C=C1C[C@@]2(O)[C@@H]3CC[C@@]4(C)[C@@H]5C=CC(=O)OC[C@]5(C(C)OC(C)=O)[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]4[C@@]3(C)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@@]2(C)C2(C(=O)OC)O[C@H]12,,Deferoxamine,
O=[N+]([O-])c1ccc(OCCCN2CCC(Nc3nc4ccccc4s3)CC2)cc1,,Etheno-Nadp,
CC1(C)CC(=O)Nc2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,PD-0325901,
CC1(C)CCNc2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,Eltrombopag,
CCCCCCCN1CCC(C)(C)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",
CC1(C)CCNc2ccc(C#Cc3ccc(C(=O)O)cc3)cc21,,"4,6-dideoxy-4-amino-beta-D-glucopyranoside",
CC(C)N1C(=O)CC(C)(C)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21,,Primaquine,
CC(C)N1C(=O)CC(C)(C)c2ccc(C#Cc3ccc(C(=O)O)cc3)cc21,,MK-0893,
O=C(O)c1ccccc1C(=O)n1ccnc1,,CPG-52852,
NCc1ccc(CNC(=O)[C@@H](CN)n2cccc2CNC(=O)CC2CCCCC2)cc1,,Muscimol,
NC(N)=NC[C@H]1C[C@@H](OCc2ccccc2)CN1C(=O)c1ccc2ccccc2c1,,Pralidoxime,
CCCCC1(CCCC)Oc2cccc(N(CCCN)C(=O)c3ccc(CN)cc3)c2O1,,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",
NCCCN1C(=O)C(CCN)N=C(c2ccccc2)c2cc(N(Cc3ccccc3)Cc3ccccc3)ccc21,,Icotinib,
N=C(N)NCCCN1C(=O)C(CN=C(N)N)N=C(c2ccccc2)c2cc(N(Cc3ccccc3)Cc3ccccc3)ccc21,,Calcium levulinate,
CCCCc1ccnc([C@H](CC2CCCCC2)NC(=O)c2ccc(CN)cc2)c1,,Flufenoxuron,
CCCCc1ccnc([C@H](CC2CCCCC2)NC(=O)CCCCN(CCCC)CCCC)c1,,VB-201,
CCCCC1(CCCC)Oc2cccc(NC(=O)c3ccc(CN)cc3)c2O1,,Remetinostat,
NC[C@H]1C[C@@H](OCc2ccccc2)CN1C(=O)c1ccc2ccccc2c1,,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,
NCc1ccc(CNC(=O)[C@@H](CN)n2cccc2CNC(=O)C(c2ccccc2)C2CCCCC2)cc1,,Indoleacetamide,
CC(=N)c1c(O)c(O)c(C(C)C)c2cc(C)c(-c3c(C)cc4c(C(C)C)c(O)c(O)c(C(C)=N)c4c3O)c(O)c12,,Fluoromisonidazole F-18,
COc1ccc(Cn2cccc(NC(=O)C(Cc3ccc(CC(=O)O)cc3)NC(=O)Cc3cccc4ccccc34)c2=O)cc1,,Ciclobendazole,
COc1ccc(Cn2ccc(C)c(NC(=O)C(Cc3ccc(C(C)(C)C(=O)O)cc3)NC(=O)C(C)(C)c3cccc4ccccc34)c2=O)cc1,,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",
Cc1cc2c(C(C)C)c(O)c(O)c(C(=O)O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C(=O)O)c2c1O,,JTK-853,
C=CCC1/C=C(\C)CCOC(=O)OC(=O)CCCC(=O)C(=O)OC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc2cccnc2)[C@H](C)CCC1=O,,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,
C=CCC1/C=C(\C)CCOC(=O)OC(=O)C2CC[C@@](C)(O2)C(=O)C(=O)C(=O)OC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc2cccnc2)[C@H](C)CCC1=O,,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",
C=CCC1/C=C(\C)CCCOC(=O)OC(=O)C2CC[C@@](C)(O2)C(=O)C(=O)C(=O)OC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc2cccnc2)[C@H](C)CCC1=O,,Isoniazid,
COc1ccc(COc2ccc(Br)cc2-c2cc(CO)on2)cc1,,Gatifloxacin,
COC(=O)C1CC(c2cc(Br)ccc2OCc2ccc(OC)cc2)=NO1,,"4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one",
C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@@H](CC(=O)O)Cc1ccc(N)c(I)c1,,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,
COCc1cc(-c2ccccc2OCc2ccc(Br)cc2)no1,,Pseudotropine,
COc1cccc(COc2ccccc2-c2cc(CO)on2)c1,,Indopan,
COc1cccc(COc2ccccc2C2=NOC(CCl)C2)c1,,S-palmitoyl-L-cysteine,
COC(=O)C1CC(c2ccccc2OCc2ccc(OC)cc2)=NO1,,Candicidin,
OCc1cc(-c2ccccc2OCc2ccc(Br)cc2)no1,,Umifenovir,
C=CCC1/C=C(\C)CCOC(=O)OC(=O)CCC(=O)C(=O)OC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc2cccnc2)[C@H](C)CCC1=O,,Bucindolol,
COc1ccc(COc2ccccc2C2=NOC(CCl)C2)cc1,,Acetyl chloride,
CCCCc1cc(-c2ccccc2OCc2ccc(OC)cc2)no1,,Latamoxef,
COc1ccc(COc2ccccc2-c2cc(CCO)on2)cc1,,Pantoprazole,
ClCc1cc(-c2ccccc2OCc2ccc(Br)cc2)no1,,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)Cc1c[nH]cn1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,Treprostinil,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,"1,4-Dithiothreitol",
Oc1ccccc1CNc1ncccc1-c1ncccn1,,Etarfolatide,
CN(C)c1ccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)cc1,,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,
CCNCCc1cnc(-c2cccc(C(F)(F)F)c2)[nH]1,,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",
CNCCc1cnc(-c2cccc(Br)c2)[nH]1,,"1,4-dithio-beta-D-glucopyranose",
CN(C)CCc1cnc(-c2cccc(Br)c2)[nH]1,,2-Aminoprop-2-Enamide,
FC(F)(F)c1cccc(-c2ncc(CCNC3CC3)[nH]2)c1,,2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine,
CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1,,Imidafenacin,
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,Thiarsahydroxy-Cysteine,
CN(CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1,,Omacetaxine mepesuccinate,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,AZD-8186,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,Triethylene glycol,
CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,
CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,"[2-(1-amino-2-hydroxy-propyl)-4-(1H-indol-3-ylmethylene)-5-oxo-4,5-dihydro-imidazol-1-yl]-acetaldehyde",
CN(CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1,,Kinetin,
CN(CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1,,Allantoate,
COC(=O)[C@]12CCCN1C(=O)[C@](Cc1ccccc1)(NC(=O)OCc1ccccc1)CC2,,"2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One",
CCO[C@@H](Cc1ccc(OCC=C(c2ccccc2)c2ccccc2)cc1)C(=O)O,,(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,
O=C(Nc1cc(Cl)c(O)cc1O)C1(c2ccccc2)CCC1,,"N-(5-chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutane-1-carboxamide",
C=C(O[C@@H]1CC(C(=O)[O-])=C[C@@H](OP(=O)([O-])O)[C@H]1O)C(=O)[O-],,Aurodox,
CSc1nc(N)nc(SCCN2CCOCC2)n1,,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",
CCCN1C(=O)C2NC(C3CCCC3)NC2N(CCCOC(=O)CBr)C1=O,,Zeatin,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,PF-4191834,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,
CC(C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCNC(=N)N)C(=O)O,,Amenamevir,
CSCC[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)O,,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O,,Ezatiostat,
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O,,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)C(C)(C)S,,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",
CSCC[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)O,,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O,,3-Oxo-Pentadecanoic Acid,
CC[C@@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O,,Sepetaprost,
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O,,Efonidipine,
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O,,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O,,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O,,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(=O)O)C(=O)O,,9-(2-carboxyethyl)-10-methylanthracene endoperoxide,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",
CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,DYPVWWR,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,Ozenoxacin,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)O,,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,Cefalonium,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O,,"N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide",
C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O,,Zinc picolinate,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O,,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",
CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,Y-27632,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",
CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,
CC(C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCNC(=N)N)C(=O)O,,"2-aminooxyethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]-methyl-sulfonium",
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CSS[C@@H]2C[C@@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@@H](Cc2cnc[nH]2)NC1=O)C(C)C,,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CCSS[C@@H]2C[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@@H](Cc2cnc[nH]2)NC1=O)C(C)C,,Linaclotide,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CC(=O)N[C@@H]2C[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@@H](Cc2cnc[nH]2)NC1=O)C(C)C,,Parsaclisib,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CSSC(C)(C)[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)NC(=O)[C@@H](Cc2cnc[nH]2)NC1=O)C(C)C,,Fenoverine,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CCC(=O)N[C@@H]2C[C@H](C(=O)N[C@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@@H](Cc2cnc[nH]2)NC1=O)C(C)C,,Podophyllin,
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](O)[C@@H](OC(=O)NCCc1ccc(O)cc1)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,Acetohydroxamic acid,
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)c2ccccc21,,(S)-blebbistatin,
CCCCN(C)C(=O)CCCCCC/C=C\CCC(c1ccc(O)c(C(C)C)c1)c1c(C)cc(OCC(=O)O)cc1C,,Glycolic acid,
COc1ccc(C(c2ccc(O)c(C(C)C)c2)c2c(C)cc(OCC(=O)O)cc2C)c(OC)c1,,bis(molybdopterin)tungsten cofactor,
CC12CCC(=O)C=C1CCC1C2CCC2(C)C(C(=O)[CH-][N+]#N)CCC12,,Cyclic adenosine monophosphate,
NN(CC(=O)O)CP(=O)(O)O,,Cymarin,
O=C(O)CCC/C=C\CC1C2CCC(O2)C1C=NNC(=O)Nc1ccccc1,,Lurbinectedin,
O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1C=NNC(=O)Nc1ccccc1,,S-octylglutathione,
C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)CSc4ccc(C(C)(C)O)cc4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,,Pranoprofen,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCCC1C(=O)NC(CCCN)C(=O)NC(Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O,,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",
CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)C(C)C)cc1,,Choline,
CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)cc1,,Lupeol,
CCOc1ccc(C[C@@H](NC(=O)CC(C)(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)cc1,,"2,4-Diamino-5-phenyl-6-ethylpyrimidine",
Cc1cc(O)cc(C)c1C[C@@H](C(=O)N1Cc2ccccc2CC1C(N)=O)N(C)C,,Nogalaviketone,
Cc1cc(O)cc(C)c1C[C@@H](C(=O)N1Cc2ccccc2CC1C(=O)O)N(C)C,,Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate,
CN[C@@H](Cc1c(C)cc(O)cc1C)C(=O)N1Cc2ccccc2CC1C(=O)O,,4-guanidinobenzoic acid,
CN[C@@H](Cc1c(C)cc(O)cc1C)C(=O)N1Cc2ccccc2CC1C(N)=O,,"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",
Oc1cccc2c1O[C@H]1CCC[C@H]3CN(CC4CC4)CC[C@]213,,Tetrahydrocannabivarin,
CCCn1c(=O)c2[nH]c(C3CC4CCC3C4)nc2n(CCCCC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O,,Guaifenesin,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OCc2ccccc2)c(O)c1,,AMG-222,
CC(NC(=O)OCCCc1cnc[nH]1)C(C)(C)C,,LY-2608204,
CCCC[C@H](NC(=O)[C@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O,,2-(4-METHOXYPHENYL)ACETAMIDE,
CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](CCCCN)C(N)=O,,Estramustine,
CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O,,Burixafor,
CCCCCCCCCCCCCCCC(=O)Oc1ccc(C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccccc2)C(=O)O)C(C)C)cc1,,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)O)C(C)C,,PH-797804,
CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1cccc2ccccc12)C(=O)O)C(C)C)C(C)C,,Telithromycin,
CCCCCCCCCCCCCCCCCCOc1ccc(C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@H]2C(=O)N[C@H](CC2=CCCC=C2)C(=O)O)C(C)C)cc1,,LGD2941,
CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1cccc2ccccc12)C(=O)O)C(C)C)C(C)C,,Vedroprevir,
CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O,,Selepressin,
CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O,,Nilutamide,
CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O,,Iopamidol,
CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)c(F)c1)C(=O)N[C@@H](CCCCN)C(N)=O,,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",
NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O,,Butanilicaine,
CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O,,Prednisolone,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(N(CC)CC)cc1O,,AVE-2865,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(N2CCOCC2)cc1,,Quinaldic Acid,
O=c1c2cc(F)c(NCCN3CCCCC3)cc2nc2n1CC/C2=C\c1ccc(OCc2ccccc2)cc1O,,Isobromindione,
O=c1c2cc(F)c(NCCCN3CCCC3)cc2nc2n1CC/C2=C\c1ccc(OCc2ccccc2)cc1O,,Verubecestat,
O=c1c2cc(F)c(NCCCN3CCOCC3)cc2nc2n1CC/C2=C\c1ccc(OCc2ccccc2)cc1,,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",
O=c1c2cc(F)c(N3CCOCC3)cc2nc2n1CC/C2=C\c1ccc(OCc2ccccc2)cc1O,,Myricetin,
COc1ccccc1CNCCCCCCN(C)CCCCCCCCN(C)CCCCCCNCc1ccccc1OC,,Rokitamycin,
CCN(CC)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,Pimodivir,
CCN(CC)c1ccc(/C=C2\CCn3c2nc2cc(NCCN(C)C)c(F)cc2c3=O)cc1,,Nadifloxacin,
COc1ccc(/C=C2\CCn3c2nc2cc(NCCCN(C)C)c(F)cc2c3=O)cc1OC,,Cyclotheonamide A,
CCN(CC)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)Cc1ccccc1OC,,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,
C#CCOc1ccc(/C=C2\CCn3c2nc2cc(NCCCN(C)C)c(F)cc2c3=O)cc1,,"(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one",
CC(=O)Oc1ccc(/C=C2\CCn3c2nc2cc(NCCCN(C)C)c(F)cc2c3=O)cc1,,2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1cc(OC)c(OC)c(OC)c1,,"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",
COc1ccc(/C=C2\CCn3c2nc2cc(NCCCN4CCOCC4)c(F)cc2c3=O)cc1,,N-[(1R)-1-(4-Bromophenyl)ethyl]-5-fluoro-2-hydroxybenzamide,
CN(C)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OCc2ccccc2)cc1O,,KOSN-1724,
CN(C)CCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(C=O)cc1,,3-Methylglutamic acid,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(C(F)(F)F)cc1,,Drotebanol,
CCN(CC)CCCNC(=O)c1ccc(/C=C2\CCn3c2nc2cc(NCCN4CCCC4)c(F)cc2c3=O)cc1,,Desoximetasone,
CCCOc1ccn2c(C(C)=O)cc(-c3cccc(OC)c3)c2c1,,GSK8573,
CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1,,GSK2801,
CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](C(N)=O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O,,Daidzin,
CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](C(N)=O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(I)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O,,Almotriptan,
COc1ccc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)cc1,,Monensin,
CCOc1ccc(C(C)=O)cc1NC(=O)/C=C/C(=O)O,,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,
COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C,,OF-1,
CCOc1ccc(C(C)=O)cc1NC(=O)c1cccc(C(=O)O)c1,,Chlorhexadol,
CCOc1ccc(C(C)=O)cc1NC(=O)c1cc(C(=O)O)cc(-c2ccoc2)c1,,Gemeprost,
CCOc1ccc(C(C)=O)cc1NC(=O)c1cccc(C(=O)OC)c1,,GW-870086,
CCOc1ccc(C(=O)NC)cc1NC(=O)c1cccc(C(=O)O)c1,,Inhibitor BEA388,
COC(=O)N1CCC(CC#Cc2nc(N)c3ncn([C@@H]4O[C@H](C(=O)NC5CC5)[C@@H](O)[C@H]4O)c3n2)CC1,,EVODENOSON,
COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21,,1809296-92-1,
CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2,,Olinone,
CC(C)C[C@@H]1CN[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,"4,4'-Dihydroxybenzophenone",
CC(C)C[C@@H]1CN[C@@H](CC(=O)O)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,Ractopamine,
CC(C)C[C@H]1NC(=O)CCNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CC2CCCCC2)NC1=O,,Omecamtiv Mecarbil,
CC(C)C[C@@H]1CN[C@@H](CC(N)=O)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,Tegafur,
CC(C)C[C@@H]1CN(C)[C@@H](CC2CCCCC2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE,
CC(C)C[C@@H]1CN[C@@H](CCC(=O)NCc2ccccc2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,Ibrutinib,
CC(C)C[C@@H]1CN[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,6-(Dihydroxy-Isobutyl)-Thymine,
CC(C)C[C@@H]1CN[C@@H](CC(=O)N(N)C[C@]23C[C@H]4C[C@H](C[C@H](C4)C2)C3)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid,
CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@H]2CCCN2C(=O)[C@H](N)CCC(=O)N[C@](C)(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)[C@@H](C)O)[C@@H](C)CC)NC(=O)[C@@H](CC(N)=O)NC1=O,,Clomocycline,
CC(C)C[C@@H]1CN[C@@H](CCC(N)OCc2ccccc2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,Betaxolol,
CC(C)C[C@@H]1CN[C@@H](Cc2ccccc2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",
CC(C)C[C@@H]1NC[C@@H](CC(C)C)NC(=O)CCNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCC(N)=O)NC1=O,,Cefoperazone,
CSCC[C@@H]1NC[C@@H](CC(C)C)NC(=O)CCNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCC(N)=O)NC1=O,,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",
CCOC(=O)/C=C1\C2C3C=CC(CC3)C2C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Ethambutol,
NC(=O)CC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(=O)OCc1cccc(N)c1)C(N)=O,,Cyclobutyrol,
CCOC(=O)/C=C1\N(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)C(=O)CC1(CC)CC,,Ribose-1-Phosphate,
CCOC(=O)/C=C1\C2C3C=CC(CCC3)C2C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Cefazedone,
CC(Cc1ccc(OP(=O)(O)O)cc1)(NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(=O)OCc1cccc(N)c1)C(=O)NC(CC(N)=O)C(N)=O,,Fluocortolone,
CC(Cc1ccc(C(=O)O)cc1)(NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(=O)OCc1cccc(N)c1)C(=O)NC(CC(N)=O)C(N)=O,,Neocitrullamon,
NC(=O)CC(NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(=O)OCc1cccc(N)c1)C(N)=O,,"4'-Methylene-5,8,10-trideazaaminopterin",
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,
COc1ccc(CCN(CCC[C@](C)(C#N)c2ccc(OC)c(OC)c2)C(C)C)cc1OC,,Domperidone,
CC(=O)N[C@@H](C)C(=O)NCC(=O)C(=O)N1CCCC1C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,,p-Heptylphenol,
CCOP(=O)(CNC(=O)[C@H](C)NC(C)=O)N1CCCC1C(=O)N[C@H](CNc1ccc([N+](=O)[O-])cc1)Cc1ccccc1,,Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose,
CCOP(=O)(CNC(=O)[C@H](C)NC(=O)CCC(=O)O)N1CCCC1C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,,GDC-0425,
CC(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N1CCCC1C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1,,Dihydroorotic Acid,
CN(C)CCOc1ccc(CN2CCCCC2)cc1,,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",
CC(NC(=O)OCCCN1CCCCC1)C(C)(C)C,,2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE),
CC(C)(C)CCCCOCCCc1cnc[nH]1,,Gimatecan,
O=C1CCC(=O)N1C(CCc1ccncc1)COc1ccc(-c2cccc([N+](=O)[O-])c2)cc1,,AZD-9496,
CCN1CC2(CN3CCC2CC3)OC1=O,,PF-03654764,
O=C1CCCC(=O)N1C(CCc1ccncc1)COc1ccc(-c2cccc([N+](=O)[O-])c2)cc1,,ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCC1,,"Tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate",
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCCCC(=O)NC1(C(=O)NCCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1,,3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCCC(=O)NC1(C(=O)NCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1,,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,
CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,Lawsone,
N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,(4-(trifluoromethoxy)phenyl)urea,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1,,"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O,,L-Saccharopine,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1C(C(=O)N[C@H](CCCNC(=N)N)C(=O)O)C[C@@H]2CCCC[C@@H]21)C1Cc2ccccc2C1)C1Cc2ccccc2C1,,B-9430,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,(Carboxyhydroxyamino)Ethanoic Acid,
N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C1Cc2ccccc2C1)C(=O)O,,Cupric glycinate,
N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(=O)O)C1Cc2ccccc2C1,,PR-104,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,Kynurenine,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,Paramethasone,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)O)C[C@H]2CCCC[C@H]21)C1Cc2ccccc2C1,,(S)-mandelonitrile,
N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1C(C(=O)O)C[C@@H]2CCCC[C@@H]21)C1Cc2ccccc2C1)C1Cc2ccccc2C1,,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,Lactulose,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCC1,,4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,
N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,"D-Myo-Inositol-1,4-Bisphosphate",
Fc1ccc(C2CC3CCC2N3)cc1,,Adriforant,
Brc1ccc(C2CC3CCC2N3)cc1,,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,
CCCN1C=CC(C)=C2C(=O)NC(N)N=C21,,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",
NC1N=C2C(=CC=CN2Cc2ccccc2)C(=O)N1,,Difenoxin,
CN1C=CC=C2C(=O)NC(N)N=C21,,Procyclidine,
CC1=C2C(=O)NC(N)N=C2N(CCC(C)C)C=C1,,Thymopentin,
CC1=C2C(=O)NC(N)N=C2N(CC(C)C)C=C1,,Valomaciclovir stearate,
CC(C)N1C=CC=C2C(=O)NC(N)N=C21,,Pidolic acid,
CC(C)CN1C=CC=C2C(=O)NC(N)N=C21,,2-Fluoro-2'-Deoxyadenosine,
CC1=CC=C2C(=O)NC(N)N=C2N1C,,"Imino[2-(2-oxo-1,2-dihydro-3-pyridinyl)-1H-benzimidazol-5-yl]methanaminium",
CCN1C=CC=C2C(=O)NC(N)N=C21,,"10-Propargyl-5,8-Dideazafolic Acid",
CCN1C=C(C)C=C2C(=O)NC(N)N=C21,,Cilazapril,
CCCN1C(C)=CC=C2C(=O)NC(N)N=C21,,Pyrimethamine,
CC1=C2C(=O)NC(N)N=C2N(C)C=C1,,Dithioerythritol,
CCCN1C=CC=C2C(=O)NC(N)N=C21,,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,
CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1,,Liothyronine I-131,
CNC(C)[C@H]1CCC(N)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1,,Eletriptan,
N=C(N)NCc1ccc(C2CC/C(=C/I)OC2=O)cc1,,Acetyl Dithranol,
NC(N)=Nc1ccc(C2C/C(=C/I)OC(=O)C2NC(=O)c2ccccc2)cc1,,Isoxicam,
NC(N)=Nc1ccc(C2CC(=O)O/C(=C\I)C2)cc1,,SB-705498,
COc1c2ccoc2cc2oc(=O)cnc12,,Salvinorin A,
CC(=O)Nc1ccc(C[C@@H](NC(=O)[C@H](Cc2ccc(NC(=O)C3CNC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Pinometostat,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,CA4P,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,UK-432097,
CNC(=O)NCc1ccc(C[C@@H](NC(=O)[C@H](Cc2ccc(NC(=O)[C@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Dihydrexidine,
CC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](Cc2ccc(CNC(N)=O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Posizolid,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Dactinomycin,
CN(C)C[C@@H](c1ccccc1)[C@@H](O)c1ccccc1,,Gestonorone caproate,
CN(C)C[C@@H](c1ccccc1)[C@@H](O)C(C)(C)C,,Aurothioglucose,
COc1cc2nc(N3CCN(S(=O)(=O)c4nonc4-c4ccccc4)CC3)nc(N)c2cc1OC,,Ciclesonide,
Cc1cc(C)c([C@H](O)[C@@H](CN(C)C)c2ccccc2)c(C)c1,,Valspodar,
COc1ccc([C@H](CN(C)C)[C@@H](O)C2CCCCC2)cc1,,S-Hydroxymethyl Glutathione,
Cc1cn(C)c2cc3c(cc12)N(C(=O)Nc1ccccc1)CC3,,Carboxylic PRPP,
CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)O,,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,
CC(C)C1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O,,PF-05175157,
O=C(CCS(=O)(=O)Cc1ccco1)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,3-Deoxy-D-Glucosamine,
O=C(CCS(=O)Cc1ccco1)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,(1R)-3-chloro-1-phenylpropan-1-ol,
COc1ccccc1CNCCCCCCNCCCCCCCCCCCNCCCCCCNCc1ccccc1OC,,Dinor-N(Omega)-Hydroxy-L-Arginine,
C=C(NC(=O)c1ccc(/C(=C\CCCCC(=O)O)c2cccnc2)cc1)C(=O)NCCCCC1CCCCC1,,"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)co2)cc1)c1cccnc1,,L-Dilinoleoyllecithin,
CNS(=O)(=O)N1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,5-fluoro-beta-L-gulosyl fluoride,
CCC1C2C(=O)c3ccc(O)cc3C1(C)CCN2CC1CC1,,Polythiazide,
O=C1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,MK-0354,
O=C1CCC(CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1C1CCCCC1,,R-9-(2-hydroxypropyl)adenine,
CC(=O)NC1(c2ccccc2)CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Mandelic acid,
CC(C)CC[C@H](NC(=O)N1CCOCC1)C(=O)N[C@@H](C#N)CCc1ccccc1,,Etonogestrel,
CC(C)CC(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Adenosine,
CSCCC(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",
CCCCC(NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Metopimazine,
N=C(N)NCCCC(NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",
CC(C)(C)C(NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Tidiacic arginine,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(Cc2ccccc2)C(=O)O)cc1,,Quercetin-3'-O-phosphate,
Nc1ccc(CC(NC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,Deamido-Nad+,
NC(=O)CCC(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Fluclorolone acetonide,
NC(=O)CC(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)N2CCCC2C(=O)O)cc1,,Batimastat,
N=C(N)NCCCC(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Anisomycin,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(CO)C(=O)O)cc1,,Pindolol,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(CCC(=O)O)C(=O)O)cc1,,Zaltoprofen,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(Cc2ccc3ccccc3c2)C(=O)O)cc1,,Deleobuvir,
NS(=O)(=O)c1ccc(C(=O)NC(Cc2ccc(F)cc2)C(=O)O)cc1,,Zn(Ii)-(20-Oxo-Protoporphyrin Ix),
NS(=O)(=O)c1ccc(C(=O)NC(Cc2ccc3ccccc3c2)C(=O)O)cc1,,Desonide,
NS(=O)(=O)c1ccc(C(=O)NC(Cc2ccc([N+](=O)[O-])cc2)C(=O)O)cc1,,R-428,
COc1ccc(CC(NC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",
NS(=O)(=O)c1ccc(C(=O)NC(Cc2ccc(Cl)cc2)C(=O)O)cc1,,Phenylalanine,
CC(C)C(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Lexacalcitol,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NC(Cc2ccc3ccccc3c2)C(=O)O)cc1,,Deoxyspergualin,
O=C(O)[C@@H](Cc1c[nH]c2ccccc12)N(C(=O)OCc1ccccc1)C(=O)OCC1c2ccccc2-c2ccccc21,,Fosaprepitant,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(Cc2ccc(F)cc2)C(=O)O)cc1,,2-acetylamino-2-deoxy-b-D-allopyranose,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(Cc2ccc([N+](=O)[O-])cc2)C(=O)O)cc1,,Fluanisone,
COc1ccc(CC(NC(=O)CNC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,Nebicapone,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(CC(=O)O)C(=O)O)cc1,,4-methylthio-2-oxobutanoic acid,
N=C(N)NCCCC(NC(=O)c1ccc2ccc3cccc4ccc1c2c34)C(=O)NCC1OC(OC2C(N)CC(N)C(O)C2O)C(N)C(O)C1O,,Phosphoaspartate,
CC(=O)NC(C(=O)N[C@H](Cc1cc2ccccc2n1C(C)=O)C(=O)N1C(C(=O)N(C)Cc2ccccc2)CC2CCCCC21)C(C)O,,4-Methyl-Pyrroline-5-Carboxylic Acid,
CC(=O)NC(C(=O)N[C@H](Cc1cc2ccccc2n1C(C)=O)C(=O)NC(Cc1ccccc1)C(=O)N(C)Cc1ccccc1)C(C)O,,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",
CC(C)(C)NCC(O)COC(=O)c1cccs1,,Beta-hydroxyfentanyl,
CC/C(C)=N\OCC(O)CNC(C)C,,Fusafungine,
C/C(CCc1ccccc1)=N/OCC(O)CNC(C)C,,"naphthalene-1,2,4,5,7-pentol",
CCC/C(C)=N\OCC(O)CNC(C)(C)C,,2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid,
C/C(CCc1ccccc1)=N/OCC(O)CNC(C)(C)C,,(S)-tacrine(10)-hupyridone,
CC(C)NCC(O)COC(=O)C1CCCCC1,,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",
CC(C)NCC(O)COC(=O)Cc1cccs1,,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",
CC(C)NCC(O)COC(=O)C(C)C,,OSI-027,
Cc1ccc(C(=O)NCCCCC(C)NCC(O)c2ccc(O)c(O)c2)cc1,,Cannabinor,
Cc1ccc(NC(=O)NCCCCC(C)NCC(O)c2ccc(O)c(O)c2)cc1,,Phenindione,
CC(CCCCN)NCC(O)c1ccc(O)c(O)c1,,"5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid",
CC(=O)OC[C@H]1C[C@H]2CCCC[C@@H]2[C@@H](/C=C/[C@H]2CCC[C@H](C)N2C)[C@H]1[C@H](C)OC(C)=O,,Masoprocol,
C[C@@H]1O[C@H](O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12,,GDC-0810,
C[C@@H]1OC[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@H]21,,Alprazolam,
CCc1nc2c(C)cc(C)nc2n1Cc1ccc2c(c1)C(Cc1nnn[nH]1)c1ccccc1-2,,KW-3433,
C[C@H](O)[C@H]1[C@@H](CO)C[C@H]2CCCC[C@@H]2[C@H]1/C=C/[C@H]1CCC[C@H](C)N1C,,Prostalene,
CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](C)CN(C)[C@@H]1C2,,Cinolazepam,
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)oc2cc(OC)ccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O,,(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O,,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O,,Nelotanserin,
CC(C)n1cc2c3c(cccc31)C1=C[C@@H](CO)CN(C)[C@@H]1C2,,Natamycin,
CC(C)n1cc2c3c(cccc31)[C@H]1C=C(CO)CN(C)[C@@H]1C2,,Ketamine,
CC1=C[C@@H]2c3cccc4c3c(cn4C(C)C)C[C@H]2N(C)C1,,Phloroglucinol,
CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](CO)CN(C)[C@@H]1C2,,(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate,
CC(=O)N1CC=C[C@H]1C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O,,Cenobamate,
O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1,,2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone,
O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1,,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,
CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O)c1cccnc1)c1cccnc1,,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",
CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1,,CG-200745,
NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1,,Cyclo(his-pro),
NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Taurine,
NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1,,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",
O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1,,Nalorphine,
O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1,,Capecitabine,
O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1,,DECANE-1-THIOL,
CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1,,Trenbolone acetate,
CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",
O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1,,AGG-523,
NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Hydroquinone,
O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1,,Metipranolol,
NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Isopropyl beta-D-thiogalactopyranoside,
CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Fidaxomicin,
CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Nicotinamide riboside,
CCCCC/C=C/Cc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Nandrolone hydrogen sulfate,
CCCCC/C=C/c1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Methyldopa,
CC1=CCC2C(C1)c1c(O)cc(C/C=C/CCCO)cc1OC2(C)C,,Dutogliptin,
CC1=CCC2C(C1)c1c(O)cc(C/C=C/CCCC[N+](=O)[O-])cc1OC2(C)C,,Chlorsulfaquinoxaline,
COC(=O)C#CCCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Thiocolchicoside,
CC1=CCC2C(C1)c1c(O)cc(CC#CCCC[N+](=O)[O-])cc1OC2(C)C,,3-hydroxyanthranilic acid,
CC1=CCC2C(C1)c1c(O)cc(CC#CCCC#N)cc1OC2(C)C,,Penamecillin,
O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1,,Nelfinavir,
O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1,,Vaborbactam,
O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1,,O-acetyl-L-serine,
C#CCCCC#CCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,SCY-635,
CC1=CCC2C(C1)c1c(O)cc(CC#CC(C)Br)cc1OC2(C)C,,Uric acid,
CC(=O)NCCC#CCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,4-phospho-L-threonic acid,
CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,Piperidione,
CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1,,"N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine",
CCCC/C=C/CCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,AMG-131,
CC1=CCC2C(C1)c1c(O)cc(CC#CCCO)cc1OC2(C)C,,N-(indole-3-acetyl)-L-aspartic acid,
CC1=CCC2C(C1)c1c(O)cc(CC#CCCCN)cc1OC2(C)C,,3-[N-[benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonylmethylbenzene,
CC1=CCC2C(C1)c1c(O)cc(C=C=CCCCC(=O)O)cc1OC2(C)C,,Verinurad,
CC1=CCC2C(C1)c1c(O)cc(C/C=C/CCCF)cc1OC2(C)C,,Iocetamic acid,
CCCCCC#CCc1cc(OC)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Meprednisone acetate,
C#CCCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Melatonin,
CCCCCCC#CCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Pimecrolimus,
COC(=O)C#CCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,(S)-atrolactic acid,
CC1=CCC2C(C1)c1c(O)cc(C#CCCCC#N)cc1OC2(C)C,,S-(Methylmercury)-L-Cysteine,
CC1=CCC2C(C1)c1c(O)cccc1OC2(C)C,,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,
CCCCCC#Cc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",
CC1=CCC2C(C1)c1c(O)cc(CC#CCCCBr)cc1OC2(C)C,,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",
C#CCCCC#Cc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Des(carbamimidoyl) zanamivir,
CC1=CCC2C(C1)c1c(O)cc(C/C=C/CCCBr)cc1OC2(C)C,,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",
CC1(C)CCC(C)(C)c2cc(C/C=C/c3ccc(C(=O)O)cc3)ccc21,,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",
O=c1c(O)c(-c2ccc(Cl)cc2Cl)oc2cc(O)cc(O)c12,,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",
COc1ccccc1CNCCCCCNCCCCCCCCNCCCCCNCc1ccccc1OC,,(South)-Methanocarba-Thymidine,
Cc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1C,,Cytidyl-2'-5'-phospho-guanosine,
Clc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1Cl,,Lixivaptan,
Cc1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccc(C)cc2)cc1,,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",
COc1ccccc1CNCCCCCCCNCCCCCCCCNCCCCCCCNCc1ccccc1OC,,Benoxaprofen,
COc1cccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2cccc(OC)c2)c1,,"2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid",
Fc1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccc(F)cc2)cc1,,Edasalonexent,
O=[N+]([O-])c1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccc([N+](=O)[O-])cc2)cc1,,Eprinomectin,
COc1ccccc1CNCCCCCCNCCCCCCCCCCCCCCNCCCCCCNCc1ccccc1C,,Z-Pro-Prolinal,
COc1ccccc1CN(C)CCCCCCNCCCCCCCCNCCCCCCN(C)Cc1ccccc1OC,,Tetrabenazine,
c1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccccc2)cc1,,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",
c1coc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccco2)c1,,Paritaprevir,
Oc1ccc([C@@H]2C[NH2+]CCc3c2cc(O)c(O)c3Cl)cc1,,Setmelanotide,
C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@@H](CC(=O)O)Cc1ccc(N)cc1,,Bepotastine,
CCOC(=O)/C=C1\CC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Deoxy-2-fluoro-beta-D-cellotrioside,
CCOC(=O)/C=C1\CC2(CCCCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",
CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Ursodeoxycholic acid,
CSCC[C@@H]1NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,QAV-680,
Nc1nc(N)c2cc(NCc3ccc(O)cc3)ccc2n1,,Loxicodegol,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)c1cnc([C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2)o1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Hydrocortisone valerate,
CC(C)(C)NCCCON=C(C1CC1)C1CC1,,Uridine,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)c1cnc([C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2)s1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Valganciclovir,
CCCc1cn(C2C(O)C(CO)OC(SC)C2O)nn1,,Vilaprisan,
COC(=O)c1cn(C2C(O)C(CO)OC(SC)C2O)nn1,,ISOTHIAZOLIDINONE ANALOG,
CSC1OC(CO)C(O)C(n2cc(C3(O)CCCCC3)nn2)C1O,,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",
CCCCNC(=O)c1cn(C2C(O)C(CO)OC(SC)C2O)nn1,,Fosravuconazole,
CSC1OC(CO)C(O)C(n2cc(C(=O)NCCCO)nn2)C1O,,Hydroflumethiazide,
Cc1ccc(Nc2nccc(-c3ccnc(N4CCN(CC[NH3+])CC4)c3)n2)cc1Cl,,4-Hydroxyphenylglycine,
CSC1OC(CO)C(O)C(NC(=O)c2ccccc2)C1O,,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE",
N[C@H](C(=O)O)[C@@H]1C(C(=O)O)[C@@H]1CO,,PF-05241328,
O=C1CC[C@](CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CCC(F)(F)CC1,,Toreforant,
O=C1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CCC(F)(F)CC4)C3)C2)CC1,,Eribaxaban,
O=C1CC[C@](CCN2CC(N3CCC(O)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CCC(F)(F)CC1,,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",
O=C1CC[C@](CCN2CC(N3CCC(F)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CC1,,Stepronin,
O=C1CC[C@](CCN2CC(N3CCC(F)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CCC1CC1,,Polmacoxib,
NC1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CCC(F)(F)CC4)C3)C2)CC1,,"1,2-Docosahexanoyl-sn-glycero-3-phosphoserine",
CCCCc1c(C)nc2nc(SCc3nc4c(c(=O)[nH]c(=O)n4CCCC)n3CC)nn2c1C,,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",
Cc1cc(=O)n(C)c2cc(NS(C)(=O)=O)ccc12,,beta-D-glucose 6-phosphate,
CNC(=O)c1cc(OCC(=O)Nc2ccccc2)ccc1OC1CCOCC1,,MF268,
COc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,,Tazemetostat,
CCn1cnc2c1c(=O)[nH]c(=O)n2Cc1ccc(Cl)cc1,,Cyclophosphamide,
CC(=O)NC(CCC(=O)O)C(=O)N1CCC[C@H]1C(N)=O,,Pseudoephedrine,
C=CC(C)(C)c1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,,Iron sucrose,
Cc1ccc2nc(-c3ccc(OCCCN4CCCCC4)cc3)cn2c1,,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,
CCCCNc1ccc(C(=O)OCC[N+](C)(C)CCC[NH3+])cc1,,2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE,
CCCCNc1ccc(C(=O)OCC[N+](C)(C)CCC[NH2+]CCC[NH3+])cc1,,Pyridoxine,
C[NH+](C)CCOC(=O)c1ccc(NCCCC[NH3+])cc1,,1-Aminocyclopropylphosphonate,
C[NH+](C)CCOC(=O)c1ccc(N)cc1,,Chromanol,
NCCCC[C@@H](NC(=O)[C@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(n2c(=O)oc3ccccc32)CC1)C(=O)N1CCN(c2ccncc2)CC1,,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,
NCCCC[C@@H](NC(=O)[C@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N(C(N)=O)c2ccccc2)CC1)C(=O)N1CCN(c2ccncc2)CC1,,AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,
NCCCC[C@@H](NC(=O)[C@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1,,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",
CCOC(Cc1ccc(OCCN(C)C2=Nc3ccccc3Sc3ccccc32)cc1)C(=O)O,,Metribolone,
O=C(COc1ccccc1)N[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)[C@@H]3O)[C@@H]2O)[C@@H]1O,,Tacedinaline,
O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCCCCC(=O)N[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)[C@@H]3O)[C@@H]2O)[C@@H]1O,,Prajmaline,
OC[C@H]1O[C@H](OCc2ccccc2)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)[C@@H]4O)[C@@H]3O)[C@@H]2O)[C@@H](O)[C@@H]1O,,X-396,
CCCCCCCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)[C@@H]3O)[C@@H]2O)[C@@H]1O,,Epicatechin,
Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccccc2)ccc1Cl,,"19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one",
Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccnc2)ccc1Cl,,FK-960,
Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccncn2)ccc1Cl,,Trandolapril,
Oc1cc(-c2[nH]c(-c3ccco3)nc2-c2ccncc2)ccc1Cl,,CTS-1027,
COC(=O)c1ccc(NC(=O)CCN2CCC(Cc3cnc[nH]3)CC2)cc1,,Mersalyl,
O=C(CCCN1CCC(Cc2cnc[nH]2)CC1)Nc1ccc(Cl)cc1,,Clobetasone,
CCCCCCC(=O)N1CCC(Cc2cnc[nH]2)CC1,,Benfotiamine,
c1ccc(CCCCN2CCC(Cc3cnc[nH]3)CC2)cc1,,alpha-D-Xylopyranose,
OCc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1,,2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE,
O=C(CCN1CCC(Cc2cnc[nH]2)CC1)Nc1ccccc1,,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",
N=C(NO)c1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1,,"4,6-Dideoxyglucose",
OC1CCc2cc(-c3[nH]c(-c4ccccc4)nc3-c3ccncc3)ccc21,,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",
Nc1nccc(-c2nc(-c3ccccc3)[nH]c2-c2ccc(Cl)c(O)c2)n1,,Hycanthone,
OCc1cccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)c1,,Fosdagrocorat,
OCc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1Cl,,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",
Oc1ccc(CNc2ccc3ccccc3n2)cc1,,1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,
c1c[nH]c(CNc2ccc3ccccc3n2)c1,,SB-269970,
O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(C/C(=N\OCCN2CCOCC2)c2ccccc2)C[C@H]1Cc1c[nH]c2ccccc12,,Demecolcine,
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN1CCN(C)CC1,,Homatropine methylbromide,
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN1CCSCC1,,S-Methyl glutathione,
O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(C/C(=N\OCCCN2CCOCC2)c2ccccc2)C[C@H]1Cc1c[nH]c2ccccc12,,Mepenzolate,
O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(CC/C(=N\OCCN2CCOCC2)c2ccccc2)C[C@H]1Cc1c[nH]c2ccccc12,,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN1CCS(=O)(=O)CC1,,Indole-3-Glycerol Phosphate,
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCc1ccccn1,,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),
CN(C)CCCOc1ccc(CN2CCC(Cc3cnc[nH]3)CC2)cc1,,Magnesium lactate,
O=C(c1ccc(OCCCN2CCC(Cc3cnc[nH]3)CC2)nc1)N1CCCCC1,,Ravidasvir,
O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(C/C=N\OCCCN2CCOCC2)C[C@H]1Cc1c[nH]c2ccccc12,,1-(5-phospho-D-ribosyl)-ATP,
Nc1ncc(-c2ccc(OCCCN3CCC(Cc4cnc[nH]4)CC3)cc2)cn1,,Ombitasvir,
c1ncc(CC2CCN(CCCCOc3ccc(CN4CCCCC4)cc3)CC2)[nH]1,,Livoletide,
CO/N=C(/C)CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1,,Besifovir,
NC(=O)C1CCN(Cc2ccc(OCCCN3CCC(Cc4cnc[nH]4)CC3)cc2)CC1,,Imeglimin,
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN,,Tyramine,
O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(CC2=NOC(CN3CCOCC3)C2)C[C@H]1Cc1c[nH]c2ccccc12,,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",
CNCCO/N=C(/C)CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1,,"2,3-di-O-phytanyl-sn-glycerol",
C/C(CCCN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN1CCOCC1,,Agomelatine,
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN(C)C,,"2,5-Diaminopyrimidin-4,6-diol",
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCC(C)(C)N1CCOCC1,,"4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid",
O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(Cc2cc(CN3CCOCC3)on2)C[C@H]1Cc1c[nH]c2ccccc12,,Elaidamide,
O=C(Nc1nccs1)N1CCC(Cc2cnc[nH]2)CC1,,Maltose,
O=C(Nc1ncccn1)N1CCC(Cc2cnc[nH]2)CC1,,Ofloxacin,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,PKI-179,
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC[C@@H](N)C(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,Clobutinol,
COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,,Quinbolone,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@](N)(CO)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,"(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid",
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Acetoacetyl-CoA,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Troxerutin,
CC(=O)N(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,L-2-amino-4-methoxy-cis-but-3-enoic acid,
NC(N)=NCCC[C@H](NC(=O)[C@@H]1CC2(CCCC2)C2CCC[C@](Cc3ccccc3)(NC(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]3CC(O)CN3C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C(=O)N21)C(=O)O,,Surufatinib,
NC(N)=NCCC[C@H](NC(=O)[C@@H]1CC2(CCCC2)C2CCC[C@@](Cc3ccccc3)(NC(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]3CC(O)CN3C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C(=O)N21)C(=O)O,,Malacidin A,
CCOc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCN(C)CC2)c(O)c(N2CCN(C)CC2)c1,,"6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE",
COc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCOCC2)c(O)c(N2CCOCC2)c1,,Phenazocine,
CCOc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCN(C)CC2)c1,,5'-O-[(L-methionyl)-sulphamoyl]adenosine,
CCOc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCCCC2)c1,,Mebutizide,
CCOc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCOCC2)c1,,Triflusal,
CCN1CCN(Cc2cc(NC(=O)c3nc4ccccc4nc3OC)ccc2O)CC1,,Imidazole-Derived Cellobiose,
COc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCCC2)c(O)c(N2CCCC2)c1,,Bombesin,
COc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCNCC2)c(O)c(N2CCNCC2)c1,,Cefozopran,
COc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCOCC2)c1,,"3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER",
CCOc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCCC2)c1,,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",
COc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCN(C)CC2)c(O)c(N2CCN(C)CC2)c1,,Ethacizine,
CCN1CCN(Cc2cc(NC(=O)c3nc4ccccc4nc3OC)cc(N3CCN(CC)CC3)c2O)CC1,,Dihydroergocristine,
COc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCCCC2)c1,,Gallium citrate Ga-67,
CCOc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCCC2)c(O)c(N2CCCC2)c1,,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,
COc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCNCC2)c1,,Gluconolactone,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)N4CCC[C@@H]4C(=O)NCCCNC(=O)c4ccc(C(=N)N)cc4)c3Cl)c2n1,,LF-16-0687,
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OCC2OC(O)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1OP(=O)([O-])[O-],,"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",
COc1ccc(C[C@H]2c3cc(OC)c(OC)cc3CC[N+]2(C)C)cc1OC,,N-Me-laudanosine,
NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)Cn2cc(nn2)CCCNC1=O,,(E)-2-Fluoro-P-Hydroxycinnamate,
NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)Cn2cc(nn2)CCCNC(=O)[C@H](CC(N)=O)NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)Cn2cc(nn2)CCCNC1=O,,Ranimustine,
CCCCCNC(=O)[C@H](CC(N)=O)NC(=O)C1(NC(=O)[C@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)Cn2cc(CCCNC(=O)[C@H](CC(N)=O)NC(=O)C3(NC(=O)[C@H](Cc4ccc(CP(=O)(O)O)cc4)NC(C)=O)CCCCC3)nn2)CCCCC1,,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",
COc1nsc(OCCOCCOCCOCCOc2nsnc2C2C=CCCN2C)n1,,2-Dimethylamino-Ethyl-Diphosphate,
COC(=O)N1CCC(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)(C(=O)N[C@@H](CC(N)=O)C(=O)NCCCc2ccc3ccccc3c2)CC1,,Oprozomib,
COCCOC(=O)N1CCC(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)(C(=O)N[C@@H](CC(N)=O)C(=O)NCCCc2ccc3ccccc3c2)CC1,,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",
NC(=O)C[C@H](NC(=O)C1(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)CCN(C(=O)OCc2ccccc2)CC1)C(=O)NCCCc1ccc2ccccc2c1,,Brivudine monophosphate,
NC(=O)C[C@H](NC(=O)C1(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)CCN(C(=O)OCCc2ccccc2)CC1)C(=O)NCCCc1ccc2ccccc2c1,,Cocarboxylase,
NC(=O)C[C@H](NC(=O)C1(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)CCN(C(=O)CCCc2ccccc2)CC1)C(=O)NCCCc1ccc2ccccc2c1,,Dextrorphan,
NC(=O)C[C@H](NC(=O)C1(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)CCN(C(=O)CCCCc2ccccc2)CC1)C(=O)NCCCc1ccc2ccccc2c1,,Diloxanide furoate,
NC(=O)C[C@H](NC(=O)C1(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)CCN(S(=O)(=O)CCc2ccccc2)CC1)C(=O)NCCCc1ccc2ccccc2c1,,PCO-371,
NC(=O)C[C@H](NC(=O)C1(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)CCN(C(=O)OCc2ccc(C(=O)O)cc2)CC1)C(=O)NCCCc1ccc2ccccc2c1,,4-Methylidene-5-One,
CC(C)[C@H](NC(=O)[C@@H]1CSSC(C)(C)[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)O,,3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid,
CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)O,,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,
CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)O,,Hydrocortisone acetate,
CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Nc2nnc(N)[nH]2)cc1)C(=O)N[C@H](Cc1ccc(Nc2nnc(N)[nH]2)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O,,"5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid",
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1COC(=O)NC(C)(C)C)[C@H](C)O,,"(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]",
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)COC(=O)NC1CCCC1)[C@H](C)O,,"2',6'-Dichloro-Biphenyl-2,6-Diol",
COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1,,Tigecycline,
COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,
COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,,Serlopitant,
COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,,alpha-maltotriose,
CC(C)C[C@H](NC(=O)[C@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(C)(C)C)C(=O)NCC(N)=O,,Oxibendazole,
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1,,"[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID",
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,"[Mpa1, D-Tyr(Et)2, Aib7]OT",
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,Basifungin,
N#C[C@H](CCc1ccccc1)NC(=O)[C@@H](CC(=O)N1CCOCC1)CC1CCCCC1,,Picosulfuric acid,
N#C[C@H](COCc1ccccc1)NC(=O)[C@@H](CC(=O)N1CCOCC1)CC1CCCCC1,,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",
N#CC1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CC1,,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",
CN1CCC(C#N)(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CC1,,Aceclofenac,
CN1CC[C@@](C#N)(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)C1,,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCN(CC2CC2)C1,,"4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid",
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCN(C2CCCCCC2)C1,,AZD-7762,
N#C[C@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCN(Cc2ccccc2)C1,,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",
CC1(C[C@H](CC(=O)N2CCOCC2)C(=O)N[C@]2(C#N)CCN(C3CCCCC3)C2)CCCCC1,,2-Amino-3-Oxo-4-Sulfo-Butyric Acid,
CC1CCC(C[C@H](CC(=O)N2CCOCC2)C(=O)N[C@]2(C#N)CCN(C3CCCCC3)C2)CC1,,7-methyl-guanosine-5'-triphosphate,
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCc3ccccc3C2)CCN(C2CCCCC2)C1,,Auriclosene,
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCC2)CCN(C2CCCCC2)C1,,Proxyphylline,
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2Cc3ccccc3C2)CCN(C2CCCCC2)C1,,3-Chlorophenol,
CSC1=S=Nn2c1nc1ccc(S(N)(=O)=O)cc12,,Cefotaxime,
NS(=O)(=O)c1ccc2nc3n(c2c1)N=S=C3,,Pramiracetam,
CN1CCN(C2=S=Nn3c2nc2ccc(S(N)(=O)=O)cc23)CC1,,N-Acetyl-L-Glutamate,
NS(=O)(=O)c1ccc2nc3n(c2c1)N=S=C3Sc1ccccc1,,METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE,
CC1(C)NC(=O)N(C/C(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)=N/O)C1=O,,Sarecycline,
N#Cc1c(-c2cc(Cl)ccc2Cl)cc(-c2cc(-c3ccccc3)ccc2O)[nH]c1=O,,"2,4,6-Triaminoquinazoline",
N#Cc1c(-c2cc(Cl)ccc2Cl)cc(-c2cc(C3CCCC3)ccc2O)[nH]c1=O,,Lidorestat,
Cc1ccc(C)c(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)c1,,Letrazuril,
N#Cc1c(-c2cc(C(F)(F)F)ccc2Cl)cc(-c2cc(Br)ccc2O)[nH]c1=O,,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,
N#Cc1c(-c2cc(C(F)(F)F)ccc2Cl)cc(-c2cc(Cl)ccc2O)[nH]c1=O,,L-Lysine,
N#Cc1c(-c2cc(-c3ccccc3)ccc2Cl)cc(-c2cc(Br)ccc2O)[nH]c1=O,,WX-UK1,
CN(Cc1cc(Cl)cc(-c2cc(-c3cc(C(F)(F)F)ccc3Cl)c(C#N)c(=O)[nH]2)c1O)C(=O)C1CCCCC1,,Bortezomib,
N#Cc1c(-c2cc(C(F)(F)F)ccc2Cl)cc(-c2cc(Cl)cc(CNC(=O)C3CCCCC3)c2O)[nH]c1=O,,"D-Erythro-2,3-diaminobutyric acid",
CC(=O)N1CCC(C(=O)NCc2cc(Cl)cc(-c3cc(-c4cc(C(F)(F)F)ccc4Cl)c(C#N)c(=O)[nH]3)c2O)CC1,,Dopamine,
CN(Cc1cc(Cl)cc(-c2cc(-c3cc(C(F)(F)F)ccc3Cl)c(C#N)c(=O)[nH]2)c1O)C(=O)CCN1CCCC1,,"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",
COC1CCC(C(=O)N(C)Cc2cc(Cl)cc(-c3cc(-c4cc(C(F)(F)F)ccc4Cl)c(C#N)c(=O)[nH]3)c2O)CC1,,Ochromycinone,
CN(Cc1cc(Cl)cc(-c2cc(-c3cc(C(F)(F)F)ccc3Cl)c(C#N)c(=O)[nH]2)c1O)C(=O)C1CCN(C(=O)OC(C)(C)C)CC1,,GW842166,
COCC(=O)N1CCC(C(=O)N(C)Cc2cc(Cl)cc(-c3cc(-c4cc(C(F)(F)F)ccc4Cl)c(C#N)c(=O)[nH]3)c2O)CC1,,Dorzolamide,
CCCN1CCC(C(=O)N(C)Cc2cc(Cl)cc(-c3cc(-c4cc(C(F)(F)F)ccc4Cl)c(C#N)c(=O)[nH]3)c2O)CC1,,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",
CCCCCN1CCC(C(=O)N(C)Cc2cc(Cl)cc(-c3cc(-c4cc(C(F)(F)F)ccc4Cl)c(C#N)c(=O)[nH]3)c2O)CC1,,SYRINGATE,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cccc(CN2CCCCC2)c1Cl,,Uridine-Diphosphate-N-Acetylgalactosamine,
CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)[C@@H](N)CCCCN)cc1,,Chromic citrate,
Cc1nnc(SCC2=NOCC2)n1-c1ccccc1,,Talampicillin,
Cc1cc(OCC(=O)N2CCOCC2)cc(C(C)C)c1Cl,,Itacitinib,
c1ccc2c(c1)nc(-c1cscn1)n2CCCc1nnn[nH]1,,Glutamic acid,
CCCc1nc2cccc(C(=O)OC)c2n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1,,Hyperforin,
CCc1nc2cccc(C(=O)OC)c2n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1,,Cefacetrile,
COC(=O)c1cccc2nc(C)n(Cc3ccc(-n4cccc4-c4nnn[nH]4)cc3)c12,,Hydroxydione,
CCCCc1nc2cccc(C(=O)OCC)c2n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1,,Rilapladib,
CCCc1nc2cccc(C(=O)OCC)c2n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1,,Levobunolol,
CCCCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-n2cccc2C(=O)O)cc1,,Triptorelin,
CCCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-n2cccc2C(=O)O)cc1,,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",
CCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-n2cccc2C(=O)O)cc1,,MK-8245,
Cc1nc2cccc(C(=O)O)c2n1Cc1ccc(-n2cccc2C(=O)O)cc1,,Ceftriaxone,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccccn4)CC3)CN(C)[C@@H]1C2,,Alphamethadol,
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2Cc3c(cccc3OS(=O)(=O)C(F)(F)F)C[C@H]21,,"6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine",
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2Cc3ccccc3C[C@H]21,,Light green SF yellowish,
CC(C)Oc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,,Fosifloxuridine nafalbenamide,
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2Cc3c(O)cccc3C[C@H]21,,Hydroxyamphetamine,
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2Cc3c(cccc3OC(=O)OC(C)(C)C)C[C@H]21,,3-Methyladenine,
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2Cc3c(cccc3OS(C)(=O)=O)C[C@H]21,,"1alpha,24S-Dihydroxyvitamin D2",
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2Cc3c(cccc3OS(=O)(=O)C(F)(F)F)C[C@H]21,,Amprenavir,
CC(=O)c1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,,3'-Phosphate-Adenosine-5'-Diphosphate,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nsnc5n4)CC3)CN(C)[C@@H]1C2,,"(4S,5S)-1,2-dithiane-4,5-diol",
CN1C[C@H](C(=O)N2CCN(c3ccc4nsnc4n3)CC2)C[C@@H]2Cc3c(cccc3OCc3ccccc3)C[C@H]21,,Ceramide NG,
CN1C[C@H](C(=O)N2CCN(c3ccc4nsnc4n3)CC2)C[C@@H]2Cc3c(cccc3OS(C)(=O)=O)C[C@H]21,,Hydroxypropyl tetrahydropyrantriol,
Cc1ccc(S(=O)(=O)Oc2cccc3c2C[C@H]2C[C@@H](C(=O)N4CCN(c5ccc6nsnc6n5)CC4)CN(C)[C@@H]2C3)cc1,,Ioxitalamic acid,
CN1C[C@H](C(=O)N2CCN(c3ccc4nsnc4n3)CC2)C[C@@H]2Cc3c(cccc3OS(=O)(=O)C(F)(F)F)C[C@H]21,,Recoflavone,
COc1ccc(Cl)c2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,,3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,
COc1ccc(Br)c2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,,3-Methylcytosine,
COc1ccc(SC)c2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,,Estradiol,
COc1ccc(C=O)c2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nsnc5n4)CC3)CN(C)[C@@H]1C2,,CGI-1842,
COc1ccc(C(C)=O)c2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nsnc5n4)CC3)CN(C)[C@@H]1C2,,D-phenylalanyl-N-benzyl-L-prolinamide,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccncc4)CC3)CN(C)[C@@H]1C2,,Diguanosine-5'-Triphosphate,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccnn4)CC3)CN(C)[C@@H]1C2,,Dantron,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ncccn4)CC3)CN(C)[C@@H]1C2,,Ripretinib,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ncccc4OS(=O)(=O)C(F)(F)F)CC3)CN(C)[C@@H]1C2,,Elismetrep,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc(OCc5ccccc5)n4)CC3)CN(C)[C@@H]1C2,,Sulfadicramide,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc(=O)[nH]4)CC3)CN(C)[C@@H]1C2,,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc(=O)n4C)CC3)CN(C)[C@@H]1C2,,Orotic acid,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc5ccc(C#N)cc45)CC3)CN(C)[C@@H]1C2,,Nalbuphine,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cc(C)nc5ccccc45)CC3)CN(C)[C@@H]1C2,,Cytidine,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5ccccc5n4)CC3)CN(C)[C@@H]1C2,,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cc5ccccc5cn4)CC3)CN(C)[C@@H]1C2,,N-DODECANOYL-L-TYROSINE,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nccnc5n4)CC3)CN(C)[C@@H]1C2,,Dasabuvir,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cc5nccnc5cn4)CC3)CN(C)[C@@H]1C2,,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc5nonc45)CC3)CN(C)[C@@H]1C2,,4-(2-Thienyl)Butyric Acid,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nonc5c4)CC3)CN(C)[C@@H]1C2,,2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc5nsnc45)CC3)CN(C)[C@@H]1C2,,Lopinavir,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nsnc5c4)CC3)CN(C)[C@@H]1C2,,Symmetric dimethylarginine,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nccn5n4)CC3)CN(C)[C@@H]1C2,,Butyl alcohol,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccccc4F)CC3)CN(C)[C@@H]1C2,,UK-500001,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc(F)c4)CC3)CN(C)[C@@H]1C2,,Sulfamethizole,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(F)cc4)CC3)CN(C)[C@@H]1C2,,Fucitol,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccccc4C#N)CC3)CN(C)[C@@H]1C2,,L-xylitol 5-phosphate,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C#N)cc4)CC3)CN(C)[C@@H]1C2,,D-naphthyl-1-acetamido boronic acid alanine,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccccc4[N+](=O)[O-])CC3)CN(C)[C@@H]1C2,,CC-220,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc([N+](=O)[O-])c4)CC3)CN(C)[C@@H]1C2,,Gossypol,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc(C(F)(F)F)c4)CC3)CN(C)[C@@H]1C2,,Z-Val-Ala-Asp fluoromethyl ketone,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C(F)(F)F)cc4)CC3)CN(C)[C@@H]1C2,,Guanosine-5'-Monophosphate,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(O)cc4)CC3)CN(C)[C@@H]1C2,,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C(C)=O)cc4)CC3)CN(C)[C@@H]1C2,,S-Methylcysteine,
COC(=O)c1ccc(N2CCN(C(=O)[C@@H]3C[C@@H]4Cc5c(cccc5OC)C[C@H]4N(C)C3)CC2)cc1,,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C(N)=O)cc4)CC3)CN(C)[C@@H]1C2,,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",
CCN(CC)C(=O)c1ccc(N2CCN(C(=O)[C@@H]3C[C@@H]4Cc5c(cccc5OC)C[C@H]4N(C)C3)CC2)cc1,,"1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(S(C)(=O)=O)cc4)CC3)CN(C)[C@@H]1C2,,"2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(S(N)(=O)=O)cc4)CC3)CN(C)[C@@H]1C2,,"7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc(F)c4C#N)CC3)CN(C)[C@@H]1C2,,Pimozide,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4C#N)CC3)CN(C)[C@@H]1C2,,4-Oxosebacic Acid,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C(F)(F)F)cc4[N+](=O)[O-])CC3)CN(C)[C@@H]1C2,,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4S(C)(=O)=O)CC3)CN(C)[C@@H]1C2,,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCCN(c4ccccn4)CC3)CN(C)[C@@H]1C2,,Ferric sodium citrate,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,,Albendazole,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CC=C(c4ccc(Cl)cc4)CC3)CN(C)[C@@H]1C2,,Gadobutrol,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CC=C(c4ccccn4)CC3)CN(C)[C@@H]1C2,,"Trencam-3,2-Hopo",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CC=C(c4ncccn4)CC3)CN(C)[C@@H]1C2,,"(5E,7E,9)-decatrien-2-one",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(Cc4ccccc4)CC3)CN(C)[C@@H]1C2,,Halofantrine,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCNCC3)CN(C)[C@@H]1C2,,SP-8203,
N#Cc1ccc(NC(=O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)c(C(=O)O)c1,,O1-Pentyl-Mannose,
Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c(C(=O)O)c1,,Acetoacetic acid,
O=C(Nc1ccc(F)cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1,,Dixyrazine,
O=C(Nc1ccc(Cl)cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1,,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,
O=C(Nc1ccc([N+](=O)[O-])cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1,,Decyloxy-Methanol,
Cc1c(CCO)sc[n+]1Cc1ccc(Cl)nc1N,,Emeramide,
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,"(R,R)-2,3-Butanediol",
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,Clascoterone,
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(I)c(c34)C[C@H]21,,Perzinfotel,
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(O)c(c34)C[C@H]21,,Prednisolone tebutate,
CSc1[nH]c2cccc3c2c1C[C@@H]1[C@@H]3C[C@@H](C(=O)N2CCN(c3ccccn3)CC2)CN1C,,Brivaracetam,
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(S(C)=O)c(c34)C[C@H]21,,Atenolol,
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(S(C)(=O)=O)c(c34)C[C@H]21,,Tafamidis,
O=C([C@H]1CN[C@@H]2Cc3c(Br)[nH]c4cccc(c34)[C@H]2C1)N1CCN(c2ccccn2)CC1,,Harmine,
CCCCN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,
CC(C)CCN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,
COCCN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,Apricoxib,
CN1C[C@H](C(=O)N2CCN(c3ccc(F)c(F)c3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,"N,N-dimethylglycine",
CCN1C[C@H](C(=O)N2CCN(c3ccc(F)c(F)c3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,N-Coeleneterazine,
CN1C[C@H](C(=O)N2CCN(c3cccc(=O)n3C)CC2)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,Emicerfont,
CN1C[C@H](C(=O)N2CCN(c3cccc(=O)n3C)CC2)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,,Fenoterol,
CCn1c(N2CCN(C(=O)[C@@H]3C[C@@H]4c5cccc6[nH]c(Cl)c(c56)C[C@H]4N(C)C3)CC2)cccc1=O,,ORG-31710,
CCn1c(N2CCN(C(=O)[C@@H]3C[C@@H]4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)CC2)cccc1=O,,"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",
CN1C[C@H](C(=O)N2CCN(c3ccc(Cl)cc3)CC2)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,Haloperidol,
CN1C[C@H](C(=O)N2CCN(c3ccc(Cl)cc3)CC2)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,,Dofetilide,
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,Idrocilamide,
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,,Ritonavir,
CN1C[C@H](C(=O)N2CCN(c3ccc(F)c(F)c3)CC2)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,,Netarsudil,
CN1C[C@H](C(=O)N2CCN(c3ccc4nonc4c3)CC2)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,,(S)-Hmg-Coa,
CN1C[C@H](C(=O)N2CCN(c3ccc4nonc4c3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,Metanitrophenyl-Alpha-D-Galactoside,
CN1C[C@H](C(=O)N2CCN(c3ccc4nsnc4n3)CC2)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,
CN1C[C@H](C(=O)N2CCN(c3ccc4nsnc4n3)CC2)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,,Pentetic acid,
CN1C[C@H](C(=O)N2CCN(c3ccc4nsnc4n3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,Voglibose,
CN1C[C@@H](C(=O)N2CCN(c3cccc(=O)n3C)CC2)C[C@H]2c3cccc4[nH]c(Br)c(c34)C[C@@H]21,,Prednisolone phosphate,
CN1C[C@@H](C(=O)N2CCN(c3ccc4nonc4c3)CC2)C[C@H]2c3cccc4[nH]c(Br)c(c34)C[C@@H]21,,Adrabetadex,
O=C(CCCCCCNC(=O)c1ccc(NCc2cn(CCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5ccccc45)c(C(=O)O)c3)nn2)cc1)NO,,3-(alpha-D-Galactopyranosyloxy)-5-nitrobenzamide,
COc1cc(OCc2cccc(-c3ccccc3)c2C)cc(OC)c1CNCCNC(C)=O,,BMS-37,
CN[C@H](CC(C)C)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)O)c1ccc(O)cc1)c1ccc(O)cc1,,Afamelanotide,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C[C@H](O)CC[C@]4(C)C3C(=C)C[C@@]21CC,,Feruloyl Coenzyme A,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C[C@@H](O)CC[C@]4(C)C3C(=C)C[C@@]21CC,,Pinacidil,
C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)C[C@H]4C[C@H](O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,,Revefenacin,
C[C@@H]1CC2CC(=O)CC[C@@H]2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,,S-Methyl Phosphocysteine,
C[C@@H]1C[C@H]2C[C@@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21,,Sotalol,
C[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]2(F)CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,,9a-fluoro-testosterone,
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@@]2(O)CCCN,,Evogliptin,
CC[C@@H](C1CCCCC1)[C@H](CC)C1CCCCC1,,Magnesium salicylate,
C[C@]12CCC3=C4CCC(=O)C=C4C=C[C@H]3[C@@H]1CC[C@@H]2O,,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,
C#C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,,"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",
C[C@@H]1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21,,Acetylcysteine magnesium,
C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)C=C4CC(O)CC[C@]4(C)[C@H]3CC[C@@]21C,,Colchiceine,
C[C@@H]1C=C2CC(O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@H]12,,QGC-001,
C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)C(=CC[C@@H]3O)[C@H]12,,"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE",
C[C@]12CCc3c(ccc4ccc(O)cc34)[C@@H]1CC[C@@H]2O,,dihydroequilenin-17beta,
CC1(C)CC2=C3C=C[C@@]4(C)[C@@H](CC[C@]4(C)O)[C@@H]3CCC2=CC1=O,,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCc1ccc(/N=N/c2ccc(C(=O)NCC(=O)N[C@@H](Cc3ccc(OP(=O)(O)O)cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)O)cc2)cc1)[C@H](C)O,,Calcitriol,
CN(c1cccc(NC(=O)CN2C(=O)N(CC(=O)C(C)(C)C)c3ccccc3N(C3CCCCC3)C2=O)c1)c1nnn[nH]1,,Cloxacillin,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(SCC(=O)O)c2)C(=O)N(C2CCCCCC2)c2ccccc21,,Argatroban,
CCCN(CCc1cccnc1)CC(O)c1cccnc1,,Sirolimus,
CCCN(CCc1ccccc1Cl)CC(O)c1ccncc1,,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",
CCCN(CCc1ccc(OC)c(OC)c1)CC(O)c1cccnc1,,N6-Benzyl Adenosine-5'-Diphosphate,
CCCN(CCc1ccc(F)c(F)c1)CC(O)c1cccnc1,,Dilmapimod,
CCCN(CCc1ccc(Cl)cc1)CC(O)c1ccncc1,,Lactitol,
CC(C)(C)C(=O)CN1C(=O)N(CCCC(=O)Nc2cccc(-c3nc(=O)o[nH]3)c2)C(=O)N(C2CCCCC2)c2ccccc21,,O-Succinylbenzoate,
CNc1cccc(NC(=O)CN2C(=O)N(CC(=O)C(C)(C)C)c3ccccc3N(C3CCCCC3)C2=O)c1,,Fominoben,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(-c3nc(=O)o[nH]3)c2)C(=O)N(C2CCCCC2)c2ccccc21,,AZD-7325,
CCN(CC)c1ccc2nc3c4cc(OCCCC(=O)O)ccc4c(=O)cc-3oc2c1,,"1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine",
Cc1cncc(C[n+]2csc(CCO)c2C)c1,,Rucaparib,
Cc1c(CCO)sc[n+]1Cc1cnccc1N,,Methylatropine,
Cc1cc(C)c(C[n+]2csc(CCO)c2C)c(N)n1,,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,
CCc1ccc(C[n+]2csc(CCO)c2C)c(N)n1,,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",
Cc1c(CCO)sc[n+]1Cc1ccc(C#N)nc1N,,Mupirocin,
Cc1c(CCO)sc[n+]1Cc1cc(I)cnc1N,,Desvancosaminyl vancomycin,
CCc1sc(CCO)c(C)[n+]1Cc1ccc(C)nc1N,,Telcagepant,
CC(=O)Nc1ccc(C[n+]2csc(CCO)c2C)c(N)n1,,ginkgolide-J,
Cc1ccc(C[n+]2cc(CCO)sc2C)c(N)n1,,4-Deoxy-Alpha-D-Glucose,
Cc1ccc(C[n+]2csc(CCO)c2CO)c(N)n1,,12-Bromo-1-dodecanol,
Cc1ccc(C[n+]2csc([C@@H](O)CO)c2C)c(N)n1,,Simeprevir,
CCc1c(CCO)sc[n+]1Cc1ccc(C)nc1N,,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,
Cc1ccc(C[n+]2csc([C@H](O)CO)c2C)c(N)n1,,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",
Cc1c(CCO)sc[n+]1Cc1ccc(C(=O)c2ccccc2C(=O)O)nc1,,Gusacitinib,
Cc1ncc(C[n+]2csc(CCOP(C)(=O)OP(=O)(O)O)c2C)c(N)n1,,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",
Cc1ccc(Cn2c(C)c(CCO)sc2=O)c(N)n1,,Moxidectin,
Cc1c(Cc2cnc(N)nc2N)csc1CCO,,Guadecitabine,
Cc1c(Cc2cnc(C3CC3)nc2N)csc1CCO,,Dansylamide,
Cc1c(Cc2cnc(C(F)(F)F)nc2N)csc1CCO,,CP-609754,
Cc1c(Cc2cnc(C(C)C)nc2N)csc1CCO,,Flumequine,
COc1ccc(CN(CCN(C)CCCCCCNS(=O)(=O)c2cccc3c(N(C)C)cccc23)c2ccccn2)cc1,,Neamine,
COc1ccc(CN(CCN(C)CCCCCCNC(=O)c2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)c2ccccn2)cc1,,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",
CN1CCCC[C@H]1/C=C/C1c2ccccc2Cc2ccccc21,,Ginsenoside B2,
CN1CCCC[C@@H]1CC=C1c2ccccc2Cc2ccccc21,,Peracetic acid,
CCOC(=O)C1C(c2ccc(I)cc2)CC2CCC1N2C,,4'-nitrophenyl-3i-thiolaminaritrioside,
CC(C)(C)NCC(O)CO/N=C(/CC(=O)C(C)(C)C)C1CC1,,3'-Uridinemonophosphate,
CC(C)(C)NCC(O)CO/N=C\C1CC1,,Norvaline,
C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O,,Griseofulvin,
CC(CCCNC(=O)c1c(C(=O)ON2C(=O)CCC2=O)cccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)O,,Macitentan,
C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1C2CC3CC(C2)CC1C3)C(=O)N[C@@H](CC(=O)O)Cc1ccc(N=[N+]=[N-])c(I)c1,,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",
COc1ccc(COc2ccccc2-c2cc(CO)on2)cc1,,Bephenium,
COc1cccc(COc2ccccc2C2=NOC(CO)C2)c1,,Amodiaquine,
COC(=O)C1CC(c2ccccc2OCc2cccc(OC)c2)=NO1,,Trospium,
COc1cccc(COc2ccccc2-c2cc(CCO)on2)c1,,N-Hydroxy-4-Phosphono-Butanamide,
COc1ccc(-c2snnc2-c2cc(Cl)c(O)cc2O)cc1,,ICPD-26,
COc1ccc(-c2snnc2-c2cc(Cl)c(O)cc2O)cc1OC,,Mannitol,
Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)c1,,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,
O=C(C[C@H]1C/C=C/CCC(=O)OCCNC1=O)NCc1ccc(Cl)cc1,,CE-326597,
O=C(C[C@H]1C/C=C/CCCC(=O)OCCNC1=O)NCc1ccc(Cl)cc1,,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,
O=C(C[C@H]1C/C=C/CCCCC(=O)OCCNC1=O)NCc1ccc(Cl)cc1,,Loracarbef,
O=C(C[C@@H]1C/C=C/CCCC(=O)OCCNC1=O)NCc1ccc(Cl)cc1,,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",
O=C(C[C@@H]1C/C=C/CCCCC(=O)OCCNC1=O)NCc1ccc(Cl)cc1,,Neopterin,
O=C(C[C@H]1C/C=C/CCCC(=O)O[C@@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,"2,2-Dimethylthiazolidine-4-Carboxylic Acid;(Dmt)Thiazolidine",
O=C(C[C@@H]1C/C=C/CCCC(=O)O[C@@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,Roxarsone,
O=C(C[C@@H]1C/C=C/CCCC(=O)O[C@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,Malonaldehyde,
O=C(C[C@H]1C/C=C/CCCC(=O)O[C@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,Cenerimod,
O=C(C[C@H]1C/C=C/CCCCC(=O)O[C@@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,Aloglutamol,
CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1,,Gedatolisib,
COC(=O)c1cccc(NC(=O)NC2CCN(c3ccnc(Nc4ccc(F)cc4)n3)C2)c1,,GSK1379725A,
COc1ccc(CNc2ccc3nc(N)nc(N)c3c2)cc1,,Volixibat,
Cc1nc(NC(C2CC2)C2CC2)c2nc(C)n(-c3ccc(OC(F)F)cc3)c2n1,,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",
Cc1nc(NC(C2CC2)C2CC2)c2nc(C)n(-c3ccc(OC(F)F)cc3Cl)c2n1,,Ivosidenib,
CC(=O)N(C)C1CCN(CCC(C)(C(=O)N(C)Cc2ccccc2Cl)c2ccc(Cl)c(Cl)c2)CC1,,Topiroxostat,
CCCCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,D-pantetheine 4'-phosphate,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,SNEWIQPRLPQH,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,Rocuronium,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,Selenoinosine,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE,
CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(N=C=S)ccc1-2,,Defluoro Flumazenil Isothiocyanate,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1OC(C)=O,,Galectin-4-IN-2,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1O[PH](=O)[O-],,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,
CO[C@@H]1[C@H](N(C)C(=O)COCCOCCNC(=O)c2ccc(-c3c4ccc(=[N+](C)C)cc-4oc4cc(N(C)C)ccc34)c(C(=O)O)c2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,RSV-604,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1O,,Galectin-8-IN-2,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1OC(=O)c1ccc(C)cc1,,Galectin-4-IN-3,
OC[C@H]1O[C@@H](COCc2ccccc2)[C@H](OCc2ccccc2)C[C@@H]1O,,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,
C[C@@]12CC[C@@H]3O[C@H](CO)[C@@H](O)C[C@H]3O[C@H]1C[C@H]1O[C@@H](COCc3ccccc3)[C@H](OCc3ccccc3)C[C@@H]1O2,,PF-06459988,
C[C@@]12CC[C@@H]3O[C@H](CO)[C@@H](O)C[C@H]3O[C@H]1C[C@H]1O[C@H]3CC[C@@]4(C)O[C@H]5C[C@@H](OCc6ccccc6)[C@H](CCOCc6ccccc6)O[C@@H]5C[C@@H]4O[C@@H]3C[C@@H]1O2,,Eravacycline,
Oc1ccc([C@H]2Oc3c(c(O)cc4c3[C@H]3c5c(O)cc(O)cc5O[C@@](c5ccc(O)c(O)c5)(O4)[C@@H]3O)C[C@@H]2O)cc1,,GERANIN B,
NCC1O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H](N)C[C@H](N)[C@H]3O)[C@@H]2O)[C@@H](N)[C@H](O)[C@H]1O,,Glucosamine 4-Phosphate,
Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)[C@H](O)[C@@H]3OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)[C@H](O)[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@@H]3[C@@H](COP(=O)(O)O[C@@H]4[C@@H](COP(=O)(O)O[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)O[C@@H]5[C@@H](COP(=O)(O)O[C@H]6C[C@H](n7cc(C)c(=O)[nH]c7=O)O[C@@H]6COP(=O)(O)O[C@@H]6[C@@H](COP(=O)(O)O[C@@H]7[C@@H](COP(=O)(O)O[C@H]8C[C@H](n9cc(C)c(=O)[nH]c9=O)O[C@@H]8COP(=O)(O)O[C@H]8C[C@H](n9cc(C)c(=O)[nH]c9=O)O[C@@H]8COP(=O)(O)O[C@@H]8[C@@H](COP(=O)(O)O[C@@H]9[C@@H](CO)O[C@@H](n%10cnc%11c(=O)[nH]c(N)nc%11%10)[C@@H]9O)O[C@@H](n9cnc%10c(=O)[nH]c(N)nc%109)[C@@H]8O)O[C@@H](n8cnc9c(=O)[nH]c(N)nc98)[C@@H]7O)O[C@@H](n7cnc8c(=O)[nH]c(N)nc87)[C@@H]6O)O[C@@H](n6cnc7c(=O)[nH]c(N)nc76)[C@@H]5O)O[C@@H](n5cnc6c(=O)[nH]c(N)nc65)[C@@H]4O)O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)[C@@H]3O)O2)c(=O)[nH]c1=O,,EC-17,
C[C@H]1CN(S(=O)(=O)C[C@]23CC[C@H](CC2=O)C3(C)C)CCN1c1ncc(C(F)(F)F)cc1F,,Acetic Acid Salicyloyl-Amino-Ester,
CCCCc1nc2cc(S(=O)(=O)NCCC)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,N-(2-Acetamido)Iminodiacetic Acid,
CCCCc1nc2cc(S(=O)(=O)NC(C)C)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Fostamatinib,
CCCCNS(=O)(=O)c1ccc2c(c1)nc(CCCC)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,BPH-608,
CCCCc1nc2cc(S(=O)(=O)NC(C)(C)C)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid,
CCCCc1nc2cc(S(=O)(=O)O)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Tylvalosin,
COCCOCOc1ccc2c(c1)[C@H](NC(=O)c1ccc3ccccc3c1)[C@@H](O)[C@H](CC(=O)O)N2C(=O)OCC[Si](C)(C)C,,"3,4-Xylenol",
COCCOCOc1ccc2c(c1)[C@H](NC(=O)c1ccc(-c3ccccc3)cc1)[C@@H](O)[C@H](CC(=O)O)N2C(=O)OCC[Si](C)(C)C,,Glucose-6-Phosphate,
COCCOCOc1ccc2c(c1)[C@H](NC(=O)c1ccccc1)[C@@H](O)[C@H](CC(=O)O)N2C(=O)c1ccccc1,,"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",
COCCOCOc1ccc2c(c1)[C@H](NC(=O)c1ccc3ccccc3c1)[C@@H](O)[C@H](CC(=O)O)N2C(=O)c1ccc2ccccc2c1,,"(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine",
COCCOCOc1ccc2c(c1)[C@H](NC(=O)c1ccc(-c3ccccc3)cc1)[C@@H](O)[C@H](CC(=O)O)N2C(=O)c1ccc(-c2ccccc2)cc1,,Cefmetazole,
C=CCOC(=O)N[C@H]1c2cc(OCOCCOC)ccc2N(C(=O)c2ccccc2)[C@@H](CC(=O)O)[C@@H]1O,,Ritodrine,
COc1cc(O)ccc1/C=C1\CCC[NH+]=C1c1cccnc1,,Montelukast,
CCC(C)CNc1nccc2[nH]c3ccccc3c12,,scyllo-inositol,
c1csc(CNc2nccc3[nH]c4ccccc4c23)c1,,"4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole",
COc1ccc(C(=O)C2=C3OC(C)(C)[C@@H](CC=C(C)C)C[C@@]34C[C@@H](CC=C(C)C)C(C)(C)[C@](CC=C(C)C)(C4)C2=O)cc1O,,Valsartan,
c1cc(OCC2CN(C3CCC3)CCO2)ccc1CN1CCOCC1,,GSK-2330672,
c1cc(OCC2CN(C3CCCC3)CCO2)ccc1CN1CCOCC1,,Flutamide,
CC(C)N1CCOC(COc2cccc(CN3CCOCC3)c2)C1,,AFN-1252,
c1cc(CN2CCOCC2)cc(OCC2CN(C3CCC3)CCO2)c1,,"(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID",
c1cc(OCC2CN(C3CCCC3)CCO2)ccc1CN1CCCCC1,,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",
c1cc(OC[C@H]2CN(C3CCCC3)CCO2)ccc1CN1CCOCC1,,CRA_9785,
N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O,,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",
CC(C)(C)OC(=O)NCCCCCC(=O)NC12CC3(CCC=O)CC(CCC=O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(C3)C1)C2,,cis-Diamminechlorocholylglycinateplatinum(II),
CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](NC(=O)C(C)(C)N)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,,943519-33-3,
O=C1OCCC1=CNc1ccccc1,,GSK-690693,
CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC1=O)[C@@H](C)CC,,Homatropine,
CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2)CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,PSYCIEGHIDGIYCFNA,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O,,ASP-3026,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Thiamine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,Ado-P-Ch2-P-Ps-Ado,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC[NH+]=C([NH-])N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Fluindione,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC[NH+]=C([NH-])N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1[N+](=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Tipranavir,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cscn1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnn[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,Galidesivir,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccn1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,Epelsiban,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccsc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,Seliciclib,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,2'-O-[1-ethyl-1H-imidazol)] thymidine-5'-monophosphate,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(N)cc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,"N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid",
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cc[nH]c1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,gamma-Hydroxybutyric acid,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC1CCNCC1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,Telinavir,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,CCX-354,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE,
CC(C)C[C@H](NC(=O)CN1CC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Cytidine 5'-diphosphoglycerol,
CC(C)C[C@H](NC(=O)CN1CCC[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,GALACTOSE GREASE,
CC(C)C[C@H](NC(=O)[C@H]1CSC2C[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C(=O)N21)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,"(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one",
CC(C)C[C@H](NC(=O)[C@H]1CS[C@@H]2CC[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C(=O)N12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,4-Hydroperoxy-2-Methoxy-Phenol,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN1CCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O,,"1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycero-3-Phosphate",
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN1CCCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O,,Lonazolac,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)[C@@H](C)O,,"(2R,3S,5S)-2-(Hydroxymethyl)-5-[(2-sulfoethyl)carbamoyl]-3-pyrrolidiniumyl 2-acetamido-2-deoxy-4-O-sulfo-beta-D-glucopyranoside",
CC(C)C[C@H](NC(=O)CN1CCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O,,3-deoxy-D-lyxo-hexonic acid,
C[N+](C)(C)CCCCCCCCCCn1c(-c2ccccc2)cc(=[NH2+])c2ccc3ccc(N)cc3c21,,Glyphosate,
COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1,,Diloxanide,
CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1,,Sapanisertib,
COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O,,Novo Nordisk a/S Compound,
CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1,,Tamsulosin,
N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1,,1093222-27-5,
O=C(N[C@@H]1[C@@H](O)[C@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=O)c3ccc4ccccc4c3)[C@H]2O)O[C@H](CO)[C@@H]1O)c1ccc2ccccc2c1,,"CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE",
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=O)c3cccc4ccccc34)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,CYCLOHEXYL-NORSTATINE,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC(=O)c1cccc2ccccc12,,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,
NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)cc1,,Hexaminolevulinate,
CC(C)NC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]2CCC[N+](C)(Cc3ccc(O)cc3)C2)cc1,,Exatecan,
Cc1noc(-c2ccc(NC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H]3CCC[N+](C)(Cc4ccc(O)cc4)C3)cc2)n1,,Factor IIIm,
Cc1nc(-c2ccc(NC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H]3CCC[N+](C)(Cc4ccc(O)cc4)C3)cc2)no1,,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,
CC(C)OC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]2CCC[N+](C)(Cc3ccc(O)cc3)C2)s1,,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",
C[N+]1(Cc2ccc(O)cc2)CCC[C@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)Nc2ccc(C(=O)OC3CCCCC3)s2)C1,,Amiloride,
C=CC[N+]1(Cc2cccc(O)c2)CCC[C@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)Nc2ccc(C(=O)OC(C)C)cc2)C1,,Balanol,
CC(C)OC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]2CCC[N+](CC3CC3)(CC3CC3)C2)cc1,,Cefuroxime,
Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNC3=O)nc1,,"2,6-diaminoquinazolin-4-ol",
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Mercaptoethanol,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Adenosine-5'-(Dithio)Phosphate,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Lumacaftor,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCCCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCCCCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Bendazac,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)CCCCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,(3R)-3-HYDROXYDODECANOIC ACID,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CC(O)CNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Acipimox,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H](O)CCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Revamilast,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)C1CN(C(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)C1)C(=O)N[C@@H](CO)C(N)=O,,S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)C1CN(C(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)CCN1)C(=O)N[C@@H](CO)C(N)=O,,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1ccc(NC(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)cc1)C(=O)N[C@@H](CO)C(N)=O,,Butyramide,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1cccc(CNC(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c1)C(=O)N[C@@H](CO)C(N)=O,,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1cccc(NC(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c1)C(=O)N[C@@H](CO)C(N)=O,,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)C1CCN(C(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)CC1)C(=O)N[C@@H](CO)C(N)=O,,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H]1CC[C@@H](NC(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)CC1)C(=O)N[C@@H](CO)C(N)=O,,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H]1CC[C@H](NC(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)CC1)C(=O)N[C@@H](CO)C(N)=O,,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1ccc(CNC(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)cc1)C(=O)N[C@@H](CO)C(N)=O,,"Inositol 2,4,5-trisphosphate",
CCOc1ccc(-c2snnc2-c2cc(CC)c(O)cc2O)cc1,,Safingol,
COc1ccc(-c2snnc2-c2cc(Cl)c(O)c(Cl)c2O)cc1,,Efinaconazole,
CCOc1ccc(-c2snnc2-c2cc(CC)c(O)c(Cl)c2O)cc1,,Chlormerodrin,
C[C@@H](NC(=O)c1nc(Cl)c2ccccc2c1O)C(=O)O,,Sulfanitran,
FC1CCN(Cc2ccc(OCCCN3CCCCC3)cc2)CC1,,Oxiranpseudoglucose,
CCCN1CCN(c2nc3ccncc3[nH]2)CC1,,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,
COCC(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1,,"US8501944, 374",
CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1,,"US8501944, 375",
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,,WZ4002,
CC(=O)N[C@@H]1[C@@H](O)C[C@](OC[C@H]2O[C@@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@@H](O)[C@H]2O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO,,Neu5NAcalpha2->6lactose,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cn4c(n3)sc3ccccc34)cc2)no1,,"1,2-Dihydroxybenzene",
CCC1(CC)C(=O)N(c2ccccc2CSc2nc3ccccc3s2)C1=O,,Samatasvir,
CCC1(CC)C(=O)N(c2ccccc2CSc2nc3ccccc3o2)C1=O,,L-Baclofen,
CCC1(CC)C(=O)N(c2ccccc2CSc2nnc(-c3ccccc3)o2)C1=O,,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",
CC1=C(/C=C/c2ccc(/C=C/C(=O)O)cc2)C(C)(C)CCC1,,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",
OCc1cn(CCOCCOCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)nn1,,L-gulonic acid 6-phosphate,
CC(C)[C@H](NC(=O)c1nc(Cl)c2ccccc2c1O)C(=O)O,,"[2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester",
CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,,Mps1-IN-2,
Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,,MK-8033,
NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O,,Tenofovir disoproxil,
O=C(NCc1ccccc1)Nc1ccccc1C(=O)O,,2-(3-Benzylureido)benzoic Acid,
NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC1=O,,BMS-919373,
CC(C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)C2(CCCCC2)NC(=O)[C@H](c2ccc(OP(=O)(O)O)cc2)NC(=O)[C@@H](N)CCCCNC1=O,,"(5Z,7E,9)-decatrien-2-one",
CC(C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)C2(CCCCC2)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC1=O,,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",
CC(C)(C)NC[C@@H](O)c1ccc(OB(O)O)c(CO)c1,,BR-AEA,
CC(C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC1=O,,Talotrexin,
NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,Quinethazone,
CC1C/C=C/C(O)C(O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1,,aigialomycin D,
CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)O,,Misonidazole,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,Fenozolone,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,Butaperazine,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,Seocalcitol,
CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)O,,Pirisudanol,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,7-(alpha-D-Glucopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,Colfosceril palmitate,
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,Clorexolone,
Nc1ccc2ccc(Br)cc2n1,,7-bromoquinolin-2-amine,
Nc1cccc(-c2ccc(N)nc2)c1,,5-(3-aminophenyl)pyridin-2-amine,
Cc1ccsc1C(=O)Nc1cccnc1,,Cytarabine,
COc1cc2c(NC3CCN(CCCCCN)CC3)nc(NCCCN(C)C)nc2cc1OCCCCCN,,Sarpogrelate,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",
Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccccc3F)c2n(C)c1=O,,Selpercatinib,
Nc1ncc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c(C(F)(F)F)n1,,Acetaminophen,
CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,,OMARIGLIPTIN,
COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1,,"US8933228, Ref 2",
CC(C)CCOc1cc(OCCCN)cc(-c2ccc(CCC(=O)O)c(CCC(N)=O)c2)c1,,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,
Cc1cc2c(C(=O)NC[C@@H](C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC[C@@H](C)c3ccccc3)c(O)c(O)cc2c1O,,Ghavamiol,
FCCOCCO/N=C1/C=C(C#Cc2ccccn2)CCC1,,Ridogrel,
CN1CCN(c2ccc(C(=O)O)cc2NC(=O)c2ccccc2Cl)CC1,,Norgestrienone,
O=[N+]([O-])c1c(Nc2ccc(F)c(Cl)c2)ccc2nonc12,,4-phospho-D-erythronic acid,
Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1,,NVP-BSK805,
CCCN1C(=O)/C(=C/c2ccc(OCC(=O)O)c(Cl)c2)NC1=S,,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",
CCCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1-c1nc(CC)c(Cl)c(=O)[nH]1,,Edaravone,
CCCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1-c1nc(CC)c(I)c(=O)[nH]1,,"(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide",
CCCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1-c1nc(CC)c(F)c(=O)[nH]1,,Hemi-Babim,
O=C(O)c1csc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1,,Bcl-xL antagonist 2,
O=C(O)c1cccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1,,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,
COc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,,"Alpha-D-Glucose 1,6-Bisphosphate",
CCN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(N4CCC(O)CC4)cn3)ncc21,,Etanidazole,
COc1cc(N(C)CCO)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,,"4,6-dideoxy-4-amino-alpha-D-glucose",
COc1cc(N(C)CCCO)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,,beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose,
CC(C)Oc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,,Antineoplaston A10,
COc1cc(N2CCN(CCO)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CCC(=O)N2C,,Phosphomethylphosphonic acid guanosyl ester,
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,,ERK5-IN-1,
CC(C)CCNc1nc(NCc2ccc(C3CCCCC3)cc2)nc2c1ncn2CC(=O)O,,4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,
Nc1nc2ccc(CN(C(=O)CSCC(=O)NC3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ccc(C(=O)N[C@H](CCC(=O)O)C(=O)O)cc3)cc2c(=O)[nH]1,,Arbekacin,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,DA-6886,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Glycine,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC/C=C\CCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC/C=C\CCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Fluorescein,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCCC=CCCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Tedizolid,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCCC/C=C\CCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Abequose,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC=CCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,A-620223,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Metolazone,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid,
C=CCN(CC(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N(CC=C)CC(N)=O)[C@@H](C)O)C(=O)CCCCNC(=S)Nc1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,,Methyl beta-galactoside,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCC/C=C\CN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,CPI-1205,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC=CCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,MKC-1,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC=CCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Alovudine,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCC=CCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC/C=C\CN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,L-N(omega)-nitroarginine-(4R)-amino-L-proline amide,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C\CN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Elacytarabine,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCCC/C=C\CN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphate",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C/CN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,PF-06821497,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C/C=C\CN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC/C=C\CN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,LY-2456302,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC=CCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C\CN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C/C=C\CN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Cholic Acid,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC/C=C\CN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Tafenoquine,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC/C=C/CN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Diphenidol,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C\CN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC=CCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Sevoflurane,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Metacycline,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C/C=C\CCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Simenepag isopropyl,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCC/C=C\CCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC/C=C/CCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,5-(2-METHOXYPHENYL)-2-FUROIC ACID,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C\CCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Cyproterone acetate,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC=CCCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C\CCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,CHIR-124,
O=C(C[C@@H]1C/C=C/CCC(=O)O[C@@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,Bromo-WR99210,
C[C@@]12CC[C@@H]3O[C@H](CO)[C@@H](O)C[C@H]3O[C@H]1C[C@H]1O[C@@H](CCOCc3ccccc3)[C@H](OCc3ccccc3)C[C@@H]1O2,,"24-Homo-1,25-dihydroxyvitamin D3",
C=CCC(=C)/C=C/[C@@](C)(O)[C@H]1O[C@@H]2C[C@@H]3O[C@@H]4C[C@@H]5O[C@@H]6C[C@@H]7O[C@@H]8C[C@@H]9O[C@@H]%10C[C@@H]%11O[C@](C)(CCO)[C@@H](O)C[C@H]%11O[C@H]%10C[C@H]9O[C@H]8CC[C@@]7(C)O[C@@]6(C)CC[C@H](C)[C@H]5O[C@H]4C[C@@]3(C)O[C@H]2CC1=C,,Desulfated yessotoxin,
OC[C@H]1O[C@@H](CCOCc2ccccc2)[C@H](OCc2ccccc2)C[C@@H]1O,,Protoporphyrin,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)c1cccc(-c2ccncc2)c1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,Bisoctrizole,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)c1cccc(-c2ccnc(N)n2)c1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,Filgotinib,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,"1,2,4-Triazole",
NCCCC[C@@H](NC(=O)CCCCCNC(=O)c1ccccc1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,C-(1-hydrogyl-beta-D-glucopyranosyl) formamide,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)Nc1ccc(C(N)=O)cc1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID",
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)Cc3ccccc3)cc2)no1,,Thio-Maltohexaose,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cccnc3)cc2)no1,,S-benzylglutathione,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ccncc3)cc2)no1,,Oxytetracycline,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cccc(=O)[nH]3)cc2)no1,,Tolvaptan,
CC(C)(C)c1cc(NC(=O)Nc2ccc(C(=O)Nc3ccccc3)cc2)no1,,5-Amidino-Benzimidazole,
CC(C)(C)c1cc(NC(=O)Nc2ccc(C(=O)Nc3cccnc3)cc2)no1,,Mercaptopurine,
CC(C)(C)c1cc(NC(=O)Nc2ccc(C(=O)Nc3ccncc3)cc2)no1,,Remacemide,
O=C(Oc1ccccc1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,"1,2-Bis[(3,4,5-Trihydroxybenzoyl)Oxy]Benzene",
CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC1=O,,Sitamaquine,
COc1ccc(C2C3=C(N=c4s/c(=C\c5ccc(-c6cccc(C(=O)O)c6)o5)c(=O)n42)c2ccccc2CC3)cc1,,Vinylglycine,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)C(C)C,,Halometasone,
CC(=O)N[C@@H]1[C@@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@@H]([C@H](O)CO)[C@H](O)[C@H]3O)[C@H]2O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@@H](OCC[Si](C)(C)C)[C@H](O)[C@H]3O)[C@@H]2O)(C(=O)O)O[C@@H]1[C@H](O)[C@H](O)CO,,4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,
Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,,1268524-70-4,
CCCc1nc2c(C)cc(C(=O)NCCc3ccc(OC)c(OC)c3)cc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Ketotifen,
COc1ncnc(NCCc2ccc(S(N)(=O)=O)cc2)c1[N+](=O)[O-],,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",
NS(=O)(=O)c1ccc(Nc2ncnc(Cl)c2[N+](=O)[O-])cc1,,4-[(6-chloro-5-nitropyrimidin-4-yl)amino]benzenesulfonamide,
CSc1nc(Cl)c(C=O)c(NCc2ccc(S(N)(=O)=O)cc2)n1,,Triphendiol,
NS(=O)(=O)c1ccc(CNc2nc[nH]c(=O)c2[N+](=O)[O-])cc1,,Calyculin A,
COc1ncnc(NCc2ccc(S(N)(=O)=O)cc2)c1[N+](=O)[O-],,Benidipine,
NS(=O)(=O)c1ccc(CNc2ncnc(NCc3ccccc3)c2[N+](=O)[O-])cc1,,Methotrexate,
CSc1nc(Cl)c(C=O)c(Nc2ccc(S(N)(=O)=O)cc2)n1,,Rabeprazole,
O=C1COc2ccc(CN3CCC(c4ccccc4)CC3)cc2N1,,Bendroflumethiazide,
NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12,,1246072-89-8,
Nc1sc(-c2cncnc2)c2c1C(=O)c1ccccc1-2,,"1-Amino-3-(pyrimidin-5-yl)-8H-indeno[1,2-c]thiophen-8-one",
CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,,1260907-17-2,
O=C(Nc1ccc(Br)cc1)O[C@H]1CN2CCC1CC2,,CZEN 002,
O=C(Nc1ccccc1)N[C@H]1CN2CCC1CC2,,Proxibarbal,
O=C(Nc1ccc(Br)cc1)N[C@H]1CN2CCC1CC2,,Ribociclib,
O=C(Nc1ccc(Br)cc1)OCCCc1cccnc1,,Salinomycin,
O[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1,,Betamethasone phosphate,
O=C(Nc1ccccc1)O[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1,,L-Glutamine,
O=C(Nc1ccc(Br)cc1)O[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1,,Meticillin,
O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1ccc(Br)cc1,,Branebrutinib,
O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cccs1,,OXIMINOARYLSULFONAMIDE,
O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)Oc1ccccc1,,"S-Adenosyl-1,8-Diamino-3-Thiooctane",
Cc1cc(C)c2cc1C(=O)NCCCNC(=O)CCSc1cc-2nc(N)n1,,CH5164840,
CSc1nc(N)nc(-c2c(Cl)cc3c4c(cccc24)COC3)n1,,959766-47-3,
CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1,,Quinaprilat,
CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,,Torin 1,
COc1cc2cc(-c3cccc(-c4ccc(-c5ccccc5)cc4)c3)[n+](C)c(C)c2cc1OC,,1-Androstenediol,
NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,NMS-P118,
NS(=O)(=O)c1cc(C(=O)CSc2nc3ccccc3[nH]2)ccc1Cl,,Oglufanide,
NS(=O)(=O)c1cc(C(=O)CSc2nc3cc4c(cc3[nH]2)OCCO4)ccc1Cl,,gamma-Aminobutyric acid,
NS(=O)(=O)c1cc(C(=O)CSc2nc3c(cnc4ccccc43)[nH]2)ccc1Cl,,APR-246,
NS(=O)(=O)c1cc(C(=O)CSc2nc3ccc(Br)cc3[nH]2)ccc1Cl,,PPI-1019,
NS(=O)(=O)c1ccc(CCNc2ncnc(NCc3ccccc3)c2[N+](=O)[O-])cc1,,Sotrastaurin,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@@H](SCCN(C)C)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,
CCS(=O)(=O)Nc1ccc2c(c1)C(C(=Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2,,Milataxel,
O=C(N[C@@H](Cn1ccnc1)c1ccc(Cl)cc1Cl)c1ccc(-c2nnc(-c3ccccc3)o2)cc1,,L8Q2ZC3ULE,
CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,,INCB9471,
COc1ccccc1NC(=O)c1sc2nc(C)c(C(=O)Nc3ccc(C)cc3C)c(-c3ccc(NC(C)=O)cc3)c2c1N,,Estazolam,
CCOc1nc2ccccc2nc1C(=O)N1CCN(c2cccc(Cl)c2)CC1,,2-[4-(3-CHLOROPHENYL)PIPERAZINE-1-CARBONYL]-3-ETHOXYQUINOXALINE,
CCc1ccc2c(c1)NC(=O)CO2,,Piceatannol,
O=C(O)c1nc(-c2cccc(F)c2)[nH]c1C(=O)O,,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",
NS(=O)(=O)c1cc(C(=O)Cn2cnc3ccccc32)ccc1Cl,,5-(1h-Benzimidazol-1-Ylacetyl)-2-Chlorobenzenesulfonamide,
OB(O)c1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",
COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O,,Cephaloglycin,
COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O,,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",
COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O,,Buquinolate,
Cc1ncsc1C(=O)Nc1cccnc1,,3-Iodo-Benzyl Alcohol,
CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21,,BMS-911543,
NC(=O)c1ccc(F)c2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",
CO[C@H]1CC[C@@H](N2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)CC1,,CAN-508,
CO[C@H]1CC[C@H](N2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)CC1,,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,
COC[C@H]1CC[C@@H](N2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)CC1,,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,
COC[C@H]1CC[C@H](N2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)CC1,,Ferric (59Fe) citrate,
NC(=O)c1cccc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",
NC(=O)c1cccc2c1C(=O)N(C1CCN(C3CCC4(CC3)OCCO4)CC1)C2,,Mebendazole,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccc(F)cc3)CC1)C2,,Candoxatrilat,
NC(=O)c1cccc2c1C(=O)N(C1CCN([C@H]3CC[C@H](CO)CC3)CC1)C2,,Acarbose Derived Hexasaccharide,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccccc3F)CC1)C2,,Lauryl glucoside,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccccc3Br)CC1)C2,,2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE),
Cn1cccc1CN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,"Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)",
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccc(C(F)(F)F)cc3)CC1)C2,,Cinitapride,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccc4ccccc4n3)CC1)C2,,2-deoxy-2-fluoro-α-D-mannose,
Cc1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1C,,Amlexanox,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccc(F)cc3F)CC1)C2,,Indole-3-carbinol,
Cc1ccccc1CN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,Ferrous cysteine glycinate,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3cccc(F)c3)CC1)C2,,Empagliflozin,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccc(Br)cc3)CC1)C2,,Netilmicin,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3cccc(C(F)(F)F)c3)CC1)C2,,2-[2-(4-Chloro-Phenylsulfanyl)-Acetylamino]-3-(4-Guanidino-Phenyl)-Propionamide,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccccc3C(F)(F)F)CC1)C2,,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",
Cc1ncsc1CN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,Bilh 434,
NC(=O)c1cccc2c1C(=O)N(C1CCN(CC3CCN(Cc4ccccc4)CC3)CC1)C2,,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3cccc4[nH]ccc34)CC1)C2,,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccc4[nH]ccc4c3)CC1)C2,,Ammonium lactate,
Cc1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1,,AZD-1305,
Cc1c(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cnn1C,,Streptozocin,
CCCOc1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1,,AZD-1480,
COc1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1,,Pimasertib,
CC(C)n1cc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)c2ccccc21,,Prulifloxacin,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3cccc(Cl)c3)CC1)C2,,Nifurtoinol,
Cc1ccc(CN2CCC(CN3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1,,1-Dodecanol,
Cc1cccc(CN2CCC(CN3Cc4cccc(C(N)=O)c4C3=O)CC2)c1,,"(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose",
NC(=O)c1cccc2c1C(=O)N(CC1CCN(Cc3ccc(F)cc3)CC1)C2,,Isosulfan blue,
NC(=O)c1c(F)ccc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,Evofosfamide,
N=C1NC(=O)/C(=C\c2c[nH]c(=O)c(-c3ccc(N4CCNCC4)nc3)c2)S1,,"Furan thiazolidinediones, A64",
CCOc1nc2ccccc2nc1C(=O)N1CCN(C)CC1,,Bentiromide,
CCOc1nc2ccccc2nc1C(=O)N1CCN(CC)CC1,,Heptyl 1-Thiohexopyranoside,
O=C(N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5)c1cccc(I)c1,,Glypromate,
CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1,,Sinapultide,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccncc3)cs2)cc1,,Sulfamethoxypyridazine,
CC(C)(C)c1cc(NC(=O)Nc2nccs2)n(-c2ccc(CC(=O)O)cc2)n1,,Digoxin,
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1,,1257628-77-5,
CCN1CCN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(C(=O)NC(c2ccccc2)c2ccccc2)C1,,Brigatinib,
CC(=O)c1c(C)[nH]c(C(=O)Nc2cc(-c3nnco3)ccc2C)c1C,,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",
Cc1cc(Nc2cc(F)c(C(F)(F)F)c(F)c2)n2nc(C(C)(F)F)nc2n1,,Lenacapavir,
Brc1cccc([C@@H]2C[C@H](c3cccc(Br)c3)n3nnnc3N2)c1,,L-Myo-Inositol-1-Phosphate,
C=CCNc1nc(-c2cc(C)n(CCC(=O)[O-])c2C)cs1,,Carmustine,
CC[C@H]1Nc2ccc(C(=O)O)cc2NC1=O,,N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine,
O=C(O)CCn1nc(-c2cccnc2)ccc1=O,,Fluzoparib,
COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12,,1300031-49-5,
CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C,,1300031-52-0,
O=C(O)/C=C/c1cccc(Nc2nc3ccc([N+](=O)[O-])cc3nc2Nc2cccc(/C=C/C(=O)O)c2)c1,,Ezetimibe,
CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2ccc(OC)cc2-n2c(C)nnc21,,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",
Nc1nc2c(-c3cnc4ccccc4c3)nccc2[nH]1,,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",
Cc1nc(-c2cnc3ccc(-c4cncc(NS(=O)(=O)c5ccccc5)c4)cn23)no1,,Urea,
NS(=O)(=O)c1cc(C(=O)Cn2c(CO)nc3ccccc32)ccc1Cl,,N-BENZOYL-D-ALANINE,
CC(C)Cc1nc2ccccc2n1CC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,
NS(=O)(=O)c1cc(C(=O)Cn2c(Cc3ccccc3)nc3ccccc32)ccc1Cl,,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,
O=C(NCc1ccccc1)c1cn([C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NCc5ccccc5)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide,
COCCNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NCCOC)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,TAK-243,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=O)c3ccc4ccccc4c3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",
CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O,,TAS-106,
COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O,,Nitroarginine,
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1,,Alobresib,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2nnc(C(N)=O)c2N)[C@H]1O,,2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER,
COc1cc(OC)cc(C(=O)N[C@@H]2[C@@H](O)[C@H](S[C@H]3O[C@H](CO)[C@H](O)[C@H](NC(=O)c4cc(OC)cc(OC)c4)[C@H]3O)O[C@H](CO)[C@@H]2O)c1,,Nimustine,
Cc1nc2ccccc2n1CC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,Chromium gluconate,
O=C(Nc1ccccc1NC(=O)c1cnc2ccccc2n1)c1ccccc1,,N-acetyl-L-arginine,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)c1ccccc1,,Hydroxyurea,
CCCCNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NCCCC)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,[1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester,
C=CCNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NCC=C)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,Medrysone,
C=CCC(=C)/C=C/[C@@](C)(O)[C@H]1O[C@@H]2C[C@@H]3O[C@@H]4C[C@@H]5O[C@@H]6C[C@@H]7O[C@@H]8C[C@@H]9O[C@@H]%10C[C@@H]%11O[C@](C)(CCO)[C@@H](O)C[C@H]%11O[C@H]%10C[C@H]9O[C@H]8CC[C@@]7(C)O[C@@]6(C)CC[C@H](C)[C@H]5O[C@H]4[C@@H](O)[C@@]3(C)O[C@H]2CC1=C,,Desulfo-Yessotoxin,
O=C(O)c1nc(-c2cccc(Cl)c2)[nH]c1C(=O)N(Cc1ccccc1)Cc1ccccc1,,Biochanin A,
CSc1nc(Cl)c(C=O)c(NCCc2ccc(S(N)(=O)=O)cc2)n1,,Chlordiazepoxide,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2nncc2S(=O)(=O)c2ccc(C)cc2)[C@H]1O,,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",
CCc1nc2ccccc2n1CC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,Mifepristone,
CSc1nc(Cl)c(C#N)c(NCc2ccc(S(N)(=O)=O)cc2)n1,,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(C(=O)NCc4ccccc4)nn3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,2-Keto-3-Deoxygluconate,
O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1,,Upamostat,
CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,,(S)-3-Hydroxy Midostaurin,
NS(=O)(=O)c1ccc(Nc2ncnc(NCc3ccccc3)c2[N+](=O)[O-])cc1,,Benzylthiouracil,
O=C(Nc1ccc(NC(=O)c2cnc3ccccc3n2)cc1)c1ccccc1,,Carmofur,
CCCc1nc2ccccc2n1CC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,Chromophore (Met-Tyr-Gly),
CC(O)CNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NCC(C)O)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",
CN(C)CCCC(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1,,5-Oxo-L-Norleucine,
CN(C)CCCC(O)(c1ccccc1)c1ccc(Cl)cc1,,Cyclohexylformamide,
NS(=O)(=O)c1cc(C(=O)Cn2c(CN3CCOCC3)nc3ccccc32)ccc1Cl,,3'-beta-Sialyl-beta-lactose,
CSc1nc(NCc2ccccc2)c(C#N)c(Nc2ccc(S(N)(=O)=O)cc2)n1,,Betulinic Acid,
CNC(=O)c1nnn([C@@H]2[C@@H](O)[C@H](SC)O[C@H](CO)[C@@H]2O)c1C(=O)NC,,Kabiramide C,
CSc1nc(Cl)c(C#N)c(NCCc2ccc(S(N)(=O)=O)cc2)n1,,3-(heptyloxy)benzoic acid,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(C(=O)Nc4cccc5ccccc45)nn3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,Vanillyl alcohol,
CSc1nc2ccccc2n1CC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,3'-Oxo-Adenosine,
CSc1nc(Cl)c(C#N)c(Nc2ccc(S(N)(=O)=O)cc2)n1,,Unoprostone,
O=C(NCCc1ccccc1)c1cn([C@@H]2[C@@H](O)[C@H](S[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NCCc5ccccc5)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,Tolfenamic acid,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(CO)nn2)[C@H]1O,,Triciribine phosphate,
CC(C)c1nc2ccccc2n1CC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,P-Hydroxybenzaldehyde,
CCCCc1nc2ccccc2n1CC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,Norelgestromin,
CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(CCCCCCCCCCNC(=O)c4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)nn3)N2C1=O,,Vorapaxar,
N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol",
Cc1[nH]nc2c1C(c1ccccn1)C1=C(CC(C)(C)CC1=O)N2,,"3,7,7-Trimethyl-4-(pyridin-2-yl)-2,4,6,7,8,9-hexahydro-5H-pyrazolo[3,4-b]quinolin-5-one",
Cc1[nH]nc2c1C(c1ccncc1)C1=C(CC(C)(C)CC1=O)N2,,865658-71-5,
Cc1[nH]nc2c1C(c1cccc(Cl)c1)C1=C(CC(C)(C)CC1=O)N2,,Pentosan polysulfate,
CN(C)c1ncc2c(=O)n(C)ccc2n1,,Fenretinide,
Cc1ccccc1-c1ccc2nc(N)c(CCC(=O)NCCC(C)(C)C)cc2c1,,Alvimopan,
O=C1N(Cc2c[nH]c3ccccc23)CCCC12CCN(c1cnc3ccccc3n1)CC2,,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,
c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1,,[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,
CO[C@H](c1ccccc1)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C[C@@H](C)CO)N(C)C(=O)[C@H]([C@H](O)c2cn(C(C)(C)[C@@H](O)CNCCCN)c3ccccc23)NC(=O)[C@H]([C@H](C)C=C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC1=O,,Cyclomarin A1 (CymA1),
O=C1N(Cc2cccc3[nH]ccc23)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Esmolol,
O=C1N(Cc2cccc3c2OCCO3)CCCC12CCN(c1cnc3ccccc3n1)CC2,,PF-03882845,
O=C1N(Cc2ccccc2C(F)(F)F)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Thiocitrulline,
O=C1N(Cc2ccc(C(F)(F)F)cc2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,
O=C1N(Cc2ccc3c(c2)OCCO3)CCCC12CCN(c1cnc3ccccc3n1)CC2,,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",
O=C1N(Cc2cccc(Cl)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Daptomycin,
O=C1N(Cc2cccc(-c3ccccn3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,
O=C1N(Cc2c[nH]c3ncccc23)CCCC12CCN(c1cnc3ccccc3n1)CC2,,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",
Cc1ccc(-n2nccn2)cc1CN1CCCC2(CCN(c3cnc4ccccc4n3)CC2)C1=O,,Degraded Cephaloridine,
O=C1N(Cc2cccc(-c3cccnc3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,2-Amino-Adenosine,
O=C1N(Cc2ccccc2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE,
O=C1N(Cc2ccc3ccccc3c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Azathioprine,
O=C1N(Cc2ccc3c(c2)OCO3)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Epsilon-N-methyllysine,
O=C1N(Cc2ccccc2)CCCC12CCN(c1nc3ccccc3[nH]1)CC2,,Fenamole,
O=C1N(Cc2cccc(-n3cccn3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Barasertib,
O=C1N(Cc2cccc(-c3ncccn3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Azidocillin,
O=C1N(Cc2ccccc2-c2ccco2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Sulfaquinoxaline,
O=C1N(Cc2cccc3ccccc23)CCCC12CCN(c1nc3ccccc3[nH]1)CC2,,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,
Cn1c(N2CCC3(CCCN(Cc4cccc5ccccc45)C3=O)CC2)nc2ccccc21,,Flavin mononucleotide,
Cc1cc2c(CN3CCCC4(CCN(c5cnc6ccccc6n5)CC4)C3=O)cccc2[nH]1,,Tritoqualine,
O=C1N(Cc2cccc(C(F)(F)F)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,AN-2718,
Cc1cccc(CN2CCCC3(CCN(c4cnc5ccccc5n4)CC3)C2=O)c1,,(R)-Atenolol,
Cc1onc(-c2ccccc2)c1CN1CCCC2(CCN(c3cnc4ccccc4n3)CC2)C1=O,,Gemcabene,
Cc1noc(-c2ccccc2CN2CCCC3(CCN(c4cnc5ccccc5n4)CC3)C2=O)n1,,Pentaerithrityl,
O=C1N(Cc2ccnc(-n3cccn3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,"1,3,2-Dioxaborolan-2-Ol",
O=C1N(Cc2cccc(-c3cnccn3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",
O=C1N(Cc2cccc3cccnc23)CCCC12CCN(c1cnc3ccccc3n1)CC2,,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,
O=C1N(Cc2cccc(-c3ccccc3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,5'-S-methyl-5'-thioadenosine,
Cc1ccc(C)c(CN2C(=O)CCCC23CCN(c2cnc4ccccc4n2)CC3)c1,,2-aminoisobutyric acid,
O=C1CCCC2(CCN(c3nc4ccccc4o3)CC2)N1Cc1cccc2[nH]ccc12,,Mephenesin,
Cn1ccc2c(CN3C(=O)CCCC34CCN(c3cnc5ccccc5n3)CC4)cccc21,,E-6005,
O=C1N(Cc2cccc(-n3ccnn3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Carboxyethyllumazine,
O=C1N(Cc2cccc3c2OCCO3)CCCC12CCN(c1nccc3occc13)CC2,,Canagliflozin,
O=C1N(Cc2cccc(-n3nccn3)c2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,BMS-906024,
O=C1N(Cc2ccccc2-n2nccn2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,NUC-1031,
COc1cccc(-n2cncc2CN2CCCC3(CCN(c4cnc5ccccc5n4)CC3)C2=O)c1,,"4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE",
O=C1N(Cc2c[nH]c3ccccc23)CCCC12CCN(c1nccc3occc13)CC2,,Malate Like Intermediate,
O=C1N(Cc2c[nH]c3ccccc23)CCCC12CCN(c1ccc3ccccc3n1)CC2,,Clopamide,
CCCNc1nc(NCc2ccc(C3CCCCC3)cc2)nc2c1ncn2CC(=O)O,,"6-hydroxy-1,6-dihydro purine nucleoside",
O=C(O)Cn1cnc2c(Oc3ccc([N+](=O)[O-])cc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",
O=C(O)Cn1cnc2c(NCc3ccccc3)nc(NC(=O)c3ccc(C4CCCCC4)cc3)nc21,,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,
CCOc1nc2ccccc2nc1C(=O)N1CCN(c2ccccc2)CC1,,Telaprevir,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Dacarbazine,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Acalisib,
CN[C@@H](C)C(=O)NC1CCC[C@H]2[C@@H](Cc3ccccc3)C[C@@H](C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,,Vorolanib,
CCCCCNc1nc(NC2CCCCC2)c2ncn(CC(=O)O)c2n1,,Dibekacin,
CCCCCNc1nc(N(C)CCCC)c2ncn(CC(=O)O)c2n1,,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",
CCCCCNc1nc(Oc2ccc([N+](=O)[O-])cc2)c2ncn(CC(=O)O)c2n1,,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",
O=C(O)Cn1cnc2c(NCc3ccccc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Tropisetron,
O=C(O)Cn1cnc2c(NCc3ccco3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Desogestrel,
CN(Cc1ccco1)c1nc(NCc2ccc(C3CCCCC3)cc2)nc2c1ncn2CC(=O)O,,ABT-072,
O=C(O)Cn1cnc2c(NC3CCCCC3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,3-(N-morpholino)propanesulfonic acid,
CCCCCCNc1nc(NCc2ccc(C3CCCCC3)cc2)nc2c1ncn2CC(=O)O,,Indinavir,
NC(=O)CC1NC(=O)C2(CCCCC2)NC(=O)C(Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CS(=O)CC(C(N)=O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,,"(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE",
CCOc1nc2ccccc2nc1C(=O)N1CCN(c2ccccc2OC)CC1,,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,
CCOc1nc2ccccc2nc1C(=O)Nc1cccnc1,,Psilocybin,
CCOc1nc2ccccc2nc1C(=O)NCCc1c[nH]c2ccccc12,,"1D-myo-inositol 1,4,5-trisphosphate",
Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1,,Relamorelin,
CCCCCNc1nc(N(C)Cc2ccccc2)c2ncn(CC(=O)O)c2n1,,Tegaserod,
CCCCCN(C(=O)OC(C)(C)C)c1nc(N(C)Cc2ccccc2)c2ncn(CC(=O)O)c2n1,,Amikacin,
CCCCCNc1nc(N(C)Cc2ccco2)c2ncn(CC(=O)O)c2n1,,Dienogest,
NC(=O)CC1NC(=O)C2(CCCCC2)NC(=O)C(Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CS(=O)CC(C(N)=O)NC(=O)C(Cc2ccc3ccccc3c2)NC1=O,,PNU177836,
CCCCCNc1nc(N(C)CCC(C)C)c2ncn(CC(=O)O)c2n1,,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",
CCCCCNc1nc(N2CCOCC2)c2ncn(CC(=O)O)c2n1,,Aminocandin,
O=C(O)Cn1cnc2c(Oc3cccc([N+](=O)[O-])c3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Enoxolone,
CCOc1nc2ccccc2nc1C(=O)Nc1ccc(N(CC)CC)cc1,,Estrone,
CC(C)C1NC(=O)C(CC(N)=O)NC(=O)C2(CCCCC2)NC(=O)C(Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CS(=O)CC(C(N)=O)NC1=O,,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",
CCOc1nc2ccccc2nc1C(=O)N1CCN(c2ccc(Cl)cc2)CC1,,Adenosine 5'-phosphosulfate,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NC(=O)COCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1,,N-Acetylglucosamine,
CCOc1nc2ccccc2nc1C(=O)N1CCN(Cc2ccccc2)CC1,,Favipiravir,
O=C(O)Cn1cnc2c(N3CCOCC3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE",
O=C(O)Cn1cnc2c(Oc3cccc(Br)c3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Atpenin A5,
CCOc1nc2ccccc2nc1C(=O)NCCN(C)C,,Lymecycline,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,4-methylumbelliferyl beta-D-glucoside,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone",
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2,,XMD8-87,
CCCCCN(C(=O)OC(C)(C)C)c1nc(N2CCOCC2)c2ncn(CC(=O)O)c2n1,,"5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol",
CCCCCN(C(=O)OC(C)(C)C)c1nc(Oc2ccc([N+](=O)[O-])cc2)c2ncn(CC(=O)O)c2n1,,Fludrocortisone,
CCOc1nc2ccccc2nc1C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1,,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,
CCOc1nc2ccccc2nc1C(=O)NCCN(CC)CC,,N-1-methylheptylformamide,
CC(=O)NCCCC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CCCCNC(C)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NC(=O)COCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1)C(C)C,,Alvespimycin,
CC(=O)NCCCC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NC(=O)COCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1)C(C)C,,Isoxaflutole,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Atamestane,
CCCCCNc1nc(NC(C)C)c2ncn(CC(=O)O)c2n1,,D-Aspartic Acid,
CCCCCNc1nc(Oc2cccc([N+](=O)[O-])c2)c2ncn(CC(=O)O)c2n1,,5'-deoxy-5'-piperidin-1-ylthymidine,
CCCCCNc1nc(NC2CCCC2)c2ncn(CC(=O)O)c2n1,,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",
CCCCCNc1nc(N(C)CC)c2ncn(CC(=O)O)c2n1,,Taranabant,
C=CCNc1nc(NCCCCC)nc2c1ncn2CC(=O)O,,Mevalonic acid,
CCCCCN(C(=O)OC(C)(C)C)c1nc(Oc2cccc([N+](=O)[O-])c2)c2ncn(CC(=O)O)c2n1,,"5-hydroxymethyl-5,6-dihydrofolic acid",
CSCC[C@H](NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1)NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(N)=O,,Danirixin,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Norgestimate,
O=C(O)Cn1cnc2c(N3CCOCC3)nc(NC(=O)C3CCCCC3)nc21,,Bithionol,
O=C(O)Cn1cnc2c(Nc3ccc(F)cc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Coenzyme M,
O=C(O)Cn1cnc2c(N3CCOCC3)nc(NC(=O)c3ccc(C4CCCCC4)cc3)nc21,,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",
CCCCc1nc2cc(OC)cc(C(=O)O)c2n1Cc1ccc(N(CC)C(C(=O)O)c2ccccc2)cc1,,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Sulfobromophthalein,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,CE-224535,
CC(C)CNc1nc(NCc2ccc(C3CCCCC3)cc2)nc2c1ncn2CC(=O)O,,Pipendoxifene,
CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cccc(C(F)(F)F)c4)[nH]3)cc2)n1,,877874-85-6,
CCCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1-c1nc(CC)c(Br)c(=O)[nH]1,,1-Methylcytosine,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NC(=O)C(C)C)C4)cc3)nn3cccc23)n[nH]1,,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1,,Tacrolimus,
COCCO[C@@H]1CCN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C1,,"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,Artesunate,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC5CCCC5)C4)cc3)nn3cccc23)n[nH]1,,Fluorodopa (18F),
CCC(C)(C)O[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O,,alpha-Methylleucine,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OCC5CC5)C4)cc3)nn3cccc23)n[nH]1,,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)C)C4)cc3)nn3cccc23)n[nH]1,,Benznidazole,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CC4)cc3)nn3cccc23)n[nH]1,,Etalocib,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C(F)(F)F)C4)cc3)nn3cccc23)n[nH]1,,Dersalazine,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1,,Argifin,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCO)C4)cc3)nn3cccc23)n[nH]1,,Lomustine,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,"3-(alpha-D-galactopyranosyloxy)-N-(3-{4-[3-({2-[(3-{4-[3-({[3-(hexopyranosyloxy)-5-nitrophenyl]carbonyl}amino)propyl]piperazin-1-yl}propyl)amino]-3,4-dioxocyclobut-1-en-1-yl}amino)propyl]piperazin-1-yl}propyl)-5-nitrobenzamide",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](SC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,Ferrous tartrate,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,Tavilermide,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1,,Umirolimus,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](S(=O)(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,Rapastinel,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN(C)C)cc3)nn3cccc23)n[nH]1,,Dyphylline,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](F)C4)cc3)nn3cccc23)n[nH]1,,Angiotensin 1-7,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](S(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,"3',5'-Dinitro-N-Acetyl-L-Thyronine",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC[C@H]4CO)cc3)nn3cccc23)n[nH]1,,Thymidine 5'-triphosphate,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](O)C4)cc3)nn3cccc23)n[nH]1,,"Brodimoprim-4,6-Dicarboxylate",
Nc1ccc2cc(-c3ccsc3)ccc2n1,,6-(Thiophen-3-Yl)quinolin-2-Amine,
O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C1/SC(=S)N(C(Cc2ccccc2)C(=O)O)C1=O,,"Thiazolidinone core, 30",
O=C(O)C(Cc1ccc(O)cc1)N1C(=O)/C(=C\c2cccc(Br)c2)SC1=S,,"Thiazolidinone core, 17",
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C\c2ccccc2Br)SC1=S,,"Thiazolidinone core, 25",
Cc1cccc(/C=C2/SC(=S)N(C(Cc3ccccc3)C(=O)O)C2=O)c1,,"Thiazolidinone core, 27",
O=C(O)N1C(=O)/C(=C\c2ccccc2)SC1=S,,"Thiazolidinone core, 31",
O=C(NCC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)n1ccnc1)c1ccccc1,,"Azole, 1",
O=C(NCC(c1ccccc1)n1ccnc1)c1cnc[nH]1,,"Azole, 5",
O=C(NCC(c1ccccc1)n1ccnc1)c1ccc2sc3ccccc3c(=O)c2c1,,"Azole, 7",
O=C(NCC(c1ccccc1)n1ccnc1)c1csc(-c2ccc(Cl)cc2)c1,,"Azole, 8",
O=C(NC(C[NH+]1C=CN=C1)c1ccc(Cl)cn1)c1ccc(-c2ccc(Cl)cc2)cc1,,"Azole, 19",
Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)[nH]1,,+ 1 mM GTP,
COc1nc2c(=O)[nH]c(N)nc2n1[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C1O,,MeGTP (6b),
Nc1nc2c(nc(N3CCCC3)n2[C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)[nH]1,,PyrrGTP (7b),
Nc1nc2c(nc(Cl)n2[C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)[nH]1,,ClGTP (4b),
Nc1nc2c(nc(Br)n2[C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)[nH]1,,BrGTP (5b),
Nc1nc2c(nc(I)n2[C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)[nH]1,,IGTP (3b),
Nc1nc2c(nc(N3CCOCC3)n2[C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C2O)c(=O)[nH]1,,MorphGTP (8b),
CC(C)C[C@H](NC(=O)c1ccc(-c2cc(=O)c3cc([N+](=O)[O-])c(N[C@H](C)C4CCCCC4)cc3o2)cc1)C(N)=O,,Trifluoroacetonyl coenzyme A,
O=C(N[C@@H]1c2ccccc2-c2c(-c3nc4ccncc4[nH]3)cccc21)c1ccnc2[nH]ccc12,,Tucatinib,
Nc1ccc2cc(-c3ccccc3)ccc2n1,,N-Pyridoxyl-Threonine-5-Monophosphate,
Cc1ccccc1-c1ccc2nc(N)ccc2c1,,Xamoterol,
Nc1ccc2cc(-c3ccccc3Cl)ccc2n1,,Glymidine,
Nc1ccc2cc(-c3cccc(Cl)c3)ccc2n1,,"5,6-dihydroxy-NADP",
Nc1ccc2cc(C3CCCCC3)ccc2n1,,"5-(6-D-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic acid",
Cc1ccccc1-c1ccc2nc(N)c(CCC(=O)N(C)C3CCCCC3)cc2c1,,5-hydroxynaphthalene-1-sulfonamide,
Cc1cc(C(C)N=O)ccc1OCCCc1cnc[nH]1,,Calcium glubionate anhydrous,
COC(=O)C1C(C)=NC(SC)=NC1c1ccccc1SC,,3-(4-NITRO-PHENOXY)-PROPAN-1-OL,
Cc1cc(OCCCc2cnc[nH]2)ccc1C(C)N=O,,Vidupiprant,
O=c1scc(O)n1C(CCc1ccncc1)COc1ccc(-c2cccc([N+](=O)[O-])c2)cc1,,"1,3-Propanediol",
COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(O)C4=O)ccc3O[C@@H]2CO)ccc1O,,"3-Carbamimidamido-1,1-diphenylurea",
CN(CCOc1ccc(Cc2sc(=O)[nH]c2O)cc1)c1ccccn1,,[3H]rosiglitazone,
O=NCc1ccc(OCCCc2cnc[nH]2)cc1,,Mestranol,
CNCCN1CCC(OCc2ccccc2)CC1,,MS049,
COC(=O)C1C(C)=NC(SC)=NC1c1cccc([N+](=O)[O-])c1,,Polydatin,
O=C(OCC(COC(=O)c1cc(O)c(O)c(O)c1)OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,CDE-082,
O=NCc1cc[n+](COC[n+]2ccc(CN=O)cc2)cc1,,VTP-27999,
C=CC(C)(C)c1[nH]c2ccccc2c1C1C(=O)C(=O)C(c2c[nH]c3c(CC=C(C)C)cccc23)C(=O)C1=O,,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,
CCOC(=O)C1C(C)=NC(SC)=NC1c1cccc([N+](=O)[O-])c1,,trans-urocanic acid,
C[n+]1ccccc1CN=O,,pralidoxime-chloride,
O=NC(c1ccc(OCCCc2cnc[nH]2)cc1)C1CC1,,Sri-9662,
COC(=O)C1=C(C)N=C(C)C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],,"2,6-dimethyl-4-(2-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester",
Nc1cccc(-c2cnc(N)nc2)c1,,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",
Oc1ccc(-n2c(O)ccc2O)cc1,,Gandotinib,
CCN[C@H]1CN(CCCO)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,O-Desmethyl Brinzolamide,
COc1cc(OCCCc2cnc[nH]2)ccc1C(C)N=O,,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",
CC1(C)CCC(C)(C)c2cc(C(N=O)c3ccc4cc(C(=O)O)ccc4c3)ccc21,,Trilostane,
CC(C)(C)NC[C@@H](O)CON=C(C1CC1)C1CC1,,trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-),
CC=CCNC(=O)OCCCc1cnc[nH]1,,Perindopril,
C=CCCNC(=O)OCCCc1cnc[nH]1,,Chloramphenicol,
CC/C=C\CNC(=O)OCCCc1cnc[nH]1,,Carbocisteine,
O=C(NCCC1=CCCCC1)OCCCc1cnc[nH]1,,Balapiravir,
CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,,JAK-IN-1,
COc1cc(OC(F)F)ccc1-n1c(C)nc2c(NC(C3CC3)C3CC3)nc(C)nc21,,Gliclazide,
COc1ccc(-n2c(C)nc3c(NC(C4CC4)C4CC4)nc(C)nc32)cc1,,Acyclovir,
N=C1NC(=O)/C(=C\c2ccc(-c3cncc4ccccc34)o2)S1,,"Furan thiazolidinediones, A47",
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12,,Methylinositol,
CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,,novobiocin,
Cc1cc(O)c2c(O)cccc2c1-c1cc(O)cc(=O)o1,,DEHYDROMUTACTIN,
O=C([O-])c1cc(NC(=S)NCCCCCCOP(=O)([O-])OP(=O)([O-])OCC2OC(n3ccc(=O)[nH]c3=O)C(O)C2O)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12,,Fluorescent Probe 1,
CCCCCCCOc1ccc(C(=O)[O-])cc1O,,"benzoic acid derivative, 10",
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12,,Cloprednol,
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12,,N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12,,4-Hydroxy-Aconitate Ion,
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12,,GW-559090,
C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,,Methysergide,
C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,,"Furo[2,3d]Pyrimidine Antifolate",
C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,,Metrizamide,
O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1,,Bempedoic acid,
O=S(=O)(NCCc1cccc(CCc2nnn[nH]2)c1)c1ccc(Cl)cc1,,Bedaquiline,
O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O,,Lactose,
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12,,Zofenopril,
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12,,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12,,Xanthinol,
CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1,,URMC-099,
Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc(F)cc3F)c2)cn1,,Talabostat,
Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1,,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",
OC[C@H]1O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,S-propylamine-L-cysteine,
O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1,,4-{[4-(Phenylamino)pyrimidin-2-Yl]amino}benzoic Acid,
O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1,,4-({4-[(2-Chlorophenyl)amino]pyrimidin-2-Yl}amino)benzoic Acid,
O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1,,"Bisanilinopyrimidine, 6a",
O=C(O)c1ccc(Nc2nccc(Nc3ccccc3-c3ccccc3)n2)cc1,,4-{[4-(Biphenyl-2-Ylamino)pyrimidin-2-Yl]amino}benzoic Acid,
O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(F)(F)F)n2)cc1,,4-[(4-{[2-(Trifluoromethyl)phenyl]amino}pyrimidin-2-Yl)amino]benzoic Acid,
O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1,,4-({4-[(2-Bromophenyl)amino]pyrimidin-2-Yl}amino)benzoic Acid,
N#Cc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1,,4-({4-[(2-Cyanophenyl)amino]pyrimidin-2-Yl}amino)benzoic Acid,
Cc1[nH]nc2c1C(C)C1=C(CC(C)(C)CC1=O)N2,,DPI59,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1O,,5-Phosphoarabinonic Acid,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1,,Chlorothiazide,
O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1,,Methylprednisolone hemisuccinate,
O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1,,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",
CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1,,Carpropamide,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1,,Cinazepam,
COc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1,,Ursadiol,
Cc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1,,Ursolic acid,
Cc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1,,Phosphonothreonine,
COc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1,,Ioglycamic acid,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(F)c1,,"N-{3-[4-Hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide",
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(F)cc1,,Aprocitentan,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Cl,,BX-528,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Br,,5-hydroxyvaleric acid,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(C(F)(F)F)c1,,Imagabalin,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(C(F)(F)F)cc1,,N-beta-D-glucopyranosylacetamide,
NC(=O)c1cc[n+](COC[n+]2ccccc2CN=O)cc1,,NoName_1433,
NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(=O)CC3)CC1)C2,,"2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol",
NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(Cl)(Cl)CC3)CC1)C2,,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,
O=c1ccc2nc3ccc(OCc4cn(CCF)nn4)cc3oc-2c1,,BMS-903452,
O=c1ccc2nc3ccc(OCCBr)cc3oc-2c1,,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",
O=c1ccc2nc3ccc(OCc4ccc(I)cc4)cc3oc-2c1,,Miglitol,
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CCCN(C)CC5)c4)ccc3F)c2)CCN1,,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,
NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C2(Cc3ccccc3C2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O,,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CCN(C)CC5)c4)ccc3F)c2)CCN1,,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O,,PF-06260414,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O,,Fosnetupitant,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccccc5F)C4)cc3)nn3cccc23)n[nH]1,,Tipelukast,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cc(F)cc(F)c5)C4)cc3)nn3cccc23)n[nH]1,,Apaziquone,
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN(C)CCCN(C)C)c4)ccc3F)c2)CCN1,,"1-deoxy-1-{2,6,8-trioxo-7-[4-(phosphonooxy)butyl]-1,2,3,6,7,8-hexahydro-9H-purin-9-yl}-D-arabinitol",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCOCC1,,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,
CCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Pridinol,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCC[C@@H]4CO)cc23)[nH]n1,,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)C(=O)N4CCN(C)CC4)cc23)[nH]n1,,Sanglifehrin A,
COCCO[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O,,"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",
CCOc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OC,,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",
COCCOc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OC,,Brexanolone,
CC(C)=CCCC(C)=Cc1c(O)cc2oc(-c3ccccc3)cc(=O)c2c1O,,LGH-447,
O=c1cc(-c2ccc(F)c(F)c2)oc2cc(O)cc(O)c12,,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,
CC(C)CNc1nc2cc3c(=O)cc(-c4ccc(C(=O)N[C@@H](Cc5ccccc5)C(N)=O)cc4)oc3cc2n1Cc1ccccc1,,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](NC(=O)c2cccc(I)c2)CC[C@@]3(O)[C@H]1C5,,Nicotinamide 8-bromo-adenine dinucleotide phosphate,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O,,Nequinate,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O,,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O,,3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)C)on4)c(F)cc3F)c2cc1OC,,2'-Deoxyuridine,
CC(C)=Cc1c(O)cc2oc(-c3ccccc3)c(O)c(=O)c2c1O,,(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 176",
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CCCCC5)c4)ccc3F)c2)CCN1,,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O,,Exemestane,
CC(C)C1NC(=O)C(Cc2ccccc2)NC(=O)C(C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O,,Andarine,
C=C([C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)CC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21,,Methscopolamine bromide,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H]5C[C@H]5[C@H]4CO)cc3)nn3cccc23)n[nH]1,,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)C)on4)ccc3F)c2cc1OC,,Valopicitabine,
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](NC(=O)c2cccc(I)c2)CC[C@@]3(O)[C@H]1C5,,Methylsamidorphan,
NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O,,Imiquimod,
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)[C@@H](C)O,,Alclometasone,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCOCC4)cc23)[nH]n1,,7-methyl-GpppA,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5F)C4)cc3)nn3cccc23)n[nH]1,,4-Methoxy-E-Rhodomycin T,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCOCC1,,Trichostatin A,
CC(C)=Cc1c(O)cc(O)c2c(=O)c(O)c(-c3ccccc3)oc12,,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(C(C)(C)C)cc4)c3)c2cc1OC,,Oxprenolol,
CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O,,Sulfaethoxypyridazine,
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CCOCC5)c4)ccc3F)c2)CCN1,,Cytidine 3'-monophosphate,
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N\OCCCO,,Idoxuridine,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@@H]4CO)cc3)nn3cccc23)n[nH]1,,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,
C=CC(C)(C)c1c(OC)cc(O)c2c(=O)c(OC)c(-c3ccccc3)oc12,,S-Selanyl Cysteine,
CC(C)=Cc1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,,Bedoradrine,
COc1cc2ncnc(Oc3ccc(Cl)c(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Firategrast,
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN(C)C)c4)ccc3F)c2)CCN1,,(R)-acetoin,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O,,"(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL",
CC[C@H](C)[C@@H]1NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O,,Ilaprazole,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCCC4)cc23)[nH]n1,,RU82209,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCOCC4)cc3)nn3cccc23)n[nH]1,,Brequinar,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)[C@H](O)C4)cc3)nn3cccc23)n[nH]1,,S-23,
CC(C)=Cc1c(O)cc2oc(-c3ccccc3)cc(=O)c2c1O,,Lithium citrate,
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CCN(C=O)CC5)c4)ccc3F)c2)CCN1,,PF-06700841,
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(C)=O)C(N)=O,,Rociletinib,
CSc1nc(N)nc(-c2ccccc2C)n1,,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CCCC4)cc3)nn3cccc23)n[nH]1,,Alfaxalone,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cccc(F)c5)C4)cc3)nn3cccc23)n[nH]1,,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",
CC(C)=Cc1c(O)c(C=C(C)C)c2oc(-c3ccccc3)cc(=O)c2c1O,,Meloxicam,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cccc(C(C)(C)C)c4)c3)c2cc1OC,,ABT-639,
COc1cccc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)c1,,3-(1-Aminoethyl)Nonanedioic Acid,
Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3cnco3)cc2)on1,,Levonordefrin,
CCOC(=O)c1ccnc2[nH]ccc12,,"Ethyl 1H-pyrrolo[2,3-b]pyridine-4-carboxylate",
O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,,[(1S)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,,CEP-32496,
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2CCCCC2)cc1,,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,
NS(=O)(=O)c1ccc(C(=O)CSc2ncccn2)cc1,,Asunaprevir,
O=C1Nc2ccccc2[C@]12CCNC2,,CP-744809,
CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN,,"Acetamide, N-[2-[(2-aminoethyl)methylamino]-5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]phenyl]-",
CN(C)c1ccc(/N=N/c2nc3ccc(OCCOCCOCCF)cc3s2)cc1,,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,
NC(=O)COc1ccc(Nc2nncc3c(-c4ccc(O)cc4)cccc23)cc1,,Xipamide,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1nc(-c2ccccc2)cs1,,ginkgolide-M,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccccc1,,1308677-14-6,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C)c3)c2cc1OC,,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)C)on4)c3)c2cc1OC,,Clinofibrate,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CCCC5)on4)c3)c2cc1OC,,Folic acid,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(-c5ccccc5)on4)c3)c2cc1OC,,N-hexadecanoylglycine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CCCC5)no4)c3)c2cc1OC,,LY-2300559,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5(C(F)(F)F)CCC5)no4)c3)c2cc1OC,,"US9730937, Example 155",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)c2cc1OC,,Larotaxel,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C(C)C)c3)c2cc1OC,,Febuxostat,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4CC(C)C)c3)c2cc1OC,,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C4CCCCC4)c3)c2cc1OC,,Lutein,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3)c2cc1OC,,Prednisolone hemisuccinate,
CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O,,EPZ004777,
CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O,,1561178-17-3,
Clc1cncc(-c2nnc[nH]2)n1,,Galeterone,
COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCOCCOCCN)nc4ccccc4n3c2=O)cc1,,Talniflumate,
COc1ccc(-n2nc3c(NC(=O)CN)nc4ccccc4n3c2=O)cc1,,Beclamide,
COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCOCCOCCNC(=O)CCCCCNC(=O)COc4ccc(C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)nc4ccccc4n3c2=O)cc1,,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,
CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2cccc(CC(=O)O)c2)n1,,Conivaptan,
O=C(O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)c1,,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",
O=C(O)Cc1ccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)cc1,,Tipranavir C-14,
Cc1ccc(NC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)NO)cc1,,Thymidine monophosphate,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc(Cl)cc1,,Nabumetone,
CC(=O)Nc1ccc(NC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)NO)cc1,,Darodipine,
N#Cc1ccc(NC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)NO)cc1,,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc(I)cc1,,Triciribine,
Cc1ccc(NC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)NO)cc1C,,2-Amino-6-Chloropyrazine,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc(-c2ccccc2)cc1,,6'-Methyl-Thiamin Diphosphate,
CCc1cccc(NC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)NO)c1,,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc(-c2cn(-c3ccccc3)nn2)cc1,,"2,4-Dihydroxy-3,3-Dimethyl-Butyrate",
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc2ccc3cccc4ccc1c2c34,,Fialuridine,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc(-c2cnnn2-c2ccccc2)cc1,,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1cccc2ccccc12,,Bisoprolol,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1cccc(-c2ccccc2)c1,,3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc2ccccc2c1,,"3-[2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate",
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccccc1-c1ccccc1,,Acetyl sulfisoxazole,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccc2cc3ccccc3cc2c1,,4-Vinylguaiacol,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1cc2ccccc2c2ccccc12,,AV-101,
O=C(NO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1cccc2cc3ccccc3cc12,,N~2~-Succinylornithine,
O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)c(Nc2ccccc2)c1)N1CCC(N2CCCC2)CC1,,UNC1215,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC,,"5-benzyl-1,3-thiazol-2-amine",
COC(=O)[C@H](CCCCN)C1C(=O)CC2C1=CC(=O)CC2(C)C,,"Cyclophilin Inhibitor, 15",
COC(=O)[C@H](CCCN=C(N)N[N+](=O)[O-])C1C(=O)CC2C1=CC(=O)CC2(C)C,,"Cyclophilin Inhibitor, 3c",
COC(=O)[C@H](CCCCNS(=O)(=O)c1cccc2c(N(C)C)cccc12)C1C(=O)CC2C1=CC(=O)CC2(C)C,,"Cyclophilin Inhibitor, 3e",
COC(=O)[C@H](CCCCNS(=O)(=O)c1cccc2c(N(C)C)cccc12)C1C(=O)C[C@@H]2C1=CC(=O)CC2(C)C,,"Cyclophilin Inhibitor, 3f",
C=CC(=O)Nc1cccc(N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,,nor-NOHA,
CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)Cc1cc(C)no1,,Dolasetron,
Cc1ccc2cc1-c1cc(nc(N)n1)Sc1cccc(c1)OCCCCO2,,UDP-alpha-D-xylose,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1,,Triptolide,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1,,Manitimus,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)Nc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1,,KOS-1584,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1,,beta-Apopicropodophyllin,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCC5)C4)cc3)nn3cccc23)n[nH]1,,Razupenem,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,"2,4-Dinitrophenol",
CO[C@@H]1CC/C=C/C=C/CCOC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1C,,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",
CO[C@@H]1CC/C=C/c2cccc(c2)[C@@H](C)OC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1C,,Cefditoren,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](O)C4)cc3)nn3cccc23)n[nH]1,,Nanaomycin D,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NS(C)(=O)=O)C4)cc3)nn3cccc23)n[nH]1,,Niguldipine,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC(C(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,Efatutazone,
CSc1nc(N)nc(-c2ccc3c4c(cc(Cl)cc24)COC3)n1,,Mitolactol,
Cc1cc(C)c2cc1C(=O)NCCOC(=O)NCCSc1cc-2nc(N)n1,,Moxifloxacin,
CCC(=O)c1cccc(Nc2nc(N)nc3nc[nH]c23)c1,,6-O-Phosphoryl Inosine Monophosphate,
Cc1ccc(Nc2nncc3c(-c4ccc(O)cc4)cccc23)cc1,,Rhodamine 6G,
Oc1ccc(-c2cccc3c(Nc4cccc(O)c4)nncc23)cc1,,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,
COc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1,,(-)-menthol 1-propylene glycol carbonate,
Nc1ncc(-c2cncc(NS(=O)(=O)c3cccc(C(F)(F)F)c3)c2)cn1,,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",
COC(=O)[C@H]1[C@@H](c2ccc(C)cc2)C[C@@H]2CC[C@H]1N2C/C=C/CF,,UNII-6WKC8VL781,
COc1cc2nncc(-c3cnc(NC(C)C)c(C)c3)c2cc1OC,,947192-73-6,
CCOC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1,,SR9009,
COc1ccc(Nc2nncc3c(-c4ccc(O)cc4)cccc23)cc1,,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,
CC(C)N(CCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21)C(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1,,Pidotimod,
O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCCCCCOP(=O)(O)O[C@@H]1[C@H](O)[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@H]1O,,Pyridoxamine-5'-Phosphate,
NC(=O)Cc1ccc(Nc2nncc3c(-c4ccc(O)cc4)cccc23)cc1,,Sulfanilamide,
Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc4ccccc4c3)c2)cn1,,"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",
COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,,Facinicline,
O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCCCCCOP(=O)(O)O[C@H]1[C@H](O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]1O,,RH-1,
O=C(Nc1ccccc1)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)Nc1ccccc1,,Ambazone,
Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1[N+](=O)[O-],,OTL-38,
O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCCCCCOP(=O)(O)O[C@H]1[C@@H](O)[C@@H](O)[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@@H]1O,,Tretazicar,
CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCNC(=O)CCOCCOCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)NC1=O,,Methylbenactyzium,
CC[C@H](C)C(=O)N[C@H](CC[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,,"1,3-Thiazol-5-Ylmethyl [(2r,5r)-5-{[(2s)-2-Methylbutanoyl]amino}-1,6-Diphenylhexan-2-Yl]carbamate",
O=S(=O)(c1ccc(O)cc1O)N1Cc2ccccc2C1,,"4-(Isoindolin-2-Ylsulfonyl)benzene-1,3-Diol",
Cc1ccc(-c2ncn(-c3ccc(Nc4nccc(-c5cccc(N6CCOCC6)c5)n4)cc3)n2)cn1,,SR-3306,
Fc1cnc(-c2c[nH]c3ncc(Cl)cc23)nc1NC1CCCCC1,,Nafarelin,
C[C@H](Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F)C(=O)N(C)C,,18-methyl-19-nortestosterone,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3Cl)ccc2n1,,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",
CN(C)C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1,,I-Coeleneterazine,
COC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,"3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one",
COC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,"N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide",
C[n+]1c(C#Cc2ccccc2)cccc1C#Cc1ccccc1,,Ergosterol,
NC(=O)c1cnc(Nc2ccc(N3CCC[C@@H](C(N)=O)C3)cc2)nc1NC1CC1,,"US8501944, 376",
CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1,,Methacrylyl-Coenzyme A,
COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,,1356013-39-2,
Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1,,Emapunil,
CCOc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OC,,1188907-53-0,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCN(CCO)CC1,,Soraphen A,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OC[C@H](O)CN1CCN(C)CC1,,Iotrolan,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5(C(F)(F)F)CC5)nn4-c4ccccc4)c3)c2cc1OC,,"US9730937, Example 383",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCCCC1,,9-Deazaadenine,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 380",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccc(F)cc4)c3)c2cc1OC,,"1-[3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl]-3-[1-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea",
CCOc1cccc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)c1,,Testosterone succinate,
CCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,Hydrocortisone butyrate,
CCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)c2cc1OC,,Bremelanotide,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)no4)c3)c2cc1OC,,"US9730937, Example 382",
CCOc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)ncnc2cc1OC,,Methylecgonine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3F)c2cc1OC,,Nandrolone phenpropionate,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)c2cc1O,,Carbamazepine,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)no4)c3)c2cc1OC,,Ticagrelor,
COc1ccc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)cc1Cl,,WRR-112,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4F)c3)c2cc1OC,,"3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"1-(3-(1,1-difluoroethyl)-1-phenyl-1H-pyrazol-5-yl)-3-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)urea",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)c2cc1OC,,L-Rhamnitol,
CCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)c2cc1OC,,Triazavirin,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4Cc4ccccc4)c3)c2cc1OC,,Pagoclone,
COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Sc3ncnc4cc(OC)c(OC)cc34)c2)cc1,,Niaprazine,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCC1CCNCC1,,Docetaxel,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C(C)C)c3)c2cc1OC,,Flortaucipir F-18,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(F)c4)c3)c2cc1OC,,Diflorasone,
CCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)c2cc1OC,,Ivacaftor,
CCOC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Oc2ncnc3cc(OCCOC)c(OC)cc23)c1,,Cpad,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)n(C)n4)c3)c2cc1OC,,"1-[3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl]-3-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]urea",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cccc(C(C)(C)C#N)c4)c3)c2cc1OC,,"1,2-icosapentoyl-sn-glycero-3-phosphoserine",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccc(C)cc4)c3)c2cc1OC,,"1-[3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl]-3-[1-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(4-(trifluoromethyl)phenyl)urea",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cccc(C(C)C)c4)c3)c2cc1OC,,N-Ethyl-5'-Carboxamido Adenosine,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)c2cc1OC,,"1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)urea",
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c(F)cc3F)c2cc1OC,,D-4-hydroxyphenylglycine,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cncc(F)c4)c3)c2cc1OC,,Melagatran,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCS(=O)(=O)CC1,,Octyl triazone,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)no4)c3)c2cc1OCCOC,,4-methoxybenzenesulfinate,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(C(C)(C)C)cc4)c3)c2cc1OC,,Oxidronic acid,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)nn4-c4ccccc4)c3)c2cc1OC,,Glesatinib,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)nn4-c4ccccc4)c3)c2cc1OC,,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccncc4)c3)c2cc1OC,,anle138b,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5(C(F)(F)F)CCC5)no4)c3)c2cc1OC,,"US9730937, Example 156",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C)c3)c2cc1OC,,"(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",
COCCOc1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)cc(C(F)(F)F)c1,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(3-(2-methoxyethoxy)-5-(trifluoromethyl)phenyl)urea",
CCc1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)n(-c2ccccc2)n1,,Methocarbamol,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)C)nn4-c4ccccc4)c3)c2cc1OC,,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(3-(trifluoromethyl)phenyl)urea",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3F)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)-2-fluorophenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea",
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)ncnc2cc1OCCN1CCOCC1,,Azintamide,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5CCCC5)on4)c3)c2cc1OC,,DAS869,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1O[C@H]1CCN(CC(F)F)C1,,"(S)-1-(5-tert-Butylisoxazol-3-yl)-3-(3-{7-[1-(2,2-difluoroethyl)pyrrolidin-3-yloxy]-6-methoxyquinazolin-4-yloxy}phenyl)urea",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CCCC5)on4)c3)c2cc1OC,,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4C)c3)c2cc1OC,,Mirogabalin,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1O[C@@H]1CCNC1,,2-Methyl-3-(2-Aminothiazolo)Propanal,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(C(F)(F)F)c(OC)c4)c3)c2cc1OC,,1-(3-methoxy-4-(trifluoromethyl)phenyl)-3-(3-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-ylthio)phenyl)urea,
COc1cc(OC2CCOCC2)c2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2c1,,"(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL",
COCCOc1ccc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2c1,,Methylergometrine,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)no4)c3)c2cc1OC,,"US9730937, Example 229",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4C)c3)c2cc1OC,,1-{3-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy]phenyl}-3-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea,
CCOc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3)ncnc2cc1OC,,"4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)c2cc1OC,,Fenyramidol,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(Cl)cc(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 140",
COc1cc2nc(Cl)nc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Clonazolam,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cccc(C(C)(C)C#N)c4)c3)c2cc1OC,,Copper usnate,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCC(CO)CC1,,Cavosonstat,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCC(CO)CC1,,N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCC(CO)CC1,,"4,7-Dioxosebacic Acid",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1O[C@H]1CCN(CC(F)(F)F)C1,,"(S)-1-(5-tert-butylisoxazol-3-yl)-3-(3-{6-methoxy-7-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yloxy]quinazolin-4-yloxy}phenyl)urea",
COc1cc2ncnc(Oc3ccc(Cl)c(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3)c2cc1OC,,Edetate disodium anhydrous,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4C)c3)c2cc1OC,,Acetone Cyanohydrin,
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c(F)cc3F)c2cc1OC,,Clefamide,
COc1ccc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2c1,,Bismuth subgallate,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3ncnc4cc5c(cc34)OCCO5)c2)no1,,"1-(5-tert-butylisoxazol-3-yl)-3-[3-(7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-yloxy)phenyl]urea",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)C)on4)c3)c2cc1OC,,BMS-564929,
COCC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)on1,,Sofosbuvir,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"1-[3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl]-3-[1-phenyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4C(F)(F)F)c3)c2cc1OC,,"US9730937, Example 376",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccn4)c3)c2cc1OC,,Tenofovir alafenamide,
CCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)c2cc1OC,,Isoferulic acid,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCN(C)CC1,,Cenisertib,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)C)nn4-c4cccnc4)c3)c2cc1OC,,"2-chloro-4,5-dimethylphenol",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CC5)nn4-c4ccccc4)c3)c2cc1OC,,beta-Hydroxyasparagine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccn4)c3)c2cc1OC,,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,
CCOC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Sc2ncnc3cc(OC)c(OC)cc23)c1,,BMS-754807,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCC(CO)CC1,,Technetium Tc-99m pertechnetate,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCC1CCN(C)CC1,,Methantheline,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(4-(trifluoromethyl)phenyl)urea",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4CC(C)C)c3)c2cc1OC,,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4C(F)(F)F)c3)c2cc1OC,,"US9730937, Example 375",
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3)c2cc1OC,,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4C)c3)c2cc1OC,,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,
COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)cn1,,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(C(F)(F)F)c(F)c4)c3)c2cc1OC,,1-(3-fluoro-4-(trifluoromethyl)phenyl)-3-(3-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy)phenyl)urea,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(Cl)cc4)c3)c2cc1OC,,NAM NAPTHYLAMINOALANINE,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)c3)c2cc1OC,,Caroxazone,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c3)c2cc1OC,,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCCCC1,,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,
COc1cc2ncnc(Oc3ccc(Cl)c(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"US9730937, Example 300",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1O[C@H]1CCNC1,,Pradefovir,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCN(C)CC1,,4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1O,,"1-(3-(6-hydroxy-7-methoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea",
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c(F)cc3F)c2cc1OC,,"US9730937, Example 271",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCC(CO)CC1,,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)C)nn4-c4ccccc4)c3)c2cc1OC,,Carvedilol,
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)C)on4)ccc3Cl)c2cc1OC,,Atropine,
CCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCC,,Rociverine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4C)c3)c2cc1OC,,"1-[3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl]-3-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)CN5CCOCC5)on4)c3)c2cc1OC,,Picropodophyllin,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(1-phenyl-3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1H-pyrazol-5-yl)urea",
COCCOc1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OCCOC)c(OC)cc34)c2)cc(C(F)(F)F)c1,,1-(3-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy)phenyl)-3-(3-(2-methoxyethoxy)-5-(trifluoromethyl)phenyl)urea,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)n(C)n4)c3)c2cc1OC,,"US9730937, Example 240",
COc1ccc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2c1,,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,
COc1ccc(-n2nc(C(C)(F)F)cc2NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)cc1,,"US9730937, Example 315",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCN(S(C)(=O)=O)CC1,,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OC1CCN(CC(F)F)CC1,,"1-(5-tert-butylisoxazol-3-yl)-3-(3-{7-[1-(2,2-difluoroethyl)piperidin-4-yloxy]-6-methoxyquinazolin-4-yloxy}phenyl)urea",
CCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3)c2cc1OC,,PX-12,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCN(C)CC1,,"N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3)c2cc1OC,,Fluorescein lisicol,
COCCOc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OC,,"(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1O[C@@H]1CCN(C)C1,,2-carboxypropyl-coenzyme A,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4Cl)c3)c2cc1OC,,Zipeprol,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CCOCC5)no4)c3)c2cc1OC,,Fenofibric acid,
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(CF)CF)on4)ccc3F)c2cc1OC,,Fasiglifam,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCC(O)C1,,NS-398,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c3C)c2cc1OC,,"US9730937, Example 291",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(Cl)c4)c3)c2cc1OC,,Bis-Napthyl Beta-Ketophosphonic Acid,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C(C)(C)C)cc4)c3)c2cc1OC,,"S,S-(2-Hydroxyethyl)Thiocysteine",
CCOc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)ncnc2cc1OC,,"1-(3-(6-ethoxy-7-methoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea",
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCOC,,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCOC,,Riboflavin,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)c2cc1OC,,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4Cl)c3)c2cc1OC,,Linrodostat,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(C(F)(F)F)c(F)c4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(3-fluoro-4-(trifluoromethyl)phenyl)urea",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4cccc(C)c4)c3)c2cc1OC,,"US9730937, Example 338",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCS(=O)(=O)CC1,,Vercirnon,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Mazaticol,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCOCC1,,Uridylyl-2'-5'-phospho-guanosine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C#N)nn4-c4ccccc4)c3)c2cc1OC,,L-methionine sulfone,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C#N)nn4-c4ccccc4)c3)c2cc1OC,,"N-[2-hydroxy-1-indanyl]-5-[(2-tertiarybutylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4-hydroxy-2-(1-phenylethyl)-pentanamide",
CCOC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Sc2ncnc3cc(OCCOC)c(OC)cc23)c1,,Florbenazine F-18,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)c3)c2cc1OC,,"US9730937, Example 142",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccnc(C)c4)c3)c2cc1OC,,Gestodene,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCN(S(C)(=O)=O)CC1,,BMS-986094,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCCCC1,,Danusertib,
COc1cc(NC(=O)Nc2cccc(Sc3ncnc4cc(OC)c(OC)cc34)c2)cc(C(F)(F)F)c1,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(3-methoxy-5-(trifluoromethyl)phenyl)urea",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccncc4)c3)c2cc1OC,,"1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cccc(C(C)(C)C)c4)c3)c2cc1OC,,Tramiprosate,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)c2cc1OCCCN1CCS(=O)(=O)CC1,,Nabiximols,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCS(=O)(=O)CC1,,Bilastine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cnccc4C)c3)c2cc1OC,,Dexloxiglumide,
COc1cc2c(Sc3cccc(NC(=O)Nc4ccc(OC)c(C(F)(F)F)c4)c3)ncnc2cc1OCCN1CCOCC1,,"US9730937, Example 249",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ncn4)c3)c2cc1OC,,"US9730937, Example 146",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC[C@H](O)CN1CCN(C)CC1,,"3-Phenyl-1,2-Propandiol",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)C(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(3-(perfluoroethyl)-1-phenyl-1H-pyrazol-5-yl)urea",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCS(=O)(=O)CC1,,MK-4965,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCN(S(C)(=O)=O)CC1,,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,
COc1cc2ncnc(Oc3ccc(Cl)c(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c3)c2cc1OC,,2-Dehydropantoate,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)no4)c3)c2cc1OC,,(3S)-3-methyl-D-aspartic acid,
Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,,Bimiralisib,
Cc1cc(O)cc2c1OC(C)(CCCC(C)C)CC2,,Melarsoprol,
CO[C@@H]1OC(CO)[C@H](O)[C@H](O)C1O,,"US8703720, Reference Compound 1",
N=C(N)c1ccc(CNC(=O)CNC(=O)[C@@H](Cc2ccccc2)NS(=O)(=O)Cc2ccccc2)cc1,,"(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE",
COCCn1c(=O)n(C2CCN(C(=O)C3CCN(Cc4ccnc(N)c4)CC3)CC2)c2ccccc21,,MK-1496,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(CC5CCCCC5)c5cc(F)ccc54)CC3)CC2)ccn1,,Ferric ammonium citrate,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(CCN5CCOCC5)c5ccccc54)CC3)CC2)ccn1,,Tyramine O-sulfate,
Nc1ncnc2c1nc(NCc1ccc(F)cc1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,Nepinalone,
NS(=O)(=O)c1cc(C(=O)CSc2ncccn2)ccc1Cl,,CRA_1144,
CC(C)(C)c1cc(=O)[nH]c(SCC(=O)c2ccc(S(N)(=O)=O)cc2)n1,,Patupilone,
CCNC(=O)c1noc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1C,,Losmapimod,
O=C(OC[C@H]1OC(OC(=O)c2cc(O)c(O)c(O)c2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,CDE-066,
O=C(O[C@@H]1CCCC[C@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",
O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Cefcapene,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCc2cc(C)ccc21,,WRR-99,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCc2cccc(C)c21,,Troxipide,
CCOc1cccc(C(=O)N(C)[C@H](CCNC(=O)c2cccn2C)Cc2ccccc2)c1,,PD173955,
O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)c1cc(F)cc(N2CCOCC2)c1,,Isepamicin,
NC[C@H](NC(=O)c1ccc(C#CC#Cc2ccccc2)cc1)C(=O)NO,,"N-[(2s)-3-Amino-1-(Hydroxyamino)-1-Oxopropan-2-Yl]-4-(4-Phenylbuta-1,3-Diyn-1-Yl)benzamide",
C[C@@H](O)[C@H](NC(=O)c1ccc(-c2ccccc2)cc1)C(=O)NO,,"N-[(2s,3r)-3-Hydroxy-1-(Hydroxyamino)-1-Oxobutan-2-Yl]biphenyl-4-Carboxamide",
C[C@@H](O)[C@H](NC(=O)c1ccc(-c2ccc(Br)cc2)cc1)C(=O)NO,,"4'-Bromo-N-[(2s,3r)-3-Hydroxy-1-(Hydroxyamino)-1-Oxobutan-2-Yl]biphenyl-4-Carboxamide",
C[C@@H](O)[C@H](NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO,,"N-[(2s,3r)-3-Hydroxy-1-(Hydroxyamino)-1-Oxobutan-2-Yl]-4-(Phenylethynyl)benzamide",
NC[C@H](NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO,,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",
NC[C@H](NC(=O)c1ccc(-c2ccccc2)cc1)C(=O)NO,,Letaxaban,
CC[C@@H](CC[C@H](CC)NC(=O)[C@H](CO)NC(=O)N(C)Cc1csc(C(C)C)n1)NC(=O)OCc1cncs1,,"1,3-Thiazol-5-Ylmethyl [(3s,6s)-6-{[n-(Methyl{[2-(Propan-2-Yl)-1,3-Thiazol-4-Yl]methyl}carbamoyl)-L-Seryl]amino}octan-3-Yl]carbamate",
CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](C)CC[C@H](C)NC(=O)OCc2cncs2)C(C)C)cs1,,GS5,
COc1cccc(-c2ccc(C(=O)NC3CCN(CC(F)(F)F)CC3)cn2)c1,,Prednisone,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1,,Halazepam,
Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1,,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,
CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4ccccc34)cc2)n(-c2cccc(N)c2)n1,,"2,5-di-tert-butylhydroquinone",
COc1cc2c(Nc3cc(Cl)c(OC)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1,,Bosutinib Isomer,
C[C@H]1CC[C@H](n2c3cnccc3c3cnc(Nc4ccc5c(n4)CCN(C(=O)CO)C5)nc32)CC1,,1401033-86-0,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(OC)cc1,,Candesartan,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1cncnc1,,Brifentanil,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccn1,,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1,,Queuine,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(O)c1,,Dapivirine,
Cc1cc2c(C(=O)c3cccc4ccccc34)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)c3cccc4ccccc34)c(O)c(O)cc2c1O,,"8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",
CC1Oc2cc(CN3CCC(c4ccccc4)CC3)ccc2NC1=O,,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,
CC1Oc2cc(CN3CC=C(c4ccc(Cl)cc4)CC3)ccc2NC1=O,,Trans-O-Hydroxy-Alpha-Methyl Cinnamate,
CC1Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2NC1=O,,Sphinxolide B,
O=C1COc2ccc(CNc3ccccc3)cc2N1,,Ronopterin,
CC1Oc2ccc(CN3CC=C(c4ccc(Cl)cc4)CC3)cc2NC1=O,,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,
CN(C)C1CCN(Cc2ccc3c(c2)NC(=O)CO3)CC1,,Nerofe,
O=C1COc2ccc(CN3CC=C(c4ccc(Cl)cc4)CC3)cc2N1,,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,
O=C1COc2ccc(CNCc3ccccc3)cc2N1,,"UK-396,082",
CC1Oc2ccc(CN3CCC(N(C)C)CC3)cc2NC1=O,,(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,
COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2cccc(Sc3ncnc4cc(OC)c(OC)cc34)c2)cc1,,"L-2,4-diaminobutyric acid",
O=C1CNc2cc(Br)ccc2N1,,"6-Bromo-3,4-dihydroquinoxalin-2(1H)-one",
NC(=O)c1cc(Cl)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3cccc(Br)c3)CC1)C2,,Dimetindene,
CC(C)c1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1,,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,
COCCN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate,
CN(C)c1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1,,Broxuridine,
Nc1nc2c(-c3ccccn3)nccc2[nH]1,,SRT-2104,
Cc1noc(-c2cccc(CN3CCCC4(CCN(c5cnc6ccccc6n5)CC4)C3=O)c2)n1,,"4,4'-Biphenyldiboronic Acid",
O=C1N(Cc2cccc(-n3cccn3)n2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Cortisone,
O=C1N(Cc2cccc3nonc23)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Digalactosyl Diacyl Glycerol (Dgdg),
Cc1nc(-c2cccc(CN3CCCC4(CCN(c5cnc6ccccc6n5)CC4)C3=O)c2)no1,,Previtamin D(3),
O=C1N(Cc2c[nH]c3ccccc23)CCCC12CCN(c1nc3ccccc3[nH]1)CC2,,Bis(5-Amidino-Benzimidazolyl)Methane,
O=C1N(Cc2ncoc2-c2ccccc2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Glutamyl Group,
Cc1nc(CN2CCCC3(CCN(c4cnc5ccccc5n4)CC3)C2=O)c(-c2cccc(F)c2)s1,,Aminophosphonic acid-guanylate ester,
Cn1cc(CN2C(=O)CCCC23CCN(c2cnc4ccccc4n2)CC3)c2cccnc21,,Posaconazole,
Cc1cnc(-c2cccc(CN3CCCC4(CCN(c5cnc6ccccc6n5)CC4)C3=O)c2)o1,,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,
Cc1ccc2oc(N3CCC4(CCCC(=O)N4Cc4cccc5[nH]ccc45)CC3)nc2c1,,Asiaticoside,
Cc1cc(N2CCC3(CCCN(Cc4c[nH]c5ccccc45)C3=O)CC2)nc2ccccc12,,Ricinoleic Acid,
O=C1N(Cc2cccc3nsnc23)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Vapitadine,
O=C1CCCC2(CCN(c3cnc4ccccc4n3)CC2)N1Cc1cccc2[nH]ccc12,,5-methyltetrahydrofolic acid,
Cn1cc(CN2CCCC3(CCN(c4cnc5ccccc5n4)CC3)C2=O)c2ccccc21,,Cinalukast,
O=C1N(Cc2c[nH]c3ccccc23)CCCC12CCN(c1cc3nccnc3cn1)CC2,,Cefixime,
O=C1N(Cc2c[nH]c3ccccc23)CCCC12CCN(c1ncc3ccccc3n1)CC2,,Dexetimide,
O=C1N(Cc2ccccc2-c2ncco2)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Propanidid,
CCC1Oc2ccc(CN3CC=C(c4ccc(Cl)cc4)CC3)cc2NC1=O,,Clofarabine,
O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,UK-390957,
O=S1(=O)NCN(C2CC2)c2ccc(F)cc21,,BPAM344,
CO[C@H]1/C=C/C=C/CCOC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)[C@H](OC)[C@H]1C,,Tetrazolyl Histidine,
C[C@]1(C(=O)O)CCCC[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,Methylthiouracil,
O=C(N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1)N1CCOCC1,,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",
CC(=O)N[C@H]1CCCC[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,Somatoprim,
O=C(O)[C@H]1CCCC[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",
OC[C@H](O)CN1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",
CC(=O)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,Sultamicillin,
CC(O)C(=O)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",
NC(=O)CN1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",
CS(=O)(=O)N1CCCC[C@@H]1CNc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",
N[C@H]1CCCC[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",
CC(=O)N1CCC[C@H](CNc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,Saquinavir,
OCC1O[C@@H](S[C@@H]2CCCC(n3cc(-c4cccc(F)c4)nn3)C2O)C(O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O,,Ubiquinol,
OCC1O[C@@H](S[C@@H]2CCCC(n3cc(-c4ccsc4)nn3)C2O)C(O)[C@@H](n2cc(-c3ccsc3)nn2)[C@H]1O,,Tarloxotinib,
OCC1O[C@@H](S[C@@H]2CCCC(n3cc(-c4ccccc4F)nn3)C2O)C(O)[C@@H](n2cc(-c3ccccc3F)nn2)[C@H]1O,,"US8703720, 15",
OCC1O[C@@H](S[C@@H]2CCCC(n3cc(-c4ccc(F)cc4)nn3)C2O)C(O)[C@@H](n2cc(-c3ccc(F)cc3)nn2)[C@H]1O,,Lefamulin,
CN1C(=O)[C@H]2CCC[C@H]2N(C2CCCC2)c2nc(Nc3ccc(C(N)=O)cc3)ncc21,,"4-[[(3~{R},7~{S})-2-cyclopentyl-9-methyl-8-oxidanylidene-2,9,12,14-tetrazatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),10,12-trien-13-yl]amino]benzamide",
NC(=O)[C@H]1CCCC[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,Epinephrine,
C[C@]1(C(=O)O)CCCC[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,SALOPHEN-10-PROPIONATE IRON CHELATE,
CN(C)C(=O)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)C1,,Rolitetracycline,
Fc1cnc(-c2c[nH]c3ncc(Cl)cc23)nc1NC1CCCC1,,Prednimustine,
CC1(CNC(=O)c2ccc(-c3ccccc3)cc2)NC(=O)NC1=O,,CS21,
COCCSc1nc2c(=O)[nH]c(N)nc2[nH]1,,Altrenogest,
O=c1[nH]c2ccccc2n1-c1cc(-c2cccnc2O)c(O)cc1O,,hsp90_34,
COc1cc(-c2cc(-n3c(=O)[nH]c4ccccc43)c(O)cc2O)cc(OC)c1OC,,hsp90_24,
COC(=O)c1cc(-n2c(=O)[nH]c3cc(C(F)(F)F)cc(Cl)c32)c(O)cc1OC,,hsp90_13,
CCCc1cc(-n2c(=O)[nH]c3ccccc32)c(O)cc1O,,"1-(2,4-Dihydroxy-5-Propylphenyl)-1,3-Dihydro-2h-Benzimidazol-2-One",
CC1c2cc(-n3c(=O)[nH]c4ccccc43)c(O)cc2OC1(C)C,,hsp90_35,
Nc1cccc(-c2ccc3ncnc(N)c3c2)c1,,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",
COc1cc(OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)COc2cc(F)cc(-c3ccc(C(=O)O)cn3)c2)c(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,"N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE",
O=C(O)COc1cc(F)cc(-c2ccc(C(=O)O)cn2)c1,,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",
Nc1ccc2cc(-c3ccccc3F)ccc2n1,,RB106,
C[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)CCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C1=O,,Warfarin,
O=S(=O)(O)OC[C@@H]1O[C@@H](O[C@@H]2[C@H](COS(=O)(=O)O)OC(OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O,,Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine,
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(I)cc32)c1C,,Daunorubicin,
CC[C@H](C)[C@H](NC(=O)CN1C/C=C\CCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(=O)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O,,"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",
N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](Cc2cccs2)N[C@@H](CCCCN)C(=O)NC1=O,,"S,R-Warfarin alcohol",
CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1C(C)=O)C(C)C)C(N)=O,,Dalfopristin,
NCCCC[C@@H](NC(=O)CCCCCCCN1CCCN(S(=O)(=O)c2cccc3cnccc23)CC1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,"Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid",
C[C@@H]1NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C1=O,,AZD-8848,
CCC(C)CNC(=O)[C@H](Cc1ccccc1)NC[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(C)=O,,U-77451E,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2cccs2)NC1=O,,Nifenazone,
C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1,,Acetylphosphate,
CS[C@H]1O[C@@H](COC2O[C@@H](O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@@H](NC(=O)c2ccc3ccccc3c2)[C@@H]1O,,Fluorouracil,
CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(N)=O,,Zileuton,
CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(C)C)C(N)=O,,Guanosine,
CCCCCC(O)/C=C\C=C/CCCCCCCC(=O)O,,Cyclopentolate,
O=S(=O)(O)OC[C@@H]1O[C@H](O[C@@H]2[C@H](COS(=O)(=O)O)OC(OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O,,Riociguat,
CCN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc3nc4ccccc4n4c(=O)n(-c5ccc(OC)cc5)nc34)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)O)ccc21,,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,
N=C(N)NCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](Cc2cccs2)NC1=O,,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",
CS[C@H]1O[C@@H](COC2O[C@@H](OC([C@H](O)CO)[C@H](O)[C@@H](NC(C)=O)C(C)=O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@@H](NC(=O)c2ccc3ccccc3c2)[C@@H]1O,,Resatorvid,
CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(N)=O,,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",
C[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C1=O,,4-Phospho-D-erythronohydroxamic acid,
N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](CO)NC(=O)[C@H](c2ccccc2)NC(=O)CCCNC1=O,,Rivoceranib,
CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(C)=O)C(N)=O,,Glibornuride,
CN1CC(=O)N[C@@H](Cc2cccs2)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2C3CCCCC3C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C1=O,,Pivagabine,
N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](Cc2cccs2)NC(=O)CCCNC1=O,,Elvucitabine,
N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](CO)NC(=O)[C@@H]2Cc3ccccc3CN2C(=O)CCCNC1=O,,Oxolinic acid,
N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2cccs2)NC(=O)CCCNC1=O,,Ovalicin,
CC[C@H](C)[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(C)=O)C(C)C)C(N)=O,,Tesetaxel,
O=[N+]([O-])c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12,,1422955-31-4,
Cc1noc(C)c1-c1cc(O)cc([C@H](O)c2ccccc2)c1,,CGS-27023,
O=C(Cc1ccc(OCC[NH+]2CCCC2)cc1)Nc1cc(C2CC2)n[nH]1,,CS11,
CC(=O)N=S(=O)([O-])c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1,,"2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole",
C[NH+](C)CCNS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1,,Dobutamine,
CC(C)COC(=O)c1ccc2c(c1)C(=NNc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,CS262,
O=C([O-])c1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1,,R-95845,
CC1(CNC(=O)c2ccc(-c3ccc(Br)cc3)cc2)NC(=O)NC1=O,,CS23,
CC1(CNC(=O)c2ccc(C#CC#Cc3ccccc3)cc2)NC(=O)NC1=O,,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",
NC[C@H](NC(=O)c1ccc(-c2ccc(Br)cc2)cc1)C(=O)NO,,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",
C[C@@H](O)[C@H](NC(=O)c1ccc(-c2ccccc2)cc1)C(=O)NCC1(C)NC(=O)NC1=O,,Fluasterone,
C[C@@H](O)[C@H](NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NCC1(C)NC(=O)NC1=O,,Phenyldehydroalanine,
C[C@@H](O)[C@H](NC(=O)c1ccc(C#CC#Cc2ccccc2)cc1)C(=O)NCC1(C)NC(=O)NC1=O,,Udenafil,
C[C@@H](O)[C@H](NC(=O)c1ccc(-c2ccc(Br)cc2)cc1)C(=O)NCC1(C)NC(=O)NC1=O,,Telatinib,
CC1(CNC(=O)[C@H](CN)NC(=O)c2ccc(-c3ccccc3)cc2)NC(=O)NC1=O,,L-Threonohydroxamate 4-Phosphate,
CC1(CNC(=O)[C@H](CN)NC(=O)c2ccc(C#CC#Cc3ccccc3)cc2)NC(=O)NC1=O,,7beta-hydroxycholesterol,
CC1(CNC(=O)[C@H](CN)NC(=O)c2ccc(C#Cc3ccccc3)cc2)NC(=O)NC1=O,,beta-Hydroxyisovaleric acid,
CC1(CNC(=O)[C@H](CN)NC(=O)c2ccc(-c3ccc(Br)cc3)cc2)NC(=O)NC1=O,,Setipiprant,
O=C(NO)[C@H]1COC(c2cc3cc(F)ccc3[nH]2)=N1,,4-Carboxyphenylboronic Acid,
O=C(NO)c1csc(-c2ccc(OC(F)(F)F)c(Cl)c2)n1,,Iothalamic acid,
O=C(NO)C1=C[SiH2]C(c2ccc(F)cc2)=N1,,Iprazochrome,
O=C(NO)c1csc(-c2ccc(F)c(C(F)(F)F)c2)n1,,Idebenone,
CN(C)c1ccc(-c2nc(C(=O)NO)cs2)cc1,,Arsanilic acid,
CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1,,"Thiazole-urea, 11",
Nc1ncnc2c1ncn2C1OC(CSCCC(N)C(=O)O)[C@@H](O)[C@H]1O,,Desoxycorticosterone acetate,
CN(CCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Terbutryn,
CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O,,LX-2931,
CC(C)CCCCOC(=O)c1cccnc1,,"Auxiliary substrate, 11a",
C=CCCOC(=O)c1cccnc1,,"Auxiliary substrate, 18a",
COc1ccc2[nH]cc(CC([NH3+])C(=O)[O-])c2c1,,"5-Methoxyu-L-tryptophan, 11",
C=[NH+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],,"L-Abrine, 12",
O=C[NH2+]C(Cc1c[nH]c2ccccc12)C(=O)[O-],,"N-Formyl-L-tryptophan, 18",
[NH3+]C(Cc1c[nH]c2ncccc12)C(=O)[O-],,"7-Aza-L-tryptophan, 21",
[N-]=[N+]=Nc1c(I)c(Cl)cc2c1Oc1cc(Cl)c(Cl)cc1O2,,"Photoaffinity ligand, 2",
[N-]=[N+]=Nc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2,,"Photoaffinity ligand, 3",
[N-]=[N+]=Nc1ccc([N+](=O)[O-])c(C(=O)NCc2c(Cl)c(Cl)cc3c2Oc2cc(Cl)c(Cl)cc2O3)c1,,"Photoaffinity ligand, 5",
[N-]=[N+]=Nc1ccc(NCCCCCC(=O)NCc2c(Cl)c(Cl)cc3c2Oc2cc(Cl)c(Cl)cc2O3)c([N+](=O)[O-])c1,,"Photoaffinity ligand, 8",
Cc1cc(CN2CCN(c3c(Br)cnc4nc(-c5cncn5C)[nH]c34)CC2)no1,,Palmidrol,
Cc1sccc1C(=O)Nc1cccnc1,,Dpb-T,
O=C1C(Cc2c[nH]c3ccccc23)NCCC12CCN(c1nccc(-n3cccn3)n1)CC2,,Prinaberel,
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCNCC1,,Sulfamethoxazole,
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(C2CCC2)CC1,,RO-5126766 free base,
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(CC2CCCCC2)CC1,,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",
Cn1c2cc(F)cc(C(N)=O)c2c(=O)n1C1CCN(C2CCCCC2)CC1,,Amifostine,
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(C2CCC(F)(F)CC2)CC1,,Methylprednisone,
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(C2CCCCC2)CC1,,9-Deazaguanine,
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(C2CCCC2)CC1,,3-Chloroalaninate,
CC(C)N1CCC(n2c(=O)c3c(C(N)=O)cccc3n2C)CC1,,GTX-758,
Cn1c2cc(F)cc(C(N)=O)c2c(=O)n1C1CCNCC1,,Propenidazole,
COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2,,PFI-1,
CNC(=O)c1ccccc1Nc1c(C(F)(F)F)cnc2[nH]c(-c3ccc(N4CCOCC4)nc3)cc12,,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,
CN(c1ncccc1CNc1c(C#N)cnc2[nH]c(-c3ccc(F)cc3)cc12)S(C)(=O)=O,,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",
CN(c1ncccc1CNc1c(C#N)cnc2[nH]c(-c3ccccc3)cc12)S(C)(=O)=O,,F-Loop of Vitamin B12,
CN(c1ncccc1CNc1ccnc2[nH]ccc12)S(C)(=O)=O,,Glycocholic acid,
Cc1cc(-c2cc3c(NCc4cccnc4N(C)S(C)(=O)=O)c(C#N)cnc3[nH]2)ccn1,,Cilofexor,
CN(c1ncccc1CNc1c(C#N)cnc2[nH]ccc12)S(C)(=O)=O,,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,
Cc1cnc2[nH]ccc2c1NCc1cccnc1N(C)S(C)(=O)=O,,2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid,
CN(c1ncccc1CNc1c(Br)cnc2nc(-c3ccc(F)cc3)[nH]c12)S(C)(=O)=O,,Estetrol,
CNC(=O)c1ccccc1Nc1c(Br)cnc2nc(-c3ccc(F)cc3)[nH]c12,,Fabomotizole,
CN(c1ncccc1CNc1c(C(F)(F)F)cnc2[nH]c(-c3ccc(F)cc3)cc12)S(C)(=O)=O,,Deoxyuridine-5'-Diphosphate,
CCCCc1ccc(-c2cc3c(NCc4cccnc4N(C)S(C)(=O)=O)c(C#N)cnc3[nH]2)cc1,,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,
CNC(=O)c1ccccc1Nc1c(C(F)(F)F)cnc2[nH]c(-c3ccc(N4CCOCC4)cc3)cc12,,Staurosporine,
CN(c1ncccc1CNc1c(C#N)cnc2[nH]c(C3CCCCC3)cc12)S(C)(=O)=O,,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,
C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,,Zinc Substituted Heme C,
NCc1ccc(OCCCc2sc(-c3ccc4c(c3)C(=NNc3nc5ccccc5s3)CCC4)nc2C(=O)O)cc1,,1431866-33-9,
Cc1cc(C)nc(Sc2c(F)c(F)c(S(N)(=O)=O)c(F)c2F)n1,,Dimetofrine,
NS(=O)(=O)c1c(F)c(F)c(S(=O)(=O)CCO)c(F)c1F,,"2,3,5,6-Tetrafluoro-4-[(2-Hydroxyethyl)sulfonyl]benzenesulfonamide",
CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O,,Uridine-Diphosphate-N-Acetylglucosamine,
CC(C)[C@@H](C)NC(=O)c1cc(-c2cc3ccccc3s2)cc(C(=O)NCCc2ccccn2)n1,,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",
C/C=C(/C=C/C=C/C=C(C)\C=C1/CCCC(CC)=C1C(C)C)C(=O)O,,Decoquinate,
CC1(C)C2CC[C@@H](Cc3cccc4ccc(=O)oc34)C1C2,,Bizelesin,
CC1(C)C2CC[C@H](Cc3cccc4ccc(=O)oc34)C1C2,,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",
Cc1cc(F)ccc1-c1cc(N2CC[C@H](O)C2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",
Cc1nn(C)cc1-c1nc2ncc(Cl)c(N3CCN(Cc4ncon4)CC3)c2[nH]1,,Oxyphenisatin,
Cc1nn(C)cc1-c1nc2ncc(Cl)c(N3CCN(Cc4ccc(Cl)cc4)CC3)c2[nH]1,,CCT241736,
Cc1cc(CN2CCN(c3c(Cl)cnc4nc(-c5cnn(C)c5)[nH]c34)CC2)no1,,Propyl Gallate,
O=C(O)CCc1ccccc1C(=O)N1C(=O)CCC1c1nc(C(=O)NCCCCC2CCCCC2)co1,,D-Isovaline,
COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1,,LY341770,
Cc1cc(F)ccc1-c1cc(N2CCC3(CC2)OCCS3(=O)=O)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,Stibophen,
Cc1cc(CN2CCN(c3c(Cl)cnc4nc(-c5cccc(N6CCN(C)CC6)c5)[nH]c34)CC2)no1,,Arginineamide,
Cc1nn(C)cc1-c1nc2ncc(Cl)c(N3CCN(Cc4cncnc4)CC3)c2[nH]1,,11-MERCAPTOUNDECANOIC ACID,
COCCN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(CCc1ccc(O)cc1)C(=O)CNCC(C)C,,L-cysteic acid,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Ceforanide,
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,BMS-394136,
CC(=O)C1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4(C)[C@H]3CCC12C(=O)[CH-][N+]#N,,Benzoxonium,
COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1,,(R)-carnitinyl-CoA betaine,
COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1,,"[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid",
CS(=O)(=O)[O-].CS(=O)(=O)[O-].NC(=O)c1cc[n+](COC[n+]2ccc(/C=N/O)cc2/C=N/O)cc1,,"7-Methyl-7,8-dihydroguanosine 5'-(dihydrogen phosphate)",
COc1cc2cc(-c3cccc(-c4ccc(C(C)(C)C)cc4)c3)[n+](C)c(C)c2cc1OC,,Glasdegib,
Cc1nc(CN2CCN(c3c(Cl)cnc4nc(-c5cn(C)nc5C)[nH]c34)CC2)no1,,Selenomethionine,
N[C@@H]1C2CCN(CC2)C1Cc1cccnc1,,Arformoterol,
O=C(N[C@@H]1C2CCN(CC2)C1Cc1cccnc1)c1ccc(Br)cc1,,Sodium ascorbate,
O=C(N[C@@H]1C2CCN(CC2)C1Cc1cccnc1)c1cc2ccccc2o1,,Hesperetin,
O=c1[nH]cnc2c(CN3C[C@H](O)[C@@H](O)C3)c[nH]c12,,"Immucillins, 13",
O=C(O)c1ccc(-c2ccc3c(c2)nc(-c2c[nH]nc2-c2ccc(C(F)(F)F)cc2)n3CCCn2ccnc2)cc1,,"Benzimidazole Inhibitor, 3",
O=C(O)c1ccc(-c2ccc3c(c2)nc(-c2c[nH]nc2-c2ccc(Cl)c(Cl)c2)n3CCCNC2CCCCC2)cc1,,"Benzimidazole Inhibitor, 6",
Cc1n[nH]c(C)c1CCCOc1cc(C(=O)O)ccc1F,,Acoramidis,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CC)C1=O,,Nonoxynol-9,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCC)C1=O,,gamma-carboxy-L-glutamic acid,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCc2ccc(C)cc2)C1=O,,(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCCCc2ccc(F)cc2)C1=O,,Trifluoroalanine,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCCCc2ccc(Cl)cc2)C1=O,,Dronedarone,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCCCc2ccc(-c3ccccc3)cc2)C1=O,,Difetarsone,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCc2ccc(Cl)cc2)C1=O,,GDP-alpha-D-mannuronic acid,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCCCn2cc(CNC(=O)c3ccc(NS(=O)(=O)c4ccc(F)cc4)cc3)nn2)C1=O,,Tubercidin,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(C)=O)C1=O,,Felodipine,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(=O)C(F)(F)F)C1=O,,"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(=O)OC)C1=O,,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(=O)CCC)C1=O,,Metampicillin,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(=O)CCCCCCCCCCCCCCC)C1=O,,BMS-188797,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(=O)CCCCc2ccc(-c3ccccc3)cc2)C1=O,,{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER,
Cc1cnc2[nH]c(-c3ccc(F)cc3)cc2c1NCc1cccnc1N(C)S(C)(=O)=O,,Glucosaminyl-(Alpha-6)-D-Myo-Inositol,
CCC(=C(c1ccc(OCCN2CCCC2)cc1)c1ccc(OCCN2CCCC2)cc1)c1cccc(OC(=O)CCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)c1,,N-Octyl-2-Hydroxyethyl Sulfoxide,
O=C(NS(=O)(=O)c1cc(Cl)ccc1Cl)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Fosmidomycin,
Cc1ccc(S(=O)(=O)NC(=O)c2cccc(Cc3cc(Cl)ccc3OCc3ccc(Cl)cc3F)n2)cc1,,"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",
O=C(NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Vincamine,
O=C(NC1CCC1)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Phenylalanylmethylchloride,
CC(C)CNC(=O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Triclabendazole,
CCC(C)NC(=O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Norgestrel,
CC(C)(C)NC(=O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Tenonitrozole,
O=C(NS(=O)(=O)c1ccc(Cl)cc1)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Deferiprone,
Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1,,Toyocamycin,
Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1,,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",
Oc1ccc([C@@H]2C[C@@H](c3c(O)cc(O)c4c3O[C@H](c3ccc(O)cc3)[C@@H](O)C4)c3c(O)cc(O)cc3O2)cc1,,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2nnc3cc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)cnn23)cc1[N+](=O)[O-],,Brequinar Analog,
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2nnc3n2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)CC3)cc1S(=O)(=O)C(F)(F)F,,Acrivastine,
Cn1c2c(c3ccc(NC(=O)C(=O)O)cc3c1=O)C(=O)c1ccccc1-2,,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1,,"US9108950, 1",
CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1,,1429617-90-2,
OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccccc4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3ccccc3)nn2)[C@H]1O,,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",
COc1cc(OCCCOCCCOc2cc(F)cc(-c3ccc(C(=O)O)cn3)c2)c(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,FR230513,
OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(O)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(O)c3)nn2)[C@H]1O,,Roluperidone,
OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)nn2)[C@H]1O,,Iloprost,
COc1cc(OCCCNC(=O)COc2cc(F)cc(-c3ccc(C(=O)O)cn3)c2)c(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,Cefpodoxime,
COc1cc(OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)COc2cc(F)cc(-c3ccc(C(=O)O)cn3)c2)c(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,ABX-464,
[N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](OCc3ccc(Oc4ccccc4)cc3)[C@H]2O)[C@H](O)[C@H]1N1C(=O)c2ccccc2C1=O,,Hydracarbazine,
[N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](OCc3ccc(Oc4ccccc4)cc3)[C@H]2O)[C@H](O)[C@H]1NC(=O)c1ccccc1,,beta-L-fucose,
COc1cc(OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CNc2cc(F)cc(-c3ccccn3)c2)c(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,Resminostat,
[N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)nn3)[C@H]2O)[C@H](O)[C@H]1N1C(=O)c2ccccc2C1=O,,3-Deazaadenosine,
[N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)nn3)[C@H]2O)[C@H](O)[C@H]1NC(=O)c1ccccc1,,D-1-naphthyl-2-acetamido-ethane boronic acid,
O=C(O)CCCOc1ccccc1-c1cc(-c2ccccc2)n(-c2ccccc2)n1,,Purine Riboside-5'-Monophosphate,
O=C(O)CCCOc1ccccc1-c1cc(-c2ccccc2)n(-c2ccc(Br)cc2)n1,,Meglumine antimoniate,
O=C(O)CCCOc1ccccc1-c1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)n1,,Aluminium glycinate,
CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)NCCCCNC(=O)OCc2cncs2)C(C)C)cs1,,"N~2~-(Methyl{[2-(Propan-2-Yl)-1,3-Thiazol-4-Yl]methyl}carbamoyl)-N-(4-{[(1,3-Thiazol-5-Ylmethoxy)carbonyl]amino}butyl)-L-Valinamide",
C=C1C(=O)O[C@@H]2C[C@]3(C)C(=C[C@H]12)[C@@H](C)CC[C@H]3O,,1beta-Hydroxyalantolactone,
O=C(O[C@@H]1[C@@H]2O[C@]2(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C[C@@H]12)[C@@H]1[C@@H](c2ccc(O)cc2)[C@H](c2ccc(O)cc2)[C@H]1C(=O)O[C@@H]1[C@@H]2O[C@]2(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C[C@@H]12,,Argenteoside A,
O=C(/C=C\c1ccc(O)cc1)O[C@@H]1C[C@@](O)(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C[C@H]21,,Pyrotinib,
O=[N+]([O-])c1c(NCc2ccc(F)cc2Cl)ccc2nonc12,,2-mercaptobenzothiazole,
O=[N+]([O-])c1c(NCc2cc(F)cc(Cl)c2)ccc2nonc12,,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",
O=[N+]([O-])c1c(NCc2ccc(F)cc2C(F)(F)F)ccc2nonc12,,1-(2-Ethanone)-2-Hydroxy-2-(1-Amino-2-Methyl-2-Ethanol)-4-(2-Dimethyl)Ethane-Imidazoline-5-One;Chromophore (Thr-Leu-Gly),
O=[N+]([O-])c1c(Nc2cccc(Cl)c2)ccc2nonc12,,N-acetyl-D-glucosamine-6-phosphate,
O=[N+]([O-])c1c(Nc2cc(F)cc(C(F)(F)F)c2)ccc2nonc12,,Fluphenazine,
O=[N+]([O-])c1ccccc1Nc1cc(F)cc(Cl)c1,,Nitrocefin Acyl-Serine,
O=[N+]([O-])c1c(Nc2cc(F)cc(Cl)c2)ccc2nn[nH]c12,,Latanoprostene bunod,
CN(c1cc(F)cc(Cl)c1)c1ccc2nonc2c1[N+](=O)[O-],,"4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE",
Nc1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12,,Gonadorelin,
CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)C(C)C)[C@@H](C)O)C(C)C,,Mepindolol,
O=C(Nc1ccc(Oc2ncnc3nc[nH]c23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,,(2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid,
O=C(Nc1ccc(Oc2ncnc3nc[nH]c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,,Palovarotene,
O=C(Nc1ccc(Oc2ncnc3nc[nH]c23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,,Spaglumic Acid,
c1ccc2cc(-c3nc4ccccc4n3-c3ccnc(NC4CCCCC4)c3)ccc2c1,,D-chiro-Inositol,
c1ccc2cc(-c3nc4ccccc4n3-c3ccnc(NC4CCOCC4)c3)ccc2c1,,Myxothiazol,
C[C@H](O)CNc1cc(-n2c(-c3ccc4ccccc4c3)nc3ccccc32)ccn1,,Sodium lauryl sulfoacetate,
COc1ccc2c(c1)nc(-c1ccc(Cl)c(Cl)c1)n2-c1ccnc(NC2CCCCC2)c1,,1-Testosterone,
O=C(C1CC1)N1CCC[C@@H](Nc2cc(-n3c(-c4ccc5ccccc5c4)nc4ccccc43)ccn2)C1,,Bekanamycin,
Oc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(NC2CCCCC2)c1,,Taurochenodeoxycholic acid,
Oc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(NC2CCOCC2)c1,,"2,3,4,5,6-Pentafluorobenzyl Alcohol",
O=C(C1CC1)N1CCC[C@@H](Nc2cc(-n3c(-c4cccc(O)c4)nc4ccccc43)ccn2)C1,,Selurampanel,
C[C@H](O)CNc1cc(-n2c(-c3cccc(O)c3)nc3ccccc32)ccn1,,Diclazuril,
c1ccc2cc(-c3nc4ccccc4n3-c3ccnc(NC4CCCCC4)n3)ccc2c1,,Proline,
c1ccc2cc(-c3nc4ccccc4n3-c3ccnc(NC4CCOCC4)n3)ccc2c1,,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,
COc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(NC2CCCCC2)n1,,2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,
COc1ccc2nc(-c3ccc4ccccc4c3)n(-c3ccnc(NC4CCCCC4)n3)c2c1,,"(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine",
Clc1ccc(-c2nc3ccccc3n2-c2ccnc(NC3CCOCC3)n2)cc1Cl,,1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,
O=C(C1CC1)N1CCC[C@@H](Nc2nccc(-n3c(-c4ccc5ccccc5c4)nc4ccccc43)n2)C1,,Betamethasone,
CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)Nc1cccc2c1N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N(CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C2,,Methionine sulfoximine,
COc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(N[C@@H]2CCCN(C(=O)C3CC3)C2)n1,,Adefovir,
O=C(C1CC1)N1CCC[C@@H](Nc2nccc(-n3c(-c4ccc(Cl)c(Cl)c4)nc4ccccc43)n2)C1,,1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL,
Oc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(NC2CCCCC2)n1,,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",
Oc1ccc2nc(-c3ccc4ccccc4c3)n(-c3ccnc(NC4CCCCC4)n3)c2c1,,Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline,
CC(=O)N[C@@H](CC(=O)O)C(=O)Nc1cccc2c1N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N(CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C2,,Vericiguat,
O=C(O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)Nc1cccc2c1N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N(CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C2,,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",
O=C(O)CN1Cc2cccc(NC(=O)OCC3c4ccccc4-c4ccccc43)c2N[C@@H](Cc2c[nH]c3ccccc23)C1=O,,Artenimol,
NNc1c(F)c(F)c(S(N)(=O)=O)c(F)c1F,,Sacubitril,
NS(=O)(=O)c1c(F)c(F)c(SCCO)c(F)c1F,,Afegostat,
CCCSc1c(F)c(F)c(S(N)(=O)=O)c(F)c1F,,"2,3,5,6-Tetrafluoro-4-(Propylsulfanyl)benzenesulfonamide",
NS(=O)(=O)c1c(F)c(F)c(SCC(=O)O)c(F)c1F,,Febantel,
NS(=O)(=O)c1c(F)c(F)c(SCCC(=O)O)c(F)c1F,,Aztreonam,
NS(=O)(=O)c1c(F)c(F)c(NCCCCCC(=O)O)c(F)c1F,,Tagetitoxin,
NS(=O)(=O)c1c(F)c(F)c(Sc2ccccc2)c(F)c1F,,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",
Oc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(NC2CCOCC2)n1,,Trifarotene,
Oc1ccc2nc(-c3ccc4ccccc4c3)n(-c3ccnc(NC4CCOCC4)n3)c2c1,,(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID,
NS(=O)(=O)c1c(F)c(F)c(S(=O)(=O)c2ccccc2)c(F)c1F,,Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide,
NS(=O)(=O)c1c(F)c(F)c(Oc2ccccc2)c(F)c1F,,2'-Deoxycytidine 5'-triphosphate,
NS(=O)(=O)c1c(F)c(F)c(SCc2ccccc2)c(F)c1F,,Cyanocobalamin,
NS(=O)(=O)c1c(F)c(F)c(NCc2ccccc2)c(F)c1F,,"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",
NS(=O)(=O)c1c(F)c(F)c(NCCc2ccc(O)cc2)c(F)c1F,,Delapril,
NS(=O)(=O)c1c(F)c(F)c(SCCc2ccccc2)c(F)c1F,,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",
NS(=O)(=O)c1c(F)c(F)c(S(=O)(=O)CCc2ccccc2)c(F)c1F,,Imiglitazar,
Cc1cc(C)c(CSc2c(F)c(F)c(S(N)(=O)=O)c(F)c2F)c(C)c1,,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",
NS(=O)(=O)c1c(F)c(F)c(Sc2nc3ccccc3s2)c(F)c1F,,"(S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide",
NS(=O)(=O)c1c(F)c(F)c(NC23CC4CC(CC(C4)C2)C3)c(F)c1F,,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",
NS(=O)(=O)c1c(F)c(F)c(SC2=S=Nn3c2nc2ccccc23)c(F)c1F,,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",
NS(=O)(=O)c1c(F)c(F)c(Sc2nc(-c3ccccc3)c(-c3ccccc3)[nH]2)c(F)c1F,,Sufugolix,
CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1,,Mivebresib,
O=c1c2ccccc2nc(-c2cccc(OS(=O)(=O)O)c2)n1CCCCn1cc(Cn2c(-c3ccc(OS(=O)(=O)O)cc3)nc3ccccc3c2=O)nn1,,Phytosphingosine,
O=c1c2ccccc2nc(-c2ccc(OS(=O)(=O)O)cc2)n1CCCCCCn1cc(Cn2c(-c3ccc(OS(=O)(=O)O)cc3)nc3ccccc3c2=O)nn1,,CVT-6883,
O=C(O)Cc1ccccc1S(=O)(=O)c1ccc(-c2ccc(OCCF)cc2)cc1,,Benazepril,
O=C(NCCN1CCOCC1)c1ccnc(-n2ncc3cc(Nc4ccccc4Cl)ccc32)c1,,Naftazone,
CCCCCCCCc1cccc(CCCCCCCC)[n+]1C,,Mangafodipir,
C[n+]1c(C#CC2CCCCC2)cccc1C#CC1CCCCC1,,Octanoyl-Coenzyme A,
C[n+]1c(C#CCOc2ccc(Cl)cc2)cccc1C#CCOc1ccc(Cl)cc1,,3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid,
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(Cc2cccs2)CC1,,SNX-5422,
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F,,N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,
CNS(=O)(=O)c1ccc(NC(=O)CSc2nc(-c3ccc(Cl)cc3)c(C#N)c(=O)[nH]2)cc1,,Benzoin,
CC(Sc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1)C(=O)Nc1ccc(S(N)(=O)=O)cc1,,Roxadustat,
CC(Sc1nc(-c2ccc(Cl)c(Cl)c2)c(C#N)c(=O)[nH]1)C(=O)Nc1ccc(S(N)(=O)=O)cc1,,methyl beta-D-glucopyranoside,
CC(Sc1nc(-c2ccc(Cl)c(F)c2)c(C#N)c(=O)[nH]1)C(=O)Nc1ccc(S(N)(=O)=O)cc1,,N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine,
CCC(Sc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1)C(=O)Nc1ccc(S(N)(=O)=O)cc1,,CB-1158,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3O[C@H](OC(C)=O)[C@@](C)(OC(C)=O)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Aclarubicin,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(OC(=O)CCC)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Tempol,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(OC(=O)C(C)C)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(OC(=O)CCCCCCC)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,"(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE",
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3O[C@H]4N=C(C)O[C@@]4(C)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Dodecyl-Alpha-D-Maltoside,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3O[C@H]4N=C(CCC)O[C@@]4(C)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,6-O-Cyclohexylmethyl Guanine,
Cc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1,,Deoxyuridine-5'-Triphosphate,
COc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1,,Gibberellic acid,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1F,,Dipivefrin,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Cl)cc1,,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Br)c1,,Bismuth subsalicylate,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1C(F)(F)F,,Tranilast,
CCN(CC)CCNS(=O)(=O)c1cccc(C(F)(F)F)c1,,Pyrithione,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1,,"1,2-Hexanediol",
CCOc1ccc(/C=C2\SC(=S)N(CCN)C2=O)cc1,,Terlipressin,
CCOC(=O)[C@H]1CCCN(C(=O)Nc2cc(-c3cccc(Cl)c3)nc3ccccc23)C1,,"CypA Inhibitor, 2b",
C[n+]1c(/C=C/c2c(-c3ccccc3)[nH]c3ccccc23)ccc2ccccc21,,Met-49,
C(=C/c1c(-c2ccccc2)[nH]c2ccccc12)\c1ccc2ccccc2n1,,Neu-49,
O=S(=O)(O)C[C@@H]1[C@H](OS(=O)(=O)O)O[C@H](OS(=O)(=O)O)[C@H](O[C@H]2O[C@@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)[C@H]1OS(=O)(=O)O,,L-phenylalaninol,
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4cc(F)ccc4-c4ccc(Cl)cc4)CC2)C3=O)cc1S(=O)(=O)C(F)(F)F,,3-Cyclohexyl-L-alanine,
CC(O)CN1CC2c3ccccc3Nc3ccccc3C2C1,,Gaxilose,
O=C(O[C@@H]1C[C@@]2(O)CO[C@H]3O[C@H](O)C[C@@H]1[C@H]32)c1ccc(O)cc1,,Catalpin,
O=C(O)c1c(O)c(-c2c[nH]c3ccccc23)nc2ccccc12,,Piracetam,
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)C2CCCCC2)CC1,,Pivmecillinam,
CN(C)C1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)CC1,,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",
CO[C@@H]1O[C@@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](COS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H]2OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,,"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4cc(F)ccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F,,Metoclopramide,
c1ccc2cc(-c3nc4ccccc4n3-c3ccnc(N[C@@H]4CCCNC4)n3)ccc2c1,,(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol,
NC(=O)CNc1nc(-c2ccc(Cl)cc2)nc2ccccc12,,"N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine",
Nc1ccc2nc(-c3ccc(Cl)cc3)cc(O)c2c1,,"2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid",
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2cccc3ncccc23)CC1,,"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccc(F)cc2Cl)CC1,,Quercetin,
Cc1cc(C(=O)Nc2cc([N+](=O)[O-])ccc2N2CCN(C)CC2)ccc1F,,Nemonoxacin,
COc1ccc2c(c1)nc(-c1ccc(C)c(Cl)c1)n2-c1ccnc(NC2CCCCC2)c1,,Tirofiban,
CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1N1CCOCC1,,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",
Cc1cc(=O)oc2cc(NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc43)ccc12,,D-Malic acid,
CN(C)CCN(C)c1ccc([N+](=O)[O-])cc1NC(=O)c1ccccc1Cl,,2-deoxy-2-fluoro-β-D-galactose,
NC(=O)c1ccc[n+]([C@H]2O[C@@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@H](O)[C@@H]2O)c1,,3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,
O=S(=O)(O)OC[C@@H]1O[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,,9-(N-methyl-L-isoleucine)-cyclosporin A,
CO[C@@H]1O[C@@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1,,Troglitazone,
OC(CC1c2ccccc2Sc2ccccc21)CN1CCCC1,,5-iodotubercidin,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(OC(C)=O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Varlitinib,
COc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(NC2CCCCC2)c1,,Edetate calcium disodium anhydrous,
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2cccc3ccccc23)CC1,,Lorazepam,
NC1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)C1,,Lisinopril,
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2cccc(O)c2)CC1,,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",
O=S(=O)(O)OC[C@@H]1O[C@H](O[C@@H]2[C@@H](OS(=O)(=O)O)C(O[C@H]3[C@@H](OS(=O)(=O)O)O[C@@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]3OS(=O)(=O)O)O[C@@H](COS(=O)(=O)O)[C@H]2S(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,,"Ethyl (4R)-4-{[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-4-oxoheptanoyl]amino}-5-[(3S)-2-oxo-3-pyrrolidinyl]pentanoate",
CO[C@H]1O[C@@H](COCC(=O)N(CCOS(=O)(=O)O)CC(=O)NC2CCCCC2)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O,,FR236913,
CCC(=O)Nc1ccc2nc(-c3ccccc3)cc(O)c2c1,,Cloridarol,
CN1CCN(c2ccc(Br)cc2NC(=O)c2ccccc2Cl)CC1,,Benserazide,
CN1CCN(c2ccc(-c3ccco3)cc2NC(=O)c2ccccc2Cl)CC1,,Somatostatin,
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccc(F)cc2)CC1,,CHROMOPHORE (GLU-TYR-GLY),
O=C(Nc1cc([N+](=O)[O-])ccc1N1CCNCC1)c1ccccc1Cl,,N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,
CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",
CO[C@H]1O[C@@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@H](O[C@H]3O[C@@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@@H](C(=O)O)[C@@H](O[C@H]5O[C@@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@@H]5OC)[C@H](OC)[C@@H]4OC)[C@H](OS(=O)(=O)O)[C@@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,,Alminoprofen,
COc1cc(OCC(O)CO)c(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,Dihydroxymethoxychalcone,
Cc1cc(-c2ccccc2)ncc1C(=O)O,,4-METHYL-6-PHENYLNICOTINIC ACID,
NS(=O)(=O)c1ccc(SCCc2ccccc2)cc1,,Cetirizine,
CN1CCN(c2ccc(N)cc2NC(=O)c2ccccc2Cl)CC1,,2-Cyclopropylmethylenepropanal,
CC1CN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)CCN1C,,Dipipanone,
CN1CCCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)CC1,,3-isobutyl-1-methyl-7H-xanthine,
CCOc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,,Propylparaben,
CC(c1ccccc1-c1ccc(Cl)cc1)N1CCC(N2CCc3c(ncnc3NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)C2)CC1,,Rose bengal,
NS(=O)(=O)c1c(F)c(F)c(N2CCOCC2)c(F)c1F,,(S)-Warfarin,
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2cccc(Cl)c2)CC1,,Menadione,
Cc1cccc(C(=O)Nc2cc([N+](=O)[O-])ccc2N2CCN(C)CC2)c1Cl,,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,
COc1ccc(OCCN2CC3CCCC(C2=O)N3S(=O)(=O)c2ccc3[nH]c(=O)sc3c2)cc1OC,,Carbamide peroxide,
CO[C@H]1O[C@@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@H](O[C@H]3O[C@@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@@H](C(=O)O)[C@@H](C[C@H]5O[C@@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@@H]5OC)[C@H](OC)[C@@H]4OC)[C@H](OS(=O)(=O)O)[C@@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,
C[C@@]12Oc3c(O)ccc4c3[C@@]13CCN(CC1CC1)[C@H](C4)[C@]3(NC(=O)CSSCC(=O)N[C@@]13CCC(=O)[C@]4(C)Oc5c(O)ccc6c5[C@]14CCN(CC1CC1)[C@@H]3C6)CCC2=O,,Lacidipine,
COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1,,Cp-Coeleneterazine,
COc1cc(Nc2cc(-c3cccc(CC#N)c3)ccn2)ccc1N1CCN(C)CC1,,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2nc(C(F)(F)F)nc3c2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F,,Nicotinamide adenine dinucleotide 3-pentanone adduct,
CN(C)c1ccc2c(-c3ccc(C(=O)NCCCCCNC(=O)CCn4cc(CCN)c5cc(O)ccc54)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1,,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",
CCCSc1ccc(S(N)(=O)=O)cc1,,4-Propylthiobenzenesulfonamide,
COc1cc(C(=O)Nc2cc([N+](=O)[O-])ccc2N2CCN(C)CC2)ccc1F,,Neosaxitoxin,
COc1ccc(OCCN2CCC3CCCC(C2=O)N3S(=O)(=O)c2ccc3[nH]c(=O)sc3c2)cc1OC,,Oxatomide,
O=C([C@@H](c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,,MMV689244,
CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl,,CEP-37440,
COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1,,Tasquinimod,
CCOC(=O)c1c(C)oc2cc(OC)c(OCc3oc4cc(OC)c(OCc5oc6cc(OCC)c(OS(=O)(=O)[O-])cc6c5C(=O)OCC)cc4c3C(=O)OCC)cc12.[Na+],,GW-468816,
O=C(O)c1sc2cc(-n3c(-c4ccc(Cl)c(Br)c4)n[nH]c3=S)ccc2c1Cl,,Cefotiam,
O=C(O)c1sc2cc(-n3c(-c4cc(Cl)cc(Cl)c4)n[nH]c3=S)ccc2c1Cl,,D-Threonine,
O=C(O)c1sc2cc(-n3c(-c4ccc(Cl)c(Cl)c4)n[nH]c3=S)ccc2c1Cl,,Cangrelor,
Cc1ccccc1-c1nnc(SCC(=O)O)n1-c1cccc(Cl)c1,,6-MORPHOLIN-4-YL-9H-PURINE,
O=C(O)CSc1nnc(-c2ccccc2Br)n1-c1cccc(Cl)c1,,Iohexol,
O=C(O)CSc1nnc(-c2ccc3ccccc3c2)n1-c1cccc(Cl)c1,,"(S,R)-fidarestat",
COc1ccc(-c2nnc(SCC(=O)O)n2-c2ccc(Cl)c(Cl)c2)cc1,,2-Nonyl-4-quinolinol 1-oxide,
O=C(O)CSc1nnc(-c2ccc(O)cc2)n1-c1ccc(Cl)c(Cl)c1,,Inositol,
Nc1ccc(-c2nnc(SCC(=O)O)n2-c2ccc(Cl)c(Cl)c2)cc1,,Flucloxacillin,
O=C(O)CSc1nnc(-c2ccc([N+](=O)[O-])cc2)n1-c1ccc(Cl)c(Cl)c1,,N-Carbamoyl-Alanine,
O=C(O)CSc1nnc(-c2ccc3ccccc3c2)n1-c1ccc(Cl)c(Cl)c1,,Doripenem,
O=C(O)CSc1nnc(-c2cc3ccccc3s2)n1-c1ccc(Cl)c(Cl)c1,,Cortivazol,
O=C(O)CSc1nnc(-c2sc3ccccc3c2Cl)n1-c1ccc(Cl)c(Cl)c1,,Latanoprost,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4ccccc34)c2)n(-c2cccc(N)c2)n1,,Guanosine-5'-Triphosphate,
O=C(O)c1cc2ccc(-n3c(-c4ccccc4)n[nH]c3=S)cc2s1,,4R-Fluoro-N6-ethanimidoyl-L-lysine,
Cc1ccccc1-c1n[nH]c(=S)n1-c1ccc2cc(C(=O)O)sc2c1,,Tirabrutinib,
Cc1cccc(-c2n[nH]c(=S)n2-c2ccc3cc(C(=O)O)sc3c2)c1,,Flupentixol,
Cc1ccc(-c2n[nH]c(=S)n2-c2ccc3cc(C(=O)O)sc3c2)cc1,,Rabacfosadine,
O=C(O)c1cc2ccc(-n3c(-c4cccc(Oc5ccccc5)c4)n[nH]c3=S)cc2s1,,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,
O=C(O)c1cc2ccc(-n3c(-c4ccc(Br)cc4)n[nH]c3=S)cc2s1,,Venglustat,
O=C(O)c1cc2ccc(-n3c(-c4ccc(Cl)cc4)n[nH]c3=S)cc2s1,,Sulfadoxine,
O=C(O)c1cc2ccc(-n3c(-c4ccc(F)cc4)n[nH]c3=S)cc2s1,,Ticarcillin,
O=C(O)c1cc2ccc(-n3c(-c4ccc(Br)c(Cl)c4)n[nH]c3=S)cc2s1,,"5alpha-androstane-3alpha,17beta-diol",
O=C(O)c1cc2ccc(-n3c(-c4cc(Cl)cc(Cl)c4)n[nH]c3=S)cc2s1,,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",
O=C(O)c1cc2ccc(-n3c(-c4ccc(Cl)c(Cl)c4)n[nH]c3=S)cc2s1,,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",
Cc1ccccc1-c1n[nH]c(=S)n1-c1ccc2c(Cl)c(C(=O)O)sc2c1,,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",
O=C(O)c1sc2cc(-n3c(-c4cccc(Oc5ccccc5)c4)n[nH]c3=S)ccc2c1Cl,,Vitamin E,
O=C(O)c1sc2cc(-n3c(-c4cccc(Br)c4)n[nH]c3=S)ccc2c1Cl,,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",
O=C(O)c1sc2cc(-n3c(-c4ccc(Cl)cc4)n[nH]c3=S)ccc2c1Cl,,"5-[Bis(2-bromoethyl)amino]-N-(2,3-dioxopropyl)-2,4-dinitrobenzamide",
O=C(O)c1sc2cc(-n3c(-c4ccc5ccccc5c4)n[nH]c3=S)ccc2c1Cl,,Elocalcitol,
Cc1cc(-c2n[nH]c(=S)n2-c2ccc3c(Cl)c(C(=O)O)sc3c2)ccc1Br,,L-tartaric acid,
O=C(O)c1sc2cc(-n3c(-c4ccc(Br)c(Cl)c4)n[nH]c3=S)ccc2c1Cl,,Pridopidine,
NS(=O)(=O)c1ccc(C(=O)CSc2ncccn2)cc1Cl,,Pinaverium,
NS(=O)(=O)c1cccc(C(=O)CSc2ncccn2)c1,,Alethine,
CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Tryptophanamide,
Cc1ccc(N)c(CN2CCCC3(CCN(c4cnc5ccccc5n4)CC3)C2=O)c1,,4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID,
N=C(CN1CCCC2(CCN(c3cnc4ccccc4n3)CC2)C1=O)c1ccccc1N,,Milademetan,
O=C(c1ccccc1)N(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,Granotapide,
O=C(c1ccccc1OC(F)(F)F)N(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,S-(Dimethylarsenic)Cysteine,
O=C(c1ccccc1Nc1cccc(C(F)(F)F)c1)N(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,"(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate",
O=C(c1cccc(Cn2cncn2)c1)N(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,PF-04418948,
O=C(c1ccc(Cn2cncn2)cc1)N(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,Otilonium,
CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,,LB-100,
CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F,,SH-4-54,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1,,Thymidine-5'- Diphosphate,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3ccnc3)cc2)cc1,,AMPCPR,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnnc3)cc2)cc1,,Alpha-Methylisocitric Acid,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3n[nH]c(=S)n3C)cc2)cc1,,9-Methylguanine,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(Cl)c3Cl)cc2)cc1,,Framycetin,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3csnn3)cc2)cc1,,TP-271,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3nnnc3C)cc2)cc1,,Fisetin,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cnco3)cc2)cc1,,Hydroxyprogesterone caproate,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnnn3)cc2)cc1,,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(N)nc3)cc2)cc1,,1-Aminocyclopropanecarboxylic Acid,
C[C@@H](Nc1nc(-c2cccc(C(=O)O)c2)cnc1N)c1ccccc1,,"(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-2-O-{2-[(piperidin-3-ylmethyl)amino]ethyl}-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside",
CCOC(=O)c1cccc(-c2cnc(N)c(N[C@H](C)c3ccccc3)n2)c1,,Monomethyl fumarate,
C[C@@H](Nc1nc(-c2ccnc(C(=O)O)c2)cnc1N)c1ccccc1,,Daniquidone,
COc1cc(OC)nc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)cc2)n1,,MMI-175,
COc1ccc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)cc2)cn1,,Codeine methylbromide,
C[C@@H](Nc1nc(-c2csc(C(=O)O)c2)cnc1N)c1ccccc1,,Practolol,
Cc1c(C(=O)O)cccc1-c1cnc(N)c(N[C@H](C)c2ccccc2)n1,,"5'-FLUORO-2',5'-DIDEOXYADENOSINE",
Cc1ccc(-c2cnc(N)c(N[C@H](C)c3ccccc3)n2)cc1C(=O)O,,Silver citrate,
Cc1cc(C(=O)O)cc(-c2cnc(N)c(N[C@H](C)c3ccccc3)n2)c1,,Selenomethionine Selenoxide,
Cc1ccc(C(=O)O)cc1-c1cnc(N)c(N[C@H](C)c2ccccc2)n1,,"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE",
COc1ccc(C(=O)O)cc1-c1cnc(N)c(N[C@H](C)c2ccccc2)n1,,Difemerine,
Nc1ncc(-c2cccc(C(=O)O)c2)nc1NCc1ccccc1,,Tasosartan,
C[C@H](Nc1nc(-c2cccc(C(=O)O)c2)cnc1N)c1ccccc1,,Dexpropranolol,
C[C@@H](Nc1nc(-c2cccc(C(=O)O)c2)cnc1N)c1ccc(Cl)cc1,,trans-2-hydroxycinnamic acid,
C[C@H](c1ccccc1)N(C)c1nc(-c2cccc(C(=O)O)c2)cnc1N,,3-Chloro-4-Hydroxyphenylglycine,
C[C@@H](Oc1nc(-c2cccc(C(=O)O)c2)cnc1N)c1ccccc1,,Acetorphine,
Nc1ncc(-c2cccc(C(=O)O)c2)nc1NCC1CCCC1,,7-Aminodesacetoxycephalosporanic acid,
C[C@@H](Nc1nc(-c2cccc(C(=O)O)c2)ccc1N)c1ccccc1,,Norleucine,
C[C@@H](Nc1cncc(-c2cccc(C(=O)O)c2)n1)c1ccccc1,,Clofoctol,
CNc1ncc(-c2cccc(C(=O)O)c2)nc1N[C@H](C)c1ccccc1,,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",
O=C(O)c1ccc(-c2ccc(C(=S)NCc3ccc(-c4ccnn4-c4ccc(Cl)c(Cl)c4)cc3)c(Cl)c2)o1,,"Ara-Alpha(1,3)-Xyl",
COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl,,SGC-CBP30,
NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,,Syk-IN-1,
O=S(=O)(c1ccc(O)cc1O)N1Cc2ccc(O)cc2C1,,"4-[(5-Hydroxy-1,3-Dihydro-2h-Isoindol-2-Yl)sulfonyl]benzene-1,3-Diol",
O=S(=O)(c1ccc(O)cc1O)N1Cc2cc(O)cc(O)c2C1,,PS10,
O=C(O)c1cc(-c2ccc(CNC(=S)c3ccc(-c4ccc(C(=O)O)o4)cc3Cl)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Nocodazole,
C[N+](C)=c1ccn(Cc2ccc(CCCCc3ccc(Cn4ccc(=[N+](C)c5ccc(Cl)cc5)cc4)cc3)cc2)cc1,,4-[(4-chlorophenyl)(methyl)amino]-1-{4-[4-(4-{[4-(dimethylamino)pyridinium-1-yl]methyl}phenyl)butyl]benzyl}pyridinium,
CCN(CC)CCNS(=O)(=O)Cc1ccc(C(F)(F)F)cc1,,3-Amino-4-Oxybenzyl-2-Butanone,
Cc1c(CNCCO)c(O)[nH]c(=O)c1C#N,,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,
Cc1c(CNCC(O)CO)c(O)[nH]c(=O)c1C#N,,Reglitazar,
Clc1cccc(-c2nnc[nH]2)n1,,Acetylcysteine amide,
OCCNc1cc(C(F)(F)F)nc(-c2n[nH]c3cnccc23)n1,,Penimepicycline,
Nc1ccn([C@@H]2O[C@H](CNC(=O)c3cscn3)[C@@H](O)[C@H]2O)c(=O)n1,,Rovatirelin,
Nc1ccn([C@@H]2O[C@H](CNC(=O)c3ccnc4nc[nH]c34)[C@@H](O)[C@H]2O)c(=O)n1,,Acemetacin,
Cc1c(O)cc2c(c1C)O[C@](C)(CCCC(C)C)CC2,,3-pyridin-4-yl-1H-indazole,
O=C(O)c1cc(-c2ccc(CNC(=O)c3ccc(-c4ccc(C(=O)O)o4)cc3Cl)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,BMS-817399,
CCCCCCCN(CC)CC#CC(c1ccccc1)c1ccccc1,,5-fluorotryptophan,
CCCCCCCN(CC)C/C=C/Cc1ccccc1,,Lorajmine,
Cc1ccc(-c2ncc(OC[C@@H]3CCNC3)cc2-c2ccc(C#N)cc2)cc1,,2101305-84-2,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(CO)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,Clofazimine,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)NS(C)(=O)=O)c2cc(-c3cccs3)ccc2n1,,Alpelisib,
C[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",
CCC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,Elubrixin,
O=NC1CCc2cc(-c3[nH]c(C4CCNCC4)nc3-c3ccncc3)ccc21,,"imidazole-based compound, 5",
O=C(Cn1c2c(c3cc(Br)ccc31)CC[C@@H](C(=O)O)C2)N[C@H](Cc1ccccc1)C(=O)O,,3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,
Cc1c(O)cc2c(c1C)OC(C)(CCCC(C)C)CC2=O,,Metaraminol,
CC(C)CCCC1(C)CCc2cc(O)cc(Br)c2O1,,Dusquetide,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CC[C@@H](C)c2ccccc21,,Temocillin,
O=C1CC(c2ccccc2)CC(O)=C1Sc1ccccc1[N+](=O)[O-],,6-Hydroxypropylthymine,
Fc1ccc(Cn2c(-c3ccc(OCC(C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,,Gluconic Acid,
Cc1cccc(Cn2c(-c3ccc(OCC(C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)c1,,Zebularine,
Cc1ccccc1Cn1c(-c2ccc(OCC(C3CCNCC3)n3c(-c4ccccc4)nc4ccccc43)cc2)nc2ccccc21,,Tioxolone,
O=C(OCC(C1CCCCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2c(F)cccc2Cl)CC1,,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",
O=C(OCC(C1CCCCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1,,Dexrabeprazole,
O=C(OCC(C1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2c(F)cccc2Cl)CC1,,1h-Benoximidazole-2-Carboxylic Acid,
O=C(OCC(C1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)N1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,"4,5-Dehydro-L-Iduronic Acid",
C=CCC(COc1ccc(-c2nc3ccccc3n2Cc2ccccc2)cc1)n1c(-c2ccccc2)nc2ccccc21,,Bisindolylmaleimide VIII,
O=C(NCC(C1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1,,NADH,
O=C(OCC(C1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",
O=C(OC[C@H](C1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1,,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",
COc1ccc(S(=O)(=O)N(CC(=O)O)c2ccc(N(CC(=O)O)S(=O)(=O)c3ccc(OC)cc3)c3ccccc23)cc1,,CPUY192018,
CCN1Cc2ccc(NC(=O)c3ccc(C(=O)N4CCC(C5CCCN5)CC4)c(Nc4ccccc4)c3)cc2C1,,Prasterone,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O)cc1,,Tetomilast,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,SNS-032,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccc([N+](=O)[O-])cc2)C(=O)O)cc1,,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N2CCC[C@H]2C(=O)O)cc1,,4-Imidazolmethylene-5-Imidazolone Chromophore,
C[C@@H](O)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Theodrenaline,
NC(=O)CC[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Naproxen,
CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,,Ledipasvir,
Nc1ncnc2c1nc(Sc1cc3c(cc1I)OCO3)n2CCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1,,Imidazole salicylate,
C[C@@H](Nc1cc(-c2cccc(C(=O)O)c2)cnc1N)c1ccccc1,,Gentamicin,
Cc1ccc2c(c1)C=C(C(=O)NS(=O)(=O)c1cc3ccccc3o1)C2CC(=O)O,,Lufenuron,
N=C(N)NCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C1CCCCC1,,Infigratinib,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N(CC(=O)N1C2CCCCC2C[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)Cc1ccccc1,,Maribavir,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)O)cc1,,BIOTINOL-5-AMP,
CCCC[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Cilnidipine,
NC(=O)CC[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Taurocholic acid,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Methylselenocysteine,
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Metahexamide,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)c1ccccc1,,Chlorzoxazone,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1,,Tramadol,
NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)O)C1CCCCC1,,TO-901317,
N=C(N)NCCC[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"4-acetamido-2,4-didexoy-D-glycero-beta-D-galacto-octopyranosylphosphonic acid",
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc1,,Eprozinol,
CC(C)(C)[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,(+)-Rutamarin alcohol,
C[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,
NC(=O)C[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"(2S)-2,3-Diaminobutanoic acid",
CC(C)C[C@@H]1NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CNC(=O)C[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC1=O,,(2S)-7-hydroxyflavanone,
O=C(O)c1sc2cc(-n3c(-c4c[nH]c5ccccc45)n[nH]c3=S)ccc2c1Cl,,"4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate",
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)c1ccccc1,,"(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",
C[C@@H](O)[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,(+)-1-bromo-2-propanol,
COc1ccc(C[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,"Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside",
CC(C)C[C@@H]1NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CC(=O)NCCC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC1=O,,AZD-3043,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCC1,,JNJ-42165279,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1,,Freselestat,
O=C([O-])CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCN2CCCCC2)co1,,Irsogladine,
CCCCC(NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)C(=O)N[C@@H](C(=O)N[C@H](CO)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CO)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O)C(C)C)[C@H](C)O,,VK-2809,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccc(F)cc2)C(=O)O)cc1,,3-Methyl-5-Sulfo-Pyrrolidine-2-Carboxylic Acid,
CSCC[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,GPI-1485,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N2CCC[C@H]2C(=O)O)cc1,,Uridine diphosphate glucose,
N=C(N)NCCC[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,S-(2-oxo)pentadecylcoa,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccc(F)cc2)C(=O)O)cc1,,Aeruginosin 98-B,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccc([N+](=O)[O-])cc2)C(=O)O)cc1,,"D-galactohydroximo-1,5-lactam",
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C2(CCCC2)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",
CCn1nc(C)cc1C(=O)NCC[C@H](Cc1ccccc1)N(C)C(=O)c1cc(C)ccc1-n1nccn1,,Pirarubicin,
CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C,,4-(Dimethylamino)benzoic acid,
Cc1cc(O)cc(C)c1C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H](C)C(=O)O)N(C)C,,Sri-9439,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC1=O,,Sovaprevir,
CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Vinorelbine,
CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Oleandomycin,
C[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",
COc1ccc(C[C@H](NC(=O)CNC(=O)CNC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,Glucosamine,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,,1-Naphthoxyacetic acid,
CC(C)C[C@@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CNC1=O,,Meprotixol,
NC(N)=NCCC[C@H](N)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)[C@@H]1CCCN1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CCCN=C(N)N)C(=O)O,,Levosalbutamol,
N=C(N)NCCCCC(=O)N1CCC[C@@H]1C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C1CCCCC1,,"2,5-Anhydroglucitol-1,6-Biphosphate",
[N-]=[N+]=Nc1ccc(C[C@@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC2=O)cc1,,Aluminium monostearate,
Cc1nc(N)c(N[C@H](C)c2ccccc2)nc1-c1cccc(C(=O)O)c1,,Risuteganib,
COc1cc2c(cc1-c1c(C)noc1C)ncc1c2[nH]c(=O)n1[C@H](C)c1ccccn1,,"2s,4r-4-Methylglutamate",
NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N(CC(=O)N1C2CCCCC2C[C@H]1C(=O)O)Cc1ccccc1,,CCT-018159,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc1,,Methyl salicylate,
CSCC[C@@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Terbutaline,
CC(C)C[C@@H]1NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CCC(=O)NC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC1=O,,Lovastatin,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1,,Furaprevir,
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@H](C)c1ccccc1)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O,,7-(Carboxyamino)-8-Amino-Nonanoic Acid,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1)C1CCCC1,,"S,S-Propylthiocysteine",
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,,Cystein-S-Yl Cacodylate,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)O)cc1,,Mevinolinic acid,
CC[C@H](C)[C@@H]1NC(=O)[C@@H]2c3[nH]c4ccccc4c3CCN2C(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,"2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine",
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@@H](O)C[C@@H]1C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1,,Mephedrone,
CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(N)=O,,Gleptoferron,
Cc1nc[nH]c1CN1CCc2cccc(N)c2C1,,GLPG-0259,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccccn3)CC1)C2,,2-(l-menthoxy)ethanol,
NS(=O)(=O)c1c(F)c(F)c(S(=O)(=O)CCO)c(NCc2ccccc2)c1F,,Cefazolin,
NS(=O)(=O)c1c(F)c(F)c(S(=O)(=O)CCO)c(NC2CCCCCCC2)c1F,,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",
NC(=O)c1cccc2c1C(=O)N(CCCc1ccccc1)C2,,Potassium bitartrate,
NC(=O)c1cccc2c1C(=O)N(CCc1ccccn1)C2,,BMS-986158,
NC(=O)c1cccc2c1C(=O)N(CCCN1CCCCC1)C2,,BPN-14770,
NC(=O)c1cccc2c1C(=O)N(CCCN1CCC(N3CCCCC3)CC1)C2,,Topotecan,
NC(=O)c1cccc2c1C(=O)N(C1CCN(C3CCOCC3)CC1)C2,,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,
NC(=O)c1cccc2c1C(=O)N(CCCN1CCC(Cc3ccccc3)CC1)C2,,Nitrilotriacetic acid,
NS(=O)(=O)c1c(F)c(F)c(SCCc2ccccc2)c(F)c1NC1CCCCCCCCCCC1,,4SC-202,
NS(=O)(=O)c1c(F)c(F)c(SCCO)c(F)c1NC1CCCCCCC1,,Acetyldigitoxin,
CC(C)(C)Nc1c(F)c(S(N)(=O)=O)c(F)c(F)c1S(=O)(=O)CCc1ccccc1,,4-dimethylaminophenol,
CNc1c(F)c(S(N)(=O)=O)c(F)c(F)c1S(=O)(=O)CCc1ccccc1,,"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",
NC(=O)c1cccc2c1C(=O)N(CCc1ccccc1)C2,,4-Nitro-Inden-1-One,
NC(=O)c1cccc2c1C(=O)N(CCN1CCCCC1)C2,,Pergolide,
NC(=O)c1cccc2c1C(=O)N(CCCN1CCOCC1)C2,,Disperse Blue 106,
NC(=O)c1cccc2c1C(=O)N(CCN1CCCc3ccccc31)C2,,6-Methylamino-5-Nitroisocytosine,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccncc3)CC1)C2,,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3cccs3)CC1)C2,,Amibegron,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3cccnc3)CC1)C2,,Clopenthixol,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccco3)CC1)C2,,"(4R,5S,6S,7R)-1,3-dibenzyl-4,7-bis(phenoxymethyl)-5,6-dihydroxy-1,3 diazepan-2-one",
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccoc3)CC1)C2,,Deltamethrin,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccc[nH]3)CC1)C2,,Abivertinib,
Cn1cncc1C(O)(c1ccc(Cl)cc1)c1ccc2nc(Cl)c(Cc3ccccc3)c(Cl)c2c1,,Avanafil,
Cc1ccc(C2=Nn3c(COc4ccc(Cl)cc4)nnc3SC2CC(=O)[O-])cc1,,4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate,
O=C([O-])CC1Sc2nnc(Cc3ccc(Br)cc3)n2N=C1c1ccc(Cl)cc1,,bis(5-amidino-benzimidazolyl)methanone zinc,
CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)c2ccc(Nc3ncc4c(n3)-c3ccc(Cl)cc3C(c3c(F)cccc3OC)=NC4)cc2OC)C(N)=O)c2cc(S(=O)(=O)O)ccc21,,Angiotensin II,
CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)C2(Cc3cccc(Nc4nccs4)n3)CCC(Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21,,Meclocycline,
Fc1cc(Br)cc([C@@H]2C[C@H](c3cccc(Br)c3)n3nnnc3N2)c1,,Debromohymenialdisine,
Clc1ccccc1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Resolvin E1,
Brc1cccc([C@@H]2C[C@H](c3ccccc3Br)n3nnnc3N2)c1,,Penciclovir,
Fc1cc(Br)cc([C@@H]2C[C@H](c3ccccc3)n3nnnc3N2)c1,,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,
Clc1ccccc1C1CC(c2cccc(I)c2)Nc2nnnn21,,2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose,
Clc1cccc(C2CC(c3cccc(Br)c3)Nc3nnnn32)c1,,Napabucasin,
Fc1c(Cl)cccc1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Methyl alpha-D-mannoside,
Clc1ccc(Br)cc1[C@H]1C[C@@H](c2cccc(Br)c2)Nc2nnnn21,,Alpha-N-Dichloroacetyl-P-Aminophenylserinol,
Fc1ccc(Br)c(F)c1[C@H]1C[C@@H](c2cccc(Br)c2)Nc2nnnn21,,N-Benzylformamide,
Fc1ccc(Cl)c(F)c1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Corticosterone,
CN(C)c1ccc2c(c1)C(C)(C)c1cc3c(cc1=C2)CCC[N+]=3CCCC(=O)NCCCCCCNCC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",
COc1ccc(-c2cc(-c3ccc(Cl)cc3Cl)nc(N)n2)c(OC)c1,,hsp90_84,
Cc1ccc(C2=Nn3c(nnc3-c3ccco3)SC2CC(=O)[O-])cc1,,Cridanimod,
O=C([O-])CC1Sc2nnc(-c3ccco3)n2N=C1c1ccc(F)cc1,,Momelotinib,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3c(F)cccc3N2C)c1=O,,Hydroxypropyl betadex,
C=CC(=C)CC[C@@]1(C)[C@@H]2C[C@@H](O)C=C3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32[C@@H](OC(=O)/C=C/c2ccccc2)C[C@H]1C,,Bafilomycin B1,
Cc1cc(CC(=O)NC(C)C)on1,,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",
Cc1scnc1C(=O)Nc1cccnc1,,PF-05105679,
CCn1ncc(C(=O)Nc2cccnc2)c1C,,Selatogrel,
C[N+](C)=c1ccn(Cc2ccc(-c3ccc(Cn4ccc(=[N+](C)c5ccc(Cl)cc5)cc4)cc3)cc2)cc1,,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",
Cc1ncc(C(=O)Nc2cccnc2)n1C,,Cortisone acetate,
CCNCc1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,,Henagliflozin,
CC(=O)O[C@@H]1O[C@H](OC(C)=O)C2=C[C@H](O)C[C@@H]3[C@@]21[C@@H](OC(=O)/C=C/c1ccccc1)C[C@@H](C)[C@@]3(C)CCC1=CCOOC1,,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3ccccc3N2C)c1=O,,Octreotide,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3ccc(F)cc3N2C)c1=O,,Kelatorphan,
CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN(C)C,,CK2-IN-9,
C[N+](C)=c1ccn(Cc2ccc(CCc3ccc(Cn4ccc(=[N+]5CCCC5)cc4)cc3)cc2)cc1,,Valomaciclovir,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3c(Cl)cccc3N2C)c1=O,,Methylumbelliferyl chitotriose,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3ccc(OC)cc3N2C)c1=O,,(R)-Praziquantel,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3cc(OC)ccc3N2C)c1=O,,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3cc(C(F)(F)F)ccc3N2C)c1=O,,Zinc citrate,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3cccc(Cl)c3N2C)c1=O,,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",
Cc1ccc(C(=O)Nc2cccnc2)n1C,,Tavapadon,
C=CC(=C)CC[C@@]1(C)[C@@H]2C[C@H](OC(=O)/C=C/c3ccccc3)C=C3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32[C@@H](O)C[C@H]1C,,Apomorphine,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3ccc(Cl)cc3N2C)c1=O,,Ferulic acid,
CC(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1,,Isoeugenol,
CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O,,Keap1-Nrf2 probe,
CCc1cc(C(=O)Nc2cccnc2)n(C)n1,,Cabergoline,
CCNCc1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,,(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID,
CCNC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,,10-hydroxycamptothecin,
Cc1cc(-c2n[nH]c3c2CN(C(=O)NC2CCCN(Cc4c(C)cccc4C)C2)CC3)ccn1,,6-O-benzylguanine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(=O)[nH]c4)c3)c2cc1OC,,5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cc[nH]c(=O)c4)c3)c2cc1OC,,CRA_1802,
NC(=O)c1c(N)n(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2nc3ccccc3nc12,,Hesperidin,
c1cncc(Nc2ncnn3cccc23)c1,,PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]2CSSC[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Arbutin,
CC(C)(C)CC(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2cnco2)cc1,,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,
Cc1ncoc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CC(C)(C)C)cc1,,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",
CC(C)(C)CC(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2cncs2)cc1,,Simotaxel,
Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CC(C)(C)C)cc1,,Roniciclib,
Cc1cc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CC(C)(C)C)ccc1-c1cncs1,,"1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene",
CC(=O)N1C[C@H](O)C[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1,,Pittsburgh Compound B,
CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,,Daporinad,
CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,,NP-G2-044,
CC(=O)N[C@H](C(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C)C(C)(C)C,,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",
CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccc(F)cc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C,,Ac-ICVWQD(5fW)GAHRCT-NH2,
CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)OC,,Ac-ICV(2Nal)QDWGAHRCT-NH2,
CCCC[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC[C@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC1=O,,Alpha-D-Galactose-1-Phosphate,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](C)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,ISO-1 F-18,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,4-Methylimidazole,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](C)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Fucose,
CSCC[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC1=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N2,,Allosamizoline,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Esculin,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](NC(C)=O)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Edonerpic,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,Dinaciclib,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Succinyl-Coenzyme A,
Cc1[nH]nc2c1C(c1ccccc1)C1=C(CC(C)(C)CC1=O)N2,,439095-16-6,
COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12,,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",
NC(=O)c1cccc2[nH]n(C3CCN(C4CCC4)CC3)c(=O)c12,,Ribose,
NC(=O)c1cccc2[nH]n(C3CCNCC3)c(=O)c12,,"7,8-dihydro-7,7-dimethyl-6-hydroxypterin",
NC(=O)c1cccc2[nH]n(C3CCN(Cc4ccco4)CC3)c(=O)c12,,Bardoxolone,
NC(=O)c1cc(F)cc2[nH]n(C3CCNCC3)c(=O)c12,,"(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate",
NC(=O)c1cccc2[nH]n(C3CCN(C4CCCCC4)CC3)c(=O)c12,,"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",
NC(=O)c1cccc2[nH]n(C3CCN(CC4CC=CCC4)CC3)c(=O)c12,,SR12813,
NC(=O)c1cc(F)cc2[nH]n(C3CCN(C4CCCCC4)CC3)c(=O)c12,,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,
CN1CCC(n2[nH]c3cccc(C(N)=O)c3c2=O)CC1,,"3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate",
NC(=O)c1cccc2[nH]n(C3CCN(CC4CCCCC4)CC3)c(=O)c12,,Tenidap,
NC(=O)c1cccc2[nH]n(C3CCN(C4CCC(F)(F)CC4)CC3)c(=O)c12,,Norethandrolone,
NCCOc1c(-c2ccc(Br)cc2)[nH]c(=O)c2cc(F)ccc12,,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",
NCCOc1c(-c2cccc(C(F)(F)F)c2)[nH]c(=O)c2cc(F)ccc12,,Pecilocin,
NCCOc1c(-c2ccc(N3CCOCC3)cc2)[nH]c(=O)c2cc(F)ccc12,,2-Bromo-2-Propene-1-Ol,
NCCOc1c(-c2ccc(N3CCOCC3)c(Br)c2)[nH]c(=O)c2cc(F)ccc12,,Antroquinonol,
NCCOc1c(-c2cccc(Br)c2)[nH]c(=O)c2cc(F)ccc12,,4-Oxoretinol,
NCCOc1c(-c2ccc(Cl)cc2)[nH]c(=O)c2cc(F)ccc12,,RU78299,
NCCOc1c(-c2ccc(F)cc2)[nH]c(=O)c2cc(F)ccc12,,Mivacurium,
Cc1cc(-c2[nH]c(=O)c3cc(F)ccc3c2OCCN)ccc1Cl,,Fluocortin,
NCCOc1c(-c2ccc(Cl)c(Cl)c2)[nH]c(=O)c2cc(F)ccc12,,2-chloro-5-nitro-N-phenylbenzamide,
NCCOc1c(-c2ccc(F)c(F)c2)[nH]c(=O)c2cc(F)ccc12,,3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,
NCCOc1c(-c2ccc(N3CCCC3)c(Br)c2)[nH]c(=O)c2cc(F)ccc12,,L-tyrosinamide,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(CCCCN=[N+]=[N-])=C1O,,TLM18,
O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O,,PFI-3,
O=C(/C=N/O)Nc1ccc[n+](CC[n+]2cccc(NC(=O)/C=N/O)c2)c1.[Br-].[Br-],,LY-3039478,
O=C(/C=N/O)Nc1ccc[n+](Cc2ccccc2C[n+]2cccc(NC(=O)/C=N/O)c2)c1.[Br-].[Br-],,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,
O=C(/C=N/O)Nc1ccc[n+](Cc2ccc(C[n+]3cccc(NC(=O)/C=N/O)c3)cc2)c1.[Br-].[Br-],,Arotinolol,
Nc1cccc(-c2cccnc2N)c1,,"[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl] -Acetaldehyde",
Cc1cc(-c2cccc(N)c2)cnc1N,,"16,17-Androstene-3-Ol",
O=C(NCC1CCCC1)C1CCCC1,,N-(Cyclopentylmethyl)cyclopentanecarboxamide,
CO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@H](O)C1NC(C)=O,,"US8703720, Reference Compound 2",
CCCNC(=O)c1cn(C2CCC[C@@H](O[C@@H]3OC(CO)[C@H](O)[C@H](n4cc(C(=O)NCCC)nn4)C3O)C2O)nn1,,Amisulpride,
CCCNC(=O)c1cn(C2CCC[C@@H](S[C@@H]3OC(CO)[C@H](O)[C@H](n4cc(C(=O)NCCC)nn4)C3O)C2O)nn1,,Furazidin,
O=C(NC1CCC[C@@H](S[C@@H]2OC(CO)[C@H](O)[C@H](NC(=O)c3ccc(Cl)cc3)C2O)C1O)c1ccc(Cl)cc1,,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,
O=C([O-])CC1Sc2nnc(C3CC3)n2N=C1c1ccccc1,,Tiocarlide,
O=C([O-])CC1Sc2nnc(Cc3ccc(F)cc3)n2N=C1c1ccccc1,,Oxymetholone,
O=C([O-])CC1Sc2nncn2N=C1c1ccc(Cl)cc1,,Methylmethionine chloride,
O=C([O-])CC1Sc2nnc(-c3cccs3)n2N=C1c1ccc(Cl)cc1,,MSX-122,
O=C([O-])CC1Sc2nnc(-c3ccc(F)cc3)n2N=C1c1ccc(Cl)cc1,,Abemaciclib,
Cc1ccc(C2=Nn3c(Cc4ccc(F)cc4)nnc3SC2CC(=O)[O-])cc1,,O2-Sulfo-Glucuronic Acid,
O=C([O-])CC1Sc2nnc(-c3ccc(F)cc3)n2N=C1c1ccccc1,,PF-06273340,
CC(=O)Oc1ccc2c(=O)c(Cc3ccccc3)c(C)oc2c1OC(C)=O,,hsp90_174,
Cc1noc(C)c1-c1ccc(-c2nc3cnccn3c2NC(C)(C)C)cc1,,UMB-32,
CN(CCC(=O)[O-])[N+](C)(C)C,,Benzyl alcohol,
CCN(CCOc1ccc([N+](=O)[O-])cc1)CCc1ccc([N+](=O)[O-])cc1,,LUF6200,
Cc1cnc(Cl)nc1-c1ccc(N(Cc2ccc(CNC(=O)C(F)F)cc2)C(=O)c2ccc(O)cc2O)cc1,,VER-246608,
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)c(Cl)c3)c3c(N)ncnc32)C1,,Gemifloxacin,
CN(CCNc1c2c(nc3ccccc13)CCCC2)Cc1ccnc(/C(N)=N/O)c1O,,PSEVGYXNNASMJH-UHFFFAOYSA-N,
CN(CCCNc1c2c(nc3ccccc13)CCCC2)Cc1ccnc(/C(N)=N/O)c1O,,Puromycin,
N#Cc1cc2cc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)ccc2[nH]1,,MI-136,
COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC,,Cypermethrin,
O=c1nc(NCc2cc3ccccc3s2)c2cccnc2n1O,,GSK5750,
Nc1nc2[nH]c(SCC(=O)c3ccc(-c4ccccc4)cc3)nc2c(=O)[nH]1,,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",
CCCCOc1cc(OCCCN(CC)CC)ccc1NC(=O)c1cc(-c2ccc(Oc3ccc(F)cc3)cc2)nn1C,,4-Fluorophenethyl Alcohol,
C#CCSc1nc(NNC(N)=S)c(C#N)c(-c2cc(OC)c(OC)c(OC)c2)n1,,Icaritin,
CN(C)CCOc1ccc(Oc2ccccc2)cc1,,Apronalide,
N#Cc1cc(F)c(N)nc1Cl,,6-amino-2-chloro-5-fluoronicotinonitrile,
CNc1ncnn2cccc12,,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",
CC(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1,,"N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",
CC(C)CCCC1(C)CCc2cc(S(N)(=O)=O)cc(Br)c2O1,,Melphalan,
Cc1c(S(N)(=O)=O)cc2c(c1C)OC(C)(CCCC(C)C)CC2,,GSK-1292263,
CC(C)CCCC1(C)CCc2cc(O)ccc2O1,,Acetamide,
CC(C)CCCC1(C)CC(=O)c2cc(O)ccc2O1,,Voruciclib,
CC(C)CCCC1(C)CCc2c(O)cccc2O1,,NGX267,
COc1cc(O)cc2c1OC(C)(CCCC(C)C)CC2,,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",
O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCCOCCOCCOCCCNC(=O)CC(COc1ccc(-c2nc3ccccc3n2Cc2ccccc2)cc1)n1c(-c2ccccc2)nc2ccccc21,,Hydroquinine,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)COC)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,LJP 1082,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CN2CCOCC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Kynurenic Acid,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CN2CCC(C#N)CC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@@H](C)CN2CCN(CCOC)CC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Epicaptopril,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CN2CCCOCC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Hydralazine,
O=C(O)[C@@H]1[C@@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)[C@H]2CC[C@@H]1C2,,S-Benzylcysteine,
Brc1cccc(C2CC(c3ccccc3Br)n3nnnc3N2)c1,,Olmutinib,
O=C(c1nccc2[nH]cnc12)N1CCC(F)(F)[C@@H](Oc2ccc3ccccc3n2)C1,,Deracoxib,
COc1ccc(-c2cnc3c(N4CCC(O)CC4)snc3c2)cc1OC,,Niraparib,
COc1ccc(-c2cnc3c(NC4CCOCC4)snc3c2)cc1OC,,Carboquone,
COc1ccc(-c2cnc3c(N(CCO)CCO)snc3c2)cc1OC,,"2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione",
COc1ccc(-c2cnc3c(N4CCCC4)snc3c2)cc1OC,,Cefotetan,
COCCNc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12,,HM-30181,
COc1ccc(-c2cnc3c(NCC4CC4)snc3c2)cc1OC,,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",
COc1ccc(-c2cnc3c(N(C)C)snc3c2)cc1OC,,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,
COc1ccc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cc1OC,,Carboxymycobactin T,
COc1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1OC,,Adinazolam,
c1cc(-c2cnc3c(N4CCOCC4)snc3c2)cs1,,Sitaxentan,
COc1cc(OC)cc(-c2cnc3c(N4CCOCC4)snc3c2)c1,,Pavinetant,
COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N,,Inosine,
c1cc(-c2cnc3c(N4CCOCC4)snc3c2)co1,,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",
COc1ccc(-c2cnc3c(N4CCCCC4)snc3c2)cc1OC,,4-Hydroxy-L-Threonine-5-Monophosphate,
COc1ccc(-c2cnc3c(N4CCSCC4)snc3c2)cc1OC,,Adenosine-2'-5'-Diphosphate,
CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1,,I-CBP112,
CCCCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]6O[C@@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]6OS(=O)(=O)[O-])[C@H](O)[C@H]5NC(C)=O)[C@H](O)[C@H]4OS(=O)(=O)[O-])[C@H](O)[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2O)[C@H](O)[C@H]1NC(C)=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",
CCCCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]6O[C@@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]6OS(=O)(=O)[O-])[C@H](O)[C@H]5NC(C)=O)[C@H](O)[C@H]4OS(=O)(=O)[O-])[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NC(C)=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,Opipramol,
NCCCCCO[C@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]6OS(=O)(=O)[O-])[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4OS(=O)(=O)[O-])[C@H](O)[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,Ethoxzolamide,
CCOC(=O)CNC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)Cc5nc6ccccc6nc5C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,
c1ccc(Cn2c(-c3ccc(OCC(C4CCCNC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,,Cromoglicic acid,
c1ccc(-c2nc3ccccc3n2C(COc2ccc(-c3nc4ccccc4n3Cc3cccnc3)cc2)C2CCNCC2)cc1,,Gamithromycin,
CC(C)C(COC(=O)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1)n1c(-c2ccccc2)nc2ccccc21,,Nicotinamide adenine dinucleotide phosphate,
O=C(OCC(C1CCCNC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,PF-06282999,
O=C(OCC(C1CCNC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,"(2s)-2,8-Diaminooctanoic Acid",
CC(C)c1nc2ccccc2n1[C@H](COC(=O)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1)C1CCNCC1,,"(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran",
CCc1nc2ccccc2n1[C@H](COC(=O)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1)C1CCNCC1,,25-desacetylrifapentine,
Cc1nc2ccccc2n1[C@H](COC(=O)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1)C1CCNCC1,,Trigonellamide,
O=C(OCCn1ccnc1-c1ccccc1)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,N-acetylserotonin,
Cc1nc2ccccc2n1CCOC(=O)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,Trifluridine,
O=C(OCCn1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,OC-459,
c1ccc(Cn2c(-c3ccc(OCCn4ccnc4-c4ccccc4)cc3)nc3ccccc32)cc1,,Etidocaine,
C=CC(=O)Oc1ccc(-c2nc3ccccc3n2Cc2ccccc2)cc1,,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",
C=CC(=O)N1CCC(c2nc3ccccc3n2Cc2ccccc2)CC1,,CP-866087,
C=CC(=O)N1CCC([C@@H](COc2ccc(-c3nc4ccccc4n3Cc3ccccc3)cc2)n2c(-c3ccccc3)nc3ccccc32)CC1,,Ingenol disoxate,
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)N1CCOCC1,,BETA-METHYLLACTOSIDE,
COCCOCCOCCCNC(=O)C[C@H](O)C[C@H](O)CCn1c(-c2ccc(F)cc2)c(-c2ccccc2)c(C(=O)Nc2ccccc2)c1C(C)C,,TMP,
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12,,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,
Cc1nccn1CCCn1c(-c2ccccc2)cc(-c2nc3ccccc3n2CC2CC2)c1C(C)C,,Clorindione,
Cc1nccn1CCCn1c(-c2ccccc2)cc(-c2nc3ccccc3n2Cc2ccccc2)c1C(C)C,,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenyl)guanidine",
O=C(OC[C@H](C1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,Bexagliflozin,
CCN1C(=O)c2cccc3c(S(=O)(=O)NCC4CCN(C(C)=O)CC4)ccc1c23,,"4-butyl-5-propyl-1,3-selenazol-2-amine",
O/N=C/c1nc(CCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,,Guanidine-3-propanol,
NC(=O)c1cc[n+](CCC[n+]2ccccc2/C=N/O)cc1,,6-Hydro-1-Methyladenosine-5'-Monophosphate,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Clavulanic acid,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,Voxelotor,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Iopodic acid,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Panobinostat,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Hexylresorcinol,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Pentabromophenol,
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,Flavin-N7 protonated-adenine dinucleotide,
CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,"3,4-Biphenyldiol",
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,Vismodegib,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,Cytochlor,
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,"4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](C)C(N)=O,,Adenine,
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(N)=O,,Calcium pangamate,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(N)=O,,Trimazosin,
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(N)=O,,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@]1(C)CCC/C=C\CCC[C@@](C)(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)O,,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@]1(C)CCC/C=C\CCC[C@@](C)(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)O,,GSK-1059615,
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@]1(C)CCC/C=C\CCC[C@@](C)(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)O,,Irbesartan,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O,,Rostaporfin,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,Droxypropine,
CC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Pitavastatin,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Taprenepag,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O,,Relugolix,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](C)O)C(N)=O,,Bafetinib,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]4[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]4O)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O,,Ditazole,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]4[C@@H](C(=O)O)O[C@@H](O[C@H]5[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]6[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]6O)[C@@H]5NC(C)=O)[C@H](O)[C@H]4O)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O,,Rabusertib,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]4[C@@H](C(=O)O)O[C@@H](O[C@H]5[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]6[C@@H](C(=O)O)O[C@@H](O[C@H]7[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]8[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]8O)[C@@H]7NC(C)=O)[C@H](O)[C@H]6O)[C@@H]5NC(C)=O)[C@H](O)[C@H]4O)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O,,"[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate",
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]4[C@@H](C(=O)O)O[C@@H](O[C@H]5[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]6[C@@H](C(=O)O)O[C@@H](O[C@H]7[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]8[C@@H](C(=O)O)O[C@@H](O[C@H]9[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]%10[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]%10O)[C@@H]9NC(C)=O)[C@H](O)[C@H]8O)[C@@H]7NC(C)=O)[C@H](O)[C@H]6O)[C@@H]5NC(C)=O)[C@H](O)[C@H]4O)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O,,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]4[C@@H](C(=O)O)O[C@@H](O[C@H]5[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]6[C@@H](C(=O)O)O[C@@H](O[C@H]7[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]8[C@@H](C(=O)O)O[C@@H](O[C@H]9[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]%10[C@@H](C(=O)O)O[C@@H](O[C@H]%11[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]%12[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]%12O)[C@@H]%11NC(C)=O)[C@H](O)[C@H]%10O)[C@@H]9NC(C)=O)[C@H](O)[C@H]8O)[C@@H]7NC(C)=O)[C@H](O)[C@H]6O)[C@@H]5NC(C)=O)[C@H](O)[C@H]4O)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O,,Opaviraline,
CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(N)=O,,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,
CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@H](CO)C(N)=O,,"(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(N)=O,,Lomibuvir,
C[C@H](NC(=O)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)NC(CO)CO)C1CCCC1,,Xanthine,
C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)NCC[NH3+])C1CCCC1,,ABT-510,
COC(=O)c1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@H](CO)C(N)=O)C2CCCC2)cc1,,Ketazolam,
COC(=O)c1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)NC(CO)CO)C2CCCC2)cc1,,3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,
CCOC(=O)c1c(C)oc2cc(OC)c(OCc3oc4cc(OCC)c(OS(=O)(=O)[O-])cc4c3C(=O)OCC)cc12.[Na+],,Sulfameter,
CNc1ncc(-c2cccc(N)c2)cn1,,4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID,
CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2cccc(C(=O)O)c2)C(=O)O1)C(C)C,,Avadomide,
CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2ccc(C(=O)O)cc2)C(=O)O1)C(C)C,,"2',3'-Dideoxyadenosine triphosphate",
CC(C)(C)C(=O)OCC1(CO)C/C(=C\c2cccc(C(=O)O)c2)C(=O)O1,,5-phenyl-1H-indazol-3-amine,
CC(C)(C)C(=O)OCC1(CO)C/C(=C\c2ccc(C(=O)O)cc2)C(=O)O1,,UDP-alpha-D-glucuronic acid,
CC(C)CC(CC(=O)OCC1(CO)C/C(=C\c2ccc(C(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)cc2)C(=O)O1)CC(C)C,,1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),
CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(CO)CO)OC1=O)CC(C)C,,Megestrol acetate,
O=C(/C=N\O)Nc1ccc[n+](CCCCCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],,7-Deaza-7-Aminomethyl-Guanine,
O=C(/C=N\O)Nc1ccc[n+](CCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],,AKOS024354508,
CSC(NCCCc1cnc[nH]1)=[NH+]CCSCc1[nH]cnc1C,,3-Bromo-7-Nitroindazole,
CO[C@H]1O[C@@H](COCC(=O)N(CC(=O)NC2CCCCC2)[C@H]2CC[C@H](N(CC(=O)NC3CCCCC3)C(=O)COC[C@@H]3O[C@H](OC)[C@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])CC2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,Tesaglitazar,
CO[C@H]1O[C@@H](COCC(=O)N(CC(=O)NCCO[C@H]2O[C@@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])Cc2ccccc2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,Propanoyl-CoA,
CO[C@H]1O[C@@H](COCC(=O)N(CC(=O)NC2CCCCC2)Cc2ccccc2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+],,4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine,
CO[C@H]1O[C@@H](COCC(=O)N(CCS(=O)(=O)[O-])CC(=O)NC2CCCCC2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,Florilglutamic acid F-18,
CC(C)(CC(=O)N(CCO[C@H]1O[C@@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-])CC(=O)NC1CCCCC1)CC(=O)N(CCO[C@H]1O[C@@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-])CC(=O)NC1CCCCC1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,Dicoumarol,
O=C(CN(Cc1ccccc1)C(=O)CO[C@@H]1[C@H](OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-])NCCO[C@H]1O[C@@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,HSD-016,
CC(Sc1nc2nc(N)[nH]c(=O)c2[nH]1)C(=O)c1ccccc1,,Aluminum zirconium octachlorohydrex gly,
O=NC1CCc2cc(-c3[nH]c(C(=O)NCCN4CCOCC4)nc3-c3ccncc3)ccc21,,"imidazole-based compound, 8",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)cc3)nc2cc1OC,,"US9725465, Example 1",
C=c1c(-c2c(O)c3cc(O)c(O)c(=C(C)C)c3c(O)c2=C)c(O)c2cc(O)c(O)c(=C(C)C)c2c1O,,N-Acetyl-D-Galactosamine 6-Sulfate,
CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4N=O)c(-c3ccncc3)o2)cc1,,"furan-based compound, 10",
O=NC1CCc2cc(-c3[nH]c(-c4ccccc4)nc3-c3ccncc3)ccc21,,Lavoltidine,
CC(C)c1cc(Oc2c(I)cc(Cc3[nH]c(=O)[nH]c3O)cc2I)ccc1O,,3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL,
CN(C)CCOc1ccc(-c2cc(-c3ccncc3)c(-c3ccc4c(c3)CCC4N=O)o2)cc1,,"furan-based compound, 12",
COC(=O)c1ccc2c(c1)NC(=O)C2C(=Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,,3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid,
O=NC1CCc2cc(-c3cc(C4CCNCC4)oc3-c3ccncc3)ccc21,,"furan-based compound, 14",
CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4N=O)c(-c3ccncc3)[nH]2)cc1,,"pyrrole-based compound, 11",
CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CCC4N=O)[nH]2)cc1,,Willardiine,
CN(C)CCNC(=O)c1cc(-c2ccc3c(c2)CCC3N=O)c(-c2ccncc2)o1,,"furan-based compound, 16",
COCCN1CCC(c2cc(-c3ccc4c(c3)CCC4N=O)c(-c3ccncc3)o2)CC1,,"furan-based compound, 15",
O=NC1CCc2cc(-c3cn(CCO)nc3-c3ccncc3)ccc21,,Fipexide,
CC(C)(CN)c1nc(-c2ccncc2)c(-c2ccc3c(c2)CCC3N=O)[nH]1,,"imidazole-based compound, 4",
Oc1c(Br)cc(CC=Nc2cc(O)c3cccnc3c2O)cc1Br,,cid_381594,
O=NC1CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21,,BMCL184373 Compound 17,
Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ncnc(Nc2ccc(OCCNC(=O)CCCCNC(=O)CCC3=[N+]4B(F)n5c(C)cc(C)c5C=C4C=C3)cc2)n1,,"BODIPY-labeled probe, 4a",
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OCc5cn([C@@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]8O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]8OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]7OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])nn5)CC[C@]4(C)[C@H]3CC[C@@]21C,,Tonabersat,
CN(CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1)C(=O)CCC[N+]1=c2cc3c(cc2CCC1)=Cc1ccc(N(C)C)cc1C3(C)C,,Brilacidin,
O=C1CC(c2c(Cl)cccc2Cl)CC(O)=C1Sc1ccccc1Cl,,Lersivirine,
CN(C)CCCC(=O)Nc1cncc(-c2cccc3[nH]ccc23)c1,,Suloctidil,
CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1,,IACS-9571,
CCN1c2ccc(F)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21,,Avobenzone,
CCN1c2ccc(F)cc2N=C(N[C@H]2CCN(C(=O)NC(C)(C)C)C2)c2cc(Cl)ccc21,,MBX-8025,
NS(=O)(=O)c1c(F)c(F)c(N2CCCCC2)c(F)c1F,,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",
CCN(CCN(C)C)C(=O)CNCc1cc(C(N)=O)ccn1,,KDOAM-25,
CN1Cc2cc(F)ccc2OCCNC(=O)c2cnn3ccc1nc23,,"(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",
Cc1cc2ccnc(N[C@@H]3CCNC[C@H]3OCC3CCCCC3)c2[nH]c1=O,,Equilenin,
COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C,,NI-57,
CC(C)(C)OC(=O)NCCCCCC(=O)NCc1cccnc1,,BIA,
CC(C)(C)OC(=O)N[C@H](CSCCC(=O)NCc1cccnc1)Cc1c[nH]c2ccccc12,,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",
N=C(N)NS(=O)(=O)c1ccc(N=CC2C(=O)Nc3ccccc32)cc1,,Oxindole-Based Inhibitor 101,
O=C1Nc2ccc3ncsc3c2C1C=Nc1ccc2c(c1)CS(=O)(=O)C2,,Oxindole-Based Inhibitor 108,
NS(=O)(=O)c1ccc(CCNC(=O)c2ccc(CN(CC(=O)[O-])CC(=O)[O-])cc2)cc1,,BR15,
NS(=O)(=O)c1ccc(CCNC(=O)c2cccc(NC(=O)CN(CC(=O)[O-])CC(=O)[O-])c2)cc1,,BR22,
NS(=O)(=O)c1ccc(C(=O)NCCN(CC(=O)[O-])CC(=O)[O-])cc1,,BR30,
CC(=CC(C)C=CC(=O)NO)C(=O)c1ccc(N(C)C)cc1,,Arabinose-5-phosphate,
COc1c(O)cc2c(O)c1C=C(C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,Suprofen,
CC(COc1nccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CCC4N=O)[nH]2)n1)N(C)C,,"imidazole-based compound, 3",
CN(C)Cc1cccc(NC(=O)c2nc(-c3ccncc3)c(-c3ccc4c(c3)CCC4N=O)[nH]2)c1,,"imidazole-based compound, 9",
C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCNCC)nc32)c1,,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,
CCNCCCCNc1ncc2c(n1)N(Cc1cccc(NC(=O)CC)c1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2,,FRIN-1,
CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C,,Climbazole,
CC(C)=CCC/C(C)=C/C[C@@]12C[C@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(C(=O)c3ccc(O)c(O)c3)C1=O)C2=O,,Difluoromethionine,
Oc1cc(N=CCc2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)c(O)c2ncccc12,,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,
Oc1ccc(CC=Nc2cc(O)c3cccnc3c2O)cc1O,,"(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER",
Oc1ccc(CC=Nc2cc(O)c3cccnc3c2O)cc1,,Ensulizole,
COc1ccc(CC=Nc2cc(O)c3cccnc3c2O)cc1Cl,,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",
Oc1cc(N=CCc2cccc(Br)c2)c(O)c2ncccc12,,Metyrosine,
Oc1c(Br)cc(CC=Nc2cc(O)c3ccncc3c2O)cc1Br,,Avacopan,
CC[C@H](C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O,,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",
CC(N=Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(=O)O)c2)o1,,Norethynodrel,
CC(N=Nc1nc2ccccc2s1)c1cccc(-c2cccc(C(=O)O)n2)c1,,Acetoxolone,
COC(=O)[C@@]12Oc3c(c(O)cc4c3C3=CC[C@]5(C4)C(C3=O)C(=O)c3c(O)cc(C)cc3[C@@H]5OC(C)=O)C(=O)C1C(=O)C=C[C@H]2O,,5-Aminoimidazole Ribonucleoside,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCCCNC(=O)Cc3ccc4c(c3)C(C)(C)C3=C5C=C6C7=[N+](CCC6OC5CCN34)c3ccc(S(=O)(=O)[O-])cc3C7(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,5'-O-(L-Serylsulfamoyl)adenosine,
CCCC(=O)O[C@@H]1[C@H](C)[C@]2(O)C(CC(=O)C[C@]3(O)C(=O)C(C)=CC32)C2C(C)(C)[C@]21OC(=O)CCC,,Phorbol ester (PDBU),
NCc1ccc(CN(CCCCN(O)C(=O)C=CC(=O)[O-])C(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)[O-])c2)cc1,,alpha-D-glucopyranosyl-2-carboxylic acid amide,
CC[C@H](C)[C@@H]1NC(=O)[C@@](C)(NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)C(C)C)C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",
CC[C@H](C)[C@@H]1NC(=O)[C@@](C)(NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)C(C)C)C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,,Glipizide,
CC[C@H](C)[C@@H]1NC(=O)[C@@](C)(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)CCC/C=C\CCC[C@@](C)(C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C,,CRA_8696,
NS(=O)(=O)c1c(F)c(F)c(N=NCc2ccccc2)c(F)c1F,,Pantoyl Adenylate,
O=C(CCCCCNC(=O)COc1ccc([CH+]/C=c2\ccc3n2[B-](F)(F)n2c(ccc2-c2cccs2)C=3)cc1)NCCCCNc1ncnc2c1ncn2C1OC(CO)C(O)C1O,,N-omega-propyl-L-arginine,
CCNC(=O)C1OC(n2cnc3c(NCCCNC(=O)CCCCCNC(=O)COc4ccc([CH+]/C=c5\ccc6n5[B-](F)(F)n5c(ccc5-c5cccs5)C=6)cc4)ncnc32)C(O)C1O,,Thiabendazole,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C(=O)[O-])cc4)CC3)CN(C)[C@@H]1C2,,Balanol Analog 1,
CCCc1nc2cc(C(=O)OC)[nH]c2n1Cc1ccc(-c2ccccc2C(=O)[O-])cc1,,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",
O=C(CNC(=O)Cc1cccc(Cl)c1)NCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,(S)-wiskostatin,
CO[C@H]1O[C@H](CNC(=O)CN(C(C)=O)c2ccccc2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,
CO[C@H]1O[C@H](CNC(=O)CN(C(C)=O)C2CCCCCCCCCCC2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Remogliflozin etabonate,
CO[C@H]1O[C@H](CNC(=O)CN(Cc2ccccc2)C(C)=O)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,
CO[C@H]1O[C@H](CNC(=O)CN(CCc2ccccc2)C(C)=O)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Didanosine,
CO[C@H]1O[C@H](CNC(=O)CN(C(C)=O)C2CCCCC2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Talinolol,
CCCCC1CCC(N(CC(=O)NC[C@H]2O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])C(C)=O)CC1,,Triclocarban,
CO[C@H]1O[C@H](CNC(=O)CN(CCOS(=O)(=O)[O-])C(C)=O)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Olmesartan,
CCN(CC(=O)NC[C@H]1O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)COS(=O)(=O)[O-],,Tricetin,
CCN(CC(=O)NC[C@H]1O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCCCC(=O)[O-],,Uridine-5'-Diphosphate,
CCN(CC(=O)NC[C@H]1O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCCCCCCCCOS(=O)(=O)[O-],,2-Acetyl-Protoporphyrin Ix,
CCN(CC(=O)NC[C@H]1O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)c1ccccc1,,Silmitasertib,
CCN(CC(=O)NC[C@H]1O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCCc1ccccc1,,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,
CC(=O)N(CC(=O)NCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])Cc1ccccc1,,Bimatoprost,
CC(=O)N(CCc1ccccc1)CC(=O)NCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",
CCN(CC(=O)NCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCC(=O)[O-],,4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID,
CCN(CC(=O)NCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCCCCCCCCOS(=O)(=O)[O-],,"(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol",
CO[C@H]1O[C@H](CN=[N+]=[N-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,PSI-697,
CO[C@H]1O[C@H](CNC(=O)CN(C(C)=O)C2CCCCCC2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Troxacitabine,
CCN(CC(=O)NC[C@H]1O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCC(=O)[O-],,Mocetinostat,
CC(=O)N(CC(=O)NCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])c1ccccc1,,Ginsenoside C,
CCN(CC(=O)NCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCCCC(=O)[O-],,Poldine,
C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C(C)(C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)CNC(=O)C(CN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",
C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C(C)(C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,,Iobitridol,
CC1(C)C(CC=C2CCCC(C=CC3=[N+](CCCCCC(=O)NC45CC6(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)[O-])C(=O)O)C(=O)O)CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(C6)C4)C5)c4ccccc4C3(C)C)=C2Oc2ccc(S(=O)(=O)[O-])cc2)=Nc2ccccc21,,Heparin Disaccharide Iii-S,
CC1(C)C(C=CC2=C(Oc3ccc(S(=O)(=O)[O-])cc3)/C(=C/C=C3/N(CCCCCC(=O)NCCCCCC(=O)NC45CC6(CCC=O)CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)[O-])C(=O)O)C(=O)O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(C6)C4)C5)c4ccc(S(=O)(=O)[O-])cc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)[O-])c2ccc(S(=O)(=O)[O-])cc21,,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",
CC1(C)C(C=CC2=C(Oc3ccc(S(=O)(=O)[O-])cc3)/C(=C/C=C3/N(CCCCCC(=O)NCCCCCC(=O)NC45CC6(CCC=O)CC(CCC=O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)[O-])C(=O)O)C(=O)O)(C6)C4)C5)c4ccc(S(=O)(=O)[O-])cc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)[O-])c2ccc(S(=O)(=O)[O-])cc21,,Cyprenorphine,
CC1(C)C(C=CC2=C(Oc3ccc(S(=O)(=O)[O-])cc3)/C(=C/C=C3/N(CCCCCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)[O-])C(=O)O)C(=O)O)c4ccc(S(=O)(=O)[O-])cc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)[O-])c2ccc(S(=O)(=O)[O-])cc21,,Hydrochlorothiazide,
CC(=O)C[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CCCC=C2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(C)C)C(=O)NCC(N)=O)NC1=O,,"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O,,"5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one",
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O,,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",
CCCCCCCN(CCc1ccc(O[C@@H](C)C(=O)[O-])cc1)c1nc2ccccc2o1,,Resiniferatoxin,
CCCCCCCN(CCc1ccc(O[C@H](C)C(=O)[O-])cc1)c1nc2ccccc2o1,,Tiagabine,
CN(CCc1ccccc1)C(=O)c1csc2c1CCCC2N=O,,"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",
C[C@@]12CCCC[C@]1(C)N(C(=O)[C@H]1Cc3ccccc3CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccc(NC(=N)CN)cc1)[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C2,,Lpc-Ether,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Endothelin -1,
CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(OC)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)N[C@](C)(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)[C@@H](C)CC)NC(=O)[C@@H](CC(N)=O)NC1=O,,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC,,Propylthiouracil,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C(C)=O)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)CC,,"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@]1(C)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O,,2-Allyl-6-Methyl-Phenol,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CCCCNC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CCC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(C)=O,,Oxetacaine,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N(C(C)=O)[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)CC,,SD146,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC1=O,,alpha-D-glucose 6-phosphate,
CCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC,,"Uridine-2',3'-vanadate",
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@]1(C)NC(=O)CC[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O,,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",
CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](c2cccnc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)c1cccnc1,,Norethisterone,
CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](N)Cc2ccc3ccccc3c2)CNC(=O)C[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC1=O,,Epigallocatechin gallate,
CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](C(=O)N[C@H]1CNC(=O)C[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](c2cccnc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)c1cccnc1,,Kanamycin,
CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](C(=O)N[C@H]1CC(=O)NC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](c2cccnc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)c1cccnc1,,Ensartinib,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCF)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,N-(5'-phosphopyridoxyl)-L-alanine,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N3CCC3)c(c2O)C=C(C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,4-amino-N-[4-(benzyloxy)phenyl]butanamide,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N)c(c2O)C=C(C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE",
C=CC=Nc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)C(=O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,Molindone,
COC(=O)C1C(C)=NC(SC)=NC1c1cc([N+](=O)[O-])ccc1SC,,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",
CC1(C)CCC(C)(C)c2cc(C(N=N)c3ccc4cc(C(=O)O)ccc4c3)ccc21,,Zopiclone,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,Acebutolol,
CCCCCCCCCCCCCCCCCC(=O)NCCCO[C@@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-],,Fulacimstat,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OCc5cn([C@@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]8O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]9O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]9OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]8OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]7OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])nn5)CC[C@]4(C)[C@H]3CC[C@@]21C,,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]7OS(=O)(=O)[O-])[C@@H]6OS(=O)(=O)[O-])[C@@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,Heptaethylene glycol,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]8O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]8OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]7OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,3-Bromo-3-buten-1-ol,
CC(=O)O[C@H]1C[C@H]2[C@@H](CC[C@H]3C[C@@H](OS(=O)(=O)[O-])CC[C@@]32C)[C@@H]2CC[C@H]([C@H](C)CCC(=O)N[C@@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]4O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]4OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@@]12C,,Hydroxyaminovaline,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]7OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",
CCCCCCCCCCCCCCCCCC(=O)NCCCO[C@@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]4O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]4OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-],,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OCc5cn([C@@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]7OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])nn5)CC[C@]4(C)[C@H]3CC[C@@]21C,,N-Methylmesoporphyrin,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,Ibutilide,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OCc5cn([C@@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]7O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]7OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]6OS(=O)(=O)[O-])nn5)CC[C@]4(C)[C@H]3CC[C@@]21C,,Inosinic Acid,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]5O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]7OS(=O)(=O)[O-])[C@@H]6OS(=O)(=O)[O-])[C@@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,
CCCCCCCCCCCCCCCCCC(=O)NCCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OCc5cn(CCCO[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]6O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]8O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]9O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]9OS(=O)(=O)[O-])[C@@H]8OS(=O)(=O)[O-])[C@@H]7OS(=O)(=O)[O-])[C@@H]6OS(=O)(=O)[O-])nn5)CC[C@]4(C)[C@H]3CC[C@@]21C,,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]5O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]5O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]6OS(=O)(=O)[O-])[C@@H]5OS(=O)(=O)[O-])CC[C@]4(C)[C@H]3CC[C@@]21C,,Timonacic,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OCc5cn(CCCO[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]6O[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]7OS(=O)(=O)[O-])[C@@H]6OS(=O)(=O)[O-])nn5)CC[C@]4(C)[C@H]3CC[C@@]21C,,Nicotinamide Mononucleotide,
CN(C)c1ccc2c(c1)OC1=CC(N(C)C)C=CC1=C2c1ccc(C(=O)O)cc1C(=O)N[C@H](CCCCN)C(=O)NC(N)=NCCC[C@@H](NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12)C(N)=O,,RU78300,
CC1(C)C2=C3C=C4C5=[N+](CCC4OC3CCN2c2ccc(S(C)(=O)=O)cc21)c1ccc(CC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCN=C(N)N)NC(=O)CCCCCCCNCCNS(=O)(=O)c2cccc3cnccc23)C(N)=O)cc1C5(C)C,,Tyrosinal,
CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccc(C)cc1)NC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC,,Virginiamycin S1,
O=P([O-])([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]4[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]5[C@@H](OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]5OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]4OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,D-fluoromethyltyrosine F-18,
CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-],,1-Naphthyl-L-alanine,
C=S(NS(=O)(=O)c1ccc(C)cc1)c1ccc(OCc2ccccc2)cc1,,Calcium glucoheptonate,
CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1cn(C)c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)OC,,Cadralazine,
CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccc(F)cc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)OC,,Polaprezinc,
CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)OC,,Diiodohydroxyquinoline,
CCOC(=O)C1C(=O)C(=Cc2cccc(O)c2)SC1=Nc1ccccc1,,Di-Stearoyl-3-Sn-Phosphatidylethanolamine,
CO[C@@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-],,Pelitrexol,
CO[C@@H]1[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2[C@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OC)O[C@@H]2COS(=O)(=O)[O-])O[C@@H]1COS(=O)(=O)[O-],,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,
CO[C@@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@H](O)[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-],,Inhibitor Bea428,
O=c1[nH]c(O)c(Cc2cc(I)c(Oc3ccc(O)c(I)c3)c(I)c2)[nH]1,,Trepibutone,
O=c1[nH]c(O)c(Cc2cc(I)c(Oc3ccc(O)cc3)c(I)c2)[nH]1,,Grapiprant,
Cc1cc(Oc2c(I)cc(Cc3[nH]c(=O)[nH]c3O)cc2I)ccc1O,,"3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran",
COc1cc(Oc2c(I)cc(Cc3[nH]c(=O)[nH]c3O)cc2I)ccc1O,,Temsirolimus,
O=c1[nH]c(O)c(Cc2cc(I)c(Oc3ccc(O)c(C4CC4)c3)c(I)c2)[nH]1,,SJ-733,
CC(C)c1cc(Oc2c(Br)cc(Cc3[nH]c(=O)[nH]c3O)cc2Br)ccc1O,,Triazolam,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,,Secoisolariciresinol,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]2CSSC[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)[C@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,Ambrisentan,
CO[C@H]1[C@H](NS(=O)(=O)[O-])[C@H](O[C@@H]2[C@@H](C(=O)[O-])O[C@H](O[C@@H]3[C@@H](COS(=O)(=O)[O-])O[C@@H](O[C@H]4[C@H](C(=O)[O-])O[C@H](O[C@@H]5[C@@H](COS(=O)(=O)[O-])O[C@@H](OC)[C@H](NS(=O)(=O)[O-])[C@H]5OC)[C@@H](OS(=O)(=O)[O-])[C@@H]4OC)[C@@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@@H](OC)[C@@H]2OC)O[C@@H](COS(=O)(=O)[O-])[C@@H]1OC,,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",
NC(=O)c1ncn(C2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1C=CC(=O)N(CC1=Nc2c(nc(N)[nH]c2=O)CC1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,,Naronapride,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(N=O)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1,,Raclopride,
O=C1CCC(=O)C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1,,Naveglitazar,
O=C1CC(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1,,Segesterone,
CC1C(=O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O,,3-deoxy-D-arabino-hexonic acid,
CC(=O)N[C@@H]1[C@@H](O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@@H](CO[C@]4(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O[C@@H](OCC[Si](C)(C)C)[C@@H]3NC(C)=O)[C@@H]2O)(C(=O)[O-])O[C@H]1[C@H](O)[C@H](O)CO,,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,
O=C(CF)N[C@@H]1[C@@H](O)C[C@](OCc2cccc(F)c2F)(C(=O)[O-])O[C@H]1[C@H](O)[C@H](O)CNC(=O)c1ccccc1,,Lodoxamide,
CC(=O)N[C@@H]1[C@@H](O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@@H](CO)O[C@@H](OCC[Si](C)(C)C)[C@@H]3O)[C@@H]2O)(C(=O)[O-])O[C@H]1[C@H](O)[C@H](O)CNC(=O)c1ccccc1,,Mezlocillin,
CC(=O)N[C@@H]1[C@@H](O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@@H](CO)O[C@@H](OCC[Si](C)(C)C)[C@@H]3NC(C)=O)[C@@H]2O)(C(=O)[O-])O[C@H]1[C@H](O)[C@H](O)CO,,Cerivastatin,
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H]1NC(C)=O,,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccccc4)O3)[C@H]2O)[C@H]1NC(C)=O,,N-(3-carboxypropanoyl)-L-norvaline,
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccc(F)cc4)O3)[C@H]2O)[C@H]1NC(C)=O,,Piroxicam,
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO[C@]2(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H]1NC(C)=O,,Carbutamide,
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO[C@]2(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c3ccc(Cl)cc3)O2)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H]1NC(C)=O,,Cannabivarin,
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO[C@]2(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H]1NC(C)=O,,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO[C@]2(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccc(F)cc4)O3)[C@H]2O)[C@H]1NC(C)=O,,Formycin B,
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO[C@]2(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c3ccc(F)cc3)O2)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H]1NC(C)=O,,Hydantocidin-5'-phosphate,
CCCCCC(N=O)c1ccc(OCCCc2cnc[nH]2)cc1,,Aluminium acetoacetate,
CC(N=O)c1ccc(OCCCc2cnc[nH]2)cc1,,"5-amino-1,3,4-thiadiazole-2-thiol",
CCCC(N=O)c1ccc(OCCCc2cnc[nH]2)cc1,,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,
CC(N=O)c1ccc(OCc2ccc(CN3CCCCC3)cc2)cc1,,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(C)=O)C(C)C)CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](CCCCNC(C)=O)C(=O)NC(C)(C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](Cc2cnc[nH]2)NC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)NC1=O,,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,
Nc1ccc2c(-c3ccc(C(=O)NCCNC(=O)COc4ccc(CCCn5ncc6c5nc(N)n5nc(-c7ccco7)nc65)cc4)cc3C(=O)[O-])c3ccc(=[NH2+])c(S(=O)(=O)[O-])c-3oc2c1S(=O)(=O)[O-],,Reldesemtiv,
O=C(NC1CCCCC1)C(c1ccccc1)N(Cc1ccccc1)C(=O)C1OC(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],,Ketorolac,
O=C(CN(CCOS(=O)(=O)[O-])C(=O)C1OC(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-])NC1CCCCC1,,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,
O=C(CN(Cc1ccccc1)C(=O)C1OC(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-])NCc1ccccc1,,Darapladib,
O=C(CN(Cc1ccccc1)C(=O)C1OC(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1O)NC1CCCCC1,,Peramivir,
C[C@@H]1NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CC(=O)NC(C(=O)NN[C@H](Cc2ccc(O)cc2)C(=O)C(N)=O)NC(=O)C(=O)[C@@H](Cc2ccccc2)NC1=O,,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,
O=C(O)c1cc(N=NCc2ccc(-c3ccc(Cl)c(C(=O)O)c3)o2)ccc1Cl,,AZD-9977,
CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C,,Diminazene,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O,,EPYGFIAFSRAAHSP,
CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)CN)C(C)C)C(=O)N[C@@H](CO)C(=O)O,,GRPPDSVFRSRGWLS,
C=c1c(-c2c(O)c3cc(O)c(O)c(=CC(C)C)c3c(O)c2=C)c(O)c2cc(O)c(O)c(=CC(C)C)c2c1O,,Dimercaprol,
C=c1c(-c2c(O)c3cc(O)c(O)c(=CCc4ccc(C)cc4)c3c(O)c2=C)c(O)c2cc(O)c(O)c(=CCc3ccc(C)cc3)c2c1O,,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,
C=c1c(-c2c(O)c3cc(O)c(O)c(=Cc4ccccc4)c3c(O)c2=C)c(O)c2cc(O)c(O)c(=Cc3ccccc3)c2c1O,,4-Deoxy-D-Mannuronic Acid,
C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccccc1)C(=O)NCC(=O)N[C@H]1CCCCNC(=O)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]2CCCCNC(=O)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC2=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC1=O,,"4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE",
CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O,,N/OFQ-NH2,
COc1cc(OC)c2c(c1)N(c1ccc3ncc(-c4cnn(C)c4)nc3c1)CCN(C(C)C)C2,,Citric acid,
Cc1[nH]n(C(=O)c2ccccc2)c(=O)c1N=Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,,Modimelanotide,
Cc1[nH]n(C(=O)c2ccc(N)cc2)c(=O)c1N=Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,,Etiprednol dicloacetate,
Cc1[nH]n(C(=O)c2ccc(O)cc2)c(=O)c1N=Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",
Cc1[nH]n(C(=O)c2ccc(Cl)cc2)c(=O)c1N=Nc1ccc(S(=O)(=O)N(C)c2ncccn2)cc1,,2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose,
CCCCCCCCCCCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]4O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Saxagliptin,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]4[C@@H](OCCCCCCCCn5cc(-c6ccccc6)nn5)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Polymyxin B,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@@H](OCCCCCCCCn4cc(-c5ccccc5)nn4)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Oxycodone,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]4[C@@H](OCCCCCCCCn5cc(-c6cccc7ccccc67)nn5)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Atrazine,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@@H](OCCCCCCCCn4cc(-c5cccc6ccccc56)nn4)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Ertiprotafib,
CN(C)c1cccc2c(S(=O)(=O)NCCCCCCCCO[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]3O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]4O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]5OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])cccc12,,Propyl alcohol,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]4[C@@H](OCCCn5cc(-c6ccccc6)nn5)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@@H](OCCCn4cc(-c5ccccc5)nn4)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,"(2R)-2-[(1R)-1-{[(2S)-2-Carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acid",
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]4[C@@H](OCCCCCCCCCCCCn5cc(-c6ccccc6)nn5)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Niclosamide,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]4[C@@H](OCCCCCCCCCCCCn5cc(-c6cccc7ccccc67)nn5)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Fructose-6-phosphate,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]4[C@@H](OCc5ccccc5)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Ampicillin,
O=S(=O)([O-])OC[C@H]1O[C@H](O[C@@H]2[C@H](OS(=O)(=O)[O-])[C@@H](O[C@@H]3[C@@H](OCc4ccccc4)O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H]2OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,Metoprolol,
CCCCCCCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]4O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,2'-Deoxyuridine 3'-Monophosphate,
CCCCCCCCO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",
CCCCc1ccc(CO[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]2O[C@H]2O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]4O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]4OS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@@H]2OS(=O)(=O)[O-])cc1,,Gentamicin C1a,
CC(=O)N[C@@H]1[C@@H](O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]3CCO[C@H](COc4ccc(-c5ccccc5)cc4)[C@@H]3O)[C@@H]2O)(C(=O)[O-])O[C@H]1[C@@H](O)[C@H](O)CNC(=O)c1ccccc1,,alpha-Ketoisovalerate,
CC1=C2O[C@]34OC5(CCN(C)CC5)O[C@@H]3C2=C(C(=O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]4C)[C@H](C)[C@H](O)[C@H]1C,,Apremilast,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O,,GWTLNSAGYLLGPHAVGNHRSFSDKNGLT,
CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O,,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,
CC(C)C[C@@H]1NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,Futibatinib,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,QRFCTGHFGGLYPC,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,RFCTGHFGGLYPCNGP,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O,,QRFCTGHFGGLYPCNG,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRACTGHFGGLYPCNGP,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCAGHFGGLYPCNGP,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGAFGGLYPCNGP,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGHAGGLYPCNGP,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGHFAGLYPCNGP,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGHFGGLAPCNGP,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGHFGGLYPCAGP,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,4-hydroxyphenacyl coenzyme A,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Sparsentan,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Aminooxyacetic acid,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(C)(C)S,,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(C)(C)S,,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(C)(C)S,,Phosphoaminophosphonic Acid-Adenylate Ester,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](C)N(C)C(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,D-Levofloxacin,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CN(C)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Efavirenz,
CC(C)C[C@H](NC(=O)CNC(=O)CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Alpha-Adenosine Monophosphate,
CC(C)C[C@H](NC(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,IDD552,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Tenalisib,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O,,"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",
CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,MK-0873,
CC(C)C[C@H](NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,CC-115,
CC(C)C[C@H](NC(=O)[C@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Caprylic alcohol,
CC(C)C[C@H](NC(=O)[C@@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"6-Chloropurine Riboside, 5'-Monophosphate",
CC(C)C[C@H](NC(=O)[C@@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,AZD-5672,
CC[C@H](C)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,
CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid",
CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Aluminum chlorohydrate,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,2-Amino-4-methylphenol,
CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE,
CC[C@H](C)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Riboflavin tetrabutyrate,
CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Butylscopolamine,
CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Oxyphenbutazone,
CC(C)C[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Isocarboxazid,
CC(C)C[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid",
CC(C)C[C@H](NC(=O)[C@@H](C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Axelopran,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)N(C)C(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O,,5-monophosphate-9-beta-D-ribofuranosyl xanthine,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)N(C)C(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O,,Dodecyl-Coa,
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Lonidamine,
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Doxifluridine,
CC(C)C[C@H](NC(=O)CN(C)C(=O)[C@@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Valine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Uridine monophosphate,
CC(C)C[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Mirodenafil,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Iopromide,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(N)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,EIDD-2801,
COc1ccc(C[C@H](NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@H]2C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2CCC[C@H]2C(=O)O)cc1,,Propylene glycol,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c(F)c(F)c(F)c(F)c1F)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,alpha-L-methyl-fucose,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Pimobendan,
Cc1ccccc1C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Acylated ceftazidime,
Cc1ccc(C[C@H](NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@H]2C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2CCC[C@H]2C(=O)O)cc1,,Benzylpenicillin,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol",
CC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2CCC[C@H]2C(=O)O)cc1,,Resveratrol,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,2'-O-Acetyl Adenosine-5-Diphosphoribose,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)c1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1Cl)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Oxtriphylline,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Edratide,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(C(C)(C)C)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Dirithromycin,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)C(CCc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O,,2-Iminiopropanoate,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,S-oxy-L-cysteine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(N)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",
COc1ccc(C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2CCC[C@H]2C(=O)O)cc1,,MK-0767,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Enoxacin,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Mitobronitol,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Nefiracetam,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Lobeglitazone,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Iodo-Willardiine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Iniparib,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Pelubiprofen,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,octyl alpha-L-altropyranoside,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Bleomycin,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Atracurium besylate,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Dihydrostreptomycin,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(=O)O)[C@H](C)O,,"[des-Phe6, Glu9] glucagon",
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)Cc1cnc[nH]1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,[des-Phe6] glucagon-NH2,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,"[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,Bromfenac,
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)C1=O,,Bimoclomol,
C=C(C)[C@@H](CC=C(C)C)C[C@@]12C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(C(=O)c3ccc(O)c(O)c3)C1=O)C2=O,,"Garcinol, 1",
NCCCC[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H](C(N)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC1=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N3)C(=O)N[C@H](CC(N)=O)C(=O)N2,,CCNCSSKWCRDHSRCC,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1OS(=O)(=O)[O-],,Hydromorphone,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1OP(=O)([O-])OCc1ccc(C)cc1,,LCB01-0371,
CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OC(=O)c2ccc(C)cc2)[C@@H]1OP(=O)([O-])OC,,Valtorcitabine,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N)c(c2O)C=C(C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,Endralazine,
C=CC=Nc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,Oseltamivir acid,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCF)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N3CCC3)c(c2O)C=C(C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,NB-001,
C=CCO[C@@H]1[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)Nc2cc(O)c(N3CCC3)c(c2O)C=C(C)C[C@@H]1OC,,Dabrafenib,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,Amcinonide,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN3CCC3)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN3CCCC3)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,Hymecromone,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN3CCCC3)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCc3cnc[nH]3)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,N-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide,
CNCC=Nc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](OC(=O)CN)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,Luprostiol,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCF)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](OC(=O)CN)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,Encorafenib,
C=CC=Nc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](OC(=O)CN)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",
COc1c(O)cc2c(O)c1C=C(C)C[C@H](OC)[C@H](OC(=O)CCCN)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](N)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,(2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](NCCF)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,JNJ-39393406,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](NCC(F)F)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,O1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](NCCC(F)(F)F)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,Cefbuperazone,
CO[C@H]1C[C@H](C)Cc2c(O)c(cc(O)c2N=CCF)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)C1=O,,4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide,
CO[C@H]1C[C@H](C)Cc2c(O)c(cc(O)c2N=CCF)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)C1N=O,,Indomethacin,
CO[C@H]1C[C@H](C)Cc2c(O)c(cc(O)c2N=CCN(C)C)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)C1=O,,2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID,
CO[C@H]1C[C@H](C)Cc2c(O)c(cc(O)c2N=CCN(C)C)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)C1N=O,,Acenocoumarol,
CO/N=C1\[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@@H]1OC,,"5-Chloryl-2,4,6-Quinazolinetriamine",
CO[C@H]1C[C@H](C)Cc2c(O)c(cc(O)c2N=CCN(C)C)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)/C1=N\OCc1ccccc1,,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",
CO[C@H]1C[C@H](C)Cc2c(O)c(cc(O)c2N=CCN(C)C)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)/C1=N\OCCN(C)C,,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,
CO[C@H]1C[C@H](C)Cc2c(O)c(cc(O)c2N=CCN(C)C)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)/C1=N\OCC(=O)O,,Ethyl (2E)-4-({(2S)-2-[(N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl)amino]-2-phenylacetyl}amino)-5-[(3S)-2-oxo-3-pyrrolidinyl]-2-pentenoate,
CC[C@H](C)[C@H](NC(=O)CN(C)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O,,3-Iodo-Tyrosine,
CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)N(C)C(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1,,BK-MDA,
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O,,Apramycin,
CNc1c(CN=O)ccc(-c2ccc(O)cc2)c1-c1ccccc1,,Lidocaine,
O=NCc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1,,Olaflur,
O=NCc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1Cl,,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,
O=NC1CCCc2cc(-c3[nH]c(-c4ccccc4)nc3-c3ccncc3)ccc21,,Oglemilast,
CC(N=O)c1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1,,N-Cyclohexyl-N'-Decylurea,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCF)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)NO,,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCF)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(O)=NN,,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",
CO[C@H]1C2=NC(=O)O[C@H]1/C(C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)Cc1c(O)c(cc(O)c1N=CCN(C)C)NC(=O)C(C)=CC2,,Fludarabine,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)NCCN(C)C,,Clobetasol propionate,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N3CCC3)c(c2O)C=C(C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)NO,,AQX-1125,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N3CCC3)c(c2O)C=C(C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(O)=NN,,Oteseconazole,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)c1cnc[nH]1,,Obicetrapib,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(O)=NN,,5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)NCCO,,Androstanedione,
C=CCC(=C)/C=C/[C@@](C)(O)[C@H]1O[C@@H]2C[C@@H]3O[C@@H]4C[C@@H]5O[C@@H]6C[C@@H]7O[C@@H]8C[C@@H]9O[C@@H]%10C[C@@H]%11O[C@](C)(CCOS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])C[C@H]%11O[C@H]%10C[C@H]9O[C@H]8CC[C@@]7(C)O[C@@]6(C)CC[C@H](C)[C@H]5O[C@H]4C[C@@]3(C)O[C@H]2CC1=C,,GDC-0077,
Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccc(N3CC[C@H](C(=O)O)C3)c3ccccc23)c1C,,1832713-02-6,
CC(=O)N(c1cc(O)ccc1C)c1cn(C(C)=O)c2ccccc12,,Ticalopride,
O=C(O)COc1ccc(-c2ccccc2)cc1C(=O)NCc1cccc([N+](=O)[O-])c1,,({3-[(3-Nitrobenzyl)carbamoyl]biphenyl-4-Yl}oxy)acetic Acid,
NCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S,,924869-80-7,
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2[C@@H](O)CC(O)(C(F)(F)F)C(F)(F)F,,NSC12,
CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)N[C@@H](CO)C(=O)OC,,UNC3866,
CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)(C)C)[C@@H](C)CC)C(C)(C)C)C(=O)N[C@H](C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CSC1(C)C)[C@@H](C)O,,Cinnamyl alcohol,
CC(C)(C)c1cc(CN(C(=O)CN(Cc2ccc(Cl)cc2)S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)c2ccc(C(=O)O)c(O)c2)cc(C(C)(C)C)c1,,(3-Formyl-but-3-Enyl)-Phosphonic Acid,
C/C=C/C=C/C=C/C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1COC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H]2CCCN2C1=O,,Antibiotic A-54556B,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2C3CCCC2CC3)cc1,,Verdoheme,
COc1ccc2c(c1)N(CCCNC(=O)c1cccc3c1N[C@H](C)C(=O)N3)CCC2,,"6,7-dioxo-5H-8-ribitylaminolumazine",
CCN(C)S(=O)(=O)Nc1cc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c(F)c1,,7-Methylguanosine,
CCCCS(=O)(=O)Nc1ccc2c3c(cccc13)C(=O)N2CC,,Zopolrestat,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O,,TNLYML-COOH,
COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C,,BI-9564,
CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1,,NVS-CECR2-1,
N#Cc1cc2cc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)c(O)cc2n1Cc1cn[nH]c1,,MI-538,
CC(=O)N1CCCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1,,Pruvanserin,
Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(C#N)c(Cc3ccc(-n4cccn4)cc3)c(C#N)c2c1,,1-Carboxyethylaminomethyl-4-Aminomethylbenzene,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)c(Cl)c2cc1OC,,"US9725465, Example 138",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCCS(C)(=O)=O,,"US9725465, Example 222",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1CC(O)CO,,"US9725465, Example 84",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCC(C)(C)O,,"US9725465, Example 246",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCN1CC[C@@H](O)C1,,"US9725465, Example 199",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)c(N=[N+]=[N-])c2cc1OC,,"US9725465, Example 141",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCOCC1,,"US9725465, Example 232",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CC(C)OC(C)C1,,"US9725465, Example 174",
CN(C)C1CCN(C(=O)c2cc3cc(-c4ccc(CC(=O)Nc5cc(C6(C(F)(F)F)CC6)on5)c(F)c4)cnc3[nH]2)C1,,"US9725465, Example 110",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)cc3F)nc2cc1OC,,"US9725465, Example 217",
CC(C)(c1cc(NC(=O)Cc2ccc(-c3cnc4[nH]nc(OCCOC(F)(F)F)c4c3)cc2F)no1)C(F)(F)F,,"US9725465, Example 114",
Nc1nc2ccccc2nc1-c1ccc(CC(=O)Nc2cc(C3(C(F)(F)F)CC3)on2)cc1,,"US9725465, Example 7",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCNC(C)=O,,"US9725465, Example 168",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCOC[C@@H]1C,,"US9725465, Example 243",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCO,,"US9725465, Example 131",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)nn4C(C)(C)C)c(F)c3)nc2cc1OC,,"US9725465, Example 173",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCOC[C@H]1C,,"US9725465, Example 247",
CN1CC(NC(=O)c2cc3cc(-c4ccc(CC(=O)Nc5cc(C6(C(F)(F)F)CC6)on5)c(F)c4)cnc3[nH]2)C1,,"US9725465, Example 113",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2cc1OCCN1CCOCC1,,"US9725465, Example 189",
CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3cnc4[nH]nc(-n5ccnn5)c4c3)cc2)no1,,Olanzapine,
O=C(Cc1ccc(-c2cnc3ccncc3c2)cc1)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 12",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCCO,,"US9725465, Example 195",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)c(F)c3)cnc2cc1OCCN1CCOCC1,,5-(2-NITROPHENYL)-2-FUROIC ACID,
CN(C)CCNC(=O)c1n[nH]c2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)cc12,,threo-3-methyl-L-aspartic acid,
COCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2cc1OCCOC,,Metisazone,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OC1CN(C)C1,,"US9725465, Example 150",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCN(C)CCO,,"US9725465, Example 200",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CC2CC(C1)O2,,"US9725465, Example 223",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)cc3)cnc2cc1OC,,"US9725465, Example 5",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)cnc2cc1OCCN1CCOCC1,,Levallorphan,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCC(C)(C)O,,"US9725465, Example 239",
COc1cc2nc(OC)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 124",
CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3cnc4[nH]cc(C5(O)COC5)c4c3)cc2)no1,,4-Phenyl-1h-Imidazole,
CNCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 175",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCS(=O)(=O)CC1,,"US9725465, Example 216",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OCCN(C)C(C)=O,,"US9725465, Example 198",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCO[C@@H](C)C1,,"US9725465, Example 248",
O=C(Cc1ccc(-c2cnc3cc4c(cc3n2)OCCO4)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 76",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCO,,"US9725465, Example 91",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OC,,"US9725465, Example 128",
COc1cc2nc(C(=O)O)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 133",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCCN1CCOCC1,,"US9725465, Example 213",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCOC(=O)N(C)C,,"US9725465, Example 136",
COCCOc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)nn4C)c(F)c3)cnc2cc1OC,,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCC(=O)N(C)C,,"US9725465, Example 186",
O=C(Cc1ccc(-c2cnc3cc4c(cc3n2)OCO4)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 119",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCc1ccccc1,,"US9725465, Example 163",
COc1cc(OC)c2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)cc3)cnc2c1,,"US9725465, Example 13",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)nn4C)c(F)c3)nc2cc1OC,,"US9725465, Example 181",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cc2cc1OCCNC(C)=O,,"US9725465, Example 193",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCc1ccccc1,,"US9725465, Example 156",
COCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCOC,,"US9725465, Example 125",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC[C@@H](C)O,,"US9725465, Example 202",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCOCC1,,"US9725465, Example 79",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 46",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)cc3)cnc2cc1OCCN1CCOCC1,,"US9725465, Example 93",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCOC(C)=O,,"US9725465, Example 130",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2cc1OCCN1CCC(F)(F)CC1,,"US9725465, Example 207",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 4",
COc1cc2nc(O)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 152",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OC1CN(C)C1,,"US9725465, Example 90",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OC1CNC1,,"US9725465, Example 148",
CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3cnc4[nH]c(C(=O)NCCO)cc4c3)cc2)no1,,Biguanide,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCn1cncn1,,"US9725465, Example 185",
CN1CCC(NC(=O)c2cc3cc(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnc3[nH]2)CC1,,CRA_9678,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2cc1OCCN1CCC(O)CC1,,"US9725465, Example 206",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCCNC(C)=O,,"US9725465, Example 214",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2cc1OCCN,,"US9725465, Example 204",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cc2cc1OCCN,,"US9725465, Example 192",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCCN1CCOCC1,,"US9725465, Example 212",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCN(C)C,,"US9725465, Example 158",
COc1cc2nc(CO)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 137",
O=C(Cc1ccc(-c2cnc3cc4c(cc3n2)OC[C@@H](CO)O4)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 121",
COc1cc2nc(N)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 123",
O=C(Cc1ccc(-c2cnc3[nH]nc(OCCF)c3c2)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 104",
CN(C)CCCN(C)C(=O)c1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)cnc2[nH]1,,Hydrocortisone phosphate,
CCN1CC(Oc2cc3ncc(-c4ccc(CC(=O)Nc5cc(C6(C(F)(F)F)CC6)on5)c(F)c4)nc3cc2OC)C1,,"US9725465, Example 142",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCOC(C)=O,,"US9725465, Example 127",
COCCOc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OC,,"US9725465, Example 77",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)cc3)nc2cc1OC,,"US9725465, Example 8",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCC(O)CO,,"US9725465, Example 238",
O=C(Cc1ccc(-c2cnc3[nH]c(CO)cc3c2)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 70",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCCN,,"US9725465, Example 227",
O=C(Cc1ccc(-c2cnc3[nH]cnc3n2)cc1)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 14",
COc1cc2nc(C(N)=O)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 135",
O=C(Cc1ccc(-c2cnc3cccnc3c2)cc1)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 11",
COCCOc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OC,,"US9725465, Example 160",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCN(C)CC1,,"US9725465, Example 81",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OC1COC1,,"US9725465, Example 144",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCn1cncn1,,"US9725465, Example 210",
COc1ccc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2n1,,"US9725465, Example 155",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OCCN1CCOCC1,,"US9725465, Example 187",
COCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cc2cc1OC,,"US9725465, Example 126",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1C2CCC1COC2,,"US9725465, Example 245",
O=C(Cc1ccc(-c2cnc3[nH]nc(OCC(F)F)c3c2)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 102",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1NCCN1CCOCC1,,"US9725465, Example 85",
CC(=O)OCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCOC(C)=O,,"US9725465, Example 74",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCC(O)CO,,"US9725465, Example 236",
CS(=O)(=O)CCNC(=O)c1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2[nH]1,,"US9725465, Example 107",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)nn4C)c(F)c3)nc2cc1OC,,Trimethobenzamide,
O=C(Cc1ccc(-c2cnc3cc4c(cc3n2)O[C@H](CO)CO4)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 122",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)nn4C)c(F)c3)nc2cc1OC,,"US9725465, Example 172",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCNCC1,,"US9725465, Example 241",
CC(=O)N(C)CCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OCCN(C)C(C)=O,,"US9725465, Example 221",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cc2cc1OCCO,,"US9725465, Example 179",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN,,"US9725465, Example 167",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CC2CCC(C1)O2,,"US9725465, Example 244",
COc1n[nH]c2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc12,,"US9725465, Example 63",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN=[N+]=[N-],,"US9725465, Example 166",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OCCN1CC[C@H](O)C1,,"US9725465, Example 191",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C)CC5)no4)c(F)c3)cnc2cc1OCCN1CCOCC1,,4-(2-AMINOETHYL)BENZENESULFONAMIDE,
COCCOc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OC,,"US9725465, Example 177",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCO,,"US9725465, Example 88",
COCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)nn4C)c(F)c3)nc2cc1OC,,Lobucavir,
COc1cc2ncc(-c3cnc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 229",
CCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cc2cc1OC,,"US9725465, Example 86",
CNC(=O)c1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)cnc2[nH]1,,2-oxopropyl-CoM,
CN(C)C(=O)COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCC(=O)N(C)C,,"US9725465, Example 154",
COc1cc2ncc(-c3cc(F)c(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)cc3F)nc2cc1OC,,"US9725465, Example 219",
Cn1ccc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)cc3)nc21,,"US9725465, Example 9",
CC(C)(c1cc(NC(=O)Cc2ccc(-c3cnc4c(N)cccc4c3)cc2F)no1)C(F)(F)F,,"US9725465, Example 151",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2cc1OC,,Prasugrel,
CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3cnc4[nH]c(C(=O)NCCS(C)(=O)=O)cc4c3)cc2)no1,,Amcasertib,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCCC1,,"US9725465, Example 134",
O=C(Cc1ccc(-c2cnc3[nH]c(C(=O)NC4CNC4)cc3c2)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 112",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCO[C@H](C)C1,,"US9725465, Example 242",
CCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCC,,"US9725465, Example 118",
CC(C)(C)c1cc(NC(=O)Cc2ccc(-c3cnc4[nH]nc(-n5nccn5)c4c3)cc2)no1,,Nanatinostat,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)cc3)cnc2cc1OCCN1CCOCC1,,"US9725465, Example 231",
CC(O)c1n[nH]c2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)c(F)c3)cc12,,Immucillin-G,
CCOC(=O)c1nc2cc(OC)c(OC)cc2nc1-c1ccc(CC(=O)Nc2cc(C3(C(F)(F)F)CC3)on2)c(F)c1,,"US9725465, Example 132",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCn1cnnc1,,"US9725465, Example 211",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1Br,,"US9725465, Example 83",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1C(C)(O)CO,,"US9725465, Example 233",
CN(C)CCNC(=O)c1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)cnc2[nH]1,,Bufotenine,
COc1cc2ncc(-c3cc(F)c(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 226",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OCCCN1CCOCC1,,"US9725465, Example 203",
COc1cc2ncc(-c3cc(F)c(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)cc3F)nc2cc1OC,,"US9725465, Example 218",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CC2CC1CO2,,"US9725465, Example 224",
CCN1CC(Oc2cc3ncc(-c4ccc(CC(=O)Nc5cc(C(C)(C)C(F)(F)F)on5)c(F)c4)nc3cc2OC)C1,,"US9725465, Example 149",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCOCC1(C)C,,"US9725465, Example 96",
O=C(Cc1ccc(-c2cnc3cc(OCCO)c(OCCO)cc3n2)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 75",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCNCCO,,"US9725465, Example 201",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OC[C@@H](C)O,,"US9725465, Example 208",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)nn4C)c(F)c3)cnc2cc1OCCN1CCOCC1,,"US9725465, Example 228",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCCOCC1,,"US9725465, Example 240",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)nn4C)c(F)c3)cnc2cc1OCCN1CCOCC1,,"US9725465, Example 94",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCC#N,,"US9725465, Example 183",
COc1cc2nc(C)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 169",
O=C(Cc1ccc(-c2cnc3[nH]c(C(=O)O)cc3c2)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 106",
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OC,,"US9725465, Example 129",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c(F)c3)nc2cc1OC,,Bacampicillin,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)c(OC)c2cc1OC,,"US9725465, Example 145",
COCCOc1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OC,,"US9725465, Example 188",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc5n(n4)CCC5(C)C)c(F)c3)nc2cc1OC,,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,
Cn1cc(-c2n[nH]c3ncc(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cc23)cn1,,AS-8112,
COc1cc2ncc(-c3cc(F)c(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 225",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2cc1OCCN1CC[C@H](O)[C@@H](F)C1,,"US9725465, Example 87",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cc2cc1OCCN1CCOCC1,,"US9725465, Example 190",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)on4)cc3)cc2c(OC)c1OC,,CRA_17693,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OC1COC1,,"US9725465, Example 147",
COc1cc2nc(Cl)c(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 146",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OCCO,,"US9725465, Example 170",
O=C(Cc1ccc(-c2cnc3ccsc3c2)cc1)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 10",
CN1CCN(C(=O)c2cc3cc(-c4ccc(CC(=O)Nc5cc(C(C)(C)C)on5)cc4)cnc3[nH]2)CC1,,Noscapine,
CN(C)NC(=O)c1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2[nH]1,,"US9725465, Example 117",
O=C(Cc1ccc(-c2cnc3[nH]ccc3n2)cc1)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 3",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCCN1CCOCC1,,"US9725465, Example 209",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN(C)C(C)=O,,"US9725465, Example 176",
CN(C)CCNC(=O)c1cc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2[nH]1,,"US9725465, Example 108",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCO,,"US9725465, Example 165",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2cc1OCCNC(C)=O,,"US9725465, Example 205",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2c(OC)c1OC,,"US9725465, Example 115",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cc2cc1OCCO,,"US9725465, Example 178",
CNCCOc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OC,,"US9725465, Example 196",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OC1CNC1,,"US9725465, Example 89",
O=C(Cc1ccc(-c2cnc3nn4c(c3c2)OC(CO)C4)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 98",
C[C@@H]1CCc2cc(F)ccc2N1C(=O)c1ccc(O)cc1O,,Levofloxacin,
C[C@H]1CCc2cc(F)ccc2N1C(=O)c1ccc(O)cc1O,,"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium",
Cc1cnc(Cl)nc1-c1ccc2c(c1)CC[C@H](C)N2C(=O)c1ccc(O)cc1O,,Defactinib,
CN(Cc1ccc2nccnc2c1)C(=O)c1ccc(N(Cc2ccccc2)C(=O)c2ccc(O)cc2O)cc1,,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",
Cc1cnc(Cl)nc1-c1ccc(N(Cc2ccccc2)C(=O)c2ccc(O)cc2O)cc1,,"2,2-Dichloro-1-methanesulfinyl-3-methyl-cyclopropanecarboxylic acid [1-(4-bromo-phenyl)-ethyl]-amide",
O=C(c1ccc(O)cc1O)N(Cc1ccccc1)c1ccccc1,,Indocyanine green acid form,
Cc1cnc(Cl)nc1-c1ccc(N(Cc2ccc(CN3CCCC3)cc2)C(=O)c2ccc(O)cc2O)cc1,,Porphobilinogen,
Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCCN3CCCCC3)ccc2c1,,Piromelatine,
Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2c(c1)CCCN2,,Dorzagliatin,
O=C([O-])CC1Sc2nnc(-c3ccco3)n2N=C1c1ccccc1,,Methylparaben,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1CC1,,Terpin hydrate,
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1C(=O)N1CCC(C(F)(F)F)CC1,,"US10201546, Example 146",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC(C)(C)O,,Estrone sulfate,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCc1cc(C)nn1C,,Benperidol,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCc1ccccc1,,"4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol",
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,"US10201546, Example 243a",
Cc1ccc(C(O)(c2ccc3nc(Cl)c(CC(F)(F)F)c(Cl)c3c2)c2cnnn2C)c(C)n1,,"US10201546, Example 141",
Cc1ccc(C(O)(c2ccc3nc(Cl)c(CC(F)(F)F)c(N4CCC4)c3c2)c2cnnn2C)c(C)n1,,"US10201546, Example 238a",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNCCCC(F)(F)F,,"US10201546, Example 195",
Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(CC(F)(F)F)c(Cl)c2c1,,"US10201546, Example 139a",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNC(=O)C1(C(F)(F)F)CCC1,,"US10201546, Example 183",
CC(C)c1c(-c2ccsc2)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CCC(n2ccc(C(F)(F)F)n2)CC1,,"US10201546, Example 196",
Cn1cncc1C(O)(c1ccc(Cl)cc1)c1ccc2nc(Cl)c(OCC(F)(F)F)c(Cl)c2c1,,"US10201546, Example 45",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCc1c(C)noc1C,,Cycrimine,
Cc1c(-c2cncnc2)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,Erdosteine,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OC1CCOCC1,,N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,
Cc1ccc(C(O)(c2ccc3nc(N4CCC4)c(CC(F)(F)F)c(Cl)c3c2)c2cnnn2C)c(C)n1,,"US10201546, Example 142a",
Cc1c(-c2ccc3cnn(C)c3c2)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",
COc1nc2ccc(C(O)(c3cnnn3C)c3cnc(C)n3C)cc2c(C#N)c1CC(F)(F)F,,"US10201546, Example 206a",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC(C)C,,4-(1H-IMIDAZOL-1-YL)PHENOL,
CCC(NCc1c(OC)nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c1Cl)C(F)(F)F,,"US10201546, Example 197",
COc1nc2ccc(C(O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CC(C)C,,Monobenzone,
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OC,,"US10201546, Example 97",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNC(=O)C1(C(F)(F)F)CC1,,"US10201546, Example 184",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"US10201546, Example 103a",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCCS(C)(=O)=O,,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,
COc1nc2ccc(C(O)(c3cncn3C)C3CCN(S(C)(=O)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,Sulisobenzone,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1CCO1,,Tiemonium iodide,
COc1nc2ccc(C(O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,Azacitidine,
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1C,,"US10201546, Example 18",
COc1nc2ccc(C(O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1C,,Gantacurium,
COc1nc2ccc(C(O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1C1CCCC1,,Carbomycin,
Cc1nc(C)c(C(O)(c2ccc3nc(N4CCC4)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)s1,,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OC(C)C1CC1,,AR-AO-14418,
COc1nc2ccc(C(O)c3ccc(C)nc3C)cc2c(Cl)c1CC(C)C,,Brotizolam,
CC(C)c1c(Cl)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,Lucerastat,
COc1nc2ccc(C(O)c3cnc(C)n3C)cc2c(Cl)c1C1CCCC1,,2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1COC1,,2'-O-butyl-5-methyluridine,
COc1nc2ccc(C(O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,"US10201546, Example 245a",
COc1nc2ccc(C(O)(c3sc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C,,(R)-Rolipram,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(=O)NCC1CC1,,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",
COc1c(CC(F)(F)F)c(Cl)nc2ccc(C(O)(c3cnnn3C)c3cnc(C)n3C)cc12,,"US10201546, Example 138",
Cc1ncc(C(O)c2ccc3nc(Cl)c(OC(C)C)c(Cl)c3c2)n1C,,2-Hydroxyestradiol,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CN[C@@H](C)C(F)(F)F,,"US10201546, Example 200",
CCOc1c(OC)nc2ccc(C(O)(c3ccc(Cl)cc3)c3cncn3C)cc2c1Cl,,4-Methyl-N-[5-(5-methyl-furan-2-ylmethylene)-4-oxo-thiazolidin-2-ylidene]-benzenesulfonamide,
COc1nc2ccc(C(O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,Calcium glycerophosphate,
COc1nc2ccc(C(O)(c3cncn3C)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(=O)NCC(F)(F)F,,"US10201546, Example 152",
Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(Cl)c(OCC(F)(F)F)c(Cl)c2c1,,"US10201546, Example 39",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCCN1CCOCC1,,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CCC1CCN(C(C)=O)CC1,,"US10201546, Example 32",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(=O)N1CCCC1,,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1CCOC1,,Chloramphenicol succinate,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(=O)NC1CC1,,HCV-086,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNCCC(F)(F)F,,"US10201546, Example 193",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(C)C,,AR-42,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC1CC1,,Acid yellow 54 free acid,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CC1(F)F,,"US10201546, Example 72a",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CC1,,Talaporfin,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(F)(F)CC1,,"(4-Chloro-3-((4,4-difluoropiperidin-1-yl)methyl)-2-methoxyquinolin-6-yl)(2,6-dimethylpyridin-3-yl)(1-methyl-1H-1,2,3-triazol-5-yl)methanol",
Cc1ncc(C(O)(c2ccc3nc(Cl)c(CC(F)(F)F)c(Cl)c3c2)c2cnc(C)n2C)n1C,,"US10201546, Example 144",
COc1nc2ccc(C(O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,"US10201546, Example 244a",
COc1nc2ccc(C(O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,1-(4-((4-Chloro-2-methoxy-3-((tetrahydro-2H-pyran-4-yl)methyl)quinolin-6-yl)(hydroxy)(phenyl)methyl)piperidin-1-yl)ethanone,
COc1nc2ccc(C(O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1OC(C)C,,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",
Cc1ncc(C(O)(c2ccc3nc(Cl)c(CC(F)(F)F)c(N4CCC4)c3c2)c2cnc(C)n2C)n1C,,"US10201546, Example 239",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OC,,Trilaciclib,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(S(C)(=O)=O)CC1,,"(4-Chloro-2-methoxy-3-((4-(methylsulfonyl)piperidin-1-yl)methyl)quinolin-6-yl)(2,6-dimethylpyridin-3-yl)(1-methyl-1H-1,2,3-triazol-5-yl)methanol",
COc1nc2ccc(C(O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,"US10201546, Example 207a",
Cc1ccc(C(O)(c2ccc3nc(N4CCC4)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)c(C)n1,,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC(C)(C)O,,Lisavanbulin,
COc1nc2ccc(C(O)(c3c(C)nn(C)c3C)c3cnc(C)n3C)cc2c(Cl)c1OCC(F)(F)F,,"US10201546, Example 248*%",
COc1nc2ccc(C(O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(OC)c1OCC(F)(F)F,,"US10201546, Example 96",
COc1nc2ccc(C(O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(C#N)c1OCC(F)(F)F,,"US10201546, Example 211b",
COc1nc2ccc(C(O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1C1CCOCC1,,Dihydrocodeine,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(=O)N(C)C,,LFF-571,
CC(C)c1c(-c2cncnc2)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,Tetrodotoxin,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C1CCCC1,,"3-methyl-benzene-1,2-diol",
Cn1cncc1C(O)(c1ccc(Cl)cc1)c1ccc2nc(N3CCC3)c(OCC(F)(F)F)c(Cl)c2c1,,"US10201546, Example 90a",
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(=O)N1CCC(C(F)(F)F)CC1,,"US10201546, Example 83",
COc1nc2ccc(C(O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"US10201546, Example 116a",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1CCCO1,,"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile",
COc1cc2cc(C(O)(c3sc(C)nc3C)c3cnnn3C)ccc2nc1-c1ccccc1,,Ranirestat,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNCCOCC(F)(F)F,,"US10201546, Example 194",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1CCCN1C,,Yohimbine,
COc1nc2ccc(C(O)c3ccc(C)nc3C)cc2c(Cl)c1OC(C)C,,Anecortave acetate,
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,"US10201546, Example 240a",
OC(c1cccnc1)(c1cccc(Cl)c1)c1ccc2nc(-c3cncnc3)c(C3CCCCC3)c(Cl)c2c1,,Fluocinolone acetonide,
CC(=O)N1CCC(C(O)(c2ccccc2)c2ccc3nc(Cl)c(OC(C)C)c(Cl)c3c2)CC1,,Cystine,
CC(C)Oc1c(Cl)nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,"US10201546, Example 48",
Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(Cl)c(OCC3CC3)c(Cl)c2c1,,"US10201546, Example 40",
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1C1=CCN(C)CC1,,"US10201546, Example 33",
CC(C)(C)c1c(/C=C/c2ccccc2)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,Dipyridamole,
Cc1ncc(C(O)(c2ccc3nc(Cl)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)n1C,,Acedoben,
CCOC(=O)c1c(C(F)(F)F)nc2ccc(C(O)(c3cccnc3)c3cccnc3)cc2c1C(F)(F)F,,"US10201546, Example 8",
Cc1nc(C)c(C(O)(c2ccc3nc(Cl)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)s1,,Loteprednol etabonate,
Cn1cncc1C(O)(c1ccc(Cl)cc1)c1ccc2nc(Cl)c(CN3CCOCC3)c(Cl)c2c1,,Mannose 6-phosphate,
O=S(=O)(c1ccc(O)cc1O)N1Cc2ccc(NC3CCNCC3)cc2C1,,Methyl 4-thio-beta-D-glucopyranoside,
CN(Cc1cc(C(CC(=O)O)c2ccc3c(c2)nnn3C)ccc1Cl)S(C)(=O)=O,,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",
CN(Cc1cc([C@H](CC(=O)O)c2ccc3c(c2)nnn3C)ccc1Cl)S(=O)(=O)c1ccccc1,,Idalopirdine,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CCN2CCOCC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,CERC-301,
CN1Cc2ccccc2OCCNC(=O)c2cnn3ccc1nc23,,Delafloxacin,
CC1Oc2ccc3ncc(n3n2)C(=O)NCCOc2ccc(F)cc21,,Vanillyl butyl ether,
O=C1NCCCOc2ccc(F)cc2CCc2ccn3ncc1c3n2,,N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,
CN1Cc2cc(F)ccc2OCCNC(=O)c2cnc3ccc1nn23,,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",
CC1Oc2ccn3ncc(c3n2)C(=O)NCCOc2ccc(F)c(Cl)c21,,Mefloquine,
CCN1Cc2cc(F)ccc2OCCNC(=O)c2cnn3ccc1nc23,,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",
CN1Cc2c(ccc(F)c2Cl)OCCNC(=O)c2cnn3ccc1nc23,,4-bromo-3-hydroxy-3-methyl butyl diphosphate,
COc1cc(O)cc2c1CN(C(C)C)CCN2c1ccc2ncc(-c3cnn(C)c3)nc2c1,,JNJ-26489112,
COc1cc(OC)c2c(c1)N(c1ccc3ncc(-c4cnn(C)c4)nc3c1)CCCN(C(C)C)C2,,GS-9256,
CCn1cc(-c2cnc3ccc(N4CCN(C)Cc5c(OC)cc(OC)cc54)cc3n2)cn1,,Fenprostalene,
COc1cc(OC)c2c(c1)N(c1ccc3ncc(-c4cn[nH]c4)nc3c1)CCN(C(C)C)C2,,Zoalene,
COc1cc(O)c2c(c1)N(c1ccc3ncc(-c4cnn(C)c4)nc3c1)CCN(C(C)C)C2,,Cariprazine,
CCn1cc(-c2cnc3ccc(N4CCN(C(C)C)Cc5c(OC)cc(OC)cc54)cc3n2)cn1,,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)Nc1ccccc1,,Prinomastat,
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)Nc1cccc(Cl)c1,,Atecegatran metoxil,
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)Nc1ccc(Br)cc1,,Bifeprunox,
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)Nc1ccccn1,,Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)Nc1nccs1,,Propofol,
CC(C)C[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Bufylline,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,"(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-oxo-3-piperidinyl beta-D-glucopyranoside",
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Compound 18,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)O,,Fenpiverinium,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)OC(C)(C)C)[C@@H](C)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Relacatib,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Quetiapine,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1cn(C(=O)OC(C)(C)C)c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Deoxyinosine,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Vapreotide,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)C1CCCCC1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Ioxaglic acid,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)c1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Nacubactam,
CC(C)C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Ronacaleret,
CSCC[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)OC(C)(C)C,,Fostemsavir,
CC(C)C[C@@H](NC(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Sulfabenzamide,
CC(C)C[C@@H](NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Gadoteridol,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Travoprost,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C,,CD564,
CC(C)C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)O,,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccc(OC(C)(C)C)cc1)C(=O)O,,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,Thiamphenicol,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1cn(C(=O)OC(C)(C)C)c2ccccc12)C(=O)O,,Ilepatril,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)C(=O)O,,R-348,
CC(C)C[C@@H](NC(=O)[C@H](CC1=CCCCC1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,4-Hydroxy-3-Methyl Butyl Diphosphate,
Cc1ccc(S(=O)(=O)/N=c2\oc3ccccc3cc2CO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1,,XL-888,
Cc1ccc(S(=O)(=O)/N=c2\oc3ccccc3cc2CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)cc1,,Fenoldopam,
CO[C@H]1O[C@H](CO)[C@H](O)[C@H](OCc2cc3ccccc3o/c2=N\S(=O)(=O)c2ccc(C)cc2)[C@H]1O,,Robalzotan,
CO[C@H]1O[C@H](CO)[C@H](O)[C@H](OCc2cc3ccccc3o/c2=N\S(=O)(=O)c2ccc(C)cc2)[C@H]1OC(C)=O,,"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",
CO[C@H]1O[C@H](CO)[C@H](O)[C@H](OCc2cc3ccccc3o/c2=N\S(=O)(=O)c2ccccc2)[C@H]1O,,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,
CO[C@H]1O[C@H](CO)[C@H](O)[C@H](OCc2cc3ccccc3o/c2=N\S(=O)(=O)c2ccccc2)[C@H]1OC(C)=O,,Ethanol,
CO[C@H]1O[C@H](CO)[C@H](O)[C@H](OCc2cc3ccccc3oc2=O)[C@H]1O,,Olopatadine,
CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C(CCCCCCCCn1cc(CCCC(=O)NC(CCCCCCCCn2cc(C[C@H](NC(C)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)nn2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)NCCNC(=O)CCCC[C@H]2SC[C@H]3NC(=O)N[C@H]32)C(C)C)nn1)NC(C)=O)C(N)=O,,Xylitol,
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2C3CCCC2CCC3)cc1,,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2CC3CCC(C3)C2)cc1,,UDP-6-sulfoquinovose,
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2C3CC4CC(C3)CC2C4)cc1,,Begacestat,
N[C@@H]1CCCC[C@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,alpha-D-quinovopyranose,
COCC(=O)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)C1,,"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",
O=C(NC1CCOCC1)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)C1,,alpha-D-mannose 6-phosphate,
Cn1cncc1C(=O)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,Bisoxatin acetate,
Cn1cncc1C(=O)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)C1,,D-Treitol,
COCC[C@]1(C(=O)O)CCCC[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,Combretastatin,
O=C1CC(c2ccccc2)CC(O)=C1Sc1ccccc1Cl,,ONO-2952,
N#Cc1ccccc1SC1=C(O)CC(c2ccccc2)CC1=O,,Pipenzolate,
O=C1CC(c2ccccc2Cl)CC(O)=C1Sc1ccccc1Cl,,Phenoperidine,
O=C1CC(c2cccc(Cl)c2)CC(O)=C1Sc1ccccc1Cl,,Ridinilazole,
COc1ccc(C2CC(=O)C(Sc3ccccc3Cl)=C(O)C2)cc1,,4-Nitrophenyl (3S)-3-({N-[(benzyloxy)carbonyl]-L-phenylalanyl}amino)-5-phenyl-1-pentanesulfonate,
O=C1CC(c2c(Cl)cccc2C(F)(F)F)CC(O)=C1Sc1ccccc1Cl,,ISO24,
N#Cc1ccccc1SC1=C(O)CC(c2c(Cl)cccc2Br)CC1=O,,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,
OC(c1ccncc1)(c1ccc2nc(Cl)c(Cc3ccc(Cl)cc3)c(Cl)c2c1)c1cncs1,,TC-6987,
CC(C)Nc1ncnn2cccc12,,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",
c1cc2c(Nc3cn[nH]c3)ncnn2c1,,Idanpramine,
c1cc2c(Nc3ccncc3)ncnn2c1,,"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",
c1cc2c(N3CCOCC3)ncnn2c1,,Barusiban,
c1cncc(Oc2ncnn3cccc23)c1,,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(CC=C(C)C)[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Eniluracil,
CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(C)=O)c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O,,Flurandrenolide,
CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(=O)CCCCN=[N+]=[N-])c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O,,Perfosfamide,
CC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,,Solabegron,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)COCCN2CCOCC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Beta-Hydroxyleucine,
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC,,Clorobiocin,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C,,PZ-128,
C[C@H]1O[C@@H](OCCOCCOCCn2cc(COc3c4cc(C(C)(C)C)cc3Cc3cc(C(C)(C)C)cc(c3OCc3cn(CCOCCOCCO[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)nn3)Cc3cc(C(C)(C)C)cc(c3OCc3cn(CCOCCOCCO[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)nn3)Cc3cc(C(C)(C)C)cc(c3OCc3cn(CCOCCOCCO[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)nn3)C4)nn2)[C@H](O)[C@@H](O)[C@H]1O,,Tecarfarin,
COc1ccc(CCSc2nc3c(=O)[nH]c(N)nc3[nH]2)cc1,,LGD-2226,
Nc1nc2[nH]c(SCc3ccccc3C(F)(F)F)nc2c(=O)[nH]1,,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",
COc1cccc(CN(C)C(=O)CCCN2c3ccccc3N(Cc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)S2(=O)=O)c1,,1-Hydroxy-2-Amino-3-Cyclohexylpropane,
CC(C)C(=O)N1CCC(CN2c3ccccc3N(Cc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)S2(=O)=O)CC1,,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,
CCC(=O)N1CCCC(CN2c3ccccc3N(Cc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)S2(=O)=O)C1,,Peruvoside,
CCC(CC)c1ccc(CN2c3ccccc3N(CCCC(=O)N3CCCC3)S2(=O)=O)cc1,,Guanosine-2'-monophosphate,
CC(C)c1ccc(CN2c3ccccc3N(CCCC(=O)N3CCCC3)S2(=O)=O)cc1,,delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine,
O=C(CCCN1c2ccccc2N(Cc2ccc(C(O)C(F)(F)F)cc2)S1(=O)=O)N1CCCC1,,Fluprednidene acetate,
O=C(CCCN1c2ccccc2N(Cc2ccccc2)S1(=O)=O)N1CCCC1,,Sultopride,
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)[C@@H](C)CC,,UNII-U8DGS69FVC,
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)[C@@H](C)CC,,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)[C@@H](C)CC,,Butorphanol,
Nc1nc(N)c2cc(NCc3ccc([N+](=O)[O-])cc3)ccc2n1,,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",
Nc1nc(N)c2cc(NCCn3c(C(F)(F)F)nc4cc(Cl)c(Cl)cc43)ccc2n1,,Manganese gluconate,
COc1cc2c(c(C)c1C)OC(C)(CCCC(C)C)CC2,,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",
Cc1cc(O)cc2c1OC(C)(CCCC(C)C)CC2=O,,"alpha,beta-Methyleneadenosine 5'-triphosphate",
Cc1cc(O)cc2c1NC(C)(CCCC(C)C)CC2,,Ozagrel,
C[N+](C)(CC#CCOC1=NOCC1)CCCCNC(=O)c1cn(Cc2ccccc2)c2c(F)cccc2c1=O,,Ondelopran,
C[N+](C)(CC#CCOC1=NOCC1)CCCCNC(=O)c1cn(Cc2ccccc2)c2cc(Cl)c(F)cc2c1=O,,Neltenexine,
C[N+](C)(CC#CCOC1=NOCC1)CCCCCCNC(=O)c1cn(Cc2ccccc2)c2c(F)cccc2c1=O,,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",
C[N+](C)(CC#CCOC1=NOCC1)CCCCCCNC(=O)c1cn(Cc2ccccc2)c2ccc(F)cc2c1=O,,Crisaborole,
CC[C@@H]1SC2(CCNCC2)N(CCCCCCCCOc2ccc3cc(Cn4cc(C(=O)O)c(=O)c5cccc(F)c54)ccc3c2)C1=O,,Carbenoxolone,
Cn1cc(Cn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1,,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",
CCN[C@H]1C[C@H](CCCO)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,(E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5-METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO-PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER,
O=C(CCCCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NCCNC(=O)CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1,,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",
CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCNC(=O)CCc2ccc(S(=O)(=O)N(CC(=O)N/N=C3\C(=O)Nc4ccccc43)c3ccc(Cl)cc3)cc2)c2cc(S(=O)(=O)O)ccc21,,Lactic acid,
COc1ccc(-n2c(COCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)c[nH+]1,,Rebaudioside A,
COc1ccc(-n2c(COCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)c[nH+]1,,Flubendazole,
O=C(c1ccccc1)C1C(=O)N(Cc2ccccc2)C(=O)N(Cc2ccccc2)C1=O,,Derenofylline,
COc1ccc(-c2cc(C(=O)O)nn2-c2cccc(Br)c2)cc1,,Etamivan,
COc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Br)cc2)cc1,,Br-Coeleneterazine,
COc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,2-Amino-3-(Cystein-S-Yl)-Isoxazolidin-5-Yl-Acetic Acid,
Cc1cccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)c1,,Bambuterol,
O=C(O)c1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,
N#Cc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,Soneclosan,
NCc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,Propicillin,
O=C(O)c1cc(-c2ccc(O)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Proglumetacin,
O=C(O)c1cc(Cc2ccc(O)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Theanine,
O=C(NCc1ccccc1)c1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,Iomeprol,
COc1ccc(CNC(=O)c2ccc(-c3cc(C(=O)O)nn3-c3ccc(Cl)c(Cl)c3)cc2)cc1,,Raluridine,
COc1ccc(C(=O)NCc2ccc(-c3cc(C(=O)O)nn3-c3ccc(Cl)c(Cl)c3)cc2)cc1,,Dopexamine,
O=C(NCc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1)c1ccc(Br)cc1,,Goserelin,
O=C(O)c1cc(-c2ccc(C(=S)NCc3ccccc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Moperone,
COc1ccc(CNC(=S)c2ccc(-c3cc(C(=O)O)nn3-c3ccc(Cl)c(Cl)c3)cc2)cc1,,Pyritinol,
O=C(O)c1cc(-c2cccc(CNCc3ccc(-c4ccc(C(=O)O)o4)cc3)c2)n(-c2ccc(Cl)c(Cl)c2)n1,,4-Methyl-5-Hydroxyethylthiazole Phosphate,
CC(=O)N(Cc1ccc(-c2ccc(C(=O)O)o2)cc1)Cc1cccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)c1,,"6-(4-{[2-(3-iodobenzyl)-3-oxocyclohex-1-en-1-yl]amino}phenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one",
O=C(NCc1ccc(-c2ccc(C(=O)O)o2)cc1Cl)c1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,Dexrazoxane,
O=C(O)c1cc(-c2ccc(C(=S)NCc3ccc(-c4ccc(C(=O)O)o4)cc3Cl)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,"4-{[(Z)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino}butanoic acid",
O=C(O)c1cc(-c2ccc(CN3CCc4cc(-c5ccc(C(=O)O)o5)ccc4C3=S)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Inosine pranobex,
NS(=O)(=O)c1ccc(C(=S)NCc2ccc(-c3cc(C(=O)O)nn3-c3ccc(Cl)c(Cl)c3)cc2)cc1,,Resorcinol,
O=C(O)c1cc(-c2ccc(CNC(=S)c3ccc(-c4nnn[nH]4)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Betadex,
CCCCCCCCC[C@@H](O)[C@@H](N)Cc1ccccc1,,Cicletanine,
NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O,,1-Hydroxy-1-Thio-Glycerol,
NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O,,Virginiamycin,
COc1ccc(-c2cnc3c(NCCO)snc3c2)cc1OC,,Procarbazine,
OCCNc1snc2cc(-c3ccsc3)cnc12,,Estradiol benzoate,
CC(C)(O)c1nc(-c2ccc(CNC(=O)c3cnc(-c4ccccn4)nc3)cc2)no1,,KP-1461,
O=C(CCc1cccnc1)Nc1cncc(-c2cccc3[nH]ccc23)c1,,5-Hydroxy-N-Propargyl-1(R)-Aminoindan,
CCC(=O)Nc1cncc(-c2cccc3[nH]ccc23)c1,,Betiatide,
O=C1CC[C@@H](C(=O)Nc2cncc(-c3cccc4[nH]ccc34)c2)N1,,DL-dimyristoylphosphatidylglycerol,
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(N2CCCCC2)nc1,,Tris(Hydroxyethyl)Aminomethane,
O=C1CN(c2ccc(C(=O)NC3CCN(CC(F)(F)F)CC3)cn2)CCN1,,Arginine,
COc1cc(-c2ccc(C(=O)NC3CCN(CC(F)(F)F)CC3)cn2)ccn1,,Reproterol,
Cc1ccc(CNc2nc3c(N)ncnc3n2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1,,beta-D-Ribose-5-phosphate,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@@H](O)[C@@H](COS(=O)(=O)O)O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNc4cccc(NC(=O)CCCCC5CCSS5)c4)[C@@H]3NC(C)=O)[C@H](OS(=O)(=O)O)[C@H]2O)O[C@H](COS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,,Phthalylsulfathiazole,
O=c1[nH]c2cc(CNS(=O)(=O)c3cccnc3)ccc2n1-c1cc(Cl)c(O)cc1O,,hsp90_44,
COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C,,BI-7273,
Cc1cc(-c2ccc(C(N)=O)cc2)cn(C)c1=O,,Dubermatinib,
COc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C)c21,,866018-94-2,
CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3C#CCC3(NC(=O)c4ccc(F)cc4)CC3)ccc2nc1N,,N-Carbamoylaspartic acid,
CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3CCc3ccc(NC(=O)c4ccc(F)cc4)cn3)ccc2nc1N,,(S)-Rolipram,
Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)Nc1ccc(S(N)(=O)=O)cc1,,CypD inhibitor C-9,
CCOc1ccc(/C=C2\SC(=S)N(CCNc3nc(Cl)nc(Cl)n3)C2=O)cc1,,BMS-986142,
CCOc1ccc(/C=C2\SC(=S)N(CCNc3nc(C)nc(Cl)n3)C2=O)cc1,,Dinoprostone,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@@H]3[C@@H](NC(C)=O)[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNc4cccc(NC(=O)CCCCC5CCSS5)c4)O[C@H](COS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@H](O)[C@H]2O)O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,,Phenylpyruvic acid,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@@H](O)[C@@H](COS(=O)(=O)[O-])O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNc4cccc(NC(=O)CCCCC5CCSS5)c4)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,,"4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE",
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@@H]3[C@@H](NC(C)=O)[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNc4cccc(NC(=O)CCCCC5CCSS5)c4)O[C@H](CO)[C@@H]3OS(=O)(=O)[O-])[C@H](O)[C@H]2O)O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,,LY249543,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@@H]3[C@@H](NC(C)=O)[C@H](OCC(O)C(O)C(O)C(O)CNc4cccc(NC(=O)CCCCC5CCSS5)c4)O[C@H](COS(=O)(=O)[O-])[C@@H]3OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]2O)O[C@H](COS(=O)(=O)[O-])[C@H](O)[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1OS(=O)(=O)[O-],,Aspartyl-Adenosine-5'-Monophosphate,
CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)[nH+]c2)c2cc(S(=O)(=O)O)ccc21,,Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose,
CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)[nH+]c2)c2cc(S(=O)(=O)O)ccc21,,Dexamethasone,
N#Cc1ccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c(F)c1,,Purvalanol,
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(-c2cc[nH]c(=O)c2)nc1,,Phenazopyridine,
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(-c2cccc(=O)[nH]2)nc1,,2-(Oxalyl-Amino)-Benzoic Acid,
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(-c2ccc(=O)[nH]c2)nc1,,Arhalofenate,
O=C(c1cccc(F)c1)N1CC=CC1,,D-Mannose 1-Phosphate,
O=c1nc2n(c3ccccc13)CC/C2=C\N1CCCCC1,,Quifenadine,
CCC(/C=C1\CCn2c1nc(=O)c1c(Cl)cccc12)CC,,PBRM1-BD2-IN-1,
CC(C)c1cc(C(=O)N2CC[C@@H](NC(=O)C3CC3)C2)[nH]n1,,KDM5A-IN-1,
CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1,,PF-CBP1,
O=C(CCNCc1ccc(-c2ccccc2)c(Cl)c1)NCCC(=O)Nc1cccc(C(=O)O)c1,,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",
Cc1[nH]nc2c1C(c1cccnc1)C1=C(CC(C)(C)CC1=O)N2,,370588-29-7,
Cc1[nH]nc2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2,,Kinome_2835,
Cc1[nH]nc2c1C(c1cccc(F)c1)C1=C(CC(C)(C)CC1=O)N2,,"1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct",
Cc1[nH]nc2c1C(c1ccc(F)cc1)C1=C(CC(C)(C)CC1=O)N2,,865658-69-1,
Cc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C)c21,,Sulfisoxazole,
COc1ccccc1[C@@H]1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C(F)(F)F)c21,,ppn-gsk-10-R-enantiomer,
COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1,,BDOIA383,
C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1,,CPI-637,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCOCC1,,"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C1CCNCC1,,Desmopressin,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(F)c1CN1CCOCC1,,CEP-1347,
Cc1c(Cc2c(CO)nc3c(C(N)=O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Trifluoromethionine,
Cc1c(Cc2c(C(O)CN)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Fludeoxyglucose (18F),
Cc1c(Cc2c(CCO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"5,6-Dimethylbenzimidazole",
CCc1c(F)cccc1Cc1c(CO)nc2c(N)cc(N3CCOCC3)nn12,,Calcium lactate,
Cc1cccc(Nc2c(C)nc3c(N)cc(N4CCOCC4)nn23)c1C,,"(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL",
CCc1c(F)cccc1Cc1c(CNCCO)nc2c(N)cc(N3CCOCC3)nn12,,Trandolaprilat,
Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,
Cc1nc2c(C(=O)O)cc(C3=CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,Piritramide,
Cc1c(Cc2c(C(C)O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,N-Formylmethionine,
Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOC(C)C4)nn23)cccc1C(F)(F)F,,Fanapanel,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CNC(C)CO,,Etiracetam,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(F)c1C1CCNCC1,,"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCN(C)CC1,,(4e)-4-Aminohex-4-Enoic Acid,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1ccccc1CN1CCOCC1,,Filibuvir,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCC(O)C1,,Depreotide,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(F)c1C1CCN(CCO)CC1,,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,
Cc1c(Nc2c(CO)nc3c(C(N)=O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Procaine benzylpenicillin,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1,,Epirubicin,
Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C,,"Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc2c1CNCC2,,2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,
Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1,,"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCC(S(C)(=O)=O)C1,,SB220025,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(S(C)(=O)=O)C1,,Prezatide copper,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(F)c1CNC(C)CO,,4-Aminohydrocinnamic Acid,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CO,,"5-Alpha-Androstane-3-Beta,17beta-Diol",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc2c1CCNC2,,"N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide",
Cc1cccc(Nc2c(C)nc3c(N)cc(N4CCOCC4)nn23)c1C1CCNCC1,,TAK-580,
Nc1cc(N2CCOCC2)nn2c(Cc3cccc(C(F)(F)F)c3C3CCNCC3)c(CO)nc12,,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C1CCN(CCO)CC1,,Capmatinib,
Nc1cc(N2CCOCC2)nn2c(Cc3cccc(F)c3C3CCN(CCO)CC3)c(CO)nc12,,Ethyl pyruvate,
Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Cc1cccc(Cl)c1C,,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(F)c1C,,1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCS(=O)(=O)CC1,,Avagacestat,
Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Nc1ccccc1N1CCOCC1,,8-chlorotheophylline,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1ccccc1N1CCOCC1,,VM4-037,
Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Nc1ccccc1N1CCOCC1,,Ornithine,
Cc1c(Cc2c(CNCCO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Elacridar,
Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,Lesogaberan,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,AZD-0424,
Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Cc1cccc(Cl)c1C,,Garenoxacin,
Cc1c(Cc2c(CO)nc3c(C(=O)O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCC(S(C)(=O)=O)CC1,,Zinc gluconate,
Cc1c(F)cccc1Cc1c(CO)nc2c(N)cc(N3CCOCC3)nn12,,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC2(CCS2(=O)=O)C1,,L-homoarginine,
Cc1nc2c(-c3ccn[nH]3)cc(N3CCOCC3)nn2c1Nc1ccccc1N1CCOCC1,,5-Bromonicotinamide,
Cc1nc2c(-c3ccn[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,GPX-150,
Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,Cipargamin,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCCC1,,2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE,
Cc1c(Cc2c(CF)nc3c(C(N)=O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Tartronate,
Cc1cccc(Cc2c(C)nc3c(C(=O)O)cc(N4CCOCC4)nn23)c1C,,Benzo[B]Thiophene-2-Boronic Acid,
Cc1c(Cc2c(CF)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",
CC(CO)NCc1c(F)cccc1Cc1c(CO)nc2c(N)cc(N3CCOCC3)nn12,,Icariin,
Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",
Cc1c(Cc2c(CO)nc3c(-c4ccn[nH]4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"2,3-Dihydroxy-Benzoic Acid",
Cc1nc2c(C(=O)O)cc(N3CCOC(C)C3)nn2c1Cc1cccc(C(F)(F)F)c1C,,TAK-448,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(F)c1CNC(C)CO,,Methylthioinosine,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(F)c1CO,,1-Deaza-Adenosine,
Cc1c(F)cccc1Cc1c(CNCCO)nc2c(N)cc(N3CCOCC3)nn12,,Flibanserin,
Nc1cc(N2CCOCC2)nn2c(Cc3cccc(C(F)(F)F)c3C3CCN(CCO)CC3)c(CO)nc12,,Monastrol,
Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C,,"4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C,,Nikkomycin Z,
Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C,,Naringenin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)on4)c3)c2cc1OCCCS(C)(=O)=O,,AUROVERTIN B,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCC(CCO)CC1,,2-Aminopropanedioic Acid,
COc1cc2cccc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)no4)c3)c2cc1OC,,2'-Deoxyguanosine-5'-Diphosphate,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C)c3)c2cc1OC,,Ellagic acid,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)COC)no4)c3)c2cc1OC,,Mavatrep,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"US9730937, Example 221",
COCCOc1cc2ncnc(Sc3cccc(NC(=O)NC4=CC(C(F)(F)F)=NC4c4ccc(F)cc4)c3)c2cc1OC,,"US9730937, Example 242",
COc1cc2ncnc(Oc3cccc(NC(=O)NC4=CC(C(C)(C)CO)=CC4)c3)c2cc1OC,,Clozapine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)CF)nn4-c4ccccc4)c3)c2cc1OC,,Diosmetin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5(C(F)F)CC5)nn4-c4ccc(C)cc4)c3)c2cc1OC,,"US9730937, Example 346",
CCOc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(F)F)nn4-c4ccccc4)c3)ncnc2cc1OC,,"US9730937, Example 391",
O=C(O)C(=O)Nc1ccc2nc(NC(=O)c3cc(Br)c(Br)[nH]3)sc2c1,,Pirenzepine,
O=C(/C=C/N1[C@H]2CC[C@@H]1c1ncnc(NC3CC3)c1C2)c1ccccc1O,,PAS219,
NC(=O)c1cc2cc(OCc3cccc(C(=O)O)c3)ccc2[nH]1,,3-(((2-Carbamoyl-1H-indol-5-yl)oxy)methyl)benzoic acid,
O=c1ccc2nc3ccc(OCCF)cc3oc-2c1,,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",
C#COc1ccc2nc3ccc(=O)cc-3oc2c1,,Coelenteramide,
CCC(=O)N1CCOc2c(cc(-c3cc(OC)cc(OC)c3)cc2C(=O)N[C@H]2CCCN(C)C2)C1,,TPOP146,
CCCCc1[nH]nc2oc(=O)c3ccccc3c12,,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",
NC(=O)c1nn(CC(=O)N2CCS[C@H]2C(=O)Nc2cccc(Br)n2)c2ncccc12,,"2-Amino-N,3,3-Trimethylbutanamide",
O=C(O)CNC(=O)Cn1c2c(c3cc(Cl)ccc31)CC[C@@H](C(=O)O)C2,,Acarbose,
C=C/C(C)=C/C[C@@]1(C)[C@@H]2C[C@@H](OC(=O)c3ccc(O)cc3)C=C3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32[C@@H](OC(C)=O)C[C@H]1C,,Solriamfetol,
C=CC(=C)CC[C@@]1(C)[C@@H]2C[C@@H](OC(C)=O)CC3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32CC[C@H]1C,,Eugenol,
C=C/C(C)=C/C[C@]1(C)[C@H](C)[C@@H](O)[C@H](O)[C@@]23C(=C[C@H](OC)C[C@@H]12)[C@@H](O)O[C@H]3O,,Flomoxef,
C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3C=C[C@]35OC[C@@]6(CCC(C)(C)C[C@H]63)[C@H](O)C[C@]54C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O,,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)CN(C)C(=O)[C@@H](C)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,beta-(1->4)-galactotriose,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)CNC(=O)[C@H](Cc2ccccc2)N(C)C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Brilliant blue G,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](c2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Saprisartan,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](c2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Cinchocaine,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CNC3=O)NC1=O,,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CNC3=O)NC1=O,,Emixustat,
C[C@@H]1NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CNC3=O)NC1=O,,L-Xylopyranose,
CN1CC(=O)N[C@H](CC(=O)O)C(=O)N2CCCC[C@@H]2C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)c3cc(cc(c3)C(=O)N3CCC[C@H]3C1=O)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc3ccccc3c1)NC(=O)[C@H](Cc1ccccc1)NC2=O,,"S-(2,4-dinitrophenyl)glutathione",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",
CC(C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"3,5-Dihydro-5-Methylidene-4h-Imidazol-4-On",
C[C@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,D-Phenylalanine,
C[C@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Resorcinol monoacetate,
CN1CC(=O)N[C@H](CC(=O)O)C(=O)N2CCCC[C@@H]2C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@H]2CNC(=O)c3cc(cc(c3)C(=O)N3CCC[C@H]3C1=O)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc3ccccc3c1)NC(=O)[C@H](Cc1ccccc1)NC2=O,,Benmoxin,
CC(C)[C@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Mafosfamide,
CN1CC(=O)N[C@H](CC(=O)O)C(=O)N2CCCC[C@@H]2C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H]2CNC(=O)c3cc(cc(c3)C(=O)N3CCC[C@H]3C1=O)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc3ccccc3c1)NC(=O)[C@H](Cc1ccccc1)NC2=O,,Temozolomide,
C[C@H](O)[C@H]1NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H]2CCCCN2C1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](C)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Tyrosine,
CC(C)[C@H]1NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,N-Acetylmannosaminitol,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Gimeracil,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Alpha-Ribazole-5'-Phosphate,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(Br)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Varespladib methyl,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2cccc(F)c2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Normethadone,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccc(C#N)cc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Tulobuterol,
CC[C@@H](C)[C@H]1NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H]2CCCCN2C1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Sulfametomidine,
C[C@H](O)[C@H]1NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H]2CCCCN2C1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](CO)CCCCN)CNC3=O,,2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,2-butyl-1-hydroxyguanidine,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC1=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Flavin adenine dinucleotide,
C[C@H](OP(=O)(O)O)[C@H]1NC(=O)CN(C)C(=O)[C@@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C1=O,,Glyoxylic acid,
Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1,,beta-Naphthoflavone,
Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCCCC3)c3[nH]c(=O)c(C)cc23)c1,,Flavin-adenine dinucleotide-N5-isobutyl ketone,
Cc1cc2c(-c3cncc(N)c3)cnc(N[C@@H]3CCNC[C@H]3OCC3CCCCC3)c2[nH]c1=O,,Cyanocobalamin Co-57,
Cc1cc2ccnc(N[C@@H]3CCNC[C@H]3OCC3CCOCC3)c2[nH]c1=O,,Fosdevirine,
N#CCN(CCOc1ccc([N+](=O)[O-])cc1)CCc1ccc([N+](=O)[O-])cc1,,Methylprednisolone,
O=C(O)CN(CCOc1ccc([N+](=O)[O-])cc1)CCc1ccc([N+](=O)[O-])cc1,,Pradigastat,
CN(CCOc1ccc(Cl)c(Cl)c1)CCc1ccc(Cl)c(Cl)c1,,"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid",
O=C(c1ccc(Cl)cc1)C1CCN(CCc2ccc(Cl)c(Cl)c2)CC1,,Racemethionine,
Cc1ccc(C(=O)C2CCN(CCCc3ccccc3)CC2)cc1,,LGD-6972,
C[N+]1(CCc2ccccc2)CCC(C(=O)c2ccc(Cl)cc2)CC1,,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",
CCCCCCCN(CC)CC#Cc1ccc(C)cc1,,7-thionicotinamide-adenine-dinucleotide phosphate,
CCCCCCCc1cccc(CCCCCCC)[n+]1C,,Tilbroquinol,
CCCCCCCCCc1cccc(CCCCCCCCC)[n+]1C,,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",
CCCCCCCCCCc1cccc(CCCCCCCCCC)[n+]1C,,"4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",
CCCCCCCCCCCCc1cccc(CCCCCCCCCCCC)[n+]1C,,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE",
CCCCCCCCCCC#Cc1cccc(C#CCCCCCCCCCC)[n+]1C,,6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,
C[n+]1c(CCc2ccc(-c3ccccc3)cc2)cccc1CCc1ccc(-c2ccccc2)cc1,,Morniflumate,
Cc1ccccc1-c1ccc(C#Cc2cccc(C#Cc3ccc(-c4ccccc4C)cc3)[n+]2C)cc1,,p-Hydroxymercuribenzoic acid,
Cc1cccc(-c2ccc(C#Cc3cccc(C#Cc4ccc(-c5cccc(C)c5)cc4)[n+]3C)cc2)c1,,Vidofludimus,
COc1cccc(-c2ccc(C#Cc3cccc(C#Cc4ccc(-c5cccc(OC)c5)cc4)[n+]3C)cc2)c1,,Fluoro-Willardiine,
C[n+]1c(C#Cc2ccc(-c3cccc(Cl)c3)cc2)cccc1C#Cc1ccc(-c2cccc(Cl)c2)cc1,,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,
COc1ccc(-c2ccc(C#Cc3cccc(C#Cc4ccc(-c5ccc(OC)cc5)cc4)[n+]3C)cc2)cc1.O=S(=O)([O-])C(F)(F)F,,Azimilide,
C[n+]1c(C#Cc2ccc(-c3ccc(Cl)cc3)cc2)cccc1C#Cc1ccc(-c2ccc(Cl)cc2)cc1.O=S(=O)([O-])C(F)(F)F,,Letermovir,
COc1ccc(S(=O)(=O)NC(=O)c2ccc(NC(=O)Cn3c(=O)sc4ccc(Cl)cc43)cc2)cc1Cl,,4-(Hydroxymethyl)Benzamidine,
Fc1ccc(I)cc1C1CC(c2cccc(Br)c2)Nc2nnnn21,,"5-(acetylamino)-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid",
Clc1ccc(Br)cc1C1CC(c2cccc(Br)c2)Nc2nnnn21,,3-Aminomethyl-Pyridinium-Adenine-Dinucleotide,
Fc1ccc(F)c(C2CC(c3cccc(Br)c3)Nc3nnnn32)c1F,,Ulipristal,
Fc1ccc(Br)c(Cl)c1C1CC(c2cccc(Br)c2)Nc2nnnn21,,4-(Hydrogen sulfate)-beta-D-galactopyranose,
Fc1c(Cl)ccc(Cl)c1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Anthralin,
Fc1c(Br)ccc(Br)c1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Tibolone,
Fc1c(Br)ccc(Cl)c1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Tefinostat,
Fc1cc(Br)cc(C2CC(c3ccccc3)n3nnnc3N2)c1,,Difluocortolone pivalate,
Ic1cccc([C@H]2C[C@@H](c3ccccc3)n3nnnc3N2)c1,,PRX-03140,
Brc1cccc([C@H]2C[C@@H](c3ccccc3Br)n3nnnc3N2)c1,,Hexoprenaline,
Clc1ccc(Br)cc1[C@@H]1C[C@H](c2cccc(Br)c2)Nc2nnnn21,,(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,
O=C1NC(=S)N/C1=C/c1ccc(=O)[nH]c1,,Tetracosactide,
NC(=O)c1cccc2c1C(=O)N(CC1CCCO1)C2,,Pemoline,
NC(=O)c1cccc2c1C(=O)N(CCO)C2,,Porphyrin Fe(III),
NC(=O)c1cccc2c1C(=O)N(CC1CCN(Cc3ccccc3)CC1)C2,,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",
CC(=O)N1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,Estradiol hemisuccinate,
CN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,Orotidylic acid,
CCN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,Glycocyamine,
CC(C)CN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,"(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE",
N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1Cl,,Isoxsuprine,
CCN1c2ccc(F)cc2N=C(N[C@H]2CCN(C(=O)OC(C)(C)C)C2)c2cc(Cl)ccc21,,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCC(C2CC2)=C1C(C)C,,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",
CCC1=C(CCC(C)C)/C(=C/C(C)=C\C=C\C(C)=C\C(=O)O)CCC1,,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCC(C(C)C)=C1CCC(C)C,,Primidone,
C[C@@H](O)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,,"[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",
C[C@@H](O)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(C(=O)O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,,8-Bromoadenosine-5'-Diphosphate,
COc1ccc(-c2cnc3c(NC(=O)C4CC4)snc3c2)cc1OC,,Hydracrylic acid,
COc1ccc(-c2cnc3c(OC(C)C)snc3c2)cc1OC,,"2-(3,4-Dihydroxyphenyl)Acetic Acid",
CCC(C)Oc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12,,(S)-Indapamide,
CCCCOc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12,,Oxilofrine,
CN1CCN(c2cccc3cc(NC(=O)Nc4ccc(Oc5ccnc6[nH]ccc56)cc4)ccc23)CC1,,Bupranolol,
CN(C)C(=O)c1ccc2c(c1)c(Oc1c(Cl)cccc1C(F)(F)F)nn2-c1ccc(C(=O)O)cc1,,Zoledronic acid,
COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1,,Apabetalone,
O=C(N[C@@H]1CCCN(Cc2ccccc2F)C1)N1CCc2[nH]nc(-c3ccncc3)c2C1,,Oxcarbazepine,
O=C(N[C@@H]1CCCN(Cc2c(F)cccc2F)C1)N1CCc2[nH]nc(-c3ccncc3)c2C1,,Vinburnine,
O=C(N[C@@H]1CCCN(Cc2csc3ccccc23)C1)N1CCc2[nH]nc(-c3ccncc3)c2C1,,(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,
O=C(N[C@@H]1CCCN(Cc2ccccc2Cl)C1)N1CCc2[nH]nc(-c3ccncc3)c2C1,,Hydroxybutyloxide,
Cc1onc(-c2ccccc2)c1CN1CCC[C@@H](NC(=O)N2CCc3[nH]nc(-c4ccncc4)c3C2)C1,,SP2456,
Cc1cncc(-c2ccc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1,,"8-[[(3r,4r)-3-[[1,1-Bis(Oxidanylidene)thian-4-Yl]methoxy]piperidin-4-Yl]amino]-3-Methyl-5-(5-Methylpyridin-3-Yl)-1h-Quinolin-2-One",
Cc1cncc(-c2cnc(N[C@@H]3CCN(C)C[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1,,PD085767,
Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCC5)ccc3C)ccc2n1,,FR221647,
N#Cc1ccc(-n2nc(C(=O)N3CCC[C@@H](N)C3)cc2OCc2ccccn2)cc1,,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",
C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C,,CHMFL-BMX-078,
CN(C)[C@H]1CN(C2CCc3cccc(F)c32)C[C@@H]1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1,,A-395,
CN(C)[C@H]1CN([C@H]2CCc3cccc(F)c32)C[C@@H]1c1cn(C)c2ccccc12,,"(3R,4S)-1-[(1S)-7-fluoroindan-1-yl]-N,N-dimethyl-4-(1-methylindol-3-yl)pyrrolidin-3-amine",
CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1,,EED226,
COc1cccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)c1,,Angiotensinamide,
COc1cccc(C[C@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)c1,,5-androstenedione,
C[C@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1,,Sparfloxacin,
C[C@@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1,,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",
C[C@H](Cc1cccc(N)c1)NC[C@@H](O)c1cc(O)cc(O)c1,,JNJ-40346527,
C[C@@H](Cc1cccc(N)c1)NC[C@@H](O)c1cc(O)cc(O)c1,,Febarbamate,
COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3S(=O)C4)CC2)cc1,,ML349-sulfoxide,
C[C@H]1[C@H]2C(=O)N(C)c3ccncc3[C@H]2CN1S(=O)(=O)c1ccc2c(c1)OCO2,,Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate,
Cc1c(/N=N/c2cccc(C(=O)O)c2)c(O)[nH]c(=O)c1C#N,,STK575477,
O=C(O)c1ccc(Nc2nccc(Nc3ccc(F)cc3OC(F)(F)F)n2)cc1,,Pactimibe,
NC(=O)c1ccc(-n2cccc2-c2ccccc2)cc1NC1CCC(O)CC1,,Narasin,
Cc1ccccc1-c1cccn1-c1ccc(C(N)=O)c(NC2CCC(O)CC2)c1,,(Rp)-cAMPS,
Cc1cccc(-c2cccn2-c2ccc(C(N)=O)c(NC3CCC(O)CC3)c2)c1,,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",
Cc1ccc(-c2cccn2-c2ccc(C(N)=O)c(NC3CCC(O)CC3)c2)cc1,,"2,3-Difluorobenzyl Alcohol",
NC(=O)c1ccc(-n2cccc2-c2ccccc2Cl)cc1NC1CCC(O)CC1,,Cerlapirdine,
NC(=O)c1ccc(-n2cccc2-c2cccc(Cl)c2)cc1NC1CCC(O)CC1,,N-Heptylformamide,
NC(=O)c1ccc(-n2cccc2-c2ccc(Cl)cc2)cc1NC1CCC(O)CC1,,Flufenamic acid,
NC(=O)c1ccc(-n2cccc2-c2ccccn2)cc1NC1CCC(O)CC1,,PF-03635659,
NC(=O)c1ccc(-n2cccc2-c2ccncc2)cc1NC1CCC(O)CC1,,Quinidine,
NC(=O)c1ccc(-n2cccc2Cc2ccccc2)cc1NC1CCC(O)CC1,,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,
NC(=O)c1ccc(-n2cccc2CCc2ccccc2)cc1NC1CCC(O)CC1,,Mavacamten,
NC(=O)c1ccc(-n2cccc2Cc2ccccc2Cl)cc1NC1CCC(O)CC1,,Hematin,
NC(=O)c1ccc(-n2cccc2Cc2cccc(Cl)c2)cc1NC1CCC(O)CC1,,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",
NC(=O)c1ccc(-n2cccc2Cc2ccc(Cl)cc2)cc1NC1CCC(O)CC1,,alpha-Tocopherol succinate,
NC(=O)c1ccc(-n2cccc2Cc2cccc(F)c2)cc1NC1CCC(O)CC1,,N(2)-(2-carboxyethyl)-L-arginine,
NC(=O)c1ccc(-n2cccc2Cc2ccc(F)cc2)cc1NC1CCC(O)CC1,,PG-701,
NC(=O)c1ccc(-n2cccc2Cc2ccccc2Br)cc1NC1CCC(O)CC1,,N-Carbamyl-D-Valine,
Cc1ccccc1Cc1cccn1-c1ccc(C(N)=O)c(NC2CCC(O)CC2)c1,,"(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate",
NC(=O)c1ccc(-n2cccc2Cc2ccccc2O)cc1NC1CCC(O)CC1,,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,
NC(=O)c1ccc(-n2cccc2Cc2cccc(O)c2)cc1NC1CCC(O)CC1,,S-4-Nitrobutyryl-CoA,
NC(=O)c1ccc(-n2cccc2Cc2ccc(O)cc2)cc1NC1CCC(O)CC1,,1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE,
COc1ccccc1Cc1cccn1-c1ccc(C(N)=O)c(NC2CCC(O)CC2)c1,,N-Benzyl-4-Sulfamoyl-Benzamide,
NC(=O)c1ccc(-n2cccc2Cc2ccccn2)cc1NC1CCC(O)CC1,,beta-D-Ribopyranose,
NC(=O)c1ccc(-n2cccc2Cc2ccncc2)cc1NC1CCC(O)CC1,,Meptazinol,
CC(C)N1Cc2cc(F)ccc2OCCNC(=O)c2cnn3ccc1nc23,,Molybdenum cofactor,
CN1Cc2cc(F)ccc2OCCCNC(=O)c2cnn3ccc1nc23,,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",
Cc1cc2ccccc2nc1-c1ccc2c(c1)CC[C@H](C)N2C(=O)c1ccc(O)cc1O,,Formycin,
CN(C)[C@H]1CN(Cc2c(F)cccc2Br)C[C@@H]1c1cn(C)c2ccccc12,,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate",
O=C(NO)c1cnc(NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)[nH]c1=O,,"2-{[3,5-Bis(Trifluoromethyl)benzyl]amino}-N-Hydroxy-6-Oxo-1,6-Dihydropyrimidine-5-Carboxamide",
O=C(NO)c1ccc(Cc2ccccc2)cc1O,,Plicamycin,
CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,,IEEVD,
CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,,DDTSRMEEVD,
CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,,EDASRMEEVD,
CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,,DDTSRIEEVD,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,,GSGPTMEEVD,
O=C(/C=C/c1ccoc1)N1CCCC1,,(2e)-3-(Furan-3-Yl)-1-(Pyrrolidin-1-Yl)prop-2-En-1-One,
O=S(=O)(CCC1CCCC1)N1CCCC1,,1-[(2-Cyclopentylethyl)sulfonyl]pyrrolidine,
COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,,CDK8/19-IN-1,
O=C(Cn1nc(-c2ccccc2)cc(-c2ccc3c(c2)OCO3)c1=O)N1CCCC1,,S-Arsonocysteine,
O=C(Cn1nc(-c2ccccc2)cc(-c2ccc3c(c2)OCO3)c1=O)N1CCOCC1,,Ceftibuten,
O=C(Cn1nc(-c2ccccc2)cc(-c2ccc3c(c2)OCO3)c1=O)N1CCCCC1,,Clobazam,
CC1CCCN(C(=O)Cn2nc(-c3ccccc3)cc(-c3ccc4c(c3)OCO4)c2=O)C1,,VS-4718,
CN1CCN(C(=O)Cn2nc(-c3ccccc3)cc(-c3ccc4c(c3)OCO4)c2=O)CC1,,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",
O=C(Cn1nc(-c2ccccc2)cc(-c2ccc3c(c2)OCO3)c1=O)N1CCN(c2ccccc2)CC1,,Delcasertib,
C/C=C/[C@H](O)C(C)(C(=O)OC)[C@@H]1C/C=C\C=C\C=C\c2nc(co2)C(=O)O[C@H](C(C)(C(=O)OC)[C@@H](O)/C=C/C)C/C=C\C=C\C=C\c2nc(co2)C(=O)O1,,Selinexor,
Cc1cccc(F)c1CN1C[C@H](c2cn(C)c3ccccc23)[C@@H](N(C)C)C1,,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",
COc1cccc(C(=O)NC2C(O)[C@H](O[C@@H]3OC(CO)[C@H](O)C(OCc4ccc5ccccc5c4)C3O)C(CO)O[C@H]2OCCNC(=O)CCCCCN2C(=O)C=CC2=O)c1,,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,
COc1cccc(C(=O)CC2C(O)[C@H](O[C@@H]3OC(CO)[C@H](O)C(OCc4ccc5ccccc5c4)C3O)C(CO)O[C@H]2OCC[N-][N+]#N)c1,,Pyrithyldione,
CC(O)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](CCCCNC(=O)C[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)[O-])NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](C)[NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](CCCC[NH3+])C(N)=O,,PPL-100,
CC(O)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](CCCCNC(=O)C[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)[O-])NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](C)[NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](CCCCNC(=O)c1ccc(-c2c3ccc(=[N+](C)C)cc-3oc3cc(N(C)C)ccc23)c(C(=O)O)c1)C(N)=O,,Buthionine Sulfoximine,
CC(O)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](CCCCNC(=O)C[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)[O-])NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](C)[NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](CCCCNC(=O)c1ccc(-c2c3ccc(=[N+](C)C)cc-3oc3cc(N(C)C)ccc23)c(C(=O)O)c1)C(N)=O,,N-Ethylretinamide,
NC(=O)c1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1,,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,
O=c1[nH]c2ccccc2n1-c1cc(-c2ccnc3ccccc23)c(O)cc1O,,hsp90_23,
CC(C)c1ccc(S(=O)(=O)NCc2ccc3c(c2)[nH]c(=O)n3-c2cc(Cl)c(O)cc2O)cc1,,hsp90_38,
O=c1[nH]c2cc(CNS(=O)(=O)c3ccccc3O)ccc2n1-c1cc(Cl)c(O)cc1O,,hsp90_43,
Nc1nc(Cl)c(/C=N/O)c(-c2ccc(Cl)cc2Cl)n1,,Phenolsulfonphthalein,
CCOC(=O)CO/N=C/c1c(Cl)nc(N)nc1-c1ccc(Cl)cc1Cl,,Ciclopirox,
Cc1cc(-n2nc(C(=O)NCC3COC(C)(C)O3)cc2C)nc(N)n1,,hsp90_95,
Cc1cc(CNC(=O)N2CCN(S(C)(=O)=O)C2=O)nc(N)n1,,hsp90_120,
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,,ELTPEERLLRAIFGEK,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O,,ELTPEERMLRLIFGRK,
CC(C)C[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O,,Cefepime,
O=C(O)CC(=O)NCCCNCc1ccc(-c2ccccc2)c(Cl)c1,,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",
C[C@H]1CCc2cc(-c3nc(Cl)nc4[nH]ccc34)ccc2N1C(=O)c1ccc(O)cc1O,,Demeclocycline,
COc1ccc(CN(C)C(=O)c2ccc(N(Cc3ccccc3)C(=O)c3ccc(O)cc3O)cc2)cc1,,Galactose,
C[C@H]1CCc2cc(-c3nc(Cl)nc4ccsc34)ccc2N1C(=O)c1ccc(O)cc1O,,Piretanide,
CC(=O)c1c(C)[nH]c(C(=O)Nc2cccc(C(=O)O)c2)c1C,,17alpha-methyl-4-hydroxynandrolone,
CCN1C(=O)c2cccc3c(NS(=O)(=O)c4cc(Cl)ccc4OC)ccc1c23,,CT-2584,
C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(N)=O,,D-glucitol 6-phosphate,
CCN1C(=O)c2cccc3c(S(=O)(=O)NCCCCNC(=O)OC(C)(C)C)ccc1c23,,Methscopolamine,
CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(N)=O,,Lometrexol,
CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(N)=O,,Pimonidazole,
CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)C(N)=O,,Dipraglurant,
CCN1C(=O)c2cccc3c(NS(=O)(=O)C4CCCCC4)ccc1c23,,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",
C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)C(N)=O,,Rimegepant,
CCN1C(=O)c2cccc3c(NS(=O)(=O)c4ccc(F)cc4)ccc1c23,,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",
CCN1C(=O)c2cccc3c(NS(=O)(=O)c4ccc(F)cc4F)ccc1c23,,"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",
CSCCC(NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)O)C(=O)NC(CCSC)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC1CCCCn2cc(nn2)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NCCC(=O)NCCC(=O)NC(CCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)C(N)=O)NC(=O)C(CCCCN)NC(=O)C(Cc2ccccc2)NC(=O)C(C)NC1=O)C(C)O,,Tiratricol,
CCOc1snc2cc(-c3ccsc3)cnc12,,ENMD-1198,
CC(C)Oc1snc2cc(-c3ccsc3)cnc12,,Lumefantrine,
COc1ccc(-c2cnc3c(N4CCN(C(C)=O)CC4)snc3c2)cc1OC,,Cefodizime,
CCOC(=O)N1CCN(c2snc3cc(-c4ccc(OC)c(OC)c4)cnc23)CC1,,N-acetylmannosamine,
COc1ccc(-c2cnc3c(N4CCCN(C)CC4)snc3c2)cc1OC,,S-Butyryl-Cystein,
COc1ccc(-c2cnc3c(NC4CCNCC4)snc3c2)cc1OC,,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",
COc1ccc(-c2cnc3c(N4CCC(C)CC4)snc3c2)cc1OC,,Eltanolone,
CCC(C)C(NC(=O)C(NC(=O)C(NC(C)=O)C(C)O)C(C)O)C(=O)NCC(=O)NC(CCSC)C(=O)NC(CCSC)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(C)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NCCC(=O)NCCC(=O)NC(CCCCNC(=O)c1ccc(C(=O)O)c(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c1)C(N)=O)C(C)O)C(C)O,,Benzbromarone,
CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCNC(=O)CCNC(=O)c1ccc(C(=O)O)c(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c1)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Azaperone,
COc1ccc(-c2cnc3c(OCCC(C)C)snc3c2)cc1OC,,SU9516,
Cc1cccnc1-c1ccc2nc(N)c(C[C@H](C)C(=O)NCCC(C)(C)C)cc2c1,,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,
NC1=NC2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ccc(C3=CCCOC3)cc12,,Beta-Hydroxyaspartic Acid,
CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3C#CC3CC(NC(=O)c4ccc(F)cc4)C3)ccc2nc1N,,Elagolix,
COc1ccc(C(=O)n2[nH]c(=O)c(-c3cn(C(C)=O)c4ccccc34)c2C)cc1,,Cyclic GMP,
CC(=O)n1cc(-c2c(C)n(C(=O)N3CCOCC3)[nH]c2=O)c2ccccc21,,Diethyltryptamine,
CC(=O)n1cc(-c2c(C)nn3c2OCC3)c2ccccc21,,Ulapualide A,
CC(=O)n1cc(-c2c(C)n(S(C)(=O)=O)n(S(C)(=O)=O)c2=O)c2ccccc21,,KRN-5500,
CCCOc1ccc2c(c1)c(-c1c(C)n(C(=O)c3ccc(OC)cc3)[nH]c1=O)cn2C(C)=O,,Sulfacytine,
CCN(CC)c1ccc(/C=N/NC(=O)CSc2nc3c(o2)=C=C=CC=3)c(O)c1,,Tegafur-uracil,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,
CC(=O)n1cc(-c2c(C)n(C(=O)CCc3ccccc3)n(C(=O)CCc3ccccc3)c2=O)c2ccccc21,,Zanamivir,
NC(=O)c1cc[n+](CCCC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],,(R)-Mandelic acid,
NC(=O)c1cc[n+](CCCCC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],,Diflunisal,
NS(=O)(=O)c1ccc(C(=O)Cn2cnc3ccccc32)cc1,,Fusidic acid,
NS(=O)(=O)c1cccc(C(=O)Cn2cnc3ccccc32)c1,,Carbarsone,
NS(=O)(=O)c1ccc(C(=O)Cn2cnc3ccccc32)cc1Cl,,Safinamide,
COc1ccc(CNc2c(F)c(F)c(F)c(F)c2S(N)(=O)=O)cc1,,Acumapimod,
Nc1nc2[nH]c(SCc3ccc(Br)cc3)nc2c(=O)[nH]1,,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,
O=c1nc2n(c3ccccc13)CC/C2=C\N1CCCC1,,ABC-294640,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccco1,,Naratriptan,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1F,,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",
CN1CCN(/C=C2\CCn3c2nc(=O)c2c(Cl)cccc23)CC1,,Glecaprevir,
Cc1ccccc1CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,Aminohippuric acid,
Nc1nc2[nH]c(SCc3ccccc3[N+](=O)[O-])nc2c(=O)[nH]1,,Moxalactam (hydrolyzed),
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(Cl)cc1,,Flutemetamol,
N#Cc1cccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1,,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",
Nc1nc2[nH]c(SCc3cccc(F)c3)nc2c(=O)[nH]1,,Chloroxylenol,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(Br)cc1,,4-Br-Bnlm,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1oc(C)cc1C,,Radalbuvir,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1cccs1,,"R,S-Warfarin alcohol",
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccsc1,,Pheneticillin,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(C)s1,,Fluoresceinylthioureido,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(Cl)s1,,Tetrahydrofolic acid,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1cc(Cl)cs1,,Hyaluronic acid,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1nccs1,,(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid,
C=Cc1ccsc1Cn1ccnc1CCc1c(Cl)c(O)cc(O)c1C(=O)OC,,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",
Cc1c(F)c([N+](=O)[O-])cc(C(=O)Nc2cc([N+](=O)[O-])ccc2N2CCN(C)CC2)c1Cl,,Tivirapine,
CCc1ccsc1Cn1ccnc1CCc1c(Cl)c(O)cc(O)c1C(=O)OC,,Ganstigmine,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1cccc(F)c1,,WP 1066,
CNC(=O)CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,Indium In-111 oxyquinoline,
CC(C)CNC(=O)CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,Isoleucine,
CN(C)C(=O)CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,D-arginine,
CNc1c(C#N)c2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,"2,3-Di-O-Sulfo-Alpha-D-Glucopyranose",
CCCOc1ccccc1Cn1ccnc1CCc1c(Cl)c(O)cc(O)c1C(=O)OC,,Picotamide,
O=C(/C=C/N1CCc2c(ncnc2NC2CC2)C1)c1ccccc1O,,Ethinylestradiol,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1C(F)(F)F,,Epoprostenol,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(C)cc1OC,,DL-Methylephedrine,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccoc1,,Technetium Tc-99m disofenin,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(C)o1,,OPC-51803,
Cc1cc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)ccc1F,,(R)-Bicalutamide,
Cc1cccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1,,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",
CN(C)/C=C1\CCn2c1nc(=O)c1c(Cl)cccc12,,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,
CCOC(=O)Nc1cc(-c2ccc(C)cc2NS(C)(=O)=O)nn2c(C)nnc12,,"2,2-bis(4-hydroxy-3-tert-butylphenyl)propane",
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccno1,,Oxabolone,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(C#N)cc1,,Hadacidin,
C#Cc1ccc(Cn2ccnc2CCc2c(Cl)c(O)cc(O)c2C(=O)OC)cc1,,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",
Nc1nc2[nH]c(SCCCO)nc2c(=O)[nH]1,,Cilostazol,
CCN(C(=O)CO)C1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)cc1,,3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol,
CCN1CCN(/C=C2\CCn3c2nc(=O)c2c(Cl)cccc23)CC1,,Sildenafil,
N#Cc1cc(F)ccc1CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,Mycophenolate mofetil,
Cc1cc(OCCOCCNc2ccc([N+](=O)[O-])c3nonc23)ccc1-c1cccc(COc2ccc(CCC(=O)O)c(F)c2)c1,,2-Iodobenzylthio Group,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1Cl,,Rimeporide,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1Br,,Vasopressin,
CNc1nc2c(N)ncnc2n1[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,,Gliquidone,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(C)cc1,,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1C,,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1OC,,Implitapide,
CCc1ccccc1Cn1ccnc1CCc1c(Cl)c(O)cc(O)c1C(=O)OC,,meso-Tartaric acid,
CCOc1ccccc1Cn1ccnc1CCc1c(Cl)c(O)cc(O)c1C(=O)OC,,KUNG29,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(F)cc1,,Trimetrexate,
CC(C)(C)OC(=O)N[C@H](CSCCC(=O)NCc1cccnc1)CC1CCCCC1,,Ferrous glycine sulfate,
Nc1nc2[nH]c(SCc3ccc(OC(F)(F)F)cc3)nc2c(=O)[nH]1,,Uracil mustard,
Cc1cc(C)cc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1,,Norepinephrine,
Cc1cc(F)ccc1CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",
Nc1nc2[nH]c(SCc3ccc(F)c(F)c3)nc2c(=O)[nH]1,,Glucaric acid,
O=C(O)COc1nc(SCC(=O)O)nc(-c2ccccc2)n1,,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",
Cc1cccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1F,,Alpha-Methylene Adenosine Monophosphate,
Cc1c(F)ccc(C(=O)Nc2cc(-c3ccncc3)ccc2N2CCN(C)CC2)c1Cl,,(R)-3-hydroxytetradecanoic acid,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1sccc1Cl,,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",
Cc1ccc(C)c(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1,,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,
COc1cccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1,,Uprifosbuvir,
Nc1nc2[nH]c(SCc3cccc(OC(F)(F)F)c3)nc2c(=O)[nH]1,,Undecoylium chloride iodine complex,
Nc1nc2[nH]c(SCc3cccc(C(=O)O)c3)nc2c(=O)[nH]1,,Patidegib,
Cn1nnc2cc(C(CC(=O)O)c3ccc(Cl)cc3)ccc21,,Ticlatone,
N#Cc1ccc(Nc2nc(N)cc(-n3ccc(CO)n3)n2)cc1,,Imino-Tryptophan,
O=C(N[C@H]1CNC[C@@H]1c1ccccc1)N1CCc2[nH]nc(-c3ccncc3)c2C1,,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,
Cc1ccccc1[C@@H]1CN(C)C[C@H]1NC(=O)N1CCc2[nH]nc(-c3ccncc3)c2C1,,(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,
Cc1ccsc1CN1CCC[C@@H](NC(=O)N2CCc3[nH]nc(-c4ccncc4)c3C2)C1,,"(3R)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicacid-L-phenylalanine ethyl ester",
Cn1cc(CN2CCC[C@@H](NC(=O)N3CCc4[nH]nc(-c5ccncc5)c4C3)C2)c2ccccc21,,Prostaglandin G2,
Cn1c(CN2CCC[C@@H](NC(=O)N3CCc4[nH]nc(-c5ccncc5)c4C3)C2)cc2ccccc21,,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",
Cc1cc(-c2n[nH]c3c2CN(C(=O)N[C@@H]2CCCN(Cc4cccc5ccccc45)C2)CC3)ccn1,,Hydromorphinol,
O=C(N[C@@H]1CCCN(Cc2csc3ccccc23)C1)N1CCc2[nH]nc(-c3ccc4nccn4c3)c2C1,,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",
O=C(N[C@@H]1CCCN(Cc2cccc3ccccc23)C1)N1CCc2[nH]nc(-c3ccc4nccn4c3)c2C1,,Xenysalate,
COc1cccc(F)c1CN1CCC[C@@H](NC(=O)N2CCc3[nH]nc(-c4ccc5nccn5c4)c3C2)C1,,PF-232798,
COc1cccc(F)c1CN1CC(NC(=O)N2CCc3[nH]nc(-c4ccnc(C)c4)c3C2)CC(C(F)(F)F)C1,,Capsaicin,
COc1cccc(COC2C(O)[C@H](O[C@@H]3C(CO)O[C@@H](N=[N+]=[N-])C(NC(=O)c4cccc(OC)c4)C3O)OC(CO)[C@@H]2O)c1,,Melengestrol acetate,
CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O,,TTFTVTKYWF,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O,,FITC-RJPXD33,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC1(C)N=N1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O,,FITC-Photo 1,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1(C)N=N1)C(=O)N1CCC[C@H]1C(N)=O,,FITC-Photo 4,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(N)=O,,FITC-RJPXD33Delta6,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O,,FITC-(betaa)TNLYML-COOH,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(N)=O,,RJPXD33Delta6,
O=C(O)COc1cc(F)ccc1C(=O)Nc1cccc([N+](=O)[O-])c1,,"ALR2 inhibitor, 8",
O=C(CCc1ccoc1)N1CCCC1,,"4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid",
CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O,,H3K27Me3 peptide,
COc1nc2ccc([C@@](C)(O)c3ccc(C)nc3C)cc2c(Cl)c1OC(C)C,,BMS-929075,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OC1CCOCC1,,Tetrabromo-2-Benzotriazole,
CC(C)Oc1c(Cl)nc2ccc(C(O)(c3ccc(Cl)nc3)c3cncn3C)cc2c1Cl,,Indole Naphthyridinone,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(C#N)c1CC(F)(F)F,,3-Nitrophenylboronic Acid,
CC(C)c1cc(C(=O)N2CC[C@H](NC(=O)C3CC3)C2)[nH]n1,,N-{(3S)-1-[5-(propan-2-yl)-1H-pyrazole-3-carbonyl]pyrrolidin-3-yl}cyclopropanecarboxamide,
COc1ccc(C[C@@]2(O)NC(=S)NC2=O)c(OC)c1,,6-Chloro-4-[(R)-cyclohexylsulfinyl]-3-propyl-2(1H)-quinolinone,
Cc1c[nH]c2ncnc(N3CCC[C@@H](CO)C3)c12,,"2',3'-Dideoxythymidine-5'-Monophosphate",
CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1,,AZ13705339,
COc1cc2c3c(ccc2cc1S(C)(=O)=O)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,
OB(O)c1ccc(/C=C/c2cc(O)cc(O)c2)c(Cl)c1,,Neladenoson bialanate,
O=C(O)c1cccc(/C=C/c2ccc(O)cc2)c1,,"(R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)benzyl)guanidine",
O=C(O)c1cccc(/C=C/c2ccc(B(O)O)cc2)c1,,Barnidipine,
O=C(O)c1cccc(/C=C/c2ccc(B(O)O)cc2Cl)c1,,Rose bengal lactone,
OB(O)c1ccc(/C=C/c2ccc(B(O)O)cc2Cl)c(Cl)c1,,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",
OB(O)c1cccc(/C=C/c2ccc(B(O)O)cc2Cl)c1,,Zafirlukast,
O=C1c2ccccc2N[C@@H](c2ccccc2F)N1CCN1CCC(N2C(=O)c3ccccc3N[C@H]2c2ccccc2F)CC1,,Brincidofovir,
NC(=O)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(CC(=O)O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCNC(=O)CC[C@H](NC1=O)C(=O)N[C@H](C(N)=O)CSCC(=O)N2,,Flunixin,
NC(=O)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCNC(=O)CC[C@H](NC1=O)C(=O)N[C@H](C(N)=O)CSCC(=O)N2,,Otenabant,
c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,AZ1495,
CC(=O)N1CCN(c2ccc([C@H]3CN(C4CCc5cccc(F)c54)C[C@@H]3N(C)C)cc2)CC1,,Deutetrabenazine,
CC(=O)N1CCN(c2ccc([C@@H]3CN([C@@H]4CCc5cccc(F)c54)C[C@H]3N(C)C)cc2)CC1,,Flutemetamol (18F),
CC(=O)N1CCN(c2ccc([C@H]3CN([C@@H]4CCc5cccc(F)c54)C[C@@H]3N(C)C)cc2)CC1,,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),
Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OCCCCCCO)c1nnc(C)n1-2,,Rhein,
Cc1c(Cc2c(CN(C)CCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",
Cc1c(Cc2c(CNCCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,XV638,
Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCC2(C1)CS(=O)(=O)C2,,Sodium tartrate,
CC(=O)OCc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C,,Motexafin lutetium,
Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F,,Elexacaftor,
Cc1c(Nc2c(COC(=O)C(C)N)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,10-decarboxymethylaclacinomycin A,
Cc1c(Nc2c(COC(=O)C(N)Cc3ccccc3)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",
CCC(C)C(N)C(=O)OCc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C,,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",
Cc1c(Nc2c(COC(=O)C(N)C(C)C)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Morinamide,
Cc1c(Nc2c(COC(=O)C3(NC(=O)OC(C)(C)C)CC3)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Dihydrouracil,
Cc1c(Nc2c(CN)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,GC-24,
O=C(O)c1ccnc2cc([C@@H](OCCN3CCCCC3)c3ccccc3Cl)[nH]c12,,Saredutant,
CCN(CC)CCNC(=O)C1C/C(=C\c2ccc(F)cc2)C(=O)/C(=C/c2ccc(F)cc2)C1,,Sodium ferric gluconate complex,
CN1C(=O)[C@@H]2CN(S(=O)(=O)c3ccc4occc4c3)C[C@@H]2c2cnccc21,,AM-1488,
C=C1C(=O)O[C@H]2c3c(C)c(OCc4ccccc4Br)cc(C)c3CC[C@@H]12,,UbcH5c-IN-1,
O=C(NCCNCCSc1ccccc1)c1ccc([N+](=O)[O-])cc1,,Fleroxacin,
CN1CCCC1CCOC(c1cc2nccc(C(=O)O)c2[nH]1)c1ccccc1Cl,,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,
O=C(O)c1ccnc2cc(C(OCC3CCC(F)(F)CC3)c3ccccc3Cl)[nH]c12,,Adenosine 5'-[gamma-thio]triphosphate,
O=C(O)c1ccnc2cc(C(OCCN3CCCCC3)c3ccccc3Cl)[nH]c12,,PD-166326,
Cc1c(F)c(N)cc(C(=O)Nc2cc(-c3ccc(NC(=O)C4CCNCC4)cc3)ccc2N2CCN(C)CC2)c1Cl,,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",
Cc1c(F)c(N)cc(C(=O)Nc2cc(-c3ccc(NC(=O)CCCN)cc3)ccc2N2CCN(C)CC2)c1Cl,,Aminopentamide,
Cc1c(F)c(N)cc(C(=O)Nc2cc(-c3ccc(N)cc3)ccc2N2CCN(C)CC2)c1Cl,,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",
CCCCC(NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)O,,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)O,,UC-781,
C[C@@]1(NCC2CCOCC2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.Cl,,Ponesimod,
CC(=O)NCc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,Asoprisnil,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O,,Glyceryl monostearate,
C[C@@]1(NCCCc2ccccc2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.Cl,,Aminoquinuride,
CS(=O)(=O)O.Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Rolofylline,
Cc1oc(/C=C/c2ccc(Cl)o2)cc1C(=O)O,,Tezampanel,
CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1,,Rifamycin,
CC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC1=O,,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,
O=C(c1cccn2cncc12)N1CCC(F)(F)[C@@H](Oc2ccc3ccccc3n2)C1,,Mapracorat,
O=C(Nc1cccc(Br)n1)[C@@H]1C[C@H]2C[C@H]2N1C(=O)Cn1ncc2ccccc21,,BMS-488043,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O,,"N,O6-Disulfo-Glucosamine",
C[C@@]1(NC(=O)c2cc(Cl)cc(Cl)c2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O,,L-methionine (R)-S-oxide,
CCc1cc(CNc2cc(Cl)nn3c(-c4ccc(OC)c(S(=O)(=O)NCc5cn(Cc6ccccc6)nn5)c4)c(C)nc23)ccn1,,Detomidine,
C[C@@]1(NCC2CCCCC2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.Cl,,Alvocidib,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](CCCCN)C(=O)O,,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",
C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c(C(F)(F)F)[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,,"2'-Chloro-Biphenyl-2,3-Diol",
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)c1ccc(N=C=S)cc1C1c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](C)O)C(N)=O,,NNZ-2591,
CC(C)C[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O,,2-(cyclohexylamino)benzoic acid,
CCc1cc(CNc2cc(Cl)nn3c(-c4ccc(OC)c(S(=O)(=O)NCc5cn(-c6cc7ccc(O)cc7oc6=O)nn5)c4)c(C)nc23)ccn1,,Plitidepsin,
C#CCNS(=O)(=O)c1cc(-c2c(C)nc3c(NCc4ccnc(CC)c4)cc(Cl)nn23)ccc1OC,,Isatoic anhydride,
COC(=O)[C@H](CO)NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)c1ccccc1,,Sutezolid,
O=C1Nc2ncccc2N[C@@H]1Cc1c[nH]c2ccccc12,,3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid,
C[C@@]1(NCC2CCCCCCC2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.Cl,,"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",
Cn1ccc(-c2ccc3c(c2)ncn3-c2ccc(CC(=O)Nc3cc(C(C)(C)C)on3)cc2)c1,,Mavoglurant,
CCCCCCC(=O)N[C@]1(C)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O,,Lonafarnib,
CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O,,Glimepiride,
C[C@@]1(NCc2ccccc2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.Cl,,Rufloxacin,
NC(=O)c1cccc(CCN(CCC[C@H](N)C(=O)O)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)c1,,Ohmefentanyl,
C=CC(=O)Nc1cc(F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1,,Etryptamine,
NC(=O)C[C@H](N)C(=O)N1CCC(Nc2ccc3c(c2)CN(S(=O)(=O)c2ccc(O)cc2O)C3)CC1,,Nicorandil,
N#Cc1ccc(-c2[nH]c(=O)c3cc(F)ccc3c2OCCN)cc1,,Desfesoterodine,
N#Cc1cccc(-c2[nH]c(=O)c3cc(F)ccc3c2OCCN)c1,,"2-Methylpentane-1,2,4-Triol",
N#Cc1cnc2cc(OC[C@H](O)CO)c(NC(=O)CC3CCSS3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,,Progabide,
N#Cc1cnc2cc(OC[C@@H](O)CO)c(NC(=O)C[C@@H]3CCSS3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,,Dihydroergotamine,
CC1(C)OC[C@H](COc2cc3ncc(C#N)c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc2NC(=O)C[C@H]2CCSS2)O1,,Ciprofibrate,
N#Cc1cnc2cc(OC[C@@H](O)CO)c(NC(=O)C[C@H]3CCSS3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,,PM-060184,
CC1(C)OC[C@H](COc2cc3ncc(C#N)c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc2NC(=O)CC2CCSS2)O1,,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",
CC1(C)OC[C@H](COc2cc3ncc(C#N)c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc2NC(=O)C[C@@H]2CCSS2)O1,,Omaveloxolone,
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)C(CSC(C)=O)CSC(C)=O,,Elafibranor,
CC(=O)SCC(CSC(C)=O)C(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c(C#N)cnc2cc1OC[C@H](O)CO,,Amlodipine,
O=C1c2cc(-c3ccc(C4CC4)nc3)ccc2CN1c1cccc(-c2nncn2C2CC2)n1,,Steviolbioside,
O=C1c2ccc(-c3cc[nH]n3)cc2CN1c1cccc(-c2nncn2C2CC2)n1,,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",
CNC(=O)c1ccc2c(c1)CN(c1cccc(-c3nncn3C3CC3)n1)C2=O,,"US10150755, Compound 3",
Cn1cnc(-c2ccc3c(c2)CN(c2cccc(-c4nncn4C4CC4)n2)C3=O)c1,,AMD-070,
Cc1ccncc1-c1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3C3CC3)n1)C2,,Danicopan,
O=C1c2ccccc2CN1c1cccc(-c2nncn2C2CC2)n1,,Antipain,
CC(C)Oc1cc2c(cc1-c1cccnc1)C(=O)N(c1cccc(-c3nncn3C3CC3)n1)C2,,Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate,
O=C1c2cc(-c3cccnc3)c(F)cc2CN1c1cccc(-c2nncn2C2CC2)n1,,Lasalocid,
Cc1cc2c(cc1-c1cccnc1)C(=O)N(c1cccc(-c3nncn3C3CC3)n1)C2,,"5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",
O=C1c2cc(-c3cnc(C4CC4)cn3)ccc2CN1c1cccc(-c2nncn2C2CC2)n1,,Pteroic acid,
O=C(c1ccc2c(c1)CN(c1cccc(-c3nncn3C3CC3)n1)C2=O)N1CCOCC1,,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",
O=C(N/N=C/c1c(O)ccc2ccccc12)c1ccccc1O,,NSAH,
C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1,,Repotrectinib,
Nc1nc2c(c(=O)[nH]1)[n+](Cc1ccccc1)cn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O,,7-Benzyl Guanine Monophosphate,
CC1NC(NCCC[C@H](N)C(=O)O)=NC1=O,,149204-50-2,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)ncnc2cc1O,,2'-Monophosphoadenosine-5'-Diphosphoribose,
CC1(C)CC(=O)C2=C(C1)Nc1n[nH]c(C(F)(F)F)c1C2c1cccc(F)c1C(F)(F)F,,Madecassoside,
CSc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C)c21,,Olorofim,
CC1(C)CC(=O)C2=C(C1)Nc1n[nH]c(C(F)(F)F)c1C2c1cc(F)ccc1C(F)(F)F,,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",
Cc1[nH]nc2c1C(c1ccc(Cl)s1)C1=C(CC(C)(C)CC1=O)N2,,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",
Cc1[nH]nc2c1C(c1ccn[nH]1)C1=C(CC(C)(C)CC1=O)N2,,Olinciguat,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)ncnc2cc1O,,"1-(3-(7-hydroxy-6-methoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea",
Cc1c(Cc2c(CNCCO)nc3c(-c4ncc[nH]4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole",
Cc1nc2c(-c3ncc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",
CC(=O)NCc1nc2c(-c3ncc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C,,"[N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine",
Cc1c(Cc2c(CO)nc3c(-c4cnc[nH]4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,L-histidinol phosphate,
Cc1c(Cc2c(CO)nc3c(-c4ncc[nH]4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Bunamiodyl,
Cc1c(Cc2c(CCO)nc3c(-c4c[nH]cn4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester",
Cc1c(Cc2c(CO)nc3c(-c4c[nH]cn4)cc(N4CCOC(C)C4)nn23)cccc1C(F)(F)F,,Valdecoxib,
Cc1c(Cc2c(C(C)O)nc3c(-c4c[nH]cn4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",
Cc1c(Cc2c(C(C)O)nc3c(-c4ncc[nH]4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F,,Tafluprost,
Cc1nc2c(-c3ncc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C,,Tryptophanyl-5'amp,
Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCOCC1,,Podofilox,
Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc2c1CNCC2,,"1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea",
Cc1nc2c(-c3c[nH]cn3)cc(N3CCOCC3)nn2c1Nc1cccc(F)c1C,,N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide,
Cc1nc2c(-c3c[nH]cn3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCN(C)CC1,,Nomegestrol,
Cc1c(Cl)cccc1Nc1c(CO)nc2c(-c3c[nH]cn3)cc(N3CCOCC3)nn12,,ONT-093,
Cc1c(Nc2c(CO)nc3c(-c4c[nH]cn4)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F,,Flecainide,
C[C@H]1Nc2ccn3ncc(c3n2)C(=O)NCCOc2ccc(F)cc21,,D-Mannuronic Acid,
O=C1NCCOc2ccc(F)cc2CNc2ccn3ncc1c3n2,,L-Threoninol,
O=C1NCCOc2ccc(F)cc2C(CO)Nc2ccn3ncc1c3n2,,Cobalamin,
C[C@@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1,,Estradiol acetate,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1O,,"US9725465, Example 164",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1O,,"US9725465, Example 157",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1O,,"US9725465, Example 78",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1O,,"US9725465, Example 184",
CC1Nc2ccn3ncc(c3n2)C(=O)NCCOc2ccc(F)cc21,,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",
O=C(N[C@H]1CCCC[C@H]1C(=O)O)c1cnn2c(O)cc(-c3ccccc3)nc12,,2378173-15-8,
CO[C@@H]1CC/C=C/c2cccc(c2)[C@@H](C)OC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1C,,(12R)-12-hydroxyeicosapentaenoic acid,
O=C(COc1cc2[nH]c(C(=O)N[C@H](CO)c3ccc(C(=O)O)cc3)cc2cc1Cl)NCCO,,Quinolinic Acid,
Cc1[nH]nc2c1C(c1ccccc1Cl)C1=C(CC(C)(C)CC1=O)N2,,P-Nitrophenol,
Cc1[nH]nc2c1C(c1ccccc1Br)C1=C(CC(C)(C)CC1=O)N2,,PF-00610355,
COc1cccc(C2C3=C(CC(C)(C)CC3=O)Nc3n[nH]c(C)c32)c1,,Gefapixant,
COc1ccc(C2C3=C(CC(C)(C)CC3=O)Nc3n[nH]c(C)c32)cc1,,329978-00-9,
Cc1[nH]nc2c1C(c1ccc3c(c1)OCO3)C1=C(CC(C)(C)CC1=O)N2,,865658-70-4,
Cc1[nH]nc2c1C(c1ccccc1C(F)(F)F)C1=C(CC(C)(C)CC1=O)N2,,arg-gsk-18,
Cc1[nH]nc2c1C(c1ccccc1C#N)C1=C(CC(C)(C)CC1=O)N2,,JNJ-28330835,
Cc1[nH]nc2c1C(c1ccc(F)cc1Cl)C1=C(CC(C)(C)CC1=O)N2,,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",
Cc1[nH]nc2c1C(c1ccc(Br)cn1)C1=C(CC(C)(C)CC1=O)N2,,"(2R,4S)-2-[(1R)-1-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid",
COc1ccccc1C1C2=C(CCC(C)(C)C2=O)Nc2n[nH]c(C)c21,,Dibromotyrosine,
COc1ccccc1C1C2=C(CCCC2=O)Nc2n[nH]c(C)c21,,IMG-7289,
COc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C(C)C)c21,,Ketobemidone,
CC1(C)CC(=O)C2=C(C1)Nc1n[nH]c(C(F)(F)F)c1C2c1ccccc1,,Bictegravir,
Cc1[nH]nc2c1C(C)(c1ccccc1)C1=C(CC(C)(C)CC1=O)N2,,arg-gsk-46,
CC1(C)CC(=O)C2=C(C1)Nc1n[nH]c(C(F)(F)F)c1C2(C)c1ccccc1,,"4,7,7-trimethyl-4-phenyl-3-(trifluoromethyl)-6,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]quinolin-5(4H)-one",
O=C1c2ccccc2NC(c2ccccn2)N1c1ccc(OCCn2c(-c3ccccc3)nc3ccccc32)cc1,,"Sar9, Met (O2)11-Substance P",
Cc1ccc(CN(CC(=O)N2CCC(CN)CC2)c2ccc(C#N)cc2)cc1,,HT-0712,
CC[C@H](C)[C@@H]1NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCC(C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC(C)(C)C)C(=O)NC(CC(C)(C)C)C(=O)N[C@@H](CCC(N)=O)C(N)=O)NC(=O)C(CC(C)(C)C)NC1=O,,Metoserpate,
OC[C@H]1O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cc(F)cc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cc(F)cc(F)c3)nn2)[C@H]1O,,Fluorometholone,
CC(C)(C)c1ccc(C(=O)NCc2ccc(NS(C)(=O)=O)cc2Cl)cc1,,Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate,
Cc1cc(COc2cc(C(=O)N3C[C@@H]4CCCN[C@@H]4C3)nn2-c2ccc(C#N)cc2)on1,,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",
O=C(O)c1ccnc2cc(C(OCCCN3CCCCC3)c3ccccc3Cl)[nH]c12,,Indenolol,
O=C1c2ccccc2NC(c2ccccc2F)N1CC1CCC(CN2C(=O)c3ccccc3NC2c2ccccc2F)CC1,,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",
COc1ccc(C(=O)Nc2ccc(C)c(NC(=O)c3ccc4nc(C)ccc4c3)c2)cc1OC,,"[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID",
O=C(CCCCC1CCSS1)NCCCS(=O)(=O)[O-].[Na+],,4-hydroxybenzyl coenzyme A,
CN(C)[C@@H]1CN(Cc2c(F)cccc2Br)C[C@H]1c1cn(C)c2ccccc12,,Nitazoxanide,
CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCNC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(N)=O,,N-methylnicotinamide,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cc(F)cc(F)c4)nn3)[C@H]2O)cc1,,Methyl-D9-choline,
COc1ccc([C@@H]2C(=O)N([C@H]3CC[C@H](N)CC3)[C@H]2c2ccc(C#N)cc2)cc1,,Niridazole,
O=C(c1ccc(F)cc1)N(Cc1ccccc1)C1CCCCC1,,Testosterone enanthate,
N#Cc1ccc(-n2nc(C(=O)N3CCC[C@@H](N)C3)cc2OC[C@@H]2CCC(=O)N2)cc1,,Sisomicin,
COc1ccc(CN(CC(=O)NC(C)C)C(=O)CCCCCn2cc[n+](C)c2/C=N\O)cc1.[I-],,Nevirapine,
N#Cc1ccc(-n2nc(C(=O)N3CCC[C@@H](N)C3)cc2OCC(O)C(F)(F)F)cc1,,LY-517717,
Cn1ncc2cc([C@@H]3CN(C(=O)[C@H]4CC[C@H](CN)CC4)C[C@H]3c3ccc(C#N)cc3)ccc21,,"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",
CN[C@@H]1CCCN(C(=O)c2cc(OCc3cc(C)no3)n(-c3ccc(C#N)cc3)n2)C1,,GW-274150,
NC(=O)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(C(=O)O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCNC(=O)CC[C@H](NC1=O)C(=O)N[C@H](C(N)=O)CSCC(=O)N2,,Bromotheophylline,
O=C(CCCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO,,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Cl)cc4)nn3)[C@H]2O)cc1,,"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",
COc1cc(N(CC(=O)N2CCC(N)CC2)S(=O)(=O)c2ccc3c(c2)CCN3C(C)=O)ccc1-n1nc(C)cc1C,,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,
COC(=O)c1cc(O)c(O)cc1NC(=O)C1Oc2ccccc2OC1C,,"[2-(Methyleneamine)-4-(4-Hydroxy-Benzylidine)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde",
O=C(O)/C=C/C=C/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,,PAC-14028,
O=C(O)CNC(=O)c1cnn2c(O)cc(-c3ccccc3)nc12,,Azlocillin,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](C23CC4CC(CC(C4)C2)C3)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",
C=C(C)[C@]12C[C@@H](C)[C@@]34O[C@@](Cc5ccccc5)(O[C@@H]1[C@H]3C=C(COC(=O)Cc1ccc(O)c(OC)c1)C[C@]1(O)C(=O)C(C)=C[C@H]14)O2,,Leflunomide,
CC[C@H](C)[C@H](NC(=O)CN1CC[S+]([O-])CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,,[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,
O=c1oc2ccc(F)c(F)c2cc1CO[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cc(F)c(F)c(F)c4)nn3)[C@H]2O)[C@@H]1O,,Edivoxetine,
Cc1ccc(-n2nc3c(=O)n(CCC(=O)N4CCC(N5C(=O)c6ccccc6NC5c5ccccc5F)CC4)nc(C)c3c2C)cc1,,Heptyl glucoside,
O=C1c2cc(F)ccc2N(CC2CCCCC2)C(c2ccccc2F)N1C1CCN(CCCn2ccnc2-c2ccccc2)CC1,,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Cl)c(Cl)c4)nn3)[C@H]2O)cc1,,Abacavir,
O=C(/C=C/c1ccc(NCCCn2cc(-c3ncnc4[nH]ccc34)cn2)cc1)NO,,NS-018,
CC(=O)N1CCc2cc(S(=O)(=O)N(CC(=O)N3CCC(N)CC3)c3ccc(C#N)cc3)ccc21,,(S)-Propafenone,
CN(C)C(=O)COc1cc(C(=O)N2CCC[C@@H](N)C2)nn1-c1ccc(C#N)cc1,,Cabozantinib,
COc1ccc(CN(CC(=O)NCc2ccccc2)C(=O)CCCCCn2ccnc2/C=N/O)cc1,,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",
O=C(CCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO,,7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,
O=c1cc(-c2ccc(OS(=O)(=O)[O-])cc2)oc2cc(OS(=O)(=O)[O-])cc(OC/C=C/COc3cc(OS(=O)(=O)[O-])cc4oc(-c5ccc(OS(=O)(=O)[O-])cc5)cc(=O)c34)c12.[Na+].[Na+].[Na+].[Na+],,(S)-oct-1-en-3-ol,
CC(C)[C@@H]1NC(=O)CCCC/C=C/c2cccc(c2)[C@@H](C)OC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](C)NC1=O,,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,
Cc1ccc(S(=O)(=O)N(CC(=O)N2CCC(N)CC2)c2ccc(C#N)cc2)cc1,,"{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone",
COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(F)cc(/C=N/O)c3O)CC1)CC2,,Zuranolone,
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CCC(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)C(=O)N[C@@H](CCCCNC(=O)C[C@H](Sc1ccc2ccccc2c1)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(N)=O)C(C)C,,Ganciclovir,
O=C(O)CCC(=O)N1CCC(N(Cc2ccccc2)C(=O)c2cc(Br)c(Br)[nH]2)CC1,,Glutethimide,
C=C1C(=O)O[C@@H]2C3[C@@H](C)[C@@H](OC(=O)c4ccc(I)cc4)CC[C@]3(C)CC[C@@H]12,,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",
CCCCCCCCCCCC(=O)N[C@H]1[C@@H](OP(=O)([O-])O)O[C@H](CO)[C@@H](OP(=O)([O-])O)[C@@H]1OC(=O)CCCCCCCCCCC.[Na+].[Na+],,Cefiderocol,
Cc1ccc(S(=O)(=O)N(CC(=O)N[C@H]2CN3CCC2CC3)c2ccc(C#N)cc2)cc1,,Novobiocin,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@](C)(Cc1ccccc1F)C(N)=O,,Maxacalcitol,
Cc1cccc(F)c1CN1C[C@H](c2ccc(S(C)(=O)=O)cc2)[C@@H](N(C)C)C1,,Ceralasertib,
COc1ccc2c(c1)NC(c1ccccc1F)N(C1CCN(CCCn3ccnc3-c3ccccc3)CC1)C2=O,,Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate],
N#Cc1ccc(-n2nc(C(=O)N3CCC[C@@H](N)C3)cc2OCC(N)=O)cc1,,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,
CCCCCCCCCC(=O)N[C@H]1[C@@H](OP(=O)([O-])O)O[C@H](CO)[C@@H](OP(=O)([O-])O)[C@@H]1OC(=O)CCCCCCCCC.[Na+].[Na+],,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",
O=C(NCc1cn([C@@H]2[C@@H](O)[C@H](SS[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(-c5cc(F)c(F)c(F)c5)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,,Alvelestat,
Cc1ccc([C@@H]2CN(C(=O)[C@H]3CC[C@H](CN)CC3)C[C@H]2c2ccc(C#N)cc2)cc1,,(S)-DES-ME-AMPA,
CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,,CP-320626,
O=C(CCCCCCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO,,3-hydroxyglutaric acid,
Cc1ccc2c(c1)NC(c1ccccc1F)N(C1CCN(CCCn3ccnc3-c3ccccc3)CC1)C2=O,,AR-67,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC1=O,,"5-methoxy-N,N-dimethyltryptamine",
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(F)c(C)c4)nn3)[C@H]2O)cc1,,Benzoyl-tyrosine-alanine-fluoro-methyl ketone,
COCCN(CC(=O)NCc1ccccc1)C(=O)CCCCCn1ccnc1/C=N/O,,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",
O=C(O)c1ccnc2cc(C(OCCN3CCC(F)(F)CC3)c3ccccc3Cl)[nH]c12,,Potassium gluconate,
NC(=O)[C@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O,,Buflomedil,
N#Cc1ccc(N(CC(=O)N2CCC(CN)CC2)Cc2ccc(C(N)=O)cc2)cc1,,Hydrocortisone probutate,
COc1cc(NS(=O)(=O)c2ccc3c(c2)CCN3C(C)=O)ccc1-n1nc(C)cc1C,,CH-5132799,
C[C@@H](Oc1ccc(Cc2ccc(OCc3coc(-c4ccccc4)n3)cc2)cc1)C(=O)O,,Isochorismic Acid,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,CP-547632,
Cc1cc(COc2cc(C(=O)N3CC[C@H](N)C3)nn2-c2ccc(C#N)cc2)on1,,4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,
O=C1c2ccccc2N[C@H](c2ccccc2F)N1C1CCN(CCN2C(=O)c3ccccc3N[C@H]2c2ccccc2F)CC1,,Selisistat,
N#Cc1ccc(-n2nc(C(=O)N3CCC[C@@H](N)C3)cc2OCC(=O)N2CCOCC2)cc1,,Cibacron Blue,
COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(C)cc(/C=N/O)c3O)CC1)CC2,,Beta-L-Arabinose,
Cc1ccc(S(=O)(=O)N(CC(=O)NC2CCNCC2)c2ccc(C#N)cc2)cc1,,Canfosfamide,
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCNC(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,Domiodol,
COC(=O)CC(=O)NCCCNCc1ccc(-c2ccccc2)c(Cl)c1.Cl,,Amphomycin,
Cc1ccc([C@@H]2CN(C(=O)CC3CCCNC3)C[C@H]2c2ccc(C#N)cc2)cc1,,Anhydrovinblastine,
O=C1c2cc(F)ccc2N(CC2CCC2)C(c2ccccc2F)N1C1CCN(CCCn2ccnc2-c2ccccc2)CC1,,Topramezone,
Cc1ccccc1-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1,,SCH-900271,
CC[C@H](C)[C@@H]1NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NCCC(=O)NC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCC(C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(N)=O)NC(=O)[C@H](CC(C)C)NC1=O,,Ibipinabant,
O=C(NCc1cn([C@@H]2[C@@H](O)[C@H](SS[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(-c5cccc(F)c5)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,,(+)-menthol,
O=C1c2cc(F)ccc2N(CC2CCCC2)C(c2ccccc2F)N1C1CCN(CCCn2ccnc2-c2ccccc2)CC1,,18-methoxycoronaridine,
O=C(CCCCCCC(=O)Nc1ccc(CCCn2cc(-c3ncnc4[nH]ccc34)cn2)cc1)NO,,Apadenoson,
O=C(CCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO,,Adafosbuvir,
Cc1ccc2c(c1)C(=O)N(C1CCN(CCCn3ccnc3-c3ccccc3)CC1)C(c1ccccc1F)N2,,N-chlorotaurine,
O=C1c2ccc(F)cc2NC(c2ccccc2F)N1CCOc1ccc(-c2nc3ccccc3n2Cc2ccncc2)cc1,,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",
Cl.NCc1ccc(-c2ccccc2)c(Cl)c1,,Dimiracetam,
COc1ccc(CN(CC(=O)NC(C)C)C(=O)CCCCCn2ccnc2/C=N/O)cc1,,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",
CS(=O)(=O)NCc1cn(-c2nc(N)nc(Nc3ccc(C#N)cc3)n2)nn1,,"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",
CC(C)(O)CCOc1cc(C(=O)N2CCC[C@@H](N)C2)nn1-c1ccc(C#N)cc1,,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",
Cc1cc(COc2cc(C(=O)N3CCC[C@H](N)C3)nn2-c2ccc(C#N)cc2)on1,,Palbociclib,
Cc1cc(COc2cc(C(=O)N3CC[C@@H](F)[C@@H](N)C3)nn2-c2ccc(C#N)cc2)on1,,Gemfibrozil,
N#Cc1ccc(Nc2nc(N)nc(-c3ccc(CO)o3)n2)cc1,,Encenicline,
O=C1c2ccccc2NC(c2ccccc2F)N1CCCCCN1C(=O)c2ccccc2NC1c1ccccc1F,,Elsamitrucin,
OC[C@H]1O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O,,Parecoxib,
Cc1ccc(CN(CC(=O)N2CCC(N)CC2)c2ccc(C#N)cc2)cc1,,Guanoxabenz,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(F)c(F)c4)nn3)[C@H]2O)cc1,,(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,
Cc1ccc(-n2nc3c(=O)n(CCCN4CCC(N5C(=O)c6ccccc6NC5c5ccccc5F)CC4)nc(C)c3c2C)cc1,,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",
O=C1c2ccccc2N[C@H](c2ccccc2F)N1CCN1CCC(N2C(=O)c3ccccc3N[C@H]2c2ccccc2F)CC1,,PF-05089771,
CN1c2ccc(F)cc2C(=O)N(C2CCN(CCCn3ccnc3-c3ccccc3)CC2)C1c1ccccc1F,,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",
O=c1oc2ccc(F)c(F)c2cc1CO[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@@H]1O,,3-Deazacytidine,
CC(Oc1cc(C(=O)N2CCC[C@@H](N)C2)nn1-c1ccc(C#N)cc1)C(N)=O,,Segesterone acetate,
CC(=O)N1CCN(c2ccc([C@H]3CN(Cc4c(C)cccc4F)C[C@@H]3N(C)C)cc2)CC1,,Rovafovir etalafenamide,
CC[C@H](C)[C@H](NC(=O)CN1CCSCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,,3-(Benzoylamino)-L-Alanine,
Cc1nnc2c(Nc3cccc(CNC(=O)C(C)C)c3)nc3ccccc3n12,,Cilomilast,
C[C@@H]1[C@H]2C(=O)N(C)c3ccncc3[C@H]2CN1S(=O)(=O)c1ccc2c(c1)OCO2,,RWJ-56423,
CCCCN(CC(=O)NCc1ccccc1)C(=O)CCCCCn1cc[n+](C)c1/C=N\O.[I-],,Chlortetracycline,
Cl.NCc1ccc(OC2CCCC2)c(Cl)c1,,Naftopidil,
O=c1c(OS(=O)(=O)[O-])c(-c2ccc(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])c2)oc2cc(OS(=O)(=O)[O-])cc(OCc3ccc(COc4cc(OS(=O)(=O)[O-])cc5oc(-c6ccc(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])c6)c(OS(=O)(=O)[O-])c(=O)c45)cc3)c12.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,Lividomycin A,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium,
COc1ccc([C@@H]2CN(C(=O)CC3CCCNC3)C[C@H]2c2ccc(C#N)cc2)cn1,,AT-7519,
O=C(O)CCC(=O)N1CCC(NC(=O)c2cc(Br)c(Br)[nH]2)CC1,,Bevonium,
Cc1cc(COc2cc(C(=O)N3CCCC(N4CCCC4)C3)nn2-c2ccc(C#N)cc2)on1,,AIT-034,
Cc1ccc(S(=O)(=O)N(CC(=O)N2C[C@@H]3C[C@H]2CN3)c2ccc(C#N)cc2)cc1,,3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE,
O=C(CCCCCCC(=O)Nc1ccc(NC(=O)CCCn2cc(-c3ncnc4[nH]ccc34)cn2)cc1)NO,,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,
COc1ccc(C2OC(=S)NC2=O)c(OC)c1,,Flunisolide acetate,
Cn1cnc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)n1,,Sulbactam,
O=c1oc2ccc(F)c(F)c2cc1CO[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](OCc3cc4c(F)c(F)ccc4oc3=O)[C@H]2O)[C@@H]1O,,"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid",
Cc1ccc(S(=O)(=O)N(CC(=O)N2CC[C@@H](N)C2)c2ccc(C#N)cc2)cc1,,GSK-3117391,
Cn1ncc2cc([C@@H]3CN(C(=O)[C@H]4CC[C@H](N)CC4)C[C@H]3c3ccc(C#N)cc3)ccc21,,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",
O=C1c2ccccc2NC(c2ccccn2)N1c1ccc(OCCn2ccnc2-c2ccccc2)cc1,,Flupirtine,
O=C1c2cc(F)ccc2N(CC2CC2)C(c2ccccc2F)N1C1CCN(CCCn2ccnc2-c2ccccc2)CC1,,Anisodamine,
Cc1nccn1CCOc1ccc(N2C(=O)c3ccccc3NC2c2ccccc2F)cc1,,Enprostil,
O=C(O)c1cccc(CN2CCC(NC(=O)c3cc(Br)c(Br)[nH]3)CC2)c1,,"4,5-Dehydro-D-Glucuronic Acid",
Cc1ccc2cc(C(=O)Nc3cc(N(C)C(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1,,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,
NC(=O)C[C@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCC=CCOC[C@H](NC1=O)C(=O)N[C@H](C(N)=O)CSCC(=O)N2,,Alpha-Amino-2-Indanacetic Acid,
COc1ccc2c(c1)C(=O)N(C1CCN(CCCn3ccnc3-c3ccccc3)CC1)C(c1ccccc1F)N2,,B-2-Octylglucoside,
Cc1nccn1CCOc1ccc(N2C(=O)c3ccccc3NC2c2ccccn2)cc1,,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",
CCCCNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](SS[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(-c5cc(F)c(F)c(F)c5)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,Metocurine iodide,
O=C1c2ccccc2NC(c2ccccc2F)N1c1ccc(OCCn2ccnc2-c2ccccc2)cc1,,Nojirimycine Tetrazole,
CNC[C@H]1CC[C@H](C(=O)N2C[C@@H](c3ccc(C#N)cc3)[C@H](c3ccc4c(cnn4C)c3)C2)CC1,,"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",
O=C1c2ccccc2NC(c2ccccc2F)N1C1CCN(CCCn2ccnc2-c2ccccc2)CC1,,Tenivastatin,
COc1ccc2c(c1)NC(c1ccccc1F)N(CCOc1ccc(-c3nc4ccccc4n3Cc3ccncc3)cc1)C2=O,,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,
COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(Br)cc(/C=N/O)c3O)CC1)CC2,,Phosphonoacetaldehyde,
COc1ccc([C@H]2CN(Cc3c(C)cccc3F)C[C@@H]2N(C)C)cc1OC,,Josamycin,
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)C(N)CCCCn1cc(CCCCNC(=O)CCCCCn2nc(N)c3cc(-c4c(-c5ccccc5)nn5ccccc45)nnc32)nn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C,,AZD-5423,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Br)cc4)nn3)[C@H]2O)cc1,,"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",
N#Cc1ccc(N(CC(=O)N2CCC(N)CC2)Cc2ccccc2)cc1,,"7,8-Diamino-Nonanoic Acid",
NC(=O)c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1.[Cl-].[Cl-],,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,
OC[C@H]1O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccccc4F)nn3)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,
COc1ccc([C@H]2CN(Cc3c(F)cccc3Br)C[C@@H]2N(C)C)cc1OC,,Tioclomarol,
Cc1cc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)n(C)n1,,PX-102,
Cn1cc2cc(N(CC(=O)N3CCC[C@@H](N)C3)S(=O)(=O)c3ccc(C#N)cc3)ccc2n1,,5-phenyl-2-keto-valeric acid,
Cc1cc(COc2cc(C(=O)N3C[C@H]4CCCN[C@H]4C3)nn2-c2ccc(C#N)cc2)on1,,TMC-647055,
Cc1ccc([C@@H]2CN(C(=O)[C@@H]3CCC[C@@H](N)C3)C[C@H]2c2ccc(C#N)cc2)cc1,,BLXA4,
COc1ccc(CN(CC(=O)N2CCC(N)CC2)c2ccc(C#N)cc2)cc1F,,Aceneuramic acid,
Cn1ncnc1COc1cc(C(=O)N2CCC[C@@H](N)C2)nn1-c1ccc(C#N)cc1,,Lysophosphotidylserine,
CNC[C@H]1CC[C@H](C(=O)N2C[C@@H](c3ccc(C)cc3)[C@H](c3ccc(C#N)cc3)C2)CC1,,Hexestrol,
CC(=O)N1CCc2cc(S(=O)(=O)N(CC(=O)N3CCC[C@@H](N)C3)c3ccc(C#N)cc3)ccc21,,Phenylalanylamide,
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)c1ccccc1)C(C)C)C(=O)N[C@@H](CCCCNC(=O)C[C@H](Sc1ccc2ccccc2c1)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(N)=O)C(C)C,,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",
CC(=O)O[C@H]1C[C@H]([C@H](C)[C@H]2C[C@]3(C)O[C@]3(C)[C@H](O)O2)[C@@]2(C)CC[C@H]3[C@@H](C[C@@H]4O[C@]45[C@@H](O)C=CC(=O)[C@]35C)[C@H]12,,3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid,
C[C@H](Oc1ccc(Cc2ccc(OCc3coc(-c4ccccc4)n3)cc2)cc1)C(=O)O,,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,
N#Cc1ccc(N(CC(=O)N2CCC(CN)CC2)Cc2ccc(Cl)cc2)cc1,,Alloin,
Cc1nc2ccccc2n1CCOc1ccc(N2C(=O)c3ccccc3NC2c2ccccc2F)cc1,,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",
CC1CCN(c2nc(C(F)(F)F)ccc2CNC(=O)Nc2cccc3c2OCC(=O)N3)CC1,,SUVN-G3031,
O=C1c2ccccc2NC(c2ccccc2F)N1CCCCCCCN1C(=O)c2ccccc2NC1c1ccccc1F,,Sarafloxacin,
Cc1cccc(F)c1CN1C[C@@H](N(C)C)[C@H](c2ccc(S(C)(=O)=O)cc2)C1,,"(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one",
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C(=O)O)C(=O)O)C(N)=O,,Terazosin,
CCCCN(CC(=O)NC(C)C)C(=O)CCCCCn1cc[n+](C)c1/C=N\O.[I-],,Derazantinib,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)cc1,,4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide,
Cc1nnc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)o1,,Lumichrome,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cc(F)c(F)c(F)c4)nn3)[C@H]2O)cc1,,"2',3'-Dideoxycytidine-5'-Monophosphate",
CCCCN(CC(=O)NCc1ccccc1)C(=O)CCCCCn1ccnc1/C=N/O,,Uracil,
CCCCNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](SS[C@@H]3O[C@H](CO)[C@H](O)[C@H](OCc4cc5c(F)c(F)ccc5oc4=O)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,Ambroxol acefyllinate,
C[C@@H](O)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,,Epalrestat,
O=C1c2ccccc2NC(c2ccccc2F)N1CCN1CCC(N2C(=O)c3ccccc3NC2c2ccccc2F)CC1,,Besifloxacin,
CCN(CC)C1CCN(C(=O)c2cc(OCc3cc(C)no3)n(-c3ccc(C#N)cc3)n2)C1,,Tapentadol,
CCCCCCCCCCCCCCCC(=O)N[C@H]1[C@@H](OP(=O)([O-])O)O[C@H](CO)[C@@H](OP(=O)([O-])O)[C@@H]1OC(=O)CCCCCCCCCCCCCCC.[Na+].[Na+],,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",
COc1cc2c(cc1OC)C(c1cccnc1)N(C(=O)c1ccc(O)cc1O)CC2,,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",
Cc1ccc(S(=O)(=O)N(CC(=O)Nc2cccnc2)c2ccc(C#N)cc2)cc1,,Daglutril,
Cc1cc(COc2cc(C(=O)N3CCOC(CN)C3)nn2-c2ccc(C#N)cc2)on1,,tert-butanol,
Cc1cc(COc2cc(OS(=O)(=O)[O-])cc3oc(-c4ccc(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])c4)c(OS(=O)(=O)[O-])c(=O)c23)c(C)cc1COc1cc(OS(=O)(=O)[O-])cc2oc(-c3ccc(OS(=O)(=O)[O-])c(OS(=O)(=O)[O-])c3)c(OS(=O)(=O)[O-])c(=O)c12.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,"2,6-Dimethyl-7-Octen-2-Ol",
Nc1nc(Nc2ccc(C(=O)NCCCCCNC(=S)Nc3ccc4c(c3)C(=O)OC43c4ccc(O)cc4Oc4cc(O)ccc43)cc2)nn1C(=O)c1c(F)cccc1F,,Beraprost,
Cc1ccc(S(=O)(=O)N(CC(=O)N2CC[C@H](N)C2)c2ccc(C#N)cc2)cc1,,Isatin,
OC[C@H]1O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(F)c(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3ccc(F)c(F)c3)nn2)[C@H]1O,,Eslicarbazepine acetate,
O=C1c2cc(F)ccc2NC(c2ccccc2F)N1C1CCN(CCCn2ccnc2-c2ccccc2)CC1,,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",
Cc1nc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)no1,,N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide,
Cn1ncc2cc(CN(CC(=O)N3CCC(N)CC3)c3ccc(C#N)cc3)ccc21,,Branaplam,
O=C(O)c1ccc(C(=O)N2CCC(NC(=O)c3cc(Br)c(Br)[nH]3)CC2)cc1,,octyl beta-D-galactopyranoside,
O=C1c2ccc(Cl)cc2NC(c2ccccc2F)N1CCOc1ccc(-c2nc3ccccc3n2Cc2ccncc2)cc1,,4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,
CN(C)c1ccc(-c2c3nc(c(-c4ccc(N(C)C)cc4)c4ccc([nH]4)c(-c4ccc(C(=O)O)cc4)c4nc(c(-c5ccc(C(=O)O)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1,,"3,3',5,5'-tetrachlorobiphenyl-4,4'-diol",
Cc1ccc(S(=O)(=O)N(CC(=O)N[C@@H]2CN3CCC2CC3)c2ccc(C#N)cc2)cc1,,"3,4-Epoxybutyl-Alpha-D-Glucopyranoside",
Cc1ccc([C@@H]2CN(C(=O)C3CCNCC3)C[C@H]2c2ccc(C#N)cc2)cc1,,Azilsartan medoxomil,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N[N+](=O)[O-])C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",
C=C1C(=O)O[C@@H]2C3=C(C)[C@@H](OC(=O)c4ccc(Cl)cc4)CC3[C@](C)(OC(C)=O)CC[C@@H]12,,Lortalamine,
CCc1cc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)on1,,N-hexanoyl-L-homoserine,
COc1ccc([C@H]2CN(C3CCc4cccc(F)c43)C[C@@H]2N(C)C)cc1OC,,Indirubin-5-sulphonate,
CC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@]1(C)CCCCCCCCCCCC[C@@](C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C(=O)O)C(=O)O)C(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C23CC4CC(CC(C4)C2)C3)NC1=O,,Zalypsis,
Cc1ccc(S(=O)(=O)N(CC(=O)N2CCC[C@@H](N)C2)c2ccc(C#N)cc2)cc1,,Boldenone undecylenate,
O=C1c2ccccc2N[C@H](c2ccccc2F)N1CCN1CCC(N2C(=O)c3ccccc3N[C@@H]2c2ccccc2F)CC1,,Dimethylaminopropionylphenothiazine,
O=C1c2ccccc2NC(c2ccccc2F)N1CCOc1ccc(-c2nc3ccccc3n2Cc2ccncc2)cc1,,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",
Cc1cc(COc2cc(C(=O)N3CC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)on1,,N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate,
O=C1c2cc(Cl)ccc2NC(c2ccccc2F)N1CCOc1ccc(-c2nc3ccccc3n2Cc2ccncc2)cc1,,Phosphoramidon,
NC(=O)c1cccc(CCN(CC[C@H](N)C(=O)O)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)c1,,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",
N#Cc1ccc(-n2nc(C(=O)N3CCC[C@@H](N)C3)cc2OC[C@H]2CCC(=O)N2)cc1,,N-Methyldehydrobutyrine,
CN1C(=O)[C@H]2CN(S(=O)(=O)c3ccc4occc4c3)C[C@H]2c2cnccc21,,Tariquidar,
NC(=O)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@H](C(N)=O)CSCC(=O)N2,,Eslicarbazepine,
Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)CCCO5)ccc3C)ccc2n1,,Beclomethasone 17-monopropionate,
COCCN(CC(=O)NC(C)C)C(=O)CCCCCn1ccnc1/C=N/O,,NCX 701,
CNC1CCN(C(=O)CN(c2ccc(C#N)cc2)S(=O)(=O)c2ccc(C)cc2)CC1,,"(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",
O=C1C=CCC(/C=C/c2c(C3CC3)nc3ccccc3c2-c2ccc(F)cc2)O1,,PF-03814735,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccccc4)nn3)[C@H]2O)cc1,,Edoxaban,
Cc1ccc2c(c1)C(=O)N(CCOc1ccc(-c3nc4ccccc4n3Cc3ccncc3)cc1)C(c1ccccc1F)N2,,Sulindac,
O=C(CCCCCCC(=O)Nc1ccc(NCCCn2cc(-c3ncnc4[nH]ccc34)cn2)cc1)NO,,AEE-788,
CN(C)[C@H]1CN(Cc2c(F)cc(O)cc2Br)C[C@@H]1c1cn(C)c2ccccc12,,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(F)cc4)nn3)[C@H]2O)cc1,,Methoxamine,
N#Cc1ccc(N(CC(=O)N2CCC(CN)CC2)Cc2cccc(C(N)=O)c2)cc1,,Chlorophetanol,
CCCCNC(=O)c1cn([C@@H]2[C@@H](O)[C@H](SS[C@@H]3O[C@H](CO)[C@H](O)[C@H](n4cc(C(=O)NCCCC)nn4)[C@H]3O)O[C@H](CO)[C@@H]2O)nn1,,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,
C[C@H]1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCN(C)CC4)cc(C(F)(F)F)c3)ccc21,,4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,
N#Cc1ccc(N(CC(=O)N2CCC(N)CC2)Cc2ccc(C#N)c(F)c2)cc1,,Phosphatidyl ethanol,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cnc(C)n3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"(S)-(4-chloro-2-methoxy-3-{[4-(trifluoromethyl)piperidin-1-yl]methyl}quinolin-6-yl)(1,2-dimethyl-1H-imidazol-5-yl)[2-(trifluoromethyl)pyridin-4-yl]methanol",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C)n[nH]4)c(F)c3)nc2cc1OC,,Trypan blue free acid,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)n[nH]4)c(F)c3)nc2cc1OC,,Nandrolone,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)n[nH]4)c(F)c3)nc2cc1OC,,"Adenosine 3',5'-diphosphate",
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)n[nH]4)c(F)c3)cnc2cc1OCCN1CCOCC1,,Vistusertib,
COc1nc2ccc([C@@](O)(c3cc(C)nc(C)c3)c3cnnn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,6-amino-1-methyl-7H-purin-1-ium,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(F)CC1,,Cholecalciferol,
Cn1cncc1[C@@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(OCC(F)(F)F)c(Cl)c2c1,,"US10201546, Example 89b",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC1CCC(F)(F)CC1,,"US10201546, Example 1b",
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC1CCC(F)(F)CC1,,"US10201546, Example 1c",
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC1CCS(=O)(=O)CC1,,"US10201546, Example 2c",
COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,"US10201546, Example 4b",
COc1nc2ccc([C@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,"US10201546, Example 4c",
COc1nc2ccc([C@](O)(c3cncn3C)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,"US10201546, Example 5b",
COc1nc2ccc([C@@](O)(c3cncn3C)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,"US10201546, Example 5c",
COc1nc2ccc([C@](O)(c3cncn3C)C3CCN(S(C)(=O)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,"US10201546, Example 6b",
COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1C1CCOCC1,,"US10201546, Example 7b",
COc1nc2ccc([C@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1C1CCOCC1,,"US10201546, Example 7c",
COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1C,,6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,
COc1nc2ccc([C@](O)(c3sc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C,,D-Serine,
COc1nc2ccc([C@@](O)(c3sc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C,,Beta-D-Glucopyranose Spirohydantoin,
COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CC1,,2-Fluoroadenosine,
COc1nc2ccc([C@@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CCN(CC(F)(F)F)CC1,,Ridaforolimus,
COc1nc2ccc([C@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CCN(CC(F)(F)F)CC1,,BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1(C)COC1,,Olsalazine,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1(C)COC1,,Ademetionine,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCCN1CCOCC1,,Aleplasinin,
Cc1ccc([C@](O)(c2ccc3nc(N4CCC4)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)c(C)n1,,Dexanabinol,
CC(C)Oc1c(Cl)nc2ccc([C@@](O)(c3ccc(Cl)nc3)c3cncn3C)cc2c1Cl,,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC(C)(C)O,,Radiprodil,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC(C)(C)O,,2-Hydroxybenzalpyruvate,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OC1CCN(C)CC1,,Desflurane,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCc1ncccn1,,Penicillamine,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CC1,,Etheno-NAD,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CC1,,"(1,2,6,7-3H)Testosterone",
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OC1CCOCC1,,Trichlormethiazide,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCCS(C)(=O)=O,,Dyclonine,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCc1c(C)noc1C,,Cysteine-S-acetamide,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CC1(F)F,,Azosemide,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCc1nccs1,,"5-Methoxy-N,N-diisopropyltryptamine",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCc1nccs1,,Tinoridine,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OCC1(C)COC1,,Bemegride,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OCC1(C)COC1,,Nicofuranose,
COCCOc1c(OC)nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,Methyl beta-L-fucopyranoside,
COc1nc2ccc([C@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1OC(C)C,,Nigericin,
COc1nc2ccc([C@@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1OC(C)C,,A-98881,
Cc1nc(C)c([C@](O)(c2ccc3nc(N4CCC4)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)s1,,Tocopherylquinone,
COc1nc2ccc([C@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1OC(C)C,,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",
COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1OC(C)C,,Aliskiren,
COc1nc2ccc([C@@](O)(c3sc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OC(C)C,,"2,4-Dihydroxybenzoic Acid",
COc1nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1OCC(F)(F)F,,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,
Cn1cncc1[C@@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(OCC3CC3)c(Cl)c2c1,,Remdesivir,
Cn1cncc1[C@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(OCC3CC3)c(Cl)c2c1,,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,Cyclouridine,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,
Cn1cncc1[C@@](O)(c1ccc(Cl)cc1)c1ccc2nc(N3CCC3)c(OCC(F)(F)F)c(Cl)c2c1,,Aspoxicillin,
Cn1cncc1[C@](O)(c1ccc(Cl)cc1)c1ccc2nc(N3CCC3)c(OCC(F)(F)F)c(Cl)c2c1,,Dasolampanel etibutil,
CCOc1c(OC)nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",
CCOc1c(OC)nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c1Cl,,Thionicotinamide-Adenine-Dinucleotide,
CC(C)Oc1c(N2CCC2)nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,"(2S,5R,6R)-6-({(6S)-6-[(Ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",
CC(C)Oc1c(N2CCC2)nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,L-Octahydroindole-2-carboxylic acid,
CC(C)Oc1c(N2CCC2)nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c1Cl,,Tezacaftor,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OC(C)C,,Pegnivacogin,
COc1nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1OC(C)C,,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,2-Oxobutanoic Acid,
COc1nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,Phenylalanine-N-Sulfonamide,
COc1nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",
COc1nc2ccc([C@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,Tasimelteon,
COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Tiamulin,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Beclomethasone dipropionate,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,Glutathione disulfide,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,ELX-02,
COc1nc2ccc([C@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(F)(F)CC1,,Chlorophyll A,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(F)CC1,,Albendazole oxide,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CC(F)(F)C1,,Velusetrag,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CC(F)C1,,8-Aminotheophylline,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CC(F)C1,,Magnesium orotate,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,GDC-0917,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1C(C)(C)CCCC1(C)C,,Amithiozone,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,Sapropterin,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,CP-271485,
COc1nc2ccc([C@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Spebrutinib,
COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Cupric oxide,
COc1nc2ccc([C@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,Alosetron,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,Chlorphenesin carbamate,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,GS-441524,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol,
COc1nc2ccc([C@](O)(c3cnnn3C)C3CCOCC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,2-phenyl-1H-imidazole-4-carboxylic acid,
COc1nc2ccc([C@@](O)(c3cnnn3C)C3CCOCC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Viminol,
COc1nc2ccc([C@](O)(c3cnnn3C)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Bromocriptine,
COc1nc2ccc([C@](O)(c3cnc(C)n3C)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Gisadenafil,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Alectinib,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Camptothecin,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cnc(C)n3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,MB-07803,
COc1nc2ccc([C@](O)(c3cnnn3C)C3CN(S(C)(=O)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Inecalcitol,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)C3CCOCC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)C3CCOCC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Prednisone acetate,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cnnn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Riluzole,
COc1nc2ccc([C@@](O)(c3cnc(C)n3C)C3CCOCC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Fenoprofen,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC(C)C,,OBP-801,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC(C)C,,Bisphenol Z,
COc1nc2ccc([C@@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CC(C)C,,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,
COc1nc2ccc([C@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CC(C)C,,Oxantel,
COc1nc2ccc([C@@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1C1CCCC1,,Glisoxepide,
COc1nc2ccc([C@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1C1CCCC1,,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C1CCCC1,,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,
Cn1cncc1[C@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(CC(F)(F)F)c(Cl)c2c1,,S-Mercaptocysteine,
Cn1cncc1[C@@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(Cl)c(CC(F)(F)F)c(N3CCC3)c2c1,,TMC-649128,
Cc1ccc([C@](O)(c2ccc3nc(N4CCC4)c(CC(F)(F)F)c(Cl)c3c2)c2cnnn2C)c(C)n1,,N-Acetylalanine,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC(F)(F)F,,Pefloxacin,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CCOCC1,,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CCOCC1,,"1-(4-Cyano-phenyl)-3-[2-(2,6-dichloro-phenyl)-1-imino-ethyl]-thiourea",
COc1nc2ccc([C@](C)(O)c3ccc(C)nc3C)cc2c(Cl)c1OC(C)C,,Loperamide,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCn2nc(C(F)(F)F)nc2C1,,Didox,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCn2c(nnc2C(F)(F)F)C1,,Pradofloxacin,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN(C)CC(F)(F)F,,Gadobenic acid,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN(C)CC(F)(F)F,,Kava,
COc1nc2ccc([C@@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",
Cn1cncc1[C@@](O)(c1ccnc(C(F)(F)F)c1)c1ccc2nc(C3CC3)c(CN3CCC(C(F)(F)F)CC3)c(Cl)c2c1,,"(4r)-2-Methylpentane-2,4-Diol",
Cn1cncc1[C@](O)(c1ccnc(C(F)(F)F)c1)c1ccc2nc(C3CC3)c(CN3CCC(C(F)(F)F)CC3)c(Cl)c2c1,,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,
COc1nc2ccc([C@@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",
COc1nc2ccc([C@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,Vadadustat,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(C#N)c1OCC(F)(F)F,,Adapalene,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(C#N)c1OCC(F)(F)F,,LY-2090314,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1OCC1CC1,,Fructose -6-Phosphate,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1OCC1CC1,,Monoxerutin,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1OCC(F)(F)F,,(R)-minalrestat,
COc1nc2ccc([C@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(C#N)c1OCC1CC1,,"3,5-dibromobiphenyl-4-ol",
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1OCC(F)(F)F,,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,
COc1nc2ccc([C@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,Dioxybenzone,
COc1nc2ccc([C@@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,Octacosanol,
COc1nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,N5-Methylglutamine,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1CC(F)(F)F,,Mometasone,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1CC(F)(F)F,,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",
CCc1nc2ccc([C@@](O)(c3cnnn3C)C3CN(C(C)=O)C3)cc2c(C#N)c1OCC1CC1,,L-thioproline,
CCc1nc2ccc([C@](O)(c3cnnn3C)C3CN(C(C)=O)C3)cc2c(C#N)c1OCC1CC1,,Balaglitazone,
COc1nc2ccc([C@@](O)(c3cnnn3C)C3CN(C(C)=O)C3)cc2c(Cl)c1CC(F)(F)F,,AL5300,
COc1nc2ccc([C@](O)(c3cnnn3C)C3CN(C(C)=O)C3)cc2c(Cl)c1CC(F)(F)F,,1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol,
CCc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(CC)c1CC(F)(F)F,,Heptanamide,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,Chlorobutanol,
CCc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1CC(F)(F)F,,Tildipirosin,
CCc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,Cardarine,
CCc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,Avilamycin,
Cc1ccc([C@@](O)(c2ccc3nc(Cl)c(CC(F)(F)F)c(N4CCC4)c3c2)c2cnnn2C)c(C)n1,,AKN-028,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,LY-294002,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(C#N)c1CC(F)(F)F,,FR117016,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,Oxyphenisatin acetate,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,BOS172722,
COc1nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,WAY-151693,
COc1nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(OC(F)(F)F)cc4)c3)c2cc1OC,,"US9730937, Example 177",
Cc1cc(=O)oc2cc(O)c(O)cc12,,4-Methylesculetin,
CCCCc1nc2cc(S(=O)(=O)NC)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",
CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,,DSSTox_GSID_49066,
C[C@@]12CC[C@@H]3O[C@H](CO)[C@@H](O)C[C@H]3O[C@H]1C[C@H]1O[C@@H](CCO)[C@H](O)C[C@@H]1O2,,Eprotirome,
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,"[Mpa1, D-Tyr(Et)2, L-Tic7]OT",
CC1(C)OC[C@@H](COc2cc3ncc(C#N)c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc2NC(=O)CC2CCSS2)O1,,Edotreotide gallium Ga-68,
O=C(c1ccccc1)c1cccc(/C=c2\[nH]c(=O)/c(=C/c3ccccn3)[nH]c2=O)c1,,Ifetroban,
CCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,Fruquintinib,
CCC1=C(C(C)C)/C(=C/C(C)=C/C=C/C(C)=C/C(=O)O)CCC1,,6-hydroxynorleucine,
NCCOc1c(-c2ccc3c(c2)OCCO3)[nH]c(=O)c2cc(F)ccc12,,Dobesilic acid,
CCOC(=O)/C=C1\C2C3CCC(C3)C2C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Eplivanserin,
N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O,,Trp-Cys-Ser,
Cc1cc2ccnc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c2[nH]c1=O,,compound 33 [PMID: 26230603],
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c3)c2cc1OC,,PCI-27483,
CCCC#CCCCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Trypanothione,
Nc1ncnc2c1nc(NCc1ccc(Cl)cc1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,Propantheline,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccncc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,
Cc1cc(COc2cc(C(=O)N3CCC(CN)CC3)nn2-c2ccc(C#N)cc2)on1,,Acitretin,
CSC1OC(CO)C(O)C(NC(=O)c2ccc3ccccc3c2)C1O,,Oxaprozin,
Cn1ncc2cc([C@@H]3CN(C(=O)[C@H]4CC[C@@H](N)CC4)C[C@H]3c3ccc(C#N)cc3)ccc21,,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",
C[C@@H](O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,
CC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",
N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](Cc2cccs2)NC(=O)CNC1=O,,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Lanraplenib,
CC(=O)Nc1ccc(-c2cc(C(=O)O)c3ccccc3n2)cc1,,298187-85-6,
CC1(C)COC(c2ccc3nc(N)ccc3c2)OC1,,Liothyronine,
O=C(CCCCN1CCN(CC2CC(=O)c3ccoc3C2)CC1)c1ccc(F)cc1,,Metoprine,
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C/c2cccc(I)c2)SC1=S,,"Thiazolidinone core, 22",
C=CCOC(=O)N[C@H]1c2cc(OCOCCOC)ccc2N(C(=O)c2ccc3ccccc3c2)[C@@H](CC(=O)O)[C@@H]1O,,Boldenone,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC1CCCNC1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,Fipamezole,
CCN1C2CCC1C(c1ccc(Cl)cc1)C2,,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,
CC(C)(C)c1cc(NC(=O)Nc2ccc(C(=O)Nc3ccccn3)cc2)no1,,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",
COc1ccc(CN(CC(=O)N2CCC(F)(CN)CC2)c2ccc(C#N)cc2)cc1F,,Azapropazone,
Clc1cccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2cccc(Cl)c2)c1,,N-Methylnaloxonium,
CCCCCCCCCCCCCCCC(=O)NCC(=O)O,,N-Palmitoylglycine,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](NCC(F)(F)F)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,D-Leucine,
CC1(C)C(NC(=O)OCCCc2cnc[nH]2)C1(C)C,,Falnidamol,
NC(=O)CNCC(O)COc1cccc2ccccc12,,"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",
COC(=O)C1CC(c2ccccc2OCc2ccc(Br)cc2)=NO1,,Rimexolone,
CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O,,"(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid",
CCCN(CCc1ccc2ccccc2c1)CC(O)c1cccnc1,,Trabectedin,
NC(=O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Cyclohexanol,
Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c2)cn1,,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,
COc1ccccc1CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O,,(C8-R)-hydantocidin 5'-phosphate,
CC(Sc1nc2ccccc2[nH]1)C(=O)Nc1ccc(S(N)(=O)=O)cc1,,CBKinase1_004031,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)no1,,Phosphomethylphosphonic acid guanylate ester,
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl,,ambenonium,
O=C1CCC(CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1,,Vidarabine,
CNC(=O)c1ccccc1Nc1c(C(F)(F)F)cnc2[nH]c(-c3cccnc3)cc12,,Serotonin,
CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](/C=C(\C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)C1CCCCC1,,beta-Alanine,
O=C(NCc1ccc(-c2ccc(C(=O)O)o2)cc1)c1cccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)c1,,Pegvaliase,
Clc1ccc(CCCCN2CCC(Cc3cnc[nH]3)CC2)cc1,,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Degarelix,
CCNC(=S)NCCCCCc1cnc[nH]1,,"(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE",
O=C(O)CCC/C=C\C[C@@H]1COCO[C@@H]1c1ccccc1,,Hymenialdisine,
O=C(Nc1cccnc1)c1ccn[nH]1,,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,
CC(C)C[C@H](NC(=O)CNC(=O)C(C)(C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Capravirine,
O=[N+]([O-])c1c(Nc2cccc(F)c2)ccc2nonc12,,"N-(3-fluorophenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine",
Cc1cc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)on1,,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,
CSC1=NC(c2ccccc2SC)c2c(coc2O)N1,,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1cccc([N+](=O)[O-])c1,,Deacetoxycephalosporin C,
CC(=O)NCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OCCNC(C)=O,,"US9725465, Example 220",
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,,Desoxycortone,
NS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1,,4-nitrophenylsulfamide,
c1ccc(C(CCc2ncc(CCNCCCc3cnc[nH]3)[nH]2)c2ccccc2)cc1,,Ceftizoxime,
CC1C/C(=N/OCC(O)CNC(C)(C)C)CC(C)(C)C1,,88135-00-6,
COc1ccc(Cc2sc(=O)[nH]c2O)cc1C(=O)NCc1ccc(C(F)(F)F)cc1,,"5-(2,4-Dioxo-thiazolidin-5-ylmethyl)-2-methoxy-N-(4-trifluoromethyl-benzyl)-benzamide(KRP297)",
C=CCC1/C=C(\C)CCOC(=O)OC(=O)CCCCC(=O)C(=O)OC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc2cccnc2)[C@H](C)CCC1=O,,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",
O=C(O)c1cc(Br)cc2c(=O)cc(-c3cccc(OCc4ccc5ccc(Cl)cc5n4)c3)oc12,,PX-478,
CNCc1ccccc1Sc1cccc2ccccc12,,IFN alpha-IFNAR-IN-1,
COc1ccc(CC2SC(=S)NC2=O)c(OC)c1,,Presatovir,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](CC(C(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(N)=O,,Linsitinib,
NC(=O)C[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Pyrazolanthrone,
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,"[Mpa1, D-Tyr(Et)2, Gly(But)7]OT",
N#Cc1ccc(-c2ccc(C(=O)O)cc2)cc1,,5728-46-1,
CC[C@H]1C[C@@H]2CN3CCc4c([nH]c5ccc(OC)cc45)[C@](C(=O)OC)(C2)[C@H]13,,Voacangine,
Cc1ccc(-c2ccc(C#Cc3cccc(C#Cc4ccc(-c5ccc(C)cc5)cc4)[n+]3C)cc2)cc1,,Isoformononetin,
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@@H](O)[C@@H](OC)C[C@@H](C)CC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](/C(C)=C/[C@@H]2CC[C@@H](O)[C@H](OC)C2)[C@H](C)[C@@H](O)CC1=O,,Motuporin,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCCNC(C)=O,,"US9725465, Example 237",
O=C(N[C@@H]1C2CCN(CC2)C1Cc1cccnc1)c1ccccc1,,Vitamin B6 Complexed with 2-Amino-Hexanoic Acid,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2cccc(C(=O)O)c12,,Verdiperstat,
c1ccc(C2CC(c3ccccc3)n3nnnc3N2)cc1,,Succinimide,
NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,"d[Cha4,Dap8]VP",
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccccc1OC(C)C,,Penicillin G Acyl-Serine,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccc(C)cc4)c3)c2cc1OC,,1-{3-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy]phenyl}-3-[1-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea,
CC1CCC(Nc2nc3ccccc3[nH]2)c2ccccc21,,Iscotrizinol,
Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1,,NVP-QAV680,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1CCCCC1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE",
O=C(Nc1cc([N+](=O)[O-])ccc1N1CCOCC1)c1ccccc1Cl,,Alfacalcidol,
CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)(C)C,,1-Deoxy-Ribofuranose-5'-Phosphate,
CC(C)(C)c1ccc([C@H](O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,,(R)-(+)-Terfenadine,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(Cl)c4)nn3)[C@H]2O)cc1,,Loteprednol,
CC(=O)Nc1ccc(Cl)cn1,,N-(5-chloropyridin-2-yl)acetamide,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC1CC1,,Alizapride,
O=c1[nH]nnc2sc3c(c12)CCCC3,,38359-86-3,
N#C[C@H](COCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccncc1,,alpha-N-Acetyl-D-galactosamine,
O=NC1CCc2cc(-c3[nH]c(CN4CCOCC4)nc3-c3ccncc3)ccc21,,"imidazole-based compound, 7",
COCCC/C=C/Cc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,17alpha-Estriol,
CC(O)c1ccc(OCCCc2cnc[nH]2)cc1,,SB-1578,
O=C(Cc1ccc(-c2cccs2)cc1)Nc1cc(C2CC2)n[nH]1,,N-(3-Cyclopropyl-1h-Pyrazol-5-Yl)-2-[4-(Thiophen-2-Yl)phenyl]acetamide,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Islatravir,
CN(C)c1ccc(NC(=O)Nc2ccnc3c(F)ccc(F)c23)cc1,,SB-410220,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cncc(F)c4)c3)c2cc1OC,,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,,ELPPEERLLRAIFGEK,
Fc1ccccc1CNC(=S)N1CCC(c2cnc[nH]2)CC1,,L-2-amino-3-butynoic acid,
NC(CO)C(=O)[C@@H]([NH3+])C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1,,3-Phosphono-D-alanine,
Cn1cncc1[C@@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(CC(F)(F)F)c(Cl)c2c1,,Cyclothiazide,
COc1ccc(CCNCC(O)COc2ccc(-c3nccs3)cc2)cc1OC,,Berzosertib,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cccc23)n[nH]1,,Oxacillin,
CN(C)c1cccc(NC(=O)CN2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Pexacerfont,
CC1Nc2ccn3ncc(c3n2)C(=O)NCCOc2ccc(F)c(Cl)c21,,VX-659,
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C,,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,
COc1ccc2cc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)cc3)cnc2c1,,"US9725465, Example 2",
Cc1[nH]nc2c1C(c1ccc(Cl)cc1)C1=C(CC(C)(C)CC1=O)N2,,370588-24-2,
C/C(=N\OC[C@H](O)CNC(C)(C)C)C1CC1,,"Falintolol, (R,Z)-",
NC(=O)COc1ccc(C=C2C(=O)NC(=S)NC2=O)cc1,,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O,,beta-D-galactose,
CC(C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)C2(CCS(=O)(=O)CC2)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC1=O,,Bimosiamose,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CC(F)(F)C1,,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,
N=C(NCC=C(c1ccc(F)cc1)c1ccccn1)NCCCc1cnc[nH]1,,Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,
CCOc1ccc(C[C@@H](NC(=O)CC23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)cc1,,Zinc glycinate citrate,
CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2c(=O)c3cc(-c4cnn(C)c4)cnc3ccc2c1,,Gadopentetic acid,
O=C(C[C@@H]1C/C=C/CCC(=O)OCCNC1=O)NCc1ccc(Cl)cc1,,Lactaldehyde,
O=C(c1ccc(OCc2ccc(CN3CCCCC3)cc2)cc1)C1CCCC1,,"3,6-dihydroxy-xanthene-9-propionic acid",
NC(=O)c1ccc(-n2cccc2-c2cccnc2)cc1NC1CCC(O)CC1,,Ansofaxine,
O=C(O)Cn1cnc2c(Oc3ccc(F)cc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,
C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O,,formestane,
NC1=Nc2ccccc2Sc2cccc(F)c21,,"N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine",
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2Cc3c(cccc3OC(=O)C(C)(C)C)C[C@H]21,,Phosphonotyrosine,
CCOc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCNCC2)c(O)c(N2CCNCC2)c1,,Acadesine,
O=C(OCC1CCCC1)N1CCCC1,,Magnesium citrate,
Cc1ccc(O)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21,,Hidrosmin,
CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,trifluoperazine,
CCOc1ccc(C(C)=O)cc1C(=O)Nc1cccc(C(=O)O)c1,,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",
CC(C)C[C@@H]1CN[C@@H](CC2CCCCC2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,Rotenone,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine,
Cc1noc(NS(=O)(=O)c2ccc(NC(=O)c3ccc4nc(-c5ccco5)c(-c5ccco5)nc4c3)cc2)c1C,,"CypA Inhibitor, 4b",
CC1=CC(=O)OC1C/C=C(\C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(C(=O)O)[C@@H]2[C@@H](O)C[C@@]1(C)O,,Nadide,
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,Edetate copper disodium,
COc1ccc(CC(CNC(=O)c2ccc(-c3ccc(Cl)cc3)cc2)n2ccnc2)cc1,,"Azole, 11",
CN(Cc1cc(Cl)cc(-c2cc(-c3cc(C(F)(F)F)ccc3Cl)c(C#N)c(=O)[nH]2)c1O)C(=O)CCN1CCOCC1,,Glyceryl 1-oleate,
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],,126-44-3,
O=C1N(Cc2c[nH]c3ccccc23)CCCC12CCN(c1cnc3ccccc3c1)CC2,,Anagliptin,
NC(=O)c1cccc2c1C(=O)N(Cc1ccccc1)C2,,4-Fluorotryptophane,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)NCC(N)=O,,Cenicriviroc,
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2nc(Cl)nc3c2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F,,"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",
CC(=O)Nc1ncc(Cc2csc(CCO)c2C)c(N)n1,,Venlafaxine,
COc1cccc(OC)c1NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1,,Ceftobiprole,
COC(=O)[C@H](CCCCNC(C)=O)C1C(=O)CC2C1=CC(=O)CC2(C)C,,"Cyclophilin Inhibitor, 3d",
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC,,Apalutamide,
O=C1c2ccccc2NC(c2ccccn2)N1c1ccc(OCCn2ccnc2)cc1,,Ifenprodil,
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,,hydrocortisone,
CCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1,,Veralipride,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3ncc(C)n3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"US10201546, Example 111",
COCCN1CCC(c2nc(-c3ccncc3)c(-c3ccc4c(c3)CCC4N=O)[nH]2)CC1,,"imidazole-based compound, 6",
O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCN(C/C=N\OCCN2CCOCC2)C[C@H]1Cc1c[nH]c2ccccc12,,Creatinine,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CC#N)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Iroxanadine,
Nc1ccn([C@@H]2O[C@H](CNC(=O)Cc3cn4ccsc4n3)[C@@H](O)[C@H]2O)c(=O)n1,,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(Cc2ccco2)CC1,,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,
Cc1ccc2c(C(=O)O)c(O)c(O)c(C(C)C)c2c1,,Acetylglycinamide chloral hydrate,
CN(C)CCCn1c(-c2c[nH]nc2-c2ccc(C(F)(F)F)cc2)nc2cc(-c3ccc(C(=O)O)cc3)ccc21,,"Benzimidazole Inhibitor, 2",
S=C(NCc1ccccc1Br)N1CCC(c2cnc[nH]2)CC1,,Aracytidine 5'-monophosphate,
Cc1ccccc1CN(C)C(=O)CCCN1c2ccccc2N(Cc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)S1(=O)=O,,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",
C[C@@H]1O[C@H](OC(=O)C(C)(C)C)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12,,Thymine,
c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,,Navoximod,
O=C(Nc1cccc2c1N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N(CCO)C2)OCC1c2ccccc2-c2ccccc21,,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",
CCCOC(c1cc2nccc(C(=O)O)c2[nH]1)c1ccccc1Cl,,NCGC00381656-01,
COc1cc2ccc3c(c2cc1OC)C[C@H](N)[C@@H](c1cc(F)c(F)cc1F)O3,,Biperiden,
Nc1ccncc1,,4-aminopyridine,
O=C([O-])c1ccc(C(=O)Nc2cc(C3CC3)n[nH]2)cc1,,"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",
[N-]=[N+]=Nc1ccc(C[C@@H]2NC(=O)[C@@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC2=O)cc1,,4-(Acetylamino)-3-Amino Benzoic Acid,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)[C@@H](C)O,,1-Methylhistidine,
O=C(COc1cc(Cl)c(Cl)cc1Cl)N1CCOCC1,,"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",
O=C1N(Cc2cccc3ccccc23)CCCC12CCN(c1cnc3ccccc3n1)CC2,,Gemcitabine,
Cn1cc(C(N)=O)c2ccccc21,,1-methyl-1H-indole-3-carboxamide,
CCOC1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,
CN1CCN(C(=O)CN(C)S(=O)(=O)c2ccc3ccccc3c2)CC1,,CBKinase1_007101,
NCCOc1c(-c2ccc(Br)cc2)[nH]c(=O)c2c(F)c(F)ccc12,,Diethylstilbestrol,
Oc1ccc2c(c1)CCc1c[nH]nc1-2,,Hydroxybenzindazole,
O=C(Cn1c(-c2cscn2)nc2ccccc21)Nc1ccc(Cl)cc1,,(4-ETHYLPHENYL)SULFAMIC ACID,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,Carumonam,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGHFGGLYACNGP,
CN1C[C@H](C(=O)N2CCN(c3ccc(Cl)cc3)CC2)C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]21,,Glucosamine 6-Phosphate,
NCCOc1c(-c2ccc3c(c2)OCO3)[nH]c(=O)c2cc(F)ccc12,,HX-1171,
Cc1ccc2cc1-c1cc(nc(N)n1)Sc1cccc(c1)OCCCO2,,5-phospho-D-arabinohydroxamic acid,
COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCCCCCCCN)nc4ccccc4n3c2=O)cc1,,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",
CC(C)CC(CC(=O)OCC1(CO)C/C(=C\c2ccc(C(=O)O)cc2)C(=O)O1)CC(C)C,,Levomethadone,
O=C(CSc1ccc(Cl)cc1)N1CCOCC1,,2-((4-chlorophenyl)thio)-1-morpholinoethan-1-one,
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,,"(2S)-2-({4-[(2S)-1-(2-Amino-4-oxo-1,4-dihydro-6-quinazolinyl)-3-{[2-({(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydro-2-furanyl}amino)-2-oxoethyl]amino}-2-hydroxy-2-propanyl]benzoyl}ami no)pentanedioic acid",
COc1ccc(NC(=O)NCCCOc2cccc(CN3CCCCC3)c2)c(OC)c1,,Anamorelin,
NC(=O)c1cc[n+](CCC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],,Flaviolin,
NCc1cnc[nH]1,,(1H-IMIDAZOL-4-YL)METHANAMINE,
COc1cccc(COc2ccc3nc4ccc(=O)cc-4oc3c2)c1,,3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN,
COc1nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1OC(C)C,,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,
C[C@]12CC[C@@H]3c4cc(I)c(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,,2-Iodoestradiol,
CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)O,,DVEEM,
NC(=O)c1cncc([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3OC(n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1,,6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,
CC(C)c1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,4-Methylthio-Alpha-D-Mannose,
COCCOc1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)ccc1C(F)(F)F,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(3-(2-methoxyethoxy)-4-(trifluoromethyl)phenyl)urea",
NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O,,Tolperisone,
Cn1ncc(-c2nn(C)c3ncnc(N4CCC4)c23)c1-c1ccc(C(F)(F)F)cc1,,1415637-72-7,
COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3SC4)CC2)cc1,,"1-(4-METHOXYPHENYL)-4-{4H-THIENO[3,2-C]THIOCHROMENE-2-CARBONYL}PIPERAZINE",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,Cathinone,
NC(=O)c1cccc2c1C(=O)N(C1CCN([C@H]3CC[C@@H](CO)CC3)CC1)C2,,Methylumbelliferyl sialic acid,
CC(C)(CO)NCc1cc(Br)ccc1OCc1ccccc1,,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1c(F)c(F)c(F)c(F)c1F)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,GET-73,
CCCn1c(=O)c2[nH]c(-c3cc(OCC(=O)Nc4ccc5c(c4)OCO5)nn3C)nc2n(CCC)c1=O,,MRE 2029F20,
Nc1nc2[nH]c(SCC(=O)c3ccc(Br)cc3)nc2c(=O)[nH]1,,Iproclozide,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3ccc(C(C)(F)F)cc3N2C)c1=O,,Flurandrenolide acetate,
Cc1nc(C)c(-c2ccnc(Nc3ccc(Cl)cc3)n2)s1,,2-Anilino-4-(thiazol-5-yl)pyrimidine deriv. 14,
COc1c(C(C)=O)c(OCCCCOc2c(C(C)=O)c(OC)c3ccoc3c2OC)c(OC)c2occc12,,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,
Cc1c(CCO)sc[n+]1Cc1cccnc1N,,Aminoglutethimide,
O=C(OCC(C1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1,,Belotecan,
CC(CCc1ccc(F)cc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1,,Thymidine-5'-(dithio)phosphate,
COc1nc2ccc(C(O)c3cnc(C)n3C)cc2c(Cl)c1OC(C)C,,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@]1(C)CCC/C=C\CCC[C@@](C)(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)O,,Mitomycin,
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C,,BzT-7,
CCC(CC)=NOCC(O)CNC(C)C,,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,
Cc1cc(C#Cc2ccccc2/C=N/N2CCOC2=O)nc(N)n1,,"2-Amino-4h-1,3-Benzoxathiin-4-Ol",
Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccccc4S(=O)(=O)[O-])n3)c(S(=O)(=O)[O-])c2)c2c1C(=O)c1ccccc1C2=O,,Cefdinir,
CS(=O)(=O)N1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CCC(F)(F)CC4)C3)C2)CC1,,"(S)-propane-1,2-diol",
Cc1ccc([C@@](O)(c2ccc3nc(N4CCC4)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)c(C)n1,,Leukotriene D4,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(/C=C/c2ccccn2)cc1,,Biphenylalanine,
OC(CNC1CC1)COc1ccc(-c2ncc(C(F)(F)F)[nH]2)cc1,,Metenolone,
C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)C[C@H](CCCCCCN)[C@@]43C)[C@@H]1CC[C@@H]2O,,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)F)no4)ccc3F)c2cc1OC,,"5-methyl-6-phenylquinazoline-2,4-diamine",
COc1ccc(NC(=O)CCN2CCC(Cc3cnc[nH]3)CC2)cc1,,Ceramide NP,
CSc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1SC,,Aluminium acetotartrate,
CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2,,tropisetron,
CC(=O)c1cccc2[nH]ccc12,,1-(1H-Indol-4-yl)ethanone,
C[NH+](C)CCNS(=O)(=O)c1ccc(N=CC2C(=O)Nc3ccccc32)cc1,,S-Acetyl-Cysteine,
O=C(NP(=O)(Cl)Cl)c1ccc(Cl)cc1,,"Carbacylamidophosphate, 1a",
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,,diclofenac,
O=C(O)COc1cccc(CC2C3CCC(O3)C2C=NNC(=O)Nc2ccccc2)c1,,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenethyl)guanidine",
CC(=O)NCCCCNc1ccc(C(=O)OCC[NH+](C)C)cc1,,VS-5584,
COc1ccc(-c2cc(C(=O)O)nn2C2CCCCC2)cc1,,"7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole",
CC(C)C[C@@H]1NC(=O)[C@@H]2CNC(=O)C[C@H](NC(=O)[C@H](C)CNC1=O)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2,,4-hydroxybutan-2-one,
O=c1[nH]c(O)c(-c2ccccc2)[nH]1,,2-amino-8-methyl-4(1H)-quinazolinone,
C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1,,Technetium Tc-99m oxidronate,
CCOc1c(OC)nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c1Cl,,Testolactone,
Cc1sc(CN2CCNCC2)cc1C(=O)NCC12CC3CC(CC(C3)C1)C2,,Levoleucovorin,
CSC1=NC(c2cc([N+](=O)[O-])ccc2SC)C2=C(COC2=[OH+])[N-]1,,HE-2200,
CCCS(=O)(=O)Nc1cc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c(F)c1,,Skf 107457,
Clc1ccc(C2CC3CCC2N3)cc1,,Niludipine,
COC(=O)[C@H](CCCC[NH3+])NC(=O)[C@]1(C)NC(=O)c2nc(oc2C)[C@](C)(C(=O)NC2c3ccccc3-c3ccccc32)NC(=O)c2nc(oc2C)[C@](C)(C(=O)NCC2CCCCC2)NC(=O)c2nc1oc2C,,galmic,
CCN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)CC1,,4-Amino Hexanoic Acid,
C/C=C1\O[C@@H]2CC(=O)N2[C@H]1C(=O)[O-],,Trifluperidol,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(C5CCCC5)c5cc(F)ccc54)CC3)CC2)ccn1,,Pivhydrazine,
COc1ccc(/C=C2\SC(=S)N(CCN)C2=O)cc1OC,,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",
Cc1cc(C)c(S(=O)(=O)NCc2ccccn2)cc1C,,433975-62-3,
CSc1ccc(Nc2nc3cc(C(N)=O)ccc3n2Cc2ccccc2C(F)(F)F)cc1,,1092829-83-8,
CC(O)C(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Metenkefalin,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(F)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,,2-deoxy-2-fluoro-α-D-glucose,
O=C(Nc1cccc(Br)n1)[C@@H]1SCCN1C(=O)Cn1ncc2ccccc21,,Isoliquiritigenin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(=O)N5CCOCC5)cc(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 149",
Cc1cccc(C)c1CN1CCC[C@@H](NC(=O)N2CCc3[nH]nc(-c4ccncc4)c3C2)C1,,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",
C/C=C/[C@H](O)C(C)(C)[C@@H]1CCC[C@H]2O[C@H]2CC[C@@H]2O[C@@H]2c2nc(co2)C(=O)O[C@H](C(C)(C)[C@@H](O)/C=C/C)C/C=C\C(C)=C/C=C/[C@H](OC)Cc2nc(co2)C(=O)O1,,Disorazole A,
CCCCc1nc2cc(N)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Phenylpropanolamine,
CC(C)C[C@H](NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Rogaratinib,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)cc1,,Manidipine,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",
Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1,,"3,5-Diiodotyrosine",
COc1ccccc1CN(C)CCCCCCN(C)CCCCCCCCN(C)CCCCCCN(C)Cc1ccccc1OC,,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",
CCCCCN(C(=O)OC(C)(C)C)c1nc(NCc2ccccc2)c2ncn(CC(=O)O)c2n1,,Penthienate,
Cc1cc(OCC(=O)O)cc(C)c1C(CCCO)c1ccc(O)c(C(C)C)c1,,Aminosalicylic acid,
NCCN1C(=O)/C(=C/C=C/c2ccccc2)SC1=S,,Rotigotine,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,Nitroxoline,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)C3CCNCC3)cc2)no1,,Rosoxacin,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CO)C(N)=O,,N-Bromoacetyl-Aminoethyl Phosphate,
NC(=O)c1ccc(-n2cccc2Cc2cccnc2)cc1NC1CCC(O)CC1,,Firocoxib,
O=C(CCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO,,1-Amino-1-Carbonyl Pentane,
C=C/C(C)=C/[C@@]1(C)SC(=O)CC1=O,,7-methyl-5'-guanylic acid,
Cc1ccc2c(ccn2CCC(=O)N2CCC(NC(=O)[C@@H](CC(=O)O)Cc3ccc(CP(=O)(O)O)cc3)(C(=O)N[C@@H](CC(N)=O)C(=O)NCCCc3ccc4ccccc4c3)CC2)c1,,Candesartan cilexetil,
CCCNC(=S)NCCCCc1cnc[nH]1,,Glucoraphanin,
CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)Nc1cccc2c1N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N(CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C2,,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3C)c2cc1OC,,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",
COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC,,Ambenonium,
CC(=O)N[C@]1(C)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O,,Di-Stearoyl-3-Sn-Phosphatidylcholine,
CCCn1c(=O)c2[nH]c(C3CCC(OC(=O)c4cccc(S(=O)(=O)F)c4)C3)nc2n(CCC)c1=O,,PF-04457845,
CCn1c(=Cc2scc[n+]2Cc2ccc(CNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@H]34)cc2)sc(=C2Sc3cccc(F)c3N2C)c1=O,,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,
O=C(O)C/C(=C/c1cccc(C(F)(F)F)c1)c1nc2ccccc2o1,,1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2F)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)CNC3=O,,Molsidomine,
O=C(O)COc1cc(F)ccc1C(=O)Nc1ccccc1,,Tenofovir exalidex,
CCCCc1nc2cc(S(=O)(=O)NC3CCCCC3)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Manganese citrate,
Cc1nc(C)c(-c2ccnc(Nc3ccc(F)cc3)n2)s1,,"[4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-fluoro-phenyl)-amine",
CCNC(=O)C1OC(n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)COc4ccc([CH+]/C=c5\ccc6n5[B-](F)(F)n5c(ccc5-c5cccs5)C=6)cc4)ncnc32)C(O)C1O,,5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(N)=O)C(C)C,,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",
Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,Marimastat,
CCCOC(C)(C)c1cc(NC(=O)Nc2cccc(Sc3ncnc4cc(OC)c(OC)cc34)c2)n(-c2ccccc2)n1,,Abiraterone,
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)NCCN(C)C,,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",
CC(C)C[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H]1CC[C@H](CNC(=O)c2cc(N=C=S)ccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)CC1)C(=O)N[C@@H](CO)C(N)=O,,Bamifylline,
CN(Cc1cc(Cl)cc(-c2cc(-c3cc(C(F)(F)F)ccc3Cl)c(C#N)c(=O)[nH]2)c1O)C(=O)C1CCNCC1,,Rebastinib,
CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](C(=O)N[C@H]1CCC(=O)NC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](c2cccnc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)c1cccnc1,,Diodone,
Cc1cc2nc3c(=O)n(CC(=O)NCCCN)c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C,,4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,
CCc1[nH]nc2c1C(c1ccccc1OC)C1=C(CC(C)(C)CC1=O)N2,,Losartan,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C,,riboflavin,
Nc1sc(-c2ccccc2)cc1C(=O)c1ccccc1,,Vatiquinone,
CC(C)(C)C#Cc1ccccc1-c1ccc2nc(N)ccc2c1,,Bropirimine,
COc1nc2ccc([C@](O)(c3cnc(C)n3C)C3CCOCC3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,N-omega-nitro-L-arginine methyl ester,
Cc1ncc([C@](O)(c2ccc3nc(N4CCC4)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)n1C,,MK-2748,
[N-]=[N+]=Nc1cc(Cl)cc2c1Oc1cc(Cl)c(Cl)cc1O2,,"Photoaffinity ligand, 1",
Oc1cccc(CNc2ccc3ccccc3n2)c1,,"(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCOCC1,,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,
CC(C)C[C@H]1NC(=O)CCNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CC(=O)N(N)C[C@]23C[C@H]4C[C@H](C[C@H](C4)C2)C3)NC1=O,,Hydronidone,
C=C/C(C)=C/C[C@]1(C)[C@H](C)[C@@H](OC(=O)CCC)[C@H](O)[C@@]23C(=C[C@H](OC)C[C@@H]12)[C@@H](OC(=O)CCC)O[C@H]3OC(C)=O,,Lysergic acid diethylamide,
CNc1c(C(N)=O)c2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,Glycerin,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CC5)no4)c3)c2cc1OC,,Sonidegib,
COCCOc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)nc2cc1OC,,"US9725465, Example 159",
O=C(O)C1C2CC=CC2c2cc(Br)cc3c2N1CC1CC=CC31,,"2,3-Anhydro-quinic acid",
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@]4(C)O[C@]34[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Furoyl-Leucine,
C=CCOC(=O)N[C@H]1c2cc(OCOCCOC)ccc2N(C(=O)c2ccc(-c3ccccc3)cc2)[C@@H](CC(=O)O)[C@@H]1O,,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)no4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(3-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-5-yl)urea",
CCCCN(CC(=O)NC(C)C)C(=O)CCCCCn1ccnc1/C=N/O,,"2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate",
OC[C@H]1O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cc(F)c(F)c(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cc(F)c(F)c(F)c3)nn2)[C@H]1O,,Mefruside,
Cc1ccc(NC(=O)NCCCOc2cccc(CN3CCCCC3)c2)cc1,,1-hydroperoxy-L-tryptophan,
Nc1nccc2ccccc12,,Isoquinolin-1-amine,
COc1nc2ccc(C(O)(c3sc(C)nc3C)c3cnnn3C)cc2c(Cl)c1Cc1ccc(C(F)(F)F)cc1,,PPI-2458,
O=C(O)CSc1nc2ccccc2n1CCOc1ccccc1,,314047-65-9,
c1ccc(C(CCc2ncc(CCNCCCCCc3ccccn3)[nH]2)c2ccccc2)cc1,,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,
C=CCN1CCC[C@](C(=O)OCC)(c2cccc(O)c2)C1,,4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,
O=C1ON=C(c2ccc(O)cc2)/C1=C/c1ccc(N2CCCC2)cc1,,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",
NS(=O)(=O)Nc1ccccc1,,phenylsulfamide,
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)ccc3F)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluorophenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1cccc(Cl)c1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Coenzyme A persulfide,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,DSM-265,
COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)cnc2cc1OCCN1CCOCC1,,"US9725465, Example 197",
O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,,Ketanserin,
O=c1[nH]c2ccc(Nc3ccc([N+](=O)[O-])cc3Cl)cc2[nH]1,,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,
c1ccc2c(c1)CCCC2Nc1nc2ccccc2[nH]1,,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,
NC(=O)c1cccc2c1C(=O)N(C1CCN(Cc3ccsc3)CC1)C2,,1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide,
CC1(C)O[C@H]2[C@@H]3OCO[C@@H]3CO[C@@]2(COS(N)(=O)=O)O1,,Tetraiodothyroacetic acid,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(CCCC(F)(F)F)c5ccccc54)CC3)CC2)ccn1,,Olcegepant,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,Cebranopadol,
Cc1ccc(OCC(=O)N2CCOCC2)cc1C,,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCCN(C)C,,N-Succinyl Methionine,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1(C)N=N1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)O,,FITC-Photo 3,
N=CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,,Taurolidine,
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O,,estriol,
CC(=O)N[C@@H]1[C@@H](O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@@H](CO)O[C@@H](OCC[Si](C)(C)C)[C@@H]3O)[C@@H]2O)(C(=O)[O-])O[C@H]1[C@@H](O)[C@H](O)CNC(=O)c1ccccc1,,Cycloserine,
c1ccc2[nH]c(NC3CCCc4sccc43)nc2c1,,"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",
C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(=O)NCCNC(=O)CBr)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,,"3,5-Diaminophthalhydrazide",
Oc1cccc2ncccc12,,5-HYDROXYQUINOLINE,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(Cl)c4)c3)c2cc1OC,,Ondansetron,
O=C(Nc1ccc(Cl)nc1)c1ccc(F)cc1,,ZTZ240,
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)O,,Alisertib,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C#N)cc4)c3)c2cc1OC,,Desaspidin,
O=C(O)c1ccnc2cc([C@H](OCCN3CCCCC3)c3ccccc3Cl)[nH]c12,,Epitestosterone,
CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1,,PHT-427,
CC1(C)CC(=O)C2=C(C1)Nc1n[nH]c(C(F)(F)F)c1C2c1ccccc1C(F)(F)F,,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",
C=C/C(C)=C/[C@@]1(C)SC(=O)C(C(=O)c2ccccc2C(=O)O)C1=O,,CRS-3123,
Cc1cc2c(cc1Oc1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C,,Phenoxymethylpenicillin,
O=C(C[C@H]1C/C=C/CCC(=O)O[C@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,"2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",
CCCn1c(=O)c2[nH]c(CCCNC(=O)c3ccc(S(=O)(=O)F)cc3)nc2n(CCC)c1=O,,5beta-dihydrotestosterone,
N#CCc1cccc(-c2ccc(O)cc2)c1,,"2,5-Dideoxy-2,5-Imino-D-Glucitol",
COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCOCCOCCNC(=O)CCCCCNC(=O)COc4ccc([CH+]/C=c5/ccc6n5[B-](F)(F)n5c(ccc5-c5cccs5)C=6)cc4)nc4ccccc4n3c2=O)cc1,,Ketodarolutamide,
CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21,,DEVAZEPIDE,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(O[C@H]2CCCNC2)ccc1Cl,,GLPG-0492,
O=c1[nH]c(=O)c2[nH]c(=O)n(C[C@@H](O)[C@H](O)[C@H](O)CO[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)c2[nH]1,,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",
CNC(=O)O[C@H]1/C(C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)Cc2c(O)c(cc(O)c2N=CCN(C)C)NC(=O)C(C)=CC=C[C@@H]1OC,,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,
OC(c1cccnc1)(c1cccc(Cl)c1)c1ccc2nc(Cl)c(C3CCCCC3)c(Cl)c2c1,,Arbaclofen,
Cc1cccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)c1,,Carboxymycobactin S,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(NC(=O)C(=O)O)cc2)NC(=O)Cc2ccccc2)cc1,,Prednicarbate,
CONC(=O)O[C@H]1/C(C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)Cc2c(O)c(cc(O)c2N=CCN(C)C)NC(=O)C(C)=CC=C[C@@H]1OC,,(2Z)-2-(Benzoylamino)-3-[4-(2-bromophenoxy)phenyl]acrylic acid,
N=C(NCCCc1cnc[nH]1)NCCC(Cc1ccccc1)c1ccc(F)cc1,,Hydrocortisone cypionate,
O[C@@H](CNC1CC1)COc1ccc(-c2ncc(C(F)(F)F)[nH]2)cc1,,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",
CC(C)c1csc(/C=C/c2cccc(NC(=O)Cc3ccccc3C(=O)O)c2)n1,,Levetiracetam,
NCc1cc(=O)[nH]o1,,muscimol,
N#CN=C(NCCCCNC(=O)c1ccc(C(=O)O)c(C2c3ccc(O)cc3OC3=CC(=O)C=CC32)c1)NCCCOc1cccc(CN2CCCCC2)c1,,Ginsenoside Rg1,
COc1ccc(CN(CCN(C)CCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)c2ccccn2)cc1,,Broxyquinoline,
O=C(O)Cc1ccccc1S(=O)(=O)c1ccc(-c2ccc(NC(=O)CF)cc2)cc1,,Acetrizoic acid,
CCc1ccc(S(N)(=O)=O)cc1,,4-Ethylbenzenesulfonamide,
O=C([O-])CCc1c[nH]c2ccccc12,,3-(1H-indol-3-yl)propanoate,
O=C1c2cc(-c3cccnc3)c(Cl)cc2CN1c1cccc(-c2nncn2C2CC2)n1,,Butalamine,
CCCCCC/C=C/c1ccc(C(=O)[O-])cc1,,"benzoic acid derivative, 7",
COc1ccc(NC(=O)CSc2nc(-c3ccc(Cl)cc3)c(C#N)c(=O)[nH]2)cc1Cl,,Theobromine,
CC1CCc2cc(F)ccc2N1C(=O)c1ccc(O)cc1O,,N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,
Oc1ccc2c(c1)nc(-c1ccc(Cl)c(Cl)c1)n2-c1ccnc(NC2CCCCC2)c1,,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,
O=C(Nc1ccc(OCC(=O)N2CCOCC2)cc1)c1ccccc1Cl,,Difluprednate,
CC(C)C[C@H](NC(=O)CN1CCCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O,,Macelignan,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N1CC=C[C@H]1C(N)=O,,Nd1-Phosphonohistidine,
c1ccc2c(c1)CCC[C@H]2Nc1nc2ccccc2[nH]1,,NS-8593,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2ccc(C(=O)O)cc12,,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c3)c2cc1OC,,"US9730937, Example 378",
COc1ccc([C@@H]2CN(C(=O)C[C@H]3CC[C@@H](N)CC3)C[C@H]2c2ccc(C#N)cc2)cn1,,5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,
C=CCO/N=C1\[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@@H]1OC,,Phensuximide,
CC1(C)CC(=O)Nc2ccc(C#Cc3ccc(C(=O)O)cc3)cc21,,Laevulinic Acid,
c1ccc2c(c1)CCC[C@@H]2Nc1nc2ccccc2[nH]1,,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1O[C@H]1CCN(C)C1,,Guanosine 3'-monophosphate,
COc1nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1OCC(F)(F)F,,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,
O=C(O)c1cc(-c2ccc(CNS(=O)(=O)c3ccc(OC(F)(F)F)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Epetraborole,
COC(=O)c1c(NC(=O)Cc2sc(N)nc2O)sc(C)c1C,,Porfiromycin,
COc1cc2nc(N3CCCC3)nc(NCCCCCN3CCCC3)c2cc1OC,,UNC0379,
CCOC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O,,Acetyleneurea,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,,Fosamprenavir,
Cc1ccc(OCC(O)CNC(C)C)cc1,,5790-46-5,
COc1cc2ncnc(Oc3ccc(F)c(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c3)c2cc1OC,,Cordycepin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC1CCN(C)C1,,Efrotomycin,
CN(C(=O)CCc1cc2ccccc2nc1N)C1CCCCC1,,Naltrexone,
CCc1nc2ccc(C(O)(c3cnnn3C)C3CN(C(C)=O)C3)cc2c(Cl)c1OCC1CC1,,N-(5'-Phosphopyridoxyl)-D-Alanine,
CN(C)C1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)C1,,Roxatidine acetate,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](N)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,Agerafenib,
NCCN1CCC(Cc2ccccc2)CC1,,2-(4-benzylpiperidin-1-yl)ethanamine,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@H](CCC[N+](C)(C)C)[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,
C=C1C[C@H](O)[C@H]2[C@](C)(C=O)CCC[C@]2(C)[C@H]1CC/C(C)=C/[C@H](O)[C@H]1OC(=O)C=C1C,,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C(F)(F)F)cn4)CC3)CN(C)[C@@H]1C2,,"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide",
CC(C)N1CCC(Oc2ccc(CN3CCCCC3)cc2)CC1,,Selitrectinib,
Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1,,CCT251236,
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,,camptothecin,
Nc1ccc(C[C@H](NC(=O)CNC(=O)CNC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),
NC(=O)c1nn(CC(=O)N2[C@H](C(=O)Nc3cccc(Br)n3)C[C@H]3C[C@H]32)c2ncccc12,,CHS-828,
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,MK-0731,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O,,QRFCTGHFGGLYPCN,
O=C(O)CC1c2ccccc2CCN1C(=O)Nc1cccc(F)c1,,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O,,3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid,
O=C(N[C@H]1CN2CCC1CC2)c1ccc(Cl)cc1,,711085-63-1,
CNS(=O)(=O)c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12,,"2,5-dibenzyloxy-3-hydroxy-hexanedioic acid bis-[(2-hydroxy-indan-1-yl)-amide]",
COc1nc2ccc(C(O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CC1,,5-Hydroxymethyl-Chonduritol,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(NC2CCCNC2)ccc1Cl,,Indecainide,
CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3nccc4ccccc34)cc2)no1,,Methsuximide,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCC(n4c(=O)[nH]c5ccccc54)CC3)CN(C)[C@@H]1C2,,Dezocine,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,Phenylboronic acid,
Cc1ccccc1-c1ccc(C(=O)O)cc1,,5748-43-6,
O=C(OCC(CC1CCNCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,
CCN1Cc2ccc(NC(=O)c3ccc(C(=O)N4CCC(C5CCCN5)CC4)cc3)cc2C1,,RAF-265,
CCc1nc(NCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2cc(OC)ccc2n1,,Ioversol,
Cc1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccccc4F)nn3)[C@H]2O)cc1,,Cerdulatinib,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(O)CC5)C4)cc3)nn3cccc23)n[nH]1,,(S)-Aspartimide,
CNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C1CCCCC1,,"proline scaffold, 29",
Cn1c(N2CCC3(CCCN(Cc4ccccc4)C3=O)CC2)nc2ccccc21,,RO-6870810,
O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,Z-Ala Prolinal,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)O)cc1,,Vitamin B6 Complexed with 2-Amino-Pentanoic Acid,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(=O)N1CC(F)(F)C1,,"US10201546, Example 153",
CC(C)(C)OC(=O)N1CCC(C(COc2ccc(-c3nc4ccccc4n3Cc3ccccc3)cc2)n2c(-c3ccccc3)nc3ccccc32)CC1,,1440754-07-3,
CC(C)(C)C(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Olorinab,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Apixaban,
Nc1ccc2cc(-c3ccccc3C(F)(F)F)ccc2n1,,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",
NS(=O)(=O)c1ccc(Nc2nncc3c(-c4ccc(O)cc4)cccc23)cc1,,Posiphen,
Cc1c(Cc2cnc(-c3ccccc3)nc2N)csc1CCO,,"(2S,3S)-2-azanyl-3-methyl-pentanedioic acid",
CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,,quinacrine,
CN(C)C(=O)Nc1ccc(CN2CCC(C(O)(c3ccc(C(F)(F)F)cc3)c3ccc(C(F)(F)F)cc3)CC2)cc1,,DCG066,
NC(=O)c1ccc(S(N)(=O)=O)cc1,,4-sulfamoylbenzamide,
CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,,Cobimetinib,
COc1ccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c(F)c1,,Lisdexamfetamine,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nc(C(N)=O)n2C,,"2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM",
NS(=O)(=O)c1ccc(CCO)cc1,,4-(2-hydroxyethyl)benzenesulfonamide,
CC(=O)n1cc(CN2CCC[C@@H](NC(=O)N3CCc4[nH]nc(-c5ccncc5)c4C3)C2)c2ccccc21,,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,
CS[C@@H]1O[C@H](CO)[C@H](O)[C@H](NC(=O)c2ccc(C)cc2)[C@H]1OS(=O)(=O)O,,Galactose-Derived Compound 12,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)C)on4)c3)c2cc1OC,,Cafedrine,
O=C(O)COc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",
CCc1ccc(-c2ccc(C(=O)O)cc2)cc1,,5731-13-5,
CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3C#Cc3ccc(NC(=O)c4ccc(F)cc4)cn3)ccc2nc1N,,Ceramide AP,
COc1ccc(CCNCC(O)COc2ccc(OCc3ncc[nH]3)cc2)cc1OC,,Tridihexethyl,
c1ccc(C(CCc2ncc(CCN3CCCC3)[nH]2)c2ccccc2)cc1,,Modified Acarbose Hexasaccharide,
COCCN1Cc2cccc(C(N)=O)c2C1=O,,Chrysin,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)c1ccc(C)cc1,,Serine vanadate,
Oc1ccc(/C=C2\CCCN=C2c2cccnc2)c(O)c1,,"3-(2,4-Dihydroxybenzylidene)anabaseine",
CCc1cc(Oc2c(I)cc(Cc3[nH]c(=O)[nH]c3O)cc2I)ccc1O,,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)NC1CCCCC1,,Rheinanthrone,
CN(C)c1ccc(CNC(=O)c2ccc(S(N)(=O)=O)cc2)cc1,,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",
O=C(O)c1ccccc1C(=O)O,,phthalic acid,
O=C(CCSCc1ccco1)CNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,"8-chloro-N-[4-[(2-furanylmethyl)thio]-2-oxobutyl]dibenz[b,f][1,4]oxazepin-10(11H)-carboxamide",
CC(C)CC(CC(=O)OCC1(CO)C/C(=C\c2cccc(C(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c2)C(=O)O1)CC(C)C,,Lusutrombopag,
CCCN(CC)CC#Cc1ccc(C)cc1,,Tmr,
Cc1nn(C)cc1C(=O)Nc1cccnc1,,Merotocin,
COc1ccc(-n2nc3c(NC(=O)c4ccc(N)cc4)nc4ccccc4n3c2=O)cc1,,"3,4-Dihydroxycinnamic Acid",
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,AC-262536,
[NH3+]C(Cc1ccccc1)C(=O)[O-],,"L-Phenylalanine, 23",
COc1nc2ccc(C(O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CC(F)(F)F,,"US10201546, Example 137",
O=C(O)c1cc(-c2ccc(CNS(=O)(=O)c3ccccc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Heptaminol,
COc1cccc(CCNC(=O)N[C@@H](Cc2cc(Br)c(O)c(Br)c2)C(=O)N[C@H](CCCCN)C(=O)N2CCN(c3ccncc3)CC2)c1,,"3,6-Anhydro-2-(hydrogen sulfate)-alpha-D-galactopyranose",
C[C@H](NC(=O)OCCCc1cnc[nH]1)C1CCCCC1,,D-Cysteine,
COc1cc(SC)ccc1C(=O)Nc1cccc(C)n1,,Enviomycin,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC,,Ethyl biscoumacetate,
NC(=O)c1ccc[n+](C2OC(COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)([O-])[O-])[C@@H]3O)[C@H](O)[C@@H]2O)c1,,beta-D-Galactopyranuronic acid,
Cc1cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c1O,,Sabutoclax,
O=C(O)CCc1ccc(Oc2ccccc2)cc1,,3-(4-phenoxyphenyl)propanoic acid,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCCN1CCC(F)(F)C1,,"US9725465, Example 82",
O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)cc1)N1CCC(N2CCCC2)CC1,,UNC1021,
CC(C)c1ccc(SCC(=O)N2CCOCC2C(=O)OCCCc2cccnc2)cc1,,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,
c1ccc2[nH]c(-c3cscn3)nc2c1,,thiabendazole,
Cc1cc2c(CCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(CCc3ccccc3)c(O)c(O)cc2c1O,,"Apogossypol derivative, 12e",
Fc1cccc(CNc2ccc3ccccc3n2)c1,,Solamargine,
CC(C)C[C@@H]1CN[C@@H](CCCCNC(=O)OCc2ccccc2)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](Cc2ccccc2)C(=O)NCCC(=O)N1,,Sodium citrate,
CCNC(=S)NCCCCc1cnc[nH]1,,Methyl vanillate,
COc1ccc(-c2cc(C(=O)O)nn2-c2cccc(C)c2)cc1,,Tetrahydrouridine,
CC(C)n1cc2c3c(cccc31)C1=C[C@@H](COC(=O)C3CCCCC3)CN(C)[C@@H]1C2,,Niacin,
COCCOc1ccc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2c1,,MONOGALACTOSYL-DIACYLGLYCEROL,
COc1ccc(Cn2cc(C(=O)O)c(=O)c3ccccc32)cc1,,BQCA,
Cc1ccc(S(=O)(=O)N(CC(=O)N2CCC[C@H](N)C2)c2ccc(C#N)cc2)cc1,,K-134,
CCOC(=O)CNCC(O)COc1ccccc1,,Tyvelose,
O=C(N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)C1)N1CCOCC1,,Mizolastine,
COc1ccc(COc2ccccc2C2=NOC(CO)C2)cc1,,Fingolimod,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(F)(F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,Temafloxacin,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,"[Mpa1, D-Tic7]OT",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC(F)(F)F,,"US10201546, Example 221",
CCOC(=O)[C@]1(c2cccc(O)c2)CCCN(CCc2ccccc2)[C@H]1C,,Progesterone,
O=NCc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1O,,Velpatasvir,
O=c1c2cc(F)c(NCCCN3CCOCC3)cc2nc2n1CC/C2=C\c1ccc(F)cc1,,Iodohippuric acid,
COc1ccc(C)c(N(C(=O)c2cccc(C(F)(F)F)c2)c2cn(C(C)=O)c3ccccc23)c1,,Uprosertib,
Cc1ccc(SCC(=O)N2CC(C)OC(C)C2)cc1,,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,Nitrazepam,
C[n+]1c(/C=C/Nc2ccccc2)sc2ccccc21,,"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CC=CCCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Formycin-5'-Monophosphate,
COc1ccc(Nc2nc3cc4c(=O)cc(-c5ccc(C(=O)N[C@@H](CC(C)C)C(N)=O)cc5)oc4cc3n2[C@H](C)C2CCCCC2)cc1,,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,Pralnacasan,
CC(C)[C@H](NC(=O)[C@@H]1CSSC(C)(C)[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)O,,URANTIDE,
O=C(Cc1ccc(OC(F)(F)F)cc1)Nc1cc(C2CC2)[nH]n1,,N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-[4-(trifluoromethoxy)phenyl]acetamide,
O=C1CCC(CCN2CC(N3CCS(=O)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,Aplindore,
COc1nc2ccc([C@@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Atipamezole,
CC(=O)N[C@@H]1[C@@H](O)C[C@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]3CCO[C@H](COc4ccc(-c5ccccc5)cc4)[C@@H]3O)[C@@H]2O)(C(=O)[O-])O[C@H]1[C@@H](O)[C@H](O)CNC(=O)c1ccc(Cl)cc1,,Sulbenicillin,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O,,DADLE,
NC(=O)C(N)Cc1c[nH]c2ccccc12,,2-Amino-3-(1H-indol-3-yl)propanamide,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)no4)c3)c2cc1OC,,4-Nitrocatechol,
COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,,Mepyramine,
CC(C)N1CCC(Oc2ccc(CN3CCC(CO)CC3)cc2)CC1,,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",
O=c1[nH]nc(Sc2ncc([N+](=O)[O-])s2)n1-c1ccc2c(c1)OCCO2,,BI-78D3,
CCCCc1nc2cc(S(N)(=O)=O)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Irinotecan,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCCOc3ccccc3)co2)cc1)c1cccnc1,,D-norleucine,
CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1,,63659-34-7,
CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O,,Melperone,
CC(C)(C)NCC(O)COc1ccccc1-c1ccccc1,,Berlafenone,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@](C)(Cc2ccccc2F)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,Dimethyltryptamine,
O=c1[nH]c2ccccc2cc1O,,3-Hydroxyquinolin-2(1h)-One,
CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](NC(=S)NCc3ccccc3)[C@H]2O)[C@H](O)[C@H]1NC(C)=O,,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,
COc1nc2ccc(C(O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCC(O)(C(F)(F)F)CC1,,"US10201546, Example 182a",
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)C[C@H](CCCN)[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,PD-0299685,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)C(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C,,Fenspiride,
COc1ccc(CCNC[C@H](O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC,,Rocaglamide,
CCC(C)CCOC(=O)c1cccnc1,,"Auxiliary substrate, 10a",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N)c(c2O)C=C(C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)c1ccc[nH]1,,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",
CC(C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)C2(CCCNC2)NC(=O)[C@H](Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC1=O,,Palifosfamide,
CCCCOc1ccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)cc1,,Tianeptine,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,[D-Tic7]OT,
CC(C)NCC(O)CO,,6452-57-9,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCc1ncccn1,,Bromisoval,
CC(C)(C)NCC(O)CNC(C)(C)C,,15046-09-0,
C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O,,nandrolone,
Cc1cc(=O)n(-c2ccc(C(=O)NCCCNC(=O)C(Cc3ccc(OP(=O)(O)O)cc3)NC(=O)Cc3cc(=O)oc4cc(O)ccc34)cc2)[nH]1,,Ozanimod,
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,,warfarin,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNC(=O)CC(F)(F)F,,"US10201546, Example 185",
O=C1c2ccccc2NC(c2ccccc2F)N1c1ccc(OCCn2c(-c3ccccc3)nc3ccccc32)cc1,,Zucapsaicin,
CCC/C(C)=N\OCC(O)CNC(C)C,,"5-(2-hydroxyethyl)nonane-1,9-diol",
CN1C(=O)CCN(C2CCCC2)c2nc(Nc3ccc(N4CCC(O)CC4)cn3)ncc21,,Carboxyatractyloside,
CC(=O)N1CCC(C(=O)N(C)Cc2cc(Cl)cc(-c3cc(-c4cc(C(F)(F)F)ccc4Cl)c(C#N)c(=O)[nH]3)c2O)CC1,,Sagopilone,
O=C(NO)[C@H]1COC(c2ccc(OC(F)(F)F)c(Cl)c2)=N1,,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,
O=C(NCCO)c1cnn2c(O)cc(-c3ccccc3)nc12,,LGD-3303,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Indibulin,
COC(=O)CCNCC(O)COc1ccccc1C,,Cysteamine,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Sarcosine,
CCN=C(NCC)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCNC(=NCC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Ganirelix,
CC(C)CCCC1(C)CCc2cc(O)cc(C(F)(F)F)c2O1,,Bumadizone,
CCC/C=C/CCCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Abafungin,
Cn1nccc1C(=O)Nc1ccc(F)cc1F,,"N-(2,4-difluorophenyl)-1-methyl-1H-pyrazole-5-carboxamide",
N#CN=C(NCCCOc1cccc(CN2CCCCC2)c1)NCCNC(=O)c1ccc(C(=O)O)c(C2c3ccc(O)cc3OC3=CC(=O)C=CC32)c1,,"3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium",
CO[C@H]1O[C@H](CNC(=O)CNC(=O)Cc2cccc(Cl)c2)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-],,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",
O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3ccccc3)s1)CC2,,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,
O=C(Cc1ccc(-c2cnc3[nH]c(C(=O)N4CC(O)C4)cc3c2)cc1F)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 111",
CC(C)COC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,CS262,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5CCC5)nn4-c4ccccc4)c3)c2cc1OC,,Epicriptine,
CCCc1ccc(S(N)(=O)=O)cc1,,4-propylbenzenesulfonamide,
Cc1ocnc1C(=O)Nc1cccnc1,,(P-Iodophenylacetylamino)Methylphosphinic Acid,
Cc1c(NS(=O)(=O)c2ccc(NC(=O)CCC(=O)O)cc2)c(=O)n(-c2ccccc2)n1C,,Enobosarm,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Oleandrin,
C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)[C@@H](O)C[C@]12O,,Gitoxigenin,
COc1cc2c(Oc3cccc(NC(=O)Nc4ccc(OC)c(C(F)(F)F)c4)c3)ncnc2cc1OCCN1CCOCC1,,1-(4-methoxy-3-(trifluoromethyl)phenyl)-3-(3-(6-methoxy-7-(2-morpholinoethoxy)quinazolin-4-yloxy)phenyl)urea,
CC(N)Cc1ccc2c(c1)OCO2,,Tenamfetamine,
O=C(O)CC[C@H](NC(=O)N[C@@H](CSC1CC(=O)N(CCCC[C@H](NC(=O)CNC(=O)c2cccc(I)c2)C(=O)O)C1=O)C(=O)O)C(=O)O,,1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide,
N[C@@H](Cn1ccc(=O)n(Cc2ccccc2C(=O)O)c1=O)C(=O)O,,UBP 302,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,Carboprost tromethamine,
Cc1nccn1CCCn1c(-c2ccccc2)cc(-c2nc3ccccc3n2CC2CCCC2)c1C(C)C,,Oxitropium,
CC[C@H](C)[C@H](NC(=O)CC(O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Saralasin,
C[C@@H](Nc1nc(-c2cccc(C(=O)O)c2)cnc1N)C1CCCCC1,,ORG-25935,
CCCCCCCN(CCc1ccc(O[C@@](C)(CC)C(=O)O)cc1)c1nc2ccccc2o1,,"(2s)-2-(4-{2-[1,3-Benzoxazol-2-Yl(Heptyl)amino]ethyl}phenoxy)-2-Methylbutanoic Acid",
O=[N+]([O-])c1ccc2nc[nH]c2c1,,5-NITROBENZIMIDAZOLE,
CNC(=O)c1ccccc1Nc1c(C#N)cnc2[nH]c(-c3ccc(F)cc3)cc12,,Ferric pyrophosphate citrate,
COc1cccc(NC(=O)CSc2nnnn2C)c1,,CBKinase1_008515,
O=C1CCC(CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CC1,,Carbendazim,
NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1C2CCCCC2C[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,Indirubin-3'-monoxime,
O=S(=O)(NCCc1c[nH]c2ccccc12)c1cc(Br)c(Cl)s1,,Cycloguanil,
NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)Cn2cc(nn2)CCCNC(=O)[C@H](CC(N)=O)NC(=O)C2(CCCCC2)NC(=O)[C@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)Cn2cc(nn2)CCCNC1=O,,Dihydro-Acarbose,
CN(C)CCC(=O)Nc1cncc(-c2cccc3[nH]ccc23)c1,,3-sulfino-L-alanine,
CCCn1c(=O)c2[nH]c(C3CCC(OC(=O)CBr)C3)nc2n(CCC)c1=O,,Erteberel,
COc1nc2ccc([C@@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,LY-2874455,
CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1,,"pyrazolourea, 1a",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)C)nn4-c4cccnc4)c3)c2cc1OC,,Brexpiprazole,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CC(F)(F)F,,"US10201546, Example 145",
O=C(c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1)N1CCCC1,,Bicuculline,
CCCCCCCCNC(=O)c1ccc(S(N)(=O)=O)cc1,,2-Pyridinethiol,
CN(C)S(=O)(=O)c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12,,CRA_10762,
COc1ccc2nc(-c3ccc4ccccc4c3)n(-c3ccnc(N[C@@H]4CCCN(C(=O)C5CC5)C4)n3)c2c1,,Aplaviroc,
C=CCN(CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N(CC=C)CC(=O)N[C@@H](CCC(=O)O)C(N)=O)[C@@H](C)O)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21,,Cyclo(prolylglycyl),
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(N3CCOCC3)c2)N=C(C2CCCCC2)c2ccccc21,,Darinaparsin,
CCCCc1ccnc([C@H](CC2CCCCC2)NC(=O)c2ccc(CNC(=N)N)cc2)c1,,Piperacillin,
C[C@@H]1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21,,7alpha-methyldihydrotestosterone,
Oc1ccc2c(c1)CCNCCc1ccccc1C2,,NADPH,
NC(=O)C1=CN(C2OC(COP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@H](O)[C@@H]2O)C=CC1,,M-Cresol,
Cc1cnc(Cl)nc1-c1ccc2c(c1)CC[C@H](c1cccnc1)N2C(=O)c1ccc(O)cc1O,,1-Naphthylamine-5-sulfonic acid,
C#CCCCNC(=O)[C@H](CC(N)=O)NC(=O)C1(NC(=O)[C@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)CN=[N+]=[N-])CCCCC1,,"5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",
COCCNc1nnc(Sc2ncc([N+](=O)[O-])s2)s1,,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",
C[n+]1c(C#Cc2ccc(-c3ccc(O)cc3)cc2)cccc1C#Cc1ccc(-c2ccc(O)cc2)cc1,,"(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}",
COc1cc([C@@H](CC(=O)O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)cc2nnn(C)c12,,KI696,
CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)O)C(C)C,,SAR-125844,
CC(C)C1NC(=O)C(Cc2ccccc2)NC(=O)C2(CCCCC2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O,,2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID,
S=C(NCc1cccc(I)c1)N1CCC(c2cnc[nH]2)CC1,,Bromamphenicol,
CC(NOCC(O)CNC(C)(C)C)C1CC1,,"3-(3,4-dimethoxyphenyl)propanoic acid",
CCOc1c(OC)nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",
Cc1ccc(S(=O)(=O)N(CC(=O)N2CCC(C)(N)CC2)c2ccc(C#N)cc2)cc1,,Aspartyl-alanyl-diketopiperazine,
O=C(c1ccc(OCCCN2CCC(Cc3cnc[nH]3)CC2)cc1)N1CCNCC1,,"5,10-Dimethylene Tetrahydromethanopterin",
O=P(O)(O)O[C@H]1[C@H](O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]1O,,"inositol 1,4,5-trisphosphate",
CCN1CCc2ccccc2Cc2ccc(O)cc2CC1,,CR665,
CN1C[C@H](C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C[C@@H]2Cc3c(C#N)cccc3C[C@H]21,,Bisindolylmaleimide I,
CN(Cc1ccccc1)c1nc(NCc2ccc(C3CCCCC3)cc2)nc2c1ncn2CC(=O)O,,Pterin Cytosine Dinucleotide,
CCOc1cccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)c1,,Inhibitor of P38 Kinase,
CC(C)(C)OC(=O)NCCCCCC(=O)NC12CC3(CCC=O)CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(C3)C1)C2,,Cannabigerol,
COc1nc2ccc([C@@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(C#N)c1OCC1CC1,,Ataluren,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1,,2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCN(C)CC5)C4)cc3)nn3cccc23)n[nH]1,,Doxazosin,
CC(C)(C)NCC(O)COC(=O)C1CCCCC1,,Droxidopa,
CC(C)(C)NCC(O)CON=C1CCCCC1,,TNP-470,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CCS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Filaminast,
N#Cc1ccc(-c2ccc(OCCCCC(=O)NO)cc2)cc1,,Pyrazole,
COc1ccc(CN(CC(=O)NCc2ccccc2)C(=O)CCCCCn2cc[n+](C)c2/C=N\O)cc1.[I-],,Fentiazac,
Nc1ccc(CC(NC(=O)CNC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",
COc1ccccc1CNCCCCCCNCCCCCCCCCCCCCNCCCCCCNCc1ccccc1OC,,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,
Cc1ccc(C(O)(c2ccc3nc(Cl)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)c(C)n1,,Ozarelix,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,6-Hydroxy-6-Methyl-Heptan-3-One,
O=c1cc(-c2ccccc2)oc2cc(OCc3ccccc3)cc(O)c12,,110506-85-9,
CC(CCC(=O)[O-])[N+](C)(C)C,,Difamilast,
COc1ccc(Cl)c(C(=O)NCC23CC4CC(CC(C4)C2)C3)c1,,4-hydroxycoumarin,
CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)c1ccccc1,,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",
O=C(Nc1ccc(S(=O)(=O)Nc2cnc3ccccc3n2)cc1)c1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1,,"CypA Inhibitor, 4g",
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O)NC(=O)OCCCCCCCCCCCCCCCCCCCCCCC,,"(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate",
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O,,"2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",
Cc1cccc(-c2ccc(C(=O)O)cc2)c1,,5728-33-6,
O=C(O)Cc1csc(=NC(=O)CS(=O)(=O)Cc2ccc3ccccc3c2)n1O,,Luteolin,
NC1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2Cl)CC1,,Dantrolene,
CSC1=NC2C(=C(C)[N-]1)C(=[OH+])OCCCCCSc1ccc([N+](=O)[O-])cc12,,JHU-75528 C-11,
CN1C2CCC1C(c1ccc(Br)cc1)C2,,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Ralinepag,
O=C(Nc1ccc([N+](=O)[O-])cc1)C1CC1,,N-(4-nitrophenyl)cyclopropanecarboxamide,
COc1ccc(CN(CCN(C)CCCCCCN)c2ccccn2)cc1,,Mefenamic acid,
NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4[nH]nnc4c32)cc1,,CS242,
COc1ccc(CN(CCN(C)CCCCN)c2ccccn2)cc1,,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",
COC(=O)c1cc(-c2ccccc2OCc2ccc(Br)cc2)no1,,Fluprednisolone acetate,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1cccnc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Anisindione,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(CC(F)(F)F)c5cc(F)ccc54)CC3)CC2)ccn1,,"4,6-Dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}hexopyranose",
CC(=O)N[C@@H](C=O)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O[C@]2(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)[C@H]1O)[C@H](O)CO,,Sialyl-Lewis X,
C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O,,Digoxigenin,
NC(=O)c1ccc(-n2cccc2Cc2c(F)cccc2F)cc1N[C@H]1CC[C@H](O)CC1,,N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE,
COc1ccc(C(=O)CSc2nc3nc(N)[nH]c(=O)c3[nH]2)cc1,,Halofuginone,
Cc1ccccc1OCCSc1nc2ccccc2n1CCC(=O)O,,Isosorbide mononitrate,
CCC(C)c1cccc(OCC(O)CNC(C)C)c1,,Ixazomib,
CCN(CC)CCNS(=O)(=O)Cc1ccc(Cl)cc1,,Tetrahydrogestrinone,
Cc1[nH]nc2c1C(c1cccc(C(F)(F)F)c1)C1=C(CC(C)(C)CC1=O)N2,,arg-gsk-19,
COc1ccc(CN(CCN(C)CCCCCCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)c2ccccn2)cc1,,"5-Phenylsulfanyl-2,4-Quinazolinediamine",
Cc1cc(C)c2cc1C(=O)NCCCOc1cccc(c1)Sc1cc-2nc(N)n1,,Dipicolinic acid,
Nc1nc(N)nc(-c2ccccc2Cl)n1,,"6-(2-Chlorophenyl)-1,3,5-triazine-2,4-diamine",
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO[C@]2(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c3ccc(F)cc3)O2)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H]1NC(C)=O,,Colforsin,
O=S(=O)(O)Oc1c[nH]c2ccccc12,,Indoxyl sulfate,
CCN(CC)Cc1ccc(OC2CCN(C(C)C)CC2)cc1,,Lurtotecan,
COCC(=O)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,"N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide",
CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1cn(C)c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccc(F)cc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C,,Ac-ICV(1MeW)QDWGAHRCT-NH2,
COc1cc(C(=O)OC2CC3CCC2(C)C3(C)I)ccc1O,,Hydroquinidine,
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(N2CCNCC2)nc1,,Taribavirin,
COc1cccc(-n2nnnc2SCC(=O)Nc2c(C)cc(C)cc2C)c1,,CBKinase1_001884,
C=CCC1/C=C(\C)CCCOC(=O)OC(=O)C2CC[C@@H](O2)C(=O)C(=O)C(=O)OC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc2cccnc2)[C@H](C)CCC1=O,,Voacamine,
C=Cc1ccoc1Cn1ccnc1CCc1c(Cl)c(O)cc(O)c1C(=O)OC,,7-Deazaguanine,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCO,,"US9725465, Example 80",
CCOP(=O)(OCC)Oc1ccc([N+](=O)[O-])cc1,,PARAOXON,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C,,Gadofosveset trisodium,
CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccc(C)cc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)OC,,6-Carboxymethyluracil,
CC(C)C[C@H](NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium,
O=C([C@@H]1C[C@@H]2c3cccc4[nH]c(Br)c(c34)C[C@H]2N(CCCO)C1)N1CCN(c2ccccn2)CC1,,Fosinopril,
O=C(NCc1ccccc1)c1cnc2ccccc2n1,,N-benzylquinoxaline-2-carboxamide,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,2-Chlorodideoxyadenosine,
CC(C)C[C@@H]1NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CC(=O)NC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC1=O,,Modified Ribosylated Glutamyl Ester,
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(N2CCOCC2)nc1,,Valrubicin,
c1ccc2c(c1)[nH]c1ccnc(NCC3CC3)c12,,Talviraline,
C=C1CC(c2ccc(N=C(N)N)cc2)C(NC(=O)c2ccccc2)C(=O)O1,,Niflumic acid,
C[C@H]1C[C@@]2(O[C@H]3C[C@H]4[C@@H]5CC[C@H]6C[C@H](O)CC[C@]6(C)[C@H]5[C@@H](O)C[C@]4(C)[C@H]3[C@@]2(C)O)OC1(C)C,,Hippuristanol,
c1ccc2c(c1)[c+]1ccn2CCCCCn2cc[c+](c3ccccc32)NCCCCCN1,,UCL1848,
Cc1c(Cc2ccccc2)c(=O)oc2c(C)c(O)ccc12,,"3-benzyl-7-hydroxy-4,8-dimethyl-2H-chromen-2-one",
COC(=O)c1c(O)ccc(O)c1C(=O)c1c(O)cc2c(c1O)C1=CC[C@]3(C2)C(C1=O)C(=O)c1c(O)cc(C)cc1[C@@H]3OC(C)=O,,Promegestone,
c1csc(-c2cnc3c(N4CCOCC4)snc3c2)c1,,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,
O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1,,GSK-1004723,
Cc1ccc(C[n+]2csc(CCO)c2)c(N)n1,,S-adenosyl-L-homocysteine,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCc3cnc[nH]3)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,Aluminium clofibrate,
CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Rosiglitazone,
COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)cc1,,Theophylline,
CC1=CN(C)C2=NC(N)NC(=O)C2=C1,,Inhibitor Idd 384,
C[C@@](O[C@@H]1CC(C(=O)[O-])=C[C@@H](OP(=O)([O-])[O-])[C@H]1O)(C(=O)[O-])P(=O)([O-])[O-],,Histamine,
CCN1CCN(CCOc2cc3ncc(-c4ccc(CC(=O)Nc5cc(C6(C(F)(F)F)CC6)on5)c(F)c4)nc3cc2OC)CC1,,"US9725465, Example 105",
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1CCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC1=O,,Inarigivir,
CN(C)c1cccc2c(S(=O)(=O)NCCNC(=NC#N)NCCCOc3cccc(CN4CCCCC4)c3)cccc12,,AZD-8418,
NC(N)=NCCC[C@H](N)C(=O)N[C@@H](Cc1cccs1)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N1C2CCCCC2C[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,2-Aminoquinazolin-4(3h)-One,
S=C(NCCc1ccccc1)NCCc1cnc[nH]1,,163565-07-9,
O=c1c2ccccc2nc(-c2ccc(OS(=O)(=O)O)cc2)n1CCCCn1cc(Cn2c(-c3ccc(OS(=O)(=O)O)cc3)nc3ccccc3c2=O)nn1,,Petesicatib,
C=CCNc1nc(NCc2ccc(C3CCCCC3)cc2)nc2c1ncn2CC(=O)O,,Merimepodib,
CN1C[C@H](C(=O)N2CCN(c3ccccn3)CC2)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,,Aprepitant,
CC(C)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C1CCCCC1,,"proline scaffold, 33",
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCC(c2ccccc2)=C1CCC(C)C,,Urolithin A,
CC(=O)NN[C@H]1CSSSSC[C@@H]2NC(=O)[C@@H]3CSSSSC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)C(N)=O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H]4CSSSSC[C@H](NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](CSSSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N3)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC2=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N4,,Castanospermine,
CN(C)CCC1=CCc2ccccc21,,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,
CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,2-Oxo-3-Pentenoic Acid,
OCc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1O,,Ortataxel,
CCCCSc1ccccc1C1N=C(SC)Nc2coc(O)c21,,N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide,
O=C(O)CCCCCCCCCn1ccnc1,,10-(1H-imidazol-1-yl)decanoic acid,
CCCc1c(OCCCOc2ccc(OCC(=O)O)cc2)ccc(C(C)=O)c1O,,79558-09-1,
Cc1nc2ccccc2n1CCOc1ccc(-c2nc3ccccc3n2Cc2ccccc2)cc1,,Disopyramide,
O=S(=O)([O-])c1cc(N=C=S)ccc1/C=C/c1ccc(N=C=S)cc1S(=O)(=O)[O-],,dids,
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2sccc21,,Apricitabine,
CCOC(=O)CNCC(O)COc1cccc2ccccc12,,Sodium glycerophosphate,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)c1ccc(C(N)=O)cc1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,Levocabastine,
OC(CNC1CC1)COc1ccc(-c2ncc[nH]2)cc1,,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",
O=[N+]([O-])c1c(Nc2cc(F)cc(F)c2)ccc2nonc12,,BMS-275183,
Nc1nc2[nH]c(SCc3ccc(F)cc3F)nc2c(=O)[nH]1,,Deslanoside,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)OP(=O)(O)O)NC(=O)CN(C)C(=O)[C@@H](C)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,
c1cncc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2cccnc2)c1,,2-Fluoroaniline,
CN(C)CCCn1c(-c2c[nH]nc2-c2ccccc2)nc2cc(-c3ccc(C(=O)O)cc3)ccc21,,"Benzimidazole Inhibitor, 1",
Fc1cccc(C2NCCc3sccc32)c1,,Doxacurium,
CC[C@H](C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O,,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CN2CC3CCC(C2)O3)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cccc(C(C)(C)C)c4)c3)c2cc1OC,,Etamsylate,
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCN(CCc2ccccc2)C1,,Padeliporfin,
O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1,,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",
O=C(NO)c1c[nH]c(NCc2ccccc2)nc1=O,,Doxefazepam,
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C1C2=O,,(S)-2-Tetrahydrofuroic acid,
O=C(O)c1cccc(/C=C/c2ccc(O)cc2Cl)c1,,Ouabain,
COc1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)cc(C(F)(F)F)c1,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(3-methoxy-5-(trifluoromethyl)phenyl)urea",
COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,,N(6)-dimethylallyladenine,
COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,,doxazosin,
CC(=O)Nc1ccc(C[C@@H](NC(=O)[C@@H](Cc2ccc(CNC(=O)[C@@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Pentoxifylline,
CO[C@@H]1CC/C=C/c2cccc(c2)COC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1C,,Vincristine,
CC[C@H](C)[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)nn4-c4ccccc4)c3)c2cc1OC,,LY-377604,
Cc1ccc(CN2CCC[C@@H](NC(=O)N3CCc4[nH]nc(-c5ccncc5)c4C3)C2)s1,,Calcium citrate,
CSC1=NC2c3ccccc3SCCCCCOC(=O)C2C(C)=N1,,Demoxytocin,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1OCC(F)(F)F,,Venetoclax,
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)C1CSSC1,,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",
CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,,Chlorquinaldol,
CCCn1nc(C(C)(C)C)c(C(=O)O)c1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,UR-7280,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=N)NCCCCCCN)CC4)c3Cl)c2n1,,Armodafinil,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)[C@@H](C)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)NC1=O,,Elobixibat,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)O)cc1,,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",
COc1ccc(/C=C/C(=O)NCCNC(=O)/C=C/c2ccc(OC)cc2OC)c(OC)c1,,Fluprednidene,
Brc1cccc(C2CC(c3cccc(I)c3)n3nnnc3N2)c1,,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,
CN(C)c1ccc2c(CC(=O)NCCNC(=O)[C@@]3(C)CC[C@]4(C)CC[C@]5(C)C(=CC(=O)[C@@H]6[C@@]7(C)CC[C@H](O)C(C)(C)[C@@H]7CC[C@]65C)[C@@H]4C3)cc(=O)oc2c1,,N-Hydroxy-N-Isopropyloxamic Acid,
O=C(c1ccc(O)cc1O)c1ccc(O)c(O)c1O,,92379-42-5,
O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,,chrysin,
C[C@@H](O)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCNC(=O)c1ccc(N=C=S)cc1C1c2ccc(O)cc2Oc2cc(O)ccc21)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Indobufen,
NCCCC[C@@H](NC(=O)[C@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(n2c(=O)[nH]c3ccccc32)CC1)C(=O)N1CCN(c2ccncc2)CC1,,ORG-34517,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)cnc2cc1OCC(C)(C)O,,"US9725465, Example 249",
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,,Fosmanogepix,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3)ncnc2cc1OCCN1CCOCC1,,2-O-Methyl-beta-L-fucopyranose,
O=C(O)c1cc(-c2ccc(Cl)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,158941-10-7,
Nc1sc(-c2cncnc2)cc1C(=O)c1ccc(Cl)cc1,,Binimetinib,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(CC(=O)O)c2)C(=O)N(C2CCCCCC2)c2ccccc21,,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",
C=CCC1/C=C(\C)CCOC(=O)OC(=O)C2CC[C@@H](O2)C(=O)C(=O)C(=O)OC(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc2cccnc2)[C@H](C)CCC1=O,,Imidocarb,
COc1cc(NC(=O)CSc2nncn2C)cc(OC)c1OC,,CBKinase1_009291,
Cn1c(=O)c2c(ncn2C)n(C)c1=O,,caffeine,
CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,,progesterone,
O=C(c1ccc(OCCCN2CCC(Cc3cnc[nH]3)CC2)cc1)N1CCCCC1,,"2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate",
OC1C[C@@H]2CCCC[C@H]2CC1N1CCC(c2ccccc2I)CC1,,Liarozole,
C[C@@H](OP(=O)(O)O)[C@H](NC(=O)CCC(C)(c1ccc(O)cc1)c1ccc(O)cc1)C(=O)N1CC=C[C@H]1C(N)=O,,Lorlatinib,
CSC1OC(CO)C(O)C(n2cc(C(=O)NCc3ccccc3)nn2)C1O,,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",
COc1ccc(-c2cnc3c(NC(=O)c4ccccc4)snc3c2)cc1OC,,GSK-376501,
COc1ccccc1-c1nnc2n1N=C(c1ccc(Cl)cc1)C(CC(=O)[O-])S2,,"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",
CC(C)c1cc(Cl)c2cc(C(=O)O)[nH]c2c1F,,ICI-164384,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C5CCCC5)on4)c3)c2cc1OC,,Danegaptide,
O=C1CC(c2c(Cl)ccc(Br)c2Cl)CC(O)=C1Sc1ccccc1Cl,,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",
CN1C(=O)CN=C(c2ccc(Cl)cc2)c2cc(Cl)ccc21,,4'-Chlorodiazepam,
[N-]=[N+]=Nc1ccc(C(=O)NCc2c(Cl)c(Cl)cc3c2Oc2cc(Cl)c(Cl)cc2O3)cc1,,"Photoaffinity ligand, 6",
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCCN1CCOCC1,,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",
CCO[C@@H](Cc1ccc(OCC=C(c2ccc(-c3ccccc3)cc2)c2ccc(-c3ccccc3)cc2)cc1)C(=O)O,,Fluorofuranylnorprogesterone F-18,
CCOC(=O)c1cnc(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)[nH]1,,"(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester",
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,,MMV689243,
C#CCOc1ccc(/C=C2\CCn3c2nc2cc(NCCN(C)C)c(F)cc2c3=O)cc1,,L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine,
O=c1cc(-c2ccccc2)oc2c(Cc3ccccc3)c(O)c(Cc3ccccc3)c(O)c12,,Delta-Amino Valeric Acid,
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2CC(C)(C)CC(C)(C)C2)cc1,,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",
CN(C)CCC(CSc1ccccc1)Nc1ccc(S(=O)(=O)N[C+]2[N-]S(=O)(=O)c3cc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc32)cc1[N+](=O)[O-],,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",
CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3ncnc4ccc(-c5ccc(CNCCS(C)(=O)=O)o5)cc34)c2)no1,,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",
O=C(O)CSc1nnc(-c2ccc(F)cc2)n1-c1ccc(Cl)cc1,,PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID,
CCNC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@H](Cc2ccc(NC(=O)NCC)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Annamycin,
CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,Medroxyprogesterone acetate,
CC(=O)N1CCC(C(O)(c2ccc3nc(C(F)(F)F)c(C(=O)N4CCCCC4)c(C(F)(F)F)c3c2)c2cncn2C)CC1,,"US10201546, Example 9",
COc1cccc(N2C=Cc3cc(S(N)(=O)=O)sc3S2(=O)=O)c1,,AL6528,
CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC(C)[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,O-(N-acetyl-alpha-D-galactosaminyl)-L-serine,
NC(=O)c1cccc2[nH]n(C3CCN(C4CCCC4)CC3)c(=O)c12,,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1cccnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate,
O=C(CCN1CCC(Cc2cnc[nH]2)CC1)NC1CCCCC1,,"4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine",
COc1c(O)cc2c(O)c1C=C(C)C[C@H](OC)[C@H](OC(=O)CN)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",
COc1nc2ccc([C@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Golvatinib,
O=C(O[C@H]1CN2CCC1CC2)C(O)(c1ccccc1)c1ccccc1,,62869-69-6,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,Procaterol,
O=C(O)[C@H](Cc1ccccc1)N1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S,,GW-493838,
CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O,,P-Anisic Acid,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,CUDC-907,
NCCc1cnc(CCCCC(c2ccccc2)c2ccccc2)[nH]1,,Xibornol,
O=C(/C=N\O)Nc1ccc[n+](CCCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],,AKOS024354510,
CCCCC1(CC)CC(=O)N(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)/C(=C/C(=O)OCC)C1,,Periciazine,
NC(=O)CCCCCNC(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,9-Deazahypoxanthine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",
O=c1c(O)c(-c2ccc(F)cc2)oc2cc(O)cc(O)c12,,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,
Nc1nc2[nH]c(SCC(O)C(F)(F)F)nc2c(=O)[nH]1,,Stanolone,
O=C(O)c1cccc(NC(=O)c2[nH]c(C3CCCCC3)nc2CCC23CC4CC(CC(C4)C2)C3)c1,,"2-[3-chloro-6-[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]imino-1-hydroxypyridin-2-yl]-N-[(1R)-1-(3-chlorophenyl)ethyl]acetamide",
Cc1ccc(-c2snnc2-c2cc(Cl)c(O)cc2O)cc1,,Ramoplanin,
CC(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,,Phenyl salicylate,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(CC(F)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"US9730937, Example 137",
Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2cc1-c1cc2c(C=O)c(O)c(O)c(C(C)C)c2cc1C,,Alpha-D-Glucose-1-Phosphate-6-Vanadate,
CC(C)N1CCC(Oc2ccc(CN(C)C)cc2)CC1,,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",
COc1ccc(-c2nnc(SCC(=O)O)n2-c2cccc(Cl)c2)cc1,,Cannabidivarin,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol,
Oc1cccc(Nc2nc(-c3ccc(F)cc3F)cs2)c1,,294893-07-5,
C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)COc4ccc(C(C)(C)O)cc4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,,"[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID",
COc1cccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)c1,,Nelivaptan,
Nc1ccc2cc(C3OCCCO3)ccc2n1,,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,
COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,,Atracurium,
COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1,,Surinabant,
O=C(O)Cn1cnc2c(Oc3c(F)c(F)c(F)c(F)c3F)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Sacubitrilat,
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3CC[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1,,penucuronium,
CCc1c(-c2ccccc2)c(-c2ccccc2)nn1-c1ccccc1-c1cccc(OCC(=O)O)c1,,300657-03-8,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCc4c([nH]c5ccccc45)C3)CN(C)[C@@H]1C2,,Mimosine,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,"(2,6-Dimethylphenoxy)acetic acid",
O=C(C1CC1)N1CCC[C@@H](Nc2nccc(-n3c(-c4ccc5ccccc5c4)nc4ccc(O)cc43)n2)C1,,Butylphthalide,
CCN(C)C(=O)C(C)Sc1nc2c(=O)[nH]c(N)nc2[nH]1,,S-9-(2-hydroxypropyl)adenine,
CC(C)(C)NCC(O)COc1ccc(Cc2nc(-c3cccs3)c[nH]2)cc1,,"{(4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-[(4-amino-1H-indol-3-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid",
CN(c1ncccc1CNc1c(C(F)(F)F)cnc2nc(-c3ccc(Br)cc3)[nH]c12)S(C)(=O)=O,,Etodolac,
OCC1O[C@@H](S[C@@H]2OC(CO)[C@H](O)C(n3cc(-c4cccc(F)c4)nn3)C2O)C(O)C(n2cc(-c3cccc(F)c3)nn2)[C@H]1O,,ILS-920,
CCOc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCN(CC)CC2)c1,,"Mdl 101,146",
N#Cc1ccccc1SC1=C(O)CC(c2c(Cl)cccc2Cl)CC1=O,,Fumagillin,
Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,,brensocatib,
COc1ccc(N2CCc3c(-n4ccc(N5CCNC5=O)n4)cc(C)nc32)c(C)c1,,EMICERFONT,
O=NCc1cc[n+](CCC[n+]2ccc(CN=O)cc2)cc1,,Bispyridinium oxime(TMB),
COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCOCCOCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c4ccc(-c5c6ccc(=[N+](C)C)cc-6oc6cc(N(C)C)ccc56)c(C(=O)[O-])c4)nc4ccccc4n3c2=O)cc1,,Timolol,
CCOc1ccc(C[C@H]2NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",
Cn1c2cccc(C(N)=O)c2c(=O)n1C1CCN(CC2CC=CCC2)CC1,,Alendronic acid,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)O)cc1,,2-[(4-sulfamoylphenyl)formamido]acetic acid,
C=COC(=O)c1ccccc1OCC(O)CNC(C)C,,LY-518674,
Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCNC(=O)O[C@@H]3[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@@H](n4cnc5c(N)ncnc54)[C@@H]3O)=[N+]1[B-]2(F)F,,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCN(S(C)(=O)=O)CC1,,GSK-256066,
CNC(=O)[C@H]1CCCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)C1,,Almitrine,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(CS(=O)(=O)O)cc2)NC(=O)Cc2cccc3ccccc23)cc1,,Amsacrine,
CC(C)Cc1ccc(O)c(-c2cc(-c3cc(Cl)ccc3Cl)c(C#N)c(=O)[nH]2)c1,,PF-06291874,
O=c1[nH]cnc2c(CN3C[C@@H](O)[C@H](O)C3)c[nH]c12,,"Immucillins, 14",
Cc1ccc2cc1-c1cc(nc(N)n1)Sc1cccc(c1)OCCCCCO2,,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(F)c4)c3)c2cc1OC,,Thiarsa Dihydroxy Cysteine,
Cc1cc(COc2cc(C(=O)N3CCCC(N(C)C)C3)nn2-c2ccc(C#N)cc2)on1,,2-Bromo-6-chloro-purine,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CN[C@H](C)C(F)(F)F,,"US10201546, Example 199",
CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)Cc1ccc2c(c1)OCO2)C(C)c1ccccc1)C(=O)CNCCCCN,,"2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCC(C)c2ccccc21,,"4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2sccc21,,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCN(CCO)CC1,,Ferrous gluconate,
Cc1cc(CN2CCN(c3c(Cl)cnc4nc(-c5cn(C)nc5C)[nH]c34)CC2)no1,,Osimertinib,
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Dipropyl-4-hydroxytryptamine,
C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CCNCC5)c4)ccc3F)c2)CCN1,,"1,3-DI(N-Propyloxy-A-mannopyranosyl)-carbomyl 5-methyazido-benzene",
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,,Cortexolone,
COc1ccc(CC(C)N)cc1,,4-Methoxyamphetamine,
O=C(NCCN1CCC(Cc2cnc[nH]2)CC1)c1ccc(Cl)cc1,,Imazaquin,
O=C(O)c1cccc2c(=O)cc(-c3ccc(OCc4ccccc4)cc3)oc12,,Namitecan,
CC(C)NCC(O)COc1ccc2ccccc2c1,,2007-72-9,
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1C(=O)NC1CC1,,"US10201546, Example 149",
CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1,,NVS-PAK1-1,
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,Mercaptocarboxylate Inhibitor,
Fc1ccc(Br)c(F)c1[C@@H]1C[C@H](c2cccc(Br)c2)Nc2nnnn21,,Ulobetasol,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)N(C)C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC,,Andrographolide,
Cc1cccc(-c2n[nH]c(=S)n2-c2ccc3c(Cl)c(C(=O)O)sc3c2)c1Br,,Tenofovir,
O=C(C1CC1)N1CCC[C@@H](Nc2nccc(-n3c(-c4ccc5ccccc5c4)nc4cc(O)ccc43)n2)C1,,Moricizine,
CCc1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)cc1,,3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID,
O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,luteolin,
C[C@@H](CO)NC(=O)c1cnn2c(O)cc(-c3ccccc3)nc12,,Calcium gluconate,
NC(=O)c1cccc2c1C(=O)N(CCN1CCc3ccccc3C1)C2,,Radotinib,
C[C@@H]1NC(=O)CCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](CO)NC1=O,,Besifovir dipivoxil,
NCCCCCCCCCCc1cnc[nH]1,,Secnidazole,
NC(=O)c1ccc(-n2cccc2Cc2ccccc2F)cc1NC1CCC(O)CC1,,Zolimidine,
CCCCCNc1nc(NCC(C)C)c2ncn(CC(=O)O)c2n1,,CoA-S-trimethylene-acetyl-tryptamine,
O=c1nc(NO)ccn1[C@H]1C[C@H](O)[C@@H](COP(=O)(O)O)O1,,2'-deoxy-n-hydroxycytidine 5'-(dihydrogen phosphate),
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCOCC1,,Rescinnamine,
C[C@H](NC(=O)CCn1ccc2c(Cl)cccc21)C(=O)O,,Nandrolone decanoate,
CCOCCNc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1,,Perindoprilat,
Brc1cnc2[nH]ccc2n1,,"2-bromo-5H-pyrrolo[2,3-b]pyrazine",
CCCCCNC(=O)[C@@H]1COC(c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)=N1,,Aminomethylbenzoic acid,
O=C(O)c1ccc(-c2cccc(Cl)c2)cc1,,5728-43-8,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(CNC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)CO,,Shikimate-3-Phosphate,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)N2C=CC(NC(=O)[C@H](Cc3ccccc3)NC(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C(CCC(N)=O)NC1=O)C2=O,,"(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline",
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,,4-epi-vancosaminyl derivative of vancomycin,
CC(C)(C)NCC(O)COc1cc(Cl)c(N=C2NCCN2)c(Cl)c1,,Peldesine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,
N[C@H](Cn1ccc(=O)n(Cc2ccccc2C(=O)O)c1=O)C(=O)O,,"2,3-Dihydroxy-Valerianic Acid",
O=C(O)c1cccc(Oc2ccccc2)c1,,3-Phenoxybenzoic acid,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1CCC(F)(F)F,,AL-4623,
Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccnnc2)ccc1Cl,,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",
CCCCCCCCCCCCCC(=O)N[C@H]1[C@@H](OP(=O)(O)O)O[C@H](CO)[C@@H](OP(=O)(O)O)[C@@H]1OC(=O)CCCCCCCCCCCCC,,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,
Cc1cc(COc2cc(C(=O)N3CCC(N)CC3)nn2-c2ccc(C#N)cc2)on1,,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(N)=O)[C@H](C)O,,Vernakalant,
O=C(O)c1sc2cc(-n3c(-c4ccc(F)cc4)n[nH]c3=S)ccc2c1Cl,,"(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID",
COc1cc(OC)c(NC(=O)CSc2nnc(-c3ccccc3)n2C)cc1Cl,,"N-(5-chloro-2,4-dimethoxyphenyl)-2-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetamide",
c1cc2c(c(N3CCNCC3)c1)OCCO2,,Eltoprazine,
Nc1ncnc2c1nc(NCc1ccc(Cl)c(Cl)c1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",
CNC(=N)NCCCc1nccs1,,Glycol salicylate,
CC(C)C[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,
COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2CCc1ccc(N=[N+]=[N-])c(I)c1,,Bivalirudin,
NS(=O)(=O)c1ccc(C(=O)NCSc2ccccc2)cc1,,N-(QUINOLIN-8-YL)METHANESULFONAMIDE,
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc([N+](=O)[O-])cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,1-[4-(hydroxymethyl)phenyl]guanidine,
CNC(=O)c1cn(C2C(O)C(CO)OC(SC)C2O)nn1,,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,
CCN1CNS(=O)(=O)c2cnccc21,,(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid,
O=P([O-])([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H](O)[C@H](O)[C@H]1OP(=O)([O-])[O-],,"1D-myo-inositol 1,4,5,6-tetrakisphosphate(8-)",
Cc1ccccc1-c1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2ccc(N(C)C)c(C(=O)O)c2)[nH]1,,TT-232,
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C1CCSS1,,Lanopepden,
Cc1ccc(S(=O)(=O)N(CC(=O)N2CCC(N(C)C)CC2)c2ccc(C#N)cc2)cc1,,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",
COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC,,Cetyl alcohol,
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OCc5cn(CCCO[C@H]6O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](O[C@H]8O[C@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]8OS(=O)(=O)[O-])[C@@H]7OS(=O)(=O)[O-])[C@@H]6OS(=O)(=O)[O-])nn5)CC[C@]4(C)[C@H]3CC[C@@]21C,,Hexachlorophene,
O=C1ON=C(c2ccc(F)cc2)/C1=C/c1ccc(N2CCCC2)cc1,,CRA_11092,
COC[C@H]1O[C@H](O[C@H]2[C@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OC)O[C@@H]2COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H](OC)[C@H]1OC,,Spirapril,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(-c5ccccc5)on4)c3)c2cc1OC,,Pibrentasvir,
C=CCN1CCCC(C)(c2cccc(O)c2)C1,,Rabeximod,
COc1ccc(CCNC[C@H](O)COc2ccc(-c3ncc(C(C)=O)[nH]3)cc2)cc1OC,,Baclofen,
N#C[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)N1CCOCC1)c1ccccc1,,Dexamethasone acetate,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)no4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(3-(trifluoromethyl)isoxazol-5-yl)urea",
c1cc(CN2CCCCC2)ccc1COc1ccc(CN2CCCCC2)cc1,,Incyclinide,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCC(=O)NC1(C(=O)NCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1,,Upadacitinib,
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4cccc5ccccc45)CC3)CN(C)[C@@H]1C2,,RU83876,
CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,,AQ-RA 741,
NCCCCc1cnc[nH]1,,Imbutamine,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](C[C@@H]2CNc3ccccc32)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,4-PIPERIDIN-4-YLBUTANAL,
O=C(CCl)NCc1cc(C(=O)c2ccc(OCCO)c(Cl)c2Cl)cc(Cl)c1O,,hsp90_171,
Cc1nc2ccccc2n1CC(O)Cn1c2ccccc2c2ccccc21,,1-Carbazol-9-yl-3-(2-methyl-benzoimidazol-1-yl)-propan-2-ol,
O=C(NCCCCS(=O)(=O)c1ccccc1)c1ccc2nccn2c1,,Azithromycin,
Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@H](NS(=O)(=O)CC(C)C)[C@H]3c3ccc(Cl)cc3)ccc12,,LP99,
Brc1cccc(C2CC(c3cccc(Br)c3)n3nnnc3N2)c1,,2-(1H-pyrazol-3-yl)-1H-benzimidazole,
Cc1c(CCO)sc[n+]1Cc1c(C(F)(F)F)cc(C(F)(F)F)nc1N,,Oxymorphone,
COc1ccc(C2(O)OC(=O)C(c3ccc4c(c3)OCO4)=C2Cc2cc(OC)c(OC)c(OC)c2)cc1,,162256-50-0,
CCCCC[C@H](C)NC[C@H](O)c1cc(O)cc(O)c1,,1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,
c1ccc2c(c1)CCCCC2Nc1nc2ccccc2[nH]1,,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",
CC1=CN(C(C)C)C2=NC(N)NC(=O)C2=C1,,Psicose,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccc1)c1ccc(Cl)c(Cl)c1,,Flumedroxone,
CC(=O)Nc1ccc(C[C@@H](NC(=O)[C@H](Cc2ccc(NC(=O)[C@@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,Edrophonium,
CC(C)C[C@@H]1NC(=O)[C@@H]2CNC(=O)C[C@H](NC(=O)[C@H](CSCC3O[C@@H](O)C(O)[C@H](O)[C@H]3O)CNC1=O)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2,,Dinoprost,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1ccc(Cl)cc1,,(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,
Cc1nn2ccc3nc2c1C(=O)NCCOc1ccc(F)cc1CN3C,,AZD-1236,
COc1ccc(CN(CC(=O)N2CCC3(CC2)CNC3)c2ccc(C#N)cc2)cc1F,,Peficitinib,
Nc1nc2[nH]c(SCc3ccccc3Br)nc2c(=O)[nH]1,,Inhibitor BEA409,
Nc1nc(-c2ccc(C(F)(F)F)cc2Cl)cc(-c2ccc(C(F)(F)F)cc2Cl)n1,,hsp90_77,
Nc1ccc2cc3ccc(N)cc3nc2c1,,Proflavine,
COc1ccc(C[C@H](NC(=O)Nc2ccc3c(CN4CCCC4)cn(Cc4ccc(OC(F)(F)F)cc4)c3c2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCc2ccccc2)cc1,,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,
NC(=O)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCc3cn(nn3)CCC[C@H](NC1=O)C(=O)N[C@H](C(N)=O)CSCC(=O)N2,,Aranidipine,
CC(C)CCCC1(C)CCc2cc(O)cc(F)c2O1,,Riboprine,
CC1(C)O[C@H]2[C@@H]3OC4(CCCC4)O[C@@H]3CO[C@@]2(COS(N)(=O)=O)O1,,"(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE",
CC(C)NC(=O)NCCCOc1cccc(CN2CCCCC2)c1,,Apilimod,
COc1nc2ccc([C@@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,Enoximone,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCC(O)(C(F)(F)F)CC1,,"5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE",
Cc1cccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1C,,"(3S)-Tetrahydro-3-furanyl {(2S,3S)-4-[(2S,4R)-4-{(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl}-2-benzyl-3-oxo-2-pyrrolidinyl]-3-hydroxy-1-phenyl-2-butanyl}carbamate",
CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccc(I)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O,,Ac-His-DPhe(pI)-Arg-Trp-NH2,
O=C(O)[C@@H]1O[C@H]2CN(Cc3ccc(-c4ccccc4)cc3)C[C@@H]1O2,,Esomeprazole,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,,ETONOGESTREL,
CC(C)(C)c1c(-c2ccco2)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1-c1ccco1,,Difloxacin,
O=C(NCC1CCCC1)N1CCCC1,,N-(cyclopentylmethyl)pyrrolidine-1-carboxamide,
CCN(CC)Cc1ccc(OCCCN2CCC(Cc3cnc[nH]3)CC2)cc1,,2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,
Cc1c[nH]c(-c2ccc(OCC(O)CNC3CC3)cc2)n1,,Tecovirimat,
CCOC(=O)/C=C1\CC2(CCCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,NCX 1022,
NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,,TPCA-1,
Cc1ncc(Cn2c(C)c(CCO[P@@](=O)(O)OP(=O)(O)O)sc2=O)c(N)n1,,Thiamine thiazolone pyrophosphate,
COc1nc2ccc([C@@](O)(c3cncn3C)C3CCN(S(C)(=O)=O)CC3)cc2c(Cl)c1CC1CCOCC1,,"US10201546, Example 6c",
O=C1CCCC2(CCN(c3cnc4ccccc4n3)CC2)N1Cc1c[nH]c2ccccc12,,P1-(adenosine-5'-P5-(uridine-5')pentaphosphate,
CC(C)n1cc2c3c(cccc31)[C@H]1C[C@@H](COC(=O)C3CC3)CN(C)[C@@H]1C2,,"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2ccccc2)CC1,,Arylomycin A2,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNC(=O)CCC(F)(F)F,,"US10201546, Example 186",
COCCNC(=O)[C@@H]1CCCN1C(=O)CC1CCCCC1,,"proline scaffold, 11",
COc1cc(/C=C2\SC(=O)N(Cc3ccccc3Cl)C2=O)cc(Cl)c1OCC(=O)O,,Linezolid,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(C(O)C(=O)O)cc2)NC(=O)Cc2cccc3ccccc23)cc1,,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",
CCCCCNc1nc(NCc2ccccc2)c2ncn(CC(=O)O)c2n1,,Decernotinib,
c1ccc2c(c1)CCN(c1ccncc1)C2,,"N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide",
COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,,AZD-5991,
C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,,"3alpha,7beta-dihydroxy-5beta-cholan-24-oate",
N=C(NCCCc1cnc[nH]1)NCCC(c1ccccn1)c1ccc(Cl)cc1Cl,,(4s)-5-Fluoro-L-Leucine,
NC1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGHFGALYPCNGP,
CC(=O)N1CCC(NS(=O)(=O)c2ccc(Cl)c(COc3cccc4c(C)cc(C)nc34)c2Cl)(C(=O)N2CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC2)CC1,,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",
CC1CCc2nnc(-c3cccc(N4Cc5ccccc5C4=O)n3)n21,,Madecassic acid,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)NC1CC1,,Orciprenaline,
Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccn4nnc(N)c34)cc2)c1,,6-Hydroxymethylpterin,
COc1cc(C)c(CC(C)N)cc1OC,,"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",
CCCCC(=O)Nc1nc(N2CCOCC2)c2ncn(CC(=O)O)c2n1,,Dichlorophen,
CN1Cc2cccc(Nc3c(C(F)(F)F)cnc4[nH]c(-c5ccc(F)cc5)cc34)c2C1=O,,Stiripentol,
Cc1[nH]nc2oc(=O)c3ccccc3c12,,NSC356476,
N#C[C@H](COCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)c1cccs1,,Taselisib,
CC(=O)CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,Sulfaphenazole,
O=C(c1cc(Br)c(O)cc1O)N1Cc2ccccc2C1,,"(5-Bromo-2,4-Dihydroxyphenyl)(1,3-Dihydro-2h-Isoindol-2-Yl)methanone",
O=S(=O)(NC1CCCCC1)c1ccccc1,,N-Cyclohexylbenzenesulfonamide,
CC1(C)C(C=CC2=C(Oc3ccc(S(=O)(=O)[O-])cc3)/C(=C/C=C3/N(CCCCCC(=O)NCCCCCC(=O)NC45CC6(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)[O-])C(=O)O)C(=O)O)CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(CC(CCC(=O)N[C@@H](CCP(=O)(O)CC(CCC(=O)O)C(=O)O)C(=O)O)(C6)C4)C5)c4ccc(S(=O)(=O)[O-])cc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)[O-])c2ccc(S(=O)(=O)[O-])cc21,,TRAZEOLIDE,
O=C(O)CSc1nnc(-c2ccc(F)cc2)n1-c1cccc(Cl)c1,,"(2s,3r)-1-Amino-2-Methylbutane-2,3-Diol",
CCOC(=O)/C=C1\CC(CC)(CC)CC(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Dicloxacillin,
Clc1ccccc1[C@@H]1C[C@H](c2cccc(Br)c2)Nc2nnnn21,,Vibegron,
Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,,(-)-Epicatechin,
CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,,Lysergide,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CCOCC1,,"3,4-Dihydroxybenzoic Acid",
O=C(O)c1ccc(-c2cccc(F)c2)cc1,,1841-58-3,
CN1CC(=O)N[C@H](CC(=O)O)C(=O)N2CCCC[C@@H]2C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H]2CNC(=O)c3cc(cc(c3)C(=O)N3CCC[C@H]3C1=O)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc3ccccc3c1)NC(=O)[C@H](Cc1ccccc1)NC2=O,,Alfuzosin,
CC(=O)C[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCN=C(C)C)C(=O)NCC(N)=O)NC1=O,,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,
CC(O)COc1cc(C(=O)N2CCC[C@@H](N)C2)nn1-c1ccc(C#N)cc1,,Carboxyamidotriazole,
c1ccc2c(c1)CCNC2,,"1,2,3,4-Tetrahydroisoquinoline",
O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1,,Terfenadine,
NS(=O)(=O)c1ccc(C(=O)NCCOCCOCCN(CC(=O)[O-])CC(=O)[O-])cc1,,BR17,
COc1nc2ccc([C@@](O)(c3cnnn3C)C3CN(S(C)(=O)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Hexanoyl-CoA,
N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,,pentamidine,
NC(=O)c1cccc2c1C(=O)N(C1CCN(C(=O)C3CCCCC3)CC1)C2,,9-Beta-D-Xylofuranosyl-Adenine,
CC(C)Oc1c(Cl)nc2ccc([C@](O)(c3ccc(Cl)nc3)c3cncn3C)cc2c1Cl,,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,
O=C(NCc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1)c1ccccc1,,Argadin,
O=C(O)c1cccc(-c2ccc3c(c2)C(=NNc2nc4ccccc4s2)CCC3)n1,,PD084737,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cnn(C(C)(C)C)c4)c3)c2cc1OC,,Ezogabine,
CCOc1c(Cl)nc2ccc(C(O)(c3ccc(Cl)nc3)c3cncn3C)cc2c1Cl,,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,
O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(O[C@@H]2CCCNC2)ccc1Cl,,Idelalisib,
Clc1ccc(OCCCc2cccc(CCCOc3ccc(Cl)cc3)n2)cc1,,"2,6-dibromo-4-phenoxyphenol",
CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Nc3c(C)noc3C)cc2F)CC1,,Sulfamoxole,
O=C1CC(c2ccc(Cl)cc2)CC(O)=C1Sc1ccccc1Cl,,Technetium Tc-99m etifenin,
CCN[C@H]1C[C@H](CCCO[N+](=O)[O-])S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,Zidovudine,
CSC1OC(CO)C(O)C(n2cc(-c3ccccc3)nn2)C1O,,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,,testosterone,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",
CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,
CN1CCN(c2ccc(-c3ccncc3)cc2NC(=O)c2ccccc2Cl)CC1,,Cefradine,
C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1,,Alisol B,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccc(F)cc4)c3)c2cc1OC,,"1-[3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl]-3-[1-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea",
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)Nc1ccccc1Cl,,5-Bromothienyldeoxyuridine,
CC(=O)NC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(C)=O)c1cccnc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(N)=O)c1cccnc1,,4-O-methyl-beta-D-glucuronic acid,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Aripiprazole,
c1ccc2c(c1)CCN2,,Indoline,
CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCCCC(NC(=O)C(CCC[NH+]=C(N)N)NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CCCNC(N)=[NH2+])NC(C)=O)C(=O)NC(CCCCNC(=O)c2ccc(Nc3ncc4c(n3)-c3ccc(Cl)cc3C(c3c(F)cccc3OC)=NC4)cc2OC)C(N)=O)c2cc(S(=O)(=O)[O-])ccc21,,Oxfenicine,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(N=C(N)N)cc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,JNJ-37822681,
CC(C)(C)COCC(O)CNC(C)(C)C,,PL-3994,
CCCCc1nc2cccnc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,FK-739 free acid,
Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)O)[C@H](O)[C@@H]2O)c(=O)[nH]1,,Aminocaproic acid,
Cc1cccc(C)c1CN1CCC[C@@H](NC(=O)N2CCc3[nH]nc(-c4ccc5nccn5c4)c3C2)C1,,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,
CS(=O)(=O)Nc1cncc(-c2cnc(N)nc2)c1,,Fospropofol,
CC(C)CC(N)C(=O)[C@@H]([NH3+])C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1,,S-Acetonylcysteine,
N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,,Sitagliptin,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Sc3ncnc4cc5c(cc34)OCCO5)c2)no1,,"1-(5-tert-butylisoxazol-3-yl)-3-[3-(7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-ylthio)phenyl]urea",
C=CCN1CCN(C(=O)c2nc3ccccc3nc2OCC)CC1,,Micronomicin,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(OC(=O)CCCCC)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Oxiracetam,
CC(=O)N=S(=O)([O-])c1ccc(N=CC2C(=O)Nc3ccc4ncsc4c32)cc1,,Ilomastat,
O=C(CCc1ccncc1)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,SC-51089,
OC[C@H]1O[C@@H](SS[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(F)cc4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3ccc(F)cc3)nn2)[C@H]1O,,Methylpentynol,
O=C([O-])c1ccccc1,,benzoate,
O=C(c1ccccc1Cn1cncn1)N(O)CCC(c1ccc(Cl)c(Cl)c1)P(=O)(O)O,,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",
C/C(=N\OC[C@@H](O)CNC(C)(C)C)C1CC1,,"Falintolol, (S,Z)-",
COc1cccc(F)c1CN1CCC[C@@H](NC(=O)N2CCc3[nH]nc(-c4ccncc4)c3C2)C1,,Colistimethate,
CCCCCNc1nc(Nc2ccccc2)c2ncn(CC(=O)O)c2n1,,[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid,
Cc1cc(NC(=O)Nc2ccc3sccc3c2)on1,,Hexafluoroacetone Hydrate,
O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1,,AT9283,
COc1c(O)cc2c(O)c1C=C(C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,9-(4-hydroxybutyl)-N2-phenylguanine,
CC(C)C[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Fenebrutinib,
NC(=O)CC1NC(=O)C2(CCCCC2)NC(=O)C(Cc2ccc(OP(=O)(O)O)cc2)NC(=O)CS(=O)CC(C(N)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC1=O,,"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",
Cc1cc(COc2cc(OS(=O)(=O)[O-])cc3oc(-c4ccc(OS(=O)(=O)[O-])cc4)cc(=O)c23)c(C)cc1COc1cc(OS(=O)(=O)[O-])cc2oc(-c3ccc(OS(=O)(=O)[O-])cc3)cc(=O)c12.[Na+].[Na+].[Na+].[Na+],,"(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid",
O=C1CCC(CCN2CC(N3CCC(O)CC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CC1,,"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE",
O=C(NO)[C@@H]1O[C@H]2CN(Cc3ccc(-c4ccccc4)cc3)C[C@@H]1O2,,Tertatolol,
O=c1[nH]c(O)c(Cc2cc(I)c(Oc3ccc(O)c(Br)c3)c(I)c2)[nH]1,,Seviteronel,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]1(C)NC(=O)CC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC1=O,,"(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cccc(C(C)(C)C#N)c4)c3)c2cc1OC,,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,
O=C(Cc1ccccc1)Nc1cccc(C(=O)Nc2ccccc2C(=O)O)c1,,BML-286,
O=C1c2ccccc2NC(c2ccccc2F)N1CCN1CCC(CN2C(=O)c3ccccc3NC2c2ccccc2F)CC1,,AZD-4017,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",
Nc1nc2[nH]c(SCCC3OCCCO3)nc2c(=O)[nH]1,,Netoglitazone,
CS(=O)(=O)NC(=O)c1ccc(NC(=O)Cn2c(=O)sc3ccc(Cl)cc32)cc1,,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4nccc(C(F)(F)F)n4)c3)c2cc1OC,,"US9730937, Example 143",
O=C(NCCCCC1CCCCC1)OCCCc1cnc[nH]1,,2-Deoxy-alpha-D-galactopyranose,
COC(=O)c1ccccc1NC(=O)CSc1nnc(C23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)n1C,,CS38,
CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2cccc(O)c2)C(=O)O1)C(C)C,,Epicept NP-1,
Cc1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,Vigabatrin,
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OCC2OC(O)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O,,Ecopipam,
CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC1=O,,Ornipressin,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CCCC5)no4)c3)c2cc1OC,,Sulfacetamide,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)O)cc1,,Ragaglitazar,
O=C1C(OP(=O)(O)O)[C@H](O)[C@@H](OP(=O)(O)O)C(OP(=O)(O)O)[C@H]1[PH](O)(O)O,,Dephospho Coenzyme A,
O=C(NCC1CC1)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Ranolazine,
Oc1ccc(/C=C/c2ccc(O)cc2Cl)c(Cl)c1,,PF-06305591,
CC(C)[C@@H](NC(=O)c1nc(Cl)c2ccccc2c1O)C(=O)O,,"N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid",
COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cccc(OC)c2)c1,,890190-22-4,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)N(C)C(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O,,Lodenafil carbonate,
CCC1(CC)C(=O)N(c2ccc(CSc3nc4ccccc4o3)cc2)C1=O,,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,
O=C(COc1ccccc1F)N1CCOCC1,,Ferric derisomaltose,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(=O)CCCCCCC)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Niraxostat,
O=C1CCC(CCN2CC(N3CCCC(O)C3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,Ibandronate,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,Docusate,
NC[C@@H](c1ccccc1)[C@@H](O)c1ccccc1,,Amrinone,
CS(=O)(=O)c1ccc(NC(=O)CSc2nnc(-c3ccccc3F)n2-c2ccccc2)cc1,,CS74,
N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1,,Brefeldin A,
CCCCNC(=O)NCCNCC(O)COc1ccc(-c2nc(C)c[nH]2)cc1,,"Heptane-1,2,3-Triol",
CC(C)N1CC[C@@](C#N)(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)C1,,Tiaprofenic acid,
Cc1c(NC(=O)C2CCCN2S(=O)(=O)c2ccccc2)c(=O)n(-c2ccccc2)n1C,,"N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-(phenylsulfonyl)prolinamide",
CC(=O)n1cc(N(C(=O)CCl)c2ccccc2)c2ccccc21,,N-(1-acetylindol-3-yl)-2-chloro-N-phenylacetamide,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,,T-900607,
CN(C)Cc1c(-c2ccccc2)nc2ccc(Cl)cc2c1O,,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",
O=C(O)c1c(O)c(-c2ccccc2)nc2ccccc12,,Oxycinchophen,
CCOC(=O)CCCCNCC(O)COc1ccccc1C,,Cefoxitin,
O=C(CSc1nnc(-c2ccco2)[nH]1)c1ccc(Br)cc1,,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,
O[C@H](COCc1ccccc1)[C@H]1CCCCN1,,Cronidipine,
O=C(Nc1ccc(Br)cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1,,Oxyfedrine,
COc1ccc(Cn2ccc(C)c(NC(=O)[C@@H](Cc3ccc(C(C)(C)C(=O)O)cc3)NC(=O)C(C)(C)c3ccc4ccccc4c3)c2=O)cc1,,Sparsomycin,
C[C@H]1Nc2cccnc2NC1=O,,Sucralfate,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccn1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Simendan,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCOCC1,,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,
O=C(/C=N\O)Nc1ccc[n+](CCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],,Morphine glucuronide,
CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1,,BMS-690514,
Cc1ccccc1CP(=O)(O)O,,2-Methylbenzylphosphonic acid,
CC(C)CCCC1(C)CCc2ccc(O)c(O)c2O1,,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol",
CCCCc1nc2cc(S(=O)(=O)NCC)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,Trimethoprim,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)on4)c3)c2cc1OC,,Codeine-N-oxide,
Brc1cccc([C@@H]2C[C@H](c3cccc(Br)c3)Nc3nnnn32)c1,,"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",
C[C@@H](O)C1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4(C)[C@H]3CCC12C(=O)[CH-][N+]#N,,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",
CC(C)CCCC1(C)CCc2cc(O)cc(O)c2O1,,Priralfinamide,
CCO[C@H]1CN([C@H]2CC[C@@](O)(c3ccc4c(c3)OCO4)CC2)C[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,,INCB3344,
COc1cc(CCc2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)cc(OC)c1,,D-Allopyranose,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCC(=O)NC(Cc1ccc2ccccc2c1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Odiparcil,
COc1ccc(CC=Nc2cc(O)c3cccnc3c2O)cc1Br,,Iclaprim,
CCCCc1ccnc([C@H](CC2CCCCC2)NC(=O)CCCCN)c1,,Denufosol,
Cc1csc([C@](C)(O)c2nnc(Nc3ccn(Cc4c(F)cccc4F)n3)s2)n1,,Delparantag,
CC(C)(C)c1c(Cl)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,2-Formyl-Protoporphryn Ix,
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,,GQVGRQLAIIGDDINR,
COc1cc(N2CCOCC2)ccc1-c1cc2c(Nc3ccccc3C#N)c(C(F)(F)F)cnc2[nH]1,,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,
CS(=O)(=O)C1=S=Nn2c1nc1ccc(S(N)(=O)=O)cc12,,"(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid",
COc1nc2ccc([C@](O)(c3cc(C)nc(C)c3)c3cnnn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Ascorbyl glucoside,
COCCNC(=O)[C@@H]1CCCN1C(=O)CC1(O)c2ccccc2-c2ccccc21,,"proline scaffold, 15",
CC(C)OCC(O)CNC(C)(C)C,,Cephalothin Group,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CCOCC5)no4)c3)c2cc1OC,,2-(aminomethyl)phenol,
CCCCCCCCCCCCCC(=O)NCCCC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](CCCCNC(=O)C[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)[O-])NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@H](C)[NH3+])C(C)O)C(=O)N[C@H](CCCCNC(=O)c1ccc(-c2c3ccc(=[N+](C)C)cc-3oc3cc(N(C)C)ccc23)c(C(=O)O)c1)C(N)=O,,Duvoglustat,
Cc1[nH]nc2c1[C@H](c1ccccc1C(F)(F)F)C1=C(CC(C)(C)CC1=O)N2,,Coenzyme A,
CN(C)[C@H]1CN(Cc2c(F)cccc2Br)C[C@@H]1c1ccccc1,,Etafenone,
CC(C)NCC(O)c1ccc(O)c(N)c1,,Pivampicillin,
Cc1ccc(Cn2cc(CSC(=S)N3CCN(C(=O)OC(C)(C)C)CC3)nn2)cc1,,Dofequidar,
CC(C)NCC(O)C1=COc2ccccc2O1,,(S)-AMPA,
Cc1c(F)ccc(C(=O)Nc2cc([N+](=O)[O-])ccc2N2CCN(C)CC2)c1Cl,,1422389-91-0,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1OCC(F)(F)F,,Homocysteine,
CC(C)C[C@H](NC(=O)C(C)(C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,8-oxo-dGMP,
COCCOc1c(OC)nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c(F)c3)c(N)c2cc1OC,,"US9725465, Example 143",
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(C)=O)C(C)C)CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)[C@@H](C)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)NC1=O,,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1O,,DL-alpha-Tocopherol,
O=C([O-])C1OC(OC2C(COS(=O)(=O)O[Na])OC(OC3C(C(=O)[O-])OC(OC4C(COS(=O)(=O)O[Na])OC(O)C(NS(=O)(=O)O[Na])C4O)C(NS(=O)(=O)O[Na])C3O)C(OS(=O)(=O)O[Na])C2OS(=O)(=O)O[Na])C(O)C(O)C1OC1OC(COS(=O)(=O)O[Na])C(O)C(O)C1NS(=O)(=O)O[Na],,Adrenalone,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1,,Darifenacin,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1,,Oxamic Acid,
CC(C)=CCC[C@@]1(C)[C@H](CC=C(C)C)C[C@@]2(CC=C(C)C)C(=O)C(C(=O)c3ccc(O)c(O)c3)C(=O)[C@]1(CC=C(C)C)C2=O,,Telapristone acetate,
CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,,XMD8-92,
COc1nc2ccc([C@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1C,,1-ACETYL-2-CARBOXYPIPERIDINE,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)c3)ncnc2cc1OCCN1CCOCC1,,"US9730937, Example 396",
CCN(CC)CCNS(=O)(=O)c1cccc(Cl)c1,,Mibefradil,
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)c1ccccc1)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)C(C)O,,Aspartame,
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCC(C)N1CCOCC1,,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",
C/C(CCN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN1CCOCC1,,2-O-methyl-alpha-L-fucopyranose,
Cc1ccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)s1,,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",
Cc1onc(N)c1-c1cccc(N)c1,,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,
Cc1ccc(OC[C@@H](O)[C@H]2CCCCN2)cc1,,Physostigmine,
CCc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(CC)c1CC(F)(F)F,,Chloral hydrate,
CC(=O)NCCC/C=C/Cc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Acteoside,
NC(=O)CC(NC(=O)C1(NC(=O)C(Cc2ccc(OP(=O)(O)O)cc2)NC(=O)OCc2cccc(N)c2)CCCCC1)C(N)=O,,"(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL",
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,
CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@@H](O)[C@@H](COS(=O)(=O)O)O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNc4cccc(NC(=O)CCCCC5CCSS5)c4)[C@@H]3NC(C)=O)[C@H](OS(=O)(=O)O)[C@H]2O)O[C@H](COS(=O)(=O)O)[C@H](O)[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1OS(=O)(=O)O,,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,
CCOc1ccc(-c2snnc2-c2cc(Cl)c(O)cc2O)cc1,,ICPD-47,
Fc1cc(Br)cc(C2CC(c3cccc(Br)c3)n3nnnc3N2)c1,,Cefpirome,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2OC)cc1OC,,102152-14-7,
Cc1cccc(C(=O)Nc2cc([N+](=O)[O-])ccc2N2CCN(C)CC2)c1,,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,
Clc1ccc2c(Nc3ccc(-c4ccco4)c(CN4CCCC4)c3)ccnc2c1,,Epitizide,
Cc1cc(NC(=O)c2ccc(Br)cc2)n[nH]1,,4-bromo-N-(5-methyl-1H-pyrazol-3-yl)benzamide,
CC(CCO)N(C)C(=O)CCCN1c2ccccc2N(Cc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)S1(=O)=O,,Demegestone,
COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,,hesperidin,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,,4N1K peptide,
c1ccc2nc(N3CCNCC3)ccc2c1,,quipazine,
CCN(CC)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,AZD-8165,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3F)c2cc1OC,,Sinapic acid,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccccc4)c3)c2cc1OC,,Phenolsulfonic acid,
C[C@H]1C[C@H]2[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12,,6alpha-Methyltestosterone,
N=C(N)N=C(N)Nc1cccc(Cl)c1Cl,,"N-(2,3-dichlorophenyl)imidodicarbonimidic diamide",
Cc1cc(-c2ccc([N+](=O)[O-])cc2Cl)nc(N)n1,,4-(2-Chloro-4-Nitrophenyl)-6-Methylpyrimidin-2-Amine,
O=S(=O)(Nc1ccc(Br)cc1)N1CCCCC1,,N-(4-bromophenyl)piperidine-1-sulfonamide,
Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1,,CCT245232,
Cn1ccnc1CCOC(c1cc2nccc(C(=O)O)c2[nH]1)c1ccccc1Cl,,Carbaphosphonate,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCc2ccc(C)cc21,,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,
O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(=O)NC2CCCCC2)co1,,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",
CC(=O)N(CC(=O)NCCO[C@H]1O[C@@H](COS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-])Cc1ccccc1.[Na+].[Na+].[Na+].[Na+],,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",
COc1ccc(-n2nc(C(=O)O)cc2-c2ccccc2)cc1,,1-(4-methoxyphenyl)-5-phenyl-1h-pyrazole-3-carboxylic acid,
O=C(O)CCCN1CCC[C@H]1COc1ccc(Oc2ccc(Cl)cc2)cc1,,DG-051,
CC[C@H](C)[C@H](OCc1ccccc1)[C@H]1[C@H]([N+](=O)[O-])[C@H](c2ccccc2)N[C@]1(C)C(=O)NCCC(=O)O,,Phenylferricrocin-iron,
Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,16806-29-4,
CC(=O)N(C)c1cccc(-c2nnc3ccc(-c4ccccc4)nn23)c1,,"N-METHYL-N-[3-(6-PHENYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-3-YL)PHENYL]ACETAMIDE",
CC1=C2O[C@]3(O)C=C2C(C(=O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]3C)[C@H](C)[C@H](O)[C@H]1C,,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide,
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,,linolenic acid,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTAHFGGLYPCNGP,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C#N)no4)c3)c2cc1OC,,Pyruvic acid,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1O,,Bolandiol,
C=CC=Nc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",
COc1ccc(OCCOC(=O)C2CCCCN2S(=O)(=O)c2ccc3[nH]c(=O)sc3c2)cc1OC,,2-Methoxyethanol,
CN(c1ncccc1CNc1ccnc2[nH]c(-c3ccc(F)cc3)cc12)S(C)(=O)=O,,7-Hydroxystaurosporine,
CCC(=O)Nc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1,,Brilaroxazine,
CCCNC(=S)NCCCCCc1cnc[nH]1,,Zofenoprilat,
O=S(=O)([O-])OC[C@H]1OCC[C@@H](OCCCOc2ccccc2)C1OS(=O)(=O)[O-],,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",
Clc1cccc(OCCCN2CCC(Cc3cnc[nH]3)CC2)c1,,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",
Cc1ccc(-c2nc(CCC34CC5CC(CC(C5)C3)C4)c(C(=O)Nc3cccc(C(=O)O)c3)[nH]2)c(C)c1,,"(4R,5R)-1,2-dithiane-4,5-diol",
CN(C)c1ccc([C+](c2ccc(C(=O)NCCCOP(=O)(O)OC3C(O)C(O)C(OP(=O)(O)O)C(OP(=O)(O)O)C3O)cc2)c2ccc(N(C)C)cc2)cc1,,N-[O-Phosphono-Pyridoxyl]-Isoleucine,
Cc1cc(C)c(CNC(=O)c2cccc(OC(C)C)c2C)c(=O)[nH]1,,Methallenestril,
CCNC(=S)NCCCc1cnc[nH]1,,Nomegestrol acetate,
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1C[C@@H](O)[C@@H]2O,,16alpha-Hydroxytestosterone,
CCc1cc(-n2c(=O)[nH]c3ccccc32)c(O)cc1O,,"1-(5-Ethyl-2,4-Dihydroxyphenyl)-1,3-Dihydro-2h-Benzimidazol-2-One",
CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,,VH032,
COC(=O)[C@@H](NC(C)=O)[C@@H](C)O[C@H]1O[C@H](CO)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccc(Cl)cc4)O3)[C@H]2O)[C@H]1NC(C)=O,,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,
CC(C)CCOc1cc(CN(CCC(=O)O)c2cccc(CCC(N)=O)c2)cc(OCCCN)c1,,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",
Clc1cccc(NCCCN2CCC(Cc3cnc[nH]3)CC2)c1,,[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,
Cc1nc[nH]c1CSCCNC(=O)NCCCc1cnc[nH]1,,Lisuride,
CCOC(=O)CCNCC(O)COc1cccc2ccccc12,,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",
O=C(O)c1cc2occ(CCc3ccccc3)c2[nH]1,,Isoamyl alcohol,
CO[C@@H]1CCO[C@H](COS(=O)(=O)[O-])C1OS(=O)(=O)[O-],,Poziotinib,
CCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,Fluticasone furoate,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2cccc(OC)c12,,Retapamulin,
COC(=O)C1=C(C)[N-]C(SC)=[NH+]C1c1cccc([N+](=O)[O-])c1SC,,Potassium citrate,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C4CCCCC4)c3)c2cc1OC,,Cefetamet,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccn4)c3)c2cc1OC,,"US9730937, Example 141",
CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1,,Ephedrine,
CCCC[C@H]1NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H]2CCCCN2C1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,RU84687,
CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O,,Tolazamide,
O=S(=O)(NCC1CCCC1)N1CCCC1,,"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",
NC(=O)[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21,,848193-69-1,
CC(C)C[C@@H](NC(=O)[C@H](CC1=CCCCC1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC1CCCCC1)C(=O)O,,Azelnidipine,
CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)Cc1cnc[nH]1)[C@H](C)O)[C@H](C)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CO)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCS)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C=O)[C@H](C)O)C(C)C,,[des-Phe6] glucagon,
Nc1nc2ccccc2cc1CCC(=O)NCC1CCCCC1,,Testosterone propionate,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1(C)COC1,,Protirelin,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(C)=O)C(C)C)CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)[C@@H](C)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)NC1=O,,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Sc3ncnc4cc(F)c(F)cc34)c2)no1,,Reidispongiolide A,
COc1cccc2c1C[C@@H]1C[C@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@H]1C2,,Cefadroxil,
Cc1ccc2c(Cl)c(-c3nnc(SCC(=O)O)n3-c3ccc(Cl)c(Cl)c3)sc2c1,,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",
NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1,,nadide,
CCCCCN(C(=O)OC(C)(C)C)c1nc(Nc2ccccc2)c2ncn(CC(=O)O)c2n1,,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",
Cc1ccc2sc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cc2c1,,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",
Cn1c(=O)n(CC(O)Cn2c3ccccc3c3ccccc32)c2ccccc21,,Salicylic acid,
Cc1ccc([C@@H]2CN(C(=O)C[C@H]3CC[C@H](N)CC3)C[C@H]2c2ccc(C#N)cc2)cc1,,Sinapoyl coenzyme A,
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@]1(C)CCC/C=C\CCC[C@@](C)(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)O,,Tolcapone,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(C(O)C(=O)O)cc2)NC(C)=O)cc1,,Golotimod,
Oc1cc(O)cc(/C=C/c2ccc(O)cc2Cl)c1,,Acalabrutinib,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(C(F)(F)F)c(F)c4)c3)c2cc1OC,,"US9730937, Example 150",
CNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C(c1ccccc1)c1ccccc1,,"proline scaffold, 25",
CC1Oc2ccc(CNCc3ccccc3)cc2NC1=O,,Nitromethyldethia coenzyme A,
CC(=O)NC(C(=O)N[C@H](Cc1cc2ccccc2n1C(C)=O)C(=O)NC(Cc1ccccc1)C(=O)N(C)C(C)c1ccccc1)C(C)O,,1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,
COc1ccccc1CN(CCCCCCN(C)CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)Cc1ccccc1OC)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,Ingenol mebutate,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1ccc(Cl)cc1,,Nepafenac,
C#C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(F)(F)CC[C@]4(C)[C@H]3CC[C@@]21C,,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",
CC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O,,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",
COCCOc1cc(NC(=O)Nc2cccc(Sc3ncnc4cc(OC)c(OC)cc34)c2)ccc1C(F)(F)F,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(3-(2-methoxyethoxy)-4-(trifluoromethyl)phenyl)urea",
CCOc1ccc(C[C@@H](NC(=O)Cc2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C)cc1,,K-252a,
CCC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,
CC(C)NCc1cc(Br)ccc1OCc1ccccc1,,Ulodesine,
COC(=O)CCc1ccc(OCC(O)CNCCc2ccc(OC)c(OC)c2)cc1,,N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1cn(C=O)c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,L-756423,
CCCCC1(C)CC(=O)N(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)/C(=C/C(=O)OCC)C1,,Protionamide,
COc1ccc(CCNCC(O)COc2ccc(-c3ncc(C(N)=O)[nH]3)cc2)cc1OC,,Lumicitabine,
C/C=C/C=C/C=C/C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1COC(=O)[C@@H]2C[C@@H](C)CN2C(=O)[C@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H]2CCCN2C1=O,,Antibiotic A 54556A,
CC(C)[C@H](N)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N[C@H](C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C,,H-VPPPVPPRRR-OH,
CCOC(=O)[C@@H]1CCCN(Cc2cc(-c3ccc4ccccc4c3)nc3ccccc23)C1,,"CypA Inhibitor, 1d",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c3)c2cc1OC,,"US9730937, Example 377",
O=C(/C=N/O)Nc1ccc[n+](Cc2cccc(C[n+]3cccc(NC(=O)/C=N/O)c3)c2)c1.[Br-].[Br-],,Protiofate,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCOCC1,,Bibrocathol,
NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1,,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCCC/C=C/CN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Topiramate,
Cc1noc(-c2ccccc2)c1CN1CCC[C@@H](NC(=O)N2CCc3[nH]nc(-c4ccncc4)c3C2)C1,,6-o-Capryloylsucrose,
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,Lifitegrast,
O=C(NCCC12CC3CC(CC(C3)C1)C2)c1ccccc1Cl,,"[(2R,3S,4R,5R)-5-(4-acetonyl-3-carbamoyl-pyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphate",
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O,,Deflazacort,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCC(F)(F)F)C4)cc3)nn3cccc23)n[nH]1,,Flovagatran,
C=CC=Nc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](OC(=O)CCN)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,Dolastatin 10,
CCCCOc1ccc(-c2ccc(C(=O)NC(Cn3ccnc3)c3ccc(Cl)cn3)cc2)cc1,,"Azole, 17",
CC1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CN5CCN(CCCO)CC5)c4)ccc3F)c2)CCN1,,Troleandomycin,
O=C(O)c1cc(-c2ccc(CNC(=S)c3ccc(-c4nc(=O)o[nH]4)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Carbaspirin calcium,
c1ccc(C(CCc2ncc(CCNCCc3ccncc3)[nH]2)c2ccccc2)cc1,,Bezafibrate,
Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(Cl)c(CC(F)(F)F)c(N3CCC3)c2c1,,"US10201546, Example 140a",
O=c1c2ccccc2nc(-c2ccc(OS(=O)(=O)O)cc2)n1CCCCCn1cc(Cn2c(-c3ccc(OS(=O)(=O)O)cc3)nc3ccccc3c2=O)nn1,,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)N(C)N,,[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,
COc1ccc(CC(NC(C)=O)c2ccc3cccnc3c2O)cc1OC,,CS32,
NCCCC[C@@H]1NC(=O)[C@H](c2ccccc2)NC(=O)[C@H](CNC(=O)Cc2ccccc2)NC(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H](CN)NC1=O,,Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,
NCCCCCCc1cnc[nH]1,,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,
O[C@H]1[C@@H]2CCO[C@@H]3OC[C@@](O)([C@@H]32)[C@@H]1O,,Rehmaglutin A,
COc1c(C(C)=O)c(OCc2ccc(COc3cc4occc4c(OC)c3C(C)=O)cc2)cc2occc12,,Pyridoxyl-Glutamic Acid-5'-Monophosphate,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1cccnc1,,2'-Monophosphoadenosine-5'-Diphosphate,
O=C1CC(c2c(Cl)cccc2Br)CC(O)=C1Sc1ccccc1Cl,,Atreleuton,
CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC1=O,,Sansalvamide A amide,
O=C(CN1C(=O)N(CC(=O)N2CCCC2)c2ccccc2N(c2ccccc2)C1=O)Nc1cccc(C(=O)O)c1,,Laquinimod,
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCN(C2CCCCC2)C1,,Pexidartinib,
C[C@@]1(NCC2CCCC2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.Cl,,Glycinamide,
O=C(OC[C@H]1O[C@@H](O[C@@H]2OC=C[C@@H]3[C@H]2[C@](O)(CO)C[C@H]3OC(=O)c2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O)c1ccc(O)cc1,,Pholcodine,
O=C1c2ccc(F)cc2NC(c2ccccc2F)N1C1CCN(CCCn2ccnc2-c2ccccc2)CC1,,PF-06650833,
Cc1cc(O)cc2cc3c(c(O)c12)C(=O)CCC3O,,Okicenone,
N=C(N)NCCC(c1ccc(F)cc1)c1ccccn1,,"(5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione",
COC(=O)c1ccccc1OCC(O)CNCCc1ccc(OC)c(OC)c1,,2-Butanol,
CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)NC2CCCCC2)cc1,,Amuvatinib,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,"({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid",
CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1,,OICR-9429,
Cc1cc(OCC(=O)N2CC(C)OC(C)C2)cc(C)c1Cl,,Varespladib,
CC[N+](C)(CC)CCCn1c2cc(=[NH2+])ccc-2c2ccc(N)cc2c1-c1ccccc1,,PROPIDIUM,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCS(C)(=O)=O,,Enrasentan,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC=CCCCCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",
CCCc1cc(C(=O)Cc2ccc3c(c2)OCO3)c(O)cc1O,,Dexamethasone isonicotinate,
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,,"3-(4-carbamoyl-1-carboxy-2-methylsulfonyl-buta-1,3-dienylamino)-indolizine-2-carboxylic acid",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,"1,3-diphenylurea",
Oc1cc(F)ccc1CNc1ncccc1-c1ncccn1,,5-Fluoro-2-({[3-(Pyrimidin-2-Yl)pyridin-2-Yl]amino}methyl)phenol,
COc1cccc(-c2nc(SCC(=O)Nc3ccc(S(N)(=O)=O)cc3)[nH]c(=O)c2C#N)c1,,5'-S-ethyl-5'-thioadenosine,
CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,,Paclitaxel docosahexaenoic acid,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)Nc1ccccc1,,Zomepirac,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)C)no4)c3)c2cc1OC,,Cytidine-5'-Triphosphate,
O=C1Nc2nc(N[C@H]3CC[C@H](O)CC3)ncc2CN1c1ccccc1Cl,,Tanomastat,
Clc1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccc(Cl)cc2)cc1,,"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid",
CC1=CCC2C(C1)c1c(O)cc(CC#CCBr)cc1OC2(C)C,,Glycopyrronium,
NC(=O)[C@@H]1CCCN1C(=O)CCNc1c(O)c(=O)c1=O,,Opicapone,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC[C@@H](O)CN1CCN(C)CC1,,Dabigatran etexilate,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(C)C,,Ipatasertib,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNC1CCCC(C(F)(F)F)C1,,"US10201546, Example 201",
CCCNc1nnc(Sc2ncc([N+](=O)[O-])s2)s1,,Ceftobiprole medocaril,
C=Cc1c2[nH]c(c1C)C=c1[nH]c(c(CCC(=O)NCCCCCCNC(=O)c3cc4ccccc4c(-c4ccccc4I)n3)c1C)=C1C=C(O)c3c1[nH]c(c3C)C=c1[nH]c(c(C)c1CC)=C2,,Nitrazolam,
CCCc1nc2c(C)cc(C(=O)NCC(C)c3ccccc3)cc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Albaconazole,
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2CCCCCCC2)cc1,,Trofinetide,
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(-c2cccc(F)c2)nc1,,1033836-12-2,
COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,Adenosine Phosphonoacetic Acid,
O=[N+]([O-])c1c(Nc2cccc(Cl)c2F)ccc2nonc12,,Bentazepam,
SCc1cccs1,,2-Thiophenemethanethiol,
CSc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1,,(R)-3-hydroxydecanoyl-CoA,
O=C(O)c1ccc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1,,195457-74-0,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCN(S(C)(=O)=O)CC1,,Clostebol,
COc1cc2c(cc1OC)CN(CC1CCN(Cc3cc(Cl)cc(/C=N/O)c3O)CC1)CC2,,"Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose",
N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CC3CCCCC3N2C(=O)[C@H]2Cc3ccccc3CN2C(=O)[C@H](Cc2ccccc2)NC(=O)CNC1=O,,Mycophenolic acid,
CCCCCCCOc1ccc(C(=O)[O-])cc1Cl,,"benzoic acid derivative, 13",
O=C(Cc1ccccc1)N(O)CCCP(=O)(O)O,,TD-139,
CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,,SSGPTIEEVD,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 181",
O=C1COc2cc(O)ccc21,,6272-26-0,
COc1cc(OC2CCOCC2)c2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2c1,,Curcumin,
CCC[C@@H](CC[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(C)Cc1csc(C(C)C)n1)C(C)C)NC(=O)OCc1cncs1,,"N~2~-(Methyl{[2-(Propan-2-Yl)-1,3-Thiazol-4-Yl]methyl}carbamoyl)-N-[(2r,5s)-1-Phenyl-5-{[(1,3-Thiazol-5-Ylmethoxy)carbonyl]amino}octan-2-Yl]-L-Valinamide",
C[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(O)cc2)NN)CSSSSC[C@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC1=O,,Biapenem,
O=C1c2cc(F)ccc2NC(c2ccccc2F)N1CCOc1ccc(-c2nc3ccccc3n2Cc2ccncc2)cc1,,[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium,
CCOc1ccc(/C=C2\SC(=S)N(CCNCc3ccc(C(=O)O)cc3)C2=O)cc1,,Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate,
N#C[C@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCN(CC2CCCCC2)C1,,Refametinib,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOc3ccccc3)co2)cc1)c1cccnc1,,Xylarohydroxamate,
O=C(NCC(c1ccccc1)n1ccnc1)c1cccc(Sc2ccccc2)c1,,"Azole, 10",
CN(CC(=O)Nc1ccccc1C(=O)N1CCCC1)CS(=O)(=O)c1ccc(Br)cc1,,"N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)-2-propanyl]acetamide",
COc1cc(OC)c(S(=O)(=O)N(C)c2ccccc2)cc1NC(C)=O,,Dazoxiben,
CCCOc1ccc(-c2cc(C(=O)O)c3ccccc3n2)cc1,,2-(4-propoxyphenyl)quinoline-4-carboxylic acid,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5CCC5)nn4-c4ccccc4)c3)c2cc1OC,,Flucytosine,
Cc1cc(C)c(CN2CCc3ccc(OC(C)C)c(C)c3C2=O)c(=O)[nH]1,,PF-04937319,
Cn1cncc1[C@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(OCC(F)(F)F)c(Cl)c2c1,,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",
COc1ccc(-c2cnc3c(OC4CCCCC4)snc3c2)cc1OC,,2-Nitro-4-cresol,
Cc1ccccc1COC[C@@H](C#N)NC(=O)[C@H](CC(C)C)NC(=O)N1CCOCC1,,4-Iodopyrazole,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)C)nn4-c4ccc(C(F)(F)F)cc4)c3)c2cc1OC,,"US9730937, Example 374",
COCCOCOc1ccc2c(c1)[C@H](NC(=O)c1ccccc1)[C@@H](O)[C@H](CC(=O)O)N2C(=O)OCC[Si](C)(C)C,,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,
COc1cc2ncnc(Oc3cc(NC(=O)Nc4cc(C(F)(F)F)nn4-c4ccccc4)ccc3F)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluorophenyl)-3-(1-phenyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)urea",
CSCC[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)O)C(C)C,,"2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN3CCC3)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,Didesmethylrocaglamide,
Nc1ccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)cc1,,MK-1064,
Nc1nc2c(c(=O)[nH]1)NCN2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,,guanidinetriphosphate,
O=C1CCCC2(CCN(c3nc4cc(Cl)ccc4o3)CC2)N1Cc1cccc2[nH]ccc12,,Ginsenoside Rb1,
CCCCC(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Cannabichromene,
CC(C)(C)NC[C@H](O)c1ccc2c(c1)CO[B-](O)(O)O2,,BMS-181156,
CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,TNYLFSPNGPIARAW,
N#Cc1c(-c2cc(Cl)ccc2Cl)cc(-c2cc(Br)ccc2O)[nH]c1=O,,Alpha-Methyl-N-Acetyl-D-Glucosamine,
Cn1cncc1[C@](O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(Cl)c(CC(F)(F)F)c(N3CCC3)c2c1,,Diundecyl Phosphatidyl Choline,
COc1cc(OC)c(CC(C)N)cc1C,,79440-50-9,
COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,,prazosin,
c1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1,,Clonazepam,
COC(=O)c1ccccc1NC(=O)CSc1nnc(-c2ccc(OC)cc2)n1C,,"methyl 2-[({[5-(4-methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetyl)amino]benzoate",
NC(N)=NCCC[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O,,"{[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum",
Ic1cccc([C@@H]2C[C@H](c3ccccc3)n3nnnc3N2)c1,,Darglitazone,
CCCc1nc2c(C)cc(C(=O)NCCc3ccccc3)cc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Bromazepam,
COc1ccc(-c2cccc(-c3cc4nccn4c(Nc4ncccc4C(N)=O)n3)c2)cc1,,L-Gluconic Acid,
COc1ccc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)cc1,,ERB-196,
O/N=C/c1nc(CCCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,,4-O-Demethylpenclomedine,
CN(C)CCC1CNc2ccccc21,,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOc3ccccc3)co2)cc1)c1cccnc1,,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,
COc1ccccc1N1CCN(CC2CC(=O)c3ccoc3C2)CC1,,Dioxyselenocysteine,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CCSS[C@@H]2C[C@@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@@H](Cc2cnc[nH]2)NC1=O)C(C)C,,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",
O=[N+]([O-])c1c(Nc2ccc(Cl)c(C(F)(F)F)c2)ccc2nonc12,,Isoprenaline,
COc1c(C(=O)CCc2ccccc2)c(O)c(OC)c2occc12,,Meprednisone,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",
COc1ccc(CN(CCN(C)CCCCCCNC(=O)c2ccc(-c3c4ccc5cc(O)ccc5c4oc4c3ccc3cc(=O)ccc34)c(C(=O)O)c2)c2ccccn2)cc1,,Merbromin,
Cc1cc(C)c2cc1C(=O)NCCCC(=O)NCCSc1cc-2nc(N)n1,,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",
c1ccc(Cn2c(-c3ccc(OCC(C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,,1440754-12-0,
O=C(COc1ccc(S(=O)(=O)NC2CCCC2)cc1)N1CCOCC1,,N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine,
CCOP(=O)(C#N)N(C)C,,TABUN,
O=C(O)c1sc2cc(Cl)ccc2c1Cl,,34576-94-8,
CC(C)Oc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1C(C)C,,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",
O=C(NP(=O)(Cl)Cl)c1ccc(Br)cc1,,"Carbacylamidophosphate, 2a",
CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](/C=C(\C)C(=O)O)C(C)C)C(C)(C)SC)C(C)(C)c1ccccc1,,(R)-Propylene glycol,
Cc1ccccc1COC[C@@H](C#N)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1CCOCC1,,Idronoxil,
C[C@@H](Nc1nc(-c2ccccc2C(=O)O)cnc1N)c1ccccc1,,Captopril,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccncc1)c1ccc(F)cc1,,"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",
C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,,"R,R-Fenoterol",
Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NCCCCCC(=O)NCCO)[C@@H](O)[C@H]1O,,"3-Aza-2,3-Dihydrogeranyl Diphosphate",
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCc1ncccn1,,Anthranilic acid,
C[n+]1c(C#Cc2ccc(-c3ccccc3)cc2)cccc1C#Cc1ccc(-c2ccccc2)cc1,,Navitoclax,
CC(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2cnco2)cc1,,Atorvastatin,
Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C,,Lumiflavin,
O=C(Nc1cccc([N+](=O)[O-])c1)c1cnc2ccccc2n1,,"6,8-DIMERCAPTO-OCTANOIC ACID AMIDE",
COCCOc1cc(NC(=O)Nc2cccc(Sc3ncnc4cc(OC)c(OC)cc34)c2)cc(C(F)(F)F)c1,,"1-(3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl)-3-(3-(2-methoxyethoxy)-5-(trifluoromethyl)phenyl)urea",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)CN(C)[C@@H]1C2,,Dienestrol,
O=C(O)CSc1nnc2c3ccccc3c3ccccc3c2n1,,NSC327704,
COC(=O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C,,Citarinostat,
Cc1cc2c(NCc3cccnc3N(C)S(C)(=O)=O)ncnc2[nH]1,,Norfenefrine,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nc(C)n2C,,"(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate",
O=C(O)CSc1nnc(-c2ccccc2Cl)n1-c1cccc(Cl)c1,,Trehalose-6-Phosphate,
CCCCOc1ccc([C@@H](C)NCCCNCCC(c2ccccc2)c2ccccc2)cc1OCCCC,,"N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(2 3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE",
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,"[Mpa1, D-Tyr(Et)2, Pip7]OT",
O=C(c1ccc(F)cc1)C1CCN(CCC2CCc3ccsc3C2=O)CC1,,4-[(Isopropylamino)Methyl]Phenylalanine,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1,,Sulfathiazole,
N#C[C@@]1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCNC1,,Birabresib,
Nc1nc(Nc2cccc(Br)c2)c2[nH]cnc2n1,,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,
CC(Cc1ccc(O)cc1)(NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(=O)OCc1cccc(N)c1)C(=O)NC(CC(N)=O)C(N)=O,,Sulfaguanidine,
CCC(=O)OCC(O)CNC(C)(C)C,,Ligandrol,
CC1(C)SCN(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)COc2ccccc2)C1C(=O)N[C@H]1c2ccccc2C[C@H]1O,,Sivifene,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 379",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CN(C)CC(F)(F)F,,"US10201546, Example 198",
CN(C)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(/C=C/c2ccccn2)cc1,,"5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole",
CCCCCN(C(=O)OC(C)(C)C)c1nc(NC2CCOCC2)c2ncn(CC(=O)O)c2n1,,Probucol,
COc1c(O)cc2c(O)c1C=C(C)C[C@H](OC)[C@H](OC(=O)CCN)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,Pyrazolam,
Oc1c(F)cc(CC=Nc2cc(O)c3cccnc3c2O)cc1F,,Leukotriene B4,
CC(C)(C)C12COC(c3ccc(N=C=S)cc3)(OC1)OC2,,119963-45-0,
COc1cccc(/C=C2/SC(=S)N(C(Cc3ccccc3)C(=O)O)C2=O)c1,,"Thiazolidinone core, 28",
O=C1c2ccccc2NC(c2ccccc2F)N1CCCCCCN1C(=O)c2ccccc2NC1c1ccccc1F,,"N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",
COc1ccc(NC(=O)CSc2nnc(-c3ccncc3)[nH]2)cc1,,CBKinase1_004714,
CC(C)c1c(O)ccc2c1CC[C@H]1C(C)(C)CCC[C@]21C,,Totarol,
NCCCCCCCCc1cnc[nH]1,,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,
Cc1[nH]n(C(=O)c2ccc(Cl)cc2)c(=O)c1N=Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,,2-deoxyglucose,
CC(C)NCC(O)COc1ccc(Cc2ncc(Br)[nH]2)cc1,,Beclabuvir,
Cc1ccc(/C=N/NC(=O)c2ccccc2Oc2ccccc2)o1,,PNU-74654,
CN(Cc1cc(Cl)cc(-c2cc(-c3cc(C(F)(F)F)ccc3Cl)c(C#N)c(=O)[nH]2)c1O)C(=O)C1CCN(C(=O)C2CCCCC2)CC1,,JE-2147,
Oc1cc(CCl)ccc1Oc1ccc(Cl)cc1Cl,,"5-(chloromethyl)-2-(2,4-dichlorophenoxy)phenol",
CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C,,GSGPTIEEVD,
O=C1c2cccc3c([N+](=O)[O-])ccc(c23)C(=O)N1Cc1cccnc1,,MLS000766022,
Cc1ccc(S(=O)(=O)CC(=O)N2CCOCC2)cc1,,1-morpholino-2-tosylethanone,
O=c1cc(-c2cccc(C=Cc3ccc4ccccc4n3)c2)oc2ccc(-c3nnn[nH]3)cc12,,Calcium silicate,
C[C@@H]1O[C@@H]2CO[C@@]3(CNS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,,Fluocinolone,
Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12,,LX7101,
CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,(Diaminomethyl-Methyl-Amino)-Acetic Acid,
Nc1nc2c(ncn2COCCO)c(=O)[nH]1,,acyclovir,
COC1CCC(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)CC1,,Olodaterol,
C[C@@H](CN[C@H](c1ccccc1)P(=O)(O)O)c1ccccc1,,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",
Cc1nnc(OC2CCNCC2)cc1C(=O)NCC12CC3CC(CC(C3)C1)C2,,Dolutegravir,
COC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)C1C(=O)CC2C1=CC(=O)CC2(C)C,,"Cyclophilin Inhibitor, 3a",
O=C(CSc1cccc2cccnc12)N1CCOCC1,,Trehalose,
CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O,,Tyropanoic acid,
O=C(Nc1nc2ccccc2[nH]1)c1ccc(Cl)cc1,,N-(1H-benzimidazol-2-yl)-4-chlorobenzamide,
CCCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1-c1nc(CC)cc(=O)[nH]1,,Phenserine,
Nc1nc2[nH]c(SCc3cccc([N+](=O)[O-])c3)nc2c(=O)[nH]1,,AZD-7687,
CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C/C=C/c2ccc(CNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O,,Iodoxamic acid,
CCCCCCc1cccc(CCCCCC)[n+]1C,,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",
CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H](CN1CCCC1)c1cccc(N=C=S)c1,,155512-49-5,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,Lenalidomide,
COc1cccc(/C=C2\Oc3c(CN(C)C)c(O)cc(C)c3C2=O)c1,,903852-67-5,
CC(=O)N[C@H](C(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C)c1ccccc1,,Ibudilast,
Cc1nc(C)c([C@@](O)(c2ccc3nc(N4CCC4)c(OC(C)C)c(Cl)c3c2)c2cnnn2C)s1,,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",
O=C([O-])C1=C[C@@H](OP(=O)(O)O)[C@@H](O)[C@H](O[C@](CF)(OP(=O)(O)O)C(=O)O)C1,,4-Nitrocatechol sulfate,
CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)CCCCCCCCCCCCC(=O)Nc3ccc4c(c3)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C4)ccc2N1C,,Arbaclofen Placarbil,
O=C(O)c1cccc(NC(=O)c2[nH]c(C34CCC(CC3)CC4)nc2COC23CC4CC(CC(C4)C2)C3)c1,,Trametinib,
CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,dorzolamide,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(-c5cc(F)cc(F)c5)c5cc(F)ccc54)CC3)CC2)ccn1,,"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1ncn2Cc1ccccc1,,Dihydroxyacetone phosphate,
COc1ccccc1C(=O)CSc1nc2nc(N)[nH]c(=O)c2[nH]1,,L-valinol,
COc1ccc(CCNCC(O)COc2ccc(CCOCC3CCC3)cc2)cc1OC,,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",
CC(C)=CCCC(C)=Cc1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12,,Lumiracoxib,
COC(=O)Cc1ccc(OCC(O)CNC(C)C)cc1,,"N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide",
O=C(O)c1cc(C(F)(F)F)ccc1SCC(=O)N1CCOCC1,,Afuresertib,
C/C(CN1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2c[nH]c3ccccc23)C1)=N/OCCN1CCOCC1,,5-Iodouracil,
CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2cccc(N)c2)n1,,"BIRB-796 derivative, 13",
CC(C)C[C@H](NC(=O)CN1CCCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,BMS-986020,
Cc1ccc(Cl)cc1NS(=O)(=O)N1CCCCC1,,N-(5-chloro-2-methylphenyl)piperidine-1-sulfonamide,
O=[N+]([O-])c1c(Nc2ccc(Cl)c(Cl)c2)ccc2nonc12,,OREGON GREEN 488 CARBOXYLATE,
CC(C)(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,
COc1ccccc1-n1nnnc1SCC(=O)Nc1ccccc1SC,,CBKinase1_007345,
O=C1C=CC(=O)c2ccccc21,,"1,4-NAPHTHOQUINONE",
CC1CN(CCCn2c3ccccc3c3ccccc32)CC(C)N1CCCCCCN=C=S,,"2,4,6-Tribromophenol",
CCC(N=O)c1ccc(OCCCc2cnc[nH]2)cc1,,Dihydroergocornine,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C,,Rutin,
COc1ccc(CCN(C)CCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,,(-)-verapamil,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCN(C)CC1,,L-methionine (S)-S-oxide,
CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C2(CCCC2)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,,S-P-Nitrobenzyloxycarbonylglutathione,
COc1ccc2c(c1)c(CC(=O)Nc1cccnc1)c(C)n2C(=O)c1ccc(Cl)cc1,,N-(3-Pyridyl)indomethacin Amide,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C,,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",
CN(C)[C@H]1CN(Cc2c(F)cccc2Br)C[C@@H]1c1ccc(O)cc1,,Aluminium nicotinate,
C[C@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,NVP-LEQ-506,
N#C[C@H](COCc1ccc(Cl)cc1)NC(=O)[C@@H](CC(=O)N1CCOCC1)CC1CCCCC1,,Methyltestosterone,
CNc1cccc(NC(=O)C[C@@H]2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Thio-Maltopentaose,
c1ccc(-c2nnn[nH]2)nc1,,33893-89-9,
CC1(O)CC[C@H]2[C@@H]3CC=C4CC(O)CC[C@]4(C)[C@H]3CC[C@@]21C,,Trifluoroethanol,
NC(=O)c1ccc(-c2ccc(C(=O)O)cc2)cc1,,4-(4-carbamoylphenyl)benzoic Acid,
O=C(CCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO,,MRX-I,
Oc1ccc2[nH]ccc2c1,,5-Hydroxyindole,
O[Se]c1ccccc1,,phenylselenenic acid,
Cn1ncc2cc([C@@H]3CN(C(=O)c4ccc(CN)cc4)C[C@H]3c3ccc(C#N)cc3)ccc21,,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC1CCCCC1)C(=O)O,,Finafloxacin,
CCOC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OCCOC)c(OC)cc34)c2)n(-c2ccccc2)n1,,Etofenamate,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CC(C(F)(F)F)C1,,"US10201546, Example 118",
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O,,"5alpha-androstane-3beta,17alpha-diol",
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1(C)CC1,,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CN2CCC(F)(F)C2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Thymol,
CCCc1ccccc1OCC(O)CNC(C)C,,DIHYDROALPRENOLOL,
Cc1ccc([C@@H]2CN(C(=O)CC3CCNCC3)C[C@H]2c2ccc(C#N)cc2)cc1,,Hydroxystilbamidine,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1(C)COC1,,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",
CCOC(=O)CCNCC(O)COc1ccc(Cl)cc1,,"D-1,4-dithiothreitol",
COc1nc2ccc([C@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1CC1CC1,,"3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one",
C[C@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@@H](O)[C@@H]1O,,Gusperimus,
CC(=O)NC1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Tetraferric tricitrate decahydrate,
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,Guanosine-5'-Diphosphate-Rhamnose,
CC(=O)Nc1cncc(-c2cnc(N)nc2)c1,,Thiocellobiose,
CN(C)CCC1CCc2ccccc21,,Sabarubicin,
Fc1cc(Br)cc([C@H]2C[C@@H](c3cccc(Br)c3)n3nnnc3N2)c1,,ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate,
Cc1ccoc1C(=O)Nc1cccnc1,,Deanol,
N#C[C@H](COCc1ccccc1Cl)NC(=O)[C@H](CC1CCCCC1)NC(=O)N1CCOCC1,,Avasimibe,
COC(=O)c1c(O)cc(O)c(Cl)c1CCC(=O)Nc1nncs1,,Histidyl-Adenosine Monophosphate,
Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@H](CC(=O)OC1CCC(O)CC1)c1nnc(C)n1-2,,Benazeprilat,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c3)c2cc1OC,,Carboxin,
COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4-c4ccccc4)CC3)nc(N)c2cc1OC,,Hydroxytyrosol,
c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1,,398473-34-2,
Brc1cnc2[nH]cc(I)c2n1,,875781-44-5,
COC(=O)[C@]12CCCN1C[C@](Cc1ccc3ccccc3c1)(NC(=O)OC(C)(C)C)CC2,,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",
CC(C)C[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Raloxifene,
CN(C)c1ccc(C(=O)NC2CCN(CC(F)(F)F)CC2)cn1,,Cilansetron,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Propionamide,
CCCCc1nc2cc(NC(=O)c3ccccc3)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,MK-6186,
O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,kaempferol,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)F)no4)c3C)c2cc1OC,,3-Amino-6-Hydroxy-Tyrosine,
CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,Phenol,
O=C(O)c1cc(-c2ccc(C(=S)NCc3ccc(-c4ccc(C(=O)O)o4)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Etelcalcetide,
Cc1cnc(Cc2ccc(OCC(O)CNC(C)(C)C)cc2)[nH]1,,Abacavir hydroxyacetate,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,Balanol Analog 2,
NC(=O)c1cccnc1Nc1nc(-c2ccc3c(c2)OCO3)cc2nccn12,,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCCN1CCCCC1,,Acetylcarnitine,
CC(C)c1csc(C=Cc2ccn3c(=O)c(-c4nnn[nH]4)cnc3c2)n1,,"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",
N[C@@H](Cn1ccc(=O)n(CCCC(=O)O)c1=O)C(=O)O,,N-Methyl-Pyridoxal-5'-Phosphate,
C#CCNCC(=C)N(CC(=O)N(CCO)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(N)=O)Cc1ccco1)Cc1ccco1)Cc1ccc2c(c1)OCO2)Cc1ccco1,,AGN-201904,
COc1cccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)c1,,Isavuconazole,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C#N)on4)c3)c2cc1OC,,"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",
O=C(Nc1ccc(OCC(=O)N2CCOCC2)cc1)c1cccnc1,,Antimony potassium tartrate,
CC(C)NC=Nc1ccc(-c2c[nH]cn2)cc1,,Mifentidine,
c1ccc(-c2cc[nH]n2)cc1,,3-Phenyl-1H-pyrazole,
c1ccc(-c2nc3ccccc3[nH]2)nc1,,2-(2-Pyridyl)benzimidazole,
COc1nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,7-Keto-8-Aminopelargonic Acid,
CC(C)C[C@H](NP(=O)([O-])O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)[O-],,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",
CCS(=O)(=O)CCC(=O)NCC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,Diosmin,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCCCC=CCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Fica,
O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,D-Proline,
O=C(O)c1cc(C(=O)O)cc(C(=O)O)c1,,Trimesic acid,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)c1cnc(C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2)s1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,5-Nitroindazole,
Nc1ccc2cc(-c3ccc(Cl)cc3)ccc2n1,,Resiquimod,
Cc1cc(O)cc(C)c1C[C@H](C(=O)N1Cc2ccccc2CC1C(=O)O)N(C)C,,Carindacillin,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccnc4)c3)c2cc1OC,,Teverelix,
c1ccc2c(c1)CCC2Nc1nc2ccccc2[nH]1,,(1H-Benzoimidazol-2-yl)indan-1-ylamine,
O=C(OC[C@H](C1CCNCC1)n1c(C2CC2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccsc2)CC1,,Thiamine(1+) monophosphate,
[N-]=[N+]=Nc1ccc(C(=O)NCc2c(Cl)c(Cl)cc3c2Oc2cc(Cl)c(Cl)cc2O3)c(O)c1,,"Photoaffinity ligand, 7",
Cl.NCc1ccc(-c2ccoc2)c(Cl)c1,,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,
CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1,,1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Phenylurea,
COc1ccccc1NC(=O)CSc1nnc(-c2ccc(F)cc2)n1C,,ZINC01124981,
C[C@@H](Nc1nc(-c2cccc(C(N)=O)c2)cnc1N)c1ccccc1,,Glutamine hydroxamate,
O=C(CCCN1c2ccccc2N(Cc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)S1(=O)=O)N1CCCC1,,Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose,
Cc1c(C(=O)O)coc1/C=C/c1ccc(Cl)o1,,Ncs-Chromophore,
O=C1CCC(CCN2CC(N3CCOC(c4ccccc4)C3)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,N-6022,
CCCCN1CCC(COC(=O)c2cc(Cl)c(N)c3c2OCCO3)CC1,,SB 204070 hydrochloride,
NCCOc1c(-c2ccc(N3CCCC3)cc2)[nH]c(=O)c2cc(F)ccc12,,Fluprostenol,
CSCC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CO)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(=O)O)[C@H](C)O,,"[des-His1, des-Phe6] glucagon",
COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCCCCCCCNC(=O)CCCCCNC(=O)COc4ccc([CH+]/C=c5/ccc6n5[B-](F)(F)n5c(ccc5-c5cccs5)C=6)cc4)nc4ccccc4n3c2=O)cc1,,(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester,
O=C(NCC(c1ccccc1)n1ccnc1)c1cccc2c1oc1ccccc12,,"Azole, 6",
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)c2cc1OC,,Diclofenac,
NC(=O)c1ccc(Nc2nnc(-c3ccc(O)cc3)c3ccccc23)cc1,,4-Methyl-N-[(2S)-1-oxo-3-phenyl-1-[[(3S)-1-phenyl-5-(phenylmethoxysulfamoyl)pentan-3-yl]amino]propan-2-yl]piperazine-1-carboxamide,
Nc1cc(C(F)(F)F)c2ccccc2n1,,4-(trifluoromethyl)quinolin-2-amine,
O=C(NO)[C@@H]1O[C@H]2CN(Cc3ccc(-c4ccccc4)cc3)C(=O)[C@@H]1O2,,Jaspisamide A,
CCCc1nc2c(C)cc(C(=O)NCCc3cccc(OC)c3)cc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Cefalotin,
C[N+](C)(CC#CCOC1=NOCC1)CCCCCCNC(=O)c1cn(Cc2ccccc2)c2cc(Br)ccc2c1=O,,Nalmefene,
COc1ccc(COc2ccc(Br)cc2-c2cc(CCl)on2)cc1,,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,
Cc1ccc([C@@H]2C(=O)N([C@H]3CC[C@H](N)CC3)[C@H]2c2ccc(C#N)cc2)cc1,,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,
COc1ccc(CN(CCN(C)CCCCCCNC(=O)CCC2=C3C(C)=CC(C)N3[B-](F)(F)n3c(C)cc(C)c32)c2ccccn2)cc1,,Androstenedione,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1ncn2C,,SAR-405838,
COc1nc2ccc([C@@](O)(c3cnc(C)n3C)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Apigenin,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O)cc1,,2'-Deoxycytidine-5'-Monophosphate,
NC(=O)c1cccc2c1C(=O)N(C1CCN(CC3CC3)CC1)C2,,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,
O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Br)cc1,,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine",
CCC1(CC)C(=O)N(c2ccc(CSc3nc4cc(C(=O)O)ccc4o3)cc2)C1=O,,D-erythrose 4-phosphate,
O=C1N=C(S)SC1=Cc1ccccc1,,5-Benzylidenerhodanine,
COc1cc(-c2nnc(SCC(N)=O)n2C)cc(OC)c1OC,,CBKinase1_003008,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=N)NCCCN(C)C)CC5)CCCC4)c3Cl)c2n1,,HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE,
Cc1cccc(C[C@H](NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@H]2C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2CCC[C@H]2C(=O)O)c1,,Ropinirole,
C[C@@H](O)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(CC(=O)O)cc2)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O,,Chromium nicotinate,
OC(CNCCc1c[nH]c2ccccc12)Cn1c2ccccc2c2ccccc21,,DC_05,
CCOC(=O)CCNCC(O)COc1ccccc1,,Lafutidine,
Cn1c(=O)ccc2ccccc21,,1-METHYL-2-QUINOLINONE,
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)NO,,AL5424,
NC(=O)[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,,Tibezonium iodide,
COC(=O)c1cc(C(=O)Nc2ccc(S(=O)(=O)Nc3onc(C)c3C)cc2)ccc1NCc1ccccc1,,"CypA Inhibitor, 3b",
CCOC(=O)C1=C(C)NC(N(C)C)=NC1c1cccc([N+](=O)[O-])c1,,Tienilic acid,
CCc1cc(NC(=O)Nc2cccc(Sc3ncnc4cc(OC)c(OC)cc34)c2)n(-c2ccccc2)n1,,4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,
COC(=O)[C@H](Cc1cccc(O)c1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1,,DEBIO-1347,
COc1ccc2c(c1)c(CC(=O)NCCc1cccc(Cl)c1)c(C)n2C(=O)c1ccc(Cl)cc1,,SC45647,
COc1cccc(CC(C)N)c1OC,,"2,3-Dimethoxyamphetamine",
COc1ccc(CCNC(=O)Cn2nc(-c3ccccc3)cc(-c3ccc4c(c3)OCO4)c2=O)cc1OC,,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",
O=C(CSc1nc2ccccc2o1)Nc1ccc(-n2cnnn2)cc1,,333414-48-5,
CC1=CC(=O)O[C@@H]1[C@@H](O)/C=C(\C)CC[C@@H]1[C@@]2(C)CCC[C@@](C)(CO)[C@@H]2[C@@H](O)C[C@@]1(C)O,,Meladrazine,
N#Cc1ccccc1CSc1nc2c(=O)[nH]c(N)nc2[nH]1,,"(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",
CS(=O)(=O)N1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,"(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",
CC[C@@H](C)[C@H](N)C(=O)N1Cc2ccccc2C1P(=O)(Oc1ccccc1)Oc1ccccc1,,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",
COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCN,,Drostanolone,
CNC(=S)NCCCCCc1cnc[nH]1,,Canrenoic acid,
N=C(N)c1ccccc1,,benzamidine,
NS(=O)(=O)c1ccc(C(=O)N2CCCC2C(=O)O)cc1,,RU78262,
Oc1ccc2c(c1)nc(-c1ccc3ccccc3c1)n2-c1ccnc(N[C@@H]2CCCNC2)c1,,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",
CC(C)N1CCC(Oc2ccc(CN3CCCCCC3)cc2)CC1,,Deslorelin,
C[C@@]1(N)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.O=C(O)C(F)(F)F,,Zalcitabine,
O=c1cc(-c2cccc(C=Cc3ccc4ccccc4n3)c2)oc2c(-c3nnn[nH]3)cc(Cl)cc12,,USL-311,
O=c1ccc2nc3ccc(O)cc3oc-2c1,,Resorufin,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,Ravoxertinib,
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,ethisterone,
Cc1ccc(C[n+]2c(C(C)O)sc(CCO)c2C)c(N)n1,,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)cc1,,Vilazodone,
CC(=O)Nc1ccc2c(c1)CN(c1cccc(-c3nncn3C3CC3)n1)C2=O,,Prezatide,
CC(C)n1cc2c3c(cccc31)[C@H]1C=C(COC(=O)C3CCC3)CN(C)[C@@H]1C2,,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",
Cn1c(=O)c2[nH]cnc2n(C)c1=O,,theophylline,
CC(C)CC(CC(=O)OCC1(CO)C/C(=C\c2cccc(C(=O)O)c2)C(=O)O1)CC(C)C,,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,
CCc1ccccc1NC(=O)CSc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1,,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCc1ccccc1,,Cyclohexyl-pentyl-maltoside,
Cc1coc2cc3c(cc12)CCN3C(=O)Nc1cccnc1,,(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol,
CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)Cc1ccccc1,,Amphotericin B,
CSC1OC(CO)C(O)C(n2cc(C(=O)NCCN3CCOCC3)nn2)C1O,,Cordycepin Triphosphate,
NC(Cc1ccccc1)C(=O)[C@@H]([NH3+])C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1,,Piclamilast,
Cc1nc(-c2cccc(NC(=O)CN3C(=O)N(CC(=O)C(C)(C)C)c4ccccc4N(C4CCCCC4)C3=O)c2)cs1,,Diazepinomicin,
N=C(NCCCc1cnc[nH]1)NCCC(c1ccc(Br)cc1)c1ccccn1,,Fluticasone propionate,
O=C(O)c1cccc(NC(=O)c2[nH]c(C3CCCCCC3)nc2CCC23CC4CC(CC(C4)C2)C3)c1,,MK-0686,
CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Sograzepide,
CC(C)(C)OC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1nc(N2CCOCC2)c2ncn(CC(=O)O)c2n1,,3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID,
CC(C)C1NC(=O)C(Cc2ccccc2)NC(=O)C(C(c2ccccc2)c2ccccc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O,,3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,
OC[C@H]1O[C@@H](Oc2cc3c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O,,Cyanin,
O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C\c2cccc(F)c2)SC1=S,,"Thiazolidinone core, 23",
CC(C)[C@@H](C)NC(=O)c1cc(-c2cc3ccccc3n2C)cc(C(=O)NCCc2ccccn2)n1,,STAT6-IN-2,
C[N+](C)(CC#CCOC1=NOCC1)CCCCNC(=O)c1cn(Cc2ccccc2)c2cc(Br)ccc2c1=O,,Ornidazole,
CN1CCN(c2cc3nc4n(c(=O)c3cc2F)CC/C4=C\c2ccc(NC(=O)CCN3CCN(CCO)CC3)cc2)CC1,,"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide",
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCc3ccccc3)co2)cc1)c1cccnc1,,Salsalate,
CCCCCCCCCCCC(=O)[O-],,Dodecanoate,
CN(C)S(=O)(=O)N1CCN(C2CN(CCC3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Fluocinonide,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NC(Cc2ccc(Cl)cc2)C(=O)O)cc1,,"5,6-Cyclic-Tetrahydropteridine",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(OC)c(C(F)(F)F)c4)c3)c2cc1OCCCN1CCS(=O)(=O)CC1,,"US9730937, Example 246",
O=C(O)CC(COc1ccc(-c2nc3ccccc3n2Cc2ccccc2)cc1)n1c(-c2ccccc2)nc2ccccc21,,5-Thio-a/B-D-Mannopyranosylamine,
CCOc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)ncnc2cc1OC,,"1-(3-(6-ethoxy-7-methoxyquinazolin-4-ylthio)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea",
Cc1ccc(C(C)C)c(OCCNC(=O)c2ccccc2OCC(=O)N2CCOCC2)c1,,Mant-Adp,
CC(C)C1=C[C@]23CC[C@H]4[C@](C)(C(=O)O)CCC[C@]4(C)[C@H]2C[C@@H]1[C@@H](C(=O)O)[C@@H]3C(=O)O,,Boldione,
CC1=CC(=O)O/C1=C\C=C(/C)CC[C@@H]1[C@@]2(C)CCC[C@@]3(C)C(O)O[C@@H](C[C@@]1(C)O)[C@H]23,,Quinapril,
[NH3+]C(Cc1c[nH]c2cc([N+](=O)[O-])ccc12)C(=O)[O-],,"6-Nitro-L-tryptophan, 17",
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C(C)C,,Metaxalone,
O=C(C[C@H]1C/C=C/CCC(=O)O[C@@H](c2ccccc2)CNC1=O)NCc1ccc(Cl)cc1,,6-Deoxyerythronolide B,
C=C(C=O)C[C@@H]1C[C@H](O)[C@]2(C)O[C@@H]3C[C@@H]4O[C@@H]5C[C@]6(C)O[C@]7(C)CC[C@@H]8O[C@@H]9C[C@]%10(C)O[C@@H]%11C(C)=CC(=O)O[C@H]%11C[C@H]%10O[C@H]9C[C@@H](C)[C@H]8O[C@H]7C[C@H]6O[C@H]5C/C=C\[C@H]4O[C@H]3C[C@H]2O1,,Ceftezole,
CN(CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,Tripitramine,
Nc1ccc(C[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c2ccc(S(N)(=O)=O)cc2)C(=O)O)cc1,,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,
COCc1[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)nc1C,,Doramectin,
Cc1nc2ncnn2c(O)c1NS(=O)(=O)c1ccc(Br)cc1,,CS237,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](COC(C)(C)C)C(=O)O,,Valpromide,
CC(C)[C@H](OC(=O)[C@H](C)NC(=O)[C@@H](OC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)C(=O)O,,Lisofylline,
O=C(CSc1nnc(-c2ccncc2)o1)Nc1ccc(F)cc1,,"N-(4-fluorophenyl)-2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide",
Nc1ccn([C@@H]2O[C@H](CNC(=O)c3ccncc3)[C@@H](O)[C@H]2O)c(=O)n1,,Foliglurax,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Sulfasalazine,
CN(C)c1cc(N2CCc3ccccc3C2)ccn1,,Acetylamino-Acetic Acid,
CCCN1CCN(c2ncc(CCN(C)C=O)s2)CC1,,Orbifloxacin,
CC(Cc1ccc(CC(=O)O)cc1)(NC(=O)C(Cc1ccc(OP(=O)(O)O)cc1)NC(=O)OCc1cccc(N)c1)C(=O)NC(CC(N)=O)C(N)=O,,Taspoglutide,
COc1nc2ccc(C(O)c3ccc(C#N)cc3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"US10201546, Example 187",
CCCCc1nc(Cl)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,Losartan carboxylic acid,
COc1nc2ccc(C(O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1OC(C)C,,"3-(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(3,5-dichlorobenzyl)-benzamide",
CCCCC#CCCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Indium In-111 pentetate,
CN1C2CCC1C(c1ccc(F)cc1)C2,,Tamibarotene,
CCCCCCOC(=O)c1ccc(Nc2c([N+](=O)[O-])cc(C(=O)O)cc2[N+](=O)[O-])cc1,,TU-514,
Cc1ccnc(NS(=O)(=O)c2ccc(NC(=O)c3cncc(Br)c3)cc2)n1,,5-bromo-N-(4-{[(4-methyl-2-pyrimidinyl)amino]sulfonyl}phenyl)nicotinamide,
COc1cc2c(cc1NS(=O)(=O)N1CCCCC1)oc1ccccc12,,MK-0533,
C[C@@]1(NC(=O)C2CCC2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O,,2H-Benzimidazol-2-amine,
CC(C)CC(CC(=O)OCC1(CO)C/C(=C\c2ccccc2C(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)O1)CC(C)C,,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,
Fc1cc(Br)cc([C@H]2C[C@@H](c3ccccc3)n3nnnc3N2)c1,,Bitopertin,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3O[C@H]4N=C(CCOCC)O[C@@]4(C)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,Ketoprofen,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CSS[C@@H]2C[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)O)N(C2)C(=O)[C@@H](Cc2cnc[nH]2)NC1=O)C(C)C,,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",
Brc1cccc([C@@H]2C[C@H](c3cccc(I)c3)n3nnnc3N2)c1,,Sulfoxone,
O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1,,Carfecillin,
Clc1ccccc1[C@H]1C[C@@H](c2cccc(Br)c2)Nc2nnnn21,,Mesoridazine,
COc1cc(/C=N/O)c(O)c(CN2CCC(CN3CCc4cc(OC)c(OC)cc4C3)CC2)c1,,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nc(-c1ccccc1)n2C,,Omipalisib,
CC(C)C[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,BV2,
c1ncc(CC2CCN(CCCOc3ccc(CN4CCCCC4)nc3)CC2)[nH]1,,2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol,
COc1ccc(CC(C)N)c(O)c1,,Nicaraven,
CC(C)NCC(O)COc1ccc(CCOCC2CCCC2)cc1,,"2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol",
CCOC(=O)/C=C1\CC(C)(C(C)C)CC(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,PF-00217830,
O=C(O)[C@H]1[C@H]2CC[C@H](C2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1F,,Cyclohexyl-Hexyl-Beta-D-Maltoside,
CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCN(c3ccc(C(F)(F)F)cn3)CC1)C(=O)C2,,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](SC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,Bufuralol,
COC(=O)C1COCCN1C(=O)CS(=O)(=O)c1ccc(C(C)C)cc1,,Phenolphthalein,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCS(C)(=O)=O,,Cefprozil,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Motretinide,
O=[N+]([O-])c1ccc(NS(=O)(=O)N2CCCCC2)cc1,,N-(4-nitrophenyl)piperidine-1-sulfonamide,
Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)c(Cl)c3)n2)s1,,"2-Chloro-N~4~-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)pyrimidin-2-Yl]-N~1~,N~1~-Dimethylbenzene-1,4-Diamine",
CCC1(CC)C(=O)N(c2ccc(C)cc2)C1=O,,4-(2-aminoethyl)-2-cyclohexylphenol,
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC(F)(F)F,,Odalasvir,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(F)(F)F)nn4C)c3)c2cc1OC,,"1-[3-(6,7-dimethoxyquinazolin-4-ylthio)phenyl]-3-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea",
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@]1(C)CCC/C=C\CCC[C@@](C)(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1)C(=O)O,,Dichloroisoproterenol,
COc1ccc(OC)c(NC(=O)NCCCOc2cccc(CN3CCCCC3)c2)c1,,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",
O=C(O)c1[nH]c2ccc(F)cc2c1NC(=O)C1CC1c1ccccc1,,RU79072,
C=CCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CN(CC=C)C(=O)[C@@H]1CCCN1C(=O)CCCCNC(=S)Nc1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](C)O,,Regorafenib,
COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C,,BIIB021,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)c1cnc([C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2)[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Cefatrizine,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(N3CCOCC3)ccc2n1,,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,
O=C(CN1CCCCC1)Nc1cc(Nc2ccnc3cc(Cl)ccc23)cc(C(=O)N2CCOCC2)c1,,Miridesap,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(N)c2)N=C(C2CCCCC2)c2ccccc21,,GS-6620,
O=C(NC(Cn1ccnc1)c1ccc(Cl)cc1Cl)c1nnc(-c2ccccc2)o1,,"Azole, 3",
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)CO)on4)c3)c2cc1OC,,Fagrocorat,
CCc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(C#N)c1CC(F)(F)F,,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,
CN(Cc1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1)C(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,,JAK2 JH2 Tracer,
Cc1cc(NC(=O)OC(C)(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,,913566-84-4,
O=C(Nc1ccccc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1,,FG-2216,
O=C(Cc1ccc(-c2cnc3[nH]ccc3c2)cc1)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 18",
Nc1ccc(C/C(=N/Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)C(=O)O)cc1[N+](=O)[O-],,Acotiamide,
COc1nc2ccc([C@](O)(c3sc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OC(C)C,,Piromidic acid,
N#Cc1cc(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)ccc1F,,dATP,
COc1nc2ccc(C(O)c3cnc(C)n3C)cc2c(Cl)c1CC(C)C,,IQP-0528,
O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1,,Isbogrel,
Cc1ccc(C(=O)NP(=O)(Cl)Cl)cc1,,54061-18-6,
O=P(O)(O)Oc1ccccc1,,Phenylphosphoric acid,
CC(C)(C)NC[C@H](O)CON=C(C1CC1)C1CC1,,L-Alpha-Glycerophosphorylserine,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1ccccc1,,Diamino-N-[(4S)-5-anilino-4-{[(2S)-2-{[(1R)-1-carboxyethyl]amino}-4-phenylbutanoyl]amino}-5-oxopentyl]methaniminium,
c1cc(CN2CCCCC2)cc(OCCCN2CCC(Cc3cnc[nH]3)CC2)c1,,beta-D-fucose,
CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)c1cnc([C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2)s1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,Isoflupredone acetate,
NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccc(CP(=O)(O)O)cc2)NC(=O)Cn2cc(nn2)CCCNC1=O,,Rubitecan,
C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,,Voriconazole,
Cn1cncc1C(O)(c1ccc(C(F)(F)F)nc1)c1ccc2nc(N3CCC3)c(OCc3ccccc3)c(Cl)c2c1,,"US10201546, Example 31",
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1COC(=O)NC1CCCCC1)[C@@H](C)O,,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",
O=C(N(CCOc1ccc([N+](=O)[O-])cc1)CCc1ccc([N+](=O)[O-])cc1)C(F)(F)F,,2-Ethoxyethanol,
O=c1nc2n(c3cccc(Cl)c13)CC/C2=C\N1CCCCC1,,Pipamperone,
CN(C)CCCOc1ccc(CCCN2CCC(Cc3cnc[nH]3)CC2)cc1,,(C8-S)-Hydantocidin 5'-phosphate,
Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1,,"N~4~-(2-Chlorophenyl)-N~2~-[4-(1h-Tetrazol-5-Yl)phenyl]pyrimidine-2,4-Diamine",
CC(C)Oc1c(N2CCC2)nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c1Cl,,Rivaroxaban,
C[C@H]1CCC[C@@H](C)N1CCCN1Cc2cccc(C(N)=O)c2C1=O,,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,
CC(C)CN1CC[C@@](C#N)(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)C1,,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,
Clc1ccc(-c2nnn[nH]2)cc1,,5-(4-chlorophenyl)-1H-tetrazole,
CC(C)NCC(O)COc1ccc(CCOC2CCCCC2)cc1,,BMS-986115,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCOCC5)C4)cc3)nn3cccc23)n[nH]1,,Sonolisib,
CN[C@@H](Cc1c(C)cc(O)cc1C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H](C)C(=O)O,,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,
OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCC4)ncnc32)[C@H](O)[C@@H]1O,,N6-Cyclohexyladenosine,
NC(=O)c1ccc(-c2c[nH]c(SCCc3cnc[nH]3)n2)cc1,,Vosaroxin,
COCC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)no1,,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",
Cc1c(CC(=O)O)c2ccccc2n1Cc1ccc(S(C)(=O)=O)cc1,,NU1025,
CNc1nc(C)nc2c1ncn2C1CC(OP(=O)(O)O)C(COP(=O)(O)O)O1,,Iodohippurate sodium I-131,
O=C(O)c1c(Sc2ccccc2)c2cc(Cl)ccc2n1Cc1ccc(Cl)cc1,,nTzDpa,
CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1,,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,
O=C(CCN1CCCC1)Nc1ccc(/C=C2\CCCn3c2nc2cc(NC(=O)CCN4CCCC4)ccc2c3=O)cc1,,Dansyllysine,
NC(=O)C[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine",
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCc2c(C)cccc21,,ACV tripeptide,
COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1O,,Entacapone,
CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,"[Mpa1, D-Tyr(Et)2, D-Tic7]OT",
O=C(CC(=O)Nc1cccc(C(=O)O)c1)NCCCNCc1ccc(-c2ccccc2)c(Cl)c1.O=C(O)C(F)(F)F,,N7-Methyl-Formycin A,
CC(C)(C)c1nc(CCC23CC4CC(CC(C4)C2)C3)c(C(=O)Nc2cccc(C(=O)O)c2)[nH]1,,Levobupivacaine,
O=[N+]([O-])c1ccc(CCNCCOc2ccc([N+](=O)[O-])cc2)cc1,,226992-13-8,
COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN4CCSC4)c3)nc(N)c2cc1OC,,Borneol,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(-c3nc(=O)o[nH]3)c2)C(=O)N(C2CCCCCC2)c2ccccc21,,7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,
COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1OC(C)=O,,Triglu-5-formyl-tetrahydrofolate,
CC(C)(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)CCc1ccccc1,,Salophen-10-carboxylate iron chelate,
CSC1=NC(c2cccc([N+](=O)[O-])c2)C2=C(COC2=[OH+])[N-]1,,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCCC5)C4)cc3)nn3cccc23)n[nH]1,,Combretastatin A4,
CCOc1ccccc1-c1ccc(-c2nc3ccc(F)cc3c(N[C@H](C)C(=O)O)c2C#N)cc1,,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,
Cc1[nH]nc2c1C(c1cccc(C#N)c1)C1=C(CC(C)(C)CC1=O)N2,,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",
O=C(O)CC[C@H](NC(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(=O)O)C(=O)O,,N-{[(1s)-1-Carboxy-2-(4-Hydroxy-3-Iodophenyl)ethyl]carbamoyl}-L-Glutamic Acid,
COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC,,N-Carbamoylphenylalanine,
CN(C)C(=O)Cc1ccc(-c2cccc3c(Nc4cccc(O)c4)nncc23)cc1,,Fenquizone,
CC(=O)N1CCN(c2ccc([C@H]3CN([C@H]4CCc5cccc(F)c54)C[C@@H]3N(C)C)cc2)CC1,,"5,10-Methylene-6-Hydrofolic Acid",
CO[C@H]1CC[C@H](C(=O)OCC2=C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CC1,,3-O-Methylfructose in Linear Form,
O=C(O)Cn1c(SCc2cccc3ccccc23)nc2ccccc21,,ETC-588,
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1COC(=O)NC1CCCC1)[C@@H](C)O,,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",
CCCN1C=C(C)C=C2C(=O)NC(N)N=C21,,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,
CN(C)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(Oc2ccccc2)cc1,,WRR-204,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,"(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid",
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",
CC(C)C(COc1ccc(-c2nc3ccccc3n2Cc2ccccc2)cc1)n1c(-c2ccccc2)nc2ccccc21,,"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",
CC(C)C[C@H](NC(=O)CN1CCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Triclosan,
Nc1ncnc2c1nc(N)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,8-Aminoadenosine,
O=C(Cn1nc(-c2ccccc2)cc(-c2ccc3c(c2)OCO3)c1=O)N1CCN(c2ccc(F)cc2)CC1,,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",
Cn1nc(-c2ccccc2)cc1N,,1-Methyl-3-phenyl-1H-pyrazol-5-amine,
N#Cc1ccccc1Cn1c(-c2cscn2)nc2ccccc21,,Ibacitabine,
CC(C)(C)NCC(O)c1ccc(O)c(N)c1,,Bevantolol,
O=C1CCC(CCN2CC(N3C4CCC3CC(O)C4)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",
Cc1noc(C)c1-c1ccc2c(c1)nc(CCc1ccccc1)n2C[C@H](C)N1CCOCC1,,1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,
Cc1ccc2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC(C)(C)C(=O)N4CCN(C(=O)CN5CCNCC5)CC4)c3Cl)c2n1,,Nifurzide,
CSc1nc(N)nc2nc[nH]c12,,6-Methylthioguanine,
COc1ccc2[nH]cc(CCN(C)C)c2c1,,"N,N-Dimethyl-5-methoxytryptamine",
O=C(Nc1cc(C2CCCCC2)n[nH]1)c1ccc(Br)cc1,,Ethotoin,
COCCOCCCSc1ccc(C(=O)Nc2ccc(C#N)cc2C(=O)O)cn1,,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",
NC(=O)c1cccc2[nH]n(C3CCN(Cc4cccs4)CC3)c(=O)c12,,Dutasteride,
Clc1ccccc1CNCC12CC3CC(CC(C3)C1)C2,,Nemorexant,
Cc1noc(C)c1-c1cc(O)cc([C@@H](O)c2ccccc2)c1,,Ceftolozane,
C[C@@]1(NCCc2ccccc2)COCCCCOC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O.Cl,,N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine,
Ic1cccc(C2CC(c3ccccc3)n3nnnc3N2)c1,,Carbromal,
NC(=NCCCc1cnc[nH]1)NC(=O)CCCCc1ccccc1,,UR-AK22,
CSCC[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC1=O,,7-alpha-D-Ribofuranosyl-2-aminopurine-5'-phosphate,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCc1c(C)noc1C,,THYMIDINE-5'-THIOPHOSPHATE,
NCc1cccc(Cn2ccc3c2C(=O)C(Cc2ccccc2)(Cc2ccccc2)CC3)c1,,LY-2886721,
COc1ccc(CN(CC(=O)N2CCC(CN)CC2)c2ccc(C#N)cc2)cc1F,,Mometasone furoate,
CC(C)c1ccc(SC(F)(F)C(=O)N2CCOCC2)cc1,,"3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C,,Etidronic acid,
C=CC=Nc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)C(N=O)[C@@H](C)C=C(C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)N2,,Sulfabromomethazine,
CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)O)NC1=O,,Triacetylchitotriose,
NC(=NCCC(c1ccc(F)cc1)c1ccccn1)NCCCc1cnc[nH]1,,Arpromidine,
Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl,,pentachlorophenol,
O=C([O-])C1=C[C@@H](OP(=O)([O-])[O-])[C@@H](O)[C@H](O)C1,,3-phosphoshikimate,
O=C(NO)c1cccc2ccccc12,,1-Naphthohydroxamic acid,
CN1CCN(CC(=O)N2N=C3/C(=C/c4ccccc4)CCCC3C2c2ccccc2)CC1,,PKUMDL_MH_1001,
O=C(O)c1ccc(Oc2ccccc2)c(O)c1,,"1,6-Fructose Diphosphate (Linear Form)",
C[C@@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,,"(S,S)-(+)-fenoterol",
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(N2CCCC2)nc1,,Chlorogenic Acid,
CCSc1nc(C)nc(N)n1,,57639-45-9,
Oc1c(Cl)cc(CC=Nc2cc(O)c3cccnc3c2O)cc1Cl,,Enrofloxacin,
O=P(O)(O)O[C@H]1[C@@H](O)[C@@H](OP(=O)(O)O)[C@H](O)[C@@H](OP(=O)(O)O)[C@@H]1OP(=O)(O)O,,"inositol 1,3,4,5-tetrakisphosphate",
CCCCCCCN1CCC(Cc2cnc[nH]2)CC1,,Cobicistat,
CC(C)(C)c1nc(-c2ccncc2)c(-c2ccc(Cl)c(O)c2)[nH]1,,Obidoxime,
NC(=O)c1cccc2c1C(=O)N(CCN1CCOCC1)C2,,Valrocemide,
CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N=C(NC2CCCCC2)NC2CCCCC2)cc1,,Muzolimine,
CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O,,TTATVTKYWF,
CC(C)Oc1c(C(C)C)c(O)c2c(=O)cc(-c3ccccc3)oc2c1C(C)C,,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",
COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc(C#N)cn4)CC3)CN(C)[C@@H]1C2,,Salvianolic acid A,
O=C1c2cccc3cccc(c23)N1c1ccc(-c2ccccc2)cc1,,CRA_10972,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,Nordazepam,
COc1ccc(CC2NC(=O)NC2=O)c(OC)c1,,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,
O=C(NCCCOc1cccc(CN2CCCCC2)c1)Nc1ccc(C(F)(F)F)cc1,,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCn2nc(C(F)(F)F)nc2C1,,Vilanterol,
COc1ccc(CCN(C)CCOc2ccccc2)cc1,,Etoxeridine,
CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C,,Nitrofurantoin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(CN5CCOCC5)cc(C(F)(F)F)c4)c3)c2cc1OC,,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(3-(morpholinomethyl)-5-(trifluoromethyl)phenyl)urea",
O=c1[nH]c2ccccc2n1-c1cc(-c2ccccc2O)c(O)cc1O,,hsp90_10,
CCCCCCCCCCCCCC(=O)OC[C@H](CO[P@](=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,,DIMYRISTOYLPHOSPHATIDYLCHOLINE,
C=C/C(C)=C/C[C@@]1(C)[C@@H]2CC(=O)C=C3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32CC[C@H]1C,,Lacosamide,
Cc1ccc([C@H](OCCN(C)C)c2ccccc2)cc1,,(R)-Neobenodine,
NCC(O)COc1ccccc1,,1-amino-3-phenoxypropan-2-ol,
CCc1cc2c(cc1CC)CC(C)(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2,,Vancomycin,
CCOc1ccc(C[C@@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)cc1,,Mephenoxalone,
CCN(C)S(=O)(=O)Nc1cc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c(F)c1,,Evatanepag,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(Cl)cc4)c3)c2cc1OC,,"7,8-Dihydroneopterin",
COc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c(C(=O)O)c1,,Rivoglitazone,
COc1cc(OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CNc2cc(F)cc(-c3ccc(C(=O)O)cn3)c2)c(Cl)cc1NC(=O)CSc1ccc(C(=O)O)cn1,,N-Acetyl-glucosamine thiazoline,
CC(C)CCOC(=O)Nc1cc(-c2ccc3ccccc3c2)nc2ccccc12,,"CypA Inhibitor, 2a",
Nc1nc2cc(Cl)ccc2o1,,Zoxazolamine,
c1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccccn2)nc1,,"(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol",
CC(CCc1ccccc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1,,Mitoguazone,
C[C@@H](Nc1nc(-c2cc(C(=O)O)ccc2Cl)cnc1N)c1ccccc1,,PLX-4720,
O=c1[nH]c2[nH]c(=S)[nH]c(=O)c2[nH]1,,2-Thiouric acid,
CC(=O)N1CCN(c2ccc([C@@H]3CN([C@H]4CCc5cccc(F)c54)C[C@H]3N(C)C)cc2)CC1,,S-Hexylglutathione,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(N)=O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1csc[n+]1C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",
CCN(CC(=O)NC[C@H]1O[C@H](OC)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])[C@@H]1OS(=O)(=O)[O-])C(=O)CCc1ccccc1,,Lanreotide,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(CC5CC5)c5cc(F)ccc54)CC3)CC2)ccn1,,Valnoctamide,
O=C1CCC(CCN2CC(N3CCOCC3=O)C2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1,,PRX-08066,
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3cccc(F)c3N2C)c1=O,,Miglustat,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CN(C)CCOC)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Cefamandole nafate,
CSCCC(NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)C(NC(=O)CCNC(=O)CCNC(=O)c1ccc(C(=O)O)c(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c1)C(C)O)C(C)O)C(=O)NC(CCSC)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC1CCCCn2cc(nn2)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(N)=O)NC(=O)C(CCCCN)NC(=O)C(Cc2ccccc2)NC(=O)C(C)NC1=O)C(C)O,,Alsterpaullone,
CCCN1CCN(c2ncc(CCN(C)C(=O)CC)s2)CC1,,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OC(C)(C)C)cc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,
C=CC(C)(C)OCC(O)CNC(C)(C)C,,"3H-pyrazolo[4,3-d]pyrimidin-7-ol",
CCS(=O)(=O)CCC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,SC 42867,
C=CC(=C)CC[C@@]1(C)[C@@H]2C[C@@H](O)C=C3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32[C@@H](OC(=O)CC(O)CCCCCCCCC)C[C@H]1C,,3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(Cl)cc4)c3)c2cc1OC,,Indirubin,
Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4nnc(N)n34)cc2)c1,,Motexafin gadolinium,
CNC(=N)NCCCc1cnc[nH]1,,CRA-9334,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOC3CCCCC3)co2)cc1)c1cccnc1,,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,
O=C(NCc1ccc(S(=O)(=O)N2CCN(C3COC3)CC2)cc1)c1cc2ccncc2o1,,C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide,
COc1ccc(CCNCC(O)C2=COc3ccccc3O2)cc1OC,,"N-1,10-phenanthrolin-5-ylacetamide",
O=C1C(Cc2ccccc2)C(=O)N(Cc2ccccc2)C(=O)N1Cc1ccccc1,,Bumetanide,
CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,Brinzolamide,
Brc1cccc(C2CC(c3ccccc3I)n3nnnc3N2)c1,,"2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(=O)c1ccc[nH]1,,Pregabalin,
N#CC1(NC(=O)[C@@H](CC(=O)N2CCOCC2)CC2CCCCC2)CCN(Cc2ccccc2)CC1,,Ifosfamide,
CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1CNCC1CCC(C(F)(F)F)CC1,,"US10201546, Example 203",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)c3)c2cc1OC,,Clinafloxacin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(F)F)nn4-c4cncc(F)c4)c3)c2cc1OC,,"US9730937, Example 316",
N=C(N)NCCCC(NC(=O)C1CC2CCCCC2N1C(=O)C1Cc2ccccc2CN1C(=O)C(Cc1cccs1)NC(=O)CCCCCCCCCN)C(=O)O,,Stavudine triphosphate,
CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)COc1cccc2cccnc12)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1COC(=O)NC(C)(C)C)[C@@H](C)O,,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCN(C)CC1,,Intoplicine,
N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)Nc1ccc2c(CN3CCCC3)cn(Cc3c(Cl)cccc3Cl)c2c1)C(=O)NCc1ccccc1,,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(OC)c(C(F)(F)F)c4)c3)c2cc1OC,,"US9730937, Example 138",
COC(=O)Cc1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)C2CCCN2P(=O)([O-])CNC(=O)[C@H](C)NC(C)=O)cc1,,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",
CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCC2)cc1,,Itopride,
CNc1cccc(NC(=O)CN2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,,Epanolol,
O=C([O-])CC1Sc2nnc(Cc3ccc(F)cc3)n2N=C1c1cccs1,,Formocortal,
CCC(C)OC(=O)C1=C(C)NC(SC)=NC1c1cccc([N+](=O)[O-])c1,,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,
O=C(NCc1cccs1)[C@@H]1CCCN1C(=O)CC1CCCCC1,,"proline scaffold, 12",
COC(=O)c1ccccc1OCC(O)CNC(C)(C)C,,Norleucine Phosphonate,
CCn1cc(C(=O)Nc2cccnc2)c(C)n1,,Ponatinib,
O[C@@H]1CCCCC1N1CCC(c2ccccc2I)CC1,,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",
COc1cc(CC(C)N)c(OC)cc1C,,"2,5-Dimethoxy-4-methylamphetamine",
CCN[C@H]1C[C@H](CO[N+](=O)[O-])S(=O)(=O)c2sc(S(N)(=O)=O)cc21,,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",
Cc1occc1-c1nnc2n1N=C(c1ccccc1)C(CC(=O)[O-])S2,,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",
CCCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-n2cccc2-c2nnn[nH]2)cc1,,4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid,
CCCN(CCc1ccc(Cl)c(Cl)c1)CC(O)c1cc(C)ccn1,,6-Methylpurine,
CCOc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCOCC2)c(O)c(N2CCOCC2)c1,,Digitoxigenin,
CCN1C(=O)c2cccc3c(S(=O)(=O)NCCCN4CCN(C)CC4)ccc1c23,,Iotroxic acid,
COc1ccc(OC)c(-c2cnc3c(N4CCOCC4)snc3c2)c1,,DCFBC,
CCCN(CCOC)c1nc(C)nc2c1c(C)nn2-c1ccc(OC)cc1C,,Magnesium gluconate,
CC/C=C\CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O,,Sorbitol,
CC(C)(C)NCC(O)C1=COc2ccccc2O1,,5-methyl-2'-deoxypseudouridine,
O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1,,Terizidone,
Cc1ccc([C@@H]2CN(C(=O)C[C@H]3CC[C@@H](N)CC3)C[C@H]2c2ccc(C#N)cc2)cc1,,Alprostadil,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C(C)(C)C)cc4)c3)c2cc1OC,,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,
CC1CCC(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)Nc2ccncc2)CC1,,LP10,
COC(=O)CNCC(O)COc1ccccc1C,,Mequinol,
NS(=O)(=O)c1ccc(C(=O)NCCOCCOCCNC(=O)C[NH3+])cc1,,Brivanib alaninate,
NC(=NCCCc1cnc[nH]1)NC(=O)Cc1ccccc1,,UR-AK26,
O=C(O)c1sc2cc(-n3c(-c4ccc(Br)cc4)n[nH]c3=S)ccc2c1Cl,,KX-01,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4ccc(OC)c(C(F)(F)F)c4)c3)c2cc1OC,,1-(4-methoxy-3-(trifluoromethyl)phenyl)-3-(3-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy)phenyl)urea,
NS(=O)(=O)c1ccc(C(=O)NCc2ccccc2)cc1,,n-benzyl-4-sulfamoyl-benzamide,
CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc3ccccc3)NC2=O)cc1,,Hydroxyzine,
O=c1[nH]cnc2c(CN3CCC(O)C3)c[nH]c12,,"Immucillins, 11",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C5(C)CC5)on4)c3)c2cc1OC,,Ioxilan,
CC(C)C[C@H](NC(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,6-phospho-D-gluconic acid,
CCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1ncn2CC(=O)O,,PHA-793887,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(CCc3ccc(Cl)cc3)ccc2n1,,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",
Cc1cc(CC(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)on1,,Lubiprostone,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cnnn3C)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Streptolydigin,
O=C(O)CCN1C(=O)/C(=C2/C(=O)Nc3ccc(Cl)cc32)SC1=S,,1426138-42-2,
O=C(O)c1ccc(OCCc2c(CCNS(=O)(=O)Cc3ccc(Cl)c(Cl)c3)n(C(c3ccccc3)c3ccccc3)c3ccc(Cl)cc23)cc1,,Ecopladib,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4ccc(C(F)(F)F)c(F)c4)c3)c2cc1OC,,1-(3-fluoro-4-(trifluoromethyl)phenyl)-3-(3-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-ylthio)phenyl)urea,
CNC(=N)NCCSCc1[nH]cnc1C,,70172-53-1,
COC(=O)c1c(O)cc(O)c(Cl)c1CCc1nccn1Cc1ccc(Cl)o1,,KUNG38,
O=C(O)Cn1cnc2c(Oc3ccccc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Nonivamide,
O=C(Cn1c2c(c3cc(Br)ccc31)CC[C@@H](C(=O)O)C2)N[C@@H](Cc1ccccc1)C(=O)O,,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,
CC(C)CC1CC(c2cccc(Br)c2)Nc2nnnn21,,Ioglicic acid,
CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1Br,,Pyrazoloacridine,
CCC(C)C(NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",
CC(C)c1ccc(OCC(=O)N2CCOCC2)cc1,,Enarodustat,
Cc1ccccc1OCC(O)CNC(C)C,,Peridinin,
Cc1c(O)cc2c(c1C)OC(C)(CCCC(C)C)CC2,,Floxuridine,
COc1cccc(CC(C)N)c1,,3-Methoxyamphetamine,
CC(C)(C)c1nc2c(=O)[nH]c(N)nc2n1[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)C(O)C1O,,tBuGTP (2b),
Nc1nc2[nH]c(SCc3cccc(Br)c3)nc2c(=O)[nH]1,,H-89,
CN(c1ncccc1CNc1c(C(F)(F)F)cnc2nc(-c3ccc(F)cc3)[nH]c12)S(C)(=O)=O,,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",
NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNc1c(O)c(=O)c1=O)NC(=O)OCC1c2ccccc2-c2ccccc21,,Acifluorfen,
N=C(N)NCCC[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCCC1,,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",
O=C(OCC1CCCC1)c1cccnc1,,"Auxiliary substrate, 20a",
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3cc(Cl)ccc3N2C)c1=O,,Calcium threonate,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(F)F)no4)c3)c2cc1OC,,"US9730937, Example 152",
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O,,Dehydroepiandrosterone,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)n(-c5ccccc5)n4)c3)c2cc1OC,,1-{3-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yloxy]phenyl}-3-[1-phenyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]urea,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Latrunculin A,
Cc1[nH]nc2c1[C@H](c1ccccc1)C1=C(CC(C)(C)CC1=O)N2,,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,
CC1(C)CC(=O)C2=C(C1)Nc1n[nH]c(C(F)(F)F)c1C2c1ccc(F)cc1C(F)(F)F,,Spectinomycin,
COc1cc2c(cc1OC)[C@@H](c1ccccc1)N(CCCCCCc1cnnn1CCNc1c3c(nc4ccccc14)CCCC3)CC2,,Faldaprevir,
CCN(CC)CCCNc1cc2nc3n(c(=O)c2cc1F)CC/C3=C\c1ccc(OCc2ccccc2)cc1,,Fluvastatin,
CN1CCC[C@H]1[C@H]1COc2ccc(Br)cc2O1,,Tetracycline,
COc1cc2ncc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c(F)c3)nc2cc1OCCN1CCOCC1,,"US9725465, Example 234",
COCCOc1ccc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2c1,,Epigallocatechin,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)C)nn4-c4cncc(F)c4)c3)c2cc1OC,,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,
O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1,,Bradanicline,
Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCCC2,,40312-34-3,
Cc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(-c3cccc(NC(=O)NC4CC4)c3)cc2)C(=O)O)c(C)c1,,Aclidinium,
COc1ccc(CNCCCCCCNCCCCCCCCNCCCCCCNCc2ccc(OC)cc2)cc1,,TAK-901,
CNC(=N)NCCc1cnc[nH]1,,Etilevodopa,
CC(C)(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1,,RPR128515,
Brc1cncc(-c2nnn[nH]2)c1,,211943-13-4,
N=C(N)N1CCCCC1,,piperidine-1-carboximidamide,
O=C(O)CCC(/C=C/Cc1ccc(OCCCCOc2ccccc2)cc1)Sc1ccc(C(=O)O)cc1,,"(2S)-2,3-bis{[(3R,7R)-3,7,11,15-tetramethylhexadecyl]oxy}propyl (2R)-2-hydroxy-3-[(hydroxyphosphinato)oxy]propyl phosphate",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OCC1CC1(F)F,,"1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE",
CC(C)=CCc1cccc2c(C3C(=O)C(=O)C(c4c(C)[nH]c5ccc(NC(=O)CCCCCNC(=O)CCCCC6SCC7NC(=O)NC76)cc45)C(=O)C3=O)c[nH]c12,,Guanfacine,
Nc1ncnc2c1nc(NCc1ccccc1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,"adenosine-derived inhibitor, 6",
COc1nc2ccc([C@@](O)(c3cnnn3C)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,Flumatinib,
CC(=O)n1cc(N(C(=O)c2cccc(C(F)(F)F)c2)c2cc(O)ccc2C)c2ccccc21,,Saroglitazar,
CN(CCCCCCCCN(C)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21,,Friulimicin B,
CC(C)C[C@H](NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Halicin,
CCCC[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Haloxyfop-P,
Cc1ccc([C@@](O)(c2ccc3nc(N4CCC4)c(CC(F)(F)F)c(Cl)c3c2)c2cnnn2C)c(C)n1,,Bacitracin,
CC(C)(C)c1cc(NC(=O)Nc2cccc(Sc3ncnc4ccc(OCCCN5CCS(=O)(=O)CC5)cc34)c2)no1,,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",
N#Cc1ccc(N(CC(=O)N2CCC(CN)CC2)Cc2ccc(F)cc2)cc1,,Nz-(Dicarboxymethyl)Lysine,
CC(C)NCC(O)COC1=CC(=O)C(=O)c2ccccc21,,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",
COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1,,NPS-2143,
N[C@@H](C(=O)N1CCC[C@H]1C(=O)NCC1CCCCC1)C1CCCCC1,,"proline scaffold, 34",
Cc1cc(C(F)(F)F)nc(N)n1,,4-methyl-6-(trifluoromethyl)pyrimidin-2-amine,
[N-]=[N+]=Nc1cc2c(cc1I)Oc1cc(Br)c(Br)cc1O2,,106463-72-3,
O=P(O)(O)[C@H](NC[C@@H]1CCCc2ccccc21)c1ccc(F)cc1,,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",
NS(=O)(=O)c1cc2c(s1)S(=O)(=O)N(Cc1cccs1)CC2O,,Sulfametopyrazine,
Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOc2cc3nccc(Nc4ccc5scnc5c4)c3cc2S(=O)(=O)C(C)(C)C)C(C)(C)C)cc1,,PROTAC RIPK degrader-2,
O=C1c2cc(-c3cccnc3)ccc2CN1c1cccc(-c2nncn2C2CC2)n1,,KH064,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)c(F)c2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",
CC(C)c1ccc(C(=O)O)cc1-c1cnc(N)c(N[C@H](C)c2ccccc2)n1,,S-NONYL-CYSTEINE,
CN(CCCCOc1ccc([N+](=O)[O-])cc1)Cc1ccc([N+](=O)[O-])cc1,,Hydroxyethylpromethazine,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)CCCCCN=C(N)N)CC5)CCCC4)c3Cl)c2n1,,"3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",
O=C(NP(=O)(N1CCOCC1)N1CCOCC1)c1ccc(Cl)cc1,,"Carbacylamidophosphate, 1b",
Clc1cccc(Nc2ccc3ccccc3c2)c1,,N-(3-Chlorophenyl)naphthalen-2-amine,
O=C(/C=C/N1CC2CC1CN2c1ccccn1)c1ccccc1O,,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA,
CCCCC(=O)N(C)CCc1cnc(N2CCN(CCC)CC2)s1,,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(NC(=O)C(=O)O)cc2)NC(=O)Cc2ccc3ccccc3c2)cc1,,Cethromycin,
CC1(C)OC[C@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1,,Mizoribine,
COc1nc2ccc([C@@](O)(c3ccc(C#N)cc3)c3cncn3C)cc2c(C#N)c1OCC(F)(F)F,,BMS-184476,
O=C(/C=N\O)Nc1ccc[n+](CCCCCC[n+]2cccc(NC(=O)/C=N\O)c2)c1.[Br-].[Br-],,Tolmetin,
O=C(O)CCCOc1ccccc1-c1cc(-c2ccccc2)n(-c2ccc(F)cc2)n1,,Nirogacestat,
CCCN(CCCc1ccccc1)CCc1ccc(N=[N+]=[N-])c(I)c1,,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,Donepezil,
NC(=NCCCc1cnc[nH]1)NC(=O)CCC1CCCCC1,,UR-AK49,
Cc1cccc(-c2n[nH]c(=S)n2-c2ccc3c(Cl)c(C(=O)O)sc3c2)c1,,"N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine]",
N=C(NCCCc1cnc[nH]1)NCCC(c1cccc(C(F)(F)F)c1)c1ccccn1,,Serine,
CCCS(=O)(=O)Nc1cc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c(F)c1,,Desomorphine,
CC(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,,Clenproperol,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4C)c3)c2cc1OC,,Methoserpidine,
Cc1nc(N=Nc2ccc(C(=O)O)c(Cl)c2)c(COP(=O)(O)O)c(C=O)c1O,,MRS-2160,
CNC(=N)NCCSCc1cnc[nH]1,,ABT-751,
O=[N+]([O-])c1ccc(CCN(CCF)CCOc2ccc([N+](=O)[O-])cc2)cc1,,PRX-07034,
NC(=O)c1cccc2c1C(=O)N(C1CCN(C(=O)C3CC3)CC1)C2,,Etrasimod,
COc1cc2ncnc(S(=O)c3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,Rolapitant,
CC(C)C(CC(=O)OCC1(CO)C/C(=C/c2ccc(C(=O)O)cc2)C(=O)O1)C(C)C,,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,
COc1cc(OC)c(CC(C)N)c(OC)c1,,"2,4,6-TRIMETHOXYAMPHETAMINE",
Cc1cc(NC(=O)OC(C)C)nn1Cc1cc(Cl)ccc1OCc1ccccc1,,Zabofloxacin,
Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1,,Pemetrexed,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)OC(C)(C)C,,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",
C[C@H]1CCc2cc(C(=O)N(C)Cc3ccc4nccnc4c3)ccc2N1C(=O)c1ccc(O)cc1O,,BPC-157,
Brc1cccc([C@H]2C[C@@H](c3cccc(I)c3)n3nnnc3N2)c1,,Tonapofylline,
O=C(OCC(C1CCCCC1)n1c(-c2ccccc2)nc2ccccc21)C1CCN(c2nc3ccccc3n2Cc2ccccc2)CC1,,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",
CCn1c(=Cc2cccc[n+]2CCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)sc(=C2Sc3cc(F)ccc3N2C)c1=O,,2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid,
O=C(O)c1cc(CCc2ccc(Cl)cc2)c[nH]1,,4-(4-chlorophenethyl)-1H-pyrrole-2-carboxylic acid,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CCC(=O)O)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Monoctanoin,
CCCNC(=O)c1cnc2ccccc2n1,,N-Propylquinoxaline-2-carboxamide,
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,Terpinen-4-ol,
NCCCC[C@@H](NC(=O)CCCCCNC(=O)c1cn(-c2ncnc3nc[nH]c23)nn1)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,Mazindol,
O=C(O)c1cc(-c2ccccc2)n(-c2ccccc2)n1,,"1,5-diphenyl-1H-pyrazole-3-carboxylic acid",
CCOc1ccc(OCC(=O)N2CCOCC2)cc1,,Profoxydim,
CCOc1nc2ccccc2nc1C(=O)Nc1cc(CN2CCN(CC)CC2)c(O)c(N2CCN(CC)CC2)c1,,Murepavadin,
CC[C@H](C)[C@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,gamma-Glutamylcysteine,
COc1ccc(CCNCC(O)COc2ccc(-c3ncco3)cc2)cc1OC,,2-(N-morpholino)ethanesulfonic acid,
C(#Cc1cccc(CN2CCCCC2)c1)CCN1CCCCC1,,Gabaculine,
O=C(c1ccccc1C(=O)N(CCCN1CCSCC1)CCc1c[nH]c2ccccc12)N(CCCN1CCSCC1)CCc1c[nH]c2ccccc12,,MK-3577,
C[C@@H](Nc1nc(-c2cccc(C(=O)O)c2)c[nH]c1=O)c1ccccc1,,"2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",
O=C(O)c1cc2ccc(-n3c(-c4cccc(Br)c4)n[nH]c3=S)cc2s1,,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",
CC(C)(C)NCC(O)c1ccccc1Cl,,tulobuterol,
O=C(c1cc2c(cc1-c1cccnc1)C(=O)N(c1cccc(-c3nncn3C3CC3)n1)C2)N1CCCC1,,Boscalid,
NC(=O)C[C@H](NC(=O)C1(NC(=O)[C@@H](CC(=O)O)Cc2ccc(CP(=O)(O)O)cc2)CCN(C(=O)NCCc2ccccc2)CC1)C(=O)NCCCc1ccc2ccccc2c1,,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",
O=C(O[C@@H]1[C@@H]2O[C@]2(CO)[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C[C@@H]12)[C@H]1[C@H](c2ccc(O)cc2)[C@H](C(=O)O[C@@H]2[C@@H]3O[C@]3(CO)[C@H]3[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)OC=C[C@@H]23)[C@H]1c1ccc(O)cc1,,Argenteoside B,
CSCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CSSSSC[C@@H]3NC(=O)[C@@H]4CCCN4C(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]4CSSSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CSSSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CC(N)=O)NC1=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CSSSSC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N4)NC3=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSSSC[C@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](CCCN=C(N)N)NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N2,,3-Hydroxypyruvic Acid,
COc1nc2ccc([C@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1OCC1CC1,,Compound 19,
CCn1c2ccccc2c2cc(/C=C/c3ccc4ccccc4[n+]3C)ccc21,,Met-33,
O=C(CSc1nnc(-c2ccc([N+](=O)[O-])cc2)n1-c1ccccc1)N1CCOCC1,,"1-(morpholin-4-yl)-2-{[5-(4-nitrophenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}ethanone",
O=C1c2ccccc2NC(c2ccccc2F)N1CCCCN1C(=O)c2ccccc2NC1c1ccccc1F,,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCCC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",
O=S(=O)([O-])CCCC[n+]1c(/C=C/c2c(-c3ccccc3)[nH]c3ccccc23)ccc2ccccc21,,Sul-49,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4C)c3)c2cc1OC,,2-Aminophenol,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)C[C@@H](N)CCCN(C)C)CC5)CCCC4)c3Cl)c2n1,,MK-7622,
O=C([O-])C[NH+](CP(=O)([O-])[O-])[C@@H]1CC(C(=O)[O-])=C[C@@H](OP(=O)([O-])[O-])[C@H]1O,,3'-1-carboxy-1-phosphonooxy-ethoxy-uridine-diphosphate-N-acetylglucosamine,
CCN1C(=O)c2cccc3c(NS(=O)(=O)c4cc(Br)ccc4OC)ccc1c23,,CXL-1020,
CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,,Repaglinide,
NCCCCCC(=O)NCc1cccnc1,,Rebimastat,
C=CC(=C)[C@H](O)C[C@@]1(C)[C@@H]2C[C@@H](O)C=C3[C@@H](OC(C)=O)O[C@@H](OC(C)=O)[C@]32[C@@H](OC(=O)CC(O)CCCCCCCCC)C[C@H]1C,,Pseudouridine-5'-Monophosphate,
Cc1c(Cl)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,2'-fluoro-5-ethylarabinosyluracil,
c1cc(OC[C@@H]2CN(C3CCCC3)CCO2)ccc1CN1CCOCC1,,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",
COCCC(=O)N1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,GDC-0623,
COc1cccc(CN2CCC(N3Cc4cccc(C(N)=O)c4C3=O)CC2)c1,,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE",
CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Anlotinib,
O=C1N(Cc2cccc3c2OCO3)CCCC12CCN(c1cnc3ccccc3n1)CC2,,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)O,,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",
O=C(NCC12CC3CC(CC(C3)C1)C2)c1ccc(CN2CCCCC2)cc1Cl,,Melengestrol,
CN(C)CCCOc1ccc(CN2CCCCC2)cc1,,GDC-0152,
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,,Entinostat,
CNCCC1CCc2ccccc21,,PF-04995274,
COc1ccc(Br)c2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nsnc5n4)CC3)CN(C)[C@@H]1C2,,S-Hydroxycysteine,
Cc1ncc(Cn2c(C)c(CCO)sc2=O)c(N)n1,,Thiamine thiazolone,
N=C(N)SCCCc1cnc[nH]1,,VUF 8328,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C,,"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",
CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1,,Anidulafungin,
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,,retinol,
COc1ccc(CN(CCN(C)CCNC(=O)c2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)c2ccccn2)cc1,,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,
CN(C)CCOc1ccc(-c2cc(-c3ccncc3)c(-c3ccc4c(c3)CCC4N=O)[nH]2)cc1,,"pyrrole-based compound, 13",
O=C(CCCCCl)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21,,PINADOLINE,
Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)c(C)c1,,Pyridoxamine,
COc1ccc(CCNCC(O)COc2ccc(COCc3ncc[nH]3)cc2)cc1OC,,Diazoxide,
CCCCC(=O)Nc1ccc2c(c1)nc(CCCC)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",
CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,,l-Menthol,
c1ccc2[nH]c(NC3CCCc4ccncc43)nc2c1,,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",
CC1=CCC2C(C1)c1c(O)cc(C/C=C/CCCC#N)cc1OC2(C)C,,3-Amino-Alanine,
COc1cc(NC(=O)c2cccc(-n3cc(NC(=O)Nc4cccc(C)c4)cn3)c2)cc(OC)c1OC,,1164153-22-3,
O=C(O)Cn1cnc2c(NC3CCCC3)nc(NCc3ccc(C4CCCCC4)cc3)nc21,,Estradiol sulfamate,
COc1cc(CNCc2cccs2)ccc1OCC(=O)N1CCOCC1,,Alcloxa,
N=C(N)NCCC[C@@H]1NC(=O)N2C3CCCCC3C[C@H]2C(=O)N2Cc3ccccc3C[C@@H]2C(=O)NCC[C@@H](NC(=O)CCc2ccccc2)C(=O)CCNC1=O,,Hypericin,
Nc1nc2[nH]c(SCc3c(F)cccc3F)nc2c(=O)[nH]1,,Edoxudine,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCN(CCO)CC1,,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,
CN1CCN(c2ccc([N+](=O)[O-])cc2NC(=O)c2cccnc2)CC1,,TAS-116,
CCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCC,,Lintitript,
Nc1nccc(-c2ccccc2)n1,,4-phenylpyrimidin-2-amine,
O=C(Nc1ccncc1)[C@@H]1C[C@H]1c1ccccc1,,4-methyl-umbelliferyl-N-acetyl-chitobiose,
O=C(NCCc1ccc(O)cc1)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1,,Niacinamide ascorbate,
c1cn(-c2ccc(OCc3ccc(CN4CCCCC4)cc3)cc2)cn1,,Citrulline,
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4)cc3)c3c(N)ncnc32)C1,,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,
COc1ccc(C[C@H](NC(=O)Nc2ccc3c(CN4CCCC4)cn(Cc4c(Cl)cccc4Cl)c3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCc2ccccc2)cc1,,6-Chloro-2-fluoropurine,
CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@]1(C)CCCCCCCCCCCC[C@](C)(NC(=O)[C@@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](CCC(N)=O)NC(=O)COCCOCCNC(=S)Nc2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O,,Histidine,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccncc3)cc2)cc1,,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",
COc1cccc(/C(=C/CNC(=O)C2CCC2)c2ccccc2)c1,,Praziquantel,
COc1nc2ccc([C@@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCC(O)(C(F)(F)F)CC1,,Isavuconazonium,
Cc1ccc(C(=O)NP(=O)(N2CCOCC2)N2CCOCC2)cc1,,"Carbacylamidophosphate, 4b",
O=C(O)c1cc(-c2ccc(CNC(=S)c3ccc(-c4ccc(C(=O)O)o4)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Coblopasvir,
O=C1c2cc(-c3cccnc3)c(OC3CCCC3)cc2CN1c1cccc(-c2nncn2C2CC2)n1,,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,CRA_9076,
c1ccc(-c2nnc(-c3ccncc3)o2)cc1,,"4-(5-phenyl-1,3,4-oxadiazol-2-yl)pyridine",
NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12,,sangivamycin,
O=C1C=CC2C(=C1)Oc1cc(O)ccc1C2c1cc(C(=O)NCCOCCOCCOCCn2cc(COc3ccc(N4CCN(C(=O)c5cc6c(s5)-c5ccccc5S(=O)(=O)C6)CC4)cc3)nn2)ccc1C(=O)O,,ML349-FL,
COc1ccc([N+](=O)[O-])cc1NC(=O)C(C)Oc1ccccc1C,,CBKinase1_012086,
O=C(O)CNC(=O)Cn1c2c(c3cc(Br)ccc31)CC[C@@H](C(=O)O)C2,,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",
CO[C@H]1C=CC=C(C)C(=O)Nc2cc(O)c(N=CCN(C)C)c(c2O)C[C@@H](C)C[C@H](OC)[C@H](NCCN(C)C)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,6-bromopurine,
Nc1nnc(N2CCN(CCOc3ccc(Br)cc3)CC2)[nH]1,,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",
COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4C4=C/C=C\C=C/C=C\4)CC3)nc(N)c2cc1OC,,N-acetylsulfanilyl chloride,
COc1cccc(OC)c1NS(=O)(=O)c1ccc(N=CC2C(=O)Nc3ccc4ncsc4c32)cc1,,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",
CCOC1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,Sulfinpyrazone,
CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](C[C@@H](C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1,,AKI-001,
COc1ccc(O)c(CCN)c1,,2-(2-aminoethyl)-4-methoxyphenol,
NCCCC[C@H](C(=O)NCc1ccc(CN)cc1)n1cccc1C(=O)NC(Cc1ccccc1)c1ccccc1,,Tarazepide,
O=C(Cn1c(=O)sc2ccc(Cl)cc21)Nc1ccc(C(=O)O)cc1,,Flumethasone,
CN(C)c1ccc(-c2ccc(C(=O)O)cc2)cc1,,4-[4-(dimethylamino)phenyl]benzoic acid,
CC1(C)O[C@H]2[C@@H]3OC4(CCCCC4)O[C@@H]3CO[C@@]2(COS(N)(=O)=O)O1,,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",
N#Cc1cnc2cc(OC[C@H](O)CO)c(NC(=O)C[C@H]3CCSS3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,,Hydrocortisone aceponate,
O=C1NC(=O)C(c2ccccc2)S1,,"5-phenyl-1,3-thiazolidine-2,4-dione",
CC[C@H](C)[C@H](OCc1ccccc1)[C@H]1[C@H]([N+](=O)[O-])[C@H](c2ccccc2)N[C@]1(C)C(=O)NCCCC(=O)O,,Tromantadine,
O[C@H](COc1ccccc1)[C@H]1CCCCN1,,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,
CCCCCCCc1ccc(C(=O)[O-])cc1,,4-heptylbenzoate,
C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,QRFCTGHFGGAYPCNGP,
Cc1ccsc1CN1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,4-hydroxybenzoic acid,
Nc1nc(=O)n(C2OC(COP(=O)(O)OP(=O)(O)O[P+]([O-])(O)O)C(O)C2O)cc1[N+](=O)[O-],,PU-H71,
CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCc1cccnc1,,Evodenoson,
C[C@@H](Nc1nc(-c2cccc(C(=O)NS(C)(=O)=O)c2)cnc1N)c1ccccc1,,Florfenicol,
COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCN1CCC(CO)CC1,,1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,
C[N+](C)(CC#CCOC1=NOCC1)CCCCCCNC(=O)c1cn(Cc2ccccc2)c2cc(Cl)c(F)cc2c1=O,,ATL-2502,
O=C(Cc1ccc(-c2cnc3[nH]ncc3c2)cc1)Nc1cc(C2(C(F)(F)F)CC2)on1,,"US9725465, Example 15",
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)CCCCC[N+](C)(C)C)CC5)CCCC4)c3Cl)c2n1,,SB-409513,
COc1cc(CC(C)N)cc(OC)c1OC,,"3,4,5-TRIMETHOXYAMPHETAMINE",
O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(Oc2ccccc2)nc1,,Phosphonopyruvate,
O=C(Nc1ccc(OCC(=O)N2CCOCC2)cc1)c1ccccc1F,,Ricolinostat,
COc1nc2ccc([C@](O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OC(C)C,,(4-Hydroxymaltosephenyl)Glycine,
O=c1[nH]cnc2c(CN3CCCC3)c[nH]c12,,Netazepide,
O=C(O)c1cc(Br)cc2c(=O)cc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)oc12,,3-Methoxybenzamide,
Cn1ccc2c3c(ccc21)N(C(=O)Nc1cccnc1)CC3,,Genz-10850,
Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)COCC5)ccc3C)ccc2n1,,Naxifylline,
C[C@H](NC(=O)CNC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,N-acetyltyrosine,
O=C1CC[C@](CCN2CC(N3CCOCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1C1(C2CC2)CCCC1,,Dexlansoprazole,
CS(=O)(=O)N1CCN(C2CN(CC[C@]3(c4ccc(Cl)c(Cl)c4)CCC(=O)N(CC4CC4)C3)C2)CC1,,6-hydroxydopa quinone,
O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1ccccc1,,Pipotiazine,
COc1ccc(C(=O)CSc2nnc(-c3ccc(OC)c(OC)c3)n2-c2ccccc2)cc1,,324052-32-6,
O=C1NC(=O)C(Cc2ccccc2)N1,,5-Benzylhydantoin,
O=C(N[C@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O)OCC1c2ccccc2-c2ccccc21,,Fmoc-D-Tyr(PO3H2)-OH,
O=c1[nH]c(=O)c2[nH]c(=O)n(C[C@@H](O)[C@H](O)[C@H](O)CO)c2[nH]1,,3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,
CCN(CC)c1nc2scc(C)c2c(=O)o1,,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,
COc1ccc2c(c1)CCN(C)CCCc1ccccc1C2,,GSK-1521498,
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(CNC(N)=O)cc1)NC(=O)[C@H](Cc1ccc(NC(=O)[C@H]2CC(=O)NC(=O)N2)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O,,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",
COc1cccc(NC(=O)NCCCOc2cccc(CN3CCCCC3)c2)c1,,4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide,
Nc1ncc2c(n1)-c1ccoc1CC2,,"5,6-dihydrofuro[2,3-h]quinazolin-2-amine",
c1ncc(CC2CCN(CCCOc3ccc(CN4CCCCC4)cc3)CC2)[nH]1,,Phenglutarimide,
CN1C(=O)[C@H]2CCC[C@H]2N(C2CCCC2)c2nc(Nc3ccc4ncccc4c3)ncc21,,OTX-008,
CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]1(C)CCCCCCCC[C@@](C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(C)C)NC1=O,,Balhimycin,
Cc1ccc(C[n+]2csc(CCO)c2C)c(N)n1,,13857-23-3,
CC(C(=O)O)N1C(=O)/C(=C2/C(=O)Nc3ccccc32)SC1=S,,928339-88-2,
Cc1ccc(F)c(CSc2nc3c(=O)[nH]c(N)nc3[nH]2)c1,,Acefylline,
CC(C)C[C@H](NC(=O)Cc1ccc(C(=O)O)c(OCCF)c1)c1ccccc1N1CCCCC1,,Guanine,
O=C1c2ccccc2NC(c2ccccc2F)N1CCOc1ccc(N2C(=O)c3ccccc3NC2c2ccccc2F)cc1,,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",
CN(c1ncccc1CNc1ncnc2[nH]ccc12)S(C)(=O)=O,,Selenium (75Se) norcholesterol,
CC(=O)NCc1ccc(C[C@@H](NC(=O)[C@H](Cc2ccc(NC(=O)[C@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1,,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",
NC(=O)c1nnc2ccccc2c1N,,4-aminocinnoline-3-carboxamide,
c1ccc(Cn2c(-c3ccc(OC[C@H](C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,,Deltarasin,
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,,etoposide,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC/C=C\CCCCCCN(CC(N)=O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,Zidovudine diphosphate,
CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)NCC(=O)N1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,NSFCRGRPGHFGGCYLF,
CC(C)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,,Pantothenyl-Aminoethanol-Acetate Pivalic Acid,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Dropropizine,
COc1ccc(CCNCC(O)COc2ccc(-c3nccn3C)cc2)cc1OC,,PSI-352938,
O=C(COc1ccccc1)N1CCOCC1,,4-Phenoxyacetylmorpholine,
N#Cc1c(-c2cc(Cl)ccc2Cl)cc(-c2cc(C3CCCCC3)ccc2O)[nH]c1=O,,Octopamine,
CC(C)CCCC1(C)CCc2cc(N)ccc2O1,,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",
Cc1cc(C)c2cc1C(=O)NCCCCCOc1cccc(c1)Sc1cc-2nc(N)n1,,Hispidulin,
C#C[C@]1(O)CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,,"17-alpha-Pregn-5-en-20-yne-3-beta,17-beta-diol",
CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=O)c1c(C(=O)ON2C(=O)CCC2=O)cccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)O,,AVPIAQKSEK-FAM,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2c1nc(S(C)=O)n2C,,Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide,
Nc1nc2[nH]c(SCc3cccc(Cl)c3)nc2c(=O)[nH]1,,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccnc4C)c3)c2cc1OC,,Oftasceine,
C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1,,CRA_1801,
Cc1cc(OCC(=O)N2CCOCC2)cc(C)c1Cl,,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,
Nc1nc(-c2nc3ccccc3[nH]2)cs1,,"4-(1H-benzimidazol-2-yl)-1,3-thiazol-2-amine",
Cc1[nH]nc2c1C(c1cccc3nonc13)C1=C(CC(C)(C)CC1=O)N2,,Satavaptan,
CCn1c(/C=C/C=C2\N(C)c3ccccc3C2(C)C)[n+](CC)c2nc3ccccc3nc21,,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,
O=C(O)c1cc(-c2ccc(CNC(=S)c3ccc(Br)cc3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,2-Amino-Vinyl-Phosphate,
Cc1cc(CC=Nc2cc(O)c3cccnc3c2O)cc(C)c1O,,Rifalazil,
CN1C[C@H](COC(=O)C2CC2)C=C2c3cccc4[nH]cc(c34)C[C@H]21,,Befunolol,
COc1ccc(Cn2ccc(C)c(NC(=O)C(Cc3ccc(CC(=O)O)cc3)NC(C)=O)c2=O)cc1,,Difenpiramide,
CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12,,Phenindamine,
NCC(O)(c1ccccc1)c1ccc(F)cc1Cl,,3-Methylphenylalanine,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)CCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Oxybutynin,
NC(=O)c1cc[n+](CC[n+]2cccc(NC(=O)/C=N\O)c2)cc1.[Br-].[Br-],,Gemcitabine elaidate,
C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC,,thapsigargin,
CN(C)[C@H]1CN(Cc2c(F)cccc2Br)C[C@@H]1c1ccccn1,,Glycinamide Ribonucleotide,
COc1ccc(-c2[nH]c(=O)c3cc(F)ccc3c2OCCN)cc1F,,Piclidenoson,
COc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCCC2)c1,,Testosterone cypionate,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(OCc4ccccc4)nc3)cc2)cc1,,Onvansertib,
O=S(=O)(CCCN1CCC(Cc2cnc[nH]2)CC1)c1ccccc1,,p-Coumaric acid,
O=C(NO)[C@@H]1O[C@H]2CN(Cc3ccccc3)C(=O)[C@@H]1O2,,3-Oxiran-2ylalanine,
Nc1nc2[nH]c(SCc3ccc(F)cc3)nc2c(=O)[nH]1,,"Biphenyl-2,3-Diol",
COc1ccccc1CN1C[C@H](c2cn(C)c3ccccc23)[C@@H](N(C)C)C1,,"(3r,4s)-1-[(2-Methoxyphenyl)methyl]-N,N-Dimethyl-4-(1-Methylindol-3-Yl)pyrrolidin-3-Amine",
CC(=O)c1cccc(NC(=O)c2c(-n3cnnn3)sc(C)c2C)c1,,"7-methyl-7,8-dihydroguanosine-5'-diphosphate",
Cn1ccnc1C(=O)Nc1cccnc1,,4-[3-carboxymethyl-3-(4-phosphonooxy-benzyl)-ureido]-4-[(3-cyclohexyl-propyl)-methyl-carbamoyl]butyric acid,
CC(=O)NCc1ccc(-c2scnc2C)cc1,,5-Exo-Hydroxycamphor,
CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCCc2ccccc21,,5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate,
CC(C)c1ccccc1OCC(=O)N1CCOCC1,,ABL-001,
COc1cccc(OC)c1-c1cc(C)nc(N)n1,,hsp90_70,
Cc1ccc2c(c1)C(Nc1nc3ccccc3[nH]1)CCC2,,Iocarmic acid,
c1ccc(Cn2c(-c3ccc(OCC(CC4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,,PF-04991532,
CO[C@@H]1OC[C@@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-],,AZD-1656,
COc1ccccc1CN(C[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CN1CCN(c2ccccc2)CC1)C(C)=O,,Simvastatin,
O=C1Nc2ccccc2/C1=C1/SC(=S)N(C(Cc2ccc(O)cc2)C(=O)O)C1=O,,"Thiazolidinone core, 20",
Cc1c(Cc2cncnc2N)csc1CCO,,Daclatasvir,
Clc1ccc(CNCCCCCc2cnc[nH]2)cc1,,Ethyl ferulate,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]([C@H](C)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CCN4CCCCC4)cc23)[nH]n1,,Dihydro-alpha-ergocryptine,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)on4)c3)c2cc1OC,,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,
CCCN(CCc1ccc(Cl)c(Cl)c1)CC(O)c1cccnc1,,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",
Cc1ccc(-c2ncc(OC[C@H]3CCNC3)cc2-c2ccc(C#N)cc2)cc1,,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(F)F)nn4-c4ccccc4)c3)c2cc1OC,,"1-(3-(1,1-difluoroethyl)-1-phenyl-1H-pyrazol-5-yl)-3-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)urea",
c1ncc(CC2CCN(CCCOc3ccc(CCN4CCCCC4)cc3)CC2)[nH]1,,N-(1-PHENYL-PROPYL)-FORMAMIDE,
CCn1c2ccccc2c2cc(/C=C/c3ccc4ccccc4[n+]3CCCCCC(=O)NCCN)ccc21,,AZD-4547,
CCCCCCSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,,s-hexylglutathione,
C[n+]1c(CCCOc2ccc(Cl)cc2)cccc1CCCOc1ccc(Cl)cc1,,Isocitric Acid,
CC/C(C)=N\OCC(O)CNC(C)(C)C,,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C,,Tecadenoson,
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(CF)CF)nn4-c4ccccc4)c3)c2cc1OC,,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",
Nc1ncc(-c2cncc(NS(=O)(=O)c3ccccc3)c2)cn1,,L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal,
CC(=O)NCCCCCC(=O)N[C@H](CCCCN)C(=O)NCCCCCC(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O,,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",
COC(=O)c1c(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)no[n+]1[O-],,CRA_10991,
CCCCSC(=O)C1CC(=O)NC(=O)C1,,2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid,
CSc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,6-Methylmercaptopurine riboside,
COc1ccc(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)cc1,,5-beta-D-ribofuranosylnicotinamide adenine dinucleotide,
CC(C)(C)OC(=O)N[C@H](CSCCC(=O)NCc1cccnc1)Cc1ccccc1,,Hydrogenobyrinic acid,
COc1cc2c(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCN(C)CC1,,Midecamycin,
COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(N)=O)c2cc(-c3cccs3)ccc2n1,,Ethosuximide,
CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)c1ccccc1,,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",
Cc1cccc(CN2CC(CCN3CC(N4CCOCC4)C3)(c3ccc(Cl)c(Cl)c3)CCC2=O)c1,,Censavudine,
O=C(Nc1ccncc1)C1c2ccccc2Oc2ccccc21,,N-(pyridin-4-yl)-9H-xanthene-9-carboxamide,
COC(=O)Cn1nc(-c2ccccc2)cc(-c2ccc3c(c2)OCO3)c1=O,,Tenapanor,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(CC(=O)O)cc2)NC(=O)Cc2cccc3ccccc23)cc1,,Odanacatib,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)C[C@@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3cc(c2)C(=O)NC[C@H](NC(=O)[C@@H](C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)CNC3=O,,Urea C-13,
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,,Rosuvastatin,
N#Cc1cc(C(=O)O)c(O)c(Br)c1N,,"(2S)-2-amino-3-phenylpropane-1,1-diol",
COc1cc2ncnc(Oc3ccc(F)c(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OC,,SGS-742,
COc1nc2ccc([C@@](O)(c3ccc(C(F)(F)F)nc3)C3CN(C(C)=O)C3)cc2c(Cl)c1CN1CCC(C(F)(F)F)CC1,,"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene",
CCCc1nc(N)ncc1C(=O)OCC,,Ethyl 2-amino-4-propylpyrimidine-5-carboxylate,
O=c1cc(-c2ccccc2)oc2cc(O)ccc12,,7-Hydroxyflavone,
Cc1nc(C(=O)N2CCC[C@H]2Cc2nnc(-c3ccccc3)o2)c(-c2ccccc2F)s1,,SB-674042,
Nc1cccc(OCC(=O)N2CCOCC2)c1,,184944-87-4,
Nc1nc(Nc2cccc(F)c2)c2[nH]cnc2n1,,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,
Cc1occ2c1C(=O)c1c(O)ccc(O)c1C2,,150045-18-4,
CC[C@H](C)[C@H](NC(=O)[C@@H](NC[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)O,,85139-12-4,
O=C(O)c1cc(-c2ccc(C(=S)NCc3cccc(-c4ccc(C(=O)O)o4)c3)cc2)n(-c2ccc(Cl)c(Cl)c2)n1,,Clocortolone acetate,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,"(1R)-2-[(Diaminomethylene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl nicotinate",
CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2CCCCCCCC2)cc1,,Glutathione S-atrazine,
NC(=NCCc1cnc[nH]1)NC(=O)CC(c1ccccc1)c1ccccc1,,UR-PG153,
Cc1ccc([C@H]2C(=O)N([C@H]3CC[C@H](N)CC3)[C@H]2c2ccc(C#N)cc2)cc1,,Henatinib,
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cccnc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O,,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",
COCCNc1nc(-c2cccc(C(=O)O)c2)cnc1N,,Deutivacaftor,
COc1cc2nc(-c3ccc(CC(=O)Nc4cc(C5(C(F)(F)F)CC5)n[nH]4)c(F)c3)cnc2cc1OCCN1CCOCC1,,BMS-830216,
COc1ccc(CN(CCN(C)CCCCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)c2ccccn2)cc1,,D-Glycero-D-Mannopyranose-7-Phosphate,
COc1ccc(CN(CCN(C)CCCCCCNC(=O)CCCCCNc2ccc([N+](=O)[O-])c3n[o+][n-]c23)c2ccccn2)cc1,,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",
CC(C)C(NC(=O)OCCCc1cnc[nH]1)C(C)C,,Iguratimod,
O=C(O)Cn1c2ccccc2c2nnc(S)nc21,,309283-89-4,
C[C@H](NC(=O)c1ccc(S(N)(=O)=O)cc1)C(=O)O,,Micafungin,
NC(N=NCc1ccc(-c2cccc([N+](=O)[O-])c2)o1)=N[N+](=O)[O-],,2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,
CC(C)(C)C(=O)CN1C(=O)N(CC(=O)Nc2cccc(CCC(=O)O)c2)C(=O)N(C2CCCCC2)c2ccccc21,,Roquinimex,
COc1nsnc1OCCOCCOCCOCCOCCOc1nsnc1C1=CCCN(C)C1,,Fentonium,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1C1CCCC1,,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",
Nc1ccn([C@@H]2O[C@H](CNC(=O)c3cn4ccsc4n3)[C@@H](O)[C@H]2O)c(=O)n1,,Carphenazine,
Cc1nc(N)[se]c1CCN,,Amselamine,
CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](C(=O)N[C@H]1CC(=O)NCCC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](c2cccnc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)c1cccnc1,,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,
Cc1nc[nH]c1CSCCNC(=N)SCCCc1cnc[nH]1,,Adenosine-5'-Rp-Alpha-Thio-Triphosphate,
CC1(C)O[C@@H]2CO[C@@]3(CNS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",
C=C1C(=O)O[C@@H]2C3[C@@H](C)[C@@H](OC(=O)c4cccc(I)c4)CC[C@]3(C)CC[C@@H]12,,"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",
O=C(CCN1CCC(Cc2cnc[nH]2)CC1)Nc1ccc(Cl)cc1,,Cyclopenthiazide,
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C,,Metandienone,
CCNC(=S)NCCc1cnc[nH]1,,Octylphenoxy polyethoxyethanol,
COc1nc2ccc([C@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CC1CC1,,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",
O=C1CCC(CCN2CC(N3CCNCC3)C2)(c2ccc(Cl)c(Cl)c2)CN1CC1CC1,,Cyclandelate,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,N-(Phosphonoacetyl)-L-Ornithine,
CO[C@H]1CC(C)=Cc2c(O)c(cc(O)c2N2CCC2)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)C(C)CC(C)=C1N=O,,Onalespib,
O=C(NC1CC2CCC1C2)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Oxidized Acetyl Dithranol,
C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)c2cc3cc(c2)C(=O)NC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CNC3=O)NC(=O)CCNC1=O,,GSK-364735,
CC(C)C[C@@H]1NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC1=O,,Leptazoline C,
CC[C@H](C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]2CSSC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,LY-2334737,
CCOC(=O)CNC(=O)OC[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)COc1ccc2ccccc2c1)C(C)C)[C@@H](C)O,,Etoposide,
CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]2CSSC[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,,(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,
CC(C)C[C@H](NP(=O)([O-])O[C@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)[O-],,Vanillic acid,
CO[C@H]1CC(C)=Cc2c(O)c(cc(O)c2N2CCC2)NC(=O)C(C)=CC=C[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)C1=O,,N-phenyl-1H-pyrazole-3-carboxamide,
CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O,,Pterin-6-Yl-Methyl-Monophosphate,
Cc1c(-c2ccc3c(cnn3C)c2)nc2ccc(C(O)(c3cccnc3)c3cccc(Cl)c3)cc2c1Cl,,alpha-D-arabinofuranose,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)C[C@H]4CO)cc3)nn3cccc23)n[nH]1,,2-(Trimethylammonium)Ethyl Thiol,
O=C(CSc1ccccc1)N1CCOCC1,,Cellotetraose,
CO[C@@H]1[C@@H](OC(N)=O)[C@H](O)[C@@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,,YJQPYGGHQPGBLI-FWPHEPGVSA-N,
COc1ccc2c(c1)CCCN(C)CCc1ccccc1C2,,Clenbuterol,
CSC(=N)NCCSCc1[nH]cnc1C,,Methyprylon,
Cc1cc(C)c(C#N)c(N2CCOCC2)n1,,142591-26-2,
O=P(O)(O)[C@H](NCCc1ccc(F)cc1)c1ccc(F)cc1,,Perillyl alcohol,
CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,,Malonyl-CoA,
CCN(CC)C(=O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1,,Fluazuron,
NC(=NCCCc1cnc[nH]1)NC(=O)CCCc1ccccc1,,UR-AK67,
CC(C)c1cc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)on1,,Estradiol cypionate,
COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2Br)cc1OC,,Arginine glutamate,
CC(C)CCCC1(C)CCc2cc(S(N)(=O)=O)cc(F)c2O1,,N-hexanoyl-L-homocysteine,
COc1c(C(C)=O)c(OCCOCCOc2c(C(C)=O)c(OC)c3ccoc3c2OC)c(OC)c2occc12,,Triamcinolone,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)C(C)C)C(N)=O,,Oxazepam acetate,
Cc1c(CNC(CO)CO)c(O)[nH]c(=O)c1C#N,,Roflumilast,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCC=CCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,LY-2881835,
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)CCCNC(=O)c1cc(N=C=S)ccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12)C(=O)N[C@@H](CO)C(N)=O,,Mesalazine,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cncc3C)cc2)cc1,,Myxopyronin B,
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,,Fructose,
O=C(O)CCCC/C=C(\c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1,,sn-glycero-3-phosphoethanolamine,
CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1,,Hopantenic acid,
COc1c(C(C)=O)c(OCc2ccc(COc3c(C(C)=O)c(OC)c4ccoc4c3OC)cc2)c(OC)c2occc12,,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",
COc1cc(CC(C)N)c(OC)cc1Br,,Brolamfetamine,
O=C(OCCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCCOC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O)c1ccc(S(=O)(=O)F)cc1,,Abrocitinib,
c1cc(OCC2CN(C3CCCC3)CCO2)ccc1CN1CCCC1,,Bendamustine,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,L-serine O-sulfate,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(CNC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)CO,,HKI-357,
c1cc(-c2nc(SCCCN3CCCCC3)nn2CCCN2CCCCC2)ccn1,,Sodium oxybate,
COc1nc2ccc([C@](O)(c3ccnc(C(F)(F)F)c3)c3cncn3C)cc2c(Cl)c1CN1CCn2c(nnc2C(F)(F)F)C1,,"US10201546, Example 189b",
COc1cc2c(cc1-c1cccnc1)C(=O)N(c1cccc(-c3nncn3C3CC3)n1)C2,,Fluconazole,
CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CCC(=O)CC1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)O,,Clazosentan,
COc1ccc(NC(C)=O)cc1Cl,,N-(3-CHLORO-4-METHOXYPHENYL)ACETAMIDE,
COCCOc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(F)F)no4)c3)c2cc1OC,,"US9730937, Example 211",
COc1nc2ccc([C@](O)(c3cnnn3C)c3cnc(C)n3C)cc2c(Cl)c1CN1CCC(n2cccn2)CC1,,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,
NS(=O)(=O)c1ccc2nc3n(c2c1)N=S=C3Cl,,Hydroxyprogesterone,
Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1,,Danofloxacin,
Nc1cncc(-c2cnc(N)nc2)c1,,Rifabutin,
CC(C)Cn1c(=O)n(C2CCN(C(=O)C3CCN(Cc4ccnc(N)c4)CC3)CC2)c2ccc(F)cc21,,Aspartate Beryllium Trifluoride,
CNC(C)[C@H]1CCC(N)[C@@H](O[C@@H]2C(N)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1,,N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,
CC(C)N1CCC(N2Cc3cccc(C(N)=O)c3C2=O)CC1,,Indigotindisulfonic acid,
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)COCC(=O)Nc2ccc(CCC(=O)N3CCC3=O)cc2)C(=O)N1)C(C)C)C(N)=O,,Cilastatin,
O=C([O-])CC1Sc2nnc(COc3ccc(Cl)cc3)n2N=C1c1cccs1,,Loxoprofen,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCNCC4)c3Cl)c2n1,,Eplerenone,
Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NCCCCCC(=O)NCc2ccccc2)[C@@H](O)[C@H]1O,,Zenarestat,
Nc1nc2[nH]c(SCCO)nc2c(=O)[nH]1,,Eosin,
O=C(O)c1sc2cc(-n3c(C4CCCCC4)n[nH]c3=S)ccc2c1Cl,,Tanaproget,
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3nncn3C)cc2)cc1,,Bosentan,
CCCCCC#CCc1cc(O)c2c(c1)OC(C)(C)C1CC=C(C)CC21,,Procainamide,
c1ccc(Cn2c(-c3ccc(OCC(C4CCCCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,,6-Bromo-1-hexanol,
CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,,metergoline,
O=C(O)CCC/C=C\C[C@H]1COCO[C@@H]1c1ccccc1,,Ataciguat,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(-c5ccccn5)c5cc(F)ccc54)CC3)CC2)ccn1,,2-phospho-D-glyceric acid,
CN1CCN(c2ccc(C3CC3)cc2NC(=O)c2ccccc2Cl)CC1,,B-nonylglucoside,
O=C(/C=C/c1ccc[n+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,,Propafenone,
CC(C)n1ccc2cc3c(cc21)CCN3C(=O)Nc1cccnc1,,"6-(adenosine tetraphosphate-methyl)-7,8-dihydropterin",
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4F)c3)c2cc1OC,,"(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",
COc1nc2ccc([C@@](O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1CN1CCC(F)(F)CC1,,Tocainide,
C[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)CN(C(=O)[C@@H]2CCCN2C(=O)CCCCNC(=S)Nc2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)CCCCC=CCCCCCCN(CC(=O)N[C@@H](CCC(=O)O)C(N)=O)C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O,,4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid,
O=C1c2ccccc2NC(c2ccccc2F)N1c1ccc(OCCn2ccnc2)cc1,,Levorphanol,
CC[C@H](C)[C@@H]1NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@H]([C@H](C)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CN)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",
Cc1cc(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)ccc1OCC(=O)N1CCOCC1,,GDC-0927,
CCCCN(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ncnc2ccc(C(=O)OC)cc12,,Indapamide,
CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O,,Adenosine 5'-methylenediphosphate,
Cc1[nH]n(C(=O)c2ccc(C(C)(C)C)cc2)c(=O)c1N=Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,,"3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid",
CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC,,"Dibenzofuran-4,6-Dicarboxylic Acid",
C/C(=C\[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](N(C)CCO)C(C)(C)c1ccccc1)C(C)(C)C)C(=O)O,,L-Lactic acid,
COc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]cc21,,Martinostat,
COc1nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c(Cl)c1OCC(F)(F)F,,"US10201546, Example 98",
CC(C)(C)NCC(O)c1ccc(O)c(C(N)=O)c1,,22560-59-4,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCC1CC1(F)F,,"US10201546, Example 56a",
CCOc1ccc(C(C)=O)cc1Cc1c(O)nc(N)nc1O,,CS55,
COc1ccc(CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(C(=O)C(=O)O)cc2)NC(C)=O)cc1,,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,
COc1cc([C@H]2OC[C@@H]3[C@@H](c4cc(OC)c(O)c(OC)c4)OC[C@H]23)cc(OC)c1O,,(+)-Syringaresinol,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O,,Ceritinib,
CCc1ccccc1OCC(=O)N1CCOCC1,,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",
O=C(O)c1ccc2oc(-c3cccc(/C=C/c4ccc5ccccc5n4)c3)cc(=O)c2c1,,PF-114,
COc1cc(C)c(O)cc1CC(C)N,,Thiorphan,
Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@H](CCCCN(C)C)N(C)C)CC5)CCCC4)c3Cl)c2n1,,Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide,
N=C(N)NCCCC(COC(N)=O)NC(=O)OCC(N)CCCNc1c(N)c(=O)c1=O,,benzyl (2-oxopropyl)carbamate,
CC(C)[C@@H]1NC(=O)CCCC/C=C/C=C/CCOC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC1=O,,N-Acetyl-Serine,
O=C(C1CC1)N1CCC[C@@H](Nc2cc(-n3c(-c4ccc5ccccc5c4)nc4cc(O)ccc43)ccn2)C1,,3-(cyclohexylamino)propanesulfonic acid,
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O,,Myristoyl-Coa,
Cc1cccc(-n2nc(C(=O)O)cc2-c2ccc(OCc3ccc(-c4ccc(C(=O)O)o4)cc3)cc2)c1,,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",
CC(C)Oc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",
O=C(O)CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)SC1=S,,"[(5Z)-4-oxo-5-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",
Cn1cc(C#N)cc1-c1c2c(=O)n(C)c(=O)n(CC3CC3)c2nn1Cc1ccnc2ccc(Cl)cc12,,946411-72-9,
CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,,cid_4507,
O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,Galunisertib,
CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccc(NC(=O)Nc2ccccc2Cl)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc1ccc(C)cc1)C(N)=O,,Pemirolast,
COc1c(OCc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)cc(C)nc1C,,ME-3221,
Cc1ccccc1NC(=O)CC12CC3CC(CC(C3)C1)C2,,Smilagenin,
C/C(CC1CC1)=N/OCC(O)CNC(C)(C)C,,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",
NC[C@H]1CC[C@H](C(=O)O)CC1,,tranexamic acid,
COc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCN(C)CC1,,7-cyano-7-deazaguanine,
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,,[L-Tic7]OT,
COc1cc(OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CNc2cc(F)cc(-c3ccc(C(=O)O)cn3)c2)c(Cl)cc1NC(=O)CSc1ccccn1,,"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide",
COc1ccc(Nc2nc(N)nc3nc[nH]c23)cc1OC,,Deferitazole,
Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(-c5ncccn5)c5cc(F)ccc54)CC3)CC2)ccn1,,Diethylamino hydroxybenzoyl hexyl benzoate,
CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",
Cc1ccc2c(ccn2C[C@@H]2C/C=C/[C@H](c3ccc(NC(=O)C(=O)O)cc3)[C@H](CC(=O)O)C(=O)NC3(CCCCC3)C(=O)N[C@@H](CC(N)=O)C(=O)NC2)c1,,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",
C/C(=N/OCC(O)CNC(C)(C)C)C(C)C,,VX-702,
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)O,,AMG-510,
COc1nc2ccc(C(O)(c3ccc(C)nc3C)c3cnnn3C)cc2c(Cl)c1OC1CCOCC1,,Lansoprazole,
C[C@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CCC2=O,,equilin,
COc1cc(Nc2nc(N)nc3nc[nH]c23)cc(OC)c1OC,,Sulfadimethoxine,
Fc1ccc(Br)c(F)c1C1CC(c2cccc(Br)c2)Nc2nnnn21,,Allantoin,
CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,"D-gluconhydroximo-1,5-lactam",
O=c1cc(O)cc2oc(C(c3ccccc3)c3ccccc3)c(O)c(O)c1-2,,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",
CCOc1nc2ccccc2nc1C(=O)N1CCN(c2ccc(OC)cc2)CC1,,S-(3-Iodobenzyl)glutathione,
O=C(O)c1cccc(-c2cc(C(=O)O)nn2-c2ccc(Cl)c(Cl)c2)c1,,Piboserod,
NS(=O)(=O)c1ccc(C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)cc1,,"Inositol 1,3-Bisphosphate",
Nc1ncnn2cccc12,,"pyrrolo[2,1-f][1,2,4]triazin-4-amine",
N=C(NCCCc1cnc[nH]1)NCCC(c1cccc(N)c1)c1ccccn1,,2-Tridecanoyloxy-Pentadecanoic Acid,
COCCOc1cc2ncnc(Sc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)c3)c2cc1OC,,Echinomycin,
CCCCCCCN(CCc1ccc(OCC(=O)[O-])cc1)c1nc2ccccc2o1,,(S)-iclaprim,
NS(=O)(=O)c1ccc(NN=C2C(=O)Nc3ccc(C(=O)NCCc4cnc[nH]4)cc32)cc1,,GW300660X,
COc1nc2c(C)cc(C(O)(c3c(C)nn(C)c3C)c3cnc(C)n3C)cc2c(Cl)c1OCC(F)(F)F,,"US10201546, Example 220",
CCOc1nc2ccccc2nc1C(=O)Nc1ccc(O)c(CN2CCNCC2)c1,,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",
C[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21,,Bolasterone,
Fc1cc(Cl)cc(Nc2ccc3nonc3c2)c1,,Relenopride,
COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OC1CCCN(C)C1,,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,
Cc1ccc(C(=O)N2CC3CNCC(C2)O3)cc1C(=O)NCC12CC3CC(CC(C3)C1)C2,,Pyridoxal,
C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1,,IPI-549,
O=C(CN1CCOCC1)N[C@@H]1CCC[C@H](Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2F)C1,,Tryptophan,
CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,,Luminespib,
OB1OCc2cc(F)ccc21,,Tavaborole,
COC(=O)c1ccccc1OCC(O)CNC(C)C,,Butylene glycol,
CCCCCCC[N+](CC)(CC)CC#Cc1ccc(Cl)cc1,,Milrinone,
CCOc1c(Cl)nc2ccc(C(O)(c3ccc(C(F)(F)F)nc3)c3cncn3C)cc2c1Cl,,"US10201546, Example 46",
COc1nc2ccc([C@@](O)(c3ccc(Cl)cc3)c3cncn3C)cc2c(Cl)c1CC(F)(F)F,,Adenosine-5'-Propylphosphate,
COC(=O)c1onc(-c2ccccc2OCc2ccc(Br)cc2)c1C(=O)OC,,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",
